Accession,Subtype,SamplingYear,PubMedID,Title,Authors,PubYear
K03455,B,,2578615,"Complete nucleotide sequence of the AIDS virus, HTLV-III","Ratner,L., Haseltine,W., Patarca,R., Livak,K.J., Starcich,B., Josephs,S.F., Doran,E.R., Rafalski,J.A., Whitehorn,E.A., Baumeister,K., Ivanoff,L., Petteway,S.R. Jr., Pearson,M.L., Lautenberger,J.A., Papas,T.S., Ghrayeb,J., Chang,N.T., Gallo,R.C. and Wong-Staal,F.",1985
A07108,D,1983,,"Variants of lav viruses, their dna- and protein components and their uses, particularly for diagnostic purposes and for the preparation of immunogenic compositions","Alizon,M., Sonigo,P., Wain-Hobson,S. and Montagnier,L.",1988
A07116,A1DK,1985,,"Variants of lav viruses, their dna- and protein components and their uses, particularly for diagnostic purposes and for the preparation of immunogenic compositions","Alizon,M., Sonigo,P., Wain-Hobson,S. and Montagnier,L.",1988
A34828,D,1983,,"HIGHLY CYTOPATHOGENIC HIV-NDK RETROVIRUS, DNA FRAGMENTS OF THIS RETROVIRUS, METHOD FOR PREPARING A PROTEIN AND/OR AN ENZYME OF THIS VIRUS, AND THE APPLICATIONS OF THESE",,1990
AB023804,C,1993,10505681,An infectious DNA clone of HIV type 1 subtype C,"Mochizuki,N., Otsuka,N., Matsuo,K., Shiino,T., Kojima,A., Kurata,T., Sakai,K., Yamamoto,N., Isomura,S., Dhole,T.N., Takebe,Y., Matsuda,M. and Tatsumi,M.",1999
AB032740,01_AE,1995,11429129,Full-length sequences of two CRF01_ae (subtype e) HIV type 1 isolates from 1995 samples of patients with sexually transmitted diseases in Thailand,"Auwanit,W., Mukai,T., Ayuthaya,P.I., Kurata,T. and Ikuta,K.",2001
AB032741,01_AE,1995,11429129,Full-length sequences of two CRF01_ae (subtype e) HIV type 1 isolates from 1995 samples of patients with sexually transmitted diseases in Thailand,"Auwanit,W., Mukai,T., Ayuthaya,P.I., Kurata,T. and Ikuta,K.",2001
AB049811,02_AG,1997,11375062,"Isolation and characterization of a full-length molecular DNA clone of Ghanaian HIV type 1 intersubtype A/G recombinant CRF02_AG, which is replication competent in a restricted host range","Kusagawa,S., Takebe,Y., Yang,R., Motomura,K., Ampofo,W., Brandful,J., Koyanagi,Y., Yamamoto,N., Sata,T., Ishikawa,K., Nagai,Y. and Tatsumi,M.",2001
AB052995,01_AE,1993,11356968,Augmentation of human immunodeficiency virus type 1 subtype E (CRF01_AE) multiple-drug resistance by insertion of a foreign 11-amino-acid fragment into the reverse transcriptase,"Sato,H., Tomita,Y., Ebisawa,K., Hachiya,A., Shibamura,K., Shiino,T., Yang,R., Tatsumi,M., Gushi,K., Umeyama,H., Oka,S., Takebe,Y. and Nagai,Y.",2001
AB070352,01_AE,1993,11839144,Isolation and characterization of replication-competent molecular DNA clones of HIV type 1 CRF01_AE with different coreceptor usages,"Kusagawa,S., Sato,H., Tomita,Y., Tatsumi,M., Kato,K., Motomura,K., Yang,R. and Takebe,Y.",2002
AB078005,B,1997,12402946,Isolation and characterization of an infectious HIV type 1 molecular clone from a patient with primary infection,"Takeuchi,H., Suzuki,Y., Tatsumi,M., Hoshino,H., Daar,E.S. and Koyanagi,Y.",2002
AB097865,01B,2000,,High prevalence of diverse forms of HIV-1 intersubtype recombinants in Central Myanmar: geographical hot spot of extensive recombination,"Takebe,Y., Motomura,K., Tatsumi,M., Lwin,H., Zaw,M. and Kusagawa,S.",
AB097866,01BC,2000,,High prevalence of diverse forms of HIV-1 intersubtype recombinants in Central Myanmar: geographical hot spot of extensive recombination,"Takebe,Y., Motomura,K., Tatsumi,M., Lwin,H., Zaw,M. and Kusagawa,S.",
AB097867,01B,1999,,High prevalence of diverse forms of HIV-1 intersubtype recombinants in Central Myanmar: geographical hot spot of extensive recombination,"Takebe,Y., Motomura,K., Tatsumi,M., Lwin,H., Zaw,M. and Kusagawa,S.",
AB097868,01BC,1999,,High prevalence of diverse forms of HIV-1 intersubtype recombinants in Central Myanmar: geographical hot spot of extensive recombination,"Takebe,Y., Motomura,K., Tatsumi,M., Lwin,H., Zaw,M. and Kusagawa,S.",
AB097869,BC,1999,,High prevalence of diverse forms of HIV-1 intersubtype recombinants in Central Myanmar: geographical hot spot of extensive recombination,"Takebe,Y., Motomura,K., Tatsumi,M., Lwin,H., Zaw,M. and Kusagawa,S.",
AB097870,B,1999,,High prevalence of diverse forms of HIV-1 intersubtype recombinants in Central Myanmar: geographical hot spot of extensive recombination,"Takebe,Y., Motomura,K., Tatsumi,M., Lwin,H., Zaw,M. and Kusagawa,S.",
AB097871,C,1999,,High prevalence of diverse forms of HIV-1 intersubtype recombinants in Central Myanmar: geographical hot spot of extensive recombination,"Takebe,Y., Motomura,K., Tatsumi,M., Lwin,H., Zaw,M. and Kusagawa,S.",
AB097872,01_AE,1999,,High prevalence of diverse forms of HIV-1 intersubtype recombinants in Central Myanmar: geographical hot spot of extensive recombination,"Takebe,Y., Motomura,K., Tatsumi,M., Lwin,H., Zaw,M. and Kusagawa,S.",
AB097873,BC,1999,,High prevalence of diverse forms of HIV-1 intersubtype recombinants in Central Myanmar: geographical hot spot of extensive recombination,"Takebe,Y., Motomura,K., Tatsumi,M., Lwin,H., Zaw,M. and Kusagawa,S.",
AB098330,A1,,,Infectious DNA clones of HIV-1 subtype A,"Tatsumi,M. and Matsuda,M.",
AB098332,A1,1992,,Infectious DNA clones of HIV-1 subtype A,"Tatsumi,M. and Matsuda,M.",
AB220948,01_AE,1993,,Infectious DNA clones of CRF01_AE HIV-1 derived from Thainian isolates,"Sakamoto,Y., Takekawa,N., Sakai,K. and Tatsumi,M.",
AB221005,B,1985,,Infectious DNA clones of subtype B HIV-1,"Tatsumi,M., Takebe,Y. and Kusagawa,S.",
AB221125,B,2004,,Infectious molecular clones of subtype B HIV-1 derived from Japanese patients,"Sakamoto,Y., Takekawa,N., Sakai,K., Sugiura,W., Nishizawa,M. and Tatsumi,M.",
AB231893,G,2003,,Infectious DNA clones of subtype G and CRF02_AG HIV-1 derived from Ghananian isolates,"Tatsumi,M., Kinomoto,M., Nii-Trebi,N., Sakamoto,Y., Tokunaga,K., Ampofo,W., Ofori-Adjei,D., Kurata,T. and Sata,T.",
AB253421,A1,1992,,Construction and characterization of HIV-1 subtype A and CRF01_AE infectious molecular clones,"Sakamoto,Y., Takekawa,N. and Tatsumi,M.",
AB253423,01_AE,,,Characterization of drug-resistance mutation profile kinetics in HIV-1 with infectious clones,"Sakamoto,Y., Takekawa,N., Hashimoto,H., Matsuda,M., Nishizawa,M., Sugiura,W. and Tatsumi,M.",
AB253424,01_AE,1993,,Construction and characterization of HIV-1 CRF01_AE infectious molecular clones,"Sakamoto,Y., Takekawa,N. and Tatsumi,M.",
AB253426,01_AE,,,Construction and characterization of HIV-1 CRF01_AE infectious molecular clones,"Sakamoto,Y., Takekawa,N. and Tatsumi,M.",
AB253428,A1,1992,,Construction and characterization of HIV-1 subtype A infectious molecular clones,"Sakamoto,Y., Takekawa,N. and Tatsumi,M.",
AB253430,BF1,,,Construction and characterization of HIV-1 BF recombinant infectious molecular clones,"Sakamoto,Y., Takekawa,N. and Tatsumi,M.",
AB253635,01_AE,,,Construction and characterization of HIV-1 subtype A and CRF01_AE infectious molecular clones,"Sakamoto,Y., Takekawa,N. and Tatsumi,M.",
AB253647,01_AE,,,Construction and characterization of HIV-1 subtype A and CRF01_AE infectious molecular clones,"Sakamoto,Y., Takekawa,N. and Tatsumi,M.",
AB253659,01_AE,,,Construction and characterization of HIV-1 subtype A and CRF01_AE infectious molecular clones,"Sakamoto,Y., Takekawa,N. and Tatsumi,M.",
AB253692,01_AE,,,Characterization of drug-resistance mutation profile kinetics in HIV-1 with infectious clones,"Sakamoto,Y., Takekawa,N., Hashimoto,O., Matsuda,M., Nishizawa,M., Sugiura,W. and Tatsumi,M.",
AB253703,01_AE,,,Characterization of drug-resistance mutation profile kinetics in HIV-1 with infectious clones,"Sakamoto,Y., Takekawa,N., Hashimoto,O., Matsuda,M., Nishizawa,M., Sugiura,W. and Tatsumi,M.",
AB254143,C,2002,,Construction and characterization of HIV-1 subtype C infectious molecular clones derived from Zambian isolates,"Tatsumi,M., Hara,T., Sakamoto,Y., Terunuma,H., Ichiyama,H., Kasolo,M., Honda,M. and Yamamoto,N.",
AB254146,C,2002,,Construction and characterization of HIV-1 subtype C infectious molecular clones derived from Zambian isolates,"Tatsumi,M., Hara,T., Sakamoto,Y., Terunuma,H., Ichiyama,H., Kasolo,M., Honda,M. and Yamamoto,N.",
AB254150,C,2002,,Construction and characterization of HIV-1 subtype C infectious molecular clones derived from Zambian isolates,"Tatsumi,M., Hara,T., Sakamoto,Y., Terunuma,H., Ichiyama,H., Kasolo,M., Honda,M. and Yamamoto,N.",
AB262952,B,,17251298,Impact of V2 Mutations on Escape from a Potent Neutralizing Anti-V3 Monoclonal Antibody during In Vitro Selection of a Primary Human Immunodeficiency Virus Type 1 Isolate,"Shibata,J., Yoshimura,K., Honda,A., Koito,A., Murakami,T. and Matsushita,S.",2007
AB286849,CU,2004,,Construction and characterization of an unique mosaic HIV-1 subtype C infectious molecular clones derived from a japanese patients,"Sakamoto,Y., Takekawa,N., Nishizawa,M., Sugiura,W. and Tatsumi,M.",
AB286851,06_cpx,2003,,Construction and characterization of mosaic HIV-1 infectious molecular clones among CRF02_AG and CRF06_cpx derived from Ghanaian patients,"Sakamoto,Y., Takekawa,N., Ampofo,W., Sata,T. and Tatsumi,M.",
AB286853,0206,2003,,Construction and characterization of mosaic HIV-1 infectious molecular clones among CRF02_AG and CRF06_cpx derived from Ghanaian patients,"Sakamoto,Y., Takekawa,N., Ampofo,W., Sata,T. and Tatsumi,M.",
AB286855,02_AG,2003,,Construction and characterization of HIV-1 CRF02_AG infectious molecular clones derived from Ghanaian patients,"Sakamoto,Y., Takekawa,N., Ampofo,W., Sata,T. and Tatsumi,M.",
AB286857,02_AG,2003,,Construction and characterization of HIV-1 CRF02_AG infectious molecular clones derived from Ghanaian patients,"Sakamoto,Y., Takekawa,N., Ampofo,W., Sata,T. and Tatsumi,M.",
AB286859,02_AG,2003,,Construction and characterization of HIV-1 CRF02_AG infectious molecular clones derived from Ghanaian patients,"Sakamoto,Y., Takekawa,N., Ampofo,W., Sata,T. and Tatsumi,M.",
AB286861,02_AG,2003,,Construction and characterization of HIV-1 CRF02_AG infectious molecular clones derived from Ghanaian patients,"Sakamoto,Y., Takekawa,N., Ampofo,W., Sata,T. and Tatsumi,M.",
AB286863,02_AG,2003,,Construction and characterization of HIV-1 CRF02_AG infectious molecular clones derived from Ghanaian patients,"Sakamoto,Y., Takekawa,N., Ampofo,W., Sata,T. and Tatsumi,M.",
AB286955,B,2004,,Construction and characterization of naive HIV-1 subtypeB infectious molecular clones derived from japanese patients for reference,"Sakamoto,Y., Takekawa,N., Nishizawa,M., Sugiura,W. and Tatsumi,M.",
AB287364,B,2005,,Construction and characterization of naive HIV-1 subtypeB infectious molecular clones derived from Japanese patients for reference,"Sakamoto,Y., Takekawa,N., Nishizawa,M., Sugiura,W. and Tatsumi,M.",
AB287366,B,2005,,Construction and characterization of naive HIV-1 subtypeB infectious molecular clones derived from Japanese patients for reference,"Sakamoto,Y., Takekawa,N., Nishizawa,M., Sugiura,W. and Tatsumi,M.",
AB287369,B,1999,,Construction and characterization of multidrug-resistant HIV-1 subtypeB infectious molecular clones derived from Japanese patients for reference,"Sakamoto,Y., Takekawa,N., Nishizawa,M., Sugiura,W. and Tatsumi,M.",
AB287376,A1,1992,,Construction and characterization of naive HIV-1 subtype A infectious molecular clones derived from Rwanda patients for reference,"Sakamoto,Y., Takekawa,N. and Tatsumi,M.",
AB287378,A1,1993,,Construction and characterization of naive HIV-1 subtype A infectious molecular clones derived from Rwanda patients for reference,"Sakamoto,Y., Takekawa,N. and Tatsumi,M.",
AB289587,B,2000,,Construction and characterization of multidrug-resistant HIV-1 subtype B infectious molecular clones derived from Japanese patients for reference,"Sato,M., Takekawa,N., Sakamoto,Y., Nishizawa,M., Sugiura,W. and Tatsumi,M.",
AB289589,B,2001,,Construction and characterization of multidrug-resistant HIV-1 subtype B infectious molecular clones derived from Japanese patients for reference,"Sato,M., Takekawa,N., Sakamoto,Y., Nishizawa,M., Sugiura,W. and Tatsumi,M.",
AB428551,B,2000,18620491,"Analysis of near full-length genomic sequences of drug-resistant HIV-1 spreading among therapy-naive individuals in Nagoya, Japan: amino acid mutations associated with viral replication activity","Ibe,S., Shigemi,U., Sawaki,K., Fujisaki,S., Hattori,J., Yokomaku,Y., Mamiya,N., Hamaguchi,M. and Kaneda,T.",2008
AB428552,B,2001,18620491,"Analysis of near full-length genomic sequences of drug-resistant HIV-1 spreading among therapy-naive individuals in Nagoya, Japan: amino acid mutations associated with viral replication activity","Ibe,S., Shigemi,U., Sawaki,K., Fujisaki,S., Hattori,J., Yokomaku,Y., Mamiya,N., Hamaguchi,M. and Kaneda,T.",2008
AB428553,B,2002,18620491,"Analysis of near full-length genomic sequences of drug-resistant HIV-1 spreading among therapy-naive individuals in Nagoya, Japan: amino acid mutations associated with viral replication activity","Ibe,S., Shigemi,U., Sawaki,K., Fujisaki,S., Hattori,J., Yokomaku,Y., Mamiya,N., Hamaguchi,M. and Kaneda,T.",2008
AB428554,B,2002,18620491,"Analysis of near full-length genomic sequences of drug-resistant HIV-1 spreading among therapy-naive individuals in Nagoya, Japan: amino acid mutations associated with viral replication activity","Ibe,S., Shigemi,U., Sawaki,K., Fujisaki,S., Hattori,J., Yokomaku,Y., Mamiya,N., Hamaguchi,M. and Kaneda,T.",2008
AB428555,B,2003,18620491,"Analysis of near full-length genomic sequences of drug-resistant HIV-1 spreading among therapy-naive individuals in Nagoya, Japan: amino acid mutations associated with viral replication activity","Ibe,S., Shigemi,U., Sawaki,K., Fujisaki,S., Hattori,J., Yokomaku,Y., Mamiya,N., Hamaguchi,M. and Kaneda,T.",2008
AB428556,B,2005,18620491,"Analysis of near full-length genomic sequences of drug-resistant HIV-1 spreading among therapy-naive individuals in Nagoya, Japan: amino acid mutations associated with viral replication activity","Ibe,S., Shigemi,U., Sawaki,K., Fujisaki,S., Hattori,J., Yokomaku,Y., Mamiya,N., Hamaguchi,M. and Kaneda,T.",2008
AB428557,B,2005,18620491,"Analysis of near full-length genomic sequences of drug-resistant HIV-1 spreading among therapy-naive individuals in Nagoya, Japan: amino acid mutations associated with viral replication activity","Ibe,S., Shigemi,U., Sawaki,K., Fujisaki,S., Hattori,J., Yokomaku,Y., Mamiya,N., Hamaguchi,M. and Kaneda,T.",2008
AB428558,B,2003,18620491,"Analysis of near full-length genomic sequences of drug-resistant HIV-1 spreading among therapy-naive individuals in Nagoya, Japan: amino acid mutations associated with viral replication activity","Ibe,S., Shigemi,U., Sawaki,K., Fujisaki,S., Hattori,J., Yokomaku,Y., Mamiya,N., Hamaguchi,M. and Kaneda,T.",2008
AB428559,B,2004,18620491,"Analysis of near full-length genomic sequences of drug-resistant HIV-1 spreading among therapy-naive individuals in Nagoya, Japan: amino acid mutations associated with viral replication activity","Ibe,S., Shigemi,U., Sawaki,K., Fujisaki,S., Hattori,J., Yokomaku,Y., Mamiya,N., Hamaguchi,M. and Kaneda,T.",2008
AB428560,B,2005,18620491,"Analysis of near full-length genomic sequences of drug-resistant HIV-1 spreading among therapy-naive individuals in Nagoya, Japan: amino acid mutations associated with viral replication activity","Ibe,S., Shigemi,U., Sawaki,K., Fujisaki,S., Hattori,J., Yokomaku,Y., Mamiya,N., Hamaguchi,M. and Kaneda,T.",2008
AB428561,B,2006,18620491,"Analysis of near full-length genomic sequences of drug-resistant HIV-1 spreading among therapy-naive individuals in Nagoya, Japan: amino acid mutations associated with viral replication activity","Ibe,S., Shigemi,U., Sawaki,K., Fujisaki,S., Hattori,J., Yokomaku,Y., Mamiya,N., Hamaguchi,M. and Kaneda,T.",2008
AB428562,B,2006,18620491,"Analysis of near full-length genomic sequences of drug-resistant HIV-1 spreading among therapy-naive individuals in Nagoya, Japan: amino acid mutations associated with viral replication activity","Ibe,S., Shigemi,U., Sawaki,K., Fujisaki,S., Hattori,J., Yokomaku,Y., Mamiya,N., Hamaguchi,M. and Kaneda,T.",2008
AB480044,02D,2003,,A new generation of recombinants between CRF02_AG and subtype A detected in Ghana : analysis by infectious molecular clones,"Takekawa,N., Sakamoto,Y., Kinomoto,M., Nii-Trebi,N., Tokunaga,K., Ampofo,W., Ofori-Adjei,D., Kurata,T., Sata,T. and Tatsumi,M.",
AB480047,02G,2003,,A new generation of recombinants between CRF02_AG and subtype A detected in Ghana : analysis by infectious molecular clones,"Takekawa,N., Sakamoto,Y., Kinomoto,M., Nii-Trebi,N., Tokunaga,K., Ampofo,W., Ofori-Adjei,D., Kurata,T., Sata,T. and Tatsumi,M.",
AB480298,BF1,2004,,Molecular characterization of subtype F infectious molecular clones possibly derived from Brazil,"Sakamoto,Y., Takekawa,N., Nishizawa,M., Sugiura,W. and Tatsumi,M.",
AB480300,BF1,2004,,Molecular characterization of subtype F infectious molecular clones possibly derived from Brazil,"Sakamoto,Y., Takekawa,N., Nishizawa,M., Sugiura,W. and Tatsumi,M.",
AB480692,B,2004,,Molecular characterization of infectious molecular clones derived from multidrug-resistant HIV-1 subtype B in Japan,"Takekawa,N., Nishizawa,M., Sugiura,W. and Tatsumi,M.",
AB480694,B,2004,,Molecular characterization of infectious molecular clones derived from multidrug-resistant HIV-1 subtype B in Japan,"Takekawa,N., Nishizawa,M., Sugiura,W. and Tatsumi,M.",
AB480696,B,2004,,Molecular characterization of infectious molecular clones derived from naive subtype B HIV-1 in Japan,"Takekawa,N., Nishizawa,M., Sugiura,W. and Tatsumi,M.",
AB480698,B,1998,,Molecular characterization of infectious molecular clones derived from multidrug-resistant HIV-1 subtype B in Japan,"Takekawa,N., Uchiyama,C., Nishizawa,M., Sugiura,W. and Tatsumi,M.",
AB485632,A1,,,A comprehensive panel of infectious molecular clones derived from HIV isolates of BBI subtype infectivity panel,"Takekawa,N., Takeda,S., Uchiyama,C. and Tatsumi,M.",
AB485633,02_AG,,,A comprehensive panel of infectious molecular clones derived from HIV isolates of BBI subtype infectivity panel,"Takekawa,N., Takeda,S., Uchiyama,C. and Tatsumi,M.",
AB485634,02_AG,,,A comprehensive panel of infectious molecular clones derived from HIV isolates of BBI subtype infectivity panel,"Takekawa,N., Takeda,S., Uchiyama,C. and Tatsumi,M.",
AB485636,02_AG,,,A comprehensive panel of infectious molecular clones derived from HIV isolates of BBI subtype infectivity panel,"Takekawa,N., Takeda,S., Uchiyama,C. and Tatsumi,M.",
AB485638,B,1991,,A comprehensive panel of infectious molecular clones derived from HIV isolates of BBI subtype infectivity panel,"Takekawa,N., Takeda,S., Uchiyama,C. and Tatsumi,M.",
AB485641,B,1990,,A comprehensive panel of infectious molecular clones derived from HIV isolates of BBI subtype infectivity panel,"Takekawa,N., Takeda,S., Uchiyama,C. and Tatsumi,M.",
AB485643,C,,,A comprehensive panel of infectious molecular clones derived from HIV isolates of BBI subtype infectivity panel,"Takekawa,N., Takeda,S., Uchiyama,C. and Tatsumi,M.",
AB485645,C,1989,,A comprehensive panel of infectious molecular clones derived from HIV isolates of BBI subtype infectivity panel,"Takekawa,N., Takeda,S., Uchiyama,C. and Tatsumi,M.",
AB485648,D,1990,,A comprehensive panel of infectious molecular clones derived from HIV isolates of BBI subtype infectivity panel,"Takekawa,N., Takeda,S., Uchiyama,C. and Tatsumi,M.",
AB485650,D,1991,,A comprehensive panel of infectious molecular clones derived from HIV isolates of BBI subtype infectivity panel,"Takekawa,N., Takeda,S., Uchiyama,C. and Tatsumi,M.",
AB485652,01_AE,1993,,A comprehensive panel of infectious molecular clones derived from HIV isolates of BBI subtype infectivity panel,"Takekawa,N., Takeda,S., Uchiyama,C. and Tatsumi,M.",
AB485654,01_AE,,,A comprehensive panel of infectious molecular clones derived from HIV isolates of BBI subtype infectivity panel,"Takekawa,N., Takeda,S., Uchiyama,C. and Tatsumi,M.",
AB485656,F1,1990,,A comprehensive panel of infectious molecular clones derived from HIV isolates of BBI subtype infectivity panel,"Takekawa,N., Takeda,S., Uchiyama,C. and Tatsumi,M.",
AB485658,F1,1996,,A comprehensive panel of infectious molecular clones derived from HIV isolates of BBI subtype infectivity panel,"Takekawa,N., Takeda,S., Uchiyama,C. and Tatsumi,M.",
AB485660,06_cpx,,,A comprehensive panel of infectious molecular clones derived from HIV isolates of BBI subtype infectivity panel,"Takekawa,N., Takeda,S., Uchiyama,C. and Tatsumi,M.",
AB485662,G,1993,,A comprehensive panel of infectious molecular clones derived from HIV isolates of BBI subtype infectivity panel,"Takekawa,N., Takeda,S., Uchiyama,C. and Tatsumi,M.",
AB485664,U,,,A comprehensive panel of infectious molecular clones derived from HIV isolates of BBI subtype infectivity panel,"Takekawa,N., Takeda,S., Uchiyama,C. and Tatsumi,M.",
AB485666,O,,,A comprehensive panel of infectious molecular clones derived from HIV isolates of BBI subtype infectivity panel,"Takekawa,N., Takeda,S., Uchiyama,C. and Tatsumi,M.",
AB485668,O,,,A comprehensive panel of infectious molecular clones derived from HIV isolates of BBI subtype infectivity panel,"Takekawa,N., Takeda,S., Uchiyama,C. and Tatsumi,M.",
AB547463,33_01B,2007,20958201,The Indonesian Variants of CRF33_01B: Near-Full Length Sequence Analysis,"Sahbandar,I.N., Takahashi,K., Motomura,K., Djoerban,Z., Firmansyah,I., Kitamura,K., Sato,H., Pohan,H.T. and Sato,S.",2011
AB547464,33_01B,2007,20958201,The Indonesian Variants of CRF33_01B: Near-Full Length Sequence Analysis,"Sahbandar,I.N., Takahashi,K., Motomura,K., Djoerban,Z., Firmansyah,I., Kitamura,K., Sato,H., Pohan,H.T. and Sato,S.",2011
AB564744,B,,,Characterization of drug-resistance mutation profile kinetics in HIV-1 with infectious molecular clones,"Umeki-Sakamoto,Y., Hirano,R. and Tatsumi,M.",
AB564746,B,,,Characterization of drug-resistance mutation profile kinetics in HIV-1 with infectious molecular clones,"Umeki-Sakamoto,Y., Hirano,R. and Tatsumi,M.",
AB565478,B,,,Characterization of drug-resistance mutation profile kinetics in HIV-1 with infectious molecular clones,"Umeki-Sakamoto,Y., Hirano,R. and Tatsumi,M.",
AB565495,B,,,Construction and characterization of infectious molecular clones derived from japanese blood donors,"Umeki-Sakamoto,Y., Takekawa,N. and Tatsumi,M.",
AB565497,B,,,Construction and characterization of infectious molecular clones derived from japanese blood donors,"Umeki-Sakamoto,Y., Takekawa,N. and Tatsumi,M.",
AB565499,B,,,Construction and characterization of infectious molecular clones derived from japanese blood donors,"Umeki-Sakamoto,Y., Takekawa,N. and Tatsumi,M.",
AB565501,B,,,Construction and characterization of infectious molecular clones derived from japanese blood donors,"Umeki-Sakamoto,Y., Takekawa,N. and Tatsumi,M.",
AB565503,01_AE,,,Construction and characterization of infectious molecular clones derived from japanese blood donors,"Umeki-Sakamoto,Y., Takekawa,N. and Tatsumi,M.",
AB588196,B,1988,21526184,Change of positive selection pressure on HIV-1 envelope gene inferred by early and recent samples,"Yoshida,I., Sugiura,W., Shibata,J., Ren,F., Yang,Z. and Tanaka,H.",2011
AB588207,B,1988,21526184,Change of positive selection pressure on HIV-1 envelope gene inferred by early and recent samples,"Yoshida,I., Sugiura,W., Shibata,J., Ren,F., Yang,Z. and Tanaka,H.",2011
AB588209,B,1989,21526184,Change of positive selection pressure on HIV-1 envelope gene inferred by early and recent samples,"Yoshida,I., Sugiura,W., Shibata,J., Ren,F., Yang,Z. and Tanaka,H.",2011
AB588211,B,1989,21526184,Change of positive selection pressure on HIV-1 envelope gene inferred by early and recent samples,"Yoshida,I., Sugiura,W., Shibata,J., Ren,F., Yang,Z. and Tanaka,H.",2011
AB588223,B,1989,21526184,Change of positive selection pressure on HIV-1 envelope gene inferred by early and recent samples,"Yoshida,I., Sugiura,W., Shibata,J., Ren,F., Yang,Z. and Tanaka,H.",2011
AB588232,B,1989,21526184,Change of positive selection pressure on HIV-1 envelope gene inferred by early and recent samples,"Yoshida,I., Sugiura,W., Shibata,J., Ren,F., Yang,Z. and Tanaka,H.",2011
AB588243,B,2005,21526184,Change of positive selection pressure on HIV-1 envelope gene inferred by early and recent samples,"Yoshida,I., Sugiura,W., Shibata,J., Ren,F., Yang,Z. and Tanaka,H.",2011
AB588253,B,2005,21526184,Change of positive selection pressure on HIV-1 envelope gene inferred by early and recent samples,"Yoshida,I., Sugiura,W., Shibata,J., Ren,F., Yang,Z. and Tanaka,H.",2011
AB588263,B,2005,21526184,Change of positive selection pressure on HIV-1 envelope gene inferred by early and recent samples,"Yoshida,I., Sugiura,W., Shibata,J., Ren,F., Yang,Z. and Tanaka,H.",2011
AB588271,B,2005,21526184,Change of positive selection pressure on HIV-1 envelope gene inferred by early and recent samples,"Yoshida,I., Sugiura,W., Shibata,J., Ren,F., Yang,Z. and Tanaka,H.",2011
AB588283,B,2005,21526184,Change of positive selection pressure on HIV-1 envelope gene inferred by early and recent samples,"Yoshida,I., Sugiura,W., Shibata,J., Ren,F., Yang,Z. and Tanaka,H.",2011
AB588291,B,2005,21526184,Change of positive selection pressure on HIV-1 envelope gene inferred by early and recent samples,"Yoshida,I., Sugiura,W., Shibata,J., Ren,F., Yang,Z. and Tanaka,H.",2011
AB588311,B,2006,21526184,Change of positive selection pressure on HIV-1 envelope gene inferred by early and recent samples,"Yoshida,I., Sugiura,W., Shibata,J., Ren,F., Yang,Z. and Tanaka,H.",2011
AB588319,B,2006,21526184,Change of positive selection pressure on HIV-1 envelope gene inferred by early and recent samples,"Yoshida,I., Sugiura,W., Shibata,J., Ren,F., Yang,Z. and Tanaka,H.",2011
AB588329,B,2006,21526184,Change of positive selection pressure on HIV-1 envelope gene inferred by early and recent samples,"Yoshida,I., Sugiura,W., Shibata,J., Ren,F., Yang,Z. and Tanaka,H.",2011
AB604946,B,,,Characterization of drug-resistance mutation profile kinetics in HIV-1 with infectious molecular clones,"Hirano,R. and Tatsumi,M.",
AB604950,B,,,Characterization of drug-resistance mutation profile kinetics in HIV-1 with infectious molecular clones,"Hirano,R. and Tatsumi,M.",
AB641836,B,,,Construction and characterization of infectious molecular clones derived from japanese blood donors,"Nagai,M., Takekawa,N. and Tatsumi,M.",
AB646289,01B,,,"Construction and characterization of infectious molecular clones deriver from HIV-1, URF between subtype B and CRF01_AE, underestimated by Cobas TaqMan version 1 HIV-1 RNA quantification assay","Nagai,M., Kondo,M. and Tatsumi,M.",
AB703607,35_AD,2010,22916738,Molecular Epidemiology of HIV Type 1 Infection in Iran: Genomic Evidence of CRF35_AD Predominance and CRF01_AE Infection Among Individuals Associated with Injection Drug Use,"Jahanbakhsh,F., Ibe,S., Hattori,J., Monavari,S.H.R., Matsuda,M., Maejima,M., Iwatani,Y., Memarnejadian,A., Keyvani,H., Azadmanesh,K. and Sugiura,W.",2013
AB703608,35_AD,2010,22916738,Molecular Epidemiology of HIV Type 1 Infection in Iran: Genomic Evidence of CRF35_AD Predominance and CRF01_AE Infection Among Individuals Associated with Injection Drug Use,"Jahanbakhsh,F., Ibe,S., Hattori,J., Monavari,S.H.R., Matsuda,M., Maejima,M., Iwatani,Y., Memarnejadian,A., Keyvani,H., Azadmanesh,K. and Sugiura,W.",2013
AB703609,35_AD,2011,22916738,Molecular Epidemiology of HIV Type 1 Infection in Iran: Genomic Evidence of CRF35_AD Predominance and CRF01_AE Infection Among Individuals Associated with Injection Drug Use,"Jahanbakhsh,F., Ibe,S., Hattori,J., Monavari,S.H.R., Matsuda,M., Maejima,M., Iwatani,Y., Memarnejadian,A., Keyvani,H., Azadmanesh,K. and Sugiura,W.",2013
AB703610,35_AD,2011,22916738,Molecular Epidemiology of HIV Type 1 Infection in Iran: Genomic Evidence of CRF35_AD Predominance and CRF01_AE Infection Among Individuals Associated with Injection Drug Use,"Jahanbakhsh,F., Ibe,S., Hattori,J., Monavari,S.H.R., Matsuda,M., Maejima,M., Iwatani,Y., Memarnejadian,A., Keyvani,H., Azadmanesh,K. and Sugiura,W.",2013
AB703611,35_AD,2011,22916738,Molecular Epidemiology of HIV Type 1 Infection in Iran: Genomic Evidence of CRF35_AD Predominance and CRF01_AE Infection Among Individuals Associated with Injection Drug Use,"Jahanbakhsh,F., Ibe,S., Hattori,J., Monavari,S.H.R., Matsuda,M., Maejima,M., Iwatani,Y., Memarnejadian,A., Keyvani,H., Azadmanesh,K. and Sugiura,W.",2013
AB703612,35_AD,2011,22916738,Molecular Epidemiology of HIV Type 1 Infection in Iran: Genomic Evidence of CRF35_AD Predominance and CRF01_AE Infection Among Individuals Associated with Injection Drug Use,"Jahanbakhsh,F., Ibe,S., Hattori,J., Monavari,S.H.R., Matsuda,M., Maejima,M., Iwatani,Y., Memarnejadian,A., Keyvani,H., Azadmanesh,K. and Sugiura,W.",2013
AB703613,35_AD,2011,22916738,Molecular Epidemiology of HIV Type 1 Infection in Iran: Genomic Evidence of CRF35_AD Predominance and CRF01_AE Infection Among Individuals Associated with Injection Drug Use,"Jahanbakhsh,F., Ibe,S., Hattori,J., Monavari,S.H.R., Matsuda,M., Maejima,M., Iwatani,Y., Memarnejadian,A., Keyvani,H., Azadmanesh,K. and Sugiura,W.",2013
AB703614,35_AD,2011,22916738,Molecular Epidemiology of HIV Type 1 Infection in Iran: Genomic Evidence of CRF35_AD Predominance and CRF01_AE Infection Among Individuals Associated with Injection Drug Use,"Jahanbakhsh,F., Ibe,S., Hattori,J., Monavari,S.H.R., Matsuda,M., Maejima,M., Iwatani,Y., Memarnejadian,A., Keyvani,H., Azadmanesh,K. and Sugiura,W.",2013
AB703615,35_AD,2010,22916738,Molecular Epidemiology of HIV Type 1 Infection in Iran: Genomic Evidence of CRF35_AD Predominance and CRF01_AE Infection Among Individuals Associated with Injection Drug Use,"Jahanbakhsh,F., Ibe,S., Hattori,J., Monavari,S.H.R., Matsuda,M., Maejima,M., Iwatani,Y., Memarnejadian,A., Keyvani,H., Azadmanesh,K. and Sugiura,W.",2013
AB703616,01_AE,2010,22916738,Molecular Epidemiology of HIV Type 1 Infection in Iran: Genomic Evidence of CRF35_AD Predominance and CRF01_AE Infection Among Individuals Associated with Injection Drug Use,"Jahanbakhsh,F., Ibe,S., Hattori,J., Monavari,S.H.R., Matsuda,M., Maejima,M., Iwatani,Y., Memarnejadian,A., Keyvani,H., Azadmanesh,K. and Sugiura,W.",2013
AB731663,B,2008,,Molecular characterization of infectious molecular clones derived from mult-idrug-resistant HIV-1 subtype B in Japan,"Umeki-Sakamoto,Y., Ibe,S., Hattori,J., Iwatani,Y., Yokomaku,Y., Sugiura,W. and Tatsumi,M.",
AB731665,B,2009,,Molecular characterization of infectious molecular clones derived from mult-idrug-resistant HIV-1 subtype B in Japan,"Umeki-Sakamoto,Y., Ibe,S., Hattori,J., Iwatani,Y., Yokomaku,Y., Sugiura,W. and Tatsumi,M.",
AB731667,B,2009,,Molecular characterization of infectious molecular clones derived from mult-idrug-resistant HIV-1 subtype B in Japan,"Umeki-Sakamoto,Y., Ibe,S., Hattori,J., Iwatani,Y., Yokomaku,Y., Sugiura,W. and Tatsumi,M.",
AB742145,B,,24795449,Impact of maraviroc-resistant and low-CCR5-adapted mutations induced by in vitro passage on sensitivity to anti-envelope neutralizing antibodies,"Yoshimura,K., Harada,S., Boonchawalit,S., Kawanami,Y. and Matsushita,S.",2014
AB746342,08_BC,2001,,"Molecular characterization of infectious molecular clones derived from HIV-1 CRF08_BC isolates in Yunnan, China","Nagai,M., Umeki-Sakamoto,Y., Kusagawa,S., Takebe,Y., Yang,R., Xia,X., Ben,K. and Tatsumi,M.",
AB746344,08_BC,2000,,"Molecular characterization of infectious molecular clones derived from HIV-1 CRF08_BC isolates in Yunnan, China","Nagai,M., Umeki-Sakamoto,Y., Kusagawa,S., Takebe,Y., Yang,R., Xia,X., Ben,K. and Tatsumi,M.",
AB773884,08_BC,2000,,"Molecular characterization of infectious molecular clones derived from HIV-1 CRF08_BC isolates in Yunnan, China","Nagai,M., Umeki-Sakamoto,Y., Kusagawa,S., Takebe,Y., Yang,R., Xia,X., Ben,K. and Tatsumi,M.",
AB845344,69_01B,2003,26571151,HIV-1 CRF01_AE and Subtype B Transmission Networks Crossover: A New AE/B Recombinant Identified in Japan,"Hosaka,M., Fujisaki,S., Masakane,A., Hattori,J., Shiino,T., Gatanaga,H., Shigemi,U., Okazaki,R., Hachiya,A., Matsuda,M., Ibe,S., Iwatani,Y., Yokomaku,Y. and Sugiura,W.",2016
AB845345,69_01B,2004,26571151,HIV-1 CRF01_AE and Subtype B Transmission Networks Crossover: A New AE/B Recombinant Identified in Japan,"Hosaka,M., Fujisaki,S., Masakane,A., Hattori,J., Shiino,T., Gatanaga,H., Shigemi,U., Okazaki,R., Hachiya,A., Matsuda,M., Ibe,S., Iwatani,Y., Yokomaku,Y. and Sugiura,W.",2016
AB845346,69_01B,2004,26571151,HIV-1 CRF01_AE and Subtype B Transmission Networks Crossover: A New AE/B Recombinant Identified in Japan,"Hosaka,M., Fujisaki,S., Masakane,A., Hattori,J., Shiino,T., Gatanaga,H., Shigemi,U., Okazaki,R., Hachiya,A., Matsuda,M., Ibe,S., Iwatani,Y., Yokomaku,Y. and Sugiura,W.",2016
AB845347,69_01B,2005,26571151,HIV-1 CRF01_AE and Subtype B Transmission Networks Crossover: A New AE/B Recombinant Identified in Japan,"Hosaka,M., Fujisaki,S., Masakane,A., Hattori,J., Shiino,T., Gatanaga,H., Shigemi,U., Okazaki,R., Hachiya,A., Matsuda,M., Ibe,S., Iwatani,Y., Yokomaku,Y. and Sugiura,W.",2016
AB845348,69_01B,2010,26571151,HIV-1 CRF01_AE and Subtype B Transmission Networks Crossover: A New AE/B Recombinant Identified in Japan,"Hosaka,M., Fujisaki,S., Masakane,A., Hattori,J., Shiino,T., Gatanaga,H., Shigemi,U., Okazaki,R., Hachiya,A., Matsuda,M., Ibe,S., Iwatani,Y., Yokomaku,Y. and Sugiura,W.",2016
AB845349,69_01B,2010,26571151,HIV-1 CRF01_AE and Subtype B Transmission Networks Crossover: A New AE/B Recombinant Identified in Japan,"Hosaka,M., Fujisaki,S., Masakane,A., Hattori,J., Shiino,T., Gatanaga,H., Shigemi,U., Okazaki,R., Hachiya,A., Matsuda,M., Ibe,S., Iwatani,Y., Yokomaku,Y. and Sugiura,W.",2016
AB859012,01B,2003,26571151,HIV-1 CRF01_AE and Subtype B Transmission Networks Crossover: A New AE/B Recombinant Identified in Japan,"Hosaka,M., Fujisaki,S., Masakane,A., Hattori,J., Shiino,T., Gatanaga,H., Shigemi,U., Okazaki,R., Hachiya,A., Matsuda,M., Ibe,S., Iwatani,Y., Yokomaku,Y. and Sugiura,W.",2016
AF003887,B,1985,9930876,PCR-mediated recombination: a general method applied to construct chimeric infectious molecular clones of plasma-derived HIV-1 RNA,"Fang,G., Weiser,B., Visosky,A., Moran,T. and Burger,H.",1999
AF004394,B,1986,8835195,Construction and characterization of a stable full-length macrophage-tropic HIV type 1 molecular clone that directs the production of high titers of progeny virions,"Theodore,T.S., Englund,G., Buckler-White,A., Buckler,C.E., Martin,M.A. and Peden,K.W.",1996
AF004885,A1,1994,10196337,"Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya","Neilson,J.R., John,G.C., Carr,J.K., Lewis,P., Kreiss,J.K., Jackson,S., Nduati,R.W., Mbori-Ngacha,D., Panteleeff,D.D., Bodrug,S., Giachetti,C., Bott,M.A., Richardson,B.A., Bwayo,J., Ndinya-Achola,J. and Overbaugh,J.",1999
AF005494,F1,1993,9621027,A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1,"Gao,F., Robertson,D.L., Carruthers,C.D., Morrison,S.G., Jian,B., Chen,Y., Barre-Sinoussi,F., Girard,M., Srinivasan,A., Abimiku,A.G., Shaw,G.M., Sharp,P.M. and Hahn,B.H.",1998
AF005495,BF1,1993,9621027,A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1,"Gao,F., Robertson,D.L., Carruthers,C.D., Morrison,S.G., Jian,B., Chen,Y., Barre-Sinoussi,F., Girard,M., Srinivasan,A., Abimiku,A.G., Shaw,G.M., Sharp,P.M. and Hahn,B.H.",1998
AF005496,H,1990,9621027,A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1,"Gao,F., Robertson,D.L., Carruthers,C.D., Morrison,S.G., Jian,B., Chen,Y., Barre-Sinoussi,F., Girard,M., Srinivasan,A., Abimiku,A.G., Shaw,G.M., Sharp,P.M. and Hahn,B.H.",1998
AF009032,O,,,HIV-1 Group O and M sequence comparisons,"Korber,B.T.",
AF015916,01_AE,1994,,Direct Submission,"Yu,X. and Wang,Z.",1997
AF015919,01_AE,1994,,Direct Submission,"Yu,X. and Wang,Z.",1997
AF025749,B,1986,9519894,Diversity of the human immunodeficiency virus type 1 envelope glycoprotein in San Francisco Men's Health Study participants,"McCutchan,F.E., Sanders-Buell,E., Salminen,M.O., Carr,J.K. and Sheppard,W.H.",1998
AF025750,B,1986,9519894,Diversity of the human immunodeficiency virus type 1 envelope glycoprotein in San Francisco Men's Health Study participants,"McCutchan,F.E., Sanders-Buell,E., Salminen,M.O., Carr,J.K. and Sheppard,W.H.",1998
AF025751,B,1985,9519894,Diversity of the human immunodeficiency virus type 1 envelope glycoprotein in San Francisco Men's Health Study participants,"McCutchan,F.E., Sanders-Buell,E., Salminen,M.O., Carr,J.K. and Sheppard,W.H.",1998
AF025752,B,1986,9519894,Diversity of the human immunodeficiency virus type 1 envelope glycoprotein in San Francisco Men's Health Study participants,"McCutchan,F.E., Sanders-Buell,E., Salminen,M.O., Carr,J.K. and Sheppard,W.H.",1998
AF025753,B,1987,9519894,Diversity of the human immunodeficiency virus type 1 envelope glycoprotein in San Francisco Men's Health Study participants,"McCutchan,F.E., Sanders-Buell,E., Salminen,M.O., Carr,J.K. and Sheppard,W.H.",1998
AF025754,B,1988,9519894,Diversity of the human immunodeficiency virus type 1 envelope glycoprotein in San Francisco Men's Health Study participants,"McCutchan,F.E., Sanders-Buell,E., Salminen,M.O., Carr,J.K. and Sheppard,W.H.",1998
AF025755,B,1987,9519894,Diversity of the human immunodeficiency virus type 1 envelope glycoprotein in San Francisco Men's Health Study participants,"McCutchan,F.E., Sanders-Buell,E., Salminen,M.O., Carr,J.K. and Sheppard,W.H.",1998
AF025756,B,1986,9519894,Diversity of the human immunodeficiency virus type 1 envelope glycoprotein in San Francisco Men's Health Study participants,"McCutchan,F.E., Sanders-Buell,E., Salminen,M.O., Carr,J.K. and Sheppard,W.H.",1998
AF025757,B,1987,9519894,Diversity of the human immunodeficiency virus type 1 envelope glycoprotein in San Francisco Men's Health Study participants,"McCutchan,F.E., Sanders-Buell,E., Salminen,M.O., Carr,J.K. and Sheppard,W.H.",1998
AF025758,B,1985,9519894,Diversity of the human immunodeficiency virus type 1 envelope glycoprotein in San Francisco Men's Health Study participants,"McCutchan,F.E., Sanders-Buell,E., Salminen,M.O., Carr,J.K. and Sheppard,W.H.",1998
AF025759,B,1986,9519894,Diversity of the human immunodeficiency virus type 1 envelope glycoprotein in San Francisco Men's Health Study participants,"McCutchan,F.E., Sanders-Buell,E., Salminen,M.O., Carr,J.K. and Sheppard,W.H.",1998
AF025760,B,1986,9519894,Diversity of the human immunodeficiency virus type 1 envelope glycoprotein in San Francisco Men's Health Study participants,"McCutchan,F.E., Sanders-Buell,E., Salminen,M.O., Carr,J.K. and Sheppard,W.H.",1998
AF025761,B,1986,9519894,Diversity of the human immunodeficiency virus type 1 envelope glycoprotein in San Francisco Men's Health Study participants,"McCutchan,F.E., Sanders-Buell,E., Salminen,M.O., Carr,J.K. and Sheppard,W.H.",1998
AF025762,B,1988,9519894,Diversity of the human immunodeficiency virus type 1 envelope glycoprotein in San Francisco Men's Health Study participants,"McCutchan,F.E., Sanders-Buell,E., Salminen,M.O., Carr,J.K. and Sheppard,W.H.",1998
AF025763,B,1989,9519894,Diversity of the human immunodeficiency virus type 1 envelope glycoprotein in San Francisco Men's Health Study participants,"McCutchan,F.E., Sanders-Buell,E., Salminen,M.O., Carr,J.K. and Sheppard,W.H.",1998
AF025764,B,1985,9519894,Diversity of the human immunodeficiency virus type 1 envelope glycoprotein in San Francisco Men's Health Study participants,"McCutchan,F.E., Sanders-Buell,E., Salminen,M.O., Carr,J.K. and Sheppard,W.H.",1998
AF035532,B,,7983734,Adaptation to persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera,"Wrin,T., Loh,T.P., Vennari,J.C., Schuitemaker,H. and Nunberg,J.H.",1995
AF041125,B,1992,10445815,Comparison of complete env gene sequences from individuals with symptomatic primary HIV type 1 infection,"Ataman-Onal,Y., Coiffier,C., Giraud,A., Babic-Erceg,A., Biron,F. and Verrier,B.",1999
AF041126,B,1992,10445815,Comparison of complete env gene sequences from individuals with symptomatic primary HIV type 1 infection,"Ataman-Onal,Y., Coiffier,C., Giraud,A., Babic-Erceg,A., Biron,F. and Verrier,B.",1999
AF041127,B,1993,10445815,Comparison of complete env gene sequences from individuals with symptomatic primary HIV type 1 infection,"Ataman-Onal,Y., Coiffier,C., Giraud,A., Babic-Erceg,A., Biron,F. and Verrier,B.",1999
AF041128,B,1993,10445815,Comparison of complete env gene sequences from individuals with symptomatic primary HIV type 1 infection,"Ataman-Onal,Y., Coiffier,C., Giraud,A., Babic-Erceg,A., Biron,F. and Verrier,B.",1999
AF041129,B,1993,10445815,Comparison of complete env gene sequences from individuals with symptomatic primary HIV type 1 infection,"Ataman-Onal,Y., Coiffier,C., Giraud,A., Babic-Erceg,A., Biron,F. and Verrier,B.",1999
AF041130,B,1993,10445815,Comparison of complete env gene sequences from individuals with symptomatic primary HIV type 1 infection,"Ataman-Onal,Y., Coiffier,C., Giraud,A., Babic-Erceg,A., Biron,F. and Verrier,B.",1999
AF041131,B,1993,10445815,Comparison of complete env gene sequences from individuals with symptomatic primary HIV type 1 infection,"Ataman-Onal,Y., Coiffier,C., Giraud,A., Babic-Erceg,A., Biron,F. and Verrier,B.",1999
AF041132,B,1994,10445815,Comparison of complete env gene sequences from individuals with symptomatic primary HIV type 1 infection,"Ataman-Onal,Y., Coiffier,C., Giraud,A., Babic-Erceg,A., Biron,F. and Verrier,B.",1999
AF041133,B,1995,10445815,Comparison of complete env gene sequences from individuals with symptomatic primary HIV type 1 infection,"Ataman-Onal,Y., Coiffier,C., Giraud,A., Babic-Erceg,A., Biron,F. and Verrier,B.",1999
AF041134,B,1995,10445815,Comparison of complete env gene sequences from individuals with symptomatic primary HIV type 1 infection,"Ataman-Onal,Y., Coiffier,C., Giraud,A., Babic-Erceg,A., Biron,F. and Verrier,B.",1999
AF041135,B,1996,10445815,Comparison of complete env gene sequences from individuals with symptomatic primary HIV type 1 infection,"Ataman-Onal,Y., Coiffier,C., Giraud,A., Babic-Erceg,A., Biron,F. and Verrier,B.",1999
AF042100,B,1986,10754387,Rapid full-length genomic sequencing of two cytopathically heterogeneous Australian primary HIV-1 isolates,"Oelrichs,R.B., Lawson,V.A., Coates,K.M., Chatfield,C., Deacon,N.J. and McPhee,D.A.",2000
AF042101,B,1987,10754387,Rapid full-length genomic sequencing of two cytopathically heterogeneous Australian primary HIV-1 isolates,"Oelrichs,R.B., Lawson,V.A., Coates,K.M., Chatfield,C., Deacon,N.J. and McPhee,D.A.",2000
AF042102,B,1993,,Genomic sequence of HIV-1 from four members of the Sydney Blood Bank Cohort of long term non-progressors,"Oelrichs,R.B., McPhee,D.A. and Deacon,N.J.",
AF042103,B,1995,,Genomic sequence of HIV-1 from four members of the Sydney Blood Bank Cohort of long term non-progressors,"Oelrichs,R.B., McPhee,D.A. and Deacon,N.J.",
AF042104,B,1996,,Genomic sequence of HIV-1 from four members of the Sydney Blood Bank Cohort of long term non-progressors,"Oelrichs,R.B., McPhee,D.A. and Deacon,N.J.",
AF042105,B,1996,,Genomic sequence of HIV-1 from four members of the Sydney Blood Bank Cohort of long term non-progressors,"Oelrichs,R.B., McPhee,D.A. and Deacon,N.J.",
AF049337,04_cpx,1994,9811767,"An isolate of human immunodeficiency virus type 1 originally classified as subtype I represents a complex mosaic comprising three different group M subtypes (A, G, and I)","Gao,F., Robertson,D.L., Carruthers,C.D., Li,Y., Jian,B., Salminen,M.O., Kostrikis,L.G., Ho,D.D., Shaw,G.M., Sharp,P.M. and Hahn,B.H.",1998
AF049494,B,,9765443,Molecular cloning and characterization of viruses isolated from chimpanzees with pathogenic human immunodeficiency virus type 1 infections,"Mwaengo,D.M. and Novembre,F.J.",1998
AF049495,B,,9765443,Molecular cloning and characterization of viruses isolated from chimpanzees with pathogenic human immunodeficiency virus type 1 infections,"Mwaengo,D.M. and Novembre,F.J.",1998
AF061642,G,1993,9683568,Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants,"Carr,J.K., Salminen,M.O., Albert,J., Sanders-Buell,E., Gotte,D., Birx,D.L. and McCutchan,F.E.",1998
AF063224,02_AG,1991,9683568,Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants,"Carr,J.K., Salminen,M.O., Albert,J., Sanders-Buell,E., Gotte,D., Birx,D.L. and McCutchan,F.E.",1998
AF064699,06_cpx,1996,9824329,A novel subtype A/G/J recombinant full-length HIV type 1 genome from Burkina Faso,"Oelrichs,R.B., Workman,C., Laukkanen,T., McCutchan,F.E. and Deacon,N.J.",1998
AF067154,C,1993,9847317,"Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination","Lole,K.S., Bollinger,R.C., Paranjape,R.S., Gadkari,D., Kulkarni,S.S., Novak,N.G., Ingersoll,R., Sheppard,H.W. and Ray,S.C.",1999
AF067155,C,1995,9847317,"Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination","Lole,K.S., Bollinger,R.C., Paranjape,R.S., Gadkari,D., Kulkarni,S.S., Novak,N.G., Ingersoll,R., Sheppard,H.W. and Ray,S.C.",1999
AF067156,A1C,1995,9847317,"Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination","Lole,K.S., Bollinger,R.C., Paranjape,R.S., Gadkari,D., Kulkarni,S.S., Novak,N.G., Ingersoll,R., Sheppard,H.W. and Ray,S.C.",1999
AF067157,C,1993,9847317,"Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination","Lole,K.S., Bollinger,R.C., Paranjape,R.S., Gadkari,D., Kulkarni,S.S., Novak,N.G., Ingersoll,R., Sheppard,H.W. and Ray,S.C.",1999
AF067158,C,1993,9847317,"Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination","Lole,K.S., Bollinger,R.C., Paranjape,R.S., Gadkari,D., Kulkarni,S.S., Novak,N.G., Ingersoll,R., Sheppard,H.W. and Ray,S.C.",1999
AF067159,C,1994,9847317,"Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination","Lole,K.S., Bollinger,R.C., Paranjape,R.S., Gadkari,D., Kulkarni,S.S., Novak,N.G., Ingersoll,R., Sheppard,H.W. and Ray,S.C.",1999
AF069139,B,1991,7769705,"Isolation and characterization of a syncytium-inducing, macrophage/T-cell line-tropic human immunodeficiency virus type 1 isolate that readily infects chimpanzee cells in vitro and in vivo","Shibata,R., Hoggan,M.D., Broscius,C., Englund,G., Theodore,T.S., Buckler-White,A., Arthur,L.O., Israel,Z., Schultz,A., Lane,H.C. and Martin,M.A.",1995
AF069524,B,1985,8679299,Completion of nucleotide sequences of non-syncytium-inducing and syncytium-inducing HIV type 1 variants isolated from the same patient,"Guillon,C., Bedin,F., Fouchier,R.A., Schuitemaker,H. and Gruters,R.A.",1995
AF069669,A1,1995,10513639,Characterization of subtype A HIV-1 from Africa by full genome sequencing,"Carr,J.K., Laukkanen,T., Salminen,M.O., Albert,J., Alaeus,A., Kim,B., Sanders-Buell,E., Birx,D.L. and McCutchan,F.E.",1999
AF069670,A1,1994,10513639,Characterization of subtype A HIV-1 from Africa by full genome sequencing,"Carr,J.K., Laukkanen,T., Salminen,M.O., Albert,J., Alaeus,A., Kim,B., Sanders-Buell,E., Birx,D.L. and McCutchan,F.E.",1999
AF069671,A1,1994,10513639,Characterization of subtype A HIV-1 from Africa by full genome sequencing,"Carr,J.K., Laukkanen,T., Salminen,M.O., Albert,J., Alaeus,A., Kim,B., Sanders-Buell,E., Birx,D.L. and McCutchan,F.E.",1999
AF069672,A1U,1993,10513639,Characterization of subtype A HIV-1 from Africa by full genome sequencing,"Carr,J.K., Laukkanen,T., Salminen,M.O., Albert,J., Alaeus,A., Kim,B., Sanders-Buell,E., Birx,D.L. and McCutchan,F.E.",1999
AF069673,A1,1995,10513639,Characterization of subtype A HIV-1 from Africa by full genome sequencing,"Carr,J.K., Laukkanen,T., Salminen,M.O., Albert,J., Alaeus,A., Kim,B., Sanders-Buell,E., Birx,D.L. and McCutchan,F.E.",1999
AF070521,B,1985,7983770,Unique insertion sequence and pattern of CD4 expression in variants selected with immunotoxins from human immunodeficiency virus type 1-infected T cells,"Fang,H. and Pincus,S.H.",1995
AF070703,01_AE,1995,10826486,Diversity of envelope glycoprotein from human immunodeficiency virus type 1 of recent seroconverters in Thailand,"McCutchan,F.E., Viputtigul,K., de Souza,M.S., Carr,J.K., Markowitz,L.E., Buapunth,P., McNeil,J.G., Robb,M.L., Nitayaphan,S., Birx,D.L. and Brown,A.E.",2000
AF070704,01_AE,1995,10826486,Diversity of envelope glycoprotein from human immunodeficiency virus type 1 of recent seroconverters in Thailand,"McCutchan,F.E., Viputtigul,K., de Souza,M.S., Carr,J.K., Markowitz,L.E., Buapunth,P., McNeil,J.G., Robb,M.L., Nitayaphan,S., Birx,D.L. and Brown,A.E.",2000
AF070705,01_AE,1995,10826486,Diversity of envelope glycoprotein from human immunodeficiency virus type 1 of recent seroconverters in Thailand,"McCutchan,F.E., Viputtigul,K., de Souza,M.S., Carr,J.K., Markowitz,L.E., Buapunth,P., McNeil,J.G., Robb,M.L., Nitayaphan,S., Birx,D.L. and Brown,A.E.",2000
AF070706,01_AE,,10826486,Diversity of envelope glycoprotein from human immunodeficiency virus type 1 of recent seroconverters in Thailand,"McCutchan,F.E., Viputtigul,K., de Souza,M.S., Carr,J.K., Markowitz,L.E., Buapunth,P., McNeil,J.G., Robb,M.L., Nitayaphan,S., Birx,D.L. and Brown,A.E.",2000
AF070707,01_AE,1995,10826486,Diversity of envelope glycoprotein from human immunodeficiency virus type 1 of recent seroconverters in Thailand,"McCutchan,F.E., Viputtigul,K., de Souza,M.S., Carr,J.K., Markowitz,L.E., Buapunth,P., McNeil,J.G., Robb,M.L., Nitayaphan,S., Birx,D.L. and Brown,A.E.",2000
AF070708,01_AE,1995,10826486,Diversity of envelope glycoprotein from human immunodeficiency virus type 1 of recent seroconverters in Thailand,"McCutchan,F.E., Viputtigul,K., de Souza,M.S., Carr,J.K., Markowitz,L.E., Buapunth,P., McNeil,J.G., Robb,M.L., Nitayaphan,S., Birx,D.L. and Brown,A.E.",2000
AF070709,01_AE,1995,10826486,Diversity of envelope glycoprotein from human immunodeficiency virus type 1 of recent seroconverters in Thailand,"McCutchan,F.E., Viputtigul,K., de Souza,M.S., Carr,J.K., Markowitz,L.E., Buapunth,P., McNeil,J.G., Robb,M.L., Nitayaphan,S., Birx,D.L. and Brown,A.E.",2000
AF070710,01_AE,1996,10826486,Diversity of envelope glycoprotein from human immunodeficiency virus type 1 of recent seroconverters in Thailand,"McCutchan,F.E., Viputtigul,K., de Souza,M.S., Carr,J.K., Markowitz,L.E., Buapunth,P., McNeil,J.G., Robb,M.L., Nitayaphan,S., Birx,D.L. and Brown,A.E.",2000
AF070711,01_AE,1996,10826486,Diversity of envelope glycoprotein from human immunodeficiency virus type 1 of recent seroconverters in Thailand,"McCutchan,F.E., Viputtigul,K., de Souza,M.S., Carr,J.K., Markowitz,L.E., Buapunth,P., McNeil,J.G., Robb,M.L., Nitayaphan,S., Birx,D.L. and Brown,A.E.",2000
AF070712,01_AE,1996,10826486,Diversity of envelope glycoprotein from human immunodeficiency virus type 1 of recent seroconverters in Thailand,"McCutchan,F.E., Viputtigul,K., de Souza,M.S., Carr,J.K., Markowitz,L.E., Buapunth,P., McNeil,J.G., Robb,M.L., Nitayaphan,S., Birx,D.L. and Brown,A.E.",2000
AF070713,01_AE,1996,10826486,Diversity of envelope glycoprotein from human immunodeficiency virus type 1 of recent seroconverters in Thailand,"McCutchan,F.E., Viputtigul,K., de Souza,M.S., Carr,J.K., Markowitz,L.E., Buapunth,P., McNeil,J.G., Robb,M.L., Nitayaphan,S., Birx,D.L. and Brown,A.E.",2000
AF071473,A1D,1994,10513639,Characterization of subtype A HIV-1 from Africa by full genome sequencing,"Carr,J.K., Laukkanen,T., Salminen,M.O., Albert,J., Alaeus,A., Kim,B., Sanders-Buell,E., Birx,D.L. and McCutchan,F.E.",1999
AF071474,A1C,1996,10513639,Characterization of subtype A HIV-1 from Africa by full genome sequencing,"Carr,J.K., Laukkanen,T., Salminen,M.O., Albert,J., Alaeus,A., Kim,B., Sanders-Buell,E., Birx,D.L. and McCutchan,F.E.",1999
AF075701,A1D,1993,,Subtype A strain of HIV-1 from Uganda,"Carr,J.K., Kim,B., Sanders-Buell,E., Salminen,M.O., Alaeus,A., Albert,J.A., Birx,D.L. and McCutchan,F.E.",
AF075702,A1CD,1995,,"HIV-1 isolate SE8603 from Uganda, complete genome","Carr,J.K., Kim,B., Sanders-Buell,E., Salminen,M.O., Alaeus,A., Albert,J.A., Birx,D.L. and McCutchan,F.E.",
AF075703,F1,1993,10725202,Virtually full-length subtype F and F/D recombinant HIV-1 from Africa and South America,"Laukkanen,T., Carr,J.K., Janssens,W., Liitsola,K., Gotte,D., McCutchan,F.E., Op de Coul,E., Cornelissen,M., Heyndrickx,L., van der Groen,G. and Salminen,M.O.",2000
AF075719,B,1987,9696803,Mutations in both gp120 and gp41 are responsible for the broad neutralization resistance of variant human immunodeficiency virus type 1 MN to antibodies directed at V3 and non-V3 epitopes,"Park,E.J., Vujcic,L.K., Anand,R., Theodore,T.S. and Quinnan,G.V. Jr.",1998
AF076474,A1GHU,,,"HIV-1 isolate VI354 from Gabon, complete genome","Carr,J.K., Kim,B., Sanders-Buell,E., Salminen,M.O., Alaeus,A., Albert,J.A., Birx,D.L. and McCutchan,F.E.",
AF076475,F2KU,1994,,Direct Submission,"Carr,J.K., Kim,B., Sanders-Buell,E., Salminen,M.O., Alaeus,A., Albert,J.A., Birx,D.L. and McCutchan,F.E.",1998
AF076998,05_DF,1993,10725202,Virtually full-length subtype F and F/D recombinant HIV-1 from Africa and South America,"Laukkanen,T., Carr,J.K., Janssens,W., Liitsola,K., Gotte,D., McCutchan,F.E., Op de Coul,E., Cornelissen,M., Heyndrickx,L., van der Groen,G. and Salminen,M.O.",2000
AF077336,F1,1993,10725202,Virtually full-length subtype F and F/D recombinant HIV-1 from Africa and South America,"Laukkanen,T., Carr,J.K., Janssens,W., Liitsola,K., Gotte,D., McCutchan,F.E., Op de Coul,E., Cornelissen,M., Heyndrickx,L., van der Groen,G. and Salminen,M.O.",2000
AF082394,J,1993,10052760,Virtually full-length sequences of HIV type 1 subtype J reference strains,"Laukkanen,T., Albert,J., Liitsola,K., Green,S.D., Carr,J.K., Leitner,T., McCutchan,F.E. and Salminen,M.O.",1999
AF082395,J,1994,10052760,Virtually full-length sequences of HIV type 1 subtype J reference strains,"Laukkanen,T., Albert,J., Liitsola,K., Green,S.D., Carr,J.K., Leitner,T., McCutchan,F.E. and Salminen,M.O.",1999
AF082485,03_AB,1996,9792392,HIV-1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad,"Liitsola,K., Tashkinova,I., Laukkanen,T., Korovina,G., Smolskaja,T., Momot,O., Mashkilleyson,N., Chaplinskas,S., Brummer-Korvenkontio,H., Vanhatalo,J., Leinikki,P. and Salminen,M.O.",1907
AF082486,A6,1997,9792392,HIV-1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad,"Liitsola,K., Tashkinova,I., Laukkanen,T., Korovina,G., Smolskaja,T., Momot,O., Mashkilleyson,N., Chaplinskas,S., Brummer-Korvenkontio,H., Vanhatalo,J., Leinikki,P. and Salminen,M.O.",1907
AF084936,G,1996,10221535,Full-length genomic sequence of an HIV type 1 subtype G from Kinshasa,"Oelrichs,R.B., Vandamme,A.M., Van Laethem,K., Debyser,Z., McCutchan,F.E. and Deacon,N.J.",1999
AF086817,B,1994,,Complete sequence of type B HIV-1 Taiwan strain,"Huang,L.-M., Chen,M.-Y. and Chuang,C.-Y.",
AF107770,02_AG,1994,,Direct Submission,"Laukkanen,T. and Salminen,M.O.",1998
AF107771,A1,1995,,Direct Submission,"Laukkanen,T. and Salminen,M.O.",1998
AF110959,C,1996,10196340,Molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: a set of 23 full-length clones from Botswana,"Novitsky,V.A., Montano,M.A., McLane,M.F., Renjifo,B., Vannberg,F., Foley,B.T., Ndung'u,T.P., Rahman,M., Makhema,M.J., Marlink,R. and Essex,M.",1999
AF110962,C,1996,10196340,Molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: a set of 23 full-length clones from Botswana,"Novitsky,V.A., Montano,M.A., McLane,M.F., Renjifo,B., Vannberg,F., Foley,B.T., Ndung'u,T.P., Rahman,M., Makhema,M.J., Marlink,R. and Essex,M.",1999
AF110967,C,1996,10196340,Molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: a set of 23 full-length clones from Botswana,"Novitsky,V.A., Montano,M.A., McLane,M.F., Renjifo,B., Vannberg,F., Foley,B.T., Ndung'u,T.P., Rahman,M., Makhema,M.J., Marlink,R. and Essex,M.",1999
AF110969,C,1996,10196340,Molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: a set of 23 full-length clones from Botswana,"Novitsky,V.A., Montano,M.A., McLane,M.F., Renjifo,B., Vannberg,F., Foley,B.T., Ndung'u,T.P., Rahman,M., Makhema,M.J., Marlink,R. and Essex,M.",1999
AF110972,C,1996,10196340,Molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: a set of 23 full-length clones from Botswana,"Novitsky,V.A., Montano,M.A., McLane,M.F., Renjifo,B., Vannberg,F., Foley,B.T., Ndung'u,T.P., Rahman,M., Makhema,M.J., Marlink,R. and Essex,M.",1999
AF110973,C,1996,10196340,Molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: a set of 23 full-length clones from Botswana,"Novitsky,V.A., Montano,M.A., McLane,M.F., Renjifo,B., Vannberg,F., Foley,B.T., Ndung'u,T.P., Rahman,M., Makhema,M.J., Marlink,R. and Essex,M.",1999
AF110976,C,1996,10196340,Molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: a set of 23 full-length clones from Botswana,"Novitsky,V.A., Montano,M.A., McLane,M.F., Renjifo,B., Vannberg,F., Foley,B.T., Ndung'u,T.P., Rahman,M., Makhema,M.J., Marlink,R. and Essex,M.",1999
AF110979,C,1996,10196340,Molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: a set of 23 full-length clones from Botswana,"Novitsky,V.A., Montano,M.A., McLane,M.F., Renjifo,B., Vannberg,F., Foley,B.T., Ndung'u,T.P., Rahman,M., Makhema,M.J., Marlink,R. and Essex,M.",1999
AF112539,B,1993,9878014,The Ariel Project: A prospective cohort study of maternal-child transmission of human immunodeficiency virus type 1 in the era of maternal antiretroviral therapy,"Van Dyke,R.B., Korber,B.T., Popek,E., Macken,C., Widmayer,S.M., Bardeguez,A., Hansen,I.C., Wiznia,A., Luzuriaga,K., Viscarello,R.R., Wolinsky,S. and the Ariel Core Investigators",1999
AF112542,B,1994,9878014,The Ariel Project: A prospective cohort study of maternal-child transmission of human immunodeficiency virus type 1 in the era of maternal antiretroviral therapy,"Van Dyke,R.B., Korber,B.T., Popek,E., Macken,C., Widmayer,S.M., Bardeguez,A., Hansen,I.C., Wiznia,A., Luzuriaga,K., Viscarello,R.R., Wolinsky,S. and the Ariel Core Investigators",1999
AF112547,B,1993,9878014,The Ariel Project: A prospective cohort study of maternal-child transmission of human immunodeficiency virus type 1 in the era of maternal antiretroviral therapy,"Van Dyke,R.B., Korber,B.T., Popek,E., Macken,C., Widmayer,S.M., Bardeguez,A., Hansen,I.C., Wiznia,A., Luzuriaga,K., Viscarello,R.R., Wolinsky,S. and the Ariel Core Investigators",1999
AF112550,B,1994,9878014,The Ariel Project: A prospective cohort study of maternal-child transmission of human immunodeficiency virus type 1 in the era of maternal antiretroviral therapy,"Van Dyke,R.B., Korber,B.T., Popek,E., Macken,C., Widmayer,S.M., Bardeguez,A., Hansen,I.C., Wiznia,A., Luzuriaga,K., Viscarello,R.R., Wolinsky,S. and the Ariel Core Investigators",1999
AF112554,B,1993,9878014,The Ariel Project: A prospective cohort study of maternal-child transmission of human immunodeficiency virus type 1 in the era of maternal antiretroviral therapy,"Van Dyke,R.B., Korber,B.T., Popek,E., Macken,C., Widmayer,S.M., Bardeguez,A., Hansen,I.C., Wiznia,A., Luzuriaga,K., Viscarello,R.R., Wolinsky,S. and the Ariel Core Investigators",1999
AF112560,B,1994,9878014,The Ariel Project: A prospective cohort study of maternal-child transmission of human immunodeficiency virus type 1 in the era of maternal antiretroviral therapy,"Van Dyke,R.B., Korber,B.T., Popek,E., Macken,C., Widmayer,S.M., Bardeguez,A., Hansen,I.C., Wiznia,A., Luzuriaga,K., Viscarello,R.R., Wolinsky,S. and the Ariel Core Investigators",1999
AF112563,B,1994,9878014,The Ariel Project: A prospective cohort study of maternal-child transmission of human immunodeficiency virus type 1 in the era of maternal antiretroviral therapy,"Van Dyke,R.B., Korber,B.T., Popek,E., Macken,C., Widmayer,S.M., Bardeguez,A., Hansen,I.C., Wiznia,A., Luzuriaga,K., Viscarello,R.R., Wolinsky,S. and the Ariel Core Investigators",1999
AF112564,B,1995,9878014,The Ariel Project: A prospective cohort study of maternal-child transmission of human immunodeficiency virus type 1 in the era of maternal antiretroviral therapy,"Van Dyke,R.B., Korber,B.T., Popek,E., Macken,C., Widmayer,S.M., Bardeguez,A., Hansen,I.C., Wiznia,A., Luzuriaga,K., Viscarello,R.R., Wolinsky,S. and the Ariel Core Investigators",1999
AF119819,04_cpx,1997,10357470,Molecular analysis of the full-length genome of HIV type 1 subtype I: evidence of A/G/I recombination,"Nasioulas,G., Paraskevis,D., Magiorkinis,E., Theodoridou,M. and Hatzakis,A.",1999
AF119820,04_cpx,1991,10357470,Molecular analysis of the full-length genome of HIV type 1 subtype I: evidence of A/G/I recombination,"Nasioulas,G., Paraskevis,D., Magiorkinis,E., Theodoridou,M. and Hatzakis,A.",1999
AF128126,B,1989,10221533,Expression and characterization of HIV type 1 envelope protein associated with a broadly reactive neutralizing antibody response,"Quinnan,G.V. Jr., Zhang,P.F., Fu,D.W., Dong,M. and Alter,H.J.",1999
AF133821,D,1993,10196337,"Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya","Neilson,J.R., John,G.C., Carr,J.K., Lewis,P., Kreiss,J.K., Jackson,S., Nduati,R.W., Mbori-Ngacha,D., Panteleeff,D.D., Bodrug,S., Giachetti,C., Bott,M.A., Richardson,B.A., Bwayo,J., Ndinya-Achola,J. and Overbaugh,J.",1999
AF146728,B,,,Near full-length proviral sequence of HIV-1 from an individual homozygous for the delta-32 CCR5 allele,"Oelrichs,R.",
AF164485,01_AE,1993,10606093,Sequence features downstream of the primer-binding site of HIV type 1 subtype E shared by subtype G and a subset of subtype A,"Chang,S.Y., Apichartpiyakul,C., Kuiken,C.L., Essex,M. and Lee,T.H.",1999
AF179368,11_cpx,,10875610,Molecular characterization of a recombinant HIV type 1 isolate (A/G/E/?): unidentified regions may be derived from parental subtype E sequences,"Paraskevis,D., Magiorkinis,M., Paparizos,V., Pavlakis,G.N. and Hatzakis,A.",2000
AF184155,0209,1997,10935981,AIDS in an HIV-seronegative Ghanaian woman with intersubtype A/G recombinant HIV-1 infection,"Candotti,D., Adu-Sarkodie,Y., Davies,F., Baldrich-Rubio,E., Stirrups,K., Lee,H. and Allain,J.P.",2000
AF190127,H,1993,10983640,HIV-1 subtype H near-full length genome reference strains and analysis of subtype-H-containing inter-subtype recombinants,"Janssens,W., Laukkanen,T., Salminen,M.O., Carr,J.K., Van der Auwera,G., Heyndrickx,L., van der Groen,G. and McCutchan,F.E.",2000
AF190128,H,1993,10983640,HIV-1 subtype H near-full length genome reference strains and analysis of subtype-H-containing inter-subtype recombinants,"Janssens,W., Laukkanen,T., Salminen,M.O., Carr,J.K., Van der Auwera,G., Heyndrickx,L., van der Groen,G. and McCutchan,F.E.",2000
AF192135,A1GJ,1998,10890363,HIV type 1 A/J recombinant with a pronounced pol gene mosaicism,"Novitsky,V.A., Gaolekwe,S., McLane,M.F., Ndung'u,T.P., Foley,B.T., Vannberg,F., Marlink,R. and Essex,M.",2000
AF193253,05_DF,,10725202,Virtually full-length subtype F and F/D recombinant HIV-1 from Africa and South America,"Laukkanen,T., Carr,J.K., Janssens,W., Liitsola,K., Gotte,D., McCutchan,F.E., Op de Coul,E., Cornelissen,M., Heyndrickx,L., van der Groen,G. and Salminen,M.O.",2000
AF193275,A6,1997,10933619,An AB recombinant and its parental HIV type 1 strains in the area of the former Soviet Union: low requirements for sequence identity in recombination. UNAIDS Virus Isolation Network,"Liitsola,K., Holm,K., Bobkov,A., Pokrovsky,V., Smolskaya,T., Leinikki,P., Osmanov,S. and Salminen,M.",2000
AF193276,03_AB,1997,10933619,An AB recombinant and its parental HIV type 1 strains in the area of the former Soviet Union: low requirements for sequence identity in recombination. UNAIDS Virus Isolation Network,"Liitsola,K., Holm,K., Bobkov,A., Pokrovsky,V., Smolskaya,T., Leinikki,P., Osmanov,S. and Salminen,M.",2000
AF193277,03_AB,1998,10933619,An AB recombinant and its parental HIV type 1 strains in the area of the former Soviet Union: low requirements for sequence identity in recombination. UNAIDS Virus Isolation Network,"Liitsola,K., Holm,K., Bobkov,A., Pokrovsky,V., Smolskaya,T., Leinikki,P., Osmanov,S. and Salminen,M.",2000
AF197340,01_AE,1990,11044120,Testing the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype E,"Anderson,J.P., Rodrigo,A.G., Learn,G.H., Madan,A., Delahunty,C., Coon,M., Girard,M., Osmanov,S., Hood,L. and Mullins,J.I.",2000
AF217150,B,,10871768,Analysis of human immunodeficiency virus type 1 gp160 sequences from a patient with HIV dementia: evidence for monocyte trafficking into brain,"Liu,Y., Tang,X.P., McArthur,J.C., Scott,J. and Gartner,S.",2000
AF219261,A1,1991,11055649,Analysis of HIV-1 genetic subtypes in Finland reveals good correlation between molecular and epidemiological data,"Liitsola,K., Holmstrom,P., Laukkanen,T., Brummer-Korvenkontio,H., Leinikki,P. and Salminen,M.O.",2000
AF219265,A1,1991,11055649,Analysis of HIV-1 genetic subtypes in Finland reveals good correlation between molecular and epidemiological data,"Liitsola,K., Holmstrom,P., Laukkanen,T., Brummer-Korvenkontio,H., Leinikki,P. and Salminen,M.O.",2000
AF219266,C,1992,11055649,Analysis of HIV-1 genetic subtypes in Finland reveals good correlation between molecular and epidemiological data,"Liitsola,K., Holmstrom,P., Laukkanen,T., Brummer-Korvenkontio,H., Leinikki,P. and Salminen,M.O.",2000
AF219269,C,1992,11055649,Analysis of HIV-1 genetic subtypes in Finland reveals good correlation between molecular and epidemiological data,"Liitsola,K., Holmstrom,P., Laukkanen,T., Brummer-Korvenkontio,H., Leinikki,P. and Salminen,M.O.",2000
AF219273,01_AE,1993,11055649,Analysis of HIV-1 genetic subtypes in Finland reveals good correlation between molecular and epidemiological data,"Liitsola,K., Holmstrom,P., Laukkanen,T., Brummer-Korvenkontio,H., Leinikki,P. and Salminen,M.O.",2000
AF219274,C,1994,11055649,Analysis of HIV-1 genetic subtypes in Finland reveals good correlation between molecular and epidemiological data,"Liitsola,K., Holmstrom,P., Laukkanen,T., Brummer-Korvenkontio,H., Leinikki,P. and Salminen,M.O.",2000
AF219627,B,,11135618,Isolation of primary HIV-1 that target CD8+ T lymphocytes using CD8 as a receptor,"Saha,K., Zhang,J., Gupta,A., Dave,R., Yimen,M. and Zerhouni,B.",2001
AF224507,B,1997,12892062,Natural polymorphisms of protease in protease inhibitor-naive HIV-1 infected patients in Korea: a novel L63M in subtype B,"Sung,H., Foley,B.T., Ahn,S.H., Kim,Y.B., Chae,J.D., Shin,Y.O., Kang,H.I. and Cho,Y.K.",2003
AF227272,B,,10623731,Determinants of syncytium formation in microglia by human immunodeficiency virus type 1: role of the V1/V2 domains,"Shieh,J.T., Martin,J., Baltuch,G., Malim,M.H. and Gonzalez-Scarano,F.",2000
AF256204,B,1989,11000225,Unusual distribution of mutations associated with serial bottleneck passages of human immunodeficiency virus type 1,"Yuste,E., Lopez-Galindez,C. and Domingo,E.",2000
AF259954,01_AE,1990,11112486,Construction and biological characterization of infectious molecular clones of HIV-1 subtypes B and E (CRF01_AE) generated by the polymerase chain reaction,"Salminen,M.O., Ehrenberg,P.K., Mascola,J.R., Dayhoff,D.E., Merling,R., Blake,B., Louder,M., Hegerich,S., Polonis,V.R., Birx,D.L., Robb,M.L., McCutchan,F.E. and Michael,N.L.",2000
AF277054,B,1994,10984542,A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago,"Cleghorn,F.R., Jack,N., Carr,J.K., Edwards,J., Mahabir,B., Sill,A., McDanal,C.B., Connolly,S.M., Goodman,D., Bennetts,R.Q., O'Brien,T.R., Weinhold,K.J., Bartholomew,C., Blattner,W.A. and Greenberg,M.L.",2000
AF277055,B,1994,10984542,A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago,"Cleghorn,F.R., Jack,N., Carr,J.K., Edwards,J., Mahabir,B., Sill,A., McDanal,C.B., Connolly,S.M., Goodman,D., Bennetts,R.Q., O'Brien,T.R., Weinhold,K.J., Bartholomew,C., Blattner,W.A. and Greenberg,M.L.",2000
AF277056,B,1994,10984542,A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago,"Cleghorn,F.R., Jack,N., Carr,J.K., Edwards,J., Mahabir,B., Sill,A., McDanal,C.B., Connolly,S.M., Goodman,D., Bennetts,R.Q., O'Brien,T.R., Weinhold,K.J., Bartholomew,C., Blattner,W.A. and Greenberg,M.L.",2000
AF277057,B,1994,10984542,A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago,"Cleghorn,F.R., Jack,N., Carr,J.K., Edwards,J., Mahabir,B., Sill,A., McDanal,C.B., Connolly,S.M., Goodman,D., Bennetts,R.Q., O'Brien,T.R., Weinhold,K.J., Bartholomew,C., Blattner,W.A. and Greenberg,M.L.",2000
AF277058,B,1993,10984542,A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago,"Cleghorn,F.R., Jack,N., Carr,J.K., Edwards,J., Mahabir,B., Sill,A., McDanal,C.B., Connolly,S.M., Goodman,D., Bennetts,R.Q., O'Brien,T.R., Weinhold,K.J., Bartholomew,C., Blattner,W.A. and Greenberg,M.L.",2000
AF277059,B,1993,10984542,A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago,"Cleghorn,F.R., Jack,N., Carr,J.K., Edwards,J., Mahabir,B., Sill,A., McDanal,C.B., Connolly,S.M., Goodman,D., Bennetts,R.Q., O'Brien,T.R., Weinhold,K.J., Bartholomew,C., Blattner,W.A. and Greenberg,M.L.",2000
AF277060,B,1993,10984542,A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago,"Cleghorn,F.R., Jack,N., Carr,J.K., Edwards,J., Mahabir,B., Sill,A., McDanal,C.B., Connolly,S.M., Goodman,D., Bennetts,R.Q., O'Brien,T.R., Weinhold,K.J., Bartholomew,C., Blattner,W.A. and Greenberg,M.L.",2000
AF277061,B,1994,10984542,A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago,"Cleghorn,F.R., Jack,N., Carr,J.K., Edwards,J., Mahabir,B., Sill,A., McDanal,C.B., Connolly,S.M., Goodman,D., Bennetts,R.Q., O'Brien,T.R., Weinhold,K.J., Bartholomew,C., Blattner,W.A. and Greenberg,M.L.",2000
AF277062,B,1994,10984542,A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago,"Cleghorn,F.R., Jack,N., Carr,J.K., Edwards,J., Mahabir,B., Sill,A., McDanal,C.B., Connolly,S.M., Goodman,D., Bennetts,R.Q., O'Brien,T.R., Weinhold,K.J., Bartholomew,C., Blattner,W.A. and Greenberg,M.L.",2000
AF277063,B,1994,10984542,A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago,"Cleghorn,F.R., Jack,N., Carr,J.K., Edwards,J., Mahabir,B., Sill,A., McDanal,C.B., Connolly,S.M., Goodman,D., Bennetts,R.Q., O'Brien,T.R., Weinhold,K.J., Bartholomew,C., Blattner,W.A. and Greenberg,M.L.",2000
AF277064,B,1994,10984542,A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago,"Cleghorn,F.R., Jack,N., Carr,J.K., Edwards,J., Mahabir,B., Sill,A., McDanal,C.B., Connolly,S.M., Goodman,D., Bennetts,R.Q., O'Brien,T.R., Weinhold,K.J., Bartholomew,C., Blattner,W.A. and Greenberg,M.L.",2000
AF277065,B,1994,10984542,A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago,"Cleghorn,F.R., Jack,N., Carr,J.K., Edwards,J., Mahabir,B., Sill,A., McDanal,C.B., Connolly,S.M., Goodman,D., Bennetts,R.Q., O'Brien,T.R., Weinhold,K.J., Bartholomew,C., Blattner,W.A. and Greenberg,M.L.",2000
AF277066,B,1994,10984542,A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago,"Cleghorn,F.R., Jack,N., Carr,J.K., Edwards,J., Mahabir,B., Sill,A., McDanal,C.B., Connolly,S.M., Goodman,D., Bennetts,R.Q., O'Brien,T.R., Weinhold,K.J., Bartholomew,C., Blattner,W.A. and Greenberg,M.L.",2000
AF277067,B,1994,10984542,A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago,"Cleghorn,F.R., Jack,N., Carr,J.K., Edwards,J., Mahabir,B., Sill,A., McDanal,C.B., Connolly,S.M., Goodman,D., Bennetts,R.Q., O'Brien,T.R., Weinhold,K.J., Bartholomew,C., Blattner,W.A. and Greenberg,M.L.",2000
AF277068,B,1995,10984542,A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago,"Cleghorn,F.R., Jack,N., Carr,J.K., Edwards,J., Mahabir,B., Sill,A., McDanal,C.B., Connolly,S.M., Goodman,D., Bennetts,R.Q., O'Brien,T.R., Weinhold,K.J., Bartholomew,C., Blattner,W.A. and Greenberg,M.L.",2000
AF277069,B,1995,10984542,A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago,"Cleghorn,F.R., Jack,N., Carr,J.K., Edwards,J., Mahabir,B., Sill,A., McDanal,C.B., Connolly,S.M., Goodman,D., Bennetts,R.Q., O'Brien,T.R., Weinhold,K.J., Bartholomew,C., Blattner,W.A. and Greenberg,M.L.",2000
AF277070,B,1995,10984542,A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago,"Cleghorn,F.R., Jack,N., Carr,J.K., Edwards,J., Mahabir,B., Sill,A., McDanal,C.B., Connolly,S.M., Goodman,D., Bennetts,R.Q., O'Brien,T.R., Weinhold,K.J., Bartholomew,C., Blattner,W.A. and Greenberg,M.L.",2000
AF277071,B,1995,10984542,A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago,"Cleghorn,F.R., Jack,N., Carr,J.K., Edwards,J., Mahabir,B., Sill,A., McDanal,C.B., Connolly,S.M., Goodman,D., Bennetts,R.Q., O'Brien,T.R., Weinhold,K.J., Bartholomew,C., Blattner,W.A. and Greenberg,M.L.",2000
AF277072,B,1995,10984542,A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago,"Cleghorn,F.R., Jack,N., Carr,J.K., Edwards,J., Mahabir,B., Sill,A., McDanal,C.B., Connolly,S.M., Goodman,D., Bennetts,R.Q., O'Brien,T.R., Weinhold,K.J., Bartholomew,C., Blattner,W.A. and Greenberg,M.L.",2000
AF277073,B,1995,10984542,A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago,"Cleghorn,F.R., Jack,N., Carr,J.K., Edwards,J., Mahabir,B., Sill,A., McDanal,C.B., Connolly,S.M., Goodman,D., Bennetts,R.Q., O'Brien,T.R., Weinhold,K.J., Bartholomew,C., Blattner,W.A. and Greenberg,M.L.",2000
AF277074,B,1995,10984542,A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago,"Cleghorn,F.R., Jack,N., Carr,J.K., Edwards,J., Mahabir,B., Sill,A., McDanal,C.B., Connolly,S.M., Goodman,D., Bennetts,R.Q., O'Brien,T.R., Weinhold,K.J., Bartholomew,C., Blattner,W.A. and Greenberg,M.L.",2000
AF277075,B,1996,10984542,A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago,"Cleghorn,F.R., Jack,N., Carr,J.K., Edwards,J., Mahabir,B., Sill,A., McDanal,C.B., Connolly,S.M., Goodman,D., Bennetts,R.Q., O'Brien,T.R., Weinhold,K.J., Bartholomew,C., Blattner,W.A. and Greenberg,M.L.",2000
AF286223,C,1994,11177395,Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents,"Rodenburg,C.M., Li,Y., Trask,S.A., Chen,Y., Decker,J., Robertson,D.L., Kalish,M.L., Shaw,G.M., Allen,S., Hahn,B.H. and Gao,F.",2001
AF286224,C,1996,11177395,Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents,"Rodenburg,C.M., Li,Y., Trask,S.A., Chen,Y., Decker,J., Robertson,D.L., Kalish,M.L., Shaw,G.M., Allen,S., Hahn,B.H. and Gao,F.",2001
AF286225,C,1996,11177395,Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents,"Rodenburg,C.M., Li,Y., Trask,S.A., Chen,Y., Decker,J., Robertson,D.L., Kalish,M.L., Shaw,G.M., Allen,S., Hahn,B.H. and Gao,F.",2001
AF286226,07_BC,1997,11177395,Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents,"Rodenburg,C.M., Li,Y., Trask,S.A., Chen,Y., Decker,J., Robertson,D.L., Kalish,M.L., Shaw,G.M., Allen,S., Hahn,B.H. and Gao,F.",2001
AF286227,C,1997,11177395,Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents,"Rodenburg,C.M., Li,Y., Trask,S.A., Chen,Y., Decker,J., Robertson,D.L., Kalish,M.L., Shaw,G.M., Allen,S., Hahn,B.H. and Gao,F.",2001
AF286228,C,1998,11177395,Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents,"Rodenburg,C.M., Li,Y., Trask,S.A., Chen,Y., Decker,J., Robertson,D.L., Kalish,M.L., Shaw,G.M., Allen,S., Hahn,B.H. and Gao,F.",2001
AF286229,08_BC,1998,11177395,Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents,"Rodenburg,C.M., Li,Y., Trask,S.A., Chen,Y., Decker,J., Robertson,D.L., Kalish,M.L., Shaw,G.M., Allen,S., Hahn,B.H. and Gao,F.",2001
AF286230,07_BC,1998,11177395,Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents,"Rodenburg,C.M., Li,Y., Trask,S.A., Chen,Y., Decker,J., Robertson,D.L., Kalish,M.L., Shaw,G.M., Allen,S., Hahn,B.H. and Gao,F.",2001
AF286231,C,1998,11177395,Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents,"Rodenburg,C.M., Li,Y., Trask,S.A., Chen,Y., Decker,J., Robertson,D.L., Kalish,M.L., Shaw,G.M., Allen,S., Hahn,B.H. and Gao,F.",2001
AF286232,C,1998,11177395,Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents,"Rodenburg,C.M., Li,Y., Trask,S.A., Chen,Y., Decker,J., Robertson,D.L., Kalish,M.L., Shaw,G.M., Allen,S., Hahn,B.H. and Gao,F.",2001
AF286233,C,1998,11177395,Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents,"Rodenburg,C.M., Li,Y., Trask,S.A., Chen,Y., Decker,J., Robertson,D.L., Kalish,M.L., Shaw,G.M., Allen,S., Hahn,B.H. and Gao,F.",2001
AF286234,C,1998,11177395,Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents,"Rodenburg,C.M., Li,Y., Trask,S.A., Chen,Y., Decker,J., Robertson,D.L., Kalish,M.L., Shaw,G.M., Allen,S., Hahn,B.H. and Gao,F.",2001
AF286235,C,1998,11177395,Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents,"Rodenburg,C.M., Li,Y., Trask,S.A., Chen,Y., Decker,J., Robertson,D.L., Kalish,M.L., Shaw,G.M., Allen,S., Hahn,B.H. and Gao,F.",2001
AF286236,U,1983,11522191,Molecular characterization of a highly divergent HIV type 1 isolate obtained early in the AIDS epidemic from the Democratic Republic of Congo,"Gao,F., Trask,S.A., Hui,H., Mamaeva,O., Chen,Y., Theodore,T.S., Foley,B.T., Korber,B.T., Shaw,G.M. and Hahn,B.H.",2001
AF286237,A2,1994,11429108,Evidence of two distinct subsubtypes within the HIV-1 subtype A radiation,"Gao,F., Vidal,N., Li,Y., Trask,S.A., Chen,Y., Kostrikis,L.G., Ho,D.D., Kim,J., Oh,M.-D., Choe,K., Salminen,M., Robertson,D.L., Shaw,G.M., Hahn,B.H. and Peeters,M.",2001
AF286238,A2,1997,11429108,Evidence of two distinct subsubtypes within the HIV-1 subtype A radiation,"Gao,F., Vidal,N., Li,Y., Trask,S.A., Chen,Y., Kostrikis,L.G., Ho,D.D., Kim,J., Oh,M.-D., Choe,K., Salminen,M., Robertson,D.L., Shaw,G.M., Hahn,B.H. and Peeters,M.",2001
AF286239,16_A2D,1997,11429108,Evidence of two distinct subsubtypes within the HIV-1 subtype A radiation,"Gao,F., Vidal,N., Li,Y., Trask,S.A., Chen,Y., Kostrikis,L.G., Ho,D.D., Kim,J., Oh,M.-D., Choe,K., Salminen,M., Robertson,D.L., Shaw,G.M., Hahn,B.H. and Peeters,M.",2001
AF286241,A2,1997,11429108,Evidence of two distinct subsubtypes within the HIV-1 subtype A radiation,"Gao,F., Vidal,N., Li,Y., Trask,S.A., Chen,Y., Kostrikis,L.G., Ho,D.D., Kim,J., Oh,M.-D., Choe,K., Salminen,M., Robertson,D.L., Shaw,G.M., Hahn,B.H. and Peeters,M.",2001
AF286245,A2,1995,,Evidence for two distinct sub-subtypes within the HIV-1 subtype A radiation,"Gao,F., Vidal,N., Li,Y., Trask,S.A., Chen,Y., Kostrikis,L.G., Ho,D.D., Kim,J., Choe,K., Oh,M.-D., Salminen,M., Robertson,D.L., Shaw,G.M., Hahn,B.H. and Peeters,M.",
AF286249,A2,1994,,Evidence for two distinct sub-subtypes within the HIV-1 subtype A radiation,"Gao,F., Vidal,N., Li,Y., Trask,S.A., Chen,Y., Kostrikis,L.G., Ho,D.D., Kim,J., Choe,K., Oh,M.-D., Salminen,M., Robertson,D.L., Shaw,G.M., Hahn,B.H. and Peeters,M.",
AF286254,A2,1994,,Evidence for two distinct sub-subtypes within the HIV-1 subtype A radiation,"Gao,F., Vidal,N., Li,Y., Trask,S.A., Chen,Y., Kostrikis,L.G., Ho,D.D., Kim,J., Choe,K., Oh,M.-D., Salminen,M., Robertson,D.L., Shaw,G.M., Hahn,B.H. and Peeters,M.",
AF286365,B,1988,11112486,Construction and biological characterization of infectious molecular clones of HIV-1 subtypes B and E (CRF01_AE) generated by the polymerase chain reaction,"Salminen,M.O., Ehrenberg,P.K., Mascola,J.R., Dayhoff,D.E., Merling,R., Blake,B., Louder,M., Hegerich,S., Polonis,V.R., Birx,D.L., Robb,M.L., McCutchan,F.E. and Michael,N.L.",2000
AF290027,C,1996,11118362,Molecular cloning and biological characterization of full-length HIV-1 subtype C from Botswana,"Ndung'u,T., Renjifo,B., Novitsky,V.A., McLane,M.F., Gaolekwe,S. and Essex,M.",2000
AF316544,A2G,1997,11429108,Evidence of two distinct subsubtypes within the HIV-1 subtype A radiation,"Gao,F., Vidal,N., Li,Y., Trask,S.A., Chen,Y., Kostrikis,L.G., Ho,D.D., Kim,J., Oh,M.-D., Choe,K., Salminen,M., Robertson,D.L., Shaw,G.M., Hahn,B.H. and Peeters,M.",2001
AF321080,B,,,Antigenicity and functional properties of recombinant envelope glycoproteins derived from ten HIV-1 clades A to G primary isolates,"Lemiale,F., Brand,D. and Barin,F.",
AF332867,BF,1999,11752707,Diversity of mosaic structures and common ancestry of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Argentina revealed by analysis of near full-length genome sequences,"Thomson,M.M., Delgado,E., Herrero,I., Villahermosa,M.L., Vazquez-de Parga,E., Cuevas,M.T., Carmona,R., Medrano,L., Perez-Alvarez,L., Cuevas,L. and Najera,R.",2002
AF361871,A1C,1997,11504977,High proportion of unrelated HIV-1 intersubtype recombinants in the Mbeya region of southwest Tanzania,"Hoelscher,M., Kim,B., Maboko,L., Mhalu,F., von Sonnenburg,F., Birx,D.L. and McCutchan,F.E.",2001
AF361872,A1,1997,11504977,High proportion of unrelated HIV-1 intersubtype recombinants in the Mbeya region of southwest Tanzania,"Hoelscher,M., Kim,B., Maboko,L., Mhalu,F., von Sonnenburg,F., Birx,D.L. and McCutchan,F.E.",2001
AF361873,A1,1997,11504977,High proportion of unrelated HIV-1 intersubtype recombinants in the Mbeya region of southwest Tanzania,"Hoelscher,M., Kim,B., Maboko,L., Mhalu,F., von Sonnenburg,F., Birx,D.L. and McCutchan,F.E.",2001
AF361874,C,1997,11504977,High proportion of unrelated HIV-1 intersubtype recombinants in the Mbeya region of southwest Tanzania,"Hoelscher,M., Kim,B., Maboko,L., Mhalu,F., von Sonnenburg,F., Birx,D.L. and McCutchan,F.E.",2001
AF361875,C,1997,11504977,High proportion of unrelated HIV-1 intersubtype recombinants in the Mbeya region of southwest Tanzania,"Hoelscher,M., Kim,B., Maboko,L., Mhalu,F., von Sonnenburg,F., Birx,D.L. and McCutchan,F.E.",2001
AF361876,A1C,1997,11504977,High proportion of unrelated HIV-1 intersubtype recombinants in the Mbeya region of southwest Tanzania,"Hoelscher,M., Kim,B., Maboko,L., Mhalu,F., von Sonnenburg,F., Birx,D.L. and McCutchan,F.E.",2001
AF361877,CD,1997,11504977,High proportion of unrelated HIV-1 intersubtype recombinants in the Mbeya region of southwest Tanzania,"Hoelscher,M., Kim,B., Maboko,L., Mhalu,F., von Sonnenburg,F., Birx,D.L. and McCutchan,F.E.",2001
AF361878,A1C,1997,11504977,High proportion of unrelated HIV-1 intersubtype recombinants in the Mbeya region of southwest Tanzania,"Hoelscher,M., Kim,B., Maboko,L., Mhalu,F., von Sonnenburg,F., Birx,D.L. and McCutchan,F.E.",2001
AF361879,A1C,1997,11504977,High proportion of unrelated HIV-1 intersubtype recombinants in the Mbeya region of southwest Tanzania,"Hoelscher,M., Kim,B., Maboko,L., Mhalu,F., von Sonnenburg,F., Birx,D.L. and McCutchan,F.E.",2001
AF362994,01B,,11399992,First CRF01_AE/B recombinant of HIV-1 is found in Thailand,"Tovanabutra,S., Polonis,V.R., De Souza,M., Trichavaroj,R., Chanbancherd,P., Kim,B., Sanders-Buell,E., Nitayaphan,S., Brown,A.E., Robb,M.R., Berx,D.L., McCutchan,F.E. and Carr,J.K.",2001
AF377954,02_AG,1997,11448170,The AG recombinant IbNG and novel strains of group M HIV-1 are common in Cameroon,"Carr,J.K., Torimiro,J.N., Wolfe,N.D., Eitel,M.N., Kim,B., Sanders-Buell,E., Jagodzinski,L.L., Gotte,D., Burke,D.S., Birx,D.L. and McCutchan,F.E.",2001
AF377955,02_AG,1997,11448170,The AG recombinant IbNG and novel strains of group M HIV-1 are common in Cameroon,"Carr,J.K., Torimiro,J.N., Wolfe,N.D., Eitel,M.N., Kim,B., Sanders-Buell,E., Jagodzinski,L.L., Gotte,D., Burke,D.S., Birx,D.L. and McCutchan,F.E.",2001
AF377956,F2,1997,11448170,The AG recombinant IbNG and novel strains of group M HIV-1 are common in Cameroon,"Carr,J.K., Torimiro,J.N., Wolfe,N.D., Eitel,M.N., Kim,B., Sanders-Buell,E., Jagodzinski,L.L., Gotte,D., Burke,D.S., Birx,D.L. and McCutchan,F.E.",2001
AF377957,37_cpx,1997,11448170,The AG recombinant IbNG and novel strains of group M HIV-1 are common in Cameroon,"Carr,J.K., Torimiro,J.N., Wolfe,N.D., Eitel,M.N., Kim,B., Sanders-Buell,E., Jagodzinski,L.L., Gotte,D., Burke,D.S., Birx,D.L. and McCutchan,F.E.",2001
AF377958,AF2G,1997,11448170,The AG recombinant IbNG and novel strains of group M HIV-1 are common in Cameroon,"Carr,J.K., Torimiro,J.N., Wolfe,N.D., Eitel,M.N., Kim,B., Sanders-Buell,E., Jagodzinski,L.L., Gotte,D., Burke,D.S., Birx,D.L. and McCutchan,F.E.",2001
AF377959,18_cpx,1997,11448170,The AG recombinant IbNG and novel strains of group M HIV-1 are common in Cameroon,"Carr,J.K., Torimiro,J.N., Wolfe,N.D., Eitel,M.N., Kim,B., Sanders-Buell,E., Jagodzinski,L.L., Gotte,D., Burke,D.S., Birx,D.L. and McCutchan,F.E.",2001
AF383228,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF383229,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF383230,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF383231,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF383232,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF383233,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF383234,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF383235,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF383236,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF383237,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF383238,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF383239,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF383240,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF383241,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF383242,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF383243,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF383244,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF383245,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF383246,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF383247,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF383248,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF383250,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF383251,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF383252,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF383253,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF383254,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF383255,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF383256,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF383257,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF383258,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF383259,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF383260,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF383261,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF383262,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF385934,12_BF,1999,11600844,Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America,"Carr,J.K., Avila,M., Gomez Carrillo,M., Salomon,H., Hierholzer,J., Watanaveeradej,V., Pando,M.A., Negrete,M., Russell,K.L., Sanchez,J., Birx,D.L., Andrade,R., Vinoles,J. and McCutchan,F.E.",2001
AF385935,12_BF,1999,11600844,Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America,"Carr,J.K., Avila,M., Gomez Carrillo,M., Salomon,H., Hierholzer,J., Watanaveeradej,V., Pando,M.A., Negrete,M., Russell,K.L., Sanchez,J., Birx,D.L., Andrade,R., Vinoles,J. and McCutchan,F.E.",2001
AF385936,12_BF,1999,11600844,Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America,"Carr,J.K., Avila,M., Gomez Carrillo,M., Salomon,H., Hierholzer,J., Watanaveeradej,V., Pando,M.A., Negrete,M., Russell,K.L., Sanchez,J., Birx,D.L., Andrade,R., Vinoles,J. and McCutchan,F.E.",2001
AF391230,C,1998,11709098,Genetic analysis of the complete gag and env genes of HIV type 1 subtype C primary isolates from South Africa,"Engelbrecht,S., de Villiers,T., Sampson,C.C., zur Megede,J., Barnett,S.W. and van Rensburg,E.J.",2001
AF391232,C,1998,11709098,Genetic analysis of the complete gag and env genes of HIV type 1 subtype C primary isolates from South Africa,"Engelbrecht,S., de Villiers,T., Sampson,C.C., zur Megede,J., Barnett,S.W. and van Rensburg,E.J.",2001
AF391233,C,1998,11709098,Genetic analysis of the complete gag and env genes of HIV type 1 subtype C primary isolates from South Africa,"Engelbrecht,S., de Villiers,T., Sampson,C.C., zur Megede,J., Barnett,S.W. and van Rensburg,E.J.",2001
AF391234,C,1998,11709098,Genetic analysis of the complete gag and env genes of HIV type 1 subtype C primary isolates from South Africa,"Engelbrecht,S., de Villiers,T., Sampson,C.C., zur Megede,J., Barnett,S.W. and van Rensburg,E.J.",2001
AF391235,C,1998,11709098,Genetic analysis of the complete gag and env genes of HIV type 1 subtype C primary isolates from South Africa,"Engelbrecht,S., de Villiers,T., Sampson,C.C., zur Megede,J., Barnett,S.W. and van Rensburg,E.J.",2001
AF391238,C,1998,11709098,Genetic analysis of the complete gag and env genes of HIV type 1 subtype C primary isolates from South Africa,"Engelbrecht,S., de Villiers,T., Sampson,C.C., zur Megede,J., Barnett,S.W. and van Rensburg,E.J.",2001
AF391240,C,1998,11709098,Genetic analysis of the complete gag and env genes of HIV type 1 subtype C primary isolates from South Africa,"Engelbrecht,S., de Villiers,T., Sampson,C.C., zur Megede,J., Barnett,S.W. and van Rensburg,E.J.",2001
AF391242,C,1998,11709098,Genetic analysis of the complete gag and env genes of HIV type 1 subtype C primary isolates from South Africa,"Engelbrecht,S., de Villiers,T., Sampson,C.C., zur Megede,J., Barnett,S.W. and van Rensburg,E.J.",2001
AF391243,C,1998,11709098,Genetic analysis of the complete gag and env genes of HIV type 1 subtype C primary isolates from South Africa,"Engelbrecht,S., de Villiers,T., Sampson,C.C., zur Megede,J., Barnett,S.W. and van Rensburg,E.J.",2001
AF391245,C,1998,11709098,Genetic analysis of the complete gag and env genes of HIV type 1 subtype C primary isolates from South Africa,"Engelbrecht,S., de Villiers,T., Sampson,C.C., zur Megede,J., Barnett,S.W. and van Rensburg,E.J.",2001
AF391247,C,1998,11709098,Genetic analysis of the complete gag and env genes of HIV type 1 subtype C primary isolates from South Africa,"Engelbrecht,S., de Villiers,T., Sampson,C.C., zur Megede,J., Barnett,S.W. and van Rensburg,E.J.",2001
AF391249,C,1998,11709098,Genetic analysis of the complete gag and env genes of HIV type 1 subtype C primary isolates from South Africa,"Engelbrecht,S., de Villiers,T., Sampson,C.C., zur Megede,J., Barnett,S.W. and van Rensburg,E.J.",2001
AF391250,C,1998,11709098,Genetic analysis of the complete gag and env genes of HIV type 1 subtype C primary isolates from South Africa,"Engelbrecht,S., de Villiers,T., Sampson,C.C., zur Megede,J., Barnett,S.W. and van Rensburg,E.J.",2001
AF395814,O,,11860674,Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters,"Yamaguchi,J., Vallari,A.S., Swanson,P., Bodelle,P., Kaptue,L., Ngansop,C., Zekeng,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2002
AF403705,B,1983,12015905,A 100-amino acid truncation in the cytoplasmic tail of glycoprotein 41 in the reference HIV type 1 strain RF,"Jones,D.R., Suzuki,K. and Piller,S.C.",2002
AF407148,A1D,1995,12036486,"HIV type 1 variants transmitted to women in Kenya require the CCR5 coreceptor for entry, regardless of the genetic complexity of the infecting virus","Long,E.M., Rainwater,S.M., Lavreys,L., Mandaliya,K. and Overbaugh,J.",2002
AF407151,A1,1994,12036486,"HIV type 1 variants transmitted to women in Kenya require the CCR5 coreceptor for entry, regardless of the genetic complexity of the infecting virus","Long,E.M., Rainwater,S.M., Lavreys,L., Mandaliya,K. and Overbaugh,J.",2002
AF407154,A1,1995,12036486,"HIV type 1 variants transmitted to women in Kenya require the CCR5 coreceptor for entry, regardless of the genetic complexity of the infecting virus","Long,E.M., Rainwater,S.M., Lavreys,L., Mandaliya,K. and Overbaugh,J.",2002
AF407157,A1,1996,12036486,"HIV type 1 variants transmitted to women in Kenya require the CCR5 coreceptor for entry, regardless of the genetic complexity of the infecting virus","Long,E.M., Rainwater,S.M., Lavreys,L., Mandaliya,K. and Overbaugh,J.",2002
AF407160,A1,1994,12036486,"HIV type 1 variants transmitted to women in Kenya require the CCR5 coreceptor for entry, regardless of the genetic complexity of the infecting virus","Long,E.M., Rainwater,S.M., Lavreys,L., Mandaliya,K. and Overbaugh,J.",2002
AF407418,O,,11907329,Sustained G-->A hypermutation during reverse transcription of an entire human immunodeficiency virus type 1 strain Vau group O genome,"Vartanian,J.P., Henry,M. and Wain-Hobson,S.",2002
AF408626,BF,1999,11752707,Diversity of mosaic structures and common ancestry of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Argentina revealed by analysis of near full-length genome sequences,"Thomson,M.M., Delgado,E., Herrero,I., Villahermosa,M.L., Vazquez-de Parga,E., Cuevas,M.T., Carmona,R., Medrano,L., Perez-Alvarez,L., Cuevas,L. and Najera,R.",2002
AF408627,BF,1999,11752707,Diversity of mosaic structures and common ancestry of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Argentina revealed by analysis of near full-length genome sequences,"Thomson,M.M., Delgado,E., Herrero,I., Villahermosa,M.L., Vazquez-de Parga,E., Cuevas,M.T., Carmona,R., Medrano,L., Perez-Alvarez,L., Cuevas,L. and Najera,R.",2002
AF408628,BF,1999,11752707,Diversity of mosaic structures and common ancestry of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Argentina revealed by analysis of near full-length genome sequences,"Thomson,M.M., Delgado,E., Herrero,I., Villahermosa,M.L., Vazquez-de Parga,E., Cuevas,M.T., Carmona,R., Medrano,L., Perez-Alvarez,L., Cuevas,L. and Najera,R.",2002
AF408629,12_BF,1997,11752707,Diversity of mosaic structures and common ancestry of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Argentina revealed by analysis of near full-length genome sequences,"Thomson,M.M., Delgado,E., Herrero,I., Villahermosa,M.L., Vazquez-de Parga,E., Cuevas,M.T., Carmona,R., Medrano,L., Perez-Alvarez,L., Cuevas,L. and Najera,R.",2002
AF408630,12_BF,1997,11752707,Diversity of mosaic structures and common ancestry of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Argentina revealed by analysis of near full-length genome sequences,"Thomson,M.M., Delgado,E., Herrero,I., Villahermosa,M.L., Vazquez-de Parga,E., Cuevas,M.T., Carmona,R., Medrano,L., Perez-Alvarez,L., Cuevas,L. and Najera,R.",2002
AF408631,BF,1997,11752707,Diversity of mosaic structures and common ancestry of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Argentina revealed by analysis of near full-length genome sequences,"Thomson,M.M., Delgado,E., Herrero,I., Villahermosa,M.L., Vazquez-de Parga,E., Cuevas,M.T., Carmona,R., Medrano,L., Perez-Alvarez,L., Cuevas,L. and Najera,R.",2002
AF408632,BF,1997,11752707,Diversity of mosaic structures and common ancestry of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Argentina revealed by analysis of near full-length genome sequences,"Thomson,M.M., Delgado,E., Herrero,I., Villahermosa,M.L., Vazquez-de Parga,E., Cuevas,M.T., Carmona,R., Medrano,L., Perez-Alvarez,L., Cuevas,L. and Najera,R.",2002
AF411964,A1CDGKU,1999,12201911,Full-length genome analysis of HIV-1 subtype C utilizing CXCR4 and intersubtype recombinants isolated in South Africa,"Papathanasopoulos,M.A., Cilliers,T., Morris,L., Mokili,J.L., Dowling,W., Birx,D.L. and McCutchan,F.E.",2002
AF411965,A2C,1998,12201911,Full-length genome analysis of HIV-1 subtype C utilizing CXCR4 and intersubtype recombinants isolated in South Africa,"Papathanasopoulos,M.A., Cilliers,T., Morris,L., Mokili,J.L., Dowling,W., Birx,D.L. and McCutchan,F.E.",2002
AF411966,C,1999,12201911,Full-length genome analysis of HIV-1 subtype C utilizing CXCR4 and intersubtype recombinants isolated in South Africa,"Papathanasopoulos,M.A., Cilliers,T., Morris,L., Mokili,J.L., Dowling,W., Birx,D.L. and McCutchan,F.E.",2002
AF411967,C,1999,12201911,Full-length genome analysis of HIV-1 subtype C utilizing CXCR4 and intersubtype recombinants isolated in South Africa,"Papathanasopoulos,M.A., Cilliers,T., Morris,L., Mokili,J.L., Dowling,W., Birx,D.L. and McCutchan,F.E.",2002
AF413980,A6,2000,14601597,Molecular cloning and analysis of full-length genome of HIV type 1 strains prevalent in countries of the former Soviet Union,"Masharsky,A.E., Klimov,N.A. and Kozlov,A.P.",2003
AF414005,03_AB,2000,14601597,Molecular cloning and analysis of full-length genome of HIV type 1 strains prevalent in countries of the former Soviet Union,"Masharsky,A.E., Klimov,N.A. and Kozlov,A.P.",2003
AF423755,BG,1999,11981372,"Identification of a newly characterized HIV-1 BG intersubtype circulating recombinant form in Galicia, Spain, which exhibits a pseudotype-like virion structure","Delgado,E., Thomson,M.M., Villahermosa,M.L., Sierra,M., Ocampo,A., Miralles,C., Rodriguez-Perez,R., Diz-Aren,J., Ojea-de Castro,R., Losada,E., Cuevas,M.T., Vazquez-de Parga,E., Carmona,R., Perez-Alvarez,L., Medrano,L., Cuevas,L., Taboada,J.A. and Najera,R.",2002
AF423756,14_BG,1999,11981372,"Identification of a newly characterized HIV-1 BG intersubtype circulating recombinant form in Galicia, Spain, which exhibits a pseudotype-like virion structure","Delgado,E., Thomson,M.M., Villahermosa,M.L., Sierra,M., Ocampo,A., Miralles,C., Rodriguez-Perez,R., Diz-Aren,J., Ojea-de Castro,R., Losada,E., Cuevas,M.T., Vazquez-de Parga,E., Carmona,R., Perez-Alvarez,L., Medrano,L., Cuevas,L., Taboada,J.A. and Najera,R.",2002
AF423757,14_BG,1999,11981372,"Identification of a newly characterized HIV-1 BG intersubtype circulating recombinant form in Galicia, Spain, which exhibits a pseudotype-like virion structure","Delgado,E., Thomson,M.M., Villahermosa,M.L., Sierra,M., Ocampo,A., Miralles,C., Rodriguez-Perez,R., Diz-Aren,J., Ojea-de Castro,R., Losada,E., Cuevas,M.T., Vazquez-de Parga,E., Carmona,R., Perez-Alvarez,L., Medrano,L., Cuevas,L., Taboada,J.A. and Najera,R.",2002
AF423758,14_BG,2000,11981372,"Identification of a newly characterized HIV-1 BG intersubtype circulating recombinant form in Galicia, Spain, which exhibits a pseudotype-like virion structure","Delgado,E., Thomson,M.M., Villahermosa,M.L., Sierra,M., Ocampo,A., Miralles,C., Rodriguez-Perez,R., Diz-Aren,J., Ojea-de Castro,R., Losada,E., Cuevas,M.T., Vazquez-de Parga,E., Carmona,R., Perez-Alvarez,L., Medrano,L., Cuevas,L., Taboada,J.A. and Najera,R.",2002
AF423759,14_BG,2000,11981372,"Identification of a newly characterized HIV-1 BG intersubtype circulating recombinant form in Galicia, Spain, which exhibits a pseudotype-like virion structure","Delgado,E., Thomson,M.M., Villahermosa,M.L., Sierra,M., Ocampo,A., Miralles,C., Rodriguez-Perez,R., Diz-Aren,J., Ojea-de Castro,R., Losada,E., Cuevas,M.T., Vazquez-de Parga,E., Carmona,R., Perez-Alvarez,L., Medrano,L., Cuevas,L., Taboada,J.A. and Najera,R.",2002
AF423760,G,2000,11981372,"Identification of a newly characterized HIV-1 BG intersubtype circulating recombinant form in Galicia, Spain, which exhibits a pseudotype-like virion structure","Delgado,E., Thomson,M.M., Villahermosa,M.L., Sierra,M., Ocampo,A., Miralles,C., Rodriguez-Perez,R., Diz-Aren,J., Ojea-de Castro,R., Losada,E., Cuevas,M.T., Vazquez-de Parga,E., Carmona,R., Perez-Alvarez,L., Medrano,L., Cuevas,L., Taboada,J.A. and Najera,R.",2002
AF442565,A1D,1996,12230937,Common genetic arrangements among human immunodeficiency virus type 1 subtype A and D recombinant genomes vertically transmitted in Tanzania,"Koulinska,I.N., Msamanga,G., Mwakagile,D., Essex,M. and Renjifo,B.",2002
AF442566,A1D,1997,12230937,Common genetic arrangements among human immunodeficiency virus type 1 subtype A and D recombinant genomes vertically transmitted in Tanzania,"Koulinska,I.N., Msamanga,G., Mwakagile,D., Essex,M. and Renjifo,B.",2002
AF442568,A1D,1997,12230937,Common genetic arrangements among human immunodeficiency virus type 1 subtype A and D recombinant genomes vertically transmitted in Tanzania,"Koulinska,I.N., Msamanga,G., Mwakagile,D., Essex,M. and Renjifo,B.",2002
AF442569,A1D,1996,12230937,Common genetic arrangements among human immunodeficiency virus type 1 subtype A and D recombinant genomes vertically transmitted in Tanzania,"Koulinska,I.N., Msamanga,G., Mwakagile,D., Essex,M. and Renjifo,B.",2002
AF442570,A1D,1996,12230937,Common genetic arrangements among human immunodeficiency virus type 1 subtype A and D recombinant genomes vertically transmitted in Tanzania,"Koulinska,I.N., Msamanga,G., Mwakagile,D., Essex,M. and Renjifo,B.",2002
AF443074,C,1996,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443075,C,1996,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443076,C,1998,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443077,C,1998,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443078,C,1998,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443079,C,1998,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443080,C,1998,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443081,C,1998,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443082,C,1998,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443083,C,1999,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443084,C,1999,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443085,C,1999,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443086,C,1999,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443087,C,1999,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443088,C,2000,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443089,C,2000,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443090,C,2000,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443091,C,2000,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443092,C,2000,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443093,C,2000,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443094,C,2000,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443095,C,2000,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443096,C,2000,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443097,C,2000,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443098,C,2000,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443099,C,2000,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443100,C,2000,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443101,C,2000,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443102,C,2000,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443103,C,2000,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443104,C,2000,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443105,C,2000,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443106,C,2000,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443107,C,2000,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443108,C,2000,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443109,C,2000,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443110,C,2000,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443111,C,2000,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443112,C,2000,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443113,C,2000,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443114,C,2000,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF443115,C,2000,11991972,Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?,"Novitsky,V., Smith,U.R., Gilbert,P., McLane,M.F., Chigwedere,P., Williamson,C., Ndung'u,T., Klein,I., Chang,S.-Y., Peter,T., Thior,I., Foley,B.T., Gaolekwe,S., Rybak,N., Gaseitsiwe,S., Vannberg,F., Marlink,R., Lee,T.-H. and Essex,M.",2002
AF450096,14_BG,2000,11981372,"Identification of a newly characterized HIV-1 BG intersubtype circulating recombinant form in Galicia, Spain, which exhibits a pseudotype-like virion structure","Delgado,E., Thomson,M.M., Villahermosa,M.L., Sierra,M., Ocampo,A., Miralles,C., Rodriguez-Perez,R., Diz-Aren,J., Ojea-de Castro,R., Losada,E., Cuevas,M.T., Vazquez-de Parga,E., Carmona,R., Perez-Alvarez,L., Medrano,L., Cuevas,L., Taboada,J.A. and Najera,R.",2002
AF450097,14_BG,2000,11981372,"Identification of a newly characterized HIV-1 BG intersubtype circulating recombinant form in Galicia, Spain, which exhibits a pseudotype-like virion structure","Delgado,E., Thomson,M.M., Villahermosa,M.L., Sierra,M., Ocampo,A., Miralles,C., Rodriguez-Perez,R., Diz-Aren,J., Ojea-de Castro,R., Losada,E., Cuevas,M.T., Vazquez-de Parga,E., Carmona,R., Perez-Alvarez,L., Medrano,L., Cuevas,L., Taboada,J.A. and Najera,R.",2002
AF450098,G,1999,11981372,"Identification of a newly characterized HIV-1 BG intersubtype circulating recombinant form in Galicia, Spain, which exhibits a pseudotype-like virion structure","Delgado,E., Thomson,M.M., Villahermosa,M.L., Sierra,M., Ocampo,A., Miralles,C., Rodriguez-Perez,R., Diz-Aren,J., Ojea-de Castro,R., Losada,E., Cuevas,M.T., Vazquez-de Parga,E., Carmona,R., Perez-Alvarez,L., Medrano,L., Cuevas,L., Taboada,J.A. and Najera,R.",2002
AF457051,21_A2D,1999,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457052,A1,2000,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457053,A1,2000,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457054,C,2000,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457055,A1,2000,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457056,A1CD,2000,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457057,A1,2000,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457058,A1D,2000,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457059,A1D,1999,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457060,16_A2D,2000,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457061,A1C,2000,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457062,A1G,1999,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457063,A1,1999,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457064,A1C,1999,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457065,A1,1999,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457066,A1,2000,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457067,A1,2000,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457068,A1,2000,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457069,A1,2000,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457070,A1,2000,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457071,A1,2000,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457072,21_A2D,1999,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457073,A1D,1999,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457074,A1D,1999,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457075,A1,1999,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457076,A1,1999,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457077,A1,2000,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457078,A1D,2000,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457079,A1,2000,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457080,A1,2000,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457081,A1,2000,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457082,A1D,2000,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457083,A1,2000,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457084,A1,2000,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457085,CD,2000,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457086,A1,2000,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457087,A1C,2000,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457088,A1A2D,2000,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457089,A1,2000,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457090,D,2001,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457091,A1,2000,12218394,Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants,"Dowling,W.E., Kim,B., Mason,C.J., Wasunna,K.M., Alam,U., Elson,L., Birx,D.L., Robb,M.L., McCutchan,F.E. and Carr,J.K.",2002
AF457101,U,1990,12167273,Identification of a novel clade of human immunodeficiency virus type 1 in democratic republic of congo,"Mokili,J.L., Rogers,M., Carr,J.K., Simmonds,P., Bopopi,J.M., Foley,B.T., Korber,B.T., Birx,D.L. and McCutchan,F.E.",2002
AF460972,13_cpx,1996,12201907,Identification of two CRF11-cpx genomes and two preliminary representatives of a new circulating recombinant form (CRF13-cpx) of HIV type 1 in Cameroon,"Wilbe,K., Casper,C., Albert,J. and Leitner,T.",2002
AF460974,13_cpx,1996,12201907,Identification of two CRF11-cpx genomes and two preliminary representatives of a new circulating recombinant form (CRF13-cpx) of HIV type 1 in Cameroon,"Wilbe,K., Casper,C., Albert,J. and Leitner,T.",2002
AF484477,D,1999,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484478,A1,1999,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484479,A1D,1999,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484480,D,1999,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484481,D,1999,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484482,A1D,1999,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484483,D,1999,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484484,A1,1999,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484485,D,1999,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484486,D,1999,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484487,D,1999,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484488,A1D,1999,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484489,D,1999,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484490,D,1999,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484491,A1C,1999,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484492,A1D,1999,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484493,A1,1999,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484494,D,1999,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484495,D,1999,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484496,A1D,1999,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484497,D,1999,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484498,D,1999,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484499,D,1999,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484500,CD,1999,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484501,A1C,1999,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484502,D,1998,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484503,A1D,1998,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484504,D,1998,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484505,D,1998,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484506,D,1998,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484507,A1,1998,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484508,A1,1998,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484509,A1,1998,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484510,A1D,1998,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484511,D,1998,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484512,A1,1998,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484513,D,1998,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484514,D,1998,11112486,Construction and biological characterization of infectious molecular clones of HIV-1 subtypes B and E (CRF01_AE) generated by the polymerase chain reaction,"Salminen,M.O., Ehrenberg,P.K., Mascola,J.R., Dayhoff,D.E., Merling,R., Blake,B., Louder,M., Hegerich,S., Polonis,V.R., Birx,D.L., Robb,M.L., McCutchan,F.E. and Michael,N.L.",2000
AF484515,D,1999,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484516,D,1998,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484517,A1D,1999,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484518,D,1999,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484519,D,1999,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484520,A1D,1999,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484521,A1D,1998,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF484522,A1D,1998,12487816,"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","Harris,M.E., Serwadda,D., Sewankambo,N., Kim,B., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Meehen,M., Lutalo,T., Lane,J.R., Merling,R., Gray,R., Wawer,M., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2002
AF490512,B,1986,,HIV-1 env sequences from primary isolates differing in tropism from a mother and her child,"Dietrich,U.",
AF490513,B,1986,,HIV-1 env sequence from a T-tropic primary HIV-1 isolate from an infected German (mother of child isolate D117III),"Dietrich,U.",
AF491737,B,,12021361,Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate,"Gorry,P.R., Taylor,J., Holm,G.H., Mehle,A., Morgan,T., Cayabyab,M., Farzan,M., Wang,H., Bell,J.E., Kunstman,K.J., Moore,J.P., Wolinsky,S.M. and Gabuzda,D.",2002
AF491740,B,,12021361,Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate,"Gorry,P.R., Taylor,J., Holm,G.H., Mehle,A., Morgan,T., Cayabyab,M., Farzan,M., Wang,H., Bell,J.E., Kunstman,K.J., Moore,J.P., Wolinsky,S.M. and Gabuzda,D.",2002
AF492623,11_cpx,1996,12201907,Identification of two CRF11-cpx genomes and two preliminary representatives of a new circulating recombinant form (CRF13-cpx) of HIV type 1 in Cameroon,"Wilbe,K., Casper,C., Albert,J. and Leitner,T.",2002
AF492624,11_cpx,1995,12201907,Identification of two CRF11-cpx genomes and two preliminary representatives of a new circulating recombinant form (CRF13-cpx) of HIV type 1 in Cameroon,"Wilbe,K., Casper,C., Albert,J. and Leitner,T.",2002
AF538302,B,1999,,Maximum Likelihood Analysis of Clock-Like Behavior in HIV: Implications on Dating Strategies in HIV Molecular Phylogenies,"Lemey,P., Salemi,M., Wang,B., Saksena,N.K. and Vandamme,A.M.",
AF538303,B,1999,,Maximum Likelihood Analysis of Clock-Like Behavior in HIV: Implications on Dating Strategies in HIV Molecular Phylogenies##,"Lemey,P., Salemi,M., Wang,B., Saksena,N.K. and Vandamme,A.M.",
AF538304,B,1995,,Maximum Likelihood Analysis of Clock-Like Behavior in HIV: Implications on Dating Strategies in HIV Molecular Phylogenies,"Lemey,P., Salemi,M., Wang,B., Saksena,N.K. and Vandamme,A.M.",
AF538305,B,1995,,Maximum Likelihood Analysis of Clock-Like Behavior in HIV: Implications on Dating Strategies in HIV Molecular Phylogenies,"Lemey,P., Salemi,M., Wang,B., Saksena,N.K. and Vandamme,A.M.",
AF538306,B,1995,,Maximum Likelihood Analysis of Clock-Like Behavior in HIV: Implications on Dating Strategies in HIV Molecular Phylogenies,"Lemey,P., Salemi,M., Wang,B., Saksena,N.K. and Vandamme,A.M.",
AF538307,B,1995,,Maximum Likelihood Analysis of Clock-Like Behavior in HIV: Implications on Dating Strategies in HIV Molecular Phylogenies,"Lemey,P., Salemi,M., Wang,B., Saksena,N.K. and Vandamme,A.M.",
AF539404,A1C,1997,15075531,Recombination following superinfection by HIV-1,"Fang,G., Weiser,B., Kuiken,C., Philpott,S.M., Rowland-Jones,S., Plummer,F., Kimani,J., Shi,B., Kaul,R., Bwayo,J., Anzala,O. and Burger,H.",2004
AF544007,C,1998,12639249,Characterization and selection of HIV-1 subtype C isolates for use in vaccine development,"Williamson,C., Morris,L., Maughan,M.F., Ping,L.H., Dryga,S.A., Thomas,R., Reap,E.A., Cilliers,T., van Harmelen,J., Pascual,A., Ramjee,G., Gray,G., Johnston,R., Karim,S.A. and Swanstrom,R.",2003
AF544008,C,1998,12639249,Characterization and selection of HIV-1 subtype C isolates for use in vaccine development,"Williamson,C., Morris,L., Maughan,M.F., Ping,L.H., Dryga,S.A., Thomas,R., Reap,E.A., Cilliers,T., van Harmelen,J., Pascual,A., Ramjee,G., Gray,G., Johnston,R., Karim,S.A. and Swanstrom,R.",2003
AH011123,22_01A1,,11448170,The AG recombinant IbNG and novel strains of group M HIV-1 are common in Cameroon,"Carr,J.K., Torimiro,J., Wolfe,N., Eitel,M., Kim,B., Sanders-Buell,E., Jagodzinski,L., Gotte,D., Burke,D., Birx,D. and McCutchan,F.",2001
AJ006022,N,,9734396,Identification of a new human immunodeficiency virus type 1 distinct from group M and group O,"Simon,F., Mauclere,P., Roques,P., Loussert-Ajaka,I., Muller-Trutwin,M.C., Saragosti,S., Georges-Courbot,M.C., Barre-Sinoussi,F. and Brun-Vezinet,F.",1998
AJ237565,A1DHK,1997,10628816,Intersubtype recombinant HIV type 1 involving HIV-MAL-like and subtype H-like sequence in four Norwegian cases,"Jonassen,T.O., Grinde,B., Asjo,B., Hasle,G. and Hungnes,O.",2000
AJ239083,02O,1997,10438826,Characterization of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient,"Peeters,M., Liegeois,F., Torimiro,N., Bourgeois,A., Mpoudi,E., Vergne,L., Saman,E., Delaporte,E. and Saragosti,S.",1999
AJ249235,K,1997,10659053,Near-full-length genome sequencing of divergent African HIV type 1 subtype F viruses leads to the identification of a new HIV type 1 subtype designated K,"Triques,K., Bourgeois,A., Vidal,N., Mpoudi-Ngole,E., Mulanga-Kabeya,C., Nzilambi,N., Torimiro,N., Saman,E., Delaporte,E. and Peeters,M.",2000
AJ249236,F2,1995,10659053,Near-full-length genome sequencing of divergent African HIV type 1 subtype F viruses leads to the identification of a new HIV type 1 subtype designated K,"Triques,K., Bourgeois,A., Vidal,N., Mpoudi-Ngole,E., Mulanga-Kabeya,C., Nzilambi,N., Torimiro,N., Saman,E., Delaporte,E. and Peeters,M.",2000
AJ249237,F2,1995,10659053,Near-full-length genome sequencing of divergent African HIV type 1 subtype F viruses leads to the identification of a new HIV type 1 subtype designated K,"Triques,K., Bourgeois,A., Vidal,N., Mpoudi-Ngole,E., Mulanga-Kabeya,C., Nzilambi,N., Torimiro,N., Saman,E., Delaporte,E. and Peeters,M.",2000
AJ249238,F1,1996,10659053,Near-full-length genome sequencing of divergent African HIV type 1 subtype F viruses leads to the identification of a new HIV type 1 subtype designated K,"Triques,K., Bourgeois,A., Vidal,N., Mpoudi-Ngole,E., Mulanga-Kabeya,C., Nzilambi,N., Torimiro,N., Saman,E., Delaporte,E. and Peeters,M.",2000
AJ249239,K,1996,10659053,Near-full-length genome sequencing of divergent African HIV type 1 subtype F viruses leads to the identification of a new HIV type 1 subtype designated K,"Triques,K., Bourgeois,A., Vidal,N., Mpoudi-Ngole,E., Mulanga-Kabeya,C., Nzilambi,N., Torimiro,N., Saman,E., Delaporte,E. and Peeters,M.",2000
AJ251056,02_AG,1998,10777151,"Identification of all HIV type 1 group M subtypes in Senegal, a country with low and stable seroprevalence","Toure-Kane,C., Montavon,C., Faye,M.A., Gueye,P.M., Sow,P.S., Ndoye,I., Gaye-Diallo,A., Delaporte,E., Peeters,M. and Mboup,S.",2000
AJ251057,02_AG,1998,10777151,"Identification of all HIV type 1 group M subtypes in Senegal, a country with low and stable seroprevalence","Toure-Kane,C., Montavon,C., Faye,M.A., Gueye,P.M., Sow,P.S., Ndoye,I., Gaye-Diallo,A., Delaporte,E., Peeters,M. and Mboup,S.",2000
AJ271111,B,,,An association between amino acid substitutions in the 'Silent Face' of Human immunodeficiency virus type 1 gp120 and resistance to antibody mediated neutralization,"Daniels,R.S., Beddows,S., Wilson,P., Douglas,N.W., Patel,D., Ives,K.J., Easterbrook,P. and Weber,J.N.",
AJ271370,N,,15199313,Phylogenetic characteristics of three new HIV-1 N strains and implications for the origin of group N,"Roques,P., Robertson,D.L., Souquiere,S., Apetrei,C., Nerrienet,E., Barre-Sinoussi,F., Muller-Trutwin,M. and Simon,F.",2004
AJ271445,B,1986,1890410,Characterisation of a series of human immunodeficiency virus isolates derived sequentially from a single patient,"Farrar,G.H., Roff,M.A., Amin,T., Ball,J., Parrett,A.M., Battacharyya,U., Booth,J., Wansbrough-Jones,M.H. and Greenaway,P.J.",1991
AJ276595,02C,1993,10954895,Near full-length genome analysis of HIV type 1 CRF02.AG subtype C and CRF02.AG subtype G recombinants,"Janssens,W., Salminen,M.O., Laukkanen,T., Heyndrickx,L., van der,Auwera., Colebunders,R., McCutchan,F.E. and van der Groen,G.",2000
AJ276596,A1G,1994,10954895,Near full-length genome analysis of HIV type 1 CRF02.AG subtype C and CRF02.AG subtype G recombinants,"Janssens,W., Salminen,M.O., Laukkanen,T., Heyndrickx,L., van der,Auwera., Colebunders,R., McCutchan,F.E. and van der Groen,G.",2000
AJ277818,01_AE,1993,,Potent broad cross-neutralising sera inhibit attachment of primary HIV-1 isolates (group M and O) to peripheral blood mononuclear cells,"Beirnaert,E., De Zutter,S., Janssens,W. and Van der Groen,G.",
AJ277819,DF,1993,,Potent broad cross-neutralising sera inhibit attachment of primary HIV-1 isolates (group M and O) to peripheral blood mononuclear cells,"Beirnaert,E., De Zutter,S., Janssens,W. and Van der Groen,G.",
AJ277822,AG,1990,,Potent broad cross-neutralising sera inhibit attachment of primary HIV-1 isolates (group M and O) to peripheral blood mononuclear cells,"Beirnaert,E., De Zutter,S., Janssens,W. and Van der Groen,G.",
AJ277823,11_cpx,,9986789,Subtype G and multiple forms of A/G intersubtype recombinant human immunodeficiency virus type 1 in Nigeria,"McCutchan,F.E., Carr,J.K., Bajani,M., Sanders-Buell,E., Harry,T.O., Stoeckli,T.C., Robbins,K.E., Gashau,W., Nasidi,A., Janssens,W. and Kalish,M.L.",1999
AJ277824,F2,1993,8709250,Multivariate analysis of human immunodeficiency virus type 1 neutralization data,"Nyambi,P.N., Nkengasong,J., Lewi,P., Andries,K., Janssens,W., Fransen,K., Heyndrickx,L., Piot,P. and van der Groen,G.",1996
AJ277825,AC,,8709250,Multivariate analysis of human immunodeficiency virus type 1 neutralization data,"Nyambi,P.N., Nkengasong,J., Lewi,P., Andries,K., Janssens,W., Fransen,K., Heyndrickx,L., Piot,P. and van der Groen,G.",1996
AJ286133,02_AG,1997,10866228,Most env and gag subtype A HIV-1 viruses circulating in West and West Central Africa are similar to the prototype AG recombinant virus IBNG,"Montavon,C., Toure-Kane,C., Liegeois,F., Mpoudi,E., Bourgeois,A., Vergne,L., Perret,J.L., Boumah,A., Saman,E., Mboup,S., Delaporte,E. and Peeters,M.",2000
AJ286330,B,,,An association between amino acid substitutions in the 'Silent Face' of Human immunodeficiency virus type 1 gp120 and resistance to antibody mediated neutralization,"Daniels,R.S., Beddows,S., Wilson,P., Douglas,N.W., Patel,D., Ives,K.J., Easterbrook,P. and Weber,J.N.",
AJ286332,B,,,An association between amino acid substitutions in the 'Silent Face' of Human immunodeficiency virus type 1 gp120 and resistance to antibody mediated neutralization,"Daniels,R.S., Beddows,S., Wilson,P., Douglas,N.W., Patel,D., Ives,K.J., Easterbrook,P. and Weber,J.N.",
AJ286334,B,,,An association between amino acid substitutions in the 'Silent Face' of Human immunodeficiency virus type 1 gp120 and resistance to antibody mediated neutralization,"Daniels,R.S., Beddows,S., Wilson,P., Douglas,N.W., Patel,D., Ives,K.J., Easterbrook,P. and Weber,J.N.",
AJ286335,B,,,An association between amino acid substitutions in the 'Silent Face' of Human immunodeficiency virus type 1 gp120 and resistance to antibody mediated neutralization,"Daniels,R.S., Beddows,S., Wilson,P., Douglas,N.W., Patel,D., Ives,K.J., Easterbrook,P. and Weber,J.N.",
AJ286337,B,,,An association between amino acid substitutions in the 'Silent Face' of Human immunodeficiency virus type 1 gp120 and resistance to antibody mediated neutralization,"Daniels,R.S., Beddows,S., Wilson,P., Douglas,N.W., Patel,D., Ives,K.J., Easterbrook,P. and Weber,J.N.",
AJ286339,B,,,An association between amino acid substitutions in the 'Silent Face' of Human immunodeficiency virus type 1 gp120 and resistance to antibody mediated neutralization,"Daniels,R.S., Beddows,S., Wilson,P., Douglas,N.W., Patel,D., Ives,K.J., Easterbrook,P. and Weber,J.N.",
AJ286341,B,,,An association between amino acid substitutions in the 'Silent Face' of Human immunodeficiency virus type 1 gp120 and resistance to antibody mediated neutralization,"Daniels,R.S., Beddows,S., Wilson,P., Douglas,N.W., Patel,D., Ives,K.J., Easterbrook,P. and Weber,J.N.",
AJ288981,06_cpx,1997,,Two new complete genomes of HIV-1 recombinant AGJ BFP90-like circulating in Mali and Senegal,"Montavon,C., Delaporte,E. and Peeters,M.",
AJ291718,11_cpx,1997,11839159,"Identification of a new circulating recombinant form of HIV type 1, CRF11-cpx, involving subtypes A, G, J, and CRF01-AE, in Central Africa","Montavon,C., Vergne,L., Bourgeois,A., Mpoudi-Ngole,E., Malonga-Mouellet,G., Butel,C., Toure-Kane,C., Delaporte,E. and Peeters,M.",2002
AJ293865,06A1,,11297684,"A complex human immunodeficiency virus type 1 A/G/J recombinant virus isolated from a seronegative patient with AIDS from Benin, West Africa","Baldrich-Rubio,E., Anagonou,S., Stirrups,K., Lafia,E., Candotti,D., Lee,H. and Allain,J.P.",2001
AJ302646,O,,11522190,Full-length genome sequencing of HIV type 1 group O viruses isolated from a heterosexual transmission cluster in Senegal,"Toure-Kane,C., Montavon,C., Toure,M., Faye,M., Ndiaye,A., Diallo,A., Ndoye,I., Liegeois,F., Delaporte,E., Mboup,S. and Peeters,M.",2001
AJ401034,A4,1997,11044094,Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa,"Vidal,N., Peeters,M., Mulanga-Kabeya,C., Nzilambi,N., Robertson,D., Ilunga,W., Sema,H., Tshimanga,K., Bongo,B. and Delaporte,E.",2000
AJ401035,FKU,1997,11044094,Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa,"Vidal,N., Peeters,M., Mulanga-Kabeya,C., Nzilambi,N., Robertson,D., Ilunga,W., Sema,H., Tshimanga,K., Bongo,B. and Delaporte,E.",2000
AJ401036,JU,1997,11044094,Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa,"Vidal,N., Peeters,M., Mulanga-Kabeya,C., Nzilambi,N., Robertson,D., Ilunga,W., Sema,H., Tshimanga,K., Bongo,B. and Delaporte,E.",2000
AJ401037,D,1997,11044094,Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa,"Vidal,N., Peeters,M., Mulanga-Kabeya,C., Nzilambi,N., Robertson,D., Ilunga,W., Sema,H., Tshimanga,K., Bongo,B. and Delaporte,E.",2000
AJ401038,26_A5U,1997,11044094,Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa,"Vidal,N., Peeters,M., Mulanga-Kabeya,C., Nzilambi,N., Robertson,D., Ilunga,W., Sema,H., Tshimanga,K., Bongo,B. and Delaporte,E.",2000
AJ401039,U,1997,11044094,Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa,"Vidal,N., Peeters,M., Mulanga-Kabeya,C., Nzilambi,N., Robertson,D., Ilunga,W., Sema,H., Tshimanga,K., Bongo,B. and Delaporte,E.",2000
AJ401040,A1,1997,11044094,Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa,"Vidal,N., Peeters,M., Mulanga-Kabeya,C., Nzilambi,N., Robertson,D., Ilunga,W., Sema,H., Tshimanga,K., Bongo,B. and Delaporte,E.",2000
AJ401041,J,1997,11044094,Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa,"Vidal,N., Peeters,M., Mulanga-Kabeya,C., Nzilambi,N., Robertson,D., Ilunga,W., Sema,H., Tshimanga,K., Bongo,B. and Delaporte,E.",2000
AJ401043,U,1997,11044094,Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa,"Vidal,N., Peeters,M., Mulanga-Kabeya,C., Nzilambi,N., Robertson,D., Ilunga,W., Sema,H., Tshimanga,K., Bongo,B. and Delaporte,E.",2000
AJ401044,26C,1997,11044094,Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa,"Vidal,N., Peeters,M., Mulanga-Kabeya,C., Nzilambi,N., Robertson,D., Ilunga,W., Sema,H., Tshimanga,K., Bongo,B. and Delaporte,E.",2000
AJ401045,J,1997,11044094,Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa,"Vidal,N., Peeters,M., Mulanga-Kabeya,C., Nzilambi,N., Robertson,D., Ilunga,W., Sema,H., Tshimanga,K., Bongo,B. and Delaporte,E.",2000
AJ401046,AJ,1997,11044094,Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa,"Vidal,N., Peeters,M., Mulanga-Kabeya,C., Nzilambi,N., Robertson,D., Ilunga,W., Sema,H., Tshimanga,K., Bongo,B. and Delaporte,E.",2000
AJ404325,27_cpx,1997,11153090,"Identification of a complex env subtype E HIV type 1 virus from the democratic republic of congo, recombinant with A, G, H, J, K, and unknown subtypes","Vidal,N., Mulanga-Kabeya,C., Nzilambi,N., Delaporte,E. and Peeters,M.",2059
AJ417408,B,1996,13678464,An HIV type 1 subtype B founder effect in Korea: gp160 signature patterns infer circulation of CTL-escape strains at the population level,"Daniels,R.S., Kang,C., Patel,D., Xiang,Z., Douglas,N.W., Zheng,N.N., Cho,H.W. and Lee,J.S.",2003
AJ417411,B,1996,13678464,An HIV type 1 subtype B founder effect in Korea: gp160 signature patterns infer circulation of CTL-escape strains at the population level,"Daniels,R.S., Kang,C., Patel,D., Xiang,Z., Douglas,N.W., Zheng,N.N., Cho,H.W. and Lee,J.S.",2003
AJ417414,B,1995,13678464,An HIV type 1 subtype B founder effect in Korea: gp160 signature patterns infer circulation of CTL-escape strains at the population level,"Daniels,R.S., Kang,C., Patel,D., Xiang,Z., Douglas,N.W., Zheng,N.N., Cho,H.W. and Lee,J.S.",2003
AJ417417,B,1996,13678464,An HIV type 1 subtype B founder effect in Korea: gp160 signature patterns infer circulation of CTL-escape strains at the population level,"Daniels,R.S., Kang,C., Patel,D., Xiang,Z., Douglas,N.W., Zheng,N.N., Cho,H.W. and Lee,J.S.",2003
AJ417420,B,1993,13678464,An HIV type 1 subtype B founder effect in Korea: gp160 signature patterns infer circulation of CTL-escape strains at the population level,"Daniels,R.S., Kang,C., Patel,D., Xiang,Z., Douglas,N.W., Zheng,N.N., Cho,H.W. and Lee,J.S.",2003
AJ417423,B,1992,13678464,An HIV type 1 subtype B founder effect in Korea: gp160 signature patterns infer circulation of CTL-escape strains at the population level,"Daniels,R.S., Kang,C., Patel,D., Xiang,Z., Douglas,N.W., Zheng,N.N., Cho,H.W. and Lee,J.S.",2003
AJ417426,B,1996,13678464,An HIV type 1 subtype B founder effect in Korea: gp160 signature patterns infer circulation of CTL-escape strains at the population level,"Daniels,R.S., Kang,C., Patel,D., Xiang,Z., Douglas,N.W., Zheng,N.N., Cho,H.W. and Lee,J.S.",2003
AJ417429,B,1995,13678464,An HIV type 1 subtype B founder effect in Korea: gp160 signature patterns infer circulation of CTL-escape strains at the population level,"Daniels,R.S., Kang,C., Patel,D., Xiang,Z., Douglas,N.W., Zheng,N.N., Cho,H.W. and Lee,J.S.",2003
AJ418478,B,1997,,Selection on isolation of HIV-1 in peripheral blood mononuclear cells and Herpesvirus saimiri transformed T-cells is comparable,"Zheng,N.N., Vella,C., Easterbrook,P.J. and Daniels,R.S.",
AJ418495,B,1997,,Selection on isolation of HIV-1 in peripheral blood mononuclear cells and Herpesvirus saimiri transformed T-cells is comparable,"Zheng,N.N., Vella,C., Easterbrook,P.J. and Daniels,R.S.",
AJ418514,B,1997,,Selection on isolation of HIV-1 in peripheral blood mononuclear cells and Herpesvirus saimiri transformed T-cells is comparable,"Zheng,N.N., Vella,C., Easterbrook,P.J. and Daniels,R.S.",
AJ418521,B,1997,,Selection on isolation of HIV-1 in peripheral blood mononuclear cells and Herpesvirus saimiri transformed T-cells is comparable,"Zheng,N.N., Vella,C., Easterbrook,P.J. and Daniels,R.S.",
AJ418531,B,1997,,Selection on isolation of HIV-1 in peripheral blood mononuclear cells and Herpesvirus saimiri transformed T-cells is comparable,"Zheng,N.N., Vella,C., Easterbrook,P.J. and Daniels,R.S.",
AJ488926,D,1999,,Genetic variability of HIV-1 strains in chad: high prevalence of recombinant strains and identification of a new D' variant,"Vidal,N.",
AJ488927,D,1999,,Genetic variability of HIV-1 strains in Chad: high prevalence of recombinant strains and identifictauion of a new D' variant,"Vidal,N.",
AJ508595,0206,1997,12596728,"Emergence of complex and diverse CRF02-AG/CRF06-cpx recombinant HIV type 1 strains in Niger, West Africa","Mamadou,S., Vidal,N., Montavon,C., Ben,A., Djibo,A., Rabiou,S., Soga,G., Delaporte,E., Mboup,S. and Peeters,M.",2003
AJ535590,B,1994,15157359,Analysis of full-length HIV type 1 env genes indicates differences between the virus infecting T cells and dendritic cells in peripheral blood of infected patients,"Daniels,R.S., Wilson,P., Patel,D., Longhurst,H. and Patterson,S.",2004
AJ535600,B,1994,15157359,Analysis of full-length HIV type 1 env genes indicates differences between the virus infecting T cells and dendritic cells in peripheral blood of infected patients,"Daniels,R.S., Wilson,P., Patel,D., Longhurst,H. and Patterson,S.",2004
AJ535608,B,1995,15157359,Analysis of full-length HIV type 1 env genes indicates differences between the virus infecting T cells and dendritic cells in peripheral blood of infected patients,"Daniels,R.S., Wilson,P., Patel,D., Longhurst,H. and Patterson,S.",2004
AJ535612,B,1996,15157359,Analysis of full-length HIV type 1 env genes indicates differences between the virus infecting T cells and dendritic cells in peripheral blood of infected patients,"Daniels,R.S., Wilson,P., Patel,D., Longhurst,H. and Patterson,S.",2004
AJ535616,B,1995,15157359,Analysis of full-length HIV type 1 env genes indicates differences between the virus infecting T cells and dendritic cells in peripheral blood of infected patients,"Daniels,R.S., Wilson,P., Patel,D., Longhurst,H. and Patterson,S.",2004
AJ634684,H,1999,15582695,A genotypic resistance assay for the detection of drug resistance in the human immunodeficiency virus type 1 envelope gene,"Van Laethem,K., Schrooten,Y., Lemey,P., Van Wijngaerden,E., De Wit,S., Van Ranst,M. and Vandamme,A.M.",2005
AJ866555,0209,1997,16060839,"Presence of CRF09_cpx and complex CRF02_AG/CRF09_cpx recombinant HIV type 1 strains in Cote d'Ivoire, West Africa","Toni,T., Adje-Toure,C., Vidal,N., Minga,A., Huet,C., Borger,M.Y., Recordon-Pinson,P., Masquelier,B., Nolan,M., Nkengasong,J., Fleury,H.J., Delaporte,E. and Peeters,M.",2005
AJ866556,0209,2001,16060839,"Presence of CRF09_cpx and complex CRF02_AG/CRF09_cpx recombinant HIV type 1 strains in Cote d'Ivoire, West Africa","Toni,T., Adje-Toure,C., Vidal,N., Minga,A., Huet,C., Borger,M.Y., Recordon-Pinson,P., Masquelier,B., Nolan,M., Nkengasong,J., Fleury,H.J., Delaporte,E. and Peeters,M.",2005
AJ866557,02GK,2001,16060839,"Presence of CRF09_cpx and complex CRF02_AG/CRF09_cpx recombinant HIV type 1 strains in Cote d'Ivoire, West Africa","Toni,T., Adje-Toure,C., Vidal,N., Minga,A., Huet,C., Borger,M.Y., Recordon-Pinson,P., Masquelier,B., Nolan,M., Nkengasong,J., Fleury,H.J., Delaporte,E. and Peeters,M.",2005
AJ866558,0209,2001,16060839,"Presence of CRF09_cpx and complex CRF02_AG/CRF09_cpx recombinant HIV type 1 strains in Cote d'Ivoire, West Africa","Toni,T., Adje-Toure,C., Vidal,N., Minga,A., Huet,C., Borger,M.Y., Recordon-Pinson,P., Masquelier,B., Nolan,M., Nkengasong,J., Fleury,H.J., Delaporte,E. and Peeters,M.",2005
AM000054,A4,1997,16478401,Identification and molecular characterization of subsubtype A4 in central Africa,"Vidal,N., Mulanga,C., Bazepeo,S.E., Lepira,F., Delaporte,E. and Peeters,M.",2006
AM000055,A4,2002,16478401,Identification and molecular characterization of subsubtype A4 in central Africa,"Vidal,N., Mulanga,C., Bazepeo,S.E., Lepira,F., Delaporte,E. and Peeters,M.",2006
AM279343,A1,1997,16817969,The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness,"Njai,H.F., Gali,Y., Vanham,G., Clybergh,C., Jennes,W., Vidal,N., Butel,C., Mpoudi-Ngolle,E., Peeters,M. and Arien,K.K.",2006
AM279344,A1,1997,16817969,The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness,"Njai,H.F., Gali,Y., Vanham,G., Clybergh,C., Jennes,W., Vidal,N., Butel,C., Mpoudi-Ngolle,E., Peeters,M. and Arien,K.K.",2006
AM279345,02A1,1999,16817969,The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness,"Njai,H.F., Gali,Y., Vanham,G., Clybergh,C., Jennes,W., Vidal,N., Butel,C., Mpoudi-Ngolle,E., Peeters,M. and Arien,K.K.",2006
AM279346,G,1997,16817969,The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness,"Njai,H.F., Gali,Y., Vanham,G., Clybergh,C., Jennes,W., Vidal,N., Butel,C., Mpoudi-Ngolle,E., Peeters,M. and Arien,K.K.",2006
AM279347,02A1,1997,16817969,The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness,"Njai,H.F., Gali,Y., Vanham,G., Clybergh,C., Jennes,W., Vidal,N., Butel,C., Mpoudi-Ngolle,E., Peeters,M. and Arien,K.K.",2006
AM279348,A1,1999,16817969,The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness,"Njai,H.F., Gali,Y., Vanham,G., Clybergh,C., Jennes,W., Vidal,N., Butel,C., Mpoudi-Ngolle,E., Peeters,M. and Arien,K.K.",2006
AM279349,02_AG,1996,16817969,The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness,"Njai,H.F., Gali,Y., Vanham,G., Clybergh,C., Jennes,W., Vidal,N., Butel,C., Mpoudi-Ngolle,E., Peeters,M. and Arien,K.K.",2006
AM279350,G,1999,16817969,The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness,"Njai,H.F., Gali,Y., Vanham,G., Clybergh,C., Jennes,W., Vidal,N., Butel,C., Mpoudi-Ngolle,E., Peeters,M. and Arien,K.K.",2006
AM279351,G,1999,16817969,The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness,"Njai,H.F., Gali,Y., Vanham,G., Clybergh,C., Jennes,W., Vidal,N., Butel,C., Mpoudi-Ngolle,E., Peeters,M. and Arien,K.K.",2006
AM279352,02_AG,1999,16817969,The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness,"Njai,H.F., Gali,Y., Vanham,G., Clybergh,C., Jennes,W., Vidal,N., Butel,C., Mpoudi-Ngolle,E., Peeters,M. and Arien,K.K.",2006
AM279353,ADU,1998,16817969,The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness,"Njai,H.F., Gali,Y., Vanham,G., Clybergh,C., Jennes,W., Vidal,N., Butel,C., Mpoudi-Ngolle,E., Peeters,M. and Arien,K.K.",2006
AM279354,A,1998,16817969,The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness,"Njai,H.F., Gali,Y., Vanham,G., Clybergh,C., Jennes,W., Vidal,N., Butel,C., Mpoudi-Ngolle,E., Peeters,M. and Arien,K.K.",2006
AM279355,02A1,1997,16817969,The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness,"Njai,H.F., Gali,Y., Vanham,G., Clybergh,C., Jennes,W., Vidal,N., Butel,C., Mpoudi-Ngolle,E., Peeters,M. and Arien,K.K.",2006
AM279356,02A1,1997,16817969,The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness,"Njai,H.F., Gali,Y., Vanham,G., Clybergh,C., Jennes,W., Vidal,N., Butel,C., Mpoudi-Ngolle,E., Peeters,M. and Arien,K.K.",2006
AM279357,02A1,1997,16817969,The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness,"Njai,H.F., Gali,Y., Vanham,G., Clybergh,C., Jennes,W., Vidal,N., Butel,C., Mpoudi-Ngolle,E., Peeters,M. and Arien,K.K.",2006
AM279358,02_AG,1997,16817969,The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness,"Njai,H.F., Gali,Y., Vanham,G., Clybergh,C., Jennes,W., Vidal,N., Butel,C., Mpoudi-Ngolle,E., Peeters,M. and Arien,K.K.",2006
AM279359,G,1999,16817969,The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness,"Njai,H.F., Gali,Y., Vanham,G., Clybergh,C., Jennes,W., Vidal,N., Butel,C., Mpoudi-Ngolle,E., Peeters,M. and Arien,K.K.",2006
AM279360,02_AG,1997,16817969,The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness,"Njai,H.F., Gali,Y., Vanham,G., Clybergh,C., Jennes,W., Vidal,N., Butel,C., Mpoudi-Ngolle,E., Peeters,M. and Arien,K.K.",2006
AM279361,02_AG,1997,16817969,The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness,"Njai,H.F., Gali,Y., Vanham,G., Clybergh,C., Jennes,W., Vidal,N., Butel,C., Mpoudi-Ngolle,E., Peeters,M. and Arien,K.K.",2006
AM279362,02A1,1996,16817969,The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness,"Njai,H.F., Gali,Y., Vanham,G., Clybergh,C., Jennes,W., Vidal,N., Butel,C., Mpoudi-Ngolle,E., Peeters,M. and Arien,K.K.",2006
AM279363,02A1,1999,16817969,The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness,"Njai,H.F., Gali,Y., Vanham,G., Clybergh,C., Jennes,W., Vidal,N., Butel,C., Mpoudi-Ngolle,E., Peeters,M. and Arien,K.K.",2006
AM279364,09A,1999,16817969,The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness,"Njai,H.F., Gali,Y., Vanham,G., Clybergh,C., Jennes,W., Vidal,N., Butel,C., Mpoudi-Ngolle,E., Peeters,M. and Arien,K.K.",2006
AM279365,G,1998,16817969,The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness,"Njai,H.F., Gali,Y., Vanham,G., Clybergh,C., Jennes,W., Vidal,N., Butel,C., Mpoudi-Ngolle,E., Peeters,M. and Arien,K.K.",2006
AM279366,A1,1997,16817969,The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness,"Njai,H.F., Gali,Y., Vanham,G., Clybergh,C., Jennes,W., Vidal,N., Butel,C., Mpoudi-Ngolle,E., Peeters,M. and Arien,K.K.",2006
AM279367,02_AG,1997,16817969,The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness,"Njai,H.F., Gali,Y., Vanham,G., Clybergh,C., Jennes,W., Vidal,N., Butel,C., Mpoudi-Ngolle,E., Peeters,M. and Arien,K.K.",2006
AM279368,AG,1999,16817969,The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness,"Njai,H.F., Gali,Y., Vanham,G., Clybergh,C., Jennes,W., Vidal,N., Butel,C., Mpoudi-Ngolle,E., Peeters,M. and Arien,K.K.",2006
AM279369,A1A3,1999,16817969,The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness,"Njai,H.F., Gali,Y., Vanham,G., Clybergh,C., Jennes,W., Vidal,N., Butel,C., Mpoudi-Ngolle,E., Peeters,M. and Arien,K.K.",2006
AM851090,27_cpx,2002,18257687,"Characterization of an old complex circulating recombinant form, CRF27_cpx, originating from the Democratic Republic of Congo (DRC) and circulating in France","Vidal,N., Frange,P., Chaix,M.L., Mulanga,C., Lepira,F., Bazepeo,S.E., Goujard,C., Meyer,L., Rouzioux,C., Delaporte,E. and Peeters,M.",2008
AM851091,27_cpx,2004,18257687,"Characterization of an old complex circulating recombinant form, CRF27_cpx, originating from the Democratic Republic of Congo (DRC) and circulating in France","Vidal,N., Frange,P., Chaix,M.L., Mulanga,C., Lepira,F., Bazepeo,S.E., Goujard,C., Meyer,L., Rouzioux,C., Delaporte,E. and Peeters,M.",2008
AP005206,0708,2000,12477871,"Identification and characterization of a new class of human immunodeficiency virus type 1 recombinants comprised of two circulating recombinant forms, CRF07_BC and CRF08_BC, in China","Yang,R., Kusagawa,S., Zhang,C., Xia,X., Ben,K. and Takebe,Y.",2003
AP005207,0708,2000,12477871,"Identification and characterization of a new class of human immunodeficiency virus type 1 recombinants comprised of two circulating recombinant forms, CRF07_BC and CRF08_BC, in China","Yang,R., Kusagawa,S., Zhang,C., Xia,X., Ben,K. and Takebe,Y.",2003
AX056837,B,,,In vivo selection method for determining inhibitory rna molecules,"Mitrophanous,K., Kim,N.H. and Kotsopoulou,E.",2000
AX457092,C,1999,,"Process for the selection of HIV-1 subtype c isolates, selected HIV-1 subtype isolates, their genes and modifications and derivatives thereof","Williamson,C., Swanstrom,R.I., Morris,L., Karim,S.A. and Johnston,R.E.",2002
AY008714,01_AE,1997,11070028,"A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant","Piyasirisilp,S., McCutchan,F.E., Carr,J.K., Sanders-Buell,E., Liu,W., Chen,J., Wagner,R., Wolf,H., Shao,Y., Lai,S., Beyrer,C. and Yu,X.F.",2000
AY008715,08_BC,1997,11070028,"A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant","Piyasirisilp,S., McCutchan,F.E., Carr,J.K., Sanders-Buell,E., Liu,W., Chen,J., Wagner,R., Wolf,H., Shao,Y., Lai,S., Beyrer,C. and Yu,X.F.",2000
AY008716,08_BC,1997,11070028,"A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant","Piyasirisilp,S., McCutchan,F.E., Carr,J.K., Sanders-Buell,E., Liu,W., Chen,J., Wagner,R., Wolf,H., Shao,Y., Lai,S., Beyrer,C. and Yu,X.F.",2000
AY008717,08_BC,1997,11070028,"A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant","Piyasirisilp,S., McCutchan,F.E., Carr,J.K., Sanders-Buell,E., Liu,W., Chen,J., Wagner,R., Wolf,H., Shao,Y., Lai,S., Beyrer,C. and Yu,X.F.",2000
AY008718,01_AE,1997,11070028,"A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant","Piyasirisilp,S., McCutchan,F.E., Carr,J.K., Sanders-Buell,E., Liu,W., Chen,J., Wagner,R., Wolf,H., Shao,Y., Lai,S., Beyrer,C. and Yu,X.F.",2000
AY037266,BF,1998,11600844,Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America,"Carr,J.K., Avila,M., Gomez Carrillo,M., Salomon,H., Hierholzer,J., Watanaveeradej,V., Pando,M.A., Negrete,M., Russell,K.L., Sanchez,J., Birx,D.L., Andrade,R., Vinoles,J. and McCutchan,F.E.",2001
AY037267,BF,2000,11600844,Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America,"Carr,J.K., Avila,M., Gomez Carrillo,M., Salomon,H., Hierholzer,J., Watanaveeradej,V., Pando,M.A., Negrete,M., Russell,K.L., Sanchez,J., Birx,D.L., Andrade,R., Vinoles,J. and McCutchan,F.E.",2001
AY037268,B,1998,11600844,Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America,"Carr,J.K., Avila,M., Gomez Carrillo,M., Salomon,H., Hierholzer,J., Watanaveeradej,V., Pando,M.A., Negrete,M., Russell,K.L., Sanchez,J., Birx,D.L., Andrade,R., Vinoles,J. and McCutchan,F.E.",2001
AY037269,B,2000,11600844,Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America,"Carr,J.K., Avila,M., Gomez Carrillo,M., Salomon,H., Hierholzer,J., Watanaveeradej,V., Pando,M.A., Negrete,M., Russell,K.L., Sanchez,J., Birx,D.L., Andrade,R., Vinoles,J. and McCutchan,F.E.",2001
AY037270,B,1999,11600844,Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America,"Carr,J.K., Avila,M., Gomez Carrillo,M., Salomon,H., Hierholzer,J., Watanaveeradej,V., Pando,M.A., Negrete,M., Russell,K.L., Sanchez,J., Birx,D.L., Andrade,R., Vinoles,J. and McCutchan,F.E.",2001
AY037271,BF,1999,11600844,Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America,"Carr,J.K., Avila,M., Gomez Carrillo,M., Salomon,H., Hierholzer,J., Watanaveeradej,V., Pando,M.A., Negrete,M., Russell,K.L., Sanchez,J., Birx,D.L., Andrade,R., Vinoles,J. and McCutchan,F.E.",2001
AY037272,BF,1999,11600844,Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America,"Carr,J.K., Avila,M., Gomez Carrillo,M., Salomon,H., Hierholzer,J., Watanaveeradej,V., Pando,M.A., Negrete,M., Russell,K.L., Sanchez,J., Birx,D.L., Andrade,R., Vinoles,J. and McCutchan,F.E.",2001
AY037273,BF,1999,11600844,Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America,"Carr,J.K., Avila,M., Gomez Carrillo,M., Salomon,H., Hierholzer,J., Watanaveeradej,V., Pando,M.A., Negrete,M., Russell,K.L., Sanchez,J., Birx,D.L., Andrade,R., Vinoles,J. and McCutchan,F.E.",2001
AY037274,B,1999,11600844,Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America,"Carr,J.K., Avila,M., Gomez Carrillo,M., Salomon,H., Hierholzer,J., Watanaveeradej,V., Pando,M.A., Negrete,M., Russell,K.L., Sanchez,J., Birx,D.L., Andrade,R., Vinoles,J. and McCutchan,F.E.",2001
AY037275,BF,1999,11600844,Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America,"Carr,J.K., Avila,M., Gomez Carrillo,M., Salomon,H., Hierholzer,J., Watanaveeradej,V., Pando,M.A., Negrete,M., Russell,K.L., Sanchez,J., Birx,D.L., Andrade,R., Vinoles,J. and McCutchan,F.E.",2001
AY037276,BF,1999,11600844,Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America,"Carr,J.K., Avila,M., Gomez Carrillo,M., Salomon,H., Hierholzer,J., Watanaveeradej,V., Pando,M.A., Negrete,M., Russell,K.L., Sanchez,J., Birx,D.L., Andrade,R., Vinoles,J. and McCutchan,F.E.",2001
AY037277,BF,1999,11600844,Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America,"Carr,J.K., Avila,M., Gomez Carrillo,M., Salomon,H., Hierholzer,J., Watanaveeradej,V., Pando,M.A., Negrete,M., Russell,K.L., Sanchez,J., Birx,D.L., Andrade,R., Vinoles,J. and McCutchan,F.E.",2001
AY037278,BF,1999,11600844,Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America,"Carr,J.K., Avila,M., Gomez Carrillo,M., Salomon,H., Hierholzer,J., Watanaveeradej,V., Pando,M.A., Negrete,M., Russell,K.L., Sanchez,J., Birx,D.L., Andrade,R., Vinoles,J. and McCutchan,F.E.",2001
AY037279,12_BF,1999,11600844,Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America,"Carr,J.K., Avila,M., Gomez Carrillo,M., Salomon,H., Hierholzer,J., Watanaveeradej,V., Pando,M.A., Negrete,M., Russell,K.L., Sanchez,J., Birx,D.L., Andrade,R., Vinoles,J. and McCutchan,F.E.",2001
AY037280,BF,1999,11600844,Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America,"Carr,J.K., Avila,M., Gomez Carrillo,M., Salomon,H., Hierholzer,J., Watanaveeradej,V., Pando,M.A., Negrete,M., Russell,K.L., Sanchez,J., Birx,D.L., Andrade,R., Vinoles,J. and McCutchan,F.E.",2001
AY037281,17_BF,1999,11600844,Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America,"Carr,J.K., Avila,M., Gomez Carrillo,M., Salomon,H., Hierholzer,J., Watanaveeradej,V., Pando,M.A., Negrete,M., Russell,K.L., Sanchez,J., Birx,D.L., Andrade,R., Vinoles,J. and McCutchan,F.E.",2001
AY037282,B,1999,11600844,Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America,"Carr,J.K., Avila,M., Gomez Carrillo,M., Salomon,H., Hierholzer,J., Watanaveeradej,V., Pando,M.A., Negrete,M., Russell,K.L., Sanchez,J., Birx,D.L., Andrade,R., Vinoles,J. and McCutchan,F.E.",2001
AY037283,BF,1999,11600844,Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America,"Carr,J.K., Avila,M., Gomez Carrillo,M., Salomon,H., Hierholzer,J., Watanaveeradej,V., Pando,M.A., Negrete,M., Russell,K.L., Sanchez,J., Birx,D.L., Andrade,R., Vinoles,J. and McCutchan,F.E.",2001
AY043175,C,1999,11709097,Characterization of full-length HIV type 1 subtype C sequences from South Africa,"van Harmelen,J., Williamson,C., Kim,B., Morris,L., Carr,J., Karim,S.S. and McCutchan,F.",2001
AY043176,C,1998,11709097,Characterization of full-length HIV type 1 subtype C sequences from South Africa,"van Harmelen,J., Williamson,C., Kim,B., Morris,L., Carr,J., Karim,S.S. and McCutchan,F.",2001
AY049708,C,1999,,Sequence of HIV-1 isolate 01IN565.10 from India,"Khurana,S., Patel,A., Kulkarni,S.S., Tripathy,S.P., Paranjape,R.S. and Chaudhary,V.K.",
AY082968,01B,,13678469,New HIV Type 1 CRF01_AE/B Recombinants Displaying Unique Distribution of Breakpoints from Incident Infections among Injecting Drug Users in Thailand,"Ramos,A., Nguyen,L., Hu,D.J., Vanichseni,S., Choopanya,K., Young,N.L., Tappero,J.W., Mastro,T.D., Folks,T.M. and Subbarao,S.",2003
AY093603,09_cpx,1995,15320986,"HIV type 1 circulating recombinant form CRF09_cpx from west Africa combines subtypes A, F, G, and may share ancestors with CRF02_AG and Z321","McCutchan,F.E., Sankale,J.L., M'Boup,S., Kim,B., Tovanabutra,S., Hamel,D.J., Brodine,S.K., Kanki,P.J. and Birx,D.L.",2004
AY093604,09_cpx,1995,15320986,"HIV type 1 circulating recombinant form CRF09_cpx from west Africa combines subtypes A, F, G, and may share ancestors with CRF02_AG and Z321","McCutchan,F.E., Sankale,J.L., M'Boup,S., Kim,B., Tovanabutra,S., Hamel,D.J., Brodine,S.K., Kanki,P.J. and Birx,D.L.",2004
AY093605,09_cpx,1996,15320986,"HIV type 1 circulating recombinant form CRF09_cpx from west Africa combines subtypes A, F, G, and may share ancestors with CRF02_AG and Z321","McCutchan,F.E., Sankale,J.L., M'Boup,S., Kim,B., Tovanabutra,S., Hamel,D.J., Brodine,S.K., Kanki,P.J. and Birx,D.L.",2004
AY093607,09_cpx,1999,15320986,"HIV type 1 circulating recombinant form CRF09_cpx from west Africa combines subtypes A, F, G, and may share ancestors with CRF02_AG and Z321","McCutchan,F.E., Sankale,J.L., M'Boup,S., Kim,B., Tovanabutra,S., Hamel,D.J., Brodine,S.K., Kanki,P.J. and Birx,D.L.",2004
AY124970,B,,,Genetic and functional analysis of full-length HIV-1 env genes derived from brain and blood of AIDS patients,"Ohagen,A., Devitt,A., Kunstman,K.J., Gorry,P.R., Rose,P., Korber,B., Taylor,J., Sodroskil,J., Levy,R., Murphy,R., Wolinsky,S. and Gabuzda,D.",
AY124973,B,,,Genetic and functional analysis of full-length HIV-1 env genes derived from brain and blood of AIDS patients,"Ohagen,A., Devitt,A., Kunstman,K.J., Gorry,P.R., Rose,P., Korber,B., Taylor,J., Sodroskil,J., Levy,R., Murphy,R., Wolinsky,S. and Gabuzda,D.",
AY124976,B,,,Genetic and functional analysis of full-length HIV-1 env genes derived from brain and blood of AIDS patients,"Ohagen,A., Devitt,A., Kunstman,K.J., Gorry,P.R., Rose,P., Korber,B., Taylor,J., Sodroskil,J., Levy,R., Murphy,R., Wolinsky,S. and Gabuzda,D.",
AY124980,B,,,Genetic and functional analysis of full-length HIV-1 env genes derived from brain and blood of AIDS patients,"Ohagen,A., Devitt,A., Kunstman,K.J., Gorry,P.R., Rose,P., Korber,B., Taylor,J., Sodroskil,J., Levy,R., Murphy,R., Wolinsky,S. and Gabuzda,D.",
AY151001,02_AG,,,Circulating Recombinant Form CRF02_AG in South America,"Carrion,G., Hierholzer,J., Montano,S., Alava,A., Perez,J., Guevara,A., Laguna-Torres,V., Mosquera,C., Russell,K., Cruz,C., Chauca,G., Kochel,T., Birx,D.L., Sanchez,J.L. and Carr,J.K.",2003
AY151002,02_AG,,,Circulating Recombinant Form CRF02_AG in South America,"Carrion,G., Hierholzer,J., Montano,S., Alava,A., Perez,J., Guevara,A., Laguna-Torres,V., Mosquera,C., Russell,K., Cruz,C., Chauca,G., Kochel,T., Birx,D.L., Sanchez,J.L. and Carr,J.K.",2003
AY158533,C,1998,12680693,Characterisation of near-full length genome sequences of three South African human immunodeficiency virus type 1 subtype C isolates,"Hunt,G.M., Papathanasopoulos,M.A., Gray,G.E. and Tiemessen,C.T.",2003
AY158534,C,1998,12680693,Characterisation of near-full length genome sequences of three South African human immunodeficiency virus type 1 subtype C isolates,"Hunt,G.M., Papathanasopoulos,M.A., Gray,G.E. and Tiemessen,C.T.",2003
AY158535,C,1998,12680693,Characterisation of near-full length genome sequences of three South African human immunodeficiency virus type 1 subtype C isolates,"Hunt,G.M., Papathanasopoulos,M.A., Gray,G.E. and Tiemessen,C.T.",2003
AY167123,01B,1991,14506784,Full-length sequence analysis of HIV-1 isolate CM237: a CRF01_AE/B intersubtype recombinant from Thailand,"Swanson,P., Devare,S.G. and Hackett,J. Jr.",2003
AY173951,B,1990,12487805,"Molecular Epidemiology of HIV Type 1 in Ecuador, Peru, Bolivia, Uruguay, and Argentina","Hierholzer,J., Montano,S., Hoelscher,M., Negrete,M., Hierholzer,M., Avila,M.M., Carrillo,M.G., Russi,J.C., Vinoles,J., Alava,A., Acosta,M.E., Gianella,A., Andrade,R., Sanchez,J.L., Carrion,G., Sanchez,J.L., Russell,K., Robb,M., Birx,D., McCutchan,F. and Carr,J.K.",2002
AY173952,B,1990,12487805,"Molecular Epidemiology of HIV Type 1 in Ecuador, Peru, Bolivia, Uruguay, and Argentina","Hierholzer,J., Montano,S., Hoelscher,M., Negrete,M., Hierholzer,M., Avila,M.M., Carrillo,M.G., Russi,J.C., Vinoles,J., Alava,A., Acosta,M.E., Gianella,A., Andrade,R., Sanchez,J.L., Carrion,G., Sanchez,J.L., Russell,K., Robb,M., Birx,D., McCutchan,F. and Carr,J.K.",2002
AY173954,B,1990,12487805,"Molecular Epidemiology of HIV Type 1 in Ecuador, Peru, Bolivia, Uruguay, and Argentina","Hierholzer,J., Montano,S., Hoelscher,M., Negrete,M., Hierholzer,M., Avila,M.M., Carrillo,M.G., Russi,J.C., Vinoles,J., Alava,A., Acosta,M.E., Gianella,A., Andrade,R., Sanchez,J.L., Carrion,G., Sanchez,J.L., Russell,K., Robb,M., Birx,D., McCutchan,F. and Carr,J.K.",2002
AY173955,B,1990,12487805,"Molecular Epidemiology of HIV Type 1 in Ecuador, Peru, Bolivia, Uruguay, and Argentina","Hierholzer,J., Montano,S., Hoelscher,M., Negrete,M., Hierholzer,M., Avila,M.M., Carrillo,M.G., Russi,J.C., Vinoles,J., Alava,A., Acosta,M.E., Gianella,A., Andrade,R., Sanchez,J.L., Carrion,G., Sanchez,J.L., Russell,K., Robb,M., Birx,D., McCutchan,F. and Carr,J.K.",2002
AY173957,F1,1989,12487805,"Molecular Epidemiology of HIV Type 1 in Ecuador, Peru, Bolivia, Uruguay, and Argentina","Hierholzer,J., Montano,S., Hoelscher,M., Negrete,M., Hierholzer,M., Avila,M.M., Carrillo,M.G., Russi,J.C., Vinoles,J., Alava,A., Acosta,M.E., Gianella,A., Andrade,R., Sanchez,J.L., Carrion,G., Sanchez,J.L., Russell,K., Robb,M., Birx,D., McCutchan,F. and Carr,J.K.",2002
AY173959,B,1989,12487805,"Molecular Epidemiology of HIV Type 1 in Ecuador, Peru, Bolivia, Uruguay, and Argentina","Hierholzer,J., Montano,S., Hoelscher,M., Negrete,M., Hierholzer,M., Avila,M.M., Carrillo,M.G., Russi,J.C., Vinoles,J., Alava,A., Acosta,M.E., Gianella,A., Andrade,R., Sanchez,J.L., Carrion,G., Sanchez,J.L., Russell,K., Robb,M., Birx,D., McCutchan,F. and Carr,J.K.",2002
AY173960,B,1989,12487805,"Molecular Epidemiology of HIV Type 1 in Ecuador, Peru, Bolivia, Uruguay, and Argentina","Hierholzer,J., Montano,S., Hoelscher,M., Negrete,M., Hierholzer,M., Avila,M.M., Carrillo,M.G., Russi,J.C., Vinoles,J., Alava,A., Acosta,M.E., Gianella,A., Andrade,R., Sanchez,J.L., Carrion,G., Sanchez,J.L., Russell,K., Robb,M., Birx,D., McCutchan,F. and Carr,J.K.",2002
AY180905,B,2001,,Cloning and Characterization of a Virtually Full-Length HIV-1 Genome of a Prevalent Subtype B-Thai Strain in Central China,"Fumin,F., Zuoyi,B., Daomin,Z., Siyang,L., Lin,L. and Jingyun,L.",
AY189526,B,,,"An unusual syncytia-inducing HIV-1 primary isolate from the central nervous system that is restricted to CXCR4, replicates efficiently in macrophages, and induces neuronal apoptosis","Yi,Y., Chen,W., Frank,I., Cutilli,J., Singh,A., Starr-Spires,L., Sulcove,J., Kolson,D. and Collman,R.",2003
AY223743,B,1990,,Antibody neutralization and escape by HIV-1,"Wei,X. and Shaw,G.M.",
AY223761,B,,12646921,Antibody neutralization and escape by HIV-1,"Wei,X., Decker,J.M., Wang,S., Hui,H., Kappes,J.C., Wu,X., Salazar-Gonzalez,J.F., Salazar,M.G., Kilby,J.M., Saag,M.S., Komarova,N.L., Nowak,M.A., Hahn,B.H., Kwong,P.D. and Shaw,G.M.",2003
AY227107,05_DF,1999,14506788,Near full-length genome characterization of an HIV type 1 CRF05_DF virus from Spain,"Casado,G., Thomson,M.M., Delgado,E., Sierra,M., Vazquez-De Parga,E., Perez-Alvarez,L., Ocampo,A. and Najera,R.",2003
AY228556,C,1999,14686322,Full-length genome characterization of HIV type 1 subtype C isolates from two slow-progressing perinatally infected siblings in South Africa,"Papathanasopoulos,M.A., Patience,T., Meyers,T.M., McCutchan,F.E. and Morris,L.",2003
AY228557,C,2001,14686322,Full-length genome characterization of HIV type 1 subtype C isolates from two slow-progressing perinatally infected siblings in South Africa,"Papathanasopoulos,M.A., Patience,T., Meyers,T.M., McCutchan,F.E. and Morris,L.",2003
AY231152,02_AG,1992,15307910,"Short communication: retrospective study to time the introduction of HIV type 1 non-B subtypes in Lyon, France, using env genes obtained from primary infection samples","Vachot,L., Ataman-Onal,Y., Terrat,C., Durand,P.Y., Ponceau,B., Biron,F. and Verrier,B.",2004
AY231153,02_AG,1994,15307910,"Short communication: retrospective study to time the introduction of HIV type 1 non-B subtypes in Lyon, France, using env genes obtained from primary infection samples","Vachot,L., Ataman-Onal,Y., Terrat,C., Durand,P.Y., Ponceau,B., Biron,F. and Verrier,B.",2004
AY231154,JKU,1995,15307910,"Short communication: retrospective study to time the introduction of HIV type 1 non-B subtypes in Lyon, France, using env genes obtained from primary infection samples","Vachot,L., Ataman-Onal,Y., Terrat,C., Durand,P.Y., Ponceau,B., Biron,F. and Verrier,B.",2004
AY231155,G,1995,15307910,"Short communication: retrospective study to time the introduction of HIV type 1 non-B subtypes in Lyon, France, using env genes obtained from primary infection samples","Vachot,L., Ataman-Onal,Y., Terrat,C., Durand,P.Y., Ponceau,B., Biron,F. and Verrier,B.",2004
AY231156,G,1995,15307910,"Short communication: retrospective study to time the introduction of HIV type 1 non-B subtypes in Lyon, France, using env genes obtained from primary infection samples","Vachot,L., Ataman-Onal,Y., Terrat,C., Durand,P.Y., Ponceau,B., Biron,F. and Verrier,B.",2004
AY231157,F1,1996,15307910,"Short communication: retrospective study to time the introduction of HIV type 1 non-B subtypes in Lyon, France, using env genes obtained from primary infection samples","Vachot,L., Ataman-Onal,Y., Terrat,C., Durand,P.Y., Ponceau,B., Biron,F. and Verrier,B.",2004
AY231158,01_AE,1996,15307910,"Short communication: retrospective study to time the introduction of HIV type 1 non-B subtypes in Lyon, France, using env genes obtained from primary infection samples","Vachot,L., Ataman-Onal,Y., Terrat,C., Durand,P.Y., Ponceau,B., Biron,F. and Verrier,B.",2004
AY237165,10A1,1996,14709248,Hypermutation of HIV type 1 genomes isolated from infants soon after vertical infection,"Koulinska,I.N., Chaplin,B., Mwakagile,D., Essex,M. and Renjifo,B.",2003
AY237166,A1D,1996,14709248,Hypermutation of HIV type 1 genomes isolated from infants soon after vertical infection,"Koulinska,I.N., Chaplin,B., Mwakagile,D., Essex,M. and Renjifo,B.",2003
AY247022,B,1998,,Viremia control despite escape from a rapid and potent autologous neutralizing antibody response after therapy cessation in an HIV-1-infected individual,"Montefiori,D.C., Altfeld,M., Lee,P.K., Bilska,M., Zhou,J., Johnston,M.N., Gao,F., Walker,B.D. and Rosenberg,E.S.",
AY247218,B,1981,12743293,"U.S. Human immunodeficiency virus type 1 epidemic: date of origin, population history, and characterization of early strains","Robbins,K.E., Lemey,P., Pybus,O.G., Jaffe,H.W., Youngpairoj,A.S., Brown,T.M., Salemi,M., Vandamme,A.M. and Kalish,M.L.",2003
AY247219,B,1981,12743293,"U.S. Human immunodeficiency virus type 1 epidemic: date of origin, population history, and characterization of early strains","Robbins,K.E., Lemey,P., Pybus,O.G., Jaffe,H.W., Youngpairoj,A.S., Brown,T.M., Salemi,M., Vandamme,A.M. and Kalish,M.L.",2003
AY247220,B,1981,12743293,"U.S. Human immunodeficiency virus type 1 epidemic: date of origin, population history, and characterization of early strains","Robbins,K.E., Lemey,P., Pybus,O.G., Jaffe,H.W., Youngpairoj,A.S., Brown,T.M., Salemi,M., Vandamme,A.M. and Kalish,M.L.",2003
AY247221,B,1981,12743293,"U.S. Human immunodeficiency virus type 1 epidemic: date of origin, population history, and characterization of early strains","Robbins,K.E., Lemey,P., Pybus,O.G., Jaffe,H.W., Youngpairoj,A.S., Brown,T.M., Salemi,M., Vandamme,A.M. and Kalish,M.L.",2003
AY247222,B,1981,12743293,"U.S. Human immunodeficiency virus type 1 epidemic: date of origin, population history, and characterization of early strains","Robbins,K.E., Lemey,P., Pybus,O.G., Jaffe,H.W., Youngpairoj,A.S., Brown,T.M., Salemi,M., Vandamme,A.M. and Kalish,M.L.",2003
AY247223,B,1981,12743293,"U.S. Human immunodeficiency virus type 1 epidemic: date of origin, population history, and characterization of early strains","Robbins,K.E., Lemey,P., Pybus,O.G., Jaffe,H.W., Youngpairoj,A.S., Brown,T.M., Salemi,M., Vandamme,A.M. and Kalish,M.L.",2003
AY247224,B,1981,12743293,"U.S. Human immunodeficiency virus type 1 epidemic: date of origin, population history, and characterization of early strains","Robbins,K.E., Lemey,P., Pybus,O.G., Jaffe,H.W., Youngpairoj,A.S., Brown,T.M., Salemi,M., Vandamme,A.M. and Kalish,M.L.",2003
AY247225,B,1982,12743293,"U.S. Human immunodeficiency virus type 1 epidemic: date of origin, population history, and characterization of early strains","Robbins,K.E., Lemey,P., Pybus,O.G., Jaffe,H.W., Youngpairoj,A.S., Brown,T.M., Salemi,M., Vandamme,A.M. and Kalish,M.L.",2003
AY253303,C,2001,15320994,HIV type 1 subtypes among blood donors in the Mbeya region of southwest Tanzania,"Arroyo,M.A., Hoelscher,M., Sanders-Buell,E., Herbinger,K.H., Samky,E., Maboko,L., Hoffmann,O., Robb,M.R., Birx,D.L. and McCutchan,F.E.",2004
AY253304,C,2001,15320994,HIV type 1 subtypes among blood donors in the Mbeya region of southwest Tanzania,"Arroyo,M.A., Hoelscher,M., Sanders-Buell,E., Herbinger,K.H., Samky,E., Maboko,L., Hoffmann,O., Robb,M.R., Birx,D.L. and McCutchan,F.E.",2004
AY253305,A1,2001,15320994,HIV type 1 subtypes among blood donors in the Mbeya region of southwest Tanzania,"Arroyo,M.A., Hoelscher,M., Sanders-Buell,E., Herbinger,K.H., Samky,E., Maboko,L., Hoffmann,O., Robb,M.R., Birx,D.L. and McCutchan,F.E.",2004
AY253306,A1,2001,15320994,HIV type 1 subtypes among blood donors in the Mbeya region of southwest Tanzania,"Arroyo,M.A., Hoelscher,M., Sanders-Buell,E., Herbinger,K.H., Samky,E., Maboko,L., Hoffmann,O., Robb,M.R., Birx,D.L. and McCutchan,F.E.",2004
AY253307,C,2001,15320994,HIV type 1 subtypes among blood donors in the Mbeya region of southwest Tanzania,"Arroyo,M.A., Hoelscher,M., Sanders-Buell,E., Herbinger,K.H., Samky,E., Maboko,L., Hoffmann,O., Robb,M.R., Birx,D.L. and McCutchan,F.E.",2004
AY253308,C,2001,15320994,HIV type 1 subtypes among blood donors in the Mbeya region of southwest Tanzania,"Arroyo,M.A., Hoelscher,M., Sanders-Buell,E., Herbinger,K.H., Samky,E., Maboko,L., Hoffmann,O., Robb,M.R., Birx,D.L. and McCutchan,F.E.",2004
AY253309,CD,2001,15320994,HIV type 1 subtypes among blood donors in the Mbeya region of southwest Tanzania,"Arroyo,M.A., Hoelscher,M., Sanders-Buell,E., Herbinger,K.H., Samky,E., Maboko,L., Hoffmann,O., Robb,M.R., Birx,D.L. and McCutchan,F.E.",2004
AY253310,C,2001,15320994,HIV type 1 subtypes among blood donors in the Mbeya region of southwest Tanzania,"Arroyo,M.A., Hoelscher,M., Sanders-Buell,E., Herbinger,K.H., Samky,E., Maboko,L., Hoffmann,O., Robb,M.R., Birx,D.L. and McCutchan,F.E.",2004
AY253311,D,2001,15320994,HIV type 1 subtypes among blood donors in the Mbeya region of southwest Tanzania,"Arroyo,M.A., Hoelscher,M., Sanders-Buell,E., Herbinger,K.H., Samky,E., Maboko,L., Hoffmann,O., Robb,M.R., Birx,D.L. and McCutchan,F.E.",2004
AY253312,C,2001,15320994,HIV type 1 subtypes among blood donors in the Mbeya region of southwest Tanzania,"Arroyo,M.A., Hoelscher,M., Sanders-Buell,E., Herbinger,K.H., Samky,E., Maboko,L., Hoffmann,O., Robb,M.R., Birx,D.L. and McCutchan,F.E.",2004
AY253313,C,2001,15320994,HIV type 1 subtypes among blood donors in the Mbeya region of southwest Tanzania,"Arroyo,M.A., Hoelscher,M., Sanders-Buell,E., Herbinger,K.H., Samky,E., Maboko,L., Hoffmann,O., Robb,M.R., Birx,D.L. and McCutchan,F.E.",2004
AY253314,A1,2001,15320994,HIV type 1 subtypes among blood donors in the Mbeya region of southwest Tanzania,"Arroyo,M.A., Hoelscher,M., Sanders-Buell,E., Herbinger,K.H., Samky,E., Maboko,L., Hoffmann,O., Robb,M.R., Birx,D.L. and McCutchan,F.E.",2004
AY253315,A1C,2001,15320994,HIV type 1 subtypes among blood donors in the Mbeya region of southwest Tanzania,"Arroyo,M.A., Hoelscher,M., Sanders-Buell,E., Herbinger,K.H., Samky,E., Maboko,L., Hoffmann,O., Robb,M.R., Birx,D.L. and McCutchan,F.E.",2004
AY253316,A1D,2001,15320994,HIV type 1 subtypes among blood donors in the Mbeya region of southwest Tanzania,"Arroyo,M.A., Hoelscher,M., Sanders-Buell,E., Herbinger,K.H., Samky,E., Maboko,L., Hoffmann,O., Robb,M.R., Birx,D.L. and McCutchan,F.E.",2004
AY253317,C,2001,15320994,HIV type 1 subtypes among blood donors in the Mbeya region of southwest Tanzania,"Arroyo,M.A., Hoelscher,M., Sanders-Buell,E., Herbinger,K.H., Samky,E., Maboko,L., Hoffmann,O., Robb,M.R., Birx,D.L. and McCutchan,F.E.",2004
AY253318,A1C,2001,15320994,HIV type 1 subtypes among blood donors in the Mbeya region of southwest Tanzania,"Arroyo,M.A., Hoelscher,M., Sanders-Buell,E., Herbinger,K.H., Samky,E., Maboko,L., Hoffmann,O., Robb,M.R., Birx,D.L. and McCutchan,F.E.",2004
AY253319,A1C,2001,15320994,HIV type 1 subtypes among blood donors in the Mbeya region of southwest Tanzania,"Arroyo,M.A., Hoelscher,M., Sanders-Buell,E., Herbinger,K.H., Samky,E., Maboko,L., Hoffmann,O., Robb,M.R., Birx,D.L. and McCutchan,F.E.",2004
AY253320,C,2001,15320994,HIV type 1 subtypes among blood donors in the Mbeya region of southwest Tanzania,"Arroyo,M.A., Hoelscher,M., Sanders-Buell,E., Herbinger,K.H., Samky,E., Maboko,L., Hoffmann,O., Robb,M.R., Birx,D.L. and McCutchan,F.E.",2004
AY253321,C,2001,15320994,HIV type 1 subtypes among blood donors in the Mbeya region of southwest Tanzania,"Arroyo,M.A., Hoelscher,M., Sanders-Buell,E., Herbinger,K.H., Samky,E., Maboko,L., Hoffmann,O., Robb,M.R., Birx,D.L. and McCutchan,F.E.",2004
AY253322,C,2001,15320994,HIV type 1 subtypes among blood donors in the Mbeya region of southwest Tanzania,"Arroyo,M.A., Hoelscher,M., Sanders-Buell,E., Herbinger,K.H., Samky,E., Maboko,L., Hoffmann,O., Robb,M.R., Birx,D.L. and McCutchan,F.E.",2004
AY255823,C,1999,14709249,"A cluster of HIV type 1 subtype C sequences from Ethiopia, observed in full genome analysis, is not sustained in subgenomic regions","Harris,M.E., Maayan,S., Kim,B., Zeira,M., Ferrari,G., Birx,D.L. and McCutchan,F.E.",2003
AY255824,C,1999,14709249,"A cluster of HIV type 1 subtype C sequences from Ethiopia, observed in full genome analysis, is not sustained in subgenomic regions","Harris,M.E., Maayan,S., Kim,B., Zeira,M., Ferrari,G., Birx,D.L. and McCutchan,F.E.",2003
AY255825,C,1999,14709249,"A cluster of HIV type 1 subtype C sequences from Ethiopia, observed in full genome analysis, is not sustained in subgenomic regions","Harris,M.E., Maayan,S., Kim,B., Zeira,M., Ferrari,G., Birx,D.L. and McCutchan,F.E.",2003
AY255826,C,1999,14709249,"A cluster of HIV type 1 subtype C sequences from Ethiopia, observed in full genome analysis, is not sustained in subgenomic regions","Harris,M.E., Maayan,S., Kim,B., Zeira,M., Ferrari,G., Birx,D.L. and McCutchan,F.E.",2003
AY255827,C,1999,14709249,"A cluster of HIV type 1 subtype C sequences from Ethiopia, observed in full genome analysis, is not sustained in subgenomic regions","Harris,M.E., Maayan,S., Kim,B., Zeira,M., Ferrari,G., Birx,D.L. and McCutchan,F.E.",2003
AY255828,C,1999,14709249,"A cluster of HIV type 1 subtype C sequences from Ethiopia, observed in full genome analysis, is not sustained in subgenomic regions","Harris,M.E., Maayan,S., Kim,B., Zeira,M., Ferrari,G., Birx,D.L. and McCutchan,F.E.",2003
AY304496,D,1999,,Development and application of a high-throughput HIV-1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H. and McCutchan,F.E.",
AY308760,B,1996,14678608,Primary infection of a male plasma donor with divergent HIV variants from the same source followed by rapid fluctuations in their relative frequency and viral recombination,"Bernardin,F., Herring,B.L., Peddada,L. and Delwart,E.L.",2003
AY314044,B,1996,15596829,Human immunodeficiency virus type 1 genomic RNA sequences in the female genital tract and blood: compartmentalization and intrapatient recombination,"Philpott,S., Burger,H., Tsoukas,C., Foley,B., Anastos,K., Kitchen,C. and Weiser,B.",2005
AY322184,A1,1986,15272396,Long-term survivors in Nairobi: complete HIV-1 RNA sequences and immunogenetic associations,"Fang,G., Kuiken,C., Weiser,B., Rowland-Jones,S., Plummer,F., Chen,C.H., Kaul,R., Anzala,A.O., Bwayo,J., Kimani,J., Philpott,S.M., Kitchen,C., Sinsheimer,J.S., Gaschen,B., Lang,D., Shi,B., Kemal,K.S., Rostron,T., Brunner,C., Beddows,S., Sattenau,Q., Paxinos,E., Oyugi,J. and Burger,H.",2004
AY322187,CD,1997,15272396,Long-term survivors in Nairobi: complete HIV-1 RNA sequences and immunogenetic associations,"Fang,G., Kuiken,C., Weiser,B., Rowland-Jones,S., Plummer,F., Chen,C.H., Kaul,R., Anzala,A.O., Bwayo,J., Kimani,J., Philpott,S.M., Kitchen,C., Sinsheimer,J.S., Gaschen,B., Lang,D., Shi,B., Kemal,K.S., Rostron,T., Brunner,C., Beddows,S., Sattenau,Q., Paxinos,E., Oyugi,J. and Burger,H.",2004
AY322189,D,1997,15272396,Long-term survivors in Nairobi: complete HIV-1 RNA sequences and immunogenetic associations,"Fang,G., Kuiken,C., Weiser,B., Rowland-Jones,S., Plummer,F., Chen,C.H., Kaul,R., Anzala,A.O., Bwayo,J., Kimani,J., Philpott,S.M., Kitchen,C., Sinsheimer,J.S., Gaschen,B., Lang,D., Shi,B., Kemal,K.S., Rostron,T., Brunner,C., Beddows,S., Sattenau,Q., Paxinos,E., Oyugi,J. and Burger,H.",2004
AY322190,A1,1997,15272396,Long-term survivors in Nairobi: complete HIV-1 RNA sequences and immunogenetic associations,"Fang,G., Kuiken,C., Weiser,B., Rowland-Jones,S., Plummer,F., Chen,C.H., Kaul,R., Anzala,A.O., Bwayo,J., Kimani,J., Philpott,S.M., Kitchen,C., Sinsheimer,J.S., Gaschen,B., Lang,D., Shi,B., Kemal,K.S., Rostron,T., Brunner,C., Beddows,S., Sattenau,Q., Paxinos,E., Oyugi,J. and Burger,H.",2004
AY322191,AC,1997,15272396,Long-term survivors in Nairobi: complete HIV-1 RNA sequences and immunogenetic associations,"Fang,G., Kuiken,C., Weiser,B., Rowland-Jones,S., Plummer,F., Chen,C.H., Kaul,R., Anzala,A.O., Bwayo,J., Kimani,J., Philpott,S.M., Kitchen,C., Sinsheimer,J.S., Gaschen,B., Lang,D., Shi,B., Kemal,K.S., Rostron,T., Brunner,C., Beddows,S., Sattenau,Q., Paxinos,E., Oyugi,J. and Burger,H.",2004
AY322193,A1,1997,15272396,Long-term survivors in Nairobi: complete HIV-1 RNA sequences and immunogenetic associations,"Fang,G., Kuiken,C., Weiser,B., Rowland-Jones,S., Plummer,F., Chen,C.H., Kaul,R., Anzala,A.O., Bwayo,J., Kimani,J., Philpott,S.M., Kitchen,C., Sinsheimer,J.S., Gaschen,B., Lang,D., Shi,B., Kemal,K.S., Rostron,T., Brunner,C., Beddows,S., Sattenau,Q., Paxinos,E., Oyugi,J. and Burger,H.",2004
AY331282,B,1997,16103205,Human immunodeficiency virus mutations during the first month of infection are preferentially found in known cytotoxic T-lymphocyte epitopes,"Bernardin,F., Kong,D., Peddada,L., Baxter-Lowe,L.A. and Delwart,E.",2005
AY331284,B,1997,16103205,Human immunodeficiency virus mutations during the first month of infection are preferentially found in known cytotoxic T-lymphocyte epitopes,"Bernardin,F., Kong,D., Peddada,L., Baxter-Lowe,L.A. and Delwart,E.",2005
AY331285,B,1997,16103205,Human immunodeficiency virus mutations during the first month of infection are preferentially found in known cytotoxic T-lymphocyte epitopes,"Bernardin,F., Kong,D., Peddada,L., Baxter-Lowe,L.A. and Delwart,E.",2005
AY331287,B,1997,16103205,Human immunodeficiency virus mutations during the first month of infection are preferentially found in known cytotoxic T-lymphocyte epitopes,"Bernardin,F., Kong,D., Peddada,L., Baxter-Lowe,L.A. and Delwart,E.",2005
AY331289,B,1997,16103205,Human immunodeficiency virus mutations during the first month of infection are preferentially found in known cytotoxic T-lymphocyte epitopes,"Bernardin,F., Kong,D., Peddada,L., Baxter-Lowe,L.A. and Delwart,E.",2005
AY331291,B,1996,16103205,Human immunodeficiency virus mutations during the first month of infection are preferentially found in known cytotoxic T-lymphocyte epitopes,"Bernardin,F., Kong,D., Peddada,L., Baxter-Lowe,L.A. and Delwart,E.",2005
AY331292,B,1996,16103205,Human immunodeficiency virus mutations during the first month of infection are preferentially found in known cytotoxic T-lymphocyte epitopes,"Bernardin,F., Kong,D., Peddada,L., Baxter-Lowe,L.A. and Delwart,E.",2005
AY331294,B,1998,16103205,Human immunodeficiency virus mutations during the first month of infection are preferentially found in known cytotoxic T-lymphocyte epitopes,"Bernardin,F., Kong,D., Peddada,L., Baxter-Lowe,L.A. and Delwart,E.",2005
AY331296,B,1999,16103205,Human immunodeficiency virus mutations during the first month of infection are preferentially found in known cytotoxic T-lymphocyte epitopes,"Bernardin,F., Kong,D., Peddada,L., Baxter-Lowe,L.A. and Delwart,E.",2005
AY352275,B,1984,2370688,"Human immunodeficiency virus type 1 cellular host range, replication, and cytopathicity are linked to the envelope region of the viral genome","York-Higgins,D., Cheng-Mayer,C., Bauer,D., Levy,J.A. and Dina,D.",1990
AY352654,GKU,1995,14599796,Characterization of novel recombinant HIV-1 genomes using the branching index,"Wilbe,K., Salminen,M., Laukkanen,T., McCutchan,F., Ray,S.C., Albert,J. and Leitner,T.",2003
AY352655,GKU,1995,14599796,Characterization of novel recombinant HIV-1 genomes using the branching index,"Wilbe,K., Salminen,M., Laukkanen,T., McCutchan,F., Ray,S.C., Albert,J. and Leitner,T.",2003
AY352656,A1D,1992,14599796,Characterization of novel recombinant HIV-1 genomes using the branching index,"Wilbe,K., Salminen,M., Laukkanen,T., McCutchan,F., Ray,S.C., Albert,J. and Leitner,T.",2003
AY352657,A1D,1990,14599796,Characterization of novel recombinant HIV-1 genomes using the branching index,"Wilbe,K., Salminen,M., Laukkanen,T., McCutchan,F., Ray,S.C., Albert,J. and Leitner,T.",2003
AY357338,B,1985,14990699,Genetic and phenotypic analyses of human immunodeficiency virus type 1 escape from a small-molecule CCR5 inhibitor,"Kuhmann,S.E., Pugach,P., Kunstman,K.J., Taylor,J., Stanfield,R.L., Snyder,A., Strizki,J.M., Riley,J., Baroudy,B.M., Wilson,I.A., Korber,B.T., Wolinsky,S.M. and Moore,J.P.",2004
AY358036,01_AE,2001,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358037,01_AE,2002,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358038,01_AE,2001,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358039,01_AE,1999,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358040,01_AE,2001,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358041,01_AE,2001,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358042,01B,1999,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358043,01_AE,1999,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358044,01_AE,1999,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358045,01_AE,1999,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358046,01_AE,2000,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358047,01_AE,1999,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358048,01_AE,1999,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358049,01_AE,1999,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358050,01_AE,2001,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358051,01_AE,1999,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358052,01_AE,2000,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358053,01_AE,2001,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358054,01_AE,2000,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358055,01_AE,2002,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358056,01_AE,2001,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358057,01_AE,2000,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358058,01_AE,2001,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358059,01_AE,2001,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358060,01_AE,2000,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358061,01_AE,2000,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358062,01_AE,2002,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358063,01_AE,2000,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358064,01_AE,2001,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358066,01_AE,2000,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358067,01_AE,2000,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358068,01_AE,2001,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358069,01B,2002,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358070,01B,2002,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358071,01B,2001,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358072,01B,2002,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY358073,01B,2002,15186520,"The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002","Tovanabutra,S., Beyrer,C., Sakkhachornphop,S., Razak,M.H., Ramos,G.L., Vongchak,T., Rungruengthanakit,K., Saokhieo,P., Tejafong,K., Kim,B., De Souza,M., Robb,M.L., Birx,D.L., Jittiwutikarn,J., Suriyanon,V., Celentano,D.D. and McCutchan,F.E.",2004
AY371121,G,2001,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371122,02_AG,2001,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371123,02_AG,2001,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371124,02_AG,2001,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371125,02_AG,2002,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371126,02_AG,2002,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371127,02_AG,2002,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371128,02_AG,2002,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371129,02_AG,2002,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371130,02_AG,2002,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371131,02_AG,2001,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371132,02_AG,2001,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371133,02_AG,2001,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371134,02_AG,2001,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371135,02_AG,2001,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371136,02_AG,2001,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371137,02_AG,2001,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371138,02_AG,2001,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371139,02_AG,2002,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371140,02_AG,2002,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371141,02_AG,2002,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371142,02_AG,2001,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371143,02A1U,2002,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371144,0102AG,2002,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371145,0102A,2001,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371146,02_AG,2002,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371147,02G,2002,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371148,0102DF,2002,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371149,11_cpx,2001,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371150,11_cpx,2001,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371151,11_cpx,2002,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371152,0211,2002,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371153,11_cpx,2002,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371154,13_cpx,2002,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371155,D,2001,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371156,D,2001,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371157,D,2001,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371158,F2,2002,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371159,22_01A1,2001,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371160,AF2,2002,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371161,AHJU,2001,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371162,AHJU,2001,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371163,22A1U,2001,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371164,A1F2,2001,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371165,22_01A1,2002,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371166,AGU,2001,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371167,0122F,2001,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371168,22DU,2001,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371169,25_cpx,2002,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY371170,01ADF2,2001,15186527,Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa,"Kijak,G.H., Sanders-Buell,E., Wolfe,N.D., Mpoudi-Ngole,E., Kim,B., Brown,B., Robb,M.L., Birx,D.L., Burke,D.S., Carr,J.K. and McCutchan,F.E.",2004
AY423381,B,1999,14610167,Identification of sequential viral escape mutants associated with altered T-cell responses in a human immunodeficiency virus type 1-infected individual,"Geels,M.J., Cornelissen,M., Schuitemaker,H., Anderson,K., Kwa,D., Maas,J., Dekker,J.T., Baan,E., Zorgdrager,F., van den Burg,R., van Beelen,M., Lukashov,V.V., Fu,T.M., Paxton,W.A., van der Hoek,L., Dubey,S.A., Shiver,J.W. and Goudsmit,J.",2003
AY423971,C,1998,15044802,Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission,"Derdeyn,C.A., Decker,J.M., Bibollet-Ruche,F., Mokili,J.L., Muldoon,M., Denham,S.A., Heil,M.L., Kasolo,F., Musonda,R., Hahn,B.H., Shaw,G.M., Korber,B.T., Allen,S. and Hunter,E.",2019
AY423984,C,2000,15044802,Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission,"Derdeyn,C.A., Decker,J.M., Bibollet-Ruche,F., Mokili,J.L., Muldoon,M., Denham,S.A., Heil,M.L., Kasolo,F., Musonda,R., Hahn,B.H., Shaw,G.M., Korber,B.T., Allen,S. and Hunter,E.",2019
AY424079,C,1998,15044802,Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission,"Derdeyn,C.A., Decker,J.M., Bibollet-Ruche,F., Mokili,J.L., Muldoon,M., Denham,S.A., Heil,M.L., Kasolo,F., Musonda,R., Hahn,B.H., Shaw,G.M., Korber,B.T., Allen,S. and Hunter,E.",2019
AY424138,C,2000,15044802,Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission,"Derdeyn,C.A., Decker,J.M., Bibollet-Ruche,F., Mokili,J.L., Muldoon,M., Denham,S.A., Heil,M.L., Kasolo,F., Musonda,R., Hahn,B.H., Shaw,G.M., Korber,B.T., Allen,S. and Hunter,E.",2019
AY424163,C,1998,15044802,Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission,"Derdeyn,C.A., Decker,J.M., Bibollet-Ruche,F., Mokili,J.L., Muldoon,M., Denham,S.A., Heil,M.L., Kasolo,F., Musonda,R., Hahn,B.H., Shaw,G.M., Korber,B.T., Allen,S. and Hunter,E.",2019
AY426125,B,1986,15220431,Intrinsic obstacles to human immunodeficiency virus type 1 coreceptor switching,"Pastore,C., Ramos,A. and Mosier,D.E.",2004
AY444799,AD,1999,15929707,Characterization of Complete HIV Type 1 Genomes from Non-B Subtype Infections in U.S. Military Personnel,"Tovanabutra,S., Brodine,S.K., Mascola,J.R., Sankale,J.L., Sanders-Buell,E., Kim,B., Birx,D.L. and McCutchan,F.E.",2005
AY444800,C,1998,15929707,Characterization of Complete HIV Type 1 Genomes from Non-B Subtype Infections in U.S. Military Personnel,"Tovanabutra,S., Brodine,S.K., Mascola,J.R., Sankale,J.L., Sanders-Buell,E., Kim,B., Birx,D.L. and McCutchan,F.E.",2005
AY444801,C,1998,15929707,Characterization of Complete HIV Type 1 Genomes from Non-B Subtype Infections in U.S. Military Personnel,"Tovanabutra,S., Brodine,S.K., Mascola,J.R., Sankale,J.L., Sanders-Buell,E., Kim,B., Birx,D.L. and McCutchan,F.E.",2005
AY444803,01_AE,1998,15929707,Characterization of Complete HIV Type 1 Genomes from Non-B Subtype Infections in U.S. Military Personnel,"Tovanabutra,S., Brodine,S.K., Mascola,J.R., Sankale,J.L., Sanders-Buell,E., Kim,B., Birx,D.L. and McCutchan,F.E.",2005
AY444804,01_AE,2000,15929707,Characterization of Complete HIV Type 1 Genomes from Non-B Subtype Infections in U.S. Military Personnel,"Tovanabutra,S., Brodine,S.K., Mascola,J.R., Sankale,J.L., Sanders-Buell,E., Kim,B., Birx,D.L. and McCutchan,F.E.",2005
AY444805,01_AE,1998,15929707,Characterization of Complete HIV Type 1 Genomes from Non-B Subtype Infections in U.S. Military Personnel,"Tovanabutra,S., Brodine,S.K., Mascola,J.R., Sankale,J.L., Sanders-Buell,E., Kim,B., Birx,D.L. and McCutchan,F.E.",2005
AY444806,01_AE,1998,15929707,Characterization of Complete HIV Type 1 Genomes from Non-B Subtype Infections in U.S. Military Personnel,"Tovanabutra,S., Brodine,S.K., Mascola,J.R., Sankale,J.L., Sanders-Buell,E., Kim,B., Birx,D.L. and McCutchan,F.E.",2005
AY444807,01_AE,1998,15929707,Characterization of Complete HIV Type 1 Genomes from Non-B Subtype Infections in U.S. Military Personnel,"Tovanabutra,S., Brodine,S.K., Mascola,J.R., Sankale,J.L., Sanders-Buell,E., Kim,B., Birx,D.L. and McCutchan,F.E.",2005
AY444808,02_AG,1998,15929707,Characterization of Complete HIV Type 1 Genomes from Non-B Subtype Infections in U.S. Military Personnel,"Tovanabutra,S., Brodine,S.K., Mascola,J.R., Sankale,J.L., Sanders-Buell,E., Kim,B., Birx,D.L. and McCutchan,F.E.",2005
AY444809,02_AG,1999,15929707,Characterization of Complete HIV Type 1 Genomes from Non-B Subtype Infections in U.S. Military Personnel,"Tovanabutra,S., Brodine,S.K., Mascola,J.R., Sankale,J.L., Sanders-Buell,E., Kim,B., Birx,D.L. and McCutchan,F.E.",2005
AY444810,02_AG,1998,15929707,Characterization of Complete HIV Type 1 Genomes from Non-B Subtype Infections in U.S. Military Personnel,"Tovanabutra,S., Brodine,S.K., Mascola,J.R., Sankale,J.L., Sanders-Buell,E., Kim,B., Birx,D.L. and McCutchan,F.E.",2005
AY444811,02_AG,2000,15929707,Characterization of Complete HIV Type 1 Genomes from Non-B Subtype Infections in U.S. Military Personnel,"Tovanabutra,S., Brodine,S.K., Mascola,J.R., Sankale,J.L., Sanders-Buell,E., Kim,B., Birx,D.L. and McCutchan,F.E.",2005
AY444812,01B,1998,15929707,Characterization of Complete HIV Type 1 Genomes from Non-B Subtype Infections in U.S. Military Personnel,"Tovanabutra,S., Brodine,S.K., Mascola,J.R., Sankale,J.L., Sanders-Buell,E., Kim,B., Birx,D.L. and McCutchan,F.E.",2005
AY455778,29_BF,1999,15585105,Analysis of near full-length genome sequences of HIV type 1 BF intersubtype recombinant viruses from Brazil reveals their independent origins and their lack of relationship to CRF12_BF,"Thomson,M.M., Sierra,M., Tanuri,A., May,S., Casado,G., Manjon,N. and Najera,R.",2004
AY455779,BF,1994,15585105,Analysis of near full-length genome sequences of HIV type 1 BF intersubtype recombinant viruses from Brazil reveals their independent origins and their lack of relationship to CRF12_BF,"Thomson,M.M., Sierra,M., Tanuri,A., May,S., Casado,G., Manjon,N. and Najera,R.",2004
AY455780,BF,1999,15585105,Analysis of near full-length genome sequences of HIV type 1 BF intersubtype recombinant viruses from Brazil reveals their independent origins and their lack of relationship to CRF12_BF,"Thomson,M.M., Sierra,M., Tanuri,A., May,S., Casado,G., Manjon,N. and Najera,R.",2004
AY455781,BF1,1994,15585105,Analysis of near full-length genome sequences of HIV type 1 BF intersubtype recombinant viruses from Brazil reveals their independent origins and their lack of relationship to CRF12_BF,"Thomson,M.M., Sierra,M., Tanuri,A., May,S., Casado,G., Manjon,N. and Najera,R.",2004
AY455782,BF1,1999,15585105,Analysis of near full-length genome sequences of HIV type 1 BF intersubtype recombinant viruses from Brazil reveals their independent origins and their lack of relationship to CRF12_BF,"Thomson,M.M., Sierra,M., Tanuri,A., May,S., Casado,G., Manjon,N. and Najera,R.",2004
AY455783,BF,1999,15585105,Analysis of near full-length genome sequences of HIV type 1 BF intersubtype recombinant viruses from Brazil reveals their independent origins and their lack of relationship to CRF12_BF,"Thomson,M.M., Sierra,M., Tanuri,A., May,S., Casado,G., Manjon,N. and Najera,R.",2004
AY455784,BF,1994,15585105,Analysis of near full-length genome sequences of HIV type 1 BF intersubtype recombinant viruses from Brazil reveals their independent origins and their lack of relationship to CRF12_BF,"Thomson,M.M., Sierra,M., Tanuri,A., May,S., Casado,G., Manjon,N. and Najera,R.",2004
AY455785,BF,1994,15585105,Analysis of near full-length genome sequences of HIV type 1 BF intersubtype recombinant viruses from Brazil reveals their independent origins and their lack of relationship to CRF12_BF,"Thomson,M.M., Sierra,M., Tanuri,A., May,S., Casado,G., Manjon,N. and Najera,R.",2004
AY463217,C,2000,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY463218,C,2000,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY463219,C,2000,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY463220,C,2000,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY463221,C,2000,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY463222,C,2000,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY463223,C,2001,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY463224,C,2000,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY463225,C,2000,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY463226,C,2000,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY463227,C,2000,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY463228,C,2000,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY463229,C,2000,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY463230,C,2000,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY463231,C,2000,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY463232,C,2000,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY463233,C,2000,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY463234,C,2000,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY463235,C,2001,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY463236,C,2000,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY463237,C,2001,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY489739,O,,15585082,HIV infections in northwestern Cameroon: identification of HIV type 1 group O and dual HIV type 1 group M and group O infections,"Yamaguchi,J., Bodelle,P., Vallari,A.S., Coffey,R., McArthur,C.P., Schochetman,G., Devare,S.G. and Brennan,C.A.",2004
AY494966,D,1994,15585084,"Substitution of hiv type-1 non-B env genes in C2, a subtype B cassette system, results in functional chimeric viruses","Zheng,N.N. and Daniels,R.S.",2004
AY494967,01_AE,1993,15585084,"Substitution of hiv type-1 non-B env genes in C2, a subtype B cassette system, results in functional chimeric viruses","Zheng,N.N. and Daniels,R.S.",2004
AY494968,01_AE,1992,8744585,"env gene sequences of primary HIV type 1 isolates of subtypes B, C, D, E, and F obtained from the World Health Organization Network for HIV Isolation and Characterization","Penny,M.A., Thomas,S.J., Douglas,N.W., Ranjbar,S., Holmes,H. and Daniels,R.S.",1996
AY500393,A6,2003,15567138,Characteristics of HIV-1 env V3 loop sequences for subtype A1 variant spread in Eastern Europe,"Papuashvili,M.N., Novokhatsky,A.S. and Shcherbakova,T.I.",2005
AY505010,B,1999,15186521,Sensitivity of HIV type 1 subtype C isolates to the entry inhibitor T-20,"Cilliers,T., Patience,T., Pillay,C., Papathanasopoulos,M. and Morris,L.",2004
AY505011,B,1999,15186521,Sensitivity of HIV type 1 subtype C isolates to the entry inhibitor T-20,"Cilliers,T., Patience,T., Pillay,C., Papathanasopoulos,M. and Morris,L.",2004
AY521629,A3,2001,15507630,Distinct human immunodeficiency virus type 1 subtype A virus circulating in West Africa: sub-subtype A3,"Meloni,S.T., Kim,B., Sankale,J.L., Hamel,D.J., Tovanabutra,S., Mboup,S., McCutchan,F.E. and Kanki,P.J.",2004
AY521630,A3,1996,15507630,Distinct human immunodeficiency virus type 1 subtype A virus circulating in West Africa: sub-subtype A3,"Meloni,S.T., Kim,B., Sankale,J.L., Hamel,D.J., Tovanabutra,S., Mboup,S., McCutchan,F.E. and Kanki,P.J.",2004
AY521631,A3,2001,15507630,Distinct human immunodeficiency virus type 1 subtype A virus circulating in West Africa: sub-subtype A3,"Meloni,S.T., Kim,B., Sankale,J.L., Hamel,D.J., Tovanabutra,S., Mboup,S., McCutchan,F.E. and Kanki,P.J.",2004
AY521632,02A3,1996,15507630,Distinct human immunodeficiency virus type 1 subtype A virus circulating in West Africa: sub-subtype A3,"Meloni,S.T., Kim,B., Sankale,J.L., Hamel,D.J., Tovanabutra,S., Mboup,S., McCutchan,F.E. and Kanki,P.J.",2004
AY521633,02A3,1996,15507630,Distinct human immunodeficiency virus type 1 subtype A virus circulating in West Africa: sub-subtype A3,"Meloni,S.T., Kim,B., Sankale,J.L., Hamel,D.J., Tovanabutra,S., Mboup,S., McCutchan,F.E. and Kanki,P.J.",2004
AY522721,C,1999,15266112,Detection of human immunodeficiency virus type 1 envelope peptide- stimulated T-helper cell responses and variations in the corresponding regions of viral isolates among vertically infected children,"Meddows-Taylor,S., Papathanasopoulos,M.A., Kuhn,L., Meyers,T.M. and Tiemessen,C.T.",2004
AY522722,C,1999,15266112,Detection of human immunodeficiency virus type 1 envelope peptide- stimulated T-helper cell responses and variations in the corresponding regions of viral isolates among vertically infected children,"Meddows-Taylor,S., Papathanasopoulos,M.A., Kuhn,L., Meyers,T.M. and Tiemessen,C.T.",2004
AY522723,C,1999,15266112,Detection of human immunodeficiency virus type 1 envelope peptide- stimulated T-helper cell responses and variations in the corresponding regions of viral isolates among vertically infected children,"Meddows-Taylor,S., Papathanasopoulos,M.A., Kuhn,L., Meyers,T.M. and Tiemessen,C.T.",2004
AY522724,C,1999,15266112,Detection of human immunodeficiency virus type 1 envelope peptide- stimulated T-helper cell responses and variations in the corresponding regions of viral isolates among vertically infected children,"Meddows-Taylor,S., Papathanasopoulos,M.A., Kuhn,L., Meyers,T.M. and Tiemessen,C.T.",2004
AY522725,C,1999,15266112,Detection of human immunodeficiency virus type 1 envelope peptide- stimulated T-helper cell responses and variations in the corresponding regions of viral isolates among vertically infected children,"Meddows-Taylor,S., Papathanasopoulos,M.A., Kuhn,L., Meyers,T.M. and Tiemessen,C.T.",2004
AY522726,C,1999,15266112,Detection of human immunodeficiency virus type 1 envelope peptide- stimulated T-helper cell responses and variations in the corresponding regions of viral isolates among vertically infected children,"Meddows-Taylor,S., Papathanasopoulos,M.A., Kuhn,L., Meyers,T.M. and Tiemessen,C.T.",2004
AY522727,C,1999,15266112,Detection of human immunodeficiency virus type 1 envelope peptide- stimulated T-helper cell responses and variations in the corresponding regions of viral isolates among vertically infected children,"Meddows-Taylor,S., Papathanasopoulos,M.A., Kuhn,L., Meyers,T.M. and Tiemessen,C.T.",2004
AY522728,C,1999,15266112,Detection of human immunodeficiency virus type 1 envelope peptide- stimulated T-helper cell responses and variations in the corresponding regions of viral isolates among vertically infected children,"Meddows-Taylor,S., Papathanasopoulos,M.A., Kuhn,L., Meyers,T.M. and Tiemessen,C.T.",2004
AY522729,C,1999,15266112,Detection of human immunodeficiency virus type 1 envelope peptide- stimulated T-helper cell responses and variations in the corresponding regions of viral isolates among vertically infected children,"Meddows-Taylor,S., Papathanasopoulos,M.A., Kuhn,L., Meyers,T.M. and Tiemessen,C.T.",2004
AY522730,C,1999,15266112,Detection of human immunodeficiency virus type 1 envelope peptide- stimulated T-helper cell responses and variations in the corresponding regions of viral isolates among vertically infected children,"Meddows-Taylor,S., Papathanasopoulos,M.A., Kuhn,L., Meyers,T.M. and Tiemessen,C.T.",2004
AY522731,C,1999,15266112,Detection of human immunodeficiency virus type 1 envelope peptide- stimulated T-helper cell responses and variations in the corresponding regions of viral isolates among vertically infected children,"Meddows-Taylor,S., Papathanasopoulos,M.A., Kuhn,L., Meyers,T.M. and Tiemessen,C.T.",2004
AY522732,C,1999,15266112,Detection of human immunodeficiency virus type 1 envelope peptide- stimulated T-helper cell responses and variations in the corresponding regions of viral isolates among vertically infected children,"Meddows-Taylor,S., Papathanasopoulos,M.A., Kuhn,L., Meyers,T.M. and Tiemessen,C.T.",2004
AY522733,C,1999,15266112,Detection of human immunodeficiency virus type 1 envelope peptide- stimulated T-helper cell responses and variations in the corresponding regions of viral isolates among vertically infected children,"Meddows-Taylor,S., Papathanasopoulos,M.A., Kuhn,L., Meyers,T.M. and Tiemessen,C.T.",2004
AY522734,C,1999,15266112,Detection of human immunodeficiency virus type 1 envelope peptide- stimulated T-helper cell responses and variations in the corresponding regions of viral isolates among vertically infected children,"Meddows-Taylor,S., Papathanasopoulos,M.A., Kuhn,L., Meyers,T.M. and Tiemessen,C.T.",2004
AY522735,C,1999,15266112,Detection of human immunodeficiency virus type 1 envelope peptide- stimulated T-helper cell responses and variations in the corresponding regions of viral isolates among vertically infected children,"Meddows-Taylor,S., Papathanasopoulos,M.A., Kuhn,L., Meyers,T.M. and Tiemessen,C.T.",2004
AY522736,C,1999,15266112,Detection of human immunodeficiency virus type 1 envelope peptide- stimulated T-helper cell responses and variations in the corresponding regions of viral isolates among vertically infected children,"Meddows-Taylor,S., Papathanasopoulos,M.A., Kuhn,L., Meyers,T.M. and Tiemessen,C.T.",2004
AY529659,C,1998,,Genetic analysis of full-length env from South African HIV-1 subtype C primary isolates that can utilize CCR5 and/or CXCR4,"Nkosi,S.P.G., Patience,T., Cilliers,T., Morris,L. and Papathanasopoulos,M.A.",
AY529660,C,1998,,Genetic analysis of full-length env from South African HIV-1 subtype C primary isolates that can utilize CCR5 and/or CXCR4,"Nkosi,S.P.G., Patience,T., Cilliers,T., Morris,L. and Papathanasopoulos,M.A.",
AY529661,C,1998,,Genetic analysis of full-length env from South African HIV-1 subtype C primary isolates that can utilize CCR5 and/or CXCR4,"Nkosi,S.P.G., Patience,T., Cilliers,T., Morris,L. and Papathanasopoulos,M.A.",
AY529662,C,1998,,Genetic analysis of full-length env from South African HIV-1 subtype C primary isolates that can utilize CCR5 and/or CXCR4,"Nkosi,S.P.G., Patience,T., Cilliers,T., Morris,L. and Papathanasopoulos,M.A.",
AY529664,C,1999,,Genetic analysis of full-length env from South African HIV-1 subtype C primary isolates that can utilize CCR5 and/or CXCR4,"Nkosi,S.P.G., Patience,T., Cilliers,T., Morris,L. and Papathanasopoulos,M.A.",
AY529665,C,1999,,Genetic analysis of full-length env from South African HIV-1 subtype C primary isolates that can utilize CCR5 and/or CXCR4,"Nkosi,S.P.G., Patience,T., Cilliers,T., Morris,L. and Papathanasopoulos,M.A.",
AY529666,C,2001,16706624,Genotypic and phenotypic characterization of viral isolates from HIV-1 subtype C-infected children with slow and rapid disease progression,"Choge,I., Cilliers,T., Walker,P., Taylor,N., Phoswa,M., Meyers,T., Viljoen,J., Violari,A., Gray,G., Moore,P.L., Papathanosopoulos,M. and Morris,L.",2006
AY529667,C,2000,,Genetic analysis of full-length env from South African HIV-1 subtype C primary isolates that can utilize CCR5 and/or CXCR4,"Nkosi,S.P.G., Patience,T., Cilliers,T., Morris,L. and Papathanasopoulos,M.A.",
AY529668,C,1999,,Genetic analysis of full-length env from South African HIV-1 subtype C primary isolates that can utilize CCR5 and/or CXCR4,"Nkosi,S.P.G., Patience,T., Cilliers,T., Morris,L. and Papathanasopoulos,M.A.",
AY529669,C,1999,,Genetic analysis of full-length env from South African HIV-1 subtype C primary isolates that can utilize CCR5 and/or CXCR4,"Nkosi,S.P.G., Patience,T., Cilliers,T., Morris,L. and Papathanasopoulos,M.A.",
AY529670,C,1999,,Genetic analysis of full-length env from South African HIV-1 subtype C primary isolates that can utilize CCR5 and/or CXCR4,"Nkosi,S.P.G., Patience,T., Cilliers,T., Morris,L. and Papathanasopoulos,M.A.",
AY529672,C,2001,,Genetic analysis of full-length env from South African HIV-1 subtype C primary isolates that can utilize CCR5 and/or CXCR4,"Nkosi,S.P.G., Patience,T., Cilliers,T., Morris,L. and Papathanasopoulos,M.A.",
AY529673,C,1999,,Genetic analysis of full-length env from South African HIV-1 subtype C primary isolates that can utilize CCR5 and/or CXCR4,"Nkosi,S.P.G., Patience,T., Cilliers,T., Morris,L. and Papathanasopoulos,M.A.",
AY529675,C,1999,,Genetic analysis of full-length env from South African HIV-1 subtype C primary isolates that can utilize CCR5 and/or CXCR4,"Nkosi,S.P.G., Patience,T., Cilliers,T., Morris,L. and Papathanasopoulos,M.A.",
AY529676,C,1999,16706624,Genotypic and phenotypic characterization of viral isolates from HIV-1 subtype C-infected children with slow and rapid disease progression,"Choge,I., Cilliers,T., Walker,P., Taylor,N., Phoswa,M., Meyers,T., Viljoen,J., Violari,A., Gray,G., Moore,P.L., Papathanosopoulos,M. and Morris,L.",2006
AY529677,C,1999,16706624,Genotypic and phenotypic characterization of viral isolates from HIV-1 subtype C-infected children with slow and rapid disease progression,"Choge,I., Cilliers,T., Walker,P., Taylor,N., Phoswa,M., Meyers,T., Viljoen,J., Violari,A., Gray,G., Moore,P.L., Papathanosopoulos,M. and Morris,L.",2006
AY529678,C,1999,16706624,Genotypic and phenotypic characterization of viral isolates from HIV-1 subtype C-infected children with slow and rapid disease progression,"Choge,I., Cilliers,T., Walker,P., Taylor,N., Phoswa,M., Meyers,T., Viljoen,J., Violari,A., Gray,G., Moore,P.L., Papathanosopoulos,M. and Morris,L.",2006
AY531116,B,2003,15316355,Biased G-to-A hypermutation in HIV-1 proviral DNA from a long-term non-progressor,"Wei,M., Xing,H., Hong,K., Huang,H., Tang,H., Qin,G. and Shao,Y.",2004
AY532635,N,,15320995,Identification and genomic sequence of an HIV type 1 group N isolate from Cameroon,"Bodelle,P., Vallari,A., Coffey,R., McArthur,C.P., Beyeme,M., Devare,S.G., Schochetman,G. and Brennan,C.A.",2004
AY535659,06_cpx,2001,16044014,Predominance of a rare type of HIV-1 in Estonia,"Adojaan,M., Kivisild,T., Mannik,A., Krispin,T., Ustina,V., Zilmer,K., Liebert,E., Jaroslavtsev,N., Priimagi,L., Tefanova,V., Schmidt,J., Krohn,K., Villems,R., Salminen,M. and Ustav,M.",2005
AY535660,32_06A6,2001,16044014,Predominance of a rare type of HIV-1 in Estonia,"Adojaan,M., Kivisild,T., Mannik,A., Krispin,T., Ustina,V., Zilmer,K., Liebert,E., Jaroslavtsev,N., Priimagi,L., Tefanova,V., Schmidt,J., Krohn,K., Villems,R., Salminen,M. and Ustav,M.",2005
AY536233,BF,2001,15737911,"The analysis of near full-length genome sequences of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Chile, Venezuela and Spain reveals their relationship to diverse lineages of recombinant viruses related to CRF12_BF","Sierra,M., Thomson,M.M., Rios,M., Casado,G., Castro,R.O., Delgado,E., Echevarria,G., Munoz,M., Colomina,J., Carmona,R., Vega,Y., Parga,E.V., Medrano,L., Perez-Alvarez,L., Contreras,G. and Najera,R.",2005
AY536234,BF,2001,15737911,"The analysis of near full-length genome sequences of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Chile, Venezuela and Spain reveals their relationship to diverse lineages of recombinant viruses related to CRF12_BF","Sierra,M., Thomson,M.M., Rios,M., Casado,G., Castro,R.O., Delgado,E., Echevarria,G., Munoz,M., Colomina,J., Carmona,R., Vega,Y., Parga,E.V., Medrano,L., Perez-Alvarez,L., Contreras,G. and Najera,R.",2005
AY536235,44_BF,2001,15737911,"The analysis of near full-length genome sequences of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Chile, Venezuela and Spain reveals their relationship to diverse lineages of recombinant viruses related to CRF12_BF","Sierra,M., Thomson,M.M., Rios,M., Casado,G., Castro,R.O., Delgado,E., Echevarria,G., Munoz,M., Colomina,J., Carmona,R., Vega,Y., Parga,E.V., Medrano,L., Perez-Alvarez,L., Contreras,G. and Najera,R.",2005
AY536236,BF1,1999,15737911,"The analysis of near full-length genome sequences of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Chile, Venezuela and Spain reveals their relationship to diverse lineages of recombinant viruses related to CRF12_BF","Sierra,M., Thomson,M.M., Rios,M., Casado,G., Castro,R.O., Delgado,E., Echevarria,G., Munoz,M., Colomina,J., Carmona,R., Vega,Y., Parga,E.V., Medrano,L., Perez-Alvarez,L., Contreras,G. and Najera,R.",2005
AY536237,BF,2002,15737911,"The analysis of near full-length genome sequences of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Chile, Venezuela and Spain reveals their relationship to diverse lineages of recombinant viruses related to CRF12_BF","Sierra,M., Thomson,M.M., Rios,M., Casado,G., Castro,R.O., Delgado,E., Echevarria,G., Munoz,M., Colomina,J., Carmona,R., Vega,Y., Parga,E.V., Medrano,L., Perez-Alvarez,L., Contreras,G. and Najera,R.",2005
AY536238,BF1,2002,15737911,"The analysis of near full-length genome sequences of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Chile, Venezuela and Spain reveals their relationship to diverse lineages of recombinant viruses related to CRF12_BF","Sierra,M., Thomson,M.M., Rios,M., Casado,G., Castro,R.O., Delgado,E., Echevarria,G., Munoz,M., Colomina,J., Carmona,R., Vega,Y., Parga,E.V., Medrano,L., Perez-Alvarez,L., Contreras,G. and Najera,R.",2005
AY560107,B,1998,,Sequence Diversity of HIV-1 Genomes from the HIV Vaccine Trials Network,"McLaughlin,S., Learn,G.H., Heath,L.M., Nickle,D., Liu,Y. and Mullins,J.I.",
AY560108,B,1998,,Sequence Diversity of HIV-1 Genomes from the HIV Vaccine Trials Network,"McLaughlin,S., Learn,G.H., Heath,L.M., Nickle,D., Liu,Y. and Mullins,J.I.",
AY560109,B,1998,,Sequence Diversity of HIV-1 Genomes from the HIV Vaccine Trials Network,"McLaughlin,S., Learn,G.H., Heath,L.M., Nickle,D., Liu,Y. and Mullins,J.I.",
AY560110,B,1998,,Sequence Diversity of HIV-1 Genomes from the HIV Vaccine Trials Network,"McLaughlin,S., Learn,G.H., Heath,L.M., Nickle,D., Liu,Y. and Mullins,J.I.",
AY561236,B,2001,,"Molecular and epidemiological characterization of HIV-1 infected individuals from Medellin, Columbia","Sanchez,G.I., Carrion,G., Eyzaguirre,L., Arias,S., Negrete,M., Montano,S., Perez,J., Russell,K.L., Sateren,W., Birx,D.L., Carr,J.K. and Sanchez,J.L.",
AY561237,B,2001,,"Molecular and epidemiological characterization of HIV-1 infected individuals from Medellin, Columbia","Sanchez,G.I., Carrion,G., Eyzaguirre,L., Arias,S., Negrete,M., Montano,S., Perez,J., Russell,K.L., Sateren,W., Birx,D.L., Carr,J.K. and Sanchez,J.L.",
AY561238,B,2001,,"Molecular and epidemiological characterization of HIV-1 infected individuals from Medellin, Columbia","Sanchez,G.I., Carrion,G., Eyzaguirre,L., Arias,S., Negrete,M., Montano,S., Perez,J., Russell,K.L., Sateren,W., Birx,D.L., Carr,J.K. and Sanchez,J.L.",
AY561239,B,2001,,"Molecular and epidemiological characterization of HIV-1 infected individuals from Medellin, Columbia","Sanchez,G.I., Carrion,G., Eyzaguirre,L., Arias,S., Negrete,M., Montano,S., Perez,J., Russell,K.L., Sateren,W., Birx,D.L., Carr,J.K. and Sanchez,J.L.",
AY561240,B,2001,,"Molecular and epidemiological characterization of HIV-1 infected individuals from Medellin, Columbia","Sanchez,G.I., Carrion,G., Eyzaguirre,L., Arias,S., Negrete,M., Montano,S., Perez,J., Russell,K.L., Sateren,W., Birx,D.L., Carr,J.K. and Sanchez,J.L.",
AY561241,B,2000,,"Molecular and epidemiological characterization of HIV-1 infected individuals from Medellin, Columbia","Sanchez,G.I., Carrion,G., Eyzaguirre,L., Arias,S., Negrete,M., Montano,S., Perez,J., Russell,K.L., Sateren,W., Birx,D.L., Carr,J.K. and Sanchez,J.L.",
AY561243,B,2001,,"Molecular and epidemiological characterization of HIV-1 infected individuals from Medellin, Columbia","Sanchez,G.I., Carrion,G., Eyzaguirre,L., Arias,S., Negrete,M., Montano,S., Perez,J., Russell,K.L., Sateren,W., Birx,D.L., Carr,J.K. and Sanchez,J.L.",
AY561245,B,2001,,"Molecular and epidemiological characterization of HIV-1 infected individuals from Medellin, Columbia","Sanchez,G.I., Carrion,G., Eyzaguirre,L., Arias,S., Negrete,M., Montano,S., Perez,J., Russell,K.L., Sateren,W., Birx,D.L., Carr,J.K. and Sanchez,J.L.",
AY563169,C,2001,15585091,"Documentation of subtype C HIV Type 1 strains in Argentina, Paraguay, and Uruguay","Carrion,G., Eyzaguirre,L., Montano,S.M., Laguna-Torres,V., Serra,M., Aguayo,N., Avila,M.M., Ruchansky,D., Pando,M.A., Vinoles,J., Perez,J., Barboza,A., Chauca,G., Romero,A., Galeano,A., Blair,P.J., Weissenbacher,M., Birx,D.L., Sanchez,J.L., Olson,J.G. and Carr,J.K.",2004
AY563170,C,2001,15585091,"Documentation of subtype C HIV Type 1 strains in Argentina, Paraguay, and Uruguay","Carrion,G., Eyzaguirre,L., Montano,S.M., Laguna-Torres,V., Serra,M., Aguayo,N., Avila,M.M., Ruchansky,D., Pando,M.A., Vinoles,J., Perez,J., Barboza,A., Chauca,G., Romero,A., Galeano,A., Blair,P.J., Weissenbacher,M., Birx,D.L., Sanchez,J.L., Olson,J.G. and Carr,J.K.",2004
AY585264,C,2000,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY585265,C,2000,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY585266,C,2000,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY585267,C,2000,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY585268,C,2000,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY586540,18_cpx,1999,,Identification of a novel HIV-1 complex circulating recombinant form (CRF18_cpx) of Central African origin in Cuba,"Thomson,M., Casado,G., Sierra,M. and Najera,R.",2005
AY586541,18_cpx,1999,,Identification of a novel HIV-1 complex circulating recombinant form (CRF18_cpx) of Central African origin in Cuba,"Thomson,M., Casado,G., Sierra,M. and Najera,R.",2005
AY586542,B,1999,17356464,Identification of 3 phylogenetically related HIV-1 BG intersubtype circulating recombinant forms in Cuba,"Sierra,M., Thomson,M.M., Posada,D., Perez,L., Aragones,C., Gonzalez,Z., Perez,J., Casado,G. and Najera,R.",2007
AY586543,B,1999,17356464,Identification of 3 phylogenetically related HIV-1 BG intersubtype circulating recombinant forms in Cuba,"Sierra,M., Thomson,M.M., Posada,D., Perez,L., Aragones,C., Gonzalez,Z., Perez,J., Casado,G. and Najera,R.",2007
AY586544,20_BG,1999,17356464,Identification of 3 phylogenetically related HIV-1 BG intersubtype circulating recombinant forms in Cuba,"Sierra,M., Thomson,M.M., Posada,D., Perez,L., Aragones,C., Gonzalez,Z., Perez,J., Casado,G. and Najera,R.",2007
AY586545,20_BG,1999,17356464,Identification of 3 phylogenetically related HIV-1 BG intersubtype circulating recombinant forms in Cuba,"Sierra,M., Thomson,M.M., Posada,D., Perez,L., Aragones,C., Gonzalez,Z., Perez,J., Casado,G. and Najera,R.",2007
AY586546,BG,,,Near full-length genome characterization of phylogenetically related HIV-1 BG intersubtype recombinant viruses and their parental subtype B and G strains from Cuba,"Sierra,M., Thomson,M.M., Casado,G. and Najera,R.",
AY586547,G,1999,17356464,Identification of 3 phylogenetically related HIV-1 BG intersubtype circulating recombinant forms in Cuba,"Sierra,M., Thomson,M.M., Posada,D., Perez,L., Aragones,C., Gonzalez,Z., Perez,J., Casado,G. and Najera,R.",2007
AY586548,G,1999,17356464,Identification of 3 phylogenetically related HIV-1 BG intersubtype circulating recombinant forms in Cuba,"Sierra,M., Thomson,M.M., Posada,D., Perez,L., Aragones,C., Gonzalez,Z., Perez,J., Casado,G. and Najera,R.",2007
AY586549,G,1999,17356464,Identification of 3 phylogenetically related HIV-1 BG intersubtype circulating recombinant forms in Cuba,"Sierra,M., Thomson,M.M., Posada,D., Perez,L., Aragones,C., Gonzalez,Z., Perez,J., Casado,G. and Najera,R.",2007
AY588970,19_cpx,1999,12172086,High HIV-1 genetic diversity in Cuba,"Cuevas,M.T., Ruibal,I., Villahermosa,M.L., Diaz,H., Delgado,E., Parga,E.V., Perez-Alvarez,L., de Armas,M.B., Cuevas,L., Medrano,L., Noa,E., Osmanov,S., Najera,R. and Thomson,M.M.",2002
AY588971,19_cpx,1999,12172086,High HIV-1 genetic diversity in Cuba,"Cuevas,M.T., Ruibal,I., Villahermosa,M.L., Diaz,H., Delgado,E., Parga,E.V., Perez-Alvarez,L., de Armas,M.B., Cuevas,L., Medrano,L., Noa,E., Osmanov,S., Najera,R. and Thomson,M.M.",2002
AY608576,B,1991,15380360,Characterization of a thymus-tropic HIV-1 isolate from a rapid progressor: role of the envelope,"Meissner,E.G., Duus,K.M., Gao,F., Yu,X.F. and Su,L.",2004
AY612637,G,,,Full-length HIV-1 subtype G molecular clone,"Esteves,A.M. and Freitas,S.P.",
AY612855,B,1994,,Direct Submission,"Sidhu,M.K., Israel,Z. and Montefiori,D.C.",2004
AY618998,O,,15321704,Construction and characterization of an HIV-1 group O infectious molecular clone and analysis of vpr- and nef-negative derivatives,"Tebit,D.M., Zekeng,L., Kaptue,L., Gurtler,L., Fackler,O.T., Keppler,O.T., Herchenroder,O. and Krausslich,H.G.",2004
AY623599,D,1992,15914218,Infection of human and non-human cells by a highly fusogenic primary CD4-independent HIV-1 isolate with a truncated envelope cytoplasmic tail,"Saha,K., Yan,H., Nelson,J.A. and Zerhouni-Layachi,B.",2005
AY624304,B,,17239419,Changes in the V3 region of gp120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Delta32 heterozygote,"Gorry,P.R., Dunfee,R.L., Mefford,M.E., Kunstman,K., Morgan,T., Moore,J.P., Mascola,J.R., Agopian,K., Holm,G.H., Mehle,A., Taylor,J., Farzan,M., Wang,H., Ellery,P., Willey,S.J., Clapham,P.R., Wolinsky,S.M., Crowe,S.M. and Gabuzda,D.",2007
AY669697,A1,1993,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669698,A1,,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669699,A1CD,1992,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669700,A1C,1992,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669701,A1,1992,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669702,A1C,1992,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669704,A1,1993,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669705,A1,1994,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669706,A1,1992,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669707,B,1996,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669709,B,1996,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669710,B,1992,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669711,B,1995,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669712,B,,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669713,B,1995,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669714,B,,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669715,B,1992,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669716,B,,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669717,B,1997,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669718,B,1992,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669719,B,1991,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669720,B,,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669721,B,1992,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669724,B,1992,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669725,B,1991,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669727,B,1993,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669729,B,1993,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669731,B,1997,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669733,B,1992,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669736,B,,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669739,C,1993,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669749,C,1993,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669750,D,1993,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669751,D,1994,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669753,D,1992,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669756,D,1993,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669758,D,1992,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669759,D,1992,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669760,D,1992,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669762,F1,,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669764,G,,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669765,G,,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669766,JU,,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669767,JU,,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669768,A1C,1994,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669769,A1C,1993,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669771,01_AE,1993,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669772,01_AE,1992,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669773,01_AE,1992,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669774,01_AE,1992,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669775,01_AE,1992,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669776,01_AE,1992,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669777,01_AE,,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669778,01_AE,1992,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669780,AG,,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669781,02_AG,,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669782,BF1,1993,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669783,12_BF,,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669784,12_BF,,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669785,BF1,,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY669786,73_BG,,15542675,Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies,"Binley,J.M., Wrin,T., Korber,B., Zwick,M.B., Wang,M., Chappey,C., Stiegler,G., Kunert,R., Zolla-Pazner,S., Katinger,H., Petropoulos,C.J. and Burton,D.R.",2004
AY682547,B,2004,17147510,Full-Length Genomic Sequencing and Analysis of Four HIV Type 1 Subtype B Isolates Circulating in the Territory of Russia,"Galkin,A.N., Gagarina,E.Y., Lukyanova,N.S. and Danilova,T.V.",2006
AY703908,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY703909,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY703910,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY703911,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY713406,A1,1993,15857994,"Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines","Brown,B.K., Darden,J.M., Tovanabutra,S., Oblander,T., Frost,J., Sanders-Buell,E., de Souza,M.S., Birx,D.L., McCutchan,F.E. and Polonis,V.R.",2005
AY713408,B,1996,15857994,"Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines","Brown,B.K., Darden,J.M., Tovanabutra,S., Oblander,T., Frost,J., Sanders-Buell,E., de Souza,M.S., Birx,D.L., McCutchan,F.E. and Polonis,V.R.",2005
AY713410,B,1994,15857994,"Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines","Brown,B.K., Darden,J.M., Tovanabutra,S., Oblander,T., Frost,J., Sanders-Buell,E., de Souza,M.S., Birx,D.L., McCutchan,F.E. and Polonis,V.R.",2005
AY713412,B,1990,15857994,"Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines","Brown,B.K., Darden,J.M., Tovanabutra,S., Oblander,T., Frost,J., Sanders-Buell,E., de Souza,M.S., Birx,D.L., McCutchan,F.E. and Polonis,V.R.",2005
AY713413,C,1993,15857994,"Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines","Brown,B.K., Darden,J.M., Tovanabutra,S., Oblander,T., Frost,J., Sanders-Buell,E., de Souza,M.S., Birx,D.L., McCutchan,F.E. and Polonis,V.R.",2005
AY713414,C,1994,15857994,"Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines","Brown,B.K., Darden,J.M., Tovanabutra,S., Oblander,T., Frost,J., Sanders-Buell,E., de Souza,M.S., Birx,D.L., McCutchan,F.E. and Polonis,V.R.",2005
AY713415,C,1989,15857994,"Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines","Brown,B.K., Darden,J.M., Tovanabutra,S., Oblander,T., Frost,J., Sanders-Buell,E., de Souza,M.S., Birx,D.L., McCutchan,F.E. and Polonis,V.R.",2005
AY713416,C,1990,15857994,"Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines","Brown,B.K., Darden,J.M., Tovanabutra,S., Oblander,T., Frost,J., Sanders-Buell,E., de Souza,M.S., Birx,D.L., McCutchan,F.E. and Polonis,V.R.",2005
AY713417,C,2002,15857994,"Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines","Brown,B.K., Darden,J.M., Tovanabutra,S., Oblander,T., Frost,J., Sanders-Buell,E., de Souza,M.S., Birx,D.L., McCutchan,F.E. and Polonis,V.R.",2005
AY713418,D,1993,15857994,"Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines","Brown,B.K., Darden,J.M., Tovanabutra,S., Oblander,T., Frost,J., Sanders-Buell,E., de Souza,M.S., Birx,D.L., McCutchan,F.E. and Polonis,V.R.",2005
AY713419,01_AE,1997,15857994,"Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines","Brown,B.K., Darden,J.M., Tovanabutra,S., Oblander,T., Frost,J., Sanders-Buell,E., de Souza,M.S., Birx,D.L., McCutchan,F.E. and Polonis,V.R.",2005
AY713420,01_AE,1997,15857994,"Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines","Brown,B.K., Darden,J.M., Tovanabutra,S., Oblander,T., Frost,J., Sanders-Buell,E., de Souza,M.S., Birx,D.L., McCutchan,F.E. and Polonis,V.R.",2005
AY713421,01_AE,1996,15857994,"Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines","Brown,B.K., Darden,J.M., Tovanabutra,S., Oblander,T., Frost,J., Sanders-Buell,E., de Souza,M.S., Birx,D.L., McCutchan,F.E. and Polonis,V.R.",2005
AY713422,01_AE,1998,15857994,"Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines","Brown,B.K., Darden,J.M., Tovanabutra,S., Oblander,T., Frost,J., Sanders-Buell,E., de Souza,M.S., Birx,D.L., McCutchan,F.E. and Polonis,V.R.",2005
AY713423,01_AE,1999,15857994,"Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines","Brown,B.K., Darden,J.M., Tovanabutra,S., Oblander,T., Frost,J., Sanders-Buell,E., de Souza,M.S., Birx,D.L., McCutchan,F.E. and Polonis,V.R.",2005
AY713424,01_AE,1996,15857994,"Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines","Brown,B.K., Darden,J.M., Tovanabutra,S., Oblander,T., Frost,J., Sanders-Buell,E., de Souza,M.S., Birx,D.L., McCutchan,F.E. and Polonis,V.R.",2005
AY713425,01_AE,1990,15857994,"Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines","Brown,B.K., Darden,J.M., Tovanabutra,S., Oblander,T., Frost,J., Sanders-Buell,E., de Souza,M.S., Birx,D.L., McCutchan,F.E. and Polonis,V.R.",2005
AY734550,C,2002,16135906,HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania,"Arroyo,M.A., Hoelscher,M., Sateren,W., Samky,E., Maboko,L., Hoffmann,O., Kijak,G., Robb,M., Birx,D.L. and McCutchan,F.E.",2005
AY734551,C,2002,16135906,HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania,"Arroyo,M.A., Hoelscher,M., Sateren,W., Samky,E., Maboko,L., Hoffmann,O., Kijak,G., Robb,M., Birx,D.L. and McCutchan,F.E.",2005
AY734552,A1C,2002,16135906,HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania,"Arroyo,M.A., Hoelscher,M., Sateren,W., Samky,E., Maboko,L., Hoffmann,O., Kijak,G., Robb,M., Birx,D.L. and McCutchan,F.E.",2005
AY734553,A1C,2002,16135906,HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania,"Arroyo,M.A., Hoelscher,M., Sateren,W., Samky,E., Maboko,L., Hoffmann,O., Kijak,G., Robb,M., Birx,D.L. and McCutchan,F.E.",2005
AY734554,A1C,2002,16135906,HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania,"Arroyo,M.A., Hoelscher,M., Sateren,W., Samky,E., Maboko,L., Hoffmann,O., Kijak,G., Robb,M., Birx,D.L. and McCutchan,F.E.",2005
AY734555,A1C,2002,16135906,HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania,"Arroyo,M.A., Hoelscher,M., Sateren,W., Samky,E., Maboko,L., Hoffmann,O., Kijak,G., Robb,M., Birx,D.L. and McCutchan,F.E.",2005
AY734556,C,2002,16135906,HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania,"Arroyo,M.A., Hoelscher,M., Sateren,W., Samky,E., Maboko,L., Hoffmann,O., Kijak,G., Robb,M., Birx,D.L. and McCutchan,F.E.",2005
AY734557,C,2002,16135906,HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania,"Arroyo,M.A., Hoelscher,M., Sateren,W., Samky,E., Maboko,L., Hoffmann,O., Kijak,G., Robb,M., Birx,D.L. and McCutchan,F.E.",2005
AY734558,C,2002,16135906,HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania,"Arroyo,M.A., Hoelscher,M., Sateren,W., Samky,E., Maboko,L., Hoffmann,O., Kijak,G., Robb,M., Birx,D.L. and McCutchan,F.E.",2005
AY734559,C,2002,16135906,HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania,"Arroyo,M.A., Hoelscher,M., Sateren,W., Samky,E., Maboko,L., Hoffmann,O., Kijak,G., Robb,M., Birx,D.L. and McCutchan,F.E.",2005
AY734560,C,2002,16135906,HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania,"Arroyo,M.A., Hoelscher,M., Sateren,W., Samky,E., Maboko,L., Hoffmann,O., Kijak,G., Robb,M., Birx,D.L. and McCutchan,F.E.",2005
AY734561,C,2002,16135906,HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania,"Arroyo,M.A., Hoelscher,M., Sateren,W., Samky,E., Maboko,L., Hoffmann,O., Kijak,G., Robb,M., Birx,D.L. and McCutchan,F.E.",2005
AY734562,A1C,2002,16135906,HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania,"Arroyo,M.A., Hoelscher,M., Sateren,W., Samky,E., Maboko,L., Hoffmann,O., Kijak,G., Robb,M., Birx,D.L. and McCutchan,F.E.",2005
AY736823,C,2002,,"Biological and genetic characterization of a panel of sixty human immunodeficiency virus type 1 (HIV-1) isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines","Brown,B.K., Darden,J.M., Tovanabutra,S., Oblander,T., Frost,J., Sanders-Buell,E., De Souza,M.S., Birx,D.L., McCutchan,F.E. and Polonis,V.R.",
AY736838,01_AE,1990,15857994,"Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines","Brown,B.K., Darden,J.M., Tovanabutra,S., Oblander,T., Frost,J., Sanders-Buell,E., de Souza,M.S., Birx,D.L., McCutchan,F.E. and Polonis,V.R.",2005
AY750999,A2,,17919099,Amino acid conservation in the gp41 transmembrane protein and natural polymorphisms associated with enfuvirtide resistance across HIV-1 variants,"Holguin,A., De Arellano,E.R. and Soriano,V.",2007
AY751010,02A1,,17919099,Amino acid conservation in the gp41 transmembrane protein and natural polymorphisms associated with enfuvirtide resistance across HIV-1 variants,"Holguin,A., De Arellano,E.R. and Soriano,V.",2007
AY751011,02A1,,17919099,Amino acid conservation in the gp41 transmembrane protein and natural polymorphisms associated with enfuvirtide resistance across HIV-1 variants,"Holguin,A., De Arellano,E.R. and Soriano,V.",2007
AY751012,02A1,,17919099,Amino acid conservation in the gp41 transmembrane protein and natural polymorphisms associated with enfuvirtide resistance across HIV-1 variants,"Holguin,A., De Arellano,E.R. and Soriano,V.",2007
AY751018,02_AG,,17919099,Amino acid conservation in the gp41 transmembrane protein and natural polymorphisms associated with enfuvirtide resistance across HIV-1 variants,"Holguin,A., De Arellano,E.R. and Soriano,V.",2007
AY751023,02_AG,,17919099,Amino acid conservation in the gp41 transmembrane protein and natural polymorphisms associated with enfuvirtide resistance across HIV-1 variants,"Holguin,A., De Arellano,E.R. and Soriano,V.",2007
AY751063,D,,17919099,Amino acid conservation in the gp41 transmembrane protein and natural polymorphisms associated with enfuvirtide resistance across HIV-1 variants,"Holguin,A., De Arellano,E.R. and Soriano,V.",2007
AY751065,D,,17919099,Amino acid conservation in the gp41 transmembrane protein and natural polymorphisms associated with enfuvirtide resistance across HIV-1 variants,"Holguin,A., De Arellano,E.R. and Soriano,V.",2007
AY751071,G,,17919099,Amino acid conservation in the gp41 transmembrane protein and natural polymorphisms associated with enfuvirtide resistance across HIV-1 variants,"Holguin,A., De Arellano,E.R. and Soriano,V.",2007
AY751073,G,,17919099,Amino acid conservation in the gp41 transmembrane protein and natural polymorphisms associated with enfuvirtide resistance across HIV-1 variants,"Holguin,A., De Arellano,E.R. and Soriano,V.",2007
AY751075,H,,17919099,Amino acid conservation in the gp41 transmembrane protein and natural polymorphisms associated with enfuvirtide resistance across HIV-1 variants,"Holguin,A., De Arellano,E.R. and Soriano,V.",2007
AY751076,11_cpx,,17919099,Amino acid conservation in the gp41 transmembrane protein and natural polymorphisms associated with enfuvirtide resistance across HIV-1 variants,"Holguin,A., De Arellano,E.R. and Soriano,V.",2007
AY751077,11_cpx,,17919099,Amino acid conservation in the gp41 transmembrane protein and natural polymorphisms associated with enfuvirtide resistance across HIV-1 variants,"Holguin,A., De Arellano,E.R. and Soriano,V.",2007
AY751406,B,2004,17147510,Full-Length Genomic Sequencing and Analysis of Four HIV Type 1 Subtype B Isolates Circulating in the Territory of Russia,"Galkin,A.N., Gagarina,E.Y., Lukyanova,N.S. and Danilova,T.V.",2006
AY751407,B,2004,17147510,Full-Length Genomic Sequencing and Analysis of Four HIV Type 1 Subtype B Isolates Circulating in the Territory of Russia,"Galkin,A.N., Gagarina,E.Y., Lukyanova,N.S. and Danilova,T.V.",2006
AY771588,BF1,1999,15725753,"Analysis of full-length human immunodeficiency virus type 1 genome reveals a variable spectrum of subtypes B and f recombinants in Sao Paulo, Brazil","Sa Filho,D.J., Sanabani,S., Diaz,R.S., Munerato,P., Brunstein,A., Fusuma,E., Sabino,E.C. and Janini,L.M.",2005
AY771589,BF1,1999,15725753,"Analysis of full-length human immunodeficiency virus type 1 genome reveals a variable spectrum of subtypes B and f recombinants in Sao Paulo, Brazil","Sa Filho,D.J., Sanabani,S., Diaz,R.S., Munerato,P., Brunstein,A., Fusuma,E., Sabino,E.C. and Janini,L.M.",2005
AY771590,29_BF,2002,15725753,"Analysis of full-length human immunodeficiency virus type 1 genome reveals a variable spectrum of subtypes B and f recombinants in Sao Paulo, Brazil","Sa Filho,D.J., Sanabani,S., Diaz,R.S., Munerato,P., Brunstein,A., Fusuma,E., Sabino,E.C. and Janini,L.M.",2005
AY771591,BF,1999,15725753,"Analysis of full-length human immunodeficiency virus type 1 genome reveals a variable spectrum of subtypes B and f recombinants in Sao Paulo, Brazil","Sa Filho,D.J., Sanabani,S., Diaz,R.S., Munerato,P., Brunstein,A., Fusuma,E., Sabino,E.C. and Janini,L.M.",2005
AY771592,BF,1999,15725753,"Analysis of full-length human immunodeficiency virus type 1 genome reveals a variable spectrum of subtypes B and f recombinants in Sao Paulo, Brazil","Sa Filho,D.J., Sanabani,S., Diaz,R.S., Munerato,P., Brunstein,A., Fusuma,E., Sabino,E.C. and Janini,L.M.",2005
AY771593,BF,1999,15725753,"Analysis of full-length human immunodeficiency virus type 1 genome reveals a variable spectrum of subtypes B and f recombinants in Sao Paulo, Brazil","Sa Filho,D.J., Sanabani,S., Diaz,R.S., Munerato,P., Brunstein,A., Fusuma,E., Sabino,E.C. and Janini,L.M.",2005
AY772535,G,1996,15929705,Near-full-length genomic sequence of a human immunodeficiency type 1 subtype g strain from cameroon,"Holzmayer,V., Zekeng,L., Kaptue,L., Gurtler,L., Devare,S.G. and Hackett,J.",2005
AY772690,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY772691,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY772692,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY772693,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY772694,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY772695,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY772696,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY772697,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY772698,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY772699,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY772700,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY772701,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY773338,D,1984,15929704,"Sequence Analysis of Near Full-Length HIV Type 1 Subtype D Primary Strains Isolated in Cape Town, South Africa, from 1984 to 1986","Loxton,A.G., Treurnicht,F., Laten,A., Rensburg,E.J. and Engelbrecht,S.",2005
AY773339,D,1985,15929704,"Sequence Analysis of Near Full-Length HIV Type 1 Subtype D Primary Strains Isolated in Cape Town, South Africa, from 1984 to 1986","Loxton,A.G., Treurnicht,F., Laten,A., Rensburg,E.J. and Engelbrecht,S.",2005
AY773340,D,1985,15929704,"Sequence Analysis of Near Full-Length HIV Type 1 Subtype D Primary Strains Isolated in Cape Town, South Africa, from 1984 to 1986","Loxton,A.G., Treurnicht,F., Laten,A., Rensburg,E.J. and Engelbrecht,S.",2005
AY773341,D,1986,15929704,"Sequence Analysis of Near Full-Length HIV Type 1 Subtype D Primary Strains Isolated in Cape Town, South Africa, from 1984 to 1986","Loxton,A.G., Treurnicht,F., Laten,A., Rensburg,E.J. and Engelbrecht,S.",2005
AY779550,B,1998,16131313,Evidence for host-driven selection of the HIV type 1 vpr gene in vivo during HIV disease progression in a transfusion-acquired cohort,"Cali,L., Wang,B., Mikhail,M., Gill,M.J., Beckthold,B., Salemi,M., Jans,D.A., Piller,S.C. and Saksena,N.K.",2005
AY779553,B,1997,16131313,Evidence for host-driven selection of the HIV type 1 vpr gene in vivo during HIV disease progression in a transfusion-acquired cohort,"Cali,L., Wang,B., Mikhail,M., Gill,M.J., Beckthold,B., Salemi,M., Jans,D.A., Piller,S.C. and Saksena,N.K.",2005
AY779557,B,1998,16131313,Evidence for host-driven selection of the HIV type 1 vpr gene in vivo during HIV disease progression in a transfusion-acquired cohort,"Cali,L., Wang,B., Mikhail,M., Gill,M.J., Beckthold,B., Salemi,M., Jans,D.A., Piller,S.C. and Saksena,N.K.",2005
AY781126,B,2001,15827294,"Seroincidence and phylogeny of human immunodeficiency virus infections in a cohort of commercial sex workers in Montevideo, Uruguay","Vinoles,J., Serra,M., Russi,J.C., Ruchansky,D., Sosa-Estani,S., Montano,S.M., Carrion,G., Eyzaguirre,L.M., Carr,J.K., Olson,J.G., Bautista,C.T., Sanchez,J.L. and Weissenbacher,M.",2005
AY781127,B,2001,15827294,"Seroincidence and phylogeny of human immunodeficiency virus infections in a cohort of commercial sex workers in Montevideo, Uruguay","Vinoles,J., Serra,M., Russi,J.C., Ruchansky,D., Sosa-Estani,S., Montano,S.M., Carrion,G., Eyzaguirre,L.M., Carr,J.K., Olson,J.G., Bautista,C.T., Sanchez,J.L. and Weissenbacher,M.",2005
AY781128,BF,2001,15827294,"Seroincidence and phylogeny of human immunodeficiency virus infections in a cohort of commercial sex workers in Montevideo, Uruguay","Vinoles,J., Serra,M., Russi,J.C., Ruchansky,D., Sosa-Estani,S., Montano,S.M., Carrion,G., Eyzaguirre,L.M., Carr,J.K., Olson,J.G., Bautista,C.T., Sanchez,J.L. and Weissenbacher,M.",2005
AY795903,D,2001,16060835,"HIV Type 1 Strains Common in Europe, Africa, and Asia Cocirculate in Yemen","Saad,M.D., Al-Jaufy,A., Grahan,R.R., Nadai,Y., Earhart,K.C., Sanchez,J.L. and Carr,J.K.",2005
AY795904,B,2002,16060835,"HIV Type 1 Strains Common in Europe, Africa, and Asia Cocirculate in Yemen","Saad,M.D., Al-Jaufy,A., Grahan,R.R., Nadai,Y., Earhart,K.C., Sanchez,J.L. and Carr,J.K.",2005
AY795905,B,2002,16060835,"HIV Type 1 Strains Common in Europe, Africa, and Asia Cocirculate in Yemen","Saad,M.D., Al-Jaufy,A., Grahan,R.R., Nadai,Y., Earhart,K.C., Sanchez,J.L. and Carr,J.K.",2005
AY795906,C,2002,16060835,"HIV Type 1 Strains Common in Europe, Africa, and Asia Cocirculate in Yemen","Saad,M.D., Al-Jaufy,A., Grahan,R.R., Nadai,Y., Earhart,K.C., Sanchez,J.L. and Carr,J.K.",2005
AY795907,D,2002,16060835,"HIV Type 1 Strains Common in Europe, Africa, and Asia Cocirculate in Yemen","Saad,M.D., Al-Jaufy,A., Grahan,R.R., Nadai,Y., Earhart,K.C., Sanchez,J.L. and Carr,J.K.",2005
AY795908,B,2002,16060835,"HIV Type 1 Strains Common in Europe, Africa, and Asia Cocirculate in Yemen","Saad,M.D., Al-Jaufy,A., Grahan,R.R., Nadai,Y., Earhart,K.C., Sanchez,J.L. and Carr,J.K.",2005
AY805330,C,,15564517,Infectious molecular clone of a recently transmitted pediatric human immunodeficiency virus clade C isolate from Africa: evidence of intraclade recombination,"Grisson,R.D., Chenine,A.L., Yeh,L.Y., He,J., Wood,C., Bhat,G.J., Xu,W., Kankasa,C. and Ruprecht,R.M.",2004
AY812751,06_cpx,2001,15588336,Two viral strains and a possible novel recombinant are responsible for the explosive injecting drug use-associated HIV type 1 epidemic in Estonia,"Zetterberg,V., Ustina,V., Liitsola,K., Zilmer,K., Kalikova,N., Sevastianova,K., Brummer-Korvenkontio,H., Leinikki,P. and Salminen,M.O.",2004
AY818641,B,2000,12890627,"First demonstration of a lack of viral sequence evolution in a nonprogressor, defining replication-incompetent HIV-1 infection","Wang,B., Mikhail,M., Dyer,W.B., Zaunders,J.J., Kelleher,A.D. and Saksena,N.K.",2003
AY819715,B,2004,17147510,Full-Length Genomic Sequencing and Analysis of Four HIV Type 1 Subtype B Isolates Circulating in the Territory of Russia,"Galkin,A.N., Gagarina,E.Y., Lukyanova,N.S. and Danilova,T.V.",2006
AY829203,A6,2002,16044009,"Outbreak of a West African recombinant of HIV-1 in Tashkent, Uzbekistan","Carr,J.K., Nadai,Y., Eyzaguirre,L., Saad,M.D., Khakimov,M.M., Yakubov,S.K., Birx,D.L., Graham,R.R., Wolfe,N.D., Earhart,K.C. and Sanchez,J.L.",2005
AY829204,02A1,2002,16044009,"Outbreak of a West African recombinant of HIV-1 in Tashkent, Uzbekistan","Carr,J.K., Nadai,Y., Eyzaguirre,L., Saad,M.D., Khakimov,M.M., Yakubov,S.K., Birx,D.L., Graham,R.R., Wolfe,N.D., Earhart,K.C. and Sanchez,J.L.",2005
AY829205,A6,2002,16044009,"Outbreak of a West African recombinant of HIV-1 in Tashkent, Uzbekistan","Carr,J.K., Nadai,Y., Eyzaguirre,L., Saad,M.D., Khakimov,M.M., Yakubov,S.K., Birx,D.L., Graham,R.R., Wolfe,N.D., Earhart,K.C. and Sanchez,J.L.",2005
AY829206,A6,2002,16044009,"Outbreak of a West African recombinant of HIV-1 in Tashkent, Uzbekistan","Carr,J.K., Nadai,Y., Eyzaguirre,L., Saad,M.D., Khakimov,M.M., Yakubov,S.K., Birx,D.L., Graham,R.R., Wolfe,N.D., Earhart,K.C. and Sanchez,J.L.",2005
AY829207,02A1,2002,16044009,"Outbreak of a West African recombinant of HIV-1 in Tashkent, Uzbekistan","Carr,J.K., Nadai,Y., Eyzaguirre,L., Saad,M.D., Khakimov,M.M., Yakubov,S.K., Birx,D.L., Graham,R.R., Wolfe,N.D., Earhart,K.C. and Sanchez,J.L.",2005
AY829208,A6,2002,16044009,"Outbreak of a West African recombinant of HIV-1 in Tashkent, Uzbekistan","Carr,J.K., Nadai,Y., Eyzaguirre,L., Saad,M.D., Khakimov,M.M., Yakubov,S.K., Birx,D.L., Graham,R.R., Wolfe,N.D., Earhart,K.C. and Sanchez,J.L.",2005
AY829209,A6,2002,16044009,"Outbreak of a West African recombinant of HIV-1 in Tashkent, Uzbekistan","Carr,J.K., Nadai,Y., Eyzaguirre,L., Saad,M.D., Khakimov,M.M., Yakubov,S.K., Birx,D.L., Graham,R.R., Wolfe,N.D., Earhart,K.C. and Sanchez,J.L.",2005
AY829210,A6,2002,16044009,"Outbreak of a West African recombinant of HIV-1 in Tashkent, Uzbekistan","Carr,J.K., Nadai,Y., Eyzaguirre,L., Saad,M.D., Khakimov,M.M., Yakubov,S.K., Birx,D.L., Graham,R.R., Wolfe,N.D., Earhart,K.C. and Sanchez,J.L.",2005
AY829212,A6,2002,16044009,"Outbreak of a West African recombinant of HIV-1 in Tashkent, Uzbekistan","Carr,J.K., Nadai,Y., Eyzaguirre,L., Saad,M.D., Khakimov,M.M., Yakubov,S.K., Birx,D.L., Graham,R.R., Wolfe,N.D., Earhart,K.C. and Sanchez,J.L.",2005
AY829213,B,2002,16044009,"Outbreak of a West African recombinant of HIV-1 in Tashkent, Uzbekistan","Carr,J.K., Nadai,Y., Eyzaguirre,L., Saad,M.D., Khakimov,M.M., Yakubov,S.K., Birx,D.L., Graham,R.R., Wolfe,N.D., Earhart,K.C. and Sanchez,J.L.",2005
AY829214,02A1,2002,16044009,"Outbreak of a West African recombinant of HIV-1 in Tashkent, Uzbekistan","Carr,J.K., Nadai,Y., Eyzaguirre,L., Saad,M.D., Khakimov,M.M., Yakubov,S.K., Birx,D.L., Graham,R.R., Wolfe,N.D., Earhart,K.C. and Sanchez,J.L.",2005
AY835436,B,1995,16051804,Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies,"Li,M., Gao,F., Mascola,J.R., Stamatatos,L., Polonis,V.R., Koutsoukos,M., Voss,G., Goepfert,P., Gilbert,P., Greene,K.M., Bilska,M., Kothe,D.L., Salazar-Gonzalez,J.F., Wei,X., Decker,J.M., Hahn,B.H. and Montefiori,D.C.",2005
AY835437,B,1994,16051804,Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies,"Li,M., Gao,F., Mascola,J.R., Stamatatos,L., Polonis,V.R., Koutsoukos,M., Voss,G., Goepfert,P., Gilbert,P., Greene,K.M., Bilska,M., Kothe,D.L., Salazar-Gonzalez,J.F., Wei,X., Decker,J.M., Hahn,B.H. and Montefiori,D.C.",2005
AY835438,B,1995,16051804,Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies,"Li,M., Gao,F., Mascola,J.R., Stamatatos,L., Polonis,V.R., Koutsoukos,M., Voss,G., Goepfert,P., Gilbert,P., Greene,K.M., Bilska,M., Kothe,D.L., Salazar-Gonzalez,J.F., Wei,X., Decker,J.M., Hahn,B.H. and Montefiori,D.C.",2005
AY835446,B,1998,16051804,Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies,"Li,M., Gao,F., Mascola,J.R., Stamatatos,L., Polonis,V.R., Koutsoukos,M., Voss,G., Goepfert,P., Gilbert,P., Greene,K.M., Bilska,M., Kothe,D.L., Salazar-Gonzalez,J.F., Wei,X., Decker,J.M., Hahn,B.H. and Montefiori,D.C.",2005
AY835447,B,2000,16051804,Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies,"Li,M., Gao,F., Mascola,J.R., Stamatatos,L., Polonis,V.R., Koutsoukos,M., Voss,G., Goepfert,P., Gilbert,P., Greene,K.M., Bilska,M., Kothe,D.L., Salazar-Gonzalez,J.F., Wei,X., Decker,J.M., Hahn,B.H. and Montefiori,D.C.",2005
AY835448,B,2000,16051804,Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies,"Li,M., Gao,F., Mascola,J.R., Stamatatos,L., Polonis,V.R., Koutsoukos,M., Voss,G., Goepfert,P., Gilbert,P., Greene,K.M., Bilska,M., Kothe,D.L., Salazar-Gonzalez,J.F., Wei,X., Decker,J.M., Hahn,B.H. and Montefiori,D.C.",2005
AY835449,B,2001,16051804,Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies,"Li,M., Gao,F., Mascola,J.R., Stamatatos,L., Polonis,V.R., Koutsoukos,M., Voss,G., Goepfert,P., Gilbert,P., Greene,K.M., Bilska,M., Kothe,D.L., Salazar-Gonzalez,J.F., Wei,X., Decker,J.M., Hahn,B.H. and Montefiori,D.C.",2005
AY835450,B,2001,16051804,Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies,"Li,M., Gao,F., Mascola,J.R., Stamatatos,L., Polonis,V.R., Koutsoukos,M., Voss,G., Goepfert,P., Gilbert,P., Greene,K.M., Bilska,M., Kothe,D.L., Salazar-Gonzalez,J.F., Wei,X., Decker,J.M., Hahn,B.H. and Montefiori,D.C.",2005
AY835451,B,2000,16051804,Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies,"Li,M., Gao,F., Mascola,J.R., Stamatatos,L., Polonis,V.R., Koutsoukos,M., Voss,G., Goepfert,P., Gilbert,P., Greene,K.M., Bilska,M., Kothe,D.L., Salazar-Gonzalez,J.F., Wei,X., Decker,J.M., Hahn,B.H. and Montefiori,D.C.",2005
AY835452,B,2004,16051804,Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies,"Li,M., Gao,F., Mascola,J.R., Stamatatos,L., Polonis,V.R., Koutsoukos,M., Voss,G., Goepfert,P., Gilbert,P., Greene,K.M., Bilska,M., Kothe,D.L., Salazar-Gonzalez,J.F., Wei,X., Decker,J.M., Hahn,B.H. and Montefiori,D.C.",2005
AY835748,B,1983,,"Full length genome analysis of HIV-1 viral evolution, and date of origin in an American cohort","Mikhail,M., Wang,B., Lemey,P., Lal,R.B., Yang,C., Vandamme,A.-M., Owen,S.M., Spira,T. and Saksena,N.K.",
AY835753,B,1996,,"Full length genome analysis of HIV-1 viral evolution, and date of origin in an American cohort","Mikhail,M., Wang,B., Lemey,P., Lal,R.B., Yang,C., Vandamme,A.-M., Owen,S.M., Spira,T. and Saksena,N.K.",
AY835754,B,1983,,"Full length genome analysis of HIV-1 viral evolution, and date of origin in an American cohort","Mikhail,M., Wang,B., Lemey,P., Lal,R.B., Yang,C., Vandamme,A.-M., Owen,S.M., Spira,T. and Saksena,N.K.",
AY835755,B,1985,,"Full length genome analysis of HIV-1 viral evolution, and date of origin in an American cohort","Mikhail,M., Wang,B., Lemey,P., Lal,R.B., Yang,C., Vandamme,A.-M., Owen,S.M., Spira,T. and Saksena,N.K.",
AY835757,B,1986,,"Full length genome analysis of HIV-1 viral evolution, and date of origin in an American cohort","Mikhail,M., Wang,B., Lemey,P., Lal,R.B., Yang,C., Vandamme,A.-M., Owen,S.M., Spira,T. and Saksena,N.K.",
AY835759,B,1982,,"Full length genome analysis of HIV-1 viral evolution, and date of origin in an American cohort","Mikhail,M., Wang,B., Lemey,P., Lal,R.B., Yang,C., Vandamme,A.-M., Owen,S.M., Spira,T. and Saksena,N.K.",
AY835762,B,1984,,"Full length genome analysis of HIV-1 viral evolution, and date of origin in an American cohort","Mikhail,M., Wang,B., Lemey,P., Lal,R.B., Yang,C., Vandamme,A.-M., Owen,S.M., Spira,T. and Saksena,N.K.",
AY835766,B,1989,,"Full length genome analysis of HIV-1 viral evolution, and date of origin in an American cohort","Mikhail,M., Wang,B., Lemey,P., Lal,R.B., Yang,C., Vandamme,A.-M., Owen,S.M., Spira,T. and Saksena,N.K.",
AY835769,B,1985,,"Full length genome analysis of HIV-1 viral evolution, and date of origin in an American cohort","Mikhail,M., Wang,B., Lemey,P., Lal,R.B., Yang,C., Vandamme,A.-M., Owen,S.M., Spira,T. and Saksena,N.K.",
AY835770,B,1983,,"Full length genome analysis of HIV-1 viral evolution, and date of origin in an American cohort","Mikhail,M., Wang,B., Lemey,P., Lal,R.B., Yang,C., Vandamme,A.-M., Owen,S.M., Spira,T. and Saksena,N.K.",
AY835774,B,1986,,"Full length genome analysis of HIV-1 viral evolution, and date of origin in an American cohort","Mikhail,M., Wang,B., Lemey,P., Lal,R.B., Yang,C., Vandamme,A.-M., Owen,S.M., Spira,T. and Saksena,N.K.",
AY835777,B,1983,,"Full length genome analysis of HIV-1 viral evolution, and date of origin in an American cohort","Mikhail,M., Wang,B., Lemey,P., Lal,R.B., Yang,C., Vandamme,A.-M., Owen,S.M., Spira,T. and Saksena,N.K.",
AY835779,B,1984,,"Full length genome analysis of HIV-1 viral evolution, and date of origin in an American cohort","Mikhail,M., Wang,B., Lemey,P., Lal,R.B., Yang,C., Vandamme,A.-M., Owen,S.M., Spira,T. and Saksena,N.K.",
AY839827,B,2004,16386114,Full sequence of HIV type 1 Korean subtype B in an AIDS case with atypical seroconversion: TAAAA at TATA box,"Cho,Y.K., Sung,H., Bae,I.G., Oh,H.B., Kim,N.J., Woo,J.H. and Kim,Y.B.",2005
AY842786,B,,15717264,HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia,"Spudich,S.S., Huang,W., Nilsson,A.C., Petropoulos,C.J., Liegler,T.J., Whitcomb,J.M. and Price,R.W.",2005
AY842808,B,,15717264,HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia,"Spudich,S.S., Huang,W., Nilsson,A.C., Petropoulos,C.J., Liegler,T.J., Whitcomb,J.M. and Price,R.W.",2005
AY842824,B,,15717264,HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia,"Spudich,S.S., Huang,W., Nilsson,A.C., Petropoulos,C.J., Liegler,T.J., Whitcomb,J.M. and Price,R.W.",2005
AY856956,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY856957,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY856958,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY856959,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY856962,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY856964,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY856965,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY856969,01B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY856970,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY856971,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY856975,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY856980,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY856981,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY856983,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY856984,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY856985,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY856989,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY856990,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY856996,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857002,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857003,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857008,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857014,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857018,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857019,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857022,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857028,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857029,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857031,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857034,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857038,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857039,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857042,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857046,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857049,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857050,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857051,BC,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857052,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857053,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857058,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857063,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857064,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857065,A1D,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857067,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857068,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857074,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857076,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857082,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857086,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857087,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857090,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857094,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857095,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857099,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857100,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857101,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857102,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857103,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857104,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857109,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857110,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857112,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857114,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857115,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857116,01BC,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857118,01B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857121,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857124,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857127,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857128,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857132,A1D,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857133,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857134,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857136,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857137,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857138,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857143,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857144,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857147,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857151,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857155,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857159,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857160,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857161,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857162,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857163,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857165,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857166,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857168,02B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857169,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857171,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857174,BC,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857176,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857180,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857182,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY857185,B,,15592417,Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA,"Kiepiela,P., Leslie,A.J., Honeyborne,I., Ramduth,D., Thobakgale,C., Chetty,S., Rathnavalu,P., Moore,C., Pfafferott,K.J., Hilton,L., Zimbwa,P., Moore,S., Allen,T., Brander,C., Addo,M.M., Altfeld,M., James,I., Mallal,S., Bunce,M., Barber,L.D., Szinger,J., Day,C., Klenerman,P., Mullins,J., Korber,B., Coovadia,H.M., Walker,B.D. and Goulder,P.J.",2004
AY878054,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY878055,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY878056,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY878057,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY878058,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY878059,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY878060,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY878061,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY878062,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY878063,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY878064,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY878065,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY878066,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY878067,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY878068,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY878069,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY878070,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY878071,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY878072,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY880686,B,1990,16820061,Characterization of HIV-1 envelope gp41 genetic diversity and functional domains following perinatal transmission,"Ramakrishnan,R., Mehta,R., Sundaravaradan,V., Davis,T. and Ahmad,N.",2006
AY880704,B,1990,16820061,Characterization of HIV-1 envelope gp41 genetic diversity and functional domains following perinatal transmission,"Ramakrishnan,R., Mehta,R., Sundaravaradan,V., Davis,T. and Ahmad,N.",2006
AY880718,B,1990,16820061,Characterization of HIV-1 envelope gp41 genetic diversity and functional domains following perinatal transmission,"Ramakrishnan,R., Mehta,R., Sundaravaradan,V., Davis,T. and Ahmad,N.",2006
AY880732,B,1990,16820061,Characterization of HIV-1 envelope gp41 genetic diversity and functional domains following perinatal transmission,"Ramakrishnan,R., Mehta,R., Sundaravaradan,V., Davis,T. and Ahmad,N.",2006
AY880752,B,1990,16820061,Characterization of HIV-1 envelope gp41 genetic diversity and functional domains following perinatal transmission,"Ramakrishnan,R., Mehta,R., Sundaravaradan,V., Davis,T. and Ahmad,N.",2006
AY880765,B,1990,16820061,Characterization of HIV-1 envelope gp41 genetic diversity and functional domains following perinatal transmission,"Ramakrishnan,R., Mehta,R., Sundaravaradan,V., Davis,T. and Ahmad,N.",2006
AY880781,B,1990,16820061,Characterization of HIV-1 envelope gp41 genetic diversity and functional domains following perinatal transmission,"Ramakrishnan,R., Mehta,R., Sundaravaradan,V., Davis,T. and Ahmad,N.",2006
AY880798,B,1990,16820061,Characterization of HIV-1 envelope gp41 genetic diversity and functional domains following perinatal transmission,"Ramakrishnan,R., Mehta,R., Sundaravaradan,V., Davis,T. and Ahmad,N.",2006
AY880808,B,1990,16820061,Characterization of HIV-1 envelope gp41 genetic diversity and functional domains following perinatal transmission,"Ramakrishnan,R., Mehta,R., Sundaravaradan,V., Davis,T. and Ahmad,N.",2006
AY880828,B,1990,16820061,Characterization of HIV-1 envelope gp41 genetic diversity and functional domains following perinatal transmission,"Ramakrishnan,R., Mehta,R., Sundaravaradan,V., Davis,T. and Ahmad,N.",2006
AY882421,73_BG,2001,16060837,Genomic Characterization of a Novel HIV Type 1 B/G Intersubtype Recombinant Strain from an Injecting Drug User in Germany,"Harris,B., Truchsess,I.V., Schatzl,H.M., Devare,S.G. and Hackett,J.",2005
AY887501,ACD,2001,16140747,"In-depth analysis of a heterosexually acquired human immunodeficiency virus type 1 superinfection: evolution, temporal fluctuation, and intercompartment dynamics from the seronegative window period through 30 months postinfection","McCutchan,F.E., Hoelscher,M., Tovanabutra,S., Piyasirisilp,S., Sanders-Buell,E., Ramos,G., Jagodzinski,L., Polonis,V., Maboko,L., Mmbando,D., Hoffmann,O., Riedner,G., von Sonnenburg,F., Robb,M. and Birx,D.L.",2005
AY894993,18_cpx,1999,,Direct Submission,"Thomson,M., Casado,G., Posada,D., Sierra,M. and Najera,R.",2005
AY894994,19_cpx,1999,16284528,Identification of a novel HIV-1 circulating ADG intersubtype recombinant form (CRF19_cpx) in Cuba,"Casado,G., Thomson,M.M., Sierra,M. and Najera,R.",2005
AY894995,1819,1999,16284528,Identification of a novel HIV-1 circulating ADG intersubtype recombinant form (CRF19_cpx) in Cuba,"Casado,G., Thomson,M.M., Sierra,M. and Najera,R.",2005
AY894996,ADGU,1999,,Direct Submission,"Casado,G., Thomson,M., Sierra,M. and Najera,R.",2005
AY900571,23_BG,2003,17356464,Identification of 3 phylogenetically related HIV-1 BG intersubtype circulating recombinant forms in Cuba,"Sierra,M., Thomson,M.M., Posada,D., Perez,L., Aragones,C., Gonzalez,Z., Perez,J., Casado,G. and Najera,R.",2007
AY900572,23_BG,2003,17356464,Identification of 3 phylogenetically related HIV-1 BG intersubtype circulating recombinant forms in Cuba,"Sierra,M., Thomson,M.M., Posada,D., Perez,L., Aragones,C., Gonzalez,Z., Perez,J., Casado,G. and Najera,R.",2007
AY900574,24_BG,2003,17356464,Identification of 3 phylogenetically related HIV-1 BG intersubtype circulating recombinant forms in Cuba,"Sierra,M., Thomson,M.M., Posada,D., Perez,L., Aragones,C., Gonzalez,Z., Perez,J., Casado,G. and Najera,R.",2007
AY900575,24_BG,2003,17356464,Identification of 3 phylogenetically related HIV-1 BG intersubtype circulating recombinant forms in Cuba,"Sierra,M., Thomson,M.M., Posada,D., Perez,L., Aragones,C., Gonzalez,Z., Perez,J., Casado,G. and Najera,R.",2007
AY900576,24_BG,2003,17356464,Identification of 3 phylogenetically related HIV-1 BG intersubtype circulating recombinant forms in Cuba,"Sierra,M., Thomson,M.M., Posada,D., Perez,L., Aragones,C., Gonzalez,Z., Perez,J., Casado,G. and Najera,R.",2007
AY901965,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY901966,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY901967,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY901968,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY901969,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY901970,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY901971,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY901972,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY901973,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY901974,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY901975,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY901976,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY901977,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY901978,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY901979,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY901980,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY901981,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
AY905493,B,2003,18670237,"A new CRF01_AE/B recombinant structure of HIV type 1 found in Heilongjiang province, China","Zhou,H.Z., Li,Y., Zhou,H., Liu,Y.C., Du,H.T., Wang,K.L., Wang,F.X. and Ling,H.",2008
AY905494,B,2004,18670237,"A new CRF01_AE/B recombinant structure of HIV type 1 found in Heilongjiang province, China","Zhou,H.Z., Li,Y., Zhou,H., Liu,Y.C., Du,H.T., Wang,K.L., Wang,F.X. and Ling,H.",2008
AY905495,B,2004,18670237,"A new CRF01_AE/B recombinant structure of HIV type 1 found in Heilongjiang province, China","Zhou,H.Z., Li,Y., Zhou,H., Liu,Y.C., Du,H.T., Wang,K.L., Wang,F.X. and Ling,H.",2008
AY905496,B,2004,18670237,"A new CRF01_AE/B recombinant structure of HIV type 1 found in Heilongjiang province, China","Zhou,H.Z., Li,Y., Zhou,H., Liu,Y.C., Du,H.T., Wang,K.L., Wang,F.X. and Ling,H.",2008
AY905497,B,2004,18670237,"A new CRF01_AE/B recombinant structure of HIV type 1 found in Heilongjiang province, China","Zhou,H.Z., Li,Y., Zhou,H., Liu,Y.C., Du,H.T., Wang,K.L., Wang,F.X. and Ling,H.",2008
AY935219,C,2001,16540936,Molecular analysis of gp41 sequences of HIV type 1 subtype C from India,"Agnihotri,K.D., Tripathy,S.P., Jere,A.P., Kale,S.M. and Paranjape,R.S.",2006
AY935221,C,2000,16540936,Molecular analysis of gp41 sequences of HIV type 1 subtype C from India,"Agnihotri,K.D., Tripathy,S.P., Jere,A.P., Kale,S.M. and Paranjape,R.S.",2006
AY935222,C,2002,16540936,Molecular analysis of gp41 sequences of HIV type 1 subtype C from India,"Agnihotri,K.D., Tripathy,S.P., Jere,A.P., Kale,S.M. and Paranjape,R.S.",2006
AY935225,C,2000,16540936,Molecular analysis of gp41 sequences of HIV type 1 subtype C from India,"Agnihotri,K.D., Tripathy,S.P., Jere,A.P., Kale,S.M. and Paranjape,R.S.",2006
AY935228,C,1997,16540936,Molecular analysis of gp41 sequences of HIV type 1 subtype C from India,"Agnihotri,K.D., Tripathy,S.P., Jere,A.P., Kale,S.M. and Paranjape,R.S.",2006
AY935229,C,2000,16540936,Molecular analysis of gp41 sequences of HIV type 1 subtype C from India,"Agnihotri,K.D., Tripathy,S.P., Jere,A.P., Kale,S.M. and Paranjape,R.S.",2006
AY935233,C,2000,16540936,Molecular analysis of gp41 sequences of HIV type 1 subtype C from India,"Agnihotri,K.D., Tripathy,S.P., Jere,A.P., Kale,S.M. and Paranjape,R.S.",2006
AY935236,C,2001,16540936,Molecular analysis of gp41 sequences of HIV type 1 subtype C from India,"Agnihotri,K.D., Tripathy,S.P., Jere,A.P., Kale,S.M. and Paranjape,R.S.",2006
AY945710,B,2000,16910837,Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping,"Watanaveeradej,V., Benenson,M.W., Souza,M.D., Sirisopana,N., Nitayaphan,S., Tontichaivanich,C., Amphaipit,R., Renzullo,P.O., Brown,A.E., McNeil,J.G., Robb,M.L., Birx,D.L., Tovanabutra,S., Carr,J.K. and McCutchan,F.E.",2006
AY945711,B,1999,16910837,Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping,"Watanaveeradej,V., Benenson,M.W., Souza,M.D., Sirisopana,N., Nitayaphan,S., Tontichaivanich,C., Amphaipit,R., Renzullo,P.O., Brown,A.E., McNeil,J.G., Robb,M.L., Birx,D.L., Tovanabutra,S., Carr,J.K. and McCutchan,F.E.",2006
AY945712,01_AE,1999,16910837,Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping,"Watanaveeradej,V., Benenson,M.W., Souza,M.D., Sirisopana,N., Nitayaphan,S., Tontichaivanich,C., Amphaipit,R., Renzullo,P.O., Brown,A.E., McNeil,J.G., Robb,M.L., Birx,D.L., Tovanabutra,S., Carr,J.K. and McCutchan,F.E.",2006
AY945713,01_AE,2001,16910837,Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping,"Watanaveeradej,V., Benenson,M.W., Souza,M.D., Sirisopana,N., Nitayaphan,S., Tontichaivanich,C., Amphaipit,R., Renzullo,P.O., Brown,A.E., McNeil,J.G., Robb,M.L., Birx,D.L., Tovanabutra,S., Carr,J.K. and McCutchan,F.E.",2006
AY945714,01_AE,2000,16910837,Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping,"Watanaveeradej,V., Benenson,M.W., Souza,M.D., Sirisopana,N., Nitayaphan,S., Tontichaivanich,C., Amphaipit,R., Renzullo,P.O., Brown,A.E., McNeil,J.G., Robb,M.L., Birx,D.L., Tovanabutra,S., Carr,J.K. and McCutchan,F.E.",2006
AY945715,01_AE,2000,16910837,Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping,"Watanaveeradej,V., Benenson,M.W., Souza,M.D., Sirisopana,N., Nitayaphan,S., Tontichaivanich,C., Amphaipit,R., Renzullo,P.O., Brown,A.E., McNeil,J.G., Robb,M.L., Birx,D.L., Tovanabutra,S., Carr,J.K. and McCutchan,F.E.",2006
AY945716,01_AE,2000,16910837,Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping,"Watanaveeradej,V., Benenson,M.W., Souza,M.D., Sirisopana,N., Nitayaphan,S., Tontichaivanich,C., Amphaipit,R., Renzullo,P.O., Brown,A.E., McNeil,J.G., Robb,M.L., Birx,D.L., Tovanabutra,S., Carr,J.K. and McCutchan,F.E.",2006
AY945717,01_AE,2000,16910837,Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping,"Watanaveeradej,V., Benenson,M.W., Souza,M.D., Sirisopana,N., Nitayaphan,S., Tontichaivanich,C., Amphaipit,R., Renzullo,P.O., Brown,A.E., McNeil,J.G., Robb,M.L., Birx,D.L., Tovanabutra,S., Carr,J.K. and McCutchan,F.E.",2006
AY945718,01_AE,1999,16910837,Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping,"Watanaveeradej,V., Benenson,M.W., Souza,M.D., Sirisopana,N., Nitayaphan,S., Tontichaivanich,C., Amphaipit,R., Renzullo,P.O., Brown,A.E., McNeil,J.G., Robb,M.L., Birx,D.L., Tovanabutra,S., Carr,J.K. and McCutchan,F.E.",2006
AY945719,01_AE,2001,16910837,Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping,"Watanaveeradej,V., Benenson,M.W., Souza,M.D., Sirisopana,N., Nitayaphan,S., Tontichaivanich,C., Amphaipit,R., Renzullo,P.O., Brown,A.E., McNeil,J.G., Robb,M.L., Birx,D.L., Tovanabutra,S., Carr,J.K. and McCutchan,F.E.",2006
AY945720,01_AE,2001,16910837,Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping,"Watanaveeradej,V., Benenson,M.W., Souza,M.D., Sirisopana,N., Nitayaphan,S., Tontichaivanich,C., Amphaipit,R., Renzullo,P.O., Brown,A.E., McNeil,J.G., Robb,M.L., Birx,D.L., Tovanabutra,S., Carr,J.K. and McCutchan,F.E.",2006
AY945721,01_AE,2000,16910837,Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping,"Watanaveeradej,V., Benenson,M.W., Souza,M.D., Sirisopana,N., Nitayaphan,S., Tontichaivanich,C., Amphaipit,R., Renzullo,P.O., Brown,A.E., McNeil,J.G., Robb,M.L., Birx,D.L., Tovanabutra,S., Carr,J.K. and McCutchan,F.E.",2006
AY945722,01_AE,2000,16910837,Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping,"Watanaveeradej,V., Benenson,M.W., Souza,M.D., Sirisopana,N., Nitayaphan,S., Tontichaivanich,C., Amphaipit,R., Renzullo,P.O., Brown,A.E., McNeil,J.G., Robb,M.L., Birx,D.L., Tovanabutra,S., Carr,J.K. and McCutchan,F.E.",2006
AY945723,01_AE,2000,16910837,Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping,"Watanaveeradej,V., Benenson,M.W., Souza,M.D., Sirisopana,N., Nitayaphan,S., Tontichaivanich,C., Amphaipit,R., Renzullo,P.O., Brown,A.E., McNeil,J.G., Robb,M.L., Birx,D.L., Tovanabutra,S., Carr,J.K. and McCutchan,F.E.",2006
AY945724,01_AE,2000,16910837,Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping,"Watanaveeradej,V., Benenson,M.W., Souza,M.D., Sirisopana,N., Nitayaphan,S., Tontichaivanich,C., Amphaipit,R., Renzullo,P.O., Brown,A.E., McNeil,J.G., Robb,M.L., Birx,D.L., Tovanabutra,S., Carr,J.K. and McCutchan,F.E.",2006
AY945725,01_AE,2000,16910837,Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping,"Watanaveeradej,V., Benenson,M.W., Souza,M.D., Sirisopana,N., Nitayaphan,S., Tontichaivanich,C., Amphaipit,R., Renzullo,P.O., Brown,A.E., McNeil,J.G., Robb,M.L., Birx,D.L., Tovanabutra,S., Carr,J.K. and McCutchan,F.E.",2006
AY945726,01_AE,1999,16910837,Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping,"Watanaveeradej,V., Benenson,M.W., Souza,M.D., Sirisopana,N., Nitayaphan,S., Tontichaivanich,C., Amphaipit,R., Renzullo,P.O., Brown,A.E., McNeil,J.G., Robb,M.L., Birx,D.L., Tovanabutra,S., Carr,J.K. and McCutchan,F.E.",2006
AY945727,01_AE,1999,16910837,Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping,"Watanaveeradej,V., Benenson,M.W., Souza,M.D., Sirisopana,N., Nitayaphan,S., Tontichaivanich,C., Amphaipit,R., Renzullo,P.O., Brown,A.E., McNeil,J.G., Robb,M.L., Birx,D.L., Tovanabutra,S., Carr,J.K. and McCutchan,F.E.",2006
AY945728,01_AE,1998,16910837,Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping,"Watanaveeradej,V., Benenson,M.W., Souza,M.D., Sirisopana,N., Nitayaphan,S., Tontichaivanich,C., Amphaipit,R., Renzullo,P.O., Brown,A.E., McNeil,J.G., Robb,M.L., Birx,D.L., Tovanabutra,S., Carr,J.K. and McCutchan,F.E.",2006
AY945729,01_AE,2000,16910837,Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping,"Watanaveeradej,V., Benenson,M.W., Souza,M.D., Sirisopana,N., Nitayaphan,S., Tontichaivanich,C., Amphaipit,R., Renzullo,P.O., Brown,A.E., McNeil,J.G., Robb,M.L., Birx,D.L., Tovanabutra,S., Carr,J.K. and McCutchan,F.E.",2006
AY945730,01_AE,2001,16910837,Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping,"Watanaveeradej,V., Benenson,M.W., Souza,M.D., Sirisopana,N., Nitayaphan,S., Tontichaivanich,C., Amphaipit,R., Renzullo,P.O., Brown,A.E., McNeil,J.G., Robb,M.L., Birx,D.L., Tovanabutra,S., Carr,J.K. and McCutchan,F.E.",2006
AY945731,01_AE,1999,16910837,Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping,"Watanaveeradej,V., Benenson,M.W., Souza,M.D., Sirisopana,N., Nitayaphan,S., Tontichaivanich,C., Amphaipit,R., Renzullo,P.O., Brown,A.E., McNeil,J.G., Robb,M.L., Birx,D.L., Tovanabutra,S., Carr,J.K. and McCutchan,F.E.",2006
AY945732,01_AE,1999,16910837,Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping,"Watanaveeradej,V., Benenson,M.W., Souza,M.D., Sirisopana,N., Nitayaphan,S., Tontichaivanich,C., Amphaipit,R., Renzullo,P.O., Brown,A.E., McNeil,J.G., Robb,M.L., Birx,D.L., Tovanabutra,S., Carr,J.K. and McCutchan,F.E.",2006
AY945733,01B,2000,16910837,Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping,"Watanaveeradej,V., Benenson,M.W., Souza,M.D., Sirisopana,N., Nitayaphan,S., Tontichaivanich,C., Amphaipit,R., Renzullo,P.O., Brown,A.E., McNeil,J.G., Robb,M.L., Birx,D.L., Tovanabutra,S., Carr,J.K. and McCutchan,F.E.",2006
AY945734,52_01B,2000,16910837,Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping,"Watanaveeradej,V., Benenson,M.W., Souza,M.D., Sirisopana,N., Nitayaphan,S., Tontichaivanich,C., Amphaipit,R., Renzullo,P.O., Brown,A.E., McNeil,J.G., Robb,M.L., Birx,D.L., Tovanabutra,S., Carr,J.K. and McCutchan,F.E.",2006
AY945735,01C,1999,16910837,Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping,"Watanaveeradej,V., Benenson,M.W., Souza,M.D., Sirisopana,N., Nitayaphan,S., Tontichaivanich,C., Amphaipit,R., Renzullo,P.O., Brown,A.E., McNeil,J.G., Robb,M.L., Birx,D.L., Tovanabutra,S., Carr,J.K. and McCutchan,F.E.",2006
AY945736,16_A2D,1991,16831094,Circulating and unique recombinant forms of HIV type 1 containing subsubtype A2,"Visawapoka,U., Tovanabutra,S., Currier,J.R., Cox,J.H., Mason,C.J., Wasunna,M., Ponglikitmongkol,M., Dowling,W.E., Robb,M.L., Birx,D.L. and McCutchan,F.E.",2006
AY945737,21_A2D,1991,16831094,Circulating and unique recombinant forms of HIV type 1 containing subsubtype A2,"Visawapoka,U., Tovanabutra,S., Currier,J.R., Cox,J.H., Mason,C.J., Wasunna,M., Ponglikitmongkol,M., Dowling,W.E., Robb,M.L., Birx,D.L. and McCutchan,F.E.",2006
AY945738,C,1991,16831094,Circulating and unique recombinant forms of HIV type 1 containing subsubtype A2,"Visawapoka,U., Tovanabutra,S., Currier,J.R., Cox,J.H., Mason,C.J., Wasunna,M., Ponglikitmongkol,M., Dowling,W.E., Robb,M.L., Birx,D.L. and McCutchan,F.E.",2006
AY945739,A1A2D,1991,16831094,Circulating and unique recombinant forms of HIV type 1 containing subsubtype A2,"Visawapoka,U., Tovanabutra,S., Currier,J.R., Cox,J.H., Mason,C.J., Wasunna,M., Ponglikitmongkol,M., Dowling,W.E., Robb,M.L., Birx,D.L. and McCutchan,F.E.",2006
AY961590,01_AE,2000,16131314,Heterosexual transmission of novel CRF01_AE and subtype B recombinant forms of HIV type 1 in northern Thailand,"Wichukchinda,N., Shiino,T., Srisawat,J., Rojanawiwat,A., Pathipvanich,P., Sawanpanyalert,P., Ariyoshi,K. and Auwanit,W.",2005
AY961591,01B,2000,16131314,Heterosexual transmission of novel CRF01_AE and subtype B recombinant forms of HIV type 1 in northern Thailand,"Wichukchinda,N., Shiino,T., Srisawat,J., Rojanawiwat,A., Pathipvanich,P., Sawanpanyalert,P., Ariyoshi,K. and Auwanit,W.",2005
AY967803,BC,1996,16379609,Characterization of Five Nearly Full-Length Genomes of Early HIV Type 1 Strains in Ruili City: Implications for the Genesis of CRF07_BC and CRF08_BC Circulating in China,"Qiu,Z., Xing,H., Wei,M., Duan,Y., Zhao,Q., Xu,J. and Shao,Y.",2005
AY967804,BC,1996,16379609,Characterization of Five Nearly Full-Length Genomes of Early HIV Type 1 Strains in Ruili City: Implications for the Genesis of CRF07_BC and CRF08_BC Circulating in China,"Qiu,Z., Xing,H., Wei,M., Duan,Y., Zhao,Q., Xu,J. and Shao,Y.",2005
AY967805,BC,1998,16379609,Characterization of Five Nearly Full-Length Genomes of Early HIV Type 1 Strains in Ruili City: Implications for the Genesis of CRF07_BC and CRF08_BC Circulating in China,"Qiu,Z., Xing,H., Wei,M., Duan,Y., Zhao,Q., Xu,J. and Shao,Y.",2005
AY967806,C,1998,16379609,Characterization of Five Nearly Full-Length Genomes of Early HIV Type 1 Strains in Ruili City: Implications for the Genesis of CRF07_BC and CRF08_BC Circulating in China,"Qiu,Z., Xing,H., Wei,M., Duan,Y., Zhao,Q., Xu,J. and Shao,Y.",2005
AY967807,BC,1996,16379609,Characterization of Five Nearly Full-Length Genomes of Early HIV Type 1 Strains in Ruili City: Implications for the Genesis of CRF07_BC and CRF08_BC Circulating in China,"Qiu,Z., Xing,H., Wei,M., Duan,Y., Zhao,Q., Xu,J. and Shao,Y.",2005
AY968312,BC,2001,16225418,Sequence analysis of a South American HIV type 1 BC recombinant,"Aulicino,P.C., Kopka,J., Rocco,C., Mangano,A. and Sen,L.",2005
AY970946,B,1986,,Differential loss of human immunodeficiency virus type I (HIV-1)-specific T-helper responses in two HIV-1 infected individuals following CTL escape,"Geels,M.J., Jansen,C., Baan,E., De Cuyper,I.M., van Schijndel,G.J.M., Pollakis,G., Schuitemaker,H., Bakker,M., Goudsmit,J., van Baarle,D., Paxton,W.A. and Miedema,F.",
BD298114,B,1983,,POLYNUCLEOTIDE AMPLIFICATION METHOD,"Nunomura,K.",2003
CQ958303,B,1985,,Materials and methods for immunizing against fiv infection,"Yamamoto,J.K.",2004
D10112,B,1983,,Nucleotide sequence of a Cambridge isolate of human immunodeficiency virus type 1,"McIntosh,A.A. and Karps,A.",
D12582,B,,1322587,Analysis of a human immunodeficiency virus type 1 isolate carrying a truncated transmembrane glycoprotein,"Shimizu,H., Hasebe,F., Tsuchie,H., Morikawa,S., Ushijima,H. and Kitamura,T.",1992
DD409979,02_AG,,,COMPOSITIONS FOR MODULATING IMMUNE CELL ACTIVITY AND METHODS FOR DETECTION THEREOF,"Poznansky,M.C. and Brainerd,D.M.",2006
DL258709,02_AG,1995,,Modified HIV-1 Envelope Proteins,"Kuinnan,G.V., Chamu,F. and Gron,G.V.D.",2008
DL258710,B,1990,,Modified HIV-1 Envelope Proteins,"Kuinnan,G.V., Chamu,F. and Gron,G.V.D.",2008
DL258711,F1,1995,,Modified HIV-1 Envelope Proteins,"Kuinnan,G.V., Chamu,F. and Gron,G.V.D.",2008
DL258715,B,1993,,Modified HIV-1 Envelope Proteins,"Kuinnan,G.V., Chamu,F. and Gron,G.V.D.",2008
DL258716,01_AE,1994,,Modified HIV-1 Envelope Proteins,"Kuinnan,G.V., Chamu,F. and Gron,G.V.D.",2008
DL258717,06A1,1996,,Modified HIV-1 Envelope Proteins,"Kuinnan,G.V., Chamu,F. and Gron,G.V.D.",2008
DQ007901,B,2002,16280709,"Genetic characterization of full-length HIV type 1 genomes from 3 infected paid blood donors in Henan, China","Liu,L., Su,B., Zhuang,K., Tien,P., Chen,Z. and Zhang,L.",2005
DQ007902,B,2002,16280709,"Genetic characterization of full-length HIV type 1 genomes from 3 infected paid blood donors in Henan, China","Liu,L., Su,B., Zhuang,K., Tien,P., Chen,Z. and Zhang,L.",2005
DQ007903,B,2002,16280709,"Genetic characterization of full-length HIV type 1 genomes from 3 infected paid blood donors in Henan, China","Liu,L., Su,B., Zhuang,K., Tien,P., Chen,Z. and Zhang,L.",2005
DQ011165,C,2003,,"HIV HLA epitope mapping from Durban, South Africa","Birditt,B.A., Rousseau,C.M., Korber,B.T., Goulder,P., Brander,C., Kiepiela,P., Walker,B.D. and Mullins,J.I.",
DQ011166,C,2004,,"HIV HLA epitope mapping from Durban, South Africa","Birditt,B.A., Rousseau,C.M., Korber,B.T., Goulder,P., Brander,C., Kiepiela,P., Walker,B.D. and Mullins,J.I.",
DQ011167,C,2004,,"HIV HLA epitope mapping from Durban, South Africa","Birditt,B.A., Rousseau,C.M., Korber,B.T., Goulder,P., Brander,C., Kiepiela,P., Walker,B.D. and Mullins,J.I.",
DQ011168,C,2004,,"HIV HLA epitope mapping from Durban, South Africa","Birditt,B.A., Rousseau,C.M., Korber,B.T., Goulder,P., Brander,C., Kiepiela,P., Walker,B.D. and Mullins,J.I.",
DQ011169,C,2003,,"HIV HLA epitope mapping from Durban, South Africa","Birditt,B.A., Rousseau,C.M., Korber,B.T., Goulder,P., Brander,C., Kiepiela,P., Walker,B.D. and Mullins,J.I.",
DQ011170,C,2004,,"HIV HLA epitope mapping from Durban, South Africa","Birditt,B.A., Rousseau,C.M., Korber,B.T., Goulder,P., Brander,C., Kiepiela,P., Walker,B.D. and Mullins,J.I.",
DQ011171,C,2004,,"HIV HLA epitope mapping from Durban, South Africa","Birditt,B.A., Rousseau,C.M., Korber,B.T., Goulder,P., Brander,C., Kiepiela,P., Walker,B.D. and Mullins,J.I.",
DQ011172,C,2004,,"HIV HLA epitope mapping from Durban, South Africa","Birditt,B.A., Rousseau,C.M., Korber,B.T., Goulder,P., Brander,C., Kiepiela,P., Walker,B.D. and Mullins,J.I.",
DQ011173,C,2004,,"HIV HLA epitope mapping from Durban, South Africa","Birditt,B.A., Rousseau,C.M., Korber,B.T., Goulder,P., Brander,C., Kiepiela,P., Walker,B.D. and Mullins,J.I.",
DQ011174,C,2004,,"HIV HLA epitope mapping from Durban, South Africa","Birditt,B.A., Rousseau,C.M., Korber,B.T., Goulder,P., Brander,C., Kiepiela,P., Walker,B.D. and Mullins,J.I.",
DQ011175,C,2003,,"HIV HLA epitope mapping from Durban, South Africa","Birditt,B.A., Rousseau,C.M., Korber,B.T., Goulder,P., Brander,C., Kiepiela,P., Walker,B.D. and Mullins,J.I.",
DQ011176,C,2003,,"HIV HLA epitope mapping from Durban, South Africa","Birditt,B.A., Rousseau,C.M., Korber,B.T., Goulder,P., Brander,C., Kiepiela,P., Walker,B.D. and Mullins,J.I.",
DQ011177,C,2004,,"HIV HLA epitope mapping from Durban, South Africa","Birditt,B.A., Rousseau,C.M., Korber,B.T., Goulder,P., Brander,C., Kiepiela,P., Walker,B.D. and Mullins,J.I.",
DQ011178,C,2004,,"HIV HLA epitope mapping from Durban, South Africa","Birditt,B.A., Rousseau,C.M., Korber,B.T., Goulder,P., Brander,C., Kiepiela,P., Walker,B.D. and Mullins,J.I.",
DQ011179,C,2004,,"HIV HLA epitope mapping from Durban, South Africa","Birditt,B.A., Rousseau,C.M., Korber,B.T., Goulder,P., Brander,C., Kiepiela,P., Walker,B.D. and Mullins,J.I.",
DQ011180,C,2004,,"HIV HLA epitope mapping from Durban, South Africa","Birditt,B.A., Rousseau,C.M., Korber,B.T., Goulder,P., Brander,C., Kiepiela,P., Walker,B.D. and Mullins,J.I.",
DQ017382,N,,16438650,Identification of HIV type 1 group N infections in a husband and wife in Cameroon: viral genome sequences provide evidence for horizontal transmission,"Yamaguchi,J., Coffey,R., Vallari,A., Ngansop,C., Mbanya,D., Ndembi,N., Kaptue,L., Gurtler,L.G., Bodelle,P., Schochetman,G., Devare,S.G. and Brennan,C.A.",2006
DQ017383,N,,16438650,Identification of HIV type 1 group N infections in a husband and wife in Cameroon: viral genome sequences provide evidence for horizontal transmission,"Yamaguchi,J., Coffey,R., Vallari,A., Ngansop,C., Mbanya,D., Ndembi,N., Kaptue,L., Gurtler,L.G., Bodelle,P., Schochetman,G., Devare,S.G. and Brennan,C.A.",2006
DQ020274,20_BG,2003,17356464,Identification of 3 phylogenetically related HIV-1 BG intersubtype circulating recombinant forms in Cuba,"Sierra,M., Thomson,M.M., Posada,D., Perez,L., Aragones,C., Gonzalez,Z., Perez,J., Casado,G. and Najera,R.",2007
DQ054367,D,2004,23199052,Phylogenetic Analysis of Near Full-Length HIV Type 1 Genomic Sequences from 21 Korean Individuals,"Cho,Y.K., Kim,J.E. and Foley,B.T.",2013
DQ056404,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ056405,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ056406,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ056407,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ056408,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ056409,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ056410,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ056411,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ056412,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ056413,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ056414,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ056415,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ056416,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ056417,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ056418,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ083238,A1C,2001,16289184,Construction and characterization of an infectious molecular clone of HIV-1 subtype A of Indian origin,"Rodriguez,M.A., Chen,Y., Craigo,J.K., Chatterjee,R., Ratner,D., Tatsumi,M., Roy,P., Neogi,D. and Gupta,P.",2006
DQ085867,BF1,1999,16438639,Identification of two HIV type 1 circulating recombinant forms in Brazil,"De Sa Filho,D.J., Sucupira,M.C., Caseiro,M.M., Sabino,E.C., Diaz,R.S. and Janini,L.M.",2006
DQ085868,BF1,1999,16438639,Identification of two HIV type 1 circulating recombinant forms in Brazil,"De Sa Filho,D.J., Sucupira,M.C., Caseiro,M.M., Sabino,E.C., Diaz,R.S. and Janini,L.M.",2006
DQ085869,BF1,1999,16438639,Identification of two HIV type 1 circulating recombinant forms in Brazil,"De Sa Filho,D.J., Sucupira,M.C., Caseiro,M.M., Sabino,E.C., Diaz,R.S. and Janini,L.M.",2006
DQ085870,BF1,1999,16438639,Identification of two HIV type 1 circulating recombinant forms in Brazil,"De Sa Filho,D.J., Sucupira,M.C., Caseiro,M.M., Sabino,E.C., Diaz,R.S. and Janini,L.M.",2006
DQ085871,29_BF,1999,16438639,Identification of two HIV type 1 circulating recombinant forms in Brazil,"De Sa Filho,D.J., Sucupira,M.C., Caseiro,M.M., Sabino,E.C., Diaz,R.S. and Janini,L.M.",2006
DQ085872,28_BF,1999,16438639,Identification of two HIV type 1 circulating recombinant forms in Brazil,"De Sa Filho,D.J., Sucupira,M.C., Caseiro,M.M., Sabino,E.C., Diaz,R.S. and Janini,L.M.",2006
DQ085873,28_BF,1999,16438639,Identification of two HIV type 1 circulating recombinant forms in Brazil,"De Sa Filho,D.J., Sucupira,M.C., Caseiro,M.M., Sabino,E.C., Diaz,R.S. and Janini,L.M.",2006
DQ085874,28_BF,1999,16438639,Identification of two HIV type 1 circulating recombinant forms in Brazil,"De Sa Filho,D.J., Sucupira,M.C., Caseiro,M.M., Sabino,E.C., Diaz,R.S. and Janini,L.M.",2006
DQ085875,BF1,2000,16438639,Identification of two HIV type 1 circulating recombinant forms in Brazil,"De Sa Filho,D.J., Sucupira,M.C., Caseiro,M.M., Sabino,E.C., Diaz,R.S. and Janini,L.M.",2006
DQ085876,29_BF,2001,16438639,Identification of two HIV type 1 circulating recombinant forms in Brazil,"De Sa Filho,D.J., Sucupira,M.C., Caseiro,M.M., Sabino,E.C., Diaz,R.S. and Janini,L.M.",2006
DQ093585,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ093586,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ093587,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ093588,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ093589,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ093590,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ093591,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ093592,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ093593,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ093594,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ093595,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ093596,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ093597,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ093598,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ093599,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ093600,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ093601,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ093602,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ093603,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ093604,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ093605,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ093606,AC,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ093607,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ127534,B,,16227247,Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution,"Allen,T.M., Altfeld,M., Geer,S.C., Kalife,E.T., Moore,C., O'sullivan,K.M., Desouza,I., Feeney,M.E., Eldridge,R.L., Maier,E.L., Kaufmann,D.E., Lahaie,M.P., Reyor,L., Tanzi,G., Johnston,M.N., Brander,C., Draenert,R., Rockstroh,J.K., Jessen,H., Rosenberg,E.S., Mallal,S.A. and Walker,B.D.",2005
DQ127537,B,,16227247,Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution,"Allen,T.M., Altfeld,M., Geer,S.C., Kalife,E.T., Moore,C., O'sullivan,K.M., Desouza,I., Feeney,M.E., Eldridge,R.L., Maier,E.L., Kaufmann,D.E., Lahaie,M.P., Reyor,L., Tanzi,G., Johnston,M.N., Brander,C., Draenert,R., Rockstroh,J.K., Jessen,H., Rosenberg,E.S., Mallal,S.A. and Walker,B.D.",2005
DQ127548,B,,16227247,Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution,"Allen,T.M., Altfeld,M., Geer,S.C., Kalife,E.T., Moore,C., O'sullivan,K.M., Desouza,I., Feeney,M.E., Eldridge,R.L., Maier,E.L., Kaufmann,D.E., Lahaie,M.P., Reyor,L., Tanzi,G., Johnston,M.N., Brander,C., Draenert,R., Rockstroh,J.K., Jessen,H., Rosenberg,E.S., Mallal,S.A. and Walker,B.D.",2005
DQ141204,D,1996,16478405,Phylogenetic analysis of Brazilian HIV type 1 subtype D strains: tracing the origin of this subtype in Brazil,"Couto-Fernandez,J.C., Eyer-Silva,W.A., Guimaraes,M.L., Chequer-Fernandez,S.L., Grinsztejn,B., Delaporte,E., Peeters,M. and Morgado,M.G.",2006
DQ141341,B,,,Genetic and functional analysis of HIV-1 envelope from long-term non-progressors,"Martinez,L. and Delgado,R.",
DQ141342,B,,,Genetic and functional analysis of HIV-1 envelope from long-term non-progressors,"Martinez,L. and Delgado,R.",
DQ141343,B,,,Genetic and functional analysis of HIV-1 envelope from long-term non-progressors,"Martinez,L. and Delgado,R.",
DQ141344,B,,,Genetic and functional analysis of HIV-1 envelope from long-term non-progressors,"Martinez,L. and Delgado,R.",
DQ141345,B,,,Genetic and functional analysis of HIV-1 envelope from long-term non-progressors,"Martinez,L. and Delgado,R.",
DQ164104,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ164106,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ164107,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ164108,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ164109,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ164110,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ164111,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ164113,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ164114,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ164115,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ164117,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ164118,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ164119,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ164120,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ164121,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ164122,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ164123,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ164124,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ164125,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ164126,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ164127,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ164128,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ164129,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ167215,32_06A6,2002,16044014,Predominance of a Rare Type of HIV-1 in Estonia,"Adojaan,M., Kivisild,T., Mannik,A., Krispin,T., Ustina,V., Zilmer,K., Liebert,E., Jaroslavtsev,N., Priimagi,L., Tefanova,V., Schmidt,J., Krohn,K., Villems,R., Salminen,M. and Ustav,M.",2005
DQ167216,A6B,2002,16044014,Predominance of a Rare Type of HIV-1 in Estonia,"Adojaan,M., Kivisild,T., Mannik,A., Krispin,T., Ustina,V., Zilmer,K., Liebert,E., Jaroslavtsev,N., Priimagi,L., Tefanova,V., Schmidt,J., Krohn,K., Villems,R., Salminen,M. and Ustav,M.",2005
DQ168573,G,2001,,"HIV Subtype and Drug Resistance Patterns among Drug Naive Persons in Jos, Nigeria","Carr,J.K., Lar,P., Bemis,K., Jelpe,J., Ayuba,L., Zella,D., Blattner,W., Kanki,P. and Abimiku,A.G.",
DQ168575,G,2001,,"HIV Subtype and Drug Resistance Patterns among Drug Naive Persons in Jos, Nigeria","Carr,J.K., Lar,P., Bemis,K., Jelpe,J., Ayuba,L., Zella,D., Blattner,W., Kanki,P. and Abimiku,A.G.",
DQ168576,G,2001,,"HIV Subtype and Drug Resistance Patterns among Drug Naive Persons in Jos, Nigeria","Carr,J.K., Lar,P., Bemis,K., Jelpe,J., Ayuba,L., Zella,D., Blattner,W., Kanki,P. and Abimiku,A.G.",
DQ168577,02_AG,2001,,"HIV Subtype and Drug Resistance Patterns among Drug Naive Persons in Jos, Nigeria","Carr,J.K., Lar,P., Bemis,K., Jelpe,J., Ayuba,L., Zella,D., Blattner,W., Kanki,P. and Abimiku,A.G.",
DQ168578,02_AG,2001,,"HIV Subtype and Drug Resistance Patterns among Drug Naive Persons in Jos, Nigeria","Carr,J.K., Lar,P., Bemis,K., Jelpe,J., Ayuba,L., Zella,D., Blattner,W., Kanki,P. and Abimiku,A.G.",
DQ168579,G,2001,,"HIV Subtype and Drug Resistance Patterns among Drug Naive Persons in Jos, Nigeria","Carr,J.K., Lar,P., Bemis,K., Jelpe,J., Ayuba,L., Zella,D., Blattner,W., Kanki,P. and Abimiku,A.G.",
DQ178989,B,1994,10708437,Pathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu mice,"Scoggins,R.M., Taylor,J.R. Jr., Patrie,J., van't Wout,A.B., Schuitemaker,H. and Camerini,D.",2000
DQ187009,A1D,,,HIV variants transmitted through breastfeeding are genetically homogeneous and resistant to neutralization by maternal antibodies,"Rainwater,S.M.J., Wu,X., Nduati,R., John-Stewart,G., Mbori-Ngacha,D. and Overbaugh,J.",
DQ189088,F1,2002,15725755,"Circulation of novel HIV type 1 A, B/C, and F subtypes in Argentina","Aulicino,P.C., Kopka,J., Mangano,A.M., Rocco,C., Iacono,M., Bologna,R. and Sen,L.",2005
DQ207940,B,2003,16706626,HIV-1 genetic diversity and genotypic drug susceptibility in the Republic of Georgia,"Zarandia,M., Tsertsvadze,T., Carr,J.K., Nadai,Y., Sanchez,J.L. and Nelson,A.K.",2006
DQ207941,C,2003,16706626,HIV-1 genetic diversity and genotypic drug susceptibility in the Republic of Georgia,"Zarandia,M., Tsertsvadze,T., Carr,J.K., Nadai,Y., Sanchez,J.L. and Nelson,A.K.",2006
DQ207942,B,2003,16706626,HIV-1 genetic diversity and genotypic drug susceptibility in the Republic of Georgia,"Zarandia,M., Tsertsvadze,T., Carr,J.K., Nadai,Y., Sanchez,J.L. and Nelson,A.K.",2006
DQ207943,B,1998,16706626,HIV-1 genetic diversity and genotypic drug susceptibility in the Republic of Georgia,"Zarandia,M., Tsertsvadze,T., Carr,J.K., Nadai,Y., Sanchez,J.L. and Nelson,A.K.",2006
DQ207944,A6,1999,16706626,HIV-1 genetic diversity and genotypic drug susceptibility in the Republic of Georgia,"Zarandia,M., Tsertsvadze,T., Carr,J.K., Nadai,Y., Sanchez,J.L. and Nelson,A.K.",2006
DQ208424,AD,,16378985,Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant,"Wu,X., Parast,A.B., Richardson,B.A., Nduati,R., John-Stewart,G., Mbori-Ngacha,D., Rainwater,S.M. and Overbaugh,J.",2006
DQ208431,AD,,16378985,Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant,"Wu,X., Parast,A.B., Richardson,B.A., Nduati,R., John-Stewart,G., Mbori-Ngacha,D., Rainwater,S.M. and Overbaugh,J.",2006
DQ208434,A1CD,,16378985,Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant,"Wu,X., Parast,A.B., Richardson,B.A., Nduati,R., John-Stewart,G., Mbori-Ngacha,D., Rainwater,S.M. and Overbaugh,J.",2006
DQ208441,A1CD,,16378985,Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant,"Wu,X., Parast,A.B., Richardson,B.A., Nduati,R., John-Stewart,G., Mbori-Ngacha,D., Rainwater,S.M. and Overbaugh,J.",2006
DQ208444,A1,,16378985,Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant,"Wu,X., Parast,A.B., Richardson,B.A., Nduati,R., John-Stewart,G., Mbori-Ngacha,D., Rainwater,S.M. and Overbaugh,J.",2006
DQ208447,A1,,16378985,Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant,"Wu,X., Parast,A.B., Richardson,B.A., Nduati,R., John-Stewart,G., Mbori-Ngacha,D., Rainwater,S.M. and Overbaugh,J.",2006
DQ208449,A1,,16378985,Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant,"Wu,X., Parast,A.B., Richardson,B.A., Nduati,R., John-Stewart,G., Mbori-Ngacha,D., Rainwater,S.M. and Overbaugh,J.",2006
DQ208456,A1,,16378985,Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant,"Wu,X., Parast,A.B., Richardson,B.A., Nduati,R., John-Stewart,G., Mbori-Ngacha,D., Rainwater,S.M. and Overbaugh,J.",2006
DQ208459,A1,,16378985,Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant,"Wu,X., Parast,A.B., Richardson,B.A., Nduati,R., John-Stewart,G., Mbori-Ngacha,D., Rainwater,S.M. and Overbaugh,J.",2006
DQ208465,A1,,16378985,Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant,"Wu,X., Parast,A.B., Richardson,B.A., Nduati,R., John-Stewart,G., Mbori-Ngacha,D., Rainwater,S.M. and Overbaugh,J.",2006
DQ208468,AD,,16378985,Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant,"Wu,X., Parast,A.B., Richardson,B.A., Nduati,R., John-Stewart,G., Mbori-Ngacha,D., Rainwater,S.M. and Overbaugh,J.",2006
DQ208478,AD,,16378985,Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant,"Wu,X., Parast,A.B., Richardson,B.A., Nduati,R., John-Stewart,G., Mbori-Ngacha,D., Rainwater,S.M. and Overbaugh,J.",2006
DQ208483,CD,,16378985,Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant,"Wu,X., Parast,A.B., Richardson,B.A., Nduati,R., John-Stewart,G., Mbori-Ngacha,D., Rainwater,S.M. and Overbaugh,J.",2006
DQ208489,CD,,16378985,Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant,"Wu,X., Parast,A.B., Richardson,B.A., Nduati,R., John-Stewart,G., Mbori-Ngacha,D., Rainwater,S.M. and Overbaugh,J.",2006
DQ208492,A1D,,16378985,Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant,"Wu,X., Parast,A.B., Richardson,B.A., Nduati,R., John-Stewart,G., Mbori-Ngacha,D., Rainwater,S.M. and Overbaugh,J.",2006
DQ208499,A1D,,16378985,Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant,"Wu,X., Parast,A.B., Richardson,B.A., Nduati,R., John-Stewart,G., Mbori-Ngacha,D., Rainwater,S.M. and Overbaugh,J.",2006
DQ222211,B,,16309726,HIV-1 tropism for the central nervous system: Brain-derived envelope glycoproteins with lower CD4 dependence and reduced sensitivity to a fusion inhibitor,"Martin-Garcia,J., Cao,W., Varela-Rohena,A., Plassmeyer,M.L. and Gonzalez-Scarano,F.",2006
DQ230841,07_BC,2004,17396997,Molecular epidemiology of HIV-1 infection and full-length genomic analysis of circulating recombinant form 07_BC strains from injection drug users in Taiwan,"Lin,Y.T., Lan,Y.C., Chen,Y.J., Huang,Y.H., Lee,C.M., Liu,T.T., Wong,W.W., Yang,J.Y., Wang,C.T. and Chen,Y.M.",2007
DQ230842,07B,2004,17396997,Molecular epidemiology of HIV-1 infection and full-length genomic analysis of circulating recombinant form 07_BC strains from injection drug users in Taiwan,"Lin,Y.T., Lan,Y.C., Chen,Y.J., Huang,Y.H., Lee,C.M., Liu,T.T., Wong,W.W., Yang,J.Y., Wang,C.T. and Chen,Y.M.",2007
DQ275642,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ275643,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ275644,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ275645,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ275646,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ275647,C,2002,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ275648,C,2002,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ275649,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ275650,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ275651,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ275652,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ275653,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ275654,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ275655,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ275656,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ275657,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ275658,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ275659,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ275660,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ275661,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ275662,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ275663,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ275664,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ275665,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ295192,B,2004,23199052,Phylogenetic Analysis of Near Full-Length HIV Type 1 Genomic Sequences from 21 Korean Individuals,"Cho,Y.K., Kim,J.E. and Foley,B.T.",2013
DQ295193,B,2004,23199052,Phylogenetic Analysis of Near Full-Length HIV Type 1 Genomic Sequences from 21 Korean Individuals,"Cho,Y.K., Kim,J.E. and Foley,B.T.",2013
DQ295195,B,2004,23199052,Phylogenetic Analysis of Near Full-Length HIV Type 1 Genomic Sequences from 21 Korean Individuals,"Cho,Y.K., Kim,J.E. and Foley,B.T.",2013
DQ295196,B,2004,17073619,High frequency of grossly deleted nef genes in HIV-1 infected long-term slow progressors treated with Korean red ginseng,"Cho,Y.K., Lim,J.Y., Jung,Y.S., Oh,S.K., Lee,H.J. and Sung,H.",2006
DQ313246,B,1994,16378633,Neutralization and infectivity characteristics of envelope glycoproteins from human immunodeficiency virus type 1 infected donors whose sera exhibit broadly cross-reactive neutralizing activity,"Cham,F., Zhang,P.F., Heyndrickx,L., Bouma,P., Zhong,P., Katinger,H., Robinson,J., van der Groen,G. and Quinnan,G.V. Jr.",2006
DQ313248,A1U,2000,16378633,Neutralization and infectivity characteristics of envelope glycoproteins from human immunodeficiency virus type 1 infected donors whose sera exhibit broadly cross-reactive neutralizing activity,"Cham,F., Zhang,P.F., Heyndrickx,L., Bouma,P., Zhong,P., Katinger,H., Robinson,J., van der Groen,G. and Quinnan,G.V. Jr.",2006
DQ322223,B,,,Direct Submission,"Bernardin,F., Bader,Y.-D., Sekaly,R.-P., Bernard,N. and Delwart,E.",2005
DQ322225,B,,,Direct Submission,"Bernardin,F., Bader,Y.-D., Sekaly,R.-P., Bernard,N. and Delwart,E.",2005
DQ322227,B,,,Direct Submission,"Bernardin,F., Bader,Y.-D., Sekaly,R.-P., Bernard,N. and Delwart,E.",2005
DQ322233,B,,,Direct Submission,"Bernardin,F., Bader,Y.-D., Sekaly,R.-P., Bernard,N. and Delwart,E.",2005
DQ339425,B,2003,,Grossly deleted HIV-1 nef gene,"Cho,Y.",
DQ351216,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ351217,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ351218,C,2002,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ351219,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ351220,C,2002,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ351221,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ351222,C,2002,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ351223,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ351224,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ351225,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ351226,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ351227,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ351228,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ351229,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ351230,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ351231,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ351232,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ351234,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ351235,C,2002,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ351236,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ351237,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ351238,A1C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ354112,B,1996,16997343,"Distinguishing molecular forms of HIV-1 in Asia with a high-throughput, fluorescent genotyping assay, MHAbce v.2","Kijak,G.H., Tovanabutra,S., Sanders-Buell,E., Watanaveeradej,V., de Souza,M.S., Nelson,K.E., Ketsararat,V., Gulgolgarn,V., Wera-arpachai,M., Sriplienchan,S., Khamboonrueng,C., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2007
DQ354113,52_01B,1996,16997343,"Distinguishing molecular forms of HIV-1 in Asia with a high-throughput, fluorescent genotyping assay, MHAbce v.2","Kijak,G.H., Tovanabutra,S., Sanders-Buell,E., Watanaveeradej,V., de Souza,M.S., Nelson,K.E., Ketsararat,V., Gulgolgarn,V., Wera-arpachai,M., Sriplienchan,S., Khamboonrueng,C., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2007
DQ354114,B,1996,16997343,"Distinguishing molecular forms of HIV-1 in Asia with a high-throughput, fluorescent genotyping assay, MHAbce v.2","Kijak,G.H., Tovanabutra,S., Sanders-Buell,E., Watanaveeradej,V., de Souza,M.S., Nelson,K.E., Ketsararat,V., Gulgolgarn,V., Wera-arpachai,M., Sriplienchan,S., Khamboonrueng,C., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2007
DQ354115,01B,1996,16997343,"Distinguishing molecular forms of HIV-1 in Asia with a high-throughput, fluorescent genotyping assay, MHAbce v.2","Kijak,G.H., Tovanabutra,S., Sanders-Buell,E., Watanaveeradej,V., de Souza,M.S., Nelson,K.E., Ketsararat,V., Gulgolgarn,V., Wera-arpachai,M., Sriplienchan,S., Khamboonrueng,C., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2007
DQ354116,B,1996,16997343,"Distinguishing molecular forms of HIV-1 in Asia with a high-throughput, fluorescent genotyping assay, MHAbce v.2","Kijak,G.H., Tovanabutra,S., Sanders-Buell,E., Watanaveeradej,V., de Souza,M.S., Nelson,K.E., Ketsararat,V., Gulgolgarn,V., Wera-arpachai,M., Sriplienchan,S., Khamboonrueng,C., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2007
DQ354117,01_AE,1996,16997343,"Distinguishing molecular forms of HIV-1 in Asia with a high-throughput, fluorescent genotyping assay, MHAbce v.2","Kijak,G.H., Tovanabutra,S., Sanders-Buell,E., Watanaveeradej,V., de Souza,M.S., Nelson,K.E., Ketsararat,V., Gulgolgarn,V., Wera-arpachai,M., Sriplienchan,S., Khamboonrueng,C., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2007
DQ354118,B,1996,16997343,"Distinguishing molecular forms of HIV-1 in Asia with a high-throughput, fluorescent genotyping assay, MHAbce v.2","Kijak,G.H., Tovanabutra,S., Sanders-Buell,E., Watanaveeradej,V., de Souza,M.S., Nelson,K.E., Ketsararat,V., Gulgolgarn,V., Wera-arpachai,M., Sriplienchan,S., Khamboonrueng,C., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2007
DQ354119,B,1996,16997343,"Distinguishing molecular forms of HIV-1 in Asia with a high-throughput, fluorescent genotyping assay, MHAbce v.2","Kijak,G.H., Tovanabutra,S., Sanders-Buell,E., Watanaveeradej,V., de Souza,M.S., Nelson,K.E., Ketsararat,V., Gulgolgarn,V., Wera-arpachai,M., Sriplienchan,S., Khamboonrueng,C., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2007
DQ354120,15_01B,1996,16997343,"Distinguishing molecular forms of HIV-1 in Asia with a high-throughput, fluorescent genotyping assay, MHAbce v.2","Kijak,G.H., Tovanabutra,S., Sanders-Buell,E., Watanaveeradej,V., de Souza,M.S., Nelson,K.E., Ketsararat,V., Gulgolgarn,V., Wera-arpachai,M., Sriplienchan,S., Khamboonrueng,C., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2007
DQ354121,01B,1996,16997343,"Distinguishing molecular forms of HIV-1 in Asia with a high-throughput, fluorescent genotyping assay, MHAbce v.2","Kijak,G.H., Tovanabutra,S., Sanders-Buell,E., Watanaveeradej,V., de Souza,M.S., Nelson,K.E., Ketsararat,V., Gulgolgarn,V., Wera-arpachai,M., Sriplienchan,S., Khamboonrueng,C., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2007
DQ354123,01B,1999,16997343,"Distinguishing molecular forms of HIV-1 in Asia with a high-throughput, fluorescent genotyping assay, MHAbce v.2","Kijak,G.H., Tovanabutra,S., Sanders-Buell,E., Watanaveeradej,V., de Souza,M.S., Nelson,K.E., Ketsararat,V., Gulgolgarn,V., Wera-arpachai,M., Sriplienchan,S., Khamboonrueng,C., Birx,D.L., Robb,M.L. and McCutchan,F.E.",2007
DQ358799,BF1,2001,16522378,"Analysis of the near full length genomes of HIV-1 subtypes B, F and BF recombinant from a cohort of 14 patients in Sao Paulo, Brazil","Sanabani,S., Kleine Neto,W., Kalmar,E.M., Diaz,R.S., Janini,L.M. and Sabino,E.C.",2006
DQ358800,BF1,2001,16522378,"Analysis of the near full length genomes of HIV-1 subtypes B, F and BF recombinant from a cohort of 14 patients in Sao Paulo, Brazil","Sanabani,S., Kleine Neto,W., Kalmar,E.M., Diaz,R.S., Janini,L.M. and Sabino,E.C.",2006
DQ358801,46_BF,2001,16522378,"Analysis of the near full length genomes of HIV-1 subtypes B, F and BF recombinant from a cohort of 14 patients in Sao Paulo, Brazil","Sanabani,S., Kleine Neto,W., Kalmar,E.M., Diaz,R.S., Janini,L.M. and Sabino,E.C.",2006
DQ358802,46_BF,2001,16522378,"Analysis of the near full length genomes of HIV-1 subtypes B, F and BF recombinant from a cohort of 14 patients in Sao Paulo, Brazil","Sanabani,S., Kleine Neto,W., Kalmar,E.M., Diaz,R.S., Janini,L.M. and Sabino,E.C.",2006
DQ358803,BF1,2001,16522378,"Analysis of the near full length genomes of HIV-1 subtypes B, F and BF recombinant from a cohort of 14 patients in Sao Paulo, Brazil","Sanabani,S., Kleine Neto,W., Kalmar,E.M., Diaz,R.S., Janini,L.M. and Sabino,E.C.",2006
DQ358804,BF1,2001,16522378,"Analysis of the near full length genomes of HIV-1 subtypes B, F and BF recombinant from a cohort of 14 patients in Sao Paulo, Brazil","Sanabani,S., Kleine Neto,W., Kalmar,E.M., Diaz,R.S., Janini,L.M. and Sabino,E.C.",2006
DQ358805,B,2002,16522378,"Analysis of the near full length genomes of HIV-1 subtypes B, F and BF recombinant from a cohort of 14 patients in Sao Paulo, Brazil","Sanabani,S., Kleine Neto,W., Kalmar,E.M., Diaz,R.S., Janini,L.M. and Sabino,E.C.",2006
DQ358806,BF1,2002,16522378,"Analysis of the near full length genomes of HIV-1 subtypes B, F and BF recombinant from a cohort of 14 patients in Sao Paulo, Brazil","Sanabani,S., Kleine Neto,W., Kalmar,E.M., Diaz,R.S., Janini,L.M. and Sabino,E.C.",2006
DQ358807,BF1,2002,16522378,"Analysis of the near full length genomes of HIV-1 subtypes B, F and BF recombinant from a cohort of 14 patients in Sao Paulo, Brazil","Sanabani,S., Kleine Neto,W., Kalmar,E.M., Diaz,R.S., Janini,L.M. and Sabino,E.C.",2006
DQ358808,B,2002,16522378,"Analysis of the near full length genomes of HIV-1 subtypes B, F and BF recombinant from a cohort of 14 patients in Sao Paulo, Brazil","Sanabani,S., Kleine Neto,W., Kalmar,E.M., Diaz,R.S., Janini,L.M. and Sabino,E.C.",2006
DQ358809,B,2002,16522378,"Analysis of the near full length genomes of HIV-1 subtypes B, F and BF recombinant from a cohort of 14 patients in Sao Paulo, Brazil","Sanabani,S., Kleine Neto,W., Kalmar,E.M., Diaz,R.S., Janini,L.M. and Sabino,E.C.",2006
DQ358810,B,2002,16522378,"Analysis of the near full length genomes of HIV-1 subtypes B, F and BF recombinant from a cohort of 14 patients in Sao Paulo, Brazil","Sanabani,S., Kleine Neto,W., Kalmar,E.M., Diaz,R.S., Janini,L.M. and Sabino,E.C.",2006
DQ358811,71_BF1,2002,16522378,"Analysis of the near full length genomes of HIV-1 subtypes B, F and BF recombinant from a cohort of 14 patients in Sao Paulo, Brazil","Sanabani,S., Kleine Neto,W., Kalmar,E.M., Diaz,R.S., Janini,L.M. and Sabino,E.C.",2006
DQ358812,BF1,2002,16522378,"Analysis of the near full length genomes of HIV-1 subtypes B, F and BF recombinant from a cohort of 14 patients in Sao Paulo, Brazil","Sanabani,S., Kleine Neto,W., Kalmar,E.M., Diaz,R.S., Janini,L.M. and Sabino,E.C.",2006
DQ366659,33_01B,2005,17031320,"Identification of a novel circulating recombinant form (CRF33_01B) disseminating widely among various risk populations in Kuala Lumpur, Malaysia","Tee,K.K., Li,X.J., Nohtomi,K., Ng,K.P., Kamarulzaman,A. and Takebe,Y.",2006
DQ366660,33_01B,2005,17031320,"Identification of a novel circulating recombinant form (CRF33_01B) disseminating widely among various risk populations in Kuala Lumpur, Malaysia","Tee,K.K., Li,X.J., Nohtomi,K., Ng,K.P., Kamarulzaman,A. and Takebe,Y.",2006
DQ366661,33_01B,2005,17031320,"Identification of a novel circulating recombinant form (CRF33_01B) disseminating widely among various risk populations in Kuala Lumpur, Malaysia","Tee,K.K., Li,X.J., Nohtomi,K., Ng,K.P., Kamarulzaman,A. and Takebe,Y.",2006
DQ366662,33_01B,2005,17031320,"Identification of a novel circulating recombinant form (CRF33_01B) disseminating widely among various risk populations in Kuala Lumpur, Malaysia","Tee,K.K., Li,X.J., Nohtomi,K., Ng,K.P., Kamarulzaman,A. and Takebe,Y.",2006
DQ366663,53_01B,2004,17031320,"Identification of a novel circulating recombinant form (CRF33_01B) disseminating widely among various risk populations in Kuala Lumpur, Malaysia","Tee,K.K., Li,X.J., Nohtomi,K., Ng,K.P., Kamarulzaman,A. and Takebe,Y.",2006
DQ366664,52_01B,2003,17031320,"Identification of a novel circulating recombinant form (CRF33_01B) disseminating widely among various risk populations in Kuala Lumpur, Malaysia","Tee,K.K., Li,X.J., Nohtomi,K., Ng,K.P., Kamarulzaman,A. and Takebe,Y.",2006
DQ366665,01B,2004,17031320,"Identification of a novel circulating recombinant form (CRF33_01B) disseminating widely among various risk populations in Kuala Lumpur, Malaysia","Tee,K.K., Li,X.J., Nohtomi,K., Ng,K.P., Kamarulzaman,A. and Takebe,Y.",2006
DQ366666,01B,2005,17031320,"Identification of a novel circulating recombinant form (CRF33_01B) disseminating widely among various risk populations in Kuala Lumpur, Malaysia","Tee,K.K., Li,X.J., Nohtomi,K., Ng,K.P., Kamarulzaman,A. and Takebe,Y.",2006
DQ369976,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ369977,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ369978,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ369979,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ369980,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ369981,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ369982,C,2005,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ369983,C,2005,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ369984,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ369985,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ369986,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ369987,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ369988,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ369989,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ369990,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ369991,C,2005,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ369992,C,2005,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ369993,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ369994,C,2005,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ369995,C,2002,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ369996,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ369997,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ369998,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ382361,C,2005,18507530,Genotypic characterization and comparison of full-length envelope glycoproteins from South African HIV type 1 subtype C primary isolates that utilize CCR5 and/or CXCR4,"Michler,K., Connell,B.J., Venter,W.D., Stevens,W.S., Capovilla,A. and Papathanasopoulos,M.A.",2008
DQ382362,C,2005,18507530,Genotypic characterization and comparison of full-length envelope glycoproteins from South African HIV type 1 subtype C primary isolates that utilize CCR5 and/or CXCR4,"Michler,K., Connell,B.J., Venter,W.D., Stevens,W.S., Capovilla,A. and Papathanasopoulos,M.A.",2008
DQ382363,C,2005,18507530,Genotypic characterization and comparison of full-length envelope glycoproteins from South African HIV type 1 subtype C primary isolates that utilize CCR5 and/or CXCR4,"Michler,K., Connell,B.J., Venter,W.D., Stevens,W.S., Capovilla,A. and Papathanasopoulos,M.A.",2008
DQ382364,C,2005,18507530,Genotypic characterization and comparison of full-length envelope glycoproteins from South African HIV type 1 subtype C primary isolates that utilize CCR5 and/or CXCR4,"Michler,K., Connell,B.J., Venter,W.D., Stevens,W.S., Capovilla,A. and Papathanasopoulos,M.A.",2008
DQ382365,C,2005,18507530,Genotypic characterization and comparison of full-length envelope glycoproteins from South African HIV type 1 subtype C primary isolates that utilize CCR5 and/or CXCR4,"Michler,K., Connell,B.J., Venter,W.D., Stevens,W.S., Capovilla,A. and Papathanasopoulos,M.A.",2008
DQ382366,C,2005,18507530,Genotypic characterization and comparison of full-length envelope glycoproteins from South African HIV type 1 subtype C primary isolates that utilize CCR5 and/or CXCR4,"Michler,K., Connell,B.J., Venter,W.D., Stevens,W.S., Capovilla,A. and Papathanasopoulos,M.A.",2008
DQ382367,C,2005,18507530,Genotypic characterization and comparison of full-length envelope glycoproteins from South African HIV type 1 subtype C primary isolates that utilize CCR5 and/or CXCR4,"Michler,K., Connell,B.J., Venter,W.D., Stevens,W.S., Capovilla,A. and Papathanasopoulos,M.A.",2008
DQ382368,CD,2005,18507530,Genotypic characterization and comparison of full-length envelope glycoproteins from South African HIV type 1 subtype C primary isolates that utilize CCR5 and/or CXCR4,"Michler,K., Connell,B.J., Venter,W.D., Stevens,W.S., Capovilla,A. and Papathanasopoulos,M.A.",2008
DQ382369,C,2005,18507530,Genotypic characterization and comparison of full-length envelope glycoproteins from South African HIV type 1 subtype C primary isolates that utilize CCR5 and/or CXCR4,"Michler,K., Connell,B.J., Venter,W.D., Stevens,W.S., Capovilla,A. and Papathanasopoulos,M.A.",2008
DQ382370,C,2005,18507530,Genotypic characterization and comparison of full-length envelope glycoproteins from South African HIV type 1 subtype C primary isolates that utilize CCR5 and/or CXCR4,"Michler,K., Connell,B.J., Venter,W.D., Stevens,W.S., Capovilla,A. and Papathanasopoulos,M.A.",2008
DQ382371,C,2005,18507530,Genotypic characterization and comparison of full-length envelope glycoproteins from South African HIV type 1 subtype C primary isolates that utilize CCR5 and/or CXCR4,"Michler,K., Connell,B.J., Venter,W.D., Stevens,W.S., Capovilla,A. and Papathanasopoulos,M.A.",2008
DQ382372,C,2005,18507530,Genotypic characterization and comparison of full-length envelope glycoproteins from South African HIV type 1 subtype C primary isolates that utilize CCR5 and/or CXCR4,"Michler,K., Connell,B.J., Venter,W.D., Stevens,W.S., Capovilla,A. and Papathanasopoulos,M.A.",2008
DQ382373,C,2005,18507530,Genotypic characterization and comparison of full-length envelope glycoproteins from South African HIV type 1 subtype C primary isolates that utilize CCR5 and/or CXCR4,"Michler,K., Connell,B.J., Venter,W.D., Stevens,W.S., Capovilla,A. and Papathanasopoulos,M.A.",2008
DQ382374,C,2005,18507530,Genotypic characterization and comparison of full-length envelope glycoproteins from South African HIV type 1 subtype C primary isolates that utilize CCR5 and/or CXCR4,"Michler,K., Connell,B.J., Venter,W.D., Stevens,W.S., Capovilla,A. and Papathanasopoulos,M.A.",2008
DQ382375,C,2005,18507530,Genotypic characterization and comparison of full-length envelope glycoproteins from South African HIV type 1 subtype C primary isolates that utilize CCR5 and/or CXCR4,"Michler,K., Connell,B.J., Venter,W.D., Stevens,W.S., Capovilla,A. and Papathanasopoulos,M.A.",2008
DQ382376,C,2005,18507530,Genotypic characterization and comparison of full-length envelope glycoproteins from South African HIV type 1 subtype C primary isolates that utilize CCR5 and/or CXCR4,"Michler,K., Connell,B.J., Venter,W.D., Stevens,W.S., Capovilla,A. and Papathanasopoulos,M.A.",2008
DQ382377,C,2005,18507530,Genotypic characterization and comparison of full-length envelope glycoproteins from South African HIV type 1 subtype C primary isolates that utilize CCR5 and/or CXCR4,"Michler,K., Connell,B.J., Venter,W.D., Stevens,W.S., Capovilla,A. and Papathanasopoulos,M.A.",2008
DQ382378,C,2005,18507530,Genotypic characterization and comparison of full-length envelope glycoproteins from South African HIV type 1 subtype C primary isolates that utilize CCR5 and/or CXCR4,"Michler,K., Connell,B.J., Venter,W.D., Stevens,W.S., Capovilla,A. and Papathanasopoulos,M.A.",2008
DQ382379,C,2005,18507530,Genotypic characterization and comparison of full-length envelope glycoproteins from South African HIV type 1 subtype C primary isolates that utilize CCR5 and/or CXCR4,"Michler,K., Connell,B.J., Venter,W.D., Stevens,W.S., Capovilla,A. and Papathanasopoulos,M.A.",2008
DQ382380,C,2005,18507530,Genotypic characterization and comparison of full-length envelope glycoproteins from South African HIV type 1 subtype C primary isolates that utilize CCR5 and/or CXCR4,"Michler,K., Connell,B.J., Venter,W.D., Stevens,W.S., Capovilla,A. and Papathanasopoulos,M.A.",2008
DQ383746,B,2002,16959032,"First report of an HIV-1 triple recombinant of subtypes B, C and F in Buenos Aires, Argentina","Pando,M.A., Eyzaguirre,L.M., Segura,M., Bautista,C.T., Marone,R., Ceballos,A., Montano,S.M., Sanchez,J.L., Weissenbacher,M., Avila,M.M. and Carr,J.K.",2006
DQ383747,BF1,2002,16959032,"First report of an HIV-1 triple recombinant of subtypes B, C and F in Buenos Aires, Argentina","Pando,M.A., Eyzaguirre,L.M., Segura,M., Bautista,C.T., Marone,R., Ceballos,A., Montano,S.M., Sanchez,J.L., Weissenbacher,M., Avila,M.M. and Carr,J.K.",2006
DQ383748,B,2003,16959032,"First report of an HIV-1 triple recombinant of subtypes B, C and F in Buenos Aires, Argentina","Pando,M.A., Eyzaguirre,L.M., Segura,M., Bautista,C.T., Marone,R., Ceballos,A., Montano,S.M., Sanchez,J.L., Weissenbacher,M., Avila,M.M. and Carr,J.K.",2006
DQ383749,B,2003,16959032,"First report of an HIV-1 triple recombinant of subtypes B, C and F in Buenos Aires, Argentina","Pando,M.A., Eyzaguirre,L.M., Segura,M., Bautista,C.T., Marone,R., Ceballos,A., Montano,S.M., Sanchez,J.L., Weissenbacher,M., Avila,M.M. and Carr,J.K.",2006
DQ383750,B,2004,16959032,"First report of an HIV-1 triple recombinant of subtypes B, C and F in Buenos Aires, Argentina","Pando,M.A., Eyzaguirre,L.M., Segura,M., Bautista,C.T., Marone,R., Ceballos,A., Montano,S.M., Sanchez,J.L., Weissenbacher,M., Avila,M.M. and Carr,J.K.",2006
DQ383751,B,2004,16959032,"First report of an HIV-1 triple recombinant of subtypes B, C and F in Buenos Aires, Argentina","Pando,M.A., Eyzaguirre,L.M., Segura,M., Bautista,C.T., Marone,R., Ceballos,A., Montano,S.M., Sanchez,J.L., Weissenbacher,M., Avila,M.M. and Carr,J.K.",2006
DQ383752,B,2004,16959032,"First report of an HIV-1 triple recombinant of subtypes B, C and F in Buenos Aires, Argentina","Pando,M.A., Eyzaguirre,L.M., Segura,M., Bautista,C.T., Marone,R., Ceballos,A., Montano,S.M., Sanchez,J.L., Weissenbacher,M., Avila,M.M. and Carr,J.K.",2006
DQ383753,BF1,2004,16959032,"First report of an HIV-1 triple recombinant of subtypes B, C and F in Buenos Aires, Argentina","Pando,M.A., Eyzaguirre,L.M., Segura,M., Bautista,C.T., Marone,R., Ceballos,A., Montano,S.M., Sanchez,J.L., Weissenbacher,M., Avila,M.M. and Carr,J.K.",2006
DQ383754,BCF1,2004,16959032,"First report of an HIV-1 triple recombinant of subtypes B, C and F in Buenos Aires, Argentina","Pando,M.A., Eyzaguirre,L.M., Segura,M., Bautista,C.T., Marone,R., Ceballos,A., Montano,S.M., Sanchez,J.L., Weissenbacher,M., Avila,M.M. and Carr,J.K.",2006
DQ383755,BF1,2005,16959032,"First report of an HIV-1 triple recombinant of subtypes B, C and F in Buenos Aires, Argentina","Pando,M.A., Eyzaguirre,L.M., Segura,M., Bautista,C.T., Marone,R., Ceballos,A., Montano,S.M., Sanchez,J.L., Weissenbacher,M., Avila,M.M. and Carr,J.K.",2006
DQ388514,C,2003,16971434,Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa,"Li,M., Salazar-Gonzalez,J.F., Derdeyn,C.A., Morris,L., Williamson,C., Robinson,J.E., Decker,J.M., Li,Y., Salazar,M.G., Polonis,V.R., Mlisana,K., Karim,S.A., Hong,K., Greene,K.M., Bilska,M., Zhou,J., Allen,S., Chomba,E., Mulenga,J., Vwalika,C., Gao,F., Zhang,M., Korber,B.T., Hunter,E., Hahn,B.H. and Montefiori,D.C.",2006
DQ388515,C,2002,16971434,Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa,"Li,M., Salazar-Gonzalez,J.F., Derdeyn,C.A., Morris,L., Williamson,C., Robinson,J.E., Decker,J.M., Li,Y., Salazar,M.G., Polonis,V.R., Mlisana,K., Karim,S.A., Hong,K., Greene,K.M., Bilska,M., Zhou,J., Allen,S., Chomba,E., Mulenga,J., Vwalika,C., Gao,F., Zhang,M., Korber,B.T., Hunter,E., Hahn,B.H. and Montefiori,D.C.",2006
DQ388516,C,2003,16971434,Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa,"Li,M., Salazar-Gonzalez,J.F., Derdeyn,C.A., Morris,L., Williamson,C., Robinson,J.E., Decker,J.M., Li,Y., Salazar,M.G., Polonis,V.R., Mlisana,K., Karim,S.A., Hong,K., Greene,K.M., Bilska,M., Zhou,J., Allen,S., Chomba,E., Mulenga,J., Vwalika,C., Gao,F., Zhang,M., Korber,B.T., Hunter,E., Hahn,B.H. and Montefiori,D.C.",2006
DQ388517,C,2002,16971434,Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa,"Li,M., Salazar-Gonzalez,J.F., Derdeyn,C.A., Morris,L., Williamson,C., Robinson,J.E., Decker,J.M., Li,Y., Salazar,M.G., Polonis,V.R., Mlisana,K., Karim,S.A., Hong,K., Greene,K.M., Bilska,M., Zhou,J., Allen,S., Chomba,E., Mulenga,J., Vwalika,C., Gao,F., Zhang,M., Korber,B.T., Hunter,E., Hahn,B.H. and Montefiori,D.C.",2006
DQ396364,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ396365,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ396367,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ396368,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ396369,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ396370,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ396371,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ396372,C,2005,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ396373,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ396374,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ396375,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ396376,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ396377,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ396378,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ396380,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ396381,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ396382,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ396383,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ396384,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ396385,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ396386,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ396387,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ396388,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ396389,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ396390,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ396391,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ396392,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ396393,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ396394,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ396395,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ396398,B,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ396399,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ396400,A1,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ398881,C,,,HIV-1 Subtype C envelope gene,"Khan,I.Fatima., Vajpayee,M. and Seth,P.",
DQ400856,06_cpx,2005,,Sequencing and analysis of full-length HIV-1 CRF06_cpx isolate from Russia,"Galkin,A.N., Gagarina,E.Y. and Lukyanova,N.S.",
DQ401572,B,1999,,Constraints on HIV-1 evolution and immunodominance revealed in monozygotic adult twins infected with the same virus,"Draenert,R., Allen,T.M., Lui,Y., Wrin,T., Chappey,C., Verrill,C.L., Sirera,G., Eldridge,R.L., Lahaie,M.P., Ruiz,L., Clotet,B., Petropoulos,C.J., Walker,B.D. and Martinez-Picado,J.",
DQ401599,B,1999,,Constraints on HIV-1 evolution and immunodominance revealed in monozygotic adult twins infected with the same virus,"Draenert,R., Allen,T.M., Lui,Y., Wrin,T., Chappey,C., Verrill,C.L., Sirera,G., Eldridge,R.L., Lahaie,M.P., Ruiz,L., Clotet,B., Petropoulos,C.J., Walker,B.D. and Martinez-Picado,J.",
DQ401638,B,2000,,Constraints on HIV-1 evolution and immunodominance revealed in monozygotic adult twins infected with the same virus,"Draenert,R., Allen,T.M., Lui,Y., Wrin,T., Chappey,C., Verrill,C.L., Sirera,G., Eldridge,R.L., Lahaie,M.P., Ruiz,L., Clotet,B., Petropoulos,C.J., Walker,B.D. and Martinez-Picado,J.",
DQ404010,C,,,"Characterization of envelope gene of HIV-1 strain from Calcutta, India","Bhanja,P. and Chakrabarti,S.",
DQ410040,B,2004,16641269,Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy,"Bailey,J.R., Lassen,K.G., Yang,H.C., Quinn,T.C., Ray,S.C., Blankson,J.N. and Siliciano,R.F.",2006
DQ410062,B,2004,16641269,Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy,"Bailey,J.R., Lassen,K.G., Yang,H.C., Quinn,T.C., Ray,S.C., Blankson,J.N. and Siliciano,R.F.",2006
DQ410069,B,2004,16641269,Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy,"Bailey,J.R., Lassen,K.G., Yang,H.C., Quinn,T.C., Ray,S.C., Blankson,J.N. and Siliciano,R.F.",2006
DQ410087,B,2004,16641269,Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy,"Bailey,J.R., Lassen,K.G., Yang,H.C., Quinn,T.C., Ray,S.C., Blankson,J.N. and Siliciano,R.F.",2006
DQ410101,B,2004,16641269,Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy,"Bailey,J.R., Lassen,K.G., Yang,H.C., Quinn,T.C., Ray,S.C., Blankson,J.N. and Siliciano,R.F.",2006
DQ410109,B,2005,16641269,Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy,"Bailey,J.R., Lassen,K.G., Yang,H.C., Quinn,T.C., Ray,S.C., Blankson,J.N. and Siliciano,R.F.",2006
DQ410129,B,2005,16641269,Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy,"Bailey,J.R., Lassen,K.G., Yang,H.C., Quinn,T.C., Ray,S.C., Blankson,J.N. and Siliciano,R.F.",2006
DQ410179,B,2004,16641269,Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy,"Bailey,J.R., Lassen,K.G., Yang,H.C., Quinn,T.C., Ray,S.C., Blankson,J.N. and Siliciano,R.F.",2006
DQ410217,B,2004,16641269,Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy,"Bailey,J.R., Lassen,K.G., Yang,H.C., Quinn,T.C., Ray,S.C., Blankson,J.N. and Siliciano,R.F.",2006
DQ410226,B,2004,16641269,Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy,"Bailey,J.R., Lassen,K.G., Yang,H.C., Quinn,T.C., Ray,S.C., Blankson,J.N. and Siliciano,R.F.",2006
DQ410243,B,2004,16641269,Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy,"Bailey,J.R., Lassen,K.G., Yang,H.C., Quinn,T.C., Ray,S.C., Blankson,J.N. and Siliciano,R.F.",2006
DQ410284,B,2004,16641269,Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy,"Bailey,J.R., Lassen,K.G., Yang,H.C., Quinn,T.C., Ray,S.C., Blankson,J.N. and Siliciano,R.F.",2006
DQ410323,B,2005,16641269,Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy,"Bailey,J.R., Lassen,K.G., Yang,H.C., Quinn,T.C., Ray,S.C., Blankson,J.N. and Siliciano,R.F.",2006
DQ410369,B,2005,16641269,Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy,"Bailey,J.R., Lassen,K.G., Yang,H.C., Quinn,T.C., Ray,S.C., Blankson,J.N. and Siliciano,R.F.",2006
DQ410404,B,2005,16641269,Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy,"Bailey,J.R., Lassen,K.G., Yang,H.C., Quinn,T.C., Ray,S.C., Blankson,J.N. and Siliciano,R.F.",2006
DQ410424,B,2003,16641269,Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy,"Bailey,J.R., Lassen,K.G., Yang,H.C., Quinn,T.C., Ray,S.C., Blankson,J.N. and Siliciano,R.F.",2006
DQ410479,B,2004,16641269,Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy,"Bailey,J.R., Lassen,K.G., Yang,H.C., Quinn,T.C., Ray,S.C., Blankson,J.N. and Siliciano,R.F.",2006
DQ410511,B,2004,16641269,Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy,"Bailey,J.R., Lassen,K.G., Yang,H.C., Quinn,T.C., Ray,S.C., Blankson,J.N. and Siliciano,R.F.",2006
DQ410527,B,2004,16641269,Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy,"Bailey,J.R., Lassen,K.G., Yang,H.C., Quinn,T.C., Ray,S.C., Blankson,J.N. and Siliciano,R.F.",2006
DQ410528,B,2004,16641269,Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy,"Bailey,J.R., Lassen,K.G., Yang,H.C., Quinn,T.C., Ray,S.C., Blankson,J.N. and Siliciano,R.F.",2006
DQ410542,B,2005,16641269,Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy,"Bailey,J.R., Lassen,K.G., Yang,H.C., Quinn,T.C., Ray,S.C., Blankson,J.N. and Siliciano,R.F.",2006
DQ410560,B,2005,16641269,Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy,"Bailey,J.R., Lassen,K.G., Yang,H.C., Quinn,T.C., Ray,S.C., Blankson,J.N. and Siliciano,R.F.",2006
DQ410573,B,2005,16641269,Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy,"Bailey,J.R., Lassen,K.G., Yang,H.C., Quinn,T.C., Ray,S.C., Blankson,J.N. and Siliciano,R.F.",2006
DQ410588,B,2005,16641269,Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy,"Bailey,J.R., Lassen,K.G., Yang,H.C., Quinn,T.C., Ray,S.C., Blankson,J.N. and Siliciano,R.F.",2006
DQ410607,B,2005,16641269,Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy,"Bailey,J.R., Lassen,K.G., Yang,H.C., Quinn,T.C., Ray,S.C., Blankson,J.N. and Siliciano,R.F.",2006
DQ410619,B,2004,16641269,Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy,"Bailey,J.R., Lassen,K.G., Yang,H.C., Quinn,T.C., Ray,S.C., Blankson,J.N. and Siliciano,R.F.",2006
DQ411853,C,1998,16971434,Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa,"Li,M., Salazar-Gonzalez,J.F., Derdeyn,C.A., Morris,L., Williamson,C., Robinson,J.E., Decker,J.M., Li,Y., Salazar,M.G., Polonis,V.R., Mlisana,K., Karim,S.A., Hong,K., Greene,K.M., Bilska,M., Zhou,J., Allen,S., Chomba,E., Mulenga,J., Vwalika,C., Gao,F., Zhang,M., Korber,B.T., Hunter,E., Hahn,B.H. and Montefiori,D.C.",2006
DQ422948,C,2002,16971434,Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa,"Li,M., Salazar-Gonzalez,J.F., Derdeyn,C.A., Morris,L., Williamson,C., Robinson,J.E., Decker,J.M., Li,Y., Salazar,M.G., Polonis,V.R., Mlisana,K., Karim,S.A., Hong,K., Greene,K.M., Bilska,M., Zhou,J., Allen,S., Chomba,E., Mulenga,J., Vwalika,C., Gao,F., Zhang,M., Korber,B.T., Hunter,E., Hahn,B.H. and Montefiori,D.C.",2006
DQ435682,C,2005,16971434,Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa,"Li,M., Salazar-Gonzalez,J.F., Derdeyn,C.A., Morris,L., Williamson,C., Robinson,J.E., Decker,J.M., Li,Y., Salazar,M.G., Polonis,V.R., Mlisana,K., Karim,S.A., Hong,K., Greene,K.M., Bilska,M., Zhou,J., Allen,S., Chomba,E., Mulenga,J., Vwalika,C., Gao,F., Zhang,M., Korber,B.T., Hunter,E., Hahn,B.H. and Montefiori,D.C.",2006
DQ435683,C,2005,16971434,Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa,"Li,M., Salazar-Gonzalez,J.F., Derdeyn,C.A., Morris,L., Williamson,C., Robinson,J.E., Decker,J.M., Li,Y., Salazar,M.G., Polonis,V.R., Mlisana,K., Karim,S.A., Hong,K., Greene,K.M., Bilska,M., Zhou,J., Allen,S., Chomba,E., Mulenga,J., Vwalika,C., Gao,F., Zhang,M., Korber,B.T., Hunter,E., Hahn,B.H. and Montefiori,D.C.",2006
DQ435684,C,2005,16971434,Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa,"Li,M., Salazar-Gonzalez,J.F., Derdeyn,C.A., Morris,L., Williamson,C., Robinson,J.E., Decker,J.M., Li,Y., Salazar,M.G., Polonis,V.R., Mlisana,K., Karim,S.A., Hong,K., Greene,K.M., Bilska,M., Zhou,J., Allen,S., Chomba,E., Mulenga,J., Vwalika,C., Gao,F., Zhang,M., Korber,B.T., Hunter,E., Hahn,B.H. and Montefiori,D.C.",2006
DQ444258,B,,16699001,Evidence for potent autologous neutralizing antibody titers and compact envelopes in early infection with subtype C human immunodeficiency virus type 1,"Li,B., Decker,J.M., Johnson,R.W., Bibollet-Ruche,F., Wei,X., Mulenga,J., Allen,S., Hunter,E., Hahn,B.H., Shaw,G.M., Blackwell,J.L. and Derdeyn,C.A.",2006
DQ444260,B,,16699001,Evidence for potent autologous neutralizing antibody titers and compact envelopes in early infection with subtype C human immunodeficiency virus type 1,"Li,B., Decker,J.M., Johnson,R.W., Bibollet-Ruche,F., Wei,X., Mulenga,J., Allen,S., Hunter,E., Hahn,B.H., Shaw,G.M., Blackwell,J.L. and Derdeyn,C.A.",2006
DQ445632,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ445633,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ445634,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ445635,C,2003,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ445636,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ445637,C,2004,16701907,"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","Rousseau,C.M., Birditt,B.A., McKay,A.R., Stoddard,J.N., Lee,T.C., McLaughlin,S., Moore,S.W., Shindo,N., Learn,G.H., Korber,B.T., Brander,C., Goulder,P.J., Kiepiela,P., Walker,B.D. and Mullins,J.I.",2006
DQ447266,C,1999,16834457,Insensitivity of paediatric HIV-1 subtype C viruses to broadly neutralising monoclonal antibodies raised against subtype B,"Gray,E.S., Meyers,T., Gray,G., Montefiori,D.C. and Morris,L.",2006
DQ447267,C,1999,16834457,Insensitivity of paediatric HIV-1 subtype C viruses to broadly neutralising monoclonal antibodies raised against subtype B,"Gray,E.S., Meyers,T., Gray,G., Montefiori,D.C. and Morris,L.",2006
DQ447268,C,1999,16834457,Insensitivity of paediatric HIV-1 subtype C viruses to broadly neutralising monoclonal antibodies raised against subtype B,"Gray,E.S., Meyers,T., Gray,G., Montefiori,D.C. and Morris,L.",2006
DQ447269,C,2002,16834457,Insensitivity of paediatric HIV-1 subtype C viruses to broadly neutralising monoclonal antibodies raised against subtype B,"Gray,E.S., Meyers,T., Gray,G., Montefiori,D.C. and Morris,L.",2006
DQ447270,C,2002,16834457,Insensitivity of paediatric HIV-1 subtype C viruses to broadly neutralising monoclonal antibodies raised against subtype B,"Gray,E.S., Meyers,T., Gray,G., Montefiori,D.C. and Morris,L.",2006
DQ447272,C,1999,16834457,Insensitivity of paediatric HIV-1 subtype C viruses to broadly neutralising monoclonal antibodies raised against subtype B,"Gray,E.S., Meyers,T., Gray,G., Montefiori,D.C. and Morris,L.",2006
DQ448819,B,,,Genetic and functional analysis of HIV-1 envelope from long-term non-progressors,"Martinez-Prats,L. and Delgado,R.",
DQ487188,B,1993,17331038,Genomic analysis of HIV type 1 strains derived from a mother and child pair of long-term nonprogressors,"Reinis,M., Weiser,B., Kuiken,C., Dong,T., Lang,D., Nachman,S., Zhang,Y., Rowland-Jones,S. and Burger,H.",2007
DQ487190,B,1993,17331038,Genomic analysis of HIV type 1 strains derived from a mother and child pair of long-term nonprogressors,"Reinis,M., Weiser,B., Kuiken,C., Dong,T., Lang,D., Nachman,S., Zhang,Y., Rowland-Jones,S. and Burger,H.",2007
DQ518410,01_AE,,19303619,Maternal neutralizing antibodies against a CRF01_AE primary isolate are associated with a low rate of intrapartum HIV-1 transmission,"Samleerat,T., Thenin,S., Jourdain,G., Ngo-Giang-Huong,N., Moreau,A., Leechanachai,P., Ithisuknanth,J., Pagdi,K., Wannarit,P., Sangsawang,S., Lallemant,M., Barin,F. and Braibant,M.",2009
DQ518411,01_AE,,19303619,Maternal neutralizing antibodies against a CRF01_AE primary isolate are associated with a low rate of intrapartum HIV-1 transmission,"Samleerat,T., Thenin,S., Jourdain,G., Ngo-Giang-Huong,N., Moreau,A., Leechanachai,P., Ithisuknanth,J., Pagdi,K., Wannarit,P., Sangsawang,S., Lallemant,M., Barin,F. and Braibant,M.",2009
DQ518412,01_AE,1994,19303619,Maternal neutralizing antibodies against a CRF01_AE primary isolate are associated with a low rate of intrapartum HIV-1 transmission,"Samleerat,T., Thenin,S., Jourdain,G., Ngo-Giang-Huong,N., Moreau,A., Leechanachai,P., Ithisuknanth,J., Pagdi,K., Wannarit,P., Sangsawang,S., Lallemant,M., Barin,F. and Braibant,M.",2009
DQ672623,B,2005,16987968,Entire genome of a strain of human immunodeficiency virus type 1 with a deletion of nef that was recovered 20 years after primary infection: large pool of proviruses with deletions of env,"Calugi,G., Montella,F., Favalli,C. and Benedetto,A.",2006
DQ676870,B,2003,17065207,Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution,"Li,B., Gladden,A.D., Altfeld,M., Kaldor,J.M., Cooper,D.A., Kelleher,A.D. and Allen,T.M.",2007
DQ676872,A1,2003,17065207,Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution,"Li,B., Gladden,A.D., Altfeld,M., Kaldor,J.M., Cooper,D.A., Kelleher,A.D. and Allen,T.M.",2007
DQ676874,B,2002,17065207,Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution,"Li,B., Gladden,A.D., Altfeld,M., Kaldor,J.M., Cooper,D.A., Kelleher,A.D. and Allen,T.M.",2007
DQ676877,B,2003,17065207,Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution,"Li,B., Gladden,A.D., Altfeld,M., Kaldor,J.M., Cooper,D.A., Kelleher,A.D. and Allen,T.M.",2007
DQ676880,B,2003,17065207,Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution,"Li,B., Gladden,A.D., Altfeld,M., Kaldor,J.M., Cooper,D.A., Kelleher,A.D. and Allen,T.M.",2007
DQ676883,B,2002,17065207,Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution,"Li,B., Gladden,A.D., Altfeld,M., Kaldor,J.M., Cooper,D.A., Kelleher,A.D. and Allen,T.M.",2007
DQ676886,B,2003,17065207,Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution,"Li,B., Gladden,A.D., Altfeld,M., Kaldor,J.M., Cooper,D.A., Kelleher,A.D. and Allen,T.M.",2007
DQ823356,A6,2001,16910825,Molecular Epidemiology of HIV Type 1 in Ukraine: Birthplace of an Epidemic,"Saad,M.D., Shcherbinskaya,A.M., Nadai,Y., Kruglov,Y.V., Antonenko,S.V., Lyulchuk,M.G., Kravchenko,O.N., Earhart,K.C., Sanchez,J.L., Brix,D.L. and Carr,J.K.",2006
DQ823357,A6,2001,16910825,Molecular Epidemiology of HIV Type 1 in Ukraine: Birthplace of an Epidemic,"Saad,M.D., Shcherbinskaya,A.M., Nadai,Y., Kruglov,Y.V., Antonenko,S.V., Lyulchuk,M.G., Kravchenko,O.N., Earhart,K.C., Sanchez,J.L., Brix,D.L. and Carr,J.K.",2006
DQ823358,A6,2001,16910825,Molecular Epidemiology of HIV Type 1 in Ukraine: Birthplace of an Epidemic,"Saad,M.D., Shcherbinskaya,A.M., Nadai,Y., Kruglov,Y.V., Antonenko,S.V., Lyulchuk,M.G., Kravchenko,O.N., Earhart,K.C., Sanchez,J.L., Brix,D.L. and Carr,J.K.",2006
DQ823359,A6,2001,16910825,Molecular Epidemiology of HIV Type 1 in Ukraine: Birthplace of an Epidemic,"Saad,M.D., Shcherbinskaya,A.M., Nadai,Y., Kruglov,Y.V., Antonenko,S.V., Lyulchuk,M.G., Kravchenko,O.N., Earhart,K.C., Sanchez,J.L., Brix,D.L. and Carr,J.K.",2006
DQ823360,A6,2001,16910825,Molecular Epidemiology of HIV Type 1 in Ukraine: Birthplace of an Epidemic,"Saad,M.D., Shcherbinskaya,A.M., Nadai,Y., Kruglov,Y.V., Antonenko,S.V., Lyulchuk,M.G., Kravchenko,O.N., Earhart,K.C., Sanchez,J.L., Brix,D.L. and Carr,J.K.",2006
DQ823361,A6,2001,16910825,Molecular Epidemiology of HIV Type 1 in Ukraine: Birthplace of an Epidemic,"Saad,M.D., Shcherbinskaya,A.M., Nadai,Y., Kruglov,Y.V., Antonenko,S.V., Lyulchuk,M.G., Kravchenko,O.N., Earhart,K.C., Sanchez,J.L., Brix,D.L. and Carr,J.K.",2006
DQ823362,B,2001,16910825,Molecular Epidemiology of HIV Type 1 in Ukraine: Birthplace of an Epidemic,"Saad,M.D., Shcherbinskaya,A.M., Nadai,Y., Kruglov,Y.V., Antonenko,S.V., Lyulchuk,M.G., Kravchenko,O.N., Earhart,K.C., Sanchez,J.L., Brix,D.L. and Carr,J.K.",2006
DQ823363,B,2001,16910825,Molecular Epidemiology of HIV Type 1 in Ukraine: Birthplace of an Epidemic,"Saad,M.D., Shcherbinskaya,A.M., Nadai,Y., Kruglov,Y.V., Antonenko,S.V., Lyulchuk,M.G., Kravchenko,O.N., Earhart,K.C., Sanchez,J.L., Brix,D.L. and Carr,J.K.",2006
DQ823364,B,2001,16910825,Molecular Epidemiology of HIV Type 1 in Ukraine: Birthplace of an Epidemic,"Saad,M.D., Shcherbinskaya,A.M., Nadai,Y., Kruglov,Y.V., Antonenko,S.V., Lyulchuk,M.G., Kravchenko,O.N., Earhart,K.C., Sanchez,J.L., Brix,D.L. and Carr,J.K.",2006
DQ823365,A6,2001,16910825,Molecular Epidemiology of HIV Type 1 in Ukraine: Birthplace of an Epidemic,"Saad,M.D., Shcherbinskaya,A.M., Nadai,Y., Kruglov,Y.V., Antonenko,S.V., Lyulchuk,M.G., Kravchenko,O.N., Earhart,K.C., Sanchez,J.L., Brix,D.L. and Carr,J.K.",2006
DQ823366,A6,2001,16910825,Molecular Epidemiology of HIV Type 1 in Ukraine: Birthplace of an Epidemic,"Saad,M.D., Shcherbinskaya,A.M., Nadai,Y., Kruglov,Y.V., Antonenko,S.V., Lyulchuk,M.G., Kravchenko,O.N., Earhart,K.C., Sanchez,J.L., Brix,D.L. and Carr,J.K.",2006
DQ823367,A6,2001,16910825,Molecular Epidemiology of HIV Type 1 in Ukraine: Birthplace of an Epidemic,"Saad,M.D., Shcherbinskaya,A.M., Nadai,Y., Kruglov,Y.V., Antonenko,S.V., Lyulchuk,M.G., Kravchenko,O.N., Earhart,K.C., Sanchez,J.L., Brix,D.L. and Carr,J.K.",2006
DQ837381,B,2005,23199052,Phylogenetic Analysis of Near Full-Length HIV Type 1 Genomic Sequences from 21 Korean Individuals,"Cho,Y.K., Kim,J.E. and Foley,B.T.",2013
DQ853426,B,1998,16973556,Selection on the human immunodeficiency virus type 1 proteome following primary infection,"Liu,Y., McNevin,J., Cao,J., Zhao,H., Genowati,I., Wong,K., McLaughlin,S., McSweyn,M.D., Diem,K., Stevens,C.E., Maenza,J., He,H., Nickle,D.C., Shriner,D., Holte,S.E., Collier,A.C., Corey,L., McElrath,M.J. and Mullins,J.I.",2006
DQ853455,B,1998,16973556,Selection on the human immunodeficiency virus type 1 proteome following primary infection,"Liu,Y., McNevin,J., Cao,J., Zhao,H., Genowati,I., Wong,K., McLaughlin,S., McSweyn,M.D., Diem,K., Stevens,C.E., Maenza,J., He,H., Nickle,D.C., Shriner,D., Holte,S.E., Collier,A.C., Corey,L., McElrath,M.J. and Mullins,J.I.",2006
DQ859178,01_AE,2005,17042975,"Genetic characterization of three CRF01_AE full-length HIV type 1 sequences from Fujian Province, China","Huang,H.L., Yan,P.P., Zheng,J., Wu,S.L., Cheng,G., Lin,X., Zheng,W.X., Xie,M.R., Zhang,J.M. and Yan,Y.S.",2006
DQ859179,01_AE,2005,17042975,"Genetic characterization of three CRF01_AE full-length HIV type 1 sequences from Fujian Province, China","Huang,H.L., Yan,P.P., Zheng,J., Wu,S.L., Cheng,G., Lin,X., Zheng,W.X., Xie,M.R., Zhang,J.M. and Yan,Y.S.",2006
DQ859180,01_AE,2006,17042975,"Genetic characterization of three CRF01_AE full-length HIV type 1 sequences from Fujian Province, China","Huang,H.L., Yan,P.P., Zheng,J., Wu,S.L., Cheng,G., Lin,X., Zheng,W.X., Xie,M.R., Zhang,J.M. and Yan,Y.S.",2006
DQ869014,B,2001,,Development of an HIV-1 Reference Panel of Recombinant Viruses that Express Envelope Proteins Derived from Recently Transmitted Subtype B Isolates,"Schweighardt,B., Liu,Y., Huang,W., Chappey,C., Lie,Y.S., Petropoulos,C.J. and Wrin,T.",
DQ869015,B,2004,,Development of an HIV-1 Reference Panel of Recombinant Viruses that Express Envelope Proteins Derived from Recently Transmitted Subtype B Isolates,"Schweighardt,B., Liu,Y., Huang,W., Chappey,C., Lie,Y.S., Petropoulos,C.J. and Wrin,T.",
DQ869016,B,2003,,Development of an HIV-1 Reference Panel of Recombinant Viruses that Express Envelope Proteins Derived from Recently Transmitted Subtype B Isolates,"Schweighardt,B., Liu,Y., Huang,W., Chappey,C., Lie,Y.S., Petropoulos,C.J. and Wrin,T.",
DQ869017,B,2001,,Development of an HIV-1 Reference Panel of Recombinant Viruses that Express Envelope Proteins Derived from Recently Transmitted Subtype B Isolates,"Schweighardt,B., Liu,Y., Huang,W., Chappey,C., Lie,Y.S., Petropoulos,C.J. and Wrin,T.",
DQ869018,02_AG,2001,,Development of an HIV-1 Reference Panel of Recombinant Viruses that Express Envelope Proteins Derived from Recently Transmitted Subtype B Isolates,"Schweighardt,B., Liu,Y., Huang,W., Chappey,C., Lie,Y.S., Petropoulos,C.J. and Wrin,T.",
DQ869019,B,2001,,Development of an HIV-1 Reference Panel of Recombinant Viruses that Express Envelope Proteins Derived from Recently Transmitted Subtype B Isolates,"Schweighardt,B., Liu,Y., Huang,W., Chappey,C., Lie,Y.S., Petropoulos,C.J. and Wrin,T.",
DQ869020,B,2002,,Development of an HIV-1 Reference Panel of Recombinant Viruses that Express Envelope Proteins Derived from Recently Transmitted Subtype B Isolates,"Schweighardt,B., Liu,Y., Huang,W., Chappey,C., Lie,Y.S., Petropoulos,C.J. and Wrin,T.",
DQ869021,B,2002,,Development of an HIV-1 Reference Panel of Recombinant Viruses that Express Envelope Proteins Derived from Recently Transmitted Subtype B Isolates,"Schweighardt,B., Liu,Y., Huang,W., Chappey,C., Lie,Y.S., Petropoulos,C.J. and Wrin,T.",
DQ869022,B,2002,,Development of an HIV-1 Reference Panel of Recombinant Viruses that Express Envelope Proteins Derived from Recently Transmitted Subtype B Isolates,"Schweighardt,B., Liu,Y., Huang,W., Chappey,C., Lie,Y.S., Petropoulos,C.J. and Wrin,T.",
DQ869023,B,2002,,Development of an HIV-1 Reference Panel of Recombinant Viruses that Express Envelope Proteins Derived from Recently Transmitted Subtype B Isolates,"Schweighardt,B., Liu,Y., Huang,W., Chappey,C., Lie,Y.S., Petropoulos,C.J. and Wrin,T.",
DQ869024,B,2003,,Development of an HIV-1 Reference Panel of Recombinant Viruses that Express Envelope Proteins Derived from Recently Transmitted Subtype B Isolates,"Schweighardt,B., Liu,Y., Huang,W., Chappey,C., Lie,Y.S., Petropoulos,C.J. and Wrin,T.",
DQ869025,B,2003,,Development of an HIV-1 Reference Panel of Recombinant Viruses that Express Envelope Proteins Derived from Recently Transmitted Subtype B Isolates,"Schweighardt,B., Liu,Y., Huang,W., Chappey,C., Lie,Y.S., Petropoulos,C.J. and Wrin,T.",
DQ869026,B,2000,,Development of an HIV-1 Reference Panel of Recombinant Viruses that Express Envelope Proteins Derived from Recently Transmitted Subtype B Isolates,"Schweighardt,B., Liu,Y., Huang,W., Chappey,C., Lie,Y.S., Petropoulos,C.J. and Wrin,T.",
DQ869027,B,2001,,Development of an HIV-1 Reference Panel of Recombinant Viruses that Express Envelope Proteins Derived from Recently Transmitted Subtype B Isolates,"Schweighardt,B., Liu,Y., Huang,W., Chappey,C., Lie,Y.S., Petropoulos,C.J. and Wrin,T.",
DQ869028,B,2001,,Development of an HIV-1 Reference Panel of Recombinant Viruses that Express Envelope Proteins Derived from Recently Transmitted Subtype B Isolates,"Schweighardt,B., Liu,Y., Huang,W., Chappey,C., Lie,Y.S., Petropoulos,C.J. and Wrin,T.",
DQ869029,B,2003,,Development of an HIV-1 Reference Panel of Recombinant Viruses that Express Envelope Proteins Derived from Recently Transmitted Subtype B Isolates,"Schweighardt,B., Liu,Y., Huang,W., Chappey,C., Lie,Y.S., Petropoulos,C.J. and Wrin,T.",
DQ869030,B,2003,,Development of an HIV-1 Reference Panel of Recombinant Viruses that Express Envelope Proteins Derived from Recently Transmitted Subtype B Isolates,"Schweighardt,B., Liu,Y., Huang,W., Chappey,C., Lie,Y.S., Petropoulos,C.J. and Wrin,T.",
DQ869031,B,2003,,Development of an HIV-1 Reference Panel of Recombinant Viruses that Express Envelope Proteins Derived from Recently Transmitted Subtype B Isolates,"Schweighardt,B., Liu,Y., Huang,W., Chappey,C., Lie,Y.S., Petropoulos,C.J. and Wrin,T.",
DQ869032,B,2003,,Development of an HIV-1 Reference Panel of Recombinant Viruses that Express Envelope Proteins Derived from Recently Transmitted Subtype B Isolates,"Schweighardt,B., Liu,Y., Huang,W., Chappey,C., Lie,Y.S., Petropoulos,C.J. and Wrin,T.",
DQ869033,B,2004,,Development of an HIV-1 Reference Panel of Recombinant Viruses that Express Envelope Proteins Derived from Recently Transmitted Subtype B Isolates,"Schweighardt,B., Liu,Y., Huang,W., Chappey,C., Lie,Y.S., Petropoulos,C.J. and Wrin,T.",
DQ886034,B,,17982054,Increased sequence diversity coverage improves detection of HIV-specific T cell responses,"Frahm,N., Kaufmann,D.E., Yusim,K., Muldoon,M., Kesmir,C., Linde,C.H., Fischer,W., Allen,T.M., Li,B., McMahon,B.H., Faircloth,K.L., Hewitt,H.S., Mackey,E.W., Miura,T., Khatri,A., Wolinsky,S., McMichael,A., Funkhouser,R.K., Walker,B.D., Brander,C. and Korber,B.T.",2007
DQ886037,B,2005,17982054,Increased sequence diversity coverage improves detection of HIV-specific T cell responses,"Frahm,N., Kaufmann,D.E., Yusim,K., Muldoon,M., Kesmir,C., Linde,C.H., Fischer,W., Allen,T.M., Li,B., McMahon,B.H., Faircloth,K.L., Hewitt,H.S., Mackey,E.W., Miura,T., Khatri,A., Wolinsky,S., McMichael,A., Funkhouser,R.K., Walker,B.D., Brander,C. and Korber,B.T.",2007
DQ886038,AKU,,17982054,Increased sequence diversity coverage improves detection of HIV-specific T cell responses,"Frahm,N., Kaufmann,D.E., Yusim,K., Muldoon,M., Kesmir,C., Linde,C.H., Fischer,W., Allen,T.M., Li,B., McMahon,B.H., Faircloth,K.L., Hewitt,H.S., Mackey,E.W., Miura,T., Khatri,A., Wolinsky,S., McMichael,A., Funkhouser,R.K., Walker,B.D., Brander,C. and Korber,B.T.",2007
DQ890515,B,,17015824,The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia,"Dunfee,R.L., Thomas,E.R., Gorry,P.R., Wang,J., Taylor,J., Kunstman,K., Wolinsky,S.M. and Gabuzda,D.",2006
DQ904348,C,1998,17331039,Longitudinal analysis of HIV type 1 subtype C envelope sequences from South Africa,"Coetzer,M., Cilliers,T., Papathanasopoulos,M., Ramjee,G., Karim,S.A., Williamson,C. and Morris,L.",2007
DQ912822,A1D,1996,18373434,Full-length characterization of A1/D intersubtype recombinant genomes from a therapy-induced HIV type 1 controller during acute infection and his noncontrolling partner,"Fomsgaard,A., Vinner,L., Therrien,D., Jorgensen,L.B., Nielsen,C., Mathiesen,L., Pedersen,C. and Corbet,S.",2008
DQ912823,A1D,1998,18373434,Full-length characterization of A1/D intersubtype recombinant genomes from a therapy-induced HIV type 1 controller during acute infection and his noncontrolling partner,"Fomsgaard,A., Vinner,L., Therrien,D., Jorgensen,L.B., Nielsen,C., Mathiesen,L., Pedersen,C. and Corbet,S.",2008
DQ926895,06_cpx,2001,18205216,Genetic characterization of complex inter-recombinant HIV-1 strains circulating in Spain and reliability of distinct rapid subtyping tools,"Holguin,A., Lospitao,E., Lopez,M., de Arellano,E.R., Pena,M.J., del Romero,J., Martin,C. and Soriano,V.",2008
DQ926896,06G,2001,18205216,Genetic characterization of complex inter-recombinant HIV-1 strains circulating in Spain and reliability of distinct rapid subtyping tools,"Holguin,A., Lospitao,E., Lopez,M., de Arellano,E.R., Pena,M.J., del Romero,J., Martin,C. and Soriano,V.",2008
DQ926897,0206A1,2001,18205216,Genetic characterization of complex inter-recombinant HIV-1 strains circulating in Spain and reliability of distinct rapid subtyping tools,"Holguin,A., Lospitao,E., Lopez,M., de Arellano,E.R., Pena,M.J., del Romero,J., Martin,C. and Soriano,V.",2008
DQ926898,06_cpx,2000,18205216,Genetic characterization of complex inter-recombinant HIV-1 strains circulating in Spain and reliability of distinct rapid subtyping tools,"Holguin,A., Lospitao,E., Lopez,M., de Arellano,E.R., Pena,M.J., del Romero,J., Martin,C. and Soriano,V.",2008
DQ926899,02B,1999,18205216,Genetic characterization of complex inter-recombinant HIV-1 strains circulating in Spain and reliability of distinct rapid subtyping tools,"Holguin,A., Lospitao,E., Lopez,M., de Arellano,E.R., Pena,M.J., del Romero,J., Martin,C. and Soriano,V.",2008
DQ976394,B,,17015824,The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia,"Dunfee,R.L., Thomas,E.R., Gorry,P.R., Wang,J., Taylor,J., Kunstman,K., Wolinsky,S.M. and Gabuzda,D.",2006
DQ979023,F1,,,Analysis of near full-length genome sequences of HIV-1 isolates of Romanian origin,"Sierra,M., Delgado,E., Munoz,M., Vega,Y., Vazquez de Parga,E., Carmona,R., Cuevas,M.T., Perez-Alvarez,L., Contreras,G., Corral,J., Ojea de Castro,R., Ocampo,A., Najera,R. and Thomson,M.M.",
DQ979024,F1,,,Analysis of near full-length genome sequences of HIV-1 isolates of Romanian origin,"Sierra,M., Delgado,E., Munoz,M., Vega,Y., Vazquez de Parga,E., Carmona,R., Cuevas,M.T., Perez-Alvarez,L., Contreras,G., Corral,J., Ojea de Castro,R., Ocampo,A., Najera,R. and Thomson,M.M.",
DQ979025,F1,,,Analysis of near full-length genome sequences of HIV-1 isolates of Romanian origin,"Sierra,M., Delgado,E., Munoz,M., Vega,Y., Vazquez de Parga,E., Carmona,R., Cuevas,M.T., Perez-Alvarez,L., Contreras,G., Corral,J., Ojea de Castro,R., Ocampo,A., Najera,R. and Thomson,M.M.",
DQ990880,B,2005,,"Construction and characterization of an infectious molecular clone of HIV-1 subtype B' isolated from Hubei Province, China","Tan,J., Zhang,W., Liu,P., Tong,X. and Yang,R.",
EF025168,A1G,2000,17607774,Quasispecies analysis of novel HIV-1 recombinants of subtypes A and G reveals no similarity to the mosaic structure of CRF02_AG,"Powell,R.L., Konings,F.A., Nanfack,A., Burda,S., Urbanski,M.M., Saa,D. and Nyambi,P.N.",2007
EF025323,A1G,2000,17607774,Quasispecies analysis of novel HIV-1 recombinants of subtypes A and G reveals no similarity to the mosaic structure of CRF02_AG,"Powell,R.L., Konings,F.A., Nanfack,A., Burda,S., Urbanski,M.M., Saa,D. and Nyambi,P.N.",2007
EF029066,U,1995,17411380,Characterization of An HIV-1 Group M Variant That Is Distinct from The Known Subtypes,"van der Hoek,L., Pollakis,G., Lukashov,V.V., Jebbink,M.F., Jeeninga,R.E., Bakker,M., Dukers,N., Jurriaans,S., Paxton,W.A., Back,N.K. and Berkhout,B.",2007
EF033657,B,,17050592,Impact of natural polymorphism within the gp41 cytoplasmic tail of human immunodeficiency virus type 1 on the intracellular distribution of envelope glycoproteins and viral assembly,"Lambele,M., Labrosse,B., Roch,E., Moreau,A., Verrier,B., Barin,F., Roingeard,P., Mammano,F. and Brand,D.",2007
EF033659,G,,17050592,Impact of natural polymorphism within the gp41 cytoplasmic tail of human immunodeficiency virus type 1 on the intracellular distribution of envelope glycoproteins and viral assembly,"Lambele,M., Labrosse,B., Roch,E., Moreau,A., Verrier,B., Barin,F., Roingeard,P., Mammano,F. and Brand,D.",2007
EF036527,01_AE,2005,17451347,"Genetic Characterization of CRF01_AE Full-Length Human Immunodeficiency Virus Type 1 Sequences from Fujian, China","Huang,H.L., Zheng,J., Yan,P.P., Cheng,L., Lin,X., Zhang,Z.S. and Yang,Y.S.",2007
EF036528,01_AE,2005,17451347,"Genetic Characterization of CRF01_AE Full-Length Human Immunodeficiency Virus Type 1 Sequences from Fujian, China","Huang,H.L., Zheng,J., Yan,P.P., Cheng,L., Lin,X., Zhang,Z.S. and Yang,Y.S.",2007
EF036529,01_AE,2005,17451347,"Genetic Characterization of CRF01_AE Full-Length Human Immunodeficiency Virus Type 1 Sequences from Fujian, China","Huang,H.L., Zheng,J., Yan,P.P., Cheng,L., Lin,X., Zhang,Z.S. and Yang,Y.S.",2007
EF036530,01_AE,2005,17451347,"Genetic Characterization of CRF01_AE Full-Length Human Immunodeficiency Virus Type 1 Sequences from Fujian, China","Huang,H.L., Zheng,J., Yan,P.P., Cheng,L., Lin,X., Zhang,Z.S. and Yang,Y.S.",2007
EF036531,01_AE,2006,17451347,"Genetic Characterization of CRF01_AE Full-Length Human Immunodeficiency Virus Type 1 Sequences from Fujian, China","Huang,H.L., Zheng,J., Yan,P.P., Cheng,L., Lin,X., Zhang,Z.S. and Yang,Y.S.",2007
EF036532,01_AE,2006,17451347,"Genetic Characterization of CRF01_AE Full-Length Human Immunodeficiency Virus Type 1 Sequences from Fujian, China","Huang,H.L., Zheng,J., Yan,P.P., Cheng,L., Lin,X., Zhang,Z.S. and Yang,Y.S.",2007
EF036533,01_AE,2006,17451347,"Genetic Characterization of CRF01_AE Full-Length Human Immunodeficiency Virus Type 1 Sequences from Fujian, China","Huang,H.L., Zheng,J., Yan,P.P., Cheng,L., Lin,X., Zhang,Z.S. and Yang,Y.S.",2007
EF036534,01_AE,2005,17451347,"Genetic Characterization of CRF01_AE Full-Length Human Immunodeficiency Virus Type 1 Sequences from Fujian, China","Huang,H.L., Zheng,J., Yan,P.P., Cheng,L., Lin,X., Zhang,Z.S. and Yang,Y.S.",2007
EF036535,01_AE,2005,17451347,"Genetic Characterization of CRF01_AE Full-Length Human Immunodeficiency Virus Type 1 Sequences from Fujian, China","Huang,H.L., Zheng,J., Yan,P.P., Cheng,L., Lin,X., Zhang,Z.S. and Yang,Y.S.",2007
EF036536,01_AE,2006,17451347,"Genetic Characterization of CRF01_AE Full-Length Human Immunodeficiency Virus Type 1 Sequences from Fujian, China","Huang,H.L., Zheng,J., Yan,P.P., Cheng,L., Lin,X., Zhang,Z.S. and Yang,Y.S.",2007
EF042692,BC,2004,,Human immunodeficiency virus type 1 CRF07_BC Env/Rev cassette clones from chronically infected individuals in China for use as Env-pseudotyped viruses in neutralizing antibody assays,"Hong,K., Tang,H., Montefiori,D. and Shao,Y.",
EF078278,C,2004,17396997,Molecular epidemiology of HIV-1 infection and full-length genomic analysis of circulating recombinant form 07_BC strains from injection drug users in Taiwan,"Lin,Y.T., Lan,Y.C., Chen,Y.J., Huang,Y.H., Lee,C.M., Liu,T.T., Wong,W.W., Yang,J.Y., Wang,C.T. and Chen,Y.M.",2007
EF078279,C,2004,17396997,Molecular epidemiology of HIV-1 infection and full-length genomic analysis of circulating recombinant form 07_BC strains from injection drug users in Taiwan,"Lin,Y.T., Lan,Y.C., Chen,Y.J., Huang,Y.H., Lee,C.M., Liu,T.T., Wong,W.W., Yang,J.Y., Wang,C.T. and Chen,Y.M.",2007
EF087994,36_cpx,2000,17725418,Identification of a novel circulating recombinant form (CRF) 36_cpx in Cameroon that combines two CRFs (01_AE and 02_AG) with ancestral lineages of subtypes A and G,"Powell,R.L., Zhao,J., Konings,F.A., Tang,S., Nanfack,A., Burda,S., Urbanski,M.M., Saa,D.R., Hewlett,I. and Nyambi,P.N.",2007
EF087995,36_cpx,2000,17725418,Identification of a novel circulating recombinant form (CRF) 36_cpx in Cameroon that combines two CRFs (01_AE and 02_AG) with ancestral lineages of subtypes A and G,"Powell,R.L., Zhao,J., Konings,F.A., Tang,S., Nanfack,A., Burda,S., Urbanski,M.M., Saa,D.R., Hewlett,I. and Nyambi,P.N.",2007
EF091932,31_BC,2002,17053347,Characterization of a new circulating recombinant form comprising HIV-1 subtypes C and B in southern Brazil,"Santos,A.F., Sousa,T.M., Soares,E.A., Sanabani,S., Martinez,A.M., Sprinz,E., Silveira,J., Sabino,E.C., Tanuri,A. and Soares,M.A.",2011
EF116594,37_cpx,2000,17678477,"Circulating Recombinant Form (CRF) 37_cpx: An Old Strain in Cameroon Composed of Diverse, Genetically Distant Lineages of Subtypes A and G","Powell,R.L., Zhao,J., Konings,F.A., Tang,S., Ewane,L., Burda,S., Urbanski,M.M., Saa,D.R., Hewlett,I. and Nyambi,P.N.",2007
EF117254,07_BC,2004,,Human immunodeficiency virus type 1 CRF07_BC Env/Rev cassette from chronically infected individuals in China for use as Env-pseudotyped viruses in neutralizing antibody assays,"Hong,K., Tang,H., Montefiori,D. and Shao,Y.",
EF117255,07_BC,2004,,Human immunodeficiency virus type 1 CRF07_BC Env/Rev cassette from chronically infected individuals in China for use as Env-pseudotyped viruses in neutralizing antibody assays,"Hong,K., Tang,H., Montefiori,D. and Shao,Y.",
EF117256,07_BC,2004,,Human immunodeficiency virus type 1 CRF07_BC Env/Rev cassette from chronically infected individuals in China for use as Env-pseudotyped viruses in neutralizing antibody assays,"Hong,K., Tang,H., Montefiori,D. and Shao,Y.",
EF117257,07_BC,2004,,Human immunodeficiency virus type 1 CRF07_BC Env/Rev cassette from chronically infected individuals in China for use as Env-pseudotyped viruses in neutralizing antibody assays,"Hong,K., Tang,H., Montefiori,D. and Shao,Y.",
EF117258,07_BC,2004,,Human immunodeficiency virus type 1 CRF07_BC Env/Rev cassette from chronically infected individuals in China for use as Env-pseudotyped viruses in neutralizing antibody assays,"Hong,K., Tang,H., Montefiori,D. and Shao,Y.",
EF117259,07_BC,2004,,Human immunodeficiency virus type 1 CRF07_BC Env/Rev cassette from chronically infected individuals in China for use as Env-pseudotyped viruses in neutralizing antibody assays,"Hong,K., Tang,H., Montefiori,D. and Shao,Y.",
EF117260,07_BC,2004,,Human immunodeficiency virus type 1 CRF07_BC Env/Rev cassette from chronically infected individuals in China for use as Env-pseudotyped viruses in neutralizing antibody assays,"Hong,K., Tang,H., Montefiori,D. and Shao,Y.",
EF117261,07_BC,2004,,Human immunodeficiency virus type 1 CRF07_BC Env/Rev cassette from chronically infected individuals in China for use as Env-pseudotyped viruses in neutralizing antibody assays,"Hong,K., Tang,H., Montefiori,D. and Shao,Y.",
EF117262,07_BC,2004,,Human immunodeficiency virus type 1 CRF07_BC Env/Rev cassette from chronically infected individuals in China for use as Env-pseudotyped viruses in neutralizing antibody assays,"Hong,K., Tang,H., Montefiori,D. and Shao,Y.",
EF117263,07_BC,2004,,Human immunodeficiency virus type 1 CRF07_BC Env/Rev cassette from chronically infected individuals in China for use as Env-pseudotyped viruses in neutralizing antibody assays,"Hong,K., Tang,H., Montefiori,D. and Shao,Y.",
EF117264,07_BC,2004,,Human immunodeficiency virus type 1 CRF07_BC Env/Rev cassette from chronically infected individuals in China for use as Env-pseudotyped viruses in neutralizing antibody assays,"Hong,K., Tang,H., Montefiori,D. and Shao,Y.",
EF117265,C,2000,19167740,Highly complex neutralization determinants on a monophyletic lineage of newly transmitted subtype C HIV-1 Env clones from India,"Kulkarni,S.S., Lapedes,A., Tang,H., Gnanakaran,S., Daniels,M.G., Zhang,M., Bhattacharya,T., Li,M., Polonis,V.R., McCutchan,F.E., Morris,L., Ellenberger,D., Butera,S.T., Bollinger,R.C., Korber,B.T., Paranjape,R.S. and Montefiori,D.C.",2009
EF117266,C,2000,19167740,Highly complex neutralization determinants on a monophyletic lineage of newly transmitted subtype C HIV-1 Env clones from India,"Kulkarni,S.S., Lapedes,A., Tang,H., Gnanakaran,S., Daniels,M.G., Zhang,M., Bhattacharya,T., Li,M., Polonis,V.R., McCutchan,F.E., Morris,L., Ellenberger,D., Butera,S.T., Bollinger,R.C., Korber,B.T., Paranjape,R.S. and Montefiori,D.C.",2009
EF117267,C,2000,19167740,Highly complex neutralization determinants on a monophyletic lineage of newly transmitted subtype C HIV-1 Env clones from India,"Kulkarni,S.S., Lapedes,A., Tang,H., Gnanakaran,S., Daniels,M.G., Zhang,M., Bhattacharya,T., Li,M., Polonis,V.R., McCutchan,F.E., Morris,L., Ellenberger,D., Butera,S.T., Bollinger,R.C., Korber,B.T., Paranjape,R.S. and Montefiori,D.C.",2009
EF117268,C,1999,19167740,Highly complex neutralization determinants on a monophyletic lineage of newly transmitted subtype C HIV-1 Env clones from India,"Kulkarni,S.S., Lapedes,A., Tang,H., Gnanakaran,S., Daniels,M.G., Zhang,M., Bhattacharya,T., Li,M., Polonis,V.R., McCutchan,F.E., Morris,L., Ellenberger,D., Butera,S.T., Bollinger,R.C., Korber,B.T., Paranjape,R.S. and Montefiori,D.C.",2009
EF117269,C,1999,19167740,Highly complex neutralization determinants on a monophyletic lineage of newly transmitted subtype C HIV-1 Env clones from India,"Kulkarni,S.S., Lapedes,A., Tang,H., Gnanakaran,S., Daniels,M.G., Zhang,M., Bhattacharya,T., Li,M., Polonis,V.R., McCutchan,F.E., Morris,L., Ellenberger,D., Butera,S.T., Bollinger,R.C., Korber,B.T., Paranjape,R.S. and Montefiori,D.C.",2009
EF117270,C,1999,19167740,Highly complex neutralization determinants on a monophyletic lineage of newly transmitted subtype C HIV-1 Env clones from India,"Kulkarni,S.S., Lapedes,A., Tang,H., Gnanakaran,S., Daniels,M.G., Zhang,M., Bhattacharya,T., Li,M., Polonis,V.R., McCutchan,F.E., Morris,L., Ellenberger,D., Butera,S.T., Bollinger,R.C., Korber,B.T., Paranjape,R.S. and Montefiori,D.C.",2009
EF117271,C,1999,19167740,Highly complex neutralization determinants on a monophyletic lineage of newly transmitted subtype C HIV-1 Env clones from India,"Kulkarni,S.S., Lapedes,A., Tang,H., Gnanakaran,S., Daniels,M.G., Zhang,M., Bhattacharya,T., Li,M., Polonis,V.R., McCutchan,F.E., Morris,L., Ellenberger,D., Butera,S.T., Bollinger,R.C., Korber,B.T., Paranjape,R.S. and Montefiori,D.C.",2009
EF117272,C,1999,19167740,Highly complex neutralization determinants on a monophyletic lineage of newly transmitted subtype C HIV-1 Env clones from India,"Kulkarni,S.S., Lapedes,A., Tang,H., Gnanakaran,S., Daniels,M.G., Zhang,M., Bhattacharya,T., Li,M., Polonis,V.R., McCutchan,F.E., Morris,L., Ellenberger,D., Butera,S.T., Bollinger,R.C., Korber,B.T., Paranjape,R.S. and Montefiori,D.C.",2009
EF117273,C,1999,19167740,Highly complex neutralization determinants on a monophyletic lineage of newly transmitted subtype C HIV-1 Env clones from India,"Kulkarni,S.S., Lapedes,A., Tang,H., Gnanakaran,S., Daniels,M.G., Zhang,M., Bhattacharya,T., Li,M., Polonis,V.R., McCutchan,F.E., Morris,L., Ellenberger,D., Butera,S.T., Bollinger,R.C., Korber,B.T., Paranjape,R.S. and Montefiori,D.C.",2009
EF117274,C,2000,19167740,Highly complex neutralization determinants on a monophyletic lineage of newly transmitted subtype C HIV-1 Env clones from India,"Kulkarni,S.S., Lapedes,A., Tang,H., Gnanakaran,S., Daniels,M.G., Zhang,M., Bhattacharya,T., Li,M., Polonis,V.R., McCutchan,F.E., Morris,L., Ellenberger,D., Butera,S.T., Bollinger,R.C., Korber,B.T., Paranjape,R.S. and Montefiori,D.C.",2009
EF121405,B,2001,,Transition from Long-Term Nonprogression to HIV-1 Disease Associated with Escape from Cellular Immune Control,"Kemal,K.S., Beattie,T., Dong,T., Weiser,B., Kuiken,C., Sutton,J., Lang,D., Yang,H., Peng,Y.C., Kaul,R., Collman,R., Philpott,S., Rowland-Jones,S. and Burger,H.",
EF125655,B,2003,17538883,Evolution of HIV-1 in an HLA-B*57-positive patient during virologic escape,"Bailey,J.R., Zhang,H., Wegweiser,B.W., Yang,H.C., Herrera,L., Ahonkhai,A., Williams,T.M., Siliciano,R.F. and Blankson,J.N.",2007
EF158040,35_AD,2005,17604548,"A Nascent HIV Type 1 Epidemic among Injecting Drug Users in Kabul, Afghanistan Is Dominated by Complex AD Recombinant Strain, CRF35_AD","Sanders-Buell,E., Saad,M.D., Abed,A.M., Bose,M., Todd,C.S., Strathdee,S.A., Botros,B.A., Safi,N., Earhart,K.C., Scott,P.T., Michael,N. and McCutchan,F.E.",2007
EF158041,35_AD,2005,17604548,"A Nascent HIV Type 1 Epidemic among Injecting Drug Users in Kabul, Afghanistan Is Dominated by Complex AD Recombinant Strain, CRF35_AD","Sanders-Buell,E., Saad,M.D., Abed,A.M., Bose,M., Todd,C.S., Strathdee,S.A., Botros,B.A., Safi,N., Earhart,K.C., Scott,P.T., Michael,N. and McCutchan,F.E.",2007
EF158042,35_AD,2005,17604548,"A Nascent HIV Type 1 Epidemic among Injecting Drug Users in Kabul, Afghanistan Is Dominated by Complex AD Recombinant Strain, CRF35_AD","Sanders-Buell,E., Saad,M.D., Abed,A.M., Bose,M., Todd,C.S., Strathdee,S.A., Botros,B.A., Safi,N., Earhart,K.C., Scott,P.T., Michael,N. and McCutchan,F.E.",2007
EF158043,35_AD,2005,17604548,"A Nascent HIV Type 1 Epidemic among Injecting Drug Users in Kabul, Afghanistan Is Dominated by Complex AD Recombinant Strain, CRF35_AD","Sanders-Buell,E., Saad,M.D., Abed,A.M., Bose,M., Todd,C.S., Strathdee,S.A., Botros,B.A., Safi,N., Earhart,K.C., Scott,P.T., Michael,N. and McCutchan,F.E.",2007
EF159970,B,1982,17978186,The emergence of HIV/AIDS in the Americas and beyond,"Gilbert,M.T., Rambaut,A., Wlasiuk,G., Spira,T.J., Pitchenik,A.E. and Worobey,M.",2007
EF159971,B,1982,17978186,The emergence of HIV/AIDS in the Americas and beyond,"Gilbert,M.T., Rambaut,A., Wlasiuk,G., Spira,T.J., Pitchenik,A.E. and Worobey,M.",2007
EF159972,B,1982,17978186,The emergence of HIV/AIDS in the Americas and beyond,"Gilbert,M.T., Rambaut,A., Wlasiuk,G., Spira,T.J., Pitchenik,A.E. and Worobey,M.",2007
EF159973,B,1983,17978186,The emergence of HIV/AIDS in the Americas and beyond,"Gilbert,M.T., Rambaut,A., Wlasiuk,G., Spira,T.J., Pitchenik,A.E. and Worobey,M.",2007
EF159974,B,1983,17978186,The emergence of HIV/AIDS in the Americas and beyond,"Gilbert,M.T., Rambaut,A., Wlasiuk,G., Spira,T.J., Pitchenik,A.E. and Worobey,M.",2007
EF165366,A1,2003,18436274,Variable contexts and levels of hypermutation in HIV-1 proviral genomes recovered from primary peripheral blood mononuclear cells,"Kijak,G.H., Janini,L.M., Tovanabutra,S., Sanders-Buell,E., Arroyo,M.A., Robb,M.L., Michael,N.L., Birx,D.L. and McCutchan,F.E.",2008
EF165539,34_01B,1999,17604547,"Identification of CRF34_01B, a Second Circulating Recombinant Form Unrelated to and More Complex Than CRF15_01B, among Injecting Drug Users in Northern Thailand","Tovanabutra,S., Kijak,G.H., Beyrer,C., Gammon-Richardson,C., Sakkhachornphop,S., Vongchak,T., Jittiwutikarn,J., Razak,M.H., Sanders-Buell,E., Robb,M.L., Suriyanon,V., Birx,D.L., Michael,N.L., Celentano,D.D. and McCutchan,F.E.",2007
EF165540,34_01B,1999,17604547,"Identification of CRF34_01B, a Second Circulating Recombinant Form Unrelated to and More Complex Than CRF15_01B, among Injecting Drug Users in Northern Thailand","Tovanabutra,S., Kijak,G.H., Beyrer,C., Gammon-Richardson,C., Sakkhachornphop,S., Vongchak,T., Jittiwutikarn,J., Razak,M.H., Sanders-Buell,E., Robb,M.L., Suriyanon,V., Birx,D.L., Michael,N.L., Celentano,D.D. and McCutchan,F.E.",2007
EF165541,34_01B,1999,17604547,"Identification of CRF34_01B, a Second Circulating Recombinant Form Unrelated to and More Complex Than CRF15_01B, among Injecting Drug Users in Northern Thailand","Tovanabutra,S., Kijak,G.H., Beyrer,C., Gammon-Richardson,C., Sakkhachornphop,S., Vongchak,T., Jittiwutikarn,J., Razak,M.H., Sanders-Buell,E., Robb,M.L., Suriyanon,V., Birx,D.L., Michael,N.L., Celentano,D.D. and McCutchan,F.E.",2007
EF192591,01B,,17336569,Aberrant life cycle of human immunodeficiency virus type 1 CRF15_01B-like clinical isolates from Thailand in human CD4+ T-cell lines,"Warachit,J., Iwabu,Y., Li,Y.G., Li,G.M., Isarangkura,P., Ibrahim,M.S., Balachandra,K., Tsuji,S. and Ikuta,K.",2007
EF203957,C,2004,17409164,Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection,"Gray,E.S., Moore,P.L., Choge,I.A., Decker,J.M., Bibollet-Ruche,F., Li,H., Leseka,N., Treurnicht,F., Mlisana,K., Shaw,G.M., Karim,S.S., Williamson,C. and Morris,L.",2007
EF203963,C,2005,17409164,Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection,"Gray,E.S., Moore,P.L., Choge,I.A., Decker,J.M., Bibollet-Ruche,F., Li,H., Leseka,N., Treurnicht,F., Mlisana,K., Shaw,G.M., Karim,S.S., Williamson,C. and Morris,L.",2007
EF203965,C,2005,17409164,Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection,"Gray,E.S., Moore,P.L., Choge,I.A., Decker,J.M., Bibollet-Ruche,F., Li,H., Leseka,N., Treurnicht,F., Mlisana,K., Shaw,G.M., Karim,S.S., Williamson,C. and Morris,L.",2007
EF203968,C,2005,17409164,Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection,"Gray,E.S., Moore,P.L., Choge,I.A., Decker,J.M., Bibollet-Ruche,F., Li,H., Leseka,N., Treurnicht,F., Mlisana,K., Shaw,G.M., Karim,S.S., Williamson,C. and Morris,L.",2007
EF203970,C,2005,17409164,Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection,"Gray,E.S., Moore,P.L., Choge,I.A., Decker,J.M., Bibollet-Ruche,F., Li,H., Leseka,N., Treurnicht,F., Mlisana,K., Shaw,G.M., Karim,S.S., Williamson,C. and Morris,L.",2007
EF203973,C,2005,17409164,Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection,"Gray,E.S., Moore,P.L., Choge,I.A., Decker,J.M., Bibollet-Ruche,F., Li,H., Leseka,N., Treurnicht,F., Mlisana,K., Shaw,G.M., Karim,S.S., Williamson,C. and Morris,L.",2007
EF203976,C,2005,17409164,Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection,"Gray,E.S., Moore,P.L., Choge,I.A., Decker,J.M., Bibollet-Ruche,F., Li,H., Leseka,N., Treurnicht,F., Mlisana,K., Shaw,G.M., Karim,S.S., Williamson,C. and Morris,L.",2007
EF203980,C,2005,17409164,Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection,"Gray,E.S., Moore,P.L., Choge,I.A., Decker,J.M., Bibollet-Ruche,F., Li,H., Leseka,N., Treurnicht,F., Mlisana,K., Shaw,G.M., Karim,S.S., Williamson,C. and Morris,L.",2007
EF203982,C,2005,17409164,Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection,"Gray,E.S., Moore,P.L., Choge,I.A., Decker,J.M., Bibollet-Ruche,F., Li,H., Leseka,N., Treurnicht,F., Mlisana,K., Shaw,G.M., Karim,S.S., Williamson,C. and Morris,L.",2007
EF203983,C,2005,17409164,Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection,"Gray,E.S., Moore,P.L., Choge,I.A., Decker,J.M., Bibollet-Ruche,F., Li,H., Leseka,N., Treurnicht,F., Mlisana,K., Shaw,G.M., Karim,S.S., Williamson,C. and Morris,L.",2007
EF203985,C,2005,17409164,Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection,"Gray,E.S., Moore,P.L., Choge,I.A., Decker,J.M., Bibollet-Ruche,F., Li,H., Leseka,N., Treurnicht,F., Mlisana,K., Shaw,G.M., Karim,S.S., Williamson,C. and Morris,L.",2007
EF210725,B,,,Human immunodeficiency virus type 1 subtype B env clones from chronically infected individuals in Peru for use as Env-pseudotyped viruses in neutralizing antibody assays,"Li,M., Zuniga,R., Brander,C. and Montefiori,D.C.",
EF210726,B,,,Human immunodeficiency virus type 1 subtype B env clones from chronically infected individuals in Peru for use as Env-pseudotyped viruses in neutralizing antibody assays,"Li,M., Zuniga,R., Brander,C. and Montefiori,D.C.",
EF210727,B,,,Human immunodeficiency virus type 1 subtype B env clones from chronically infected individuals in Peru for use as Env-pseudotyped viruses in neutralizing antibody assays,"Li,M., Zuniga,R., Brander,C. and Montefiori,D.C.",
EF210729,B,,,Human immunodeficiency virus type 1 subtype B env clones from chronically infected individuals in Peru for use as Env-pseudotyped viruses in neutralizing antibody assays,"Li,M., Zuniga,R., Brander,C. and Montefiori,D.C.",
EF210730,B,,,Human immunodeficiency virus type 1 subtype B env clones from chronically infected individuals in Peru for use as Env-pseudotyped viruses in neutralizing antibody assays,"Li,M., Zuniga,R., Brander,C. and Montefiori,D.C.",
EF210731,B,,,Human immunodeficiency virus type 1 subtype B env clones from chronically infected individuals in Peru for use as Env-pseudotyped viruses in neutralizing antibody assays,"Li,M., Zuniga,R., Brander,C. and Montefiori,D.C.",
EF210732,B,,,Human immunodeficiency virus type 1 subtype B env clones from chronically infected individuals in Peru for use as Env-pseudotyped viruses in neutralizing antibody assays,"Li,M., Zuniga,R., Brander,C. and Montefiori,D.C.",
EF210734,B,,,Human immunodeficiency virus type 1 subtype B env clones from chronically infected individuals in Peru for use as Env-pseudotyped viruses in neutralizing antibody assays,"Li,M., Zuniga,R., Brander,C. and Montefiori,D.C.",
EF210735,B,,,Human immunodeficiency virus type 1 subtype B env clones from chronically infected individuals in Peru for use as Env-pseudotyped viruses in neutralizing antibody assays,"Li,M., Zuniga,R., Brander,C. and Montefiori,D.C.",
EF363122,B,2000,17151109,Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors,"Blankson,J.N., Bailey,J.R., Thayil,S., Yang,H.C., Lassen,K., Lai,J., Gandhi,S.K., Siliciano,J.D., Williams,T.M. and Siliciano,R.F.",2007
EF367208,G,,17182681,Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry,"Westby,M., Smith-Burchnell,C., Mori,J., Lewis,M., Mosley,M., Stockdale,M., Dorr,P., Ciaramella,G. and Perros,M.",2007
EF368370,07_BC,2005,17725423,Genetic characterization of three newly isolated CRF07_BC near full-length genomes in China,"Meng,Z., Xing,H., He,X., Ma,L., Xu,W. and Shao,Y.",2007
EF368371,07_BC,2005,17725423,Genetic characterization of three newly isolated CRF07_BC near full-length genomes in China,"Meng,Z., Xing,H., He,X., Ma,L., Xu,W. and Shao,Y.",2007
EF368372,07_BC,2005,17725423,Genetic characterization of three newly isolated CRF07_BC near full-length genomes in China,"Meng,Z., Xing,H., He,X., Ma,L., Xu,W. and Shao,Y.",2007
EF374125,02_AG,,17961119,gp41 sequence variability in HIV type 1 non-B subtypes infected patients undergoing enfuvirtide pressure,"D'Arrigo,R., Ciccozzi,M., Gori,C., Montieri,S., Aquaro,S., Bellagamba,R., Boumis,E., Di Perri,G., Pizzi,D., Antinori,A., Rezza,G. and Perno,C.F.",2007
EF374127,AC,,17961119,gp41 sequence variability in HIV type 1 non-B subtypes infected patients undergoing enfuvirtide pressure,"D'Arrigo,R., Ciccozzi,M., Gori,C., Montieri,S., Aquaro,S., Bellagamba,R., Boumis,E., Di Perri,G., Pizzi,D., Antinori,A., Rezza,G. and Perno,C.F.",2007
EF374130,F1,,17961119,gp41 sequence variability in HIV type 1 non-B subtypes infected patients undergoing enfuvirtide pressure,"D'Arrigo,R., Ciccozzi,M., Gori,C., Montieri,S., Aquaro,S., Bellagamba,R., Boumis,E., Di Perri,G., Pizzi,D., Antinori,A., Rezza,G. and Perno,C.F.",2007
EF420986,07_BC,2005,18257686,Construction and characterization of an infectious molecular clone of HIV type 1 CRF07_BC,"Meng,Z., He,X., Xing,H., Xin,R., Sun,J., Yi,F., Ma,L. and Shao,Y.",2008
EF440689,B,,18385252,Characterization of the follicular dendritic cell reservoir of human immunodeficiency virus type 1,"Keele,B.F., Tazi,L., Gartner,S., Liu,Y., Burgon,T.B., Estes,J.D., Thacker,T.C., Crandall,K.A., McArthur,J.C. and Burton,G.F.",2008
EF469243,C,2003,18328091,Exceptional molecular and coreceptor-requirement properties of molecular clones isolated from an Human Immunodeficiency Virus Type-1 subtype C infection,"Dash,P.K., Siddappa,N.B., Mangaiarkarasi,A., Mahendarkar,A.V., Roshan,P., Anand,K.K., Mahadevan,A., Satishchandra,P., Shankar,S.K., Prasad,V.R. and Ranga,U.",2008
EF495062,01B,2006,17919110,"Near full-length sequence analysis of a Unique CRF01_AE/B recombinant from Kuala Lumpur, Malaysia","Lau,K.A., Wang,B., Kamarulzaman,A., Ng,K.P. and Saksena,N.K.",2007
EF514697,B,2004,18184088,Characterization of near full-length genomes of HIV type 1 strains in Denmark: basis for a universal therapeutic vaccine,"Andresen,B.S., Vinner,L., Tang,S., Bragstad,K., Kronborg,G., Gerstoft,J., Corbet,S. and Fomsgaard,A.",2007
EF514698,B,2004,18184088,Characterization of near full-length genomes of HIV type 1 strains in Denmark: basis for a universal therapeutic vaccine,"Andresen,B.S., Vinner,L., Tang,S., Bragstad,K., Kronborg,G., Gerstoft,J., Corbet,S. and Fomsgaard,A.",2007
EF514699,B,2004,18184088,Characterization of near full-length genomes of HIV type 1 strains in Denmark: basis for a universal therapeutic vaccine,"Andresen,B.S., Vinner,L., Tang,S., Bragstad,K., Kronborg,G., Gerstoft,J., Corbet,S. and Fomsgaard,A.",2007
EF514700,B,2004,18184088,Characterization of near full-length genomes of HIV type 1 strains in Denmark: basis for a universal therapeutic vaccine,"Andresen,B.S., Vinner,L., Tang,S., Bragstad,K., Kronborg,G., Gerstoft,J., Corbet,S. and Fomsgaard,A.",2007
EF514701,B,2004,18184088,Characterization of near full-length genomes of HIV type 1 strains in Denmark: basis for a universal therapeutic vaccine,"Andresen,B.S., Vinner,L., Tang,S., Bragstad,K., Kronborg,G., Gerstoft,J., Corbet,S. and Fomsgaard,A.",2007
EF514702,B,2004,18184088,Characterization of near full-length genomes of HIV type 1 strains in Denmark: basis for a universal therapeutic vaccine,"Andresen,B.S., Vinner,L., Tang,S., Bragstad,K., Kronborg,G., Gerstoft,J., Corbet,S. and Fomsgaard,A.",2007
EF514703,B,2004,18184088,Characterization of near full-length genomes of HIV type 1 strains in Denmark: basis for a universal therapeutic vaccine,"Andresen,B.S., Vinner,L., Tang,S., Bragstad,K., Kronborg,G., Gerstoft,J., Corbet,S. and Fomsgaard,A.",2007
EF514704,B,2001,18184088,Characterization of near full-length genomes of HIV type 1 strains in Denmark: basis for a universal therapeutic vaccine,"Andresen,B.S., Vinner,L., Tang,S., Bragstad,K., Kronborg,G., Gerstoft,J., Corbet,S. and Fomsgaard,A.",2007
EF514705,B,2001,18184088,Characterization of near full-length genomes of HIV type 1 strains in Denmark: basis for a universal therapeutic vaccine,"Andresen,B.S., Vinner,L., Tang,S., Bragstad,K., Kronborg,G., Gerstoft,J., Corbet,S. and Fomsgaard,A.",2007
EF514706,B,2001,18184088,Characterization of near full-length genomes of HIV type 1 strains in Denmark: basis for a universal therapeutic vaccine,"Andresen,B.S., Vinner,L., Tang,S., Bragstad,K., Kronborg,G., Gerstoft,J., Corbet,S. and Fomsgaard,A.",2007
EF514707,B,2001,18184088,Characterization of near full-length genomes of HIV type 1 strains in Denmark: basis for a universal therapeutic vaccine,"Andresen,B.S., Vinner,L., Tang,S., Bragstad,K., Kronborg,G., Gerstoft,J., Corbet,S. and Fomsgaard,A.",2007
EF514708,B,2001,18184088,Characterization of near full-length genomes of HIV type 1 strains in Denmark: basis for a universal therapeutic vaccine,"Andresen,B.S., Vinner,L., Tang,S., Bragstad,K., Kronborg,G., Gerstoft,J., Corbet,S. and Fomsgaard,A.",2007
EF514709,B,2001,18184088,Characterization of near full-length genomes of HIV type 1 strains in Denmark: basis for a universal therapeutic vaccine,"Andresen,B.S., Vinner,L., Tang,S., Bragstad,K., Kronborg,G., Gerstoft,J., Corbet,S. and Fomsgaard,A.",2007
EF514710,B,2001,18184088,Characterization of near full-length genomes of HIV type 1 strains in Denmark: basis for a universal therapeutic vaccine,"Andresen,B.S., Vinner,L., Tang,S., Bragstad,K., Kronborg,G., Gerstoft,J., Corbet,S. and Fomsgaard,A.",2007
EF514711,B,2001,18184088,Characterization of near full-length genomes of HIV type 1 strains in Denmark: basis for a universal therapeutic vaccine,"Andresen,B.S., Vinner,L., Tang,S., Bragstad,K., Kronborg,G., Gerstoft,J., Corbet,S. and Fomsgaard,A.",2007
EF514712,B,2001,18184088,Characterization of near full-length genomes of HIV type 1 strains in Denmark: basis for a universal therapeutic vaccine,"Andresen,B.S., Vinner,L., Tang,S., Bragstad,K., Kronborg,G., Gerstoft,J., Corbet,S. and Fomsgaard,A.",2007
EF514713,C,2001,18184088,Characterization of near full-length genomes of HIV type 1 strains in Denmark: basis for a universal therapeutic vaccine,"Andresen,B.S., Vinner,L., Tang,S., Bragstad,K., Kronborg,G., Gerstoft,J., Corbet,S. and Fomsgaard,A.",2007
EF531328,B,,18184081,Genetic and biological characterization of recombinant HIV type 1 with Env derived from long-term nonprogressor (LTNP) viruses,"Antoni,S., Walz,N., Landersz,M., Humbert,M., Seidl,C., Dittmar,M.T. and Dietrich,U.",2007
EF531329,B,2002,18184081,Genetic and biological characterization of recombinant HIV type 1 with Env derived from long-term nonprogressor (LTNP) viruses,"Antoni,S., Walz,N., Landersz,M., Humbert,M., Seidl,C., Dittmar,M.T. and Dietrich,U.",2007
EF531330,B,,18184081,Genetic and biological characterization of recombinant HIV type 1 with Env derived from long-term nonprogressor (LTNP) viruses,"Antoni,S., Walz,N., Landersz,M., Humbert,M., Seidl,C., Dittmar,M.T. and Dietrich,U.",2007
EF531331,B,,18184081,Genetic and biological characterization of recombinant HIV type 1 with Env derived from long-term nonprogressor (LTNP) viruses,"Antoni,S., Walz,N., Landersz,M., Humbert,M., Seidl,C., Dittmar,M.T. and Dietrich,U.",2007
EF531332,B,,18184081,Genetic and biological characterization of recombinant HIV type 1 with Env derived from long-term nonprogressor (LTNP) viruses,"Antoni,S., Walz,N., Landersz,M., Humbert,M., Seidl,C., Dittmar,M.T. and Dietrich,U.",2007
EF531333,B,,18184081,Genetic and biological characterization of recombinant HIV type 1 with Env derived from long-term nonprogressor (LTNP) viruses,"Antoni,S., Walz,N., Landersz,M., Humbert,M., Seidl,C., Dittmar,M.T. and Dietrich,U.",2007
EF531334,B,,18184081,Genetic and biological characterization of recombinant HIV type 1 with Env derived from long-term nonprogressor (LTNP) viruses,"Antoni,S., Walz,N., Landersz,M., Humbert,M., Seidl,C., Dittmar,M.T. and Dietrich,U.",2007
EF531335,C,,18184081,Genetic and biological characterization of recombinant HIV type 1 with Env derived from long-term nonprogressor (LTNP) viruses,"Antoni,S., Walz,N., Landersz,M., Humbert,M., Seidl,C., Dittmar,M.T. and Dietrich,U.",2007
EF531336,B,2001,18184081,Genetic and biological characterization of recombinant HIV type 1 with Env derived from long-term nonprogressor (LTNP) viruses,"Antoni,S., Walz,N., Landersz,M., Humbert,M., Seidl,C., Dittmar,M.T. and Dietrich,U.",2007
EF531337,B,,18184081,Genetic and biological characterization of recombinant HIV type 1 with Env derived from long-term nonprogressor (LTNP) viruses,"Antoni,S., Walz,N., Landersz,M., Humbert,M., Seidl,C., Dittmar,M.T. and Dietrich,U.",2007
EF531338,B,2003,18184081,Genetic and biological characterization of recombinant HIV type 1 with Env derived from long-term nonprogressor (LTNP) viruses,"Antoni,S., Walz,N., Landersz,M., Humbert,M., Seidl,C., Dittmar,M.T. and Dietrich,U.",2007
EF545108,A6,2000,18160020,New insights into the origin of the HIV type 1 subtype A epidemic in former Soviet Union's countries derived from sequence analyses of preepidemically transmitted viruses,"Thomson,M.M., de Parga,E.V., Vinogradova,A., Sierra,M., Yakovlev,A., Rakhmanova,A., Delgado,E., Casado,G., Munoz,M., Carmona,R., Vega,Y., Perez-Alvarez,L., Contreras,G., Medrano,L., Osmanov,S. and Najera,R.",2007
EF575354,D,,,Co-receptor Tropism in Subtype D HIV-1: High Prevalence of CXCR4 Tropism and Heterogeneous Composition of Viral Populations,"Huang,W., Eshleman,S.H., Toma,J., Fransen,S., Stawiski,E., Paxinos,E.E., Whitcomb,J.M., Young,A.M., Donnell,D., Mmiro,F., Musoke,P., Guay,L.A., Jackson,J.B., Parkin,N.T. and Petropoulos,C.J.",
EF575370,D,,,Co-receptor Tropism in Subtype D HIV-1: High Prevalence of CXCR4 Tropism and Heterogeneous Composition of Viral Populations,"Huang,W., Eshleman,S.H., Toma,J., Fransen,S., Stawiski,E., Paxinos,E.E., Whitcomb,J.M., Young,A.M., Donnell,D., Mmiro,F., Musoke,P., Guay,L.A., Jackson,J.B., Parkin,N.T. and Petropoulos,C.J.",
EF575384,D,,,Co-receptor Tropism in Subtype D HIV-1: High Prevalence of CXCR4 Tropism and Heterogeneous Composition of Viral Populations,"Huang,W., Eshleman,S.H., Toma,J., Fransen,S., Stawiski,E., Paxinos,E.E., Whitcomb,J.M., Young,A.M., Donnell,D., Mmiro,F., Musoke,P., Guay,L.A., Jackson,J.B., Parkin,N.T. and Petropoulos,C.J.",
EF575400,D,,,Co-receptor Tropism in Subtype D HIV-1: High Prevalence of CXCR4 Tropism and Heterogeneous Composition of Viral Populations,"Huang,W., Eshleman,S.H., Toma,J., Fransen,S., Stawiski,E., Paxinos,E.E., Whitcomb,J.M., Young,A.M., Donnell,D., Mmiro,F., Musoke,P., Guay,L.A., Jackson,J.B., Parkin,N.T. and Petropoulos,C.J.",
EF575414,D,,,Co-receptor Tropism in Subtype D HIV-1: High Prevalence of CXCR4 Tropism and Heterogeneous Composition of Viral Populations,"Huang,W., Eshleman,S.H., Toma,J., Fransen,S., Stawiski,E., Paxinos,E.E., Whitcomb,J.M., Young,A.M., Donnell,D., Mmiro,F., Musoke,P., Guay,L.A., Jackson,J.B., Parkin,N.T. and Petropoulos,C.J.",
EF575429,D,,,Co-receptor Tropism in Subtype D HIV-1: High Prevalence of CXCR4 Tropism and Heterogeneous Composition of Viral Populations,"Huang,W., Eshleman,S.H., Toma,J., Fransen,S., Stawiski,E., Paxinos,E.E., Whitcomb,J.M., Young,A.M., Donnell,D., Mmiro,F., Musoke,P., Guay,L.A., Jackson,J.B., Parkin,N.T. and Petropoulos,C.J.",
EF575444,D,,,Co-receptor Tropism in Subtype D HIV-1: High Prevalence of CXCR4 Tropism and Heterogeneous Composition of Viral Populations,"Huang,W., Eshleman,S.H., Toma,J., Fransen,S., Stawiski,E., Paxinos,E.E., Whitcomb,J.M., Young,A.M., Donnell,D., Mmiro,F., Musoke,P., Guay,L.A., Jackson,J.B., Parkin,N.T. and Petropoulos,C.J.",
EF575455,D,,,Co-receptor Tropism in Subtype D HIV-1: High Prevalence of CXCR4 Tropism and Heterogeneous Composition of Viral Populations,"Huang,W., Eshleman,S.H., Toma,J., Fransen,S., Stawiski,E., Paxinos,E.E., Whitcomb,J.M., Young,A.M., Donnell,D., Mmiro,F., Musoke,P., Guay,L.A., Jackson,J.B., Parkin,N.T. and Petropoulos,C.J.",
EF575471,D,,,Co-receptor Tropism in Subtype D HIV-1: High Prevalence of CXCR4 Tropism and Heterogeneous Composition of Viral Populations,"Huang,W., Eshleman,S.H., Toma,J., Fransen,S., Stawiski,E., Paxinos,E.E., Whitcomb,J.M., Young,A.M., Donnell,D., Mmiro,F., Musoke,P., Guay,L.A., Jackson,J.B., Parkin,N.T. and Petropoulos,C.J.",
EF589039,A6,2002,17514018,Genetic characterization of HIV-1 strains circulating in Kazakhstan,"Eyzaguirre,L.M., Erasilova,I.B., Nadai,Y., Saad,M.D., Kovtunenko,N.G., Gomatos,P.J., Zeman,V.V., Botros,B.A., Sanchez,J.L., Birx,D.L., Earhart,K.C. and Carr,J.K.",2007
EF589040,A6,2002,17514018,Genetic characterization of HIV-1 strains circulating in Kazakhstan,"Eyzaguirre,L.M., Erasilova,I.B., Nadai,Y., Saad,M.D., Kovtunenko,N.G., Gomatos,P.J., Zeman,V.V., Botros,B.A., Sanchez,J.L., Birx,D.L., Earhart,K.C. and Carr,J.K.",2007
EF589041,A6,2002,17514018,Genetic characterization of HIV-1 strains circulating in Kazakhstan,"Eyzaguirre,L.M., Erasilova,I.B., Nadai,Y., Saad,M.D., Kovtunenko,N.G., Gomatos,P.J., Zeman,V.V., Botros,B.A., Sanchez,J.L., Birx,D.L., Earhart,K.C. and Carr,J.K.",2007
EF589042,A6,2002,17514018,Genetic characterization of HIV-1 strains circulating in Kazakhstan,"Eyzaguirre,L.M., Erasilova,I.B., Nadai,Y., Saad,M.D., Kovtunenko,N.G., Gomatos,P.J., Zeman,V.V., Botros,B.A., Sanchez,J.L., Birx,D.L., Earhart,K.C. and Carr,J.K.",2007
EF589043,A6,2002,17514018,Genetic characterization of HIV-1 strains circulating in Kazakhstan,"Eyzaguirre,L.M., Erasilova,I.B., Nadai,Y., Saad,M.D., Kovtunenko,N.G., Gomatos,P.J., Zeman,V.V., Botros,B.A., Sanchez,J.L., Birx,D.L., Earhart,K.C. and Carr,J.K.",2007
EF589044,A6,2002,17514018,Genetic characterization of HIV-1 strains circulating in Kazakhstan,"Eyzaguirre,L.M., Erasilova,I.B., Nadai,Y., Saad,M.D., Kovtunenko,N.G., Gomatos,P.J., Zeman,V.V., Botros,B.A., Sanchez,J.L., Birx,D.L., Earhart,K.C. and Carr,J.K.",2007
EF593181,B,1997,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593182,B,1997,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593183,B,1997,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593184,B,1998,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593186,B,1998,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593187,B,1999,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593188,B,2004,,SGA full length env HIV-1 chronic infection,"Anderson,J., Ping,L.-H., Takamune,N., Galvin,S., Fiscus,S., Pilcher,C., Hicks,C., Eron,J. and Swanstrom,R.",
EF593189,B,2005,,SGA full length env HIV-1 chronic infection,"Anderson,J., Ping,L.-H., Takamune,N., Galvin,S., Fiscus,S., Pilcher,C., Hicks,C., Eron,J. and Swanstrom,R.",
EF593190,B,2004,,SGA full length env HIV-1 chronic infection,"Anderson,J., Ping,L.-H., Takamune,N., Galvin,S., Fiscus,S., Pilcher,C., Hicks,C., Eron,J. and Swanstrom,R.",
EF593191,B,2005,,SGA full length env HIV-1 chronic infection,"Anderson,J., Ping,L.-H., Takamune,N., Galvin,S., Fiscus,S., Pilcher,C., Hicks,C., Eron,J. and Swanstrom,R.",
EF593192,B,2004,,SGA full length env HIV-1 chronic infection,"Anderson,J., Ping,L.-H., Takamune,N., Galvin,S., Fiscus,S., Pilcher,C., Hicks,C., Eron,J. and Swanstrom,R.",
EF593193,B,2004,,SGA full length env HIV-1 chronic infection,"Anderson,J., Ping,L.-H., Takamune,N., Galvin,S., Fiscus,S., Pilcher,C., Hicks,C., Eron,J. and Swanstrom,R.",
EF593194,B,2005,,SGA full length env HIV-1 chronic infection,"Anderson,J., Ping,L.-H., Takamune,N., Galvin,S., Fiscus,S., Pilcher,C., Hicks,C., Eron,J. and Swanstrom,R.",
EF593195,B,1996,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593196,B,1996,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593197,B,1995,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593198,B,1996,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593199,B,1996,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593200,B,1997,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593201,B,1997,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593202,B,1997,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593203,B,2004,,SGA full length env HIV-1 chronic infection,"Anderson,J., Ping,L.-H., Takamune,N., Galvin,S., Fiscus,S., Pilcher,C., Hicks,C., Eron,J. and Swanstrom,R.",
EF593204,B,1997,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593205,B,1997,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593206,B,1997,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593207,B,1997,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593208,B,1998,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593209,B,1998,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593210,B,1998,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593211,B,1997,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593212,B,1999,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593213,B,1999,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593216,B,2006,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593217,B,2006,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593218,B,2006,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593219,B,2006,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593220,B,2006,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593221,B,2001,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593222,B,2003,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593223,B,2002,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593224,B,2002,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593225,B,2004,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593226,B,2004,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593227,B,2006,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593228,B,2003,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593229,B,2002,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593230,B,1994,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593231,B,1995,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593232,B,1997,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593233,B,1999,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593234,B,2000,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593238,B,2004,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593240,B,2000,,Direct Submission,"Keele,B.F., Hahn,B.H., Tamaras,G.D., Greenberg,M.L., Weinhold,K.J., Blattner,W.A., Cleghorn,F. and Jack,N.",2007
EF593253,B,2002,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593254,B,2001,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593256,B,2003,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593259,B,2001,,Direct Submission,"Keele,B.F., Hahn,B.H., Tamaras,G.D., Greenberg,M.L., Weinhold,K.J., Blattner,W.A., Cleghorn,F. and Jack,N.",2007
EF593260,B,2001,,Direct Submission,"Keele,B.F., Hahn,B.H., Tamaras,G.D., Greenberg,M.L., Weinhold,K.J., Blattner,W.A., Cleghorn,F. and Jack,N.",2007
EF593261,B,2001,,Direct Submission,"Keele,B.F., Hahn,B.H., Tamaras,G.D., Greenberg,M.L., Weinhold,K.J., Blattner,W.A., Cleghorn,F. and Jack,N.",2007
EF593262,B,2001,,Direct Submission,"Keele,B.F., Hahn,B.H., Tamaras,G.D., Greenberg,M.L., Weinhold,K.J., Blattner,W.A., Cleghorn,F. and Jack,N.",2007
EF593263,B,1998,,Direct Submission,"Keele,B.F., Hahn,B.H., Tamaras,G.D., Greenberg,M.L., Weinhold,K.J., Blattner,W.A., Cleghorn,F. and Jack,N.",2007
EF593264,B,1998,,Direct Submission,"Keele,B.F., Hahn,B.H., Tamaras,G.D., Greenberg,M.L., Weinhold,K.J., Blattner,W.A., Cleghorn,F. and Jack,N.",2007
EF593265,B,1998,,Direct Submission,"Keele,B.F., Hahn,B.H., Tamaras,G.D., Greenberg,M.L., Weinhold,K.J., Blattner,W.A., Cleghorn,F. and Jack,N.",2007
EF593266,B,2000,,Direct Submission,"Keele,B.F., Hahn,B.H., Tamaras,G.D., Greenberg,M.L., Weinhold,K.J., Blattner,W.A., Cleghorn,F. and Jack,N.",2007
EF593267,B,1999,,Direct Submission,"Keele,B.F., Hahn,B.H., Tamaras,G.D., Greenberg,M.L., Weinhold,K.J., Blattner,W.A., Cleghorn,F. and Jack,N.",2007
EF593268,B,1999,,Direct Submission,"Keele,B.F., Hahn,B.H., Tamaras,G.D., Greenberg,M.L., Weinhold,K.J., Blattner,W.A., Cleghorn,F. and Jack,N.",2007
EF593269,B,2004,,Direct Submission,"Kirchherr,J.L., Jiang,C. and Gao,F.",2007
EF593270,B,2004,,Direct Submission,"Kirchherr,J.L., Jiang,C. and Gao,F.",2007
EF593271,B,2004,,Direct Submission,"Kirchherr,J.L., Jiang,C. and Gao,F.",2007
EF593272,B,2004,,Direct Submission,"Kirchherr,J.L., Jiang,C. and Gao,F.",2007
EF593273,B,2004,,Direct Submission,"Kirchherr,J.L., Jiang,C. and Gao,F.",2007
EF593274,B,2004,,Direct Submission,"Kirchherr,J.L., Jiang,C. and Gao,F.",2007
EF593275,B,2004,,Direct Submission,"Kirchherr,J.L., Jiang,C. and Gao,F.",2007
EF593276,B,2004,,Direct Submission,"Kirchherr,J.L., Jiang,C. and Gao,F.",2007
EF593277,B,2004,,Direct Submission,"Kirchherr,J.L., Jiang,C. and Gao,F.",2007
EF593279,B,2005,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593281,B,2006,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593282,B,1998,,Acute Subtype B SGA env Z Patients,"Ping,L.-H., Anderson,J.A., Takamune,N., Pilcher,C.D., Fiscus,S.A., Hicks,C.B., Eron,J.J. Jr. and Swanstrom,R.",
EF593283,B,1998,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593284,B,1998,,Acute Subtype B SGA env Z Patients,"Ping,L.-H., Anderson,J.A., Takamune,N. and Swanstrom,R.",
EF593285,B,1999,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593286,B,1999,,Acute Subtype B SGA env Z Patients,"Ping,L.-H., Anderson,J.A., Takamune,N. and Swanstrom,R.",
EF593287,B,1999,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593288,B,2000,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593289,B,2000,,Acute Subtype B SGA env Z Patients,"Ping,L.-H., Anderson,J.A., Takamune,N. and Swanstrom,R.",
EF593290,B,2001,,Acute Subtype B SGA env Z Patients,"Ping,L.-H., Anderson,J.A., Takamune,N. and Swanstrom,R.",
EF593291,B,2001,,Acute Subtype B SGA env Z Patients,"Ping,L.-H., Anderson,J.A., Takamune,N. and Swanstrom,R.",
EF593292,B,2001,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593293,B,2001,,Direct Submission,"Salazar-Gonzalez,J.",2007
EF593294,B,2001,,Acute Subtype B SGA env Z Patients,"Anderson,J., Ping,L.-H., Takamune,N. and Swanstrom,R.",
EF593295,B,2002,,Acute Subtype B SGA env Z Patients,"Anderson,J., Ping,L.-H., Takamune,N. and Swanstrom,R.",
EF593296,B,2002,,Acute Subtype B SGA env Z Patients,"Anderson,J., Ping,L.-H., Takamune,N. and Swanstrom,R.",
EF593297,B,2002,,Acute Subtype B SGA env Z Patients,"Anderson,J., Ping,L.-H., Takamune,N. and Swanstrom,R.",
EF593298,B,2003,,Acute Subtype B SGA env Z Patients,"Anderson,J., Ping,L.-H., Takamune,N. and Swanstrom,R.",
EF593299,B,2003,,Acute Subtype B SGA env Z Patients,"Anderson,J., Ping,L.-H., Takamune,N. and Swanstrom,R.",
EF593300,B,1999,,Direct Submission,"Jiang,C., Kirchherr,J., Haynes,B. and Gao,F.",2007
EF593301,B,1996,,Direct Submission,"Jiang,C., Kirchherr,J., Haynes,B. and Gao,F.",2007
EF593302,B,1997,,Direct Submission,"Jiang,C., Kirchherr,J., Haynes,B. and Gao,F.",2007
EF593303,B,1996,,Direct Submission,"Jiang,C., Kirchherr,J., Haynes,B. and Gao,F.",2007
EF593304,B,1997,,Direct Submission,"Jiang,C., Kirchherr,J., Haynes,B. and Gao,F.",2007
EF593305,B,1997,,Direct Submission,"Jiang,C., Kirchherr,J., Haynes,B. and Gao,F.",2007
EF593306,B,1997,,Direct Submission,"Jiang,C., Kirchherr,J., Haynes,B. and Gao,F.",2007
EF593307,B,1997,,Direct Submission,"Jiang,C., Kirchherr,J., Haynes,B. and Gao,F.",2007
EF593308,B,1997,,Direct Submission,"Jiang,C., Kirchherr,J., Haynes,B. and Gao,F.",2007
EF593309,B,1997,,Direct Submission,"Jiang,C., Kirchherr,J., Haynes,B. and Gao,F.",2007
EF593310,B,1998,,Direct Submission,"Jiang,C., Kirchherr,J., Haynes,B. and Gao,F.",2007
EF593311,B,1997,,Direct Submission,"Jiang,C., Kirchherr,J., Haynes,B. and Gao,F.",2007
EF593312,B,1998,,Direct Submission,"Jiang,C., Kirchherr,J., Haynes,B. and Gao,F.",2007
EF593313,B,1998,,Direct Submission,"Jiang,C., Kirchherr,J., Haynes,B. and Gao,F.",2007
EF593314,B,1998,,Direct Submission,"Jiang,C., Kirchherr,J., Haynes,B. and Gao,F.",2007
EF593315,B,1998,,Direct Submission,"Jiang,C., Kirchherr,J., Haynes,B. and Gao,F.",2007
EF593316,B,1998,,Direct Submission,"Jiang,C., Kirchherr,J., Haynes,B. and Gao,F.",2007
EF593317,B,1998,,Direct Submission,"Jiang,C., Kirchherr,J., Haynes,B. and Gao,F.",2007
EF593318,B,1998,,Direct Submission,"Jiang,C., Kirchherr,J., Haynes,B. and Gao,F.",2007
EF593319,B,1996,,Direct Submission,"Jiang,C., Kirchherr,J., Haynes,B. and Gao,F.",2007
EF633445,D,1990,18160016,"Complete genome sequencing of a non-syncytium-inducing HIV type 1 subtype D strain from Cape Town, South Africa","Jacobs,G.B., Loxton,A.G., Laten,A. and Engelbrecht,S.",2007
EF637046,B,2003,17919103,Characterization of the full-length human immunodeficiency virus-1 genome from recently infected subjects in Brazil,"Sa-Filho,D., Kallas,E.G., Sanabani,S., Sabino,E., Sucupira,M.C., Sanchez-Rosa,A.C., Tescarollo,G., Tomiyama,H., Bassichetto,K., Janini,L.M. and Diaz,R.S.",2007
EF637047,B,2003,17919103,Characterization of the full-length human immunodeficiency virus-1 genome from recently infected subjects in Brazil,"Sa-Filho,D., Kallas,E.G., Sanabani,S., Sabino,E., Sucupira,M.C., Sanchez-Rosa,A.C., Tescarollo,G., Tomiyama,H., Bassichetto,K., Janini,L.M. and Diaz,R.S.",2007
EF637048,B,2003,17919103,Characterization of the full-length human immunodeficiency virus-1 genome from recently infected subjects in Brazil,"Sa-Filho,D., Kallas,E.G., Sanabani,S., Sabino,E., Sucupira,M.C., Sanchez-Rosa,A.C., Tescarollo,G., Tomiyama,H., Bassichetto,K., Janini,L.M. and Diaz,R.S.",2007
EF637049,B,2003,17919103,Characterization of the full-length human immunodeficiency virus-1 genome from recently infected subjects in Brazil,"Sa-Filho,D., Kallas,E.G., Sanabani,S., Sabino,E., Sucupira,M.C., Sanchez-Rosa,A.C., Tescarollo,G., Tomiyama,H., Bassichetto,K., Janini,L.M. and Diaz,R.S.",2007
EF637050,B,2003,17919103,Characterization of the full-length human immunodeficiency virus-1 genome from recently infected subjects in Brazil,"Sa-Filho,D., Kallas,E.G., Sanabani,S., Sabino,E., Sucupira,M.C., Sanchez-Rosa,A.C., Tescarollo,G., Tomiyama,H., Bassichetto,K., Janini,L.M. and Diaz,R.S.",2007
EF637051,B,2003,17919103,Characterization of the full-length human immunodeficiency virus-1 genome from recently infected subjects in Brazil,"Sa-Filho,D., Kallas,E.G., Sanabani,S., Sabino,E., Sucupira,M.C., Sanchez-Rosa,A.C., Tescarollo,G., Tomiyama,H., Bassichetto,K., Janini,L.M. and Diaz,R.S.",2007
EF637052,BF,2003,17919103,Characterization of the full-length human immunodeficiency virus-1 genome from recently infected subjects in Brazil,"Sa-Filho,D., Kallas,E.G., Sanabani,S., Sabino,E., Sucupira,M.C., Sanchez-Rosa,A.C., Tescarollo,G., Tomiyama,H., Bassichetto,K., Janini,L.M. and Diaz,R.S.",2007
EF637053,B,2003,17919103,Characterization of the full-length human immunodeficiency virus-1 genome from recently infected subjects in Brazil,"Sa-Filho,D., Kallas,E.G., Sanabani,S., Sabino,E., Sucupira,M.C., Sanchez-Rosa,A.C., Tescarollo,G., Tomiyama,H., Bassichetto,K., Janini,L.M. and Diaz,R.S.",2007
EF637054,B,2003,17919103,Characterization of the full-length human immunodeficiency virus-1 genome from recently infected subjects in Brazil,"Sa-Filho,D., Kallas,E.G., Sanabani,S., Sabino,E., Sucupira,M.C., Sanchez-Rosa,A.C., Tescarollo,G., Tomiyama,H., Bassichetto,K., Janini,L.M. and Diaz,R.S.",2007
EF637055,BF,2003,17919103,Characterization of the full-length human immunodeficiency virus-1 genome from recently infected subjects in Brazil,"Sa-Filho,D., Kallas,E.G., Sanabani,S., Sabino,E., Sucupira,M.C., Sanchez-Rosa,A.C., Tescarollo,G., Tomiyama,H., Bassichetto,K., Janini,L.M. and Diaz,R.S.",2007
EF637056,B,2003,17919103,Characterization of the full-length human immunodeficiency virus-1 genome from recently infected subjects in Brazil,"Sa-Filho,D., Kallas,E.G., Sanabani,S., Sabino,E., Sucupira,M.C., Sanchez-Rosa,A.C., Tescarollo,G., Tomiyama,H., Bassichetto,K., Janini,L.M. and Diaz,R.S.",2007
EF637057,B,2003,17919103,Characterization of the full-length human immunodeficiency virus-1 genome from recently infected subjects in Brazil,"Sa-Filho,D., Kallas,E.G., Sanabani,S., Sabino,E., Sucupira,M.C., Sanchez-Rosa,A.C., Tescarollo,G., Tomiyama,H., Bassichetto,K., Janini,L.M. and Diaz,R.S.",2007
EF643652,B,2001,17567707,"In vivo and in vitro escape from neutralizing antibodies 2G12, 2F5, and 4E10","Manrique,A., Rusert,P., Joos,B., Fischer,M., Kuster,H., Leemann,C., Niederost,B., Weber,R., Stiegler,G., Katinger,H., Gunthard,H.F. and Trkola,A.",2007
EF643656,B,2003,17567707,"In vivo and in vitro escape from neutralizing antibodies 2G12, 2F5, and 4E10","Manrique,A., Rusert,P., Joos,B., Fischer,M., Kuster,H., Leemann,C., Niederost,B., Weber,R., Stiegler,G., Katinger,H., Gunthard,H.F. and Trkola,A.",2007
EF643659,B,2003,17567707,"In vivo and in vitro escape from neutralizing antibodies 2G12, 2F5, and 4E10","Manrique,A., Rusert,P., Joos,B., Fischer,M., Kuster,H., Leemann,C., Niederost,B., Weber,R., Stiegler,G., Katinger,H., Gunthard,H.F. and Trkola,A.",2007
EF643662,B,,17567707,"In vivo and in vitro escape from neutralizing antibodies 2G12, 2F5, and 4E10","Manrique,A., Rusert,P., Joos,B., Fischer,M., Kuster,H., Leemann,C., Niederost,B., Weber,R., Stiegler,G., Katinger,H., Gunthard,H.F. and Trkola,A.",2007
EF694032,C,,18275353,Characterization of B/C recombinants of near full-length HIV type 1 from northeastern India with mosaics identical to ARE195FL but with a different ancestral origin,"Lakhashe,S., Tripathy,S., Paranjape,R. and Bhattacharya,J.",2008
EF694034,C,,18275353,Characterization of B/C recombinants of near full-length HIV type 1 from northeastern India with mosaics identical to ARE195FL but with a different ancestral origin,"Lakhashe,S., Tripathy,S., Paranjape,R. and Bhattacharya,J.",2008
EU000506,BC,2002,18275353,Characterization of B/C recombinants of near full-length HIV type 1 from northeastern India with mosaics identical to ARE195FL but with a different ancestral origin,"Lakhashe,S., Tripathy,S., Paranjape,R. and Bhattacharya,J.",2008
EU000509,BC,2002,18275353,Characterization of B/C recombinants of near full-length HIV type 1 from northeastern India with mosaics identical to ARE195FL but with a different ancestral origin,"Lakhashe,S., Tripathy,S., Paranjape,R. and Bhattacharya,J.",2008
EU000512,BC,2002,18275353,Characterization of B/C recombinants of near full-length HIV type 1 from northeastern India with mosaics identical to ARE195FL but with a different ancestral origin,"Lakhashe,S., Tripathy,S., Paranjape,R. and Bhattacharya,J.",2008
EU000515,BC,1999,18284322,Evidence of a novel B/C recombinant exhibiting unique breakpoints of near full-length HIV type 1 genome from Northeastern India,"Lakhashe,S., Tripathy,S., Paranjape,R. and Bhattacharya,J.",2008
EU023922,B,2003,18032508,In vivo efficacy of human immunodeficiency virus neutralizing antibodies: estimates for protective titers,"Trkola,A., Kuster,H., Rusert,P., von Wyl,V., Leemann,C., Weber,R., Stiegler,G., Katinger,H., Joos,B. and Gunthard,H.F.",2008
EU023929,B,,18032508,In vivo efficacy of human immunodeficiency virus neutralizing antibodies: estimates for protective titers,"Trkola,A., Kuster,H., Rusert,P., von Wyl,V., Leemann,C., Weber,R., Stiegler,G., Katinger,H., Joos,B. and Gunthard,H.F.",2008
EU023932,B,,18032508,In vivo efficacy of human immunodeficiency virus neutralizing antibodies: estimates for protective titers,"Trkola,A., Kuster,H., Rusert,P., von Wyl,V., Leemann,C., Weber,R., Stiegler,G., Katinger,H., Joos,B. and Gunthard,H.F.",2008
EU023933,B,,18032508,In vivo efficacy of human immunodeficiency virus neutralizing antibodies: estimates for protective titers,"Trkola,A., Kuster,H., Rusert,P., von Wyl,V., Leemann,C., Weber,R., Stiegler,G., Katinger,H., Joos,B. and Gunthard,H.F.",2008
EU023937,G,,18032508,In vivo efficacy of human immunodeficiency virus neutralizing antibodies: estimates for protective titers,"Trkola,A., Kuster,H., Rusert,P., von Wyl,V., Leemann,C., Weber,R., Stiegler,G., Katinger,H., Joos,B. and Gunthard,H.F.",2008
EU110086,CD,2001,18544023,"Full-length HIV type 1 proviral sequencing of 10 highly exposed women from Nairobi, Kenya reveals a high proportion of intersubtype recombinants","Land,A.M., Ball,T.B., Luo,M., Rutherford,J., Sarna,C., Wachihi,C., Kimani,J. and Plummer,F.A.",2008
EU110087,A1,2001,18544023,"Full-length HIV type 1 proviral sequencing of 10 highly exposed women from Nairobi, Kenya reveals a high proportion of intersubtype recombinants","Land,A.M., Ball,T.B., Luo,M., Rutherford,J., Sarna,C., Wachihi,C., Kimani,J. and Plummer,F.A.",2008
EU110088,A1,2001,18544023,"Full-length HIV type 1 proviral sequencing of 10 highly exposed women from Nairobi, Kenya reveals a high proportion of intersubtype recombinants","Land,A.M., Ball,T.B., Luo,M., Rutherford,J., Sarna,C., Wachihi,C., Kimani,J. and Plummer,F.A.",2008
EU110089,A2CD,2001,18544023,"Full-length HIV type 1 proviral sequencing of 10 highly exposed women from Nairobi, Kenya reveals a high proportion of intersubtype recombinants","Land,A.M., Ball,T.B., Luo,M., Rutherford,J., Sarna,C., Wachihi,C., Kimani,J. and Plummer,F.A.",2008
EU110090,A1D,2002,18544023,"Full-length HIV type 1 proviral sequencing of 10 highly exposed women from Nairobi, Kenya reveals a high proportion of intersubtype recombinants","Land,A.M., Ball,T.B., Luo,M., Rutherford,J., Sarna,C., Wachihi,C., Kimani,J. and Plummer,F.A.",2008
EU110091,A1CG,2002,18544023,"Full-length HIV type 1 proviral sequencing of 10 highly exposed women from Nairobi, Kenya reveals a high proportion of intersubtype recombinants","Land,A.M., Ball,T.B., Luo,M., Rutherford,J., Sarna,C., Wachihi,C., Kimani,J. and Plummer,F.A.",2008
EU110092,A1,2002,18544023,"Full-length HIV type 1 proviral sequencing of 10 highly exposed women from Nairobi, Kenya reveals a high proportion of intersubtype recombinants","Land,A.M., Ball,T.B., Luo,M., Rutherford,J., Sarna,C., Wachihi,C., Kimani,J. and Plummer,F.A.",2008
EU110093,A1CD,2002,18544023,"Full-length HIV type 1 proviral sequencing of 10 highly exposed women from Nairobi, Kenya reveals a high proportion of intersubtype recombinants","Land,A.M., Ball,T.B., Luo,M., Rutherford,J., Sarna,C., Wachihi,C., Kimani,J. and Plummer,F.A.",2008
EU110094,A1,2002,18544023,"Full-length HIV type 1 proviral sequencing of 10 highly exposed women from Nairobi, Kenya reveals a high proportion of intersubtype recombinants","Land,A.M., Ball,T.B., Luo,M., Rutherford,J., Sarna,C., Wachihi,C., Kimani,J. and Plummer,F.A.",2008
EU131787,B,2004,18670237,"A new CRF01_AE/B recombinant structure of HIV type 1 found in Heilongjiang province, China","Zhou,H.Z., Li,Y., Zhou,H., Liu,Y.C., Du,H.T., Wang,K.L., Wang,F.X. and Ling,H.",2008
EU131788,B,2004,18670237,"A new CRF01_AE/B recombinant structure of HIV type 1 found in Heilongjiang province, China","Zhou,H.Z., Li,Y., Zhou,H., Liu,Y.C., Du,H.T., Wang,K.L., Wang,F.X. and Ling,H.",2008
EU131789,B,2004,18670237,"A new CRF01_AE/B recombinant structure of HIV type 1 found in Heilongjiang province, China","Zhou,H.Z., Li,Y., Zhou,H., Liu,Y.C., Du,H.T., Wang,K.L., Wang,F.X. and Ling,H.",2008
EU131790,B,2004,18670237,"A new CRF01_AE/B recombinant structure of HIV type 1 found in Heilongjiang province, China","Zhou,H.Z., Li,Y., Zhou,H., Liu,Y.C., Du,H.T., Wang,K.L., Wang,F.X. and Ling,H.",2008
EU131791,B,2004,18670237,"A new CRF01_AE/B recombinant structure of HIV type 1 found in Heilongjiang province, China","Zhou,H.Z., Li,Y., Zhou,H., Liu,Y.C., Du,H.T., Wang,K.L., Wang,F.X. and Ling,H.",2008
EU131792,B,2004,18670237,"A new CRF01_AE/B recombinant structure of HIV type 1 found in Heilongjiang province, China","Zhou,H.Z., Li,Y., Zhou,H., Liu,Y.C., Du,H.T., Wang,K.L., Wang,F.X. and Ling,H.",2008
EU131793,B,2003,18670237,"A new CRF01_AE/B recombinant structure of HIV type 1 found in Heilongjiang province, China","Zhou,H.Z., Li,Y., Zhou,H., Liu,Y.C., Du,H.T., Wang,K.L., Wang,F.X. and Ling,H.",2008
EU131794,B,2006,18670237,"A new CRF01_AE/B recombinant structure of HIV type 1 found in Heilongjiang province, China","Zhou,H.Z., Li,Y., Zhou,H., Liu,Y.C., Du,H.T., Wang,K.L., Wang,F.X. and Ling,H.",2008
EU131795,B,2006,18670237,"A new CRF01_AE/B recombinant structure of HIV type 1 found in Heilongjiang province, China","Zhou,H.Z., Li,Y., Zhou,H., Liu,Y.C., Du,H.T., Wang,K.L., Wang,F.X. and Ling,H.",2008
EU131796,B,2004,18670237,"A new CRF01_AE/B recombinant structure of HIV type 1 found in Heilongjiang province, China","Zhou,H.Z., Li,Y., Zhou,H., Liu,Y.C., Du,H.T., Wang,K.L., Wang,F.X. and Ling,H.",2008
EU131797,B,2004,18670237,"A new CRF01_AE/B recombinant structure of HIV type 1 found in Heilongjiang province, China","Zhou,H.Z., Li,Y., Zhou,H., Liu,Y.C., Du,H.T., Wang,K.L., Wang,F.X. and Ling,H.",2008
EU131798,B,2006,18670237,"A new CRF01_AE/B recombinant structure of HIV type 1 found in Heilongjiang province, China","Zhou,H.Z., Li,Y., Zhou,H., Liu,Y.C., Du,H.T., Wang,K.L., Wang,F.X. and Ling,H.",2008
EU131799,01B,2006,18670237,"A new CRF01_AE/B recombinant structure of HIV type 1 found in Heilongjiang province, China","Zhou,H.Z., Li,Y., Zhou,H., Liu,Y.C., Du,H.T., Wang,K.L., Wang,F.X. and Ling,H.",2008
EU131800,B,2006,18670237,"A new CRF01_AE/B recombinant structure of HIV type 1 found in Heilongjiang province, China","Zhou,H.Z., Li,Y., Zhou,H., Liu,Y.C., Du,H.T., Wang,K.L., Wang,F.X. and Ling,H.",2008
EU131801,B,2004,18670237,"A new CRF01_AE/B recombinant structure of HIV type 1 found in Heilongjiang province, China","Zhou,H.Z., Li,Y., Zhou,H., Liu,Y.C., Du,H.T., Wang,K.L., Wang,F.X. and Ling,H.",2008
EU131802,B,2006,18670237,"A new CRF01_AE/B recombinant structure of HIV type 1 found in Heilongjiang province, China","Zhou,H.Z., Li,Y., Zhou,H., Liu,Y.C., Du,H.T., Wang,K.L., Wang,F.X. and Ling,H.",2008
EU131803,B,2005,18670237,"A new CRF01_AE/B recombinant structure of HIV type 1 found in Heilongjiang province, China","Zhou,H.Z., Li,Y., Zhou,H., Liu,Y.C., Du,H.T., Wang,K.L., Wang,F.X. and Ling,H.",2008
EU131804,B,2006,18670237,"A new CRF01_AE/B recombinant structure of HIV type 1 found in Heilongjiang province, China","Zhou,H.Z., Li,Y., Zhou,H., Liu,Y.C., Du,H.T., Wang,K.L., Wang,F.X. and Ling,H.",2008
EU131805,B,2006,18670237,"A new CRF01_AE/B recombinant structure of HIV type 1 found in Heilongjiang province, China","Zhou,H.Z., Li,Y., Zhou,H., Liu,Y.C., Du,H.T., Wang,K.L., Wang,F.X. and Ling,H.",2008
EU131806,B,2004,18670237,"A new CRF01_AE/B recombinant structure of HIV type 1 found in Heilongjiang province, China","Zhou,H.Z., Li,Y., Zhou,H., Liu,Y.C., Du,H.T., Wang,K.L., Wang,F.X. and Ling,H.",2008
EU131807,B,2006,18670237,"A new CRF01_AE/B recombinant structure of HIV type 1 found in Heilongjiang province, China","Zhou,H.Z., Li,Y., Zhou,H., Liu,Y.C., Du,H.T., Wang,K.L., Wang,F.X. and Ling,H.",2008
EU131808,B,2004,18670237,"A new CRF01_AE/B recombinant structure of HIV type 1 found in Heilongjiang province, China","Zhou,H.Z., Li,Y., Zhou,H., Liu,Y.C., Du,H.T., Wang,K.L., Wang,F.X. and Ling,H.",2008
EU131809,B,2006,18670237,"A new CRF01_AE/B recombinant structure of HIV type 1 found in Heilongjiang province, China","Zhou,H.Z., Li,Y., Zhou,H., Liu,Y.C., Du,H.T., Wang,K.L., Wang,F.X. and Ling,H.",2008
EU131810,B,2006,18670237,"A new CRF01_AE/B recombinant structure of HIV type 1 found in Heilongjiang province, China","Zhou,H.Z., Li,Y., Zhou,H., Liu,Y.C., Du,H.T., Wang,K.L., Wang,F.X. and Ling,H.",2008
EU131811,07_BC,2006,18670237,"A new CRF01_AE/B recombinant structure of HIV type 1 found in Heilongjiang province, China","Zhou,H.Z., Li,Y., Zhou,H., Liu,Y.C., Du,H.T., Wang,K.L., Wang,F.X. and Ling,H.",2008
EU161643,C,2000,18094155,4E10-resistant variants in a human immunodeficiency virus type 1 subtype C-infected individual with an anti-membrane-proximal external region-neutralizing antibody response,"Gray,E.S., Moore,P.L., Bibollet-Ruche,F., Li,H., Decker,J.M., Meyers,T., Shaw,G.M. and Morris,L.",2008
EU166353,C,2003,18256145,Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing,"Salazar-Gonzalez,J.F., Bailes,E., Pham,K.T., Salazar,M.G., Guffey,M.B., Keele,B.F., Derdeyn,C.A., Farmer,P., Hunter,E., Allen,S., Manigart,O., Mulenga,J., Anderson,J.A., Swanstrom,R., Haynes,B.F., Athreya,G.S., Korber,B.T., Sharp,P.M., Shaw,G.M. and Hahn,B.H.",2008
EU166379,C,2002,18256145,Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing,"Salazar-Gonzalez,J.F., Bailes,E., Pham,K.T., Salazar,M.G., Guffey,M.B., Keele,B.F., Derdeyn,C.A., Farmer,P., Hunter,E., Allen,S., Manigart,O., Mulenga,J., Anderson,J.A., Swanstrom,R., Haynes,B.F., Athreya,G.S., Korber,B.T., Sharp,P.M., Shaw,G.M. and Hahn,B.H.",2008
EU166413,C,2003,18256145,Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing,"Salazar-Gonzalez,J.F., Bailes,E., Pham,K.T., Salazar,M.G., Guffey,M.B., Keele,B.F., Derdeyn,C.A., Farmer,P., Hunter,E., Allen,S., Manigart,O., Mulenga,J., Anderson,J.A., Swanstrom,R., Haynes,B.F., Athreya,G.S., Korber,B.T., Sharp,P.M., Shaw,G.M. and Hahn,B.H.",2008
EU166439,C,2002,18256145,Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing,"Salazar-Gonzalez,J.F., Bailes,E., Pham,K.T., Salazar,M.G., Guffey,M.B., Keele,B.F., Derdeyn,C.A., Farmer,P., Hunter,E., Allen,S., Manigart,O., Mulenga,J., Anderson,J.A., Swanstrom,R., Haynes,B.F., Athreya,G.S., Korber,B.T., Sharp,P.M., Shaw,G.M. and Hahn,B.H.",2008
EU166576,C,2002,18256145,Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing,"Salazar-Gonzalez,J.F., Bailes,E., Pham,K.T., Salazar,M.G., Guffey,M.B., Keele,B.F., Derdeyn,C.A., Farmer,P., Hunter,E., Allen,S., Manigart,O., Mulenga,J., Anderson,J.A., Swanstrom,R., Haynes,B.F., Athreya,G.S., Korber,B.T., Sharp,P.M., Shaw,G.M. and Hahn,B.H.",2008
EU166605,CF1U,2002,18256145,Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing,"Salazar-Gonzalez,J.F., Bailes,E., Pham,K.T., Salazar,M.G., Guffey,M.B., Keele,B.F., Derdeyn,C.A., Farmer,P., Hunter,E., Allen,S., Manigart,O., Mulenga,J., Anderson,J.A., Swanstrom,R., Haynes,B.F., Athreya,G.S., Korber,B.T., Sharp,P.M., Shaw,G.M. and Hahn,B.H.",2008
EU166653,C,2002,18256145,Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing,"Salazar-Gonzalez,J.F., Bailes,E., Pham,K.T., Salazar,M.G., Guffey,M.B., Keele,B.F., Derdeyn,C.A., Farmer,P., Hunter,E., Allen,S., Manigart,O., Mulenga,J., Anderson,J.A., Swanstrom,R., Haynes,B.F., Athreya,G.S., Korber,B.T., Sharp,P.M., Shaw,G.M. and Hahn,B.H.",2008
EU166681,C,2003,18256145,Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing,"Salazar-Gonzalez,J.F., Bailes,E., Pham,K.T., Salazar,M.G., Guffey,M.B., Keele,B.F., Derdeyn,C.A., Farmer,P., Hunter,E., Allen,S., Manigart,O., Mulenga,J., Anderson,J.A., Swanstrom,R., Haynes,B.F., Athreya,G.S., Korber,B.T., Sharp,P.M., Shaw,G.M. and Hahn,B.H.",2008
EU166718,C,2003,18256145,Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing,"Salazar-Gonzalez,J.F., Bailes,E., Pham,K.T., Salazar,M.G., Guffey,M.B., Keele,B.F., Derdeyn,C.A., Farmer,P., Hunter,E., Allen,S., Manigart,O., Mulenga,J., Anderson,J.A., Swanstrom,R., Haynes,B.F., Athreya,G.S., Korber,B.T., Sharp,P.M., Shaw,G.M. and Hahn,B.H.",2008
EU166759,C,2003,18256145,Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing,"Salazar-Gonzalez,J.F., Bailes,E., Pham,K.T., Salazar,M.G., Guffey,M.B., Keele,B.F., Derdeyn,C.A., Farmer,P., Hunter,E., Allen,S., Manigart,O., Mulenga,J., Anderson,J.A., Swanstrom,R., Haynes,B.F., Athreya,G.S., Korber,B.T., Sharp,P.M., Shaw,G.M. and Hahn,B.H.",2008
EU166779,C,2003,18256145,Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing,"Salazar-Gonzalez,J.F., Bailes,E., Pham,K.T., Salazar,M.G., Guffey,M.B., Keele,B.F., Derdeyn,C.A., Farmer,P., Hunter,E., Allen,S., Manigart,O., Mulenga,J., Anderson,J.A., Swanstrom,R., Haynes,B.F., Athreya,G.S., Korber,B.T., Sharp,P.M., Shaw,G.M. and Hahn,B.H.",2008
EU170135,42_BF,2005,,A new HIV-1 B/F1 unique recombinant form (URF) outbreak in Luxembourg: near full-length genome characterization and phylogenetic analysis,"Struck,D., Roman,F., Lambert,C., Masquelier,C., Servais,J.-Y., Arendt,V., Hemmer,R., Staub,T., Devaux,C. and Schmit,J.-C.",
EU170136,42_BF,2005,,A new HIV-1 B/F1 unique recombinant form (URF) outbreak in Luxembourg: near full-length genome characterization and phylogenetic analysis,"Struck,D., Roman,F., Lambert,C., Masquelier,C., Servais,J.-Y., Arendt,V., Hemmer,R., Staub,T., Devaux,C. and Schmit,J.-C.",
EU170137,42_BF,2006,,A new HIV-1 B/F1 unique recombinant form (URF) outbreak in Luxembourg: near full-length genome characterization and phylogenetic analysis,"Struck,D., Roman,F., Lambert,C., Masquelier,C., Servais,J.-Y., Arendt,V., Hemmer,R., Staub,T., Devaux,C. and Schmit,J.-C.",
EU170138,42_BF,2006,,A new HIV-1 B/F1 unique recombinant form (URF) outbreak in Luxembourg: near full-length genome characterization and phylogenetic analysis,"Struck,D., Roman,F., Lambert,C., Masquelier,C., Servais,J.-Y., Arendt,V., Hemmer,R., Staub,T., Devaux,C. and Schmit,J.-C.",
EU170139,42_BF,2006,,A new HIV-1 B/F1 unique recombinant form (URF) outbreak in Luxembourg: near full-length genome characterization and phylogenetic analysis,"Struck,D., Roman,F., Lambert,C., Masquelier,C., Servais,J.-Y., Arendt,V., Hemmer,R., Staub,T., Devaux,C. and Schmit,J.-C.",
EU170140,42_BF,2003,,A new HIV-1 B/F1 unique recombinant form (URF) outbreak in Luxembourg: near full-length genome characterization and phylogenetic analysis,"Struck,D., Roman,F., Lambert,C., Masquelier,C., Servais,J.-Y., Arendt,V., Hemmer,R., Staub,T., Devaux,C. and Schmit,J.-C.",
EU170141,42_BF,2006,,A new HIV-1 B/F1 unique recombinant form (URF) outbreak in Luxembourg: near full-length genome characterization and phylogenetic analysis,"Struck,D., Roman,F., Lambert,C., Masquelier,C., Servais,J.-Y., Arendt,V., Hemmer,R., Staub,T., Devaux,C. and Schmit,J.-C.",
EU170142,42_BF,2004,,A new HIV-1 B/F1 unique recombinant form (URF) outbreak in Luxembourg: near full-length genome characterization and phylogenetic analysis,"Struck,D., Roman,F., Lambert,C., Masquelier,C., Servais,J.-Y., Arendt,V., Hemmer,R., Staub,T., Devaux,C. and Schmit,J.-C.",
EU170143,42_BF,2005,,A new HIV-1 B/F1 unique recombinant form (URF) outbreak in Luxembourg: near full-length genome characterization and phylogenetic analysis,"Struck,D., Roman,F., Lambert,C., Masquelier,C., Servais,J.-Y., Arendt,V., Hemmer,R., Staub,T., Devaux,C. and Schmit,J.-C.",
EU170144,42_BF,2005,,A new HIV-1 B/F1 unique recombinant form (URF) outbreak in Luxembourg: near full-length genome characterization and phylogenetic analysis,"Struck,D., Roman,F., Lambert,C., Masquelier,C., Servais,J.-Y., Arendt,V., Hemmer,R., Staub,T., Devaux,C. and Schmit,J.-C.",
EU170145,42_BF,2003,,A new HIV-1 B/F1 unique recombinant form (URF) outbreak in Luxembourg: near full-length genome characterization and phylogenetic analysis,"Struck,D., Roman,F., Lambert,C., Masquelier,C., Servais,J.-Y., Arendt,V., Hemmer,R., Staub,T., Devaux,C. and Schmit,J.-C.",
EU170146,42_BF,2004,,A new HIV-1 B/F1 unique recombinant form (URF) outbreak in Luxembourg: near full-length genome characterization and phylogenetic analysis,"Struck,D., Roman,F., Lambert,C., Masquelier,C., Servais,J.-Y., Arendt,V., Hemmer,R., Staub,T., Devaux,C. and Schmit,J.-C.",
EU170147,42_BF,2003,,A new HIV-1 B/F1 unique recombinant form (URF) outbreak in Luxembourg: near full-length genome characterization and phylogenetic analysis,"Struck,D., Roman,F., Lambert,C., Masquelier,C., Servais,J.-Y., Arendt,V., Hemmer,R., Staub,T., Devaux,C. and Schmit,J.-C.",
EU170148,42_BF,2003,,A new HIV-1 B/F1 unique recombinant form (URF) outbreak in Luxembourg: near full-length genome characterization and phylogenetic analysis,"Struck,D., Roman,F., Lambert,C., Masquelier,C., Servais,J.-Y., Arendt,V., Hemmer,R., Staub,T., Devaux,C. and Schmit,J.-C.",
EU170149,42_BF,2003,,A new HIV-1 B/F1 unique recombinant form (URF) outbreak in Luxembourg: near full-length genome characterization and phylogenetic analysis,"Struck,D., Roman,F., Lambert,C., Masquelier,C., Servais,J.-Y., Arendt,V., Hemmer,R., Staub,T., Devaux,C. and Schmit,J.-C.",
EU170150,42_BF,2003,,A new HIV-1 B/F1 unique recombinant form (URF) outbreak in Luxembourg: near full-length genome characterization and phylogenetic analysis,"Struck,D., Roman,F., Lambert,C., Masquelier,C., Servais,J.-Y., Arendt,V., Hemmer,R., Staub,T., Devaux,C. and Schmit,J.-C.",
EU170151,42_BF,2003,,A new HIV-1 B/F1 unique recombinant form (URF) outbreak in Luxembourg: near full-length genome characterization and phylogenetic analysis,"Struck,D., Roman,F., Lambert,C., Masquelier,C., Servais,J.-Y., Arendt,V., Hemmer,R., Staub,T., Devaux,C. and Schmit,J.-C.",
EU170152,42_BF,2003,,A new HIV-1 B/F1 unique recombinant form (URF) outbreak in Luxembourg: near full-length genome characterization and phylogenetic analysis,"Struck,D., Roman,F., Lambert,C., Masquelier,C., Servais,J.-Y., Arendt,V., Hemmer,R., Staub,T., Devaux,C. and Schmit,J.-C.",
EU170153,42_BF,2005,,A new HIV-1 B/F1 unique recombinant form (URF) outbreak in Luxembourg: near full-length genome characterization and phylogenetic analysis,"Struck,D., Roman,F., Lambert,C., Masquelier,C., Servais,J.-Y., Arendt,V., Hemmer,R., Staub,T., Devaux,C. and Schmit,J.-C.",
EU170154,42_BF,2003,,A new HIV-1 B/F1 unique recombinant form (URF) outbreak in Luxembourg: near full-length genome characterization and phylogenetic analysis,"Struck,D., Roman,F., Lambert,C., Masquelier,C., Servais,J.-Y., Arendt,V., Hemmer,R., Staub,T., Devaux,C. and Schmit,J.-C.",
EU170155,42_BF,2003,,A new HIV-1 B/F1 unique recombinant form (URF) outbreak in Luxembourg: near full-length genome characterization and phylogenetic analysis,"Struck,D., Roman,F., Lambert,C., Masquelier,C., Servais,J.-Y., Arendt,V., Hemmer,R., Staub,T., Devaux,C. and Schmit,J.-C.",
EU191613,C,,18192031,Antiviral compounds show enhanced activity in HIV-1 single cycle pseudovirus assays as compared to classical PBMC assays,"Heyndrickx,L., Vermoesen,T., Vereecken,K., Kurth,J., Coppens,S., Aerts,L., Ohagen,A., Van Herrewege,Y., Lewi,P. and Vanham,G.",2008
EU191615,A1,,18192031,Antiviral compounds show enhanced activity in HIV-1 single cycle pseudovirus assays as compared to classical PBMC assays,"Heyndrickx,L., Vermoesen,T., Vereecken,K., Kurth,J., Coppens,S., Aerts,L., Ohagen,A., Van Herrewege,Y., Lewi,P. and Vanham,G.",2008
EU191616,B,,18192031,Antiviral compounds show enhanced activity in HIV-1 single cycle pseudovirus assays as compared to classical PBMC assays,"Heyndrickx,L., Vermoesen,T., Vereecken,K., Kurth,J., Coppens,S., Aerts,L., Ohagen,A., Van Herrewege,Y., Lewi,P. and Vanham,G.",2008
EU191618,A1G,1989,18192031,Antiviral compounds show enhanced activity in HIV-1 single cycle pseudovirus assays as compared to classical PBMC assays,"Heyndrickx,L., Vermoesen,T., Vereecken,K., Kurth,J., Coppens,S., Aerts,L., Ohagen,A., Van Herrewege,Y., Lewi,P. and Vanham,G.",2008
EU220698,A1C,2004,18366312,Near full-length genomic analysis of a novel subtype A1/C recombinant HIV type 1 isolate from Canada,"Ntemgwa,M., Toni,T.D., Brenner,B.G., Routy,J.P., Moisi,D., Oliveira,M. and Wainberg,M.A.",2008
EU251192,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251194,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251195,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251201,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251207,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251208,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251210,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251211,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251212,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251214,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251216,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251220,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251222,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251223,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251225,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251226,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251228,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251232,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251235,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251237,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251242,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251247,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251249,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251251,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251253,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251254,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251258,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251260,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251264,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251265,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251269,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251270,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251271,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251273,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251275,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251279,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251281,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251284,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251285,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251289,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251290,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251291,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251297,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251300,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251304,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251306,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251308,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251310,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251313,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251315,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251317,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251320,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251325,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251328,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251331,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251336,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251345,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251347,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251351,02_AG,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251353,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251358,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251361,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251363,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251367,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251370,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251371,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251375,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU251378,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281662,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281665,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281666,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281668,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281669,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281670,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281671,AG,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281674,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281675,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281676,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281677,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281678,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281679,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281680,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281681,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281682,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281683,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281684,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281685,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281686,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281691,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281693,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281694,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281695,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281698,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281699,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281700,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281701,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281702,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281704,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281706,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281709,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281710,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281715,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281716,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281718,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281720,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281722,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281726,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281727,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281728,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281729,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281730,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281731,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281732,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281733,B,,18419549,"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure","Svicher,V., Aquaro,S., D'Arrigo,R., Artese,A., Dimonte,S., Alcaro,S., Santoro,M.M., Di Perri,G., Caputo,S.L., Bellagamba,R., Zaccarelli,M., Visco-Comandini,U., Antinori,A., Narciso,P., Ceccherini-Silberstein,F. and Perno,C.F.",2008
EU281995,D,1997,18444795,HIV-1 tropism and survival in vertically infected Ugandan infants,"Church,J.D., Huang,W., Mwatha,A., Toma,J., Stawiski,E., Donnell,D., Guay,L.A., Mmiro,F., Musoke,P., Jackson,J.B., Parkin,N. and Eshleman,S.H.",2008
EU281996,D,1997,18444795,HIV-1 tropism and survival in vertically infected Ugandan infants,"Church,J.D., Huang,W., Mwatha,A., Toma,J., Stawiski,E., Donnell,D., Guay,L.A., Mmiro,F., Musoke,P., Jackson,J.B., Parkin,N. and Eshleman,S.H.",2008
EU281997,A1D,1997,18444795,HIV-1 tropism and survival in vertically infected Ugandan infants,"Church,J.D., Huang,W., Mwatha,A., Toma,J., Stawiski,E., Donnell,D., Guay,L.A., Mmiro,F., Musoke,P., Jackson,J.B., Parkin,N. and Eshleman,S.H.",2008
EU281998,D,1997,18444795,HIV-1 tropism and survival in vertically infected Ugandan infants,"Church,J.D., Huang,W., Mwatha,A., Toma,J., Stawiski,E., Donnell,D., Guay,L.A., Mmiro,F., Musoke,P., Jackson,J.B., Parkin,N. and Eshleman,S.H.",2008
EU281999,A1,1997,18444795,HIV-1 tropism and survival in vertically infected Ugandan infants,"Church,J.D., Huang,W., Mwatha,A., Toma,J., Stawiski,E., Donnell,D., Guay,L.A., Mmiro,F., Musoke,P., Jackson,J.B., Parkin,N. and Eshleman,S.H.",2008
EU293444,C,1999,19895210,Viral genetic determinants of nonprogressive HIV type 1 subtype C infection in antiretroviral drug-naive children,"Tzitzivacos,D.B., Tiemessen,C.T., Stevens,W.S. and Papathanasopoulos,M.A.",2009
EU293450,C,1999,19895210,Viral genetic determinants of nonprogressive HIV type 1 subtype C infection in antiretroviral drug-naive children,"Tzitzivacos,D.B., Tiemessen,C.T., Stevens,W.S. and Papathanasopoulos,M.A.",2009
EU342828,A1U,2005,18691031,Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain,"Holguin,A., de Mulder,M., Yebra,G., Lopez,M. and Soriano,V.",2008
EU342829,C,2006,18691031,Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain,"Holguin,A., de Mulder,M., Yebra,G., Lopez,M. and Soriano,V.",2008
EU342831,G,2006,18691031,Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain,"Holguin,A., de Mulder,M., Yebra,G., Lopez,M. and Soriano,V.",2008
EU342833,11_cpx,2006,18691031,Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain,"Holguin,A., de Mulder,M., Yebra,G., Lopez,M. and Soriano,V.",2008
EU342834,02_AG,2006,18691031,Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain,"Holguin,A., de Mulder,M., Yebra,G., Lopez,M. and Soriano,V.",2008
EU342836,F2,2006,18691031,Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain,"Holguin,A., de Mulder,M., Yebra,G., Lopez,M. and Soriano,V.",2008
EU342837,11_cpx,2006,18691031,Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain,"Holguin,A., de Mulder,M., Yebra,G., Lopez,M. and Soriano,V.",2008
EU342838,02_AG,2006,18691031,Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain,"Holguin,A., de Mulder,M., Yebra,G., Lopez,M. and Soriano,V.",2008
EU342839,A1,2006,18691031,Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain,"Holguin,A., de Mulder,M., Yebra,G., Lopez,M. and Soriano,V.",2008
EU342840,G,2006,18691031,Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain,"Holguin,A., de Mulder,M., Yebra,G., Lopez,M. and Soriano,V.",2008
EU342841,A1D,2006,18691031,Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain,"Holguin,A., de Mulder,M., Yebra,G., Lopez,M. and Soriano,V.",2008
EU342843,02_AG,2006,18691031,Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain,"Holguin,A., de Mulder,M., Yebra,G., Lopez,M. and Soriano,V.",2008
EU342845,02_AG,2005,18691031,Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain,"Holguin,A., de Mulder,M., Yebra,G., Lopez,M. and Soriano,V.",2008
EU342846,C,2006,18691031,Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain,"Holguin,A., de Mulder,M., Yebra,G., Lopez,M. and Soriano,V.",2008
EU342848,02_AG,2006,18691031,Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain,"Holguin,A., de Mulder,M., Yebra,G., Lopez,M. and Soriano,V.",2008
EU342850,A,2006,18691031,Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain,"Holguin,A., de Mulder,M., Yebra,G., Lopez,M. and Soriano,V.",2008
EU342852,11_cpx,2006,18691031,Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain,"Holguin,A., de Mulder,M., Yebra,G., Lopez,M. and Soriano,V.",2008
EU342854,22_01A1,2006,18691031,Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain,"Holguin,A., de Mulder,M., Yebra,G., Lopez,M. and Soriano,V.",2008
EU342857,02_AG,2007,18691031,Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain,"Holguin,A., de Mulder,M., Yebra,G., Lopez,M. and Soriano,V.",2008
EU342858,1113,2007,18691031,Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain,"Holguin,A., de Mulder,M., Yebra,G., Lopez,M. and Soriano,V.",2008
EU342859,06_cpx,2007,18691031,Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain,"Holguin,A., de Mulder,M., Yebra,G., Lopez,M. and Soriano,V.",2008
EU342863,02_AG,2007,18691031,Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain,"Holguin,A., de Mulder,M., Yebra,G., Lopez,M. and Soriano,V.",2008
EU342865,02_AG,2007,18691031,Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain,"Holguin,A., de Mulder,M., Yebra,G., Lopez,M. and Soriano,V.",2008
EU363825,B,2003,,Genetic and Neutralization Properties of HIV-1 env Clones from Subtype B/BC/AE Infections in China,"Chong,H., Hong,K., Zhang,C., Nie,J., Song,A., Kong,W. and Wang,Y.",2008
EU363826,B,2003,,Genetic and Neutralization Properties of HIV-1 env Clones from Subtype B/BC/AE Infections in China,"Chong,H., Hong,K., Zhang,C., Nie,J., Song,A., Kong,W. and Wang,Y.",2008
EU363827,B,2003,,Genetic and Neutralization Properties of HIV-1 env Clones from Subtype B/BC/AE Infections in China,"Chong,H., Hong,K., Zhang,C., Nie,J., Song,A., Kong,W. and Wang,Y.",2008
EU363828,B,2006,,Genetic and Neutralization Properties of HIV-1 env Clones from Subtype B/BC/AE Infections in China,"Chong,H., Hong,K., Zhang,C., Nie,J., Song,A., Kong,W. and Wang,Y.",2008
EU363829,B,2006,,Genetic and Neutralization Properties of HIV-1 env Clones from Subtype B/BC/AE Infections in China,"Chong,H., Hong,K., Zhang,C., Nie,J., Song,A., Kong,W. and Wang,Y.",2008
EU363830,B,,,Genetic and Neutralization Properties of HIV-1 env Clones from Subtype B/BC/AE Infections in China,"Chong,H., Hong,K., Zhang,C., Nie,J., Song,A., Kong,W. and Wang,Y.",2008
EU363831,08_BC,2006,,Genetic and Neutralization Properties of HIV-1 env Clones from Subtype B/BC/AE Infections in China,"Chong,H., Hong,K., Zhang,C., Nie,J., Song,A., Kong,W. and Wang,Y.",2008
EU363832,07_BC,,,Genetic and Neutralization Properties of HIV-1 env Clones from Subtype B/BC/AE Infections in China,"Chong,H., Hong,K., Zhang,C., Nie,J., Song,A., Kong,W. and Wang,Y.",2008
EU363833,BC,2003,,Genetic and Neutralization Properties of HIV-1 env Clones from Subtype B/BC/AE Infections in China,"Chong,H., Hong,K., Zhang,C., Nie,J., Song,A., Kong,W. and Wang,Y.",2008
EU363834,BC,2007,,Genetic and Neutralization Properties of HIV-1 env Clones from Subtype B/BC/AE Infections in China,"Chong,H., Hong,K., Zhang,C., Nie,J., Song,A., Kong,W. and Wang,Y.",2008
EU363835,BC,2007,,Genetic and Neutralization Properties of HIV-1 env Clones from Subtype B/BC/AE Infections in China,"Chong,H., Hong,K., Zhang,C., Nie,J., Song,A., Kong,W. and Wang,Y.",2008
EU363836,08_BC,2005,,Genetic and Neutralization Properties of HIV-1 env Clones from Subtype B/BC/AE Infections in China,"Chong,H., Hong,K., Zhang,C., Nie,J., Song,A., Kong,W. and Wang,Y.",2008
EU363837,07_BC,2005,,Genetic and Neutralization Properties of HIV-1 env Clones from Subtype B/BC/AE Infections in China,"Chong,H., Hong,K., Zhang,C., Nie,J., Song,A., Kong,W. and Wang,Y.",2008
EU363838,BC,2006,,Genetic and Neutralization Properties of HIV-1 env Clones from Subtype B/BC/AE Infections in China,"Chong,H., Hong,K., Zhang,C., Nie,J., Song,A., Kong,W. and Wang,Y.",2008
EU363839,BC,2003,,Genetic and Neutralization Properties of HIV-1 env Clones from Subtype B/BC/AE Infections in China,"Chong,H., Hong,K., Zhang,C., Nie,J., Song,A., Kong,W. and Wang,Y.",2008
EU363840,07_BC,2005,,Genetic and Neutralization Properties of HIV-1 env Clones from Subtype B/BC/AE Infections in China,"Chong,H., Hong,K., Zhang,C., Nie,J., Song,A., Kong,W. and Wang,Y.",2008
EU363841,BC,2005,,Genetic and Neutralization Properties of HIV-1 env Clones from Subtype B/BC/AE Infections in China,"Chong,H., Hong,K., Zhang,C., Nie,J., Song,A., Kong,W. and Wang,Y.",2008
EU363842,07_BC,,,Genetic and Neutralization Properties of HIV-1 env Clones from Subtype B/BC/AE Infections in China,"Chong,H., Hong,K., Zhang,C., Nie,J., Song,A., Kong,W. and Wang,Y.",2008
EU363843,BC,,,Genetic and Neutralization Properties of HIV-1 env Clones from Subtype B/BC/AE Infections in China,"Chong,H., Hong,K., Zhang,C., Nie,J., Song,A., Kong,W. and Wang,Y.",2008
EU363844,07_BC,2003,,Genetic and Neutralization Properties of HIV-1 env Clones from Subtype B/BC/AE Infections in China,"Chong,H., Hong,K., Zhang,C., Nie,J., Song,A., Kong,W. and Wang,Y.",2008
EU363845,BC,2003,,Genetic and Neutralization Properties of HIV-1 env Clones from Subtype B/BC/AE Infections in China,"Chong,H., Hong,K., Zhang,C., Nie,J., Song,A., Kong,W. and Wang,Y.",2008
EU363846,07_BC,,,Genetic and Neutralization Properties of HIV-1 env Clones from Subtype B/BC/AE Infections in China,"Chong,H., Hong,K., Zhang,C., Nie,J., Song,A., Kong,W. and Wang,Y.",2008
EU363847,08_BC,2006,,Genetic and Neutralization Properties of HIV-1 env Clones from Subtype B/BC/AE Infections in China,"Chong,H., Hong,K., Zhang,C., Nie,J., Song,A., Kong,W. and Wang,Y.",2008
EU363848,07_BC,2005,,Genetic and Neutralization Properties of HIV-1 env Clones from Subtype B/BC/AE Infections in China,"Chong,H., Hong,K., Zhang,C., Nie,J., Song,A., Kong,W. and Wang,Y.",2008
EU363849,01_AE,1999,,Genetic and Neutralization Properties of HIV-1 env Clones from Subtype B/BC/AE Infections in China,"Chong,H., Hong,K., Zhang,C., Nie,J., Song,A., Kong,W. and Wang,Y.",2008
EU363850,01_AE,2006,,Genetic and Neutralization Properties of HIV-1 env Clones from Subtype B/BC/AE Infections in China,"Chong,H., Hong,K., Zhang,C., Nie,J., Song,A., Kong,W. and Wang,Y.",2008
EU363851,01_AE,2005,,Genetic and Neutralization Properties of HIV-1 env Clones from Subtype B/BC/AE Infections in China,"Chong,H., Hong,K., Zhang,C., Nie,J., Song,A., Kong,W. and Wang,Y.",2008
EU448295,45_cpx,2004,,New and Old Complex Recombinant HIV-1 Strains Among Patients with Primary Infection in 1996-2006 in France: the French ANRS CO06 Primo Cohort Study,"Frange,P., Galimand,J., Vidal,N., Goujard,C., Deveau,C., Souala,F., Peeters,M., Meyer,L., Rouzioux,C. and Chaix,M.-L.",
EU448296,BCU,2006,,New and Old Complex Recombinant HIV-1 Strains Among Patients with Primary Infection in 1996-2006 in France: the French ANRS CO06 Primo Cohort Study,"Frange,P., Galimand,J., Vidal,N., Goujard,C., Deveau,C., Souala,F., Peeters,M., Meyer,L., Rouzioux,C. and Chaix,M.-L.",
EU480455,02_AG,2003,19182920,"Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa","Imamichi,H., Koita,O., Dabitao,D., Dao,S., Ibrah,M., Sogoba,D., Dewar,R.L., Berg,S.C., Jiang,M.K., Parta,M., Washington,J.A., Polis,M.A., Lane,H.C. and Tounkara,A.",2009
EU480456,02_AG,2003,19182920,"Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa","Imamichi,H., Koita,O., Dabitao,D., Dao,S., Ibrah,M., Sogoba,D., Dewar,R.L., Berg,S.C., Jiang,M.K., Parta,M., Washington,J.A., Polis,M.A., Lane,H.C. and Tounkara,A.",2009
EU480457,A,2003,19182920,"Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa","Imamichi,H., Koita,O., Dabitao,D., Dao,S., Ibrah,M., Sogoba,D., Dewar,R.L., Berg,S.C., Jiang,M.K., Parta,M., Washington,J.A., Polis,M.A., Lane,H.C. and Tounkara,A.",2009
EU480458,02_AG,2003,19182920,"Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa","Imamichi,H., Koita,O., Dabitao,D., Dao,S., Ibrah,M., Sogoba,D., Dewar,R.L., Berg,S.C., Jiang,M.K., Parta,M., Washington,J.A., Polis,M.A., Lane,H.C. and Tounkara,A.",2009
EU480459,02_AG,2003,19182920,"Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa","Imamichi,H., Koita,O., Dabitao,D., Dao,S., Ibrah,M., Sogoba,D., Dewar,R.L., Berg,S.C., Jiang,M.K., Parta,M., Washington,J.A., Polis,M.A., Lane,H.C. and Tounkara,A.",2009
EU480460,02_AG,2003,19182920,"Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa","Imamichi,H., Koita,O., Dabitao,D., Dao,S., Ibrah,M., Sogoba,D., Dewar,R.L., Berg,S.C., Jiang,M.K., Parta,M., Washington,J.A., Polis,M.A., Lane,H.C. and Tounkara,A.",2009
EU480461,09_cpx,2003,19182920,"Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa","Imamichi,H., Koita,O., Dabitao,D., Dao,S., Ibrah,M., Sogoba,D., Dewar,R.L., Berg,S.C., Jiang,M.K., Parta,M., Washington,J.A., Polis,M.A., Lane,H.C. and Tounkara,A.",2009
EU480462,06_cpx,2003,19182920,"Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa","Imamichi,H., Koita,O., Dabitao,D., Dao,S., Ibrah,M., Sogoba,D., Dewar,R.L., Berg,S.C., Jiang,M.K., Parta,M., Washington,J.A., Polis,M.A., Lane,H.C. and Tounkara,A.",2009
EU480463,02_AG,2003,19182920,"Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa","Imamichi,H., Koita,O., Dabitao,D., Dao,S., Ibrah,M., Sogoba,D., Dewar,R.L., Berg,S.C., Jiang,M.K., Parta,M., Washington,J.A., Polis,M.A., Lane,H.C. and Tounkara,A.",2009
EU480464,02_AG,2003,19182920,"Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa","Imamichi,H., Koita,O., Dabitao,D., Dao,S., Ibrah,M., Sogoba,D., Dewar,R.L., Berg,S.C., Jiang,M.K., Parta,M., Washington,J.A., Polis,M.A., Lane,H.C. and Tounkara,A.",2009
EU480465,02_AG,2003,19182920,"Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa","Imamichi,H., Koita,O., Dabitao,D., Dao,S., Ibrah,M., Sogoba,D., Dewar,R.L., Berg,S.C., Jiang,M.K., Parta,M., Washington,J.A., Polis,M.A., Lane,H.C. and Tounkara,A.",2009
EU480466,02_AG,2003,19182920,"Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa","Imamichi,H., Koita,O., Dabitao,D., Dao,S., Ibrah,M., Sogoba,D., Dewar,R.L., Berg,S.C., Jiang,M.K., Parta,M., Washington,J.A., Polis,M.A., Lane,H.C. and Tounkara,A.",2009
EU480467,A,2003,19182920,"Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa","Imamichi,H., Koita,O., Dabitao,D., Dao,S., Ibrah,M., Sogoba,D., Dewar,R.L., Berg,S.C., Jiang,M.K., Parta,M., Washington,J.A., Polis,M.A., Lane,H.C. and Tounkara,A.",2009
EU480468,02_AG,2003,19182920,"Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa","Imamichi,H., Koita,O., Dabitao,D., Dao,S., Ibrah,M., Sogoba,D., Dewar,R.L., Berg,S.C., Jiang,M.K., Parta,M., Washington,J.A., Polis,M.A., Lane,H.C. and Tounkara,A.",2009
EU480469,02_AG,2003,19182920,"Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa","Imamichi,H., Koita,O., Dabitao,D., Dao,S., Ibrah,M., Sogoba,D., Dewar,R.L., Berg,S.C., Jiang,M.K., Parta,M., Washington,J.A., Polis,M.A., Lane,H.C. and Tounkara,A.",2009
EU480470,02_AG,2003,19182920,"Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa","Imamichi,H., Koita,O., Dabitao,D., Dao,S., Ibrah,M., Sogoba,D., Dewar,R.L., Berg,S.C., Jiang,M.K., Parta,M., Washington,J.A., Polis,M.A., Lane,H.C. and Tounkara,A.",2009
EU480471,02_AG,2004,19182920,"Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa","Imamichi,H., Koita,O., Dabitao,D., Dao,S., Ibrah,M., Sogoba,D., Dewar,R.L., Berg,S.C., Jiang,M.K., Parta,M., Washington,J.A., Polis,M.A., Lane,H.C. and Tounkara,A.",2009
EU480472,02_AG,2004,19182920,"Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa","Imamichi,H., Koita,O., Dabitao,D., Dao,S., Ibrah,M., Sogoba,D., Dewar,R.L., Berg,S.C., Jiang,M.K., Parta,M., Washington,J.A., Polis,M.A., Lane,H.C. and Tounkara,A.",2009
EU480473,09_cpx,2004,19182920,"Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa","Imamichi,H., Koita,O., Dabitao,D., Dao,S., Ibrah,M., Sogoba,D., Dewar,R.L., Berg,S.C., Jiang,M.K., Parta,M., Washington,J.A., Polis,M.A., Lane,H.C. and Tounkara,A.",2009
EU480474,A,2004,19182920,"Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa","Imamichi,H., Koita,O., Dabitao,D., Dao,S., Ibrah,M., Sogoba,D., Dewar,R.L., Berg,S.C., Jiang,M.K., Parta,M., Washington,J.A., Polis,M.A., Lane,H.C. and Tounkara,A.",2009
EU480475,02_AG,2004,19182920,"Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa","Imamichi,H., Koita,O., Dabitao,D., Dao,S., Ibrah,M., Sogoba,D., Dewar,R.L., Berg,S.C., Jiang,M.K., Parta,M., Washington,J.A., Polis,M.A., Lane,H.C. and Tounkara,A.",2009
EU480476,02_AG,2004,19182920,"Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa","Imamichi,H., Koita,O., Dabitao,D., Dao,S., Ibrah,M., Sogoba,D., Dewar,R.L., Berg,S.C., Jiang,M.K., Parta,M., Washington,J.A., Polis,M.A., Lane,H.C. and Tounkara,A.",2009
EU480477,06_cpx,2005,19182920,"Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa","Imamichi,H., Koita,O., Dabitao,D., Dao,S., Ibrah,M., Sogoba,D., Dewar,R.L., Berg,S.C., Jiang,M.K., Parta,M., Washington,J.A., Polis,M.A., Lane,H.C. and Tounkara,A.",2009
EU513182,02_AG,2004,,Functional env clones of clade AG Human immunodeficiency virus type 1 as standard reference reagents for neutralizing antibody assays,"Ellenberger,D., Li,B., Callahan,M., Butera,S., Folks,T., Nkengasong,J. and Pieniazek,D.",
EU513183,02A1,2005,,Functional env clones of clade AG/A1 Human immunodeficiency virus type 1 as standard reference reagents for neutralizing antibody assays,"Ellenberger,D., Li,B., Callahan,M., Butera,S., Folks,T., Nkengasong,J. and Pieniazek,D.",
EU513184,02_AG,2004,,Functional env clones of clade AG Human immunodeficiency virus type 1 as standard reference reagents for neutralizing antibody assays,"Ellenberger,D., Li,B., Callahan,M., Butera,S., Folks,T., Nkengasong,J. and Pieniazek,D.",
EU513185,02A1,2004,,Functional env clones of clade AG Human immunodeficiency virus type 1 as standard reference reagents for neutralizing antibody assays,"Ellenberger,D., Li,B., Callahan,M., Butera,S., Folks,T., Nkengasong,J. and Pieniazek,D.",
EU513186,02_AG,2004,,Functional env clones of clade AG Human immunodeficiency virus type 1 as standard reference reagents for neutralizing antibody assays,"Ellenberger,D., Li,B., Callahan,M., Butera,S., Folks,T., Nkengasong,J. and Pieniazek,D.",
EU513187,02_AG,2004,,Functional env clones of clade AG Human immunodeficiency virus type 1 as standard reference reagents for neutralizing antibody assays,"Ellenberger,D., Li,B., Callahan,M., Butera,S., Folks,T., Nkengasong,J. and Pieniazek,D.",
EU513188,02A1,2004,,Functional env clones of clade AG Human immunodeficiency virus type 1 as standard reference reagents for neutralizing antibody assays,"Ellenberger,D., Li,B., Callahan,M., Butera,S., Folks,T., Nkengasong,J. and Pieniazek,D.",
EU513189,02_AG,2004,,Functional env clones of clade AG Human immunodeficiency virus type 1 as standard reference reagents for neutralizing antibody assays,"Ellenberger,D., Li,B., Callahan,M., Butera,S., Folks,T., Nkengasong,J. and Pieniazek,D.",
EU513190,A1G,2004,,Functional env clones of clade G Human immunodeficiency virus type 1 as standard reference reagents for neutralizing antibody assays,"Ellenberger,D., Li,B., Callahan,M., Butera,S., Folks,T., Nkengasong,J. and Pieniazek,D.",
EU513191,02_AG,2004,,Functional env clones of clade AG Human immunodeficiency virus type 1 as standard reference reagents for neutralizing antibody assays,"Ellenberger,D., Li,B., Callahan,M., Butera,S., Folks,T., Nkengasong,J. and Pieniazek,D.",
EU513192,13U,2004,,Functional env clones of clade CRF13_cpx Human immunodeficiency virus type 1 as standard reference reagents for neutralizing antibody assays,"Ellenberger,D., Li,B., Callahan,M., Butera,S., Folks,T., Nkengasong,J. and Pieniazek,D.",
EU513193,02_AG,2004,,Functional env clones of clade AG Human immunodeficiency virus type 1 as standard reference reagents for neutralizing antibody assays,"Ellenberger,D., Li,B., Callahan,M., Butera,S., Folks,T., Nkengasong,J. and Pieniazek,D.",
EU513194,02A1,2004,,Functional env clones of clade AG Human immunodeficiency virus type 1 as standard reference reagents for neutralizing antibody assays,"Ellenberger,D., Li,B., Callahan,M., Butera,S., Folks,T., Nkengasong,J. and Pieniazek,D.",
EU513195,02_AG,2004,,Functional env clones of clade AG Human immunodeficiency virus type 1 as standard reference reagents for neutralizing antibody assays,"Ellenberger,D., Li,B., Callahan,M., Butera,S., Folks,T., Nkengasong,J. and Pieniazek,D.",
EU513196,02_AG,2004,,Functional env clones of clade AG Human immunodeficiency virus type 1 as standard reference reagents for neutralizing antibody assays,"Ellenberger,D., Li,B., Callahan,M., Butera,S., Folks,T., Nkengasong,J. and Pieniazek,D.",
EU513198,02_AG,2005,,Functional env clones of clade AG Human immunodeficiency virus type 1 as standard reference reagents for neutralizing antibody assays,"Ellenberger,D., Li,B., Callahan,M., Butera,S., Folks,T., Nkengasong,J. and Pieniazek,D.",
EU513199,02_AG,1999,,Functional env clones of clade AG Human immunodeficiency virus type 1 as standard reference reagents for neutralizing antibody assays,"Ellenberger,D., Li,B., Callahan,M., Butera,S., Folks,T., Nkengasong,J. and Pieniazek,D.",
EU517815,B,,18562530,Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes,"Miura,T., Brockman,M.A., Brumme,C.J., Brumme,Z.L., Carlson,J.M., Pereyra,F., Trocha,A., Addo,M.M., Block,B.L., Rothchild,A.C., Baker,B.M., Flynn,T., Schneidewind,A., Li,B., Wang,Y.E., Heckerman,D., Allen,T.M. and Walker,B.D.",2008
EU517816,B,,18562530,Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes,"Miura,T., Brockman,M.A., Brumme,C.J., Brumme,Z.L., Carlson,J.M., Pereyra,F., Trocha,A., Addo,M.M., Block,B.L., Rothchild,A.C., Baker,B.M., Flynn,T., Schneidewind,A., Li,B., Wang,Y.E., Heckerman,D., Allen,T.M. and Walker,B.D.",2008
EU517817,B,,18562530,Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes,"Miura,T., Brockman,M.A., Brumme,C.J., Brumme,Z.L., Carlson,J.M., Pereyra,F., Trocha,A., Addo,M.M., Block,B.L., Rothchild,A.C., Baker,B.M., Flynn,T., Schneidewind,A., Li,B., Wang,Y.E., Heckerman,D., Allen,T.M. and Walker,B.D.",2008
EU517818,B,,18562530,Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes,"Miura,T., Brockman,M.A., Brumme,C.J., Brumme,Z.L., Carlson,J.M., Pereyra,F., Trocha,A., Addo,M.M., Block,B.L., Rothchild,A.C., Baker,B.M., Flynn,T., Schneidewind,A., Li,B., Wang,Y.E., Heckerman,D., Allen,T.M. and Walker,B.D.",2008
EU517819,B,,18562530,Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes,"Miura,T., Brockman,M.A., Brumme,C.J., Brumme,Z.L., Carlson,J.M., Pereyra,F., Trocha,A., Addo,M.M., Block,B.L., Rothchild,A.C., Baker,B.M., Flynn,T., Schneidewind,A., Li,B., Wang,Y.E., Heckerman,D., Allen,T.M. and Walker,B.D.",2008
EU517820,B,,18562530,Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes,"Miura,T., Brockman,M.A., Brumme,C.J., Brumme,Z.L., Carlson,J.M., Pereyra,F., Trocha,A., Addo,M.M., Block,B.L., Rothchild,A.C., Baker,B.M., Flynn,T., Schneidewind,A., Li,B., Wang,Y.E., Heckerman,D., Allen,T.M. and Walker,B.D.",2008
EU517821,B,,18562530,Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes,"Miura,T., Brockman,M.A., Brumme,C.J., Brumme,Z.L., Carlson,J.M., Pereyra,F., Trocha,A., Addo,M.M., Block,B.L., Rothchild,A.C., Baker,B.M., Flynn,T., Schneidewind,A., Li,B., Wang,Y.E., Heckerman,D., Allen,T.M. and Walker,B.D.",2008
EU517822,B,,18562530,Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes,"Miura,T., Brockman,M.A., Brumme,C.J., Brumme,Z.L., Carlson,J.M., Pereyra,F., Trocha,A., Addo,M.M., Block,B.L., Rothchild,A.C., Baker,B.M., Flynn,T., Schneidewind,A., Li,B., Wang,Y.E., Heckerman,D., Allen,T.M. and Walker,B.D.",2008
EU517823,B,,18562530,Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes,"Miura,T., Brockman,M.A., Brumme,C.J., Brumme,Z.L., Carlson,J.M., Pereyra,F., Trocha,A., Addo,M.M., Block,B.L., Rothchild,A.C., Baker,B.M., Flynn,T., Schneidewind,A., Li,B., Wang,Y.E., Heckerman,D., Allen,T.M. and Walker,B.D.",2008
EU517824,B,,18562530,Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes,"Miura,T., Brockman,M.A., Brumme,C.J., Brumme,Z.L., Carlson,J.M., Pereyra,F., Trocha,A., Addo,M.M., Block,B.L., Rothchild,A.C., Baker,B.M., Flynn,T., Schneidewind,A., Li,B., Wang,Y.E., Heckerman,D., Allen,T.M. and Walker,B.D.",2008
EU517825,B,,18562530,Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes,"Miura,T., Brockman,M.A., Brumme,C.J., Brumme,Z.L., Carlson,J.M., Pereyra,F., Trocha,A., Addo,M.M., Block,B.L., Rothchild,A.C., Baker,B.M., Flynn,T., Schneidewind,A., Li,B., Wang,Y.E., Heckerman,D., Allen,T.M. and Walker,B.D.",2008
EU517826,B,,18562530,Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes,"Miura,T., Brockman,M.A., Brumme,C.J., Brumme,Z.L., Carlson,J.M., Pereyra,F., Trocha,A., Addo,M.M., Block,B.L., Rothchild,A.C., Baker,B.M., Flynn,T., Schneidewind,A., Li,B., Wang,Y.E., Heckerman,D., Allen,T.M. and Walker,B.D.",2008
EU517827,B,,18562530,Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes,"Miura,T., Brockman,M.A., Brumme,C.J., Brumme,Z.L., Carlson,J.M., Pereyra,F., Trocha,A., Addo,M.M., Block,B.L., Rothchild,A.C., Baker,B.M., Flynn,T., Schneidewind,A., Li,B., Wang,Y.E., Heckerman,D., Allen,T.M. and Walker,B.D.",2008
EU517828,B,,18562530,Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes,"Miura,T., Brockman,M.A., Brumme,C.J., Brumme,Z.L., Carlson,J.M., Pereyra,F., Trocha,A., Addo,M.M., Block,B.L., Rothchild,A.C., Baker,B.M., Flynn,T., Schneidewind,A., Li,B., Wang,Y.E., Heckerman,D., Allen,T.M. and Walker,B.D.",2008
EU517829,B,,18562530,Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes,"Miura,T., Brockman,M.A., Brumme,C.J., Brumme,Z.L., Carlson,J.M., Pereyra,F., Trocha,A., Addo,M.M., Block,B.L., Rothchild,A.C., Baker,B.M., Flynn,T., Schneidewind,A., Li,B., Wang,Y.E., Heckerman,D., Allen,T.M. and Walker,B.D.",2008
EU517830,B,,18562530,Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes,"Miura,T., Brockman,M.A., Brumme,C.J., Brumme,Z.L., Carlson,J.M., Pereyra,F., Trocha,A., Addo,M.M., Block,B.L., Rothchild,A.C., Baker,B.M., Flynn,T., Schneidewind,A., Li,B., Wang,Y.E., Heckerman,D., Allen,T.M. and Walker,B.D.",2008
EU517831,B,,18562530,Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes,"Miura,T., Brockman,M.A., Brumme,C.J., Brumme,Z.L., Carlson,J.M., Pereyra,F., Trocha,A., Addo,M.M., Block,B.L., Rothchild,A.C., Baker,B.M., Flynn,T., Schneidewind,A., Li,B., Wang,Y.E., Heckerman,D., Allen,T.M. and Walker,B.D.",2008
EU517832,B,,18562530,Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes,"Miura,T., Brockman,M.A., Brumme,C.J., Brumme,Z.L., Carlson,J.M., Pereyra,F., Trocha,A., Addo,M.M., Block,B.L., Rothchild,A.C., Baker,B.M., Flynn,T., Schneidewind,A., Li,B., Wang,Y.E., Heckerman,D., Allen,T.M. and Walker,B.D.",2008
EU517833,B,,18562530,Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes,"Miura,T., Brockman,M.A., Brumme,C.J., Brumme,Z.L., Carlson,J.M., Pereyra,F., Trocha,A., Addo,M.M., Block,B.L., Rothchild,A.C., Baker,B.M., Flynn,T., Schneidewind,A., Li,B., Wang,Y.E., Heckerman,D., Allen,T.M. and Walker,B.D.",2008
EU517834,B,,18562530,Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes,"Miura,T., Brockman,M.A., Brumme,C.J., Brumme,Z.L., Carlson,J.M., Pereyra,F., Trocha,A., Addo,M.M., Block,B.L., Rothchild,A.C., Baker,B.M., Flynn,T., Schneidewind,A., Li,B., Wang,Y.E., Heckerman,D., Allen,T.M. and Walker,B.D.",2008
EU517835,B,,18562530,Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes,"Miura,T., Brockman,M.A., Brumme,C.J., Brumme,Z.L., Carlson,J.M., Pereyra,F., Trocha,A., Addo,M.M., Block,B.L., Rothchild,A.C., Baker,B.M., Flynn,T., Schneidewind,A., Li,B., Wang,Y.E., Heckerman,D., Allen,T.M. and Walker,B.D.",2008
EU517836,B,,18562530,Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes,"Miura,T., Brockman,M.A., Brumme,C.J., Brumme,Z.L., Carlson,J.M., Pereyra,F., Trocha,A., Addo,M.M., Block,B.L., Rothchild,A.C., Baker,B.M., Flynn,T., Schneidewind,A., Li,B., Wang,Y.E., Heckerman,D., Allen,T.M. and Walker,B.D.",2008
EU517837,B,,18562530,Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes,"Miura,T., Brockman,M.A., Brumme,C.J., Brumme,Z.L., Carlson,J.M., Pereyra,F., Trocha,A., Addo,M.M., Block,B.L., Rothchild,A.C., Baker,B.M., Flynn,T., Schneidewind,A., Li,B., Wang,Y.E., Heckerman,D., Allen,T.M. and Walker,B.D.",2008
EU517838,B,,18562530,Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes,"Miura,T., Brockman,M.A., Brumme,C.J., Brumme,Z.L., Carlson,J.M., Pereyra,F., Trocha,A., Addo,M.M., Block,B.L., Rothchild,A.C., Baker,B.M., Flynn,T., Schneidewind,A., Li,B., Wang,Y.E., Heckerman,D., Allen,T.M. and Walker,B.D.",2008
EU517839,B,,18562530,Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes,"Miura,T., Brockman,M.A., Brumme,C.J., Brumme,Z.L., Carlson,J.M., Pereyra,F., Trocha,A., Addo,M.M., Block,B.L., Rothchild,A.C., Baker,B.M., Flynn,T., Schneidewind,A., Li,B., Wang,Y.E., Heckerman,D., Allen,T.M. and Walker,B.D.",2008
EU521727,C,2007,21524671,HIV-1 clade C envelopes obtained from late stage symptomatic Indian patients varied in their ability towards relative CD4 usages and sensitivity to CCR5 antagonist TAK-779,"Gharu,L., Ringe,R. and Bhattacharya,J.",2011
EU521728,C,,21524671,HIV-1 clade C envelopes obtained from late stage symptomatic Indian patients varied in their ability towards relative CD4 usages and sensitivity to CCR5 antagonist TAK-779,"Gharu,L., Ringe,R. and Bhattacharya,J.",2011
EU521729,C,2000,19409946,HIV-1 clade C env clones obtained from an Indian patient exhibiting expanded coreceptor tropism are presented with naturally occurring unusual amino acid substitutions in V3 loop,"Gharu,L., Ringe,R., Pandey,S., Paranjape,R. and Bhattacharya,J.",2009
EU577479,B,1999,18490657,Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection,"Keele,B.F., Giorgi,E.E., Salazar-Gonzalez,J.F., Decker,J.M., Pham,K.T., Salazar,M.G., Sun,C., Grayson,T., Wang,S., Li,H., Wei,X., Jiang,C., Kirchherr,J.L., Gao,F., Anderson,J.A., Ping,L.H., Swanstrom,R., Tomaras,G.D., Blattner,W.A., Goepfert,P.A., Kilby,J.M., Saag,M.S., Delwart,E.L., Busch,M.P., Cohen,M.S., Montefiori,D.C., Haynes,B.F., Gaschen,B., Athreya,G.S., Lee,H.Y., Wood,N., Seoighe,C., Perelson,A.S., Bhattacharya,T., Korber,B.T., Hahn,B.H. and Shaw,G.M.",2008
EU577589,B,2001,18490657,Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection,"Keele,B.F., Giorgi,E.E., Salazar-Gonzalez,J.F., Decker,J.M., Pham,K.T., Salazar,M.G., Sun,C., Grayson,T., Wang,S., Li,H., Wei,X., Jiang,C., Kirchherr,J.L., Gao,F., Anderson,J.A., Ping,L.H., Swanstrom,R., Tomaras,G.D., Blattner,W.A., Goepfert,P.A., Kilby,J.M., Saag,M.S., Delwart,E.L., Busch,M.P., Cohen,M.S., Montefiori,D.C., Haynes,B.F., Gaschen,B., Athreya,G.S., Lee,H.Y., Wood,N., Seoighe,C., Perelson,A.S., Bhattacharya,T., Korber,B.T., Hahn,B.H. and Shaw,G.M.",2008
EU581823,17_BF,2002,,Identification of CRF17_BF in Four South American Countries,"Carr,J.K., Gomez-Carrillo,M., Avila,M., Montano,S., Sanchez,J.L. and Eyzaguirre,L.M.",
EU581824,17_BF,2002,,Identification of CRF17_BF in Four South American Countries,"Carr,J.K., Gomez-Carrillo,M., Avila,M., Montano,S., Sanchez,J.L. and Eyzaguirre,L.M.",
EU581825,17_BF,2002,,Identification of CRF17_BF in Four South American Countries,"Carr,J.K., Gomez-Carrillo,M., Avila,M., Montano,S., Sanchez,J.L. and Eyzaguirre,L.M.",
EU581826,17_BF,2002,,Identification of CRF17_BF in Four South American Countries,"Carr,J.K., Gomez-Carrillo,M., Avila,M., Montano,S., Sanchez,J.L. and Eyzaguirre,L.M.",
EU581827,17_BF,2002,,Identification of CRF17_BF in Four South American Countries,"Carr,J.K., Gomez-Carrillo,M., Avila,M., Montano,S., Sanchez,J.L. and Eyzaguirre,L.M.",
EU581828,17_BF,2002,,Identification of CRF17_BF in Four South American Countries,"Carr,J.K., Gomez-Carrillo,M., Avila,M., Montano,S., Sanchez,J.L. and Eyzaguirre,L.M.",
EU604549,B,,18443125,Suppression of dualtropic human immunodeficiency virus type 1 by the CXCR4 antagonist AMD3100 is associated with efficiency of CXCR4 use and baseline virus composition,"Fransen,S., Bridger,G., Whitcomb,J.M., Toma,J., Stawiski,E., Parkin,N., Petropoulos,C.J. and Huang,W.",2008
EU604591,B,,18443125,Suppression of dualtropic human immunodeficiency virus type 1 by the CXCR4 antagonist AMD3100 is associated with efficiency of CXCR4 use and baseline virus composition,"Fransen,S., Bridger,G., Whitcomb,J.M., Toma,J., Stawiski,E., Parkin,N., Petropoulos,C.J. and Huang,W.",2008
EU616639,B,,18625749,Immune-driven recombination and loss of control after HIV superinfection,"Streeck,H., Li,B., Poon,A.F., Schneidewind,A., Gladden,A.D., Power,K.A., Daskalakis,D., Bazner,S., Zuniga,R., Brander,C., Rosenberg,E.S., Frost,S.D., Altfeld,M. and Allen,T.M.",2008
EU622001,C,,21524671,HIV-1 clade C envelopes obtained from late stage symptomatic Indian patients varied in their ability towards relative CD4 usages and sensitivity to CCR5 antagonist TAK-779,"Gharu,L., Ringe,R. and Bhattacharya,J.",2011
EU622006,C,,21524671,HIV-1 clade C envelopes obtained from late stage symptomatic Indian patients varied in their ability towards relative CD4 usages and sensitivity to CCR5 antagonist TAK-779,"Gharu,L., Ringe,R. and Bhattacharya,J.",2011
EU622009,C,,21524671,HIV-1 clade C envelopes obtained from late stage symptomatic Indian patients varied in their ability towards relative CD4 usages and sensitivity to CCR5 antagonist TAK-779,"Gharu,L., Ringe,R. and Bhattacharya,J.",2011
EU622012,C,,21524671,HIV-1 clade C envelopes obtained from late stage symptomatic Indian patients varied in their ability towards relative CD4 usages and sensitivity to CCR5 antagonist TAK-779,"Gharu,L., Ringe,R. and Bhattacharya,J.",2011
EU663615,C,2004,,In vivo emergence of vicriviroc resistance in an HIV-1 subtype C-infected subject,"Tsibris,A.M.N., Manish,S., Gulick,R.M., Su,Z., Hughes,M., Greaves,W., Subramanian,M., Flexner,C., Giguel,F., Leopold,K.E., Coakley,E. and Kuritzkes,D.R.",
EU668962,C,2003,19182918,Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance,"Kousiappa,I., van de Vijver,D.A., Demetriades,I. and Kostrikis,L.G.",2009
EU668963,B,2003,19182918,Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance,"Kousiappa,I., van de Vijver,D.A., Demetriades,I. and Kostrikis,L.G.",2009
EU668964,D,2004,19182918,Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance,"Kousiappa,I., van de Vijver,D.A., Demetriades,I. and Kostrikis,L.G.",2009
EU668966,A1,2004,19182918,Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance,"Kousiappa,I., van de Vijver,D.A., Demetriades,I. and Kostrikis,L.G.",2009
EU668967,B,2004,19182918,Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance,"Kousiappa,I., van de Vijver,D.A., Demetriades,I. and Kostrikis,L.G.",2009
EU668968,A1,2005,19182918,Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance,"Kousiappa,I., van de Vijver,D.A., Demetriades,I. and Kostrikis,L.G.",2009
EU668969,B,2005,19182918,Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance,"Kousiappa,I., van de Vijver,D.A., Demetriades,I. and Kostrikis,L.G.",2009
EU668970,B,2005,19182918,Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance,"Kousiappa,I., van de Vijver,D.A., Demetriades,I. and Kostrikis,L.G.",2009
EU668971,A1,2005,19182918,Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance,"Kousiappa,I., van de Vijver,D.A., Demetriades,I. and Kostrikis,L.G.",2009
EU668972,B,2005,19182918,Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance,"Kousiappa,I., van de Vijver,D.A., Demetriades,I. and Kostrikis,L.G.",2009
EU668973,B,2005,19182918,Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance,"Kousiappa,I., van de Vijver,D.A., Demetriades,I. and Kostrikis,L.G.",2009
EU668974,02_AG,2005,19182918,Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance,"Kousiappa,I., van de Vijver,D.A., Demetriades,I. and Kostrikis,L.G.",2009
EU668975,A6,2005,19182918,Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance,"Kousiappa,I., van de Vijver,D.A., Demetriades,I. and Kostrikis,L.G.",2009
EU668976,A6,2005,19182918,Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance,"Kousiappa,I., van de Vijver,D.A., Demetriades,I. and Kostrikis,L.G.",2009
EU668977,C,2005,19182918,Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance,"Kousiappa,I., van de Vijver,D.A., Demetriades,I. and Kostrikis,L.G.",2009
EU668978,B,2005,19182918,Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance,"Kousiappa,I., van de Vijver,D.A., Demetriades,I. and Kostrikis,L.G.",2009
EU668979,A1U,2005,19182918,Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance,"Kousiappa,I., van de Vijver,D.A., Demetriades,I. and Kostrikis,L.G.",2009
EU668980,A1U,2005,19182918,Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance,"Kousiappa,I., van de Vijver,D.A., Demetriades,I. and Kostrikis,L.G.",2009
EU668981,B,2005,19182918,Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance,"Kousiappa,I., van de Vijver,D.A., Demetriades,I. and Kostrikis,L.G.",2009
EU668982,A1,2005,19182918,Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance,"Kousiappa,I., van de Vijver,D.A., Demetriades,I. and Kostrikis,L.G.",2009
EU668983,01A1,2006,19182918,Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance,"Kousiappa,I., van de Vijver,D.A., Demetriades,I. and Kostrikis,L.G.",2009
EU668984,C,2006,19182918,Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance,"Kousiappa,I., van de Vijver,D.A., Demetriades,I. and Kostrikis,L.G.",2009
EU668985,A6,2006,19182918,Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance,"Kousiappa,I., van de Vijver,D.A., Demetriades,I. and Kostrikis,L.G.",2009
EU668986,A6,2006,19182918,Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance,"Kousiappa,I., van de Vijver,D.A., Demetriades,I. and Kostrikis,L.G.",2009
EU668987,A6,2006,19182918,Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance,"Kousiappa,I., van de Vijver,D.A., Demetriades,I. and Kostrikis,L.G.",2009
EU668988,C,2006,19182918,Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance,"Kousiappa,I., van de Vijver,D.A., Demetriades,I. and Kostrikis,L.G.",2009
EU668989,C,2006,19182918,Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance,"Kousiappa,I., van de Vijver,D.A., Demetriades,I. and Kostrikis,L.G.",2009
EU668990,01A1,2006,19182918,Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance,"Kousiappa,I., van de Vijver,D.A., Demetriades,I. and Kostrikis,L.G.",2009
EU668991,01_AE,2006,19182918,Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance,"Kousiappa,I., van de Vijver,D.A., Demetriades,I. and Kostrikis,L.G.",2009
EU683891,DU,,,Functional env clone of clade D Human immunodeficiency virus type 1 as standard reference reagents for neutralizing antibody assays,"Ellenberger,D., Li,B., Callahan,M., Butera,S., Folks,T., Nkengasong,J., Kalish,M. and Pieniazek,D.",
EU693240,25_cpx,2006,18851680,Near full-length genome characterization of an HIV type 1 CRF25_cpx strain from Cameroon,"Luk,K.-C., Holzmayer,V., Ndembi,N., Swanson,P., Brennan,C.A., Ngansop,C., Mbanya,D., Kaptue,L., Gurtler,L., Devare,S.G. and Hackett,J. Jr.",2008
EU697904,43_02G,2003,17530991,Identification and characterization of HIV type 1 subtypes present in the Kingdom of Saudi Arabia: high level of genetic diversity found,"Badreddine,S., Smith,K., van Zyl,H., Bodelle,P., Yamaguchi,J., Swanson,P., Devare,S.G. and Brennan,C.A.",2007
EU697905,43_02G,2003,17530991,Identification and characterization of HIV type 1 subtypes present in the Kingdom of Saudi Arabia: high level of genetic diversity found,"Badreddine,S., Smith,K., van Zyl,H., Bodelle,P., Yamaguchi,J., Swanson,P., Devare,S.G. and Brennan,C.A.",2007
EU697906,25_cpx,2003,17530991,Identification and characterization of HIV type 1 subtypes present in the Kingdom of Saudi Arabia: high level of genetic diversity found,"Badreddine,S., Smith,K., van Zyl,H., Bodelle,P., Yamaguchi,J., Swanson,P., Devare,S.G. and Brennan,C.A.",2007
EU697907,43_02G,2003,17530991,Identification and characterization of HIV type 1 subtypes present in the Kingdom of Saudi Arabia: high level of genetic diversity found,"Badreddine,S., Smith,K., van Zyl,H., Bodelle,P., Yamaguchi,J., Swanson,P., Devare,S.G. and Brennan,C.A.",2007
EU697908,25_cpx,2003,17530991,Identification and characterization of HIV type 1 subtypes present in the Kingdom of Saudi Arabia: high level of genetic diversity found,"Badreddine,S., Smith,K., van Zyl,H., Bodelle,P., Yamaguchi,J., Swanson,P., Devare,S.G. and Brennan,C.A.",2007
EU697909,43_02G,2003,17530991,Identification and characterization of HIV type 1 subtypes present in the Kingdom of Saudi Arabia: high level of genetic diversity found,"Badreddine,S., Smith,K., van Zyl,H., Bodelle,P., Yamaguchi,J., Swanson,P., Devare,S.G. and Brennan,C.A.",2007
EU735540,40_BF,2004,18195572,"Identification of two new CRF_BF in Rio de Janeiro State, Brazil","Guimaraes,M.L., Eyer-Silva,W.A., Couto-Fernandez,J.C. and Morgado,M.G.",2008
EU743963,22_01A1,2002,20812894,Identification and Genetic Characterization of a Novel CRF22_01A1 Recombinant Form of HIV Type 1 in Cameroon,"Zhao,J., Tang,S., Ragupathy,V., Carr,J.K., Wolfe,N.D., Awazi,B. and Hewlett,I.",2010
EU743964,0222,2002,,Identification of new recombinant of CRF22 with subtype A1 or CRF02_AG of HIV-1 in Cameroon,"Zhao,J., Tang,S., Viswanath,R., Wang,X., Awazi,B. and Hewlett,I.",
EU743973,B,1986,18524815,Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection,"Bunnik,E.M., Pisas,L., van Nuenen,A.C. and Schuitemaker,H.",2008
EU744014,B,1985,18524815,Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection,"Bunnik,E.M., Pisas,L., van Nuenen,A.C. and Schuitemaker,H.",2008
EU744055,B,1987,18524815,Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection,"Bunnik,E.M., Pisas,L., van Nuenen,A.C. and Schuitemaker,H.",2008
EU744097,B,1986,18524815,Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection,"Bunnik,E.M., Pisas,L., van Nuenen,A.C. and Schuitemaker,H.",2008
EU744146,B,1985,18524815,Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection,"Bunnik,E.M., Pisas,L., van Nuenen,A.C. and Schuitemaker,H.",2008
EU786670,G,2005,19113978,Development of a panel of well-characterized human immunodeficiency virus type 1 isolates from newly diagnosed patients including acute and recent infections,"Fernandez-Garcia,A., Cuevas,M.T., Munoz-Nieto,M., Ocampo,A., Pinilla,M., Garcia,V., Serrano-Bengoechea,E., Lezaun,M.J., Delgado,E., Thomson,M., Gonzalez-Galeano,M., Contreras,G., Najera,R. and Perez-Alvarez,L.",2009
EU786671,02_AG,2006,19113978,Development of a panel of well-characterized human immunodeficiency virus type 1 isolates from newly diagnosed patients including acute and recent infections,"Fernandez-Garcia,A., Cuevas,M.T., Munoz-Nieto,M., Ocampo,A., Pinilla,M., Garcia,V., Serrano-Bengoechea,E., Lezaun,M.J., Delgado,E., Thomson,M., Gonzalez-Galeano,M., Contreras,G., Najera,R. and Perez-Alvarez,L.",2009
EU786672,B,2005,19113978,Development of a panel of well-characterized human immunodeficiency virus type 1 isolates from newly diagnosed patients including acute and recent infections,"Fernandez-Garcia,A., Cuevas,M.T., Munoz-Nieto,M., Ocampo,A., Pinilla,M., Garcia,V., Serrano-Bengoechea,E., Lezaun,M.J., Delgado,E., Thomson,M., Gonzalez-Galeano,M., Contreras,G., Najera,R. and Perez-Alvarez,L.",2009
EU786673,C,2006,19113978,Development of a panel of well-characterized human immunodeficiency virus type 1 isolates from newly diagnosed patients including acute and recent infections,"Fernandez-Garcia,A., Cuevas,M.T., Munoz-Nieto,M., Ocampo,A., Pinilla,M., Garcia,V., Serrano-Bengoechea,E., Lezaun,M.J., Delgado,E., Thomson,M., Gonzalez-Galeano,M., Contreras,G., Najera,R. and Perez-Alvarez,L.",2009
EU786674,B,2006,19113978,Development of a panel of well-characterized human immunodeficiency virus type 1 isolates from newly diagnosed patients including acute and recent infections,"Fernandez-Garcia,A., Cuevas,M.T., Munoz-Nieto,M., Ocampo,A., Pinilla,M., Garcia,V., Serrano-Bengoechea,E., Lezaun,M.J., Delgado,E., Thomson,M., Gonzalez-Galeano,M., Contreras,G., Najera,R. and Perez-Alvarez,L.",2009
EU786675,B,2006,19113978,Development of a panel of well-characterized human immunodeficiency virus type 1 isolates from newly diagnosed patients including acute and recent infections,"Fernandez-Garcia,A., Cuevas,M.T., Munoz-Nieto,M., Ocampo,A., Pinilla,M., Garcia,V., Serrano-Bengoechea,E., Lezaun,M.J., Delgado,E., Thomson,M., Gonzalez-Galeano,M., Contreras,G., Najera,R. and Perez-Alvarez,L.",2009
EU786676,B,2006,19113978,Development of a panel of well-characterized human immunodeficiency virus type 1 isolates from newly diagnosed patients including acute and recent infections,"Fernandez-Garcia,A., Cuevas,M.T., Munoz-Nieto,M., Ocampo,A., Pinilla,M., Garcia,V., Serrano-Bengoechea,E., Lezaun,M.J., Delgado,E., Thomson,M., Gonzalez-Galeano,M., Contreras,G., Najera,R. and Perez-Alvarez,L.",2009
EU786677,B,2006,19113978,Development of a panel of well-characterized human immunodeficiency virus type 1 isolates from newly diagnosed patients including acute and recent infections,"Fernandez-Garcia,A., Cuevas,M.T., Munoz-Nieto,M., Ocampo,A., Pinilla,M., Garcia,V., Serrano-Bengoechea,E., Lezaun,M.J., Delgado,E., Thomson,M., Gonzalez-Galeano,M., Contreras,G., Najera,R. and Perez-Alvarez,L.",2009
EU786678,B,2007,19113978,Development of a panel of well-characterized human immunodeficiency virus type 1 isolates from newly diagnosed patients including acute and recent infections,"Fernandez-Garcia,A., Cuevas,M.T., Munoz-Nieto,M., Ocampo,A., Pinilla,M., Garcia,V., Serrano-Bengoechea,E., Lezaun,M.J., Delgado,E., Thomson,M., Gonzalez-Galeano,M., Contreras,G., Najera,R. and Perez-Alvarez,L.",2009
EU786679,B,2007,19113978,Development of a panel of well-characterized human immunodeficiency virus type 1 isolates from newly diagnosed patients including acute and recent infections,"Fernandez-Garcia,A., Cuevas,M.T., Munoz-Nieto,M., Ocampo,A., Pinilla,M., Garcia,V., Serrano-Bengoechea,E., Lezaun,M.J., Delgado,E., Thomson,M., Gonzalez-Galeano,M., Contreras,G., Najera,R. and Perez-Alvarez,L.",2009
EU786680,B,2007,19113978,Development of a panel of well-characterized human immunodeficiency virus type 1 isolates from newly diagnosed patients including acute and recent infections,"Fernandez-Garcia,A., Cuevas,M.T., Munoz-Nieto,M., Ocampo,A., Pinilla,M., Garcia,V., Serrano-Bengoechea,E., Lezaun,M.J., Delgado,E., Thomson,M., Gonzalez-Galeano,M., Contreras,G., Najera,R. and Perez-Alvarez,L.",2009
EU786681,C,2008,19113978,Development of a panel of well-characterized human immunodeficiency virus type 1 isolates from newly diagnosed patients including acute and recent infections,"Fernandez-Garcia,A., Cuevas,M.T., Munoz-Nieto,M., Ocampo,A., Pinilla,M., Garcia,V., Serrano-Bengoechea,E., Lezaun,M.J., Delgado,E., Thomson,M., Gonzalez-Galeano,M., Contreras,G., Najera,R. and Perez-Alvarez,L.",2009
EU807761,B,,18495769,Transmission of human immunodeficiency virus type 1 from a patient who developed AIDS to an elite suppressor,"Bailey,J.R., O'Connell,K., Yang,H.C., Han,Y., Xu,J., Jilek,B., Williams,T.M., Ray,S.C., Siliciano,R.F. and Blankson,J.N.",2008
EU839596,B,2005,19279683,HIV-1 epidemic in the Caribbean is dominated by subtype B,"Nadai,Y., Eyzaguirre,L.M., Sill,A., Cleghorn,F., Nolte,C., Charurat,M., Collado-Chastel,S., Jack,N., Bartholomew,C., Pape,J.W., Figueroa,P., Blattner,W.A. and Carr,J.K.",2009
EU839597,B,2005,19279683,HIV-1 epidemic in the Caribbean is dominated by subtype B,"Nadai,Y., Eyzaguirre,L.M., Sill,A., Cleghorn,F., Nolte,C., Charurat,M., Collado-Chastel,S., Jack,N., Bartholomew,C., Pape,J.W., Figueroa,P., Blattner,W.A. and Carr,J.K.",2009
EU839598,B,2005,19279683,HIV-1 epidemic in the Caribbean is dominated by subtype B,"Nadai,Y., Eyzaguirre,L.M., Sill,A., Cleghorn,F., Nolte,C., Charurat,M., Collado-Chastel,S., Jack,N., Bartholomew,C., Pape,J.W., Figueroa,P., Blattner,W.A. and Carr,J.K.",2009
EU839600,B,2005,19279683,HIV-1 epidemic in the Caribbean is dominated by subtype B,"Nadai,Y., Eyzaguirre,L.M., Sill,A., Cleghorn,F., Nolte,C., Charurat,M., Collado-Chastel,S., Jack,N., Bartholomew,C., Pape,J.W., Figueroa,P., Blattner,W.A. and Carr,J.K.",2009
EU839601,B,2005,19279683,HIV-1 epidemic in the Caribbean is dominated by subtype B,"Nadai,Y., Eyzaguirre,L.M., Sill,A., Cleghorn,F., Nolte,C., Charurat,M., Collado-Chastel,S., Jack,N., Bartholomew,C., Pape,J.W., Figueroa,P., Blattner,W.A. and Carr,J.K.",2009
EU839602,B,2005,19279683,HIV-1 epidemic in the Caribbean is dominated by subtype B,"Nadai,Y., Eyzaguirre,L.M., Sill,A., Cleghorn,F., Nolte,C., Charurat,M., Collado-Chastel,S., Jack,N., Bartholomew,C., Pape,J.W., Figueroa,P., Blattner,W.A. and Carr,J.K.",2009
EU839603,B,2005,19279683,HIV-1 epidemic in the Caribbean is dominated by subtype B,"Nadai,Y., Eyzaguirre,L.M., Sill,A., Cleghorn,F., Nolte,C., Charurat,M., Collado-Chastel,S., Jack,N., Bartholomew,C., Pape,J.W., Figueroa,P., Blattner,W.A. and Carr,J.K.",2009
EU839604,B,2005,19279683,HIV-1 epidemic in the Caribbean is dominated by subtype B,"Nadai,Y., Eyzaguirre,L.M., Sill,A., Cleghorn,F., Nolte,C., Charurat,M., Collado-Chastel,S., Jack,N., Bartholomew,C., Pape,J.W., Figueroa,P., Blattner,W.A. and Carr,J.K.",2009
EU839605,B,2005,19279683,HIV-1 epidemic in the Caribbean is dominated by subtype B,"Nadai,Y., Eyzaguirre,L.M., Sill,A., Cleghorn,F., Nolte,C., Charurat,M., Collado-Chastel,S., Jack,N., Bartholomew,C., Pape,J.W., Figueroa,P., Blattner,W.A. and Carr,J.K.",2009
EU839606,B,2000,19279683,HIV-1 epidemic in the Caribbean is dominated by subtype B,"Nadai,Y., Eyzaguirre,L.M., Sill,A., Cleghorn,F., Nolte,C., Charurat,M., Collado-Chastel,S., Jack,N., Bartholomew,C., Pape,J.W., Figueroa,P., Blattner,W.A. and Carr,J.K.",2009
EU839607,B,2000,19279683,HIV-1 epidemic in the Caribbean is dominated by subtype B,"Nadai,Y., Eyzaguirre,L.M., Sill,A., Cleghorn,F., Nolte,C., Charurat,M., Collado-Chastel,S., Jack,N., Bartholomew,C., Pape,J.W., Figueroa,P., Blattner,W.A. and Carr,J.K.",2009
EU839608,B,2001,19279683,HIV-1 epidemic in the Caribbean is dominated by subtype B,"Nadai,Y., Eyzaguirre,L.M., Sill,A., Cleghorn,F., Nolte,C., Charurat,M., Collado-Chastel,S., Jack,N., Bartholomew,C., Pape,J.W., Figueroa,P., Blattner,W.A. and Carr,J.K.",2009
EU839609,B,2000,19279683,HIV-1 epidemic in the Caribbean is dominated by subtype B,"Nadai,Y., Eyzaguirre,L.M., Sill,A., Cleghorn,F., Nolte,C., Charurat,M., Collado-Chastel,S., Jack,N., Bartholomew,C., Pape,J.W., Figueroa,P., Blattner,W.A. and Carr,J.K.",2009
EU839610,B,2001,19279683,HIV-1 epidemic in the Caribbean is dominated by subtype B,"Nadai,Y., Eyzaguirre,L.M., Sill,A., Cleghorn,F., Nolte,C., Charurat,M., Collado-Chastel,S., Jack,N., Bartholomew,C., Pape,J.W., Figueroa,P., Blattner,W.A. and Carr,J.K.",2009
EU850429,B,,9557714,Chemokine receptor utilization by human immunodeficiency virus type 1 isolates that replicate in microglia,"Shieh,J.T., Albright,A.V., Sharron,M., Gartner,S., Strizki,J., Doms,R.W. and Gonzalez-Scarano,F.",1998
EU852934,D,1997,19143562,Selection of HIV Variants with Signature Genotypic Characteristics during Heterosexual Transmission,"Sagar,M., Laeyendecker,O., Lee,S., Gamiel,J., Wawer,M.J., Gray,R.H., Serwadda,D., Sewankambo,N.K., Shepherd,J.C., Toma,J., Huang,W. and Quinn,T.C.",2009
EU852942,D,1997,19143562,Selection of HIV Variants with Signature Genotypic Characteristics during Heterosexual Transmission,"Sagar,M., Laeyendecker,O., Lee,S., Gamiel,J., Wawer,M.J., Gray,R.H., Serwadda,D., Sewankambo,N.K., Shepherd,J.C., Toma,J., Huang,W. and Quinn,T.C.",2009
EU852950,A1,1998,19143562,Selection of HIV Variants with Signature Genotypic Characteristics during Heterosexual Transmission,"Sagar,M., Laeyendecker,O., Lee,S., Gamiel,J., Wawer,M.J., Gray,R.H., Serwadda,D., Sewankambo,N.K., Shepherd,J.C., Toma,J., Huang,W. and Quinn,T.C.",2009
EU852958,A1,1998,19143562,Selection of HIV Variants with Signature Genotypic Characteristics during Heterosexual Transmission,"Sagar,M., Laeyendecker,O., Lee,S., Gamiel,J., Wawer,M.J., Gray,R.H., Serwadda,D., Sewankambo,N.K., Shepherd,J.C., Toma,J., Huang,W. and Quinn,T.C.",2009
EU852966,D,1997,19143562,Selection of HIV Variants with Signature Genotypic Characteristics during Heterosexual Transmission,"Sagar,M., Laeyendecker,O., Lee,S., Gamiel,J., Wawer,M.J., Gray,R.H., Serwadda,D., Sewankambo,N.K., Shepherd,J.C., Toma,J., Huang,W. and Quinn,T.C.",2009
EU852974,D,1997,19143562,Selection of HIV Variants with Signature Genotypic Characteristics during Heterosexual Transmission,"Sagar,M., Laeyendecker,O., Lee,S., Gamiel,J., Wawer,M.J., Gray,R.H., Serwadda,D., Sewankambo,N.K., Shepherd,J.C., Toma,J., Huang,W. and Quinn,T.C.",2009
EU852982,D,1997,19143562,Selection of HIV Variants with Signature Genotypic Characteristics during Heterosexual Transmission,"Sagar,M., Laeyendecker,O., Lee,S., Gamiel,J., Wawer,M.J., Gray,R.H., Serwadda,D., Sewankambo,N.K., Shepherd,J.C., Toma,J., Huang,W. and Quinn,T.C.",2009
EU852990,D,1997,19143562,Selection of HIV Variants with Signature Genotypic Characteristics during Heterosexual Transmission,"Sagar,M., Laeyendecker,O., Lee,S., Gamiel,J., Wawer,M.J., Gray,R.H., Serwadda,D., Sewankambo,N.K., Shepherd,J.C., Toma,J., Huang,W. and Quinn,T.C.",2009
EU852998,D,1996,19143562,Selection of HIV Variants with Signature Genotypic Characteristics during Heterosexual Transmission,"Sagar,M., Laeyendecker,O., Lee,S., Gamiel,J., Wawer,M.J., Gray,R.H., Serwadda,D., Sewankambo,N.K., Shepherd,J.C., Toma,J., Huang,W. and Quinn,T.C.",2009
EU853006,D,1996,19143562,Selection of HIV Variants with Signature Genotypic Characteristics during Heterosexual Transmission,"Sagar,M., Laeyendecker,O., Lee,S., Gamiel,J., Wawer,M.J., Gray,R.H., Serwadda,D., Sewankambo,N.K., Shepherd,J.C., Toma,J., Huang,W. and Quinn,T.C.",2009
EU853014,D,1997,19143562,Selection of HIV Variants with Signature Genotypic Characteristics during Heterosexual Transmission,"Sagar,M., Laeyendecker,O., Lee,S., Gamiel,J., Wawer,M.J., Gray,R.H., Serwadda,D., Sewankambo,N.K., Shepherd,J.C., Toma,J., Huang,W. and Quinn,T.C.",2009
EU853022,D,1997,19143562,Selection of HIV Variants with Signature Genotypic Characteristics during Heterosexual Transmission,"Sagar,M., Laeyendecker,O., Lee,S., Gamiel,J., Wawer,M.J., Gray,R.H., Serwadda,D., Sewankambo,N.K., Shepherd,J.C., Toma,J., Huang,W. and Quinn,T.C.",2009
EU853030,A1,1999,19143562,Selection of HIV Variants with Signature Genotypic Characteristics during Heterosexual Transmission,"Sagar,M., Laeyendecker,O., Lee,S., Gamiel,J., Wawer,M.J., Gray,R.H., Serwadda,D., Sewankambo,N.K., Shepherd,J.C., Toma,J., Huang,W. and Quinn,T.C.",2009
EU853038,A1,1999,19143562,Selection of HIV Variants with Signature Genotypic Characteristics during Heterosexual Transmission,"Sagar,M., Laeyendecker,O., Lee,S., Gamiel,J., Wawer,M.J., Gray,R.H., Serwadda,D., Sewankambo,N.K., Shepherd,J.C., Toma,J., Huang,W. and Quinn,T.C.",2009
EU853046,D,1997,19143562,Selection of HIV Variants with Signature Genotypic Characteristics during Heterosexual Transmission,"Sagar,M., Laeyendecker,O., Lee,S., Gamiel,J., Wawer,M.J., Gray,R.H., Serwadda,D., Sewankambo,N.K., Shepherd,J.C., Toma,J., Huang,W. and Quinn,T.C.",2009
EU853054,D,1997,19143562,Selection of HIV Variants with Signature Genotypic Characteristics during Heterosexual Transmission,"Sagar,M., Laeyendecker,O., Lee,S., Gamiel,J., Wawer,M.J., Gray,R.H., Serwadda,D., Sewankambo,N.K., Shepherd,J.C., Toma,J., Huang,W. and Quinn,T.C.",2009
EU853062,A1,1997,19143562,Selection of HIV Variants with Signature Genotypic Characteristics during Heterosexual Transmission,"Sagar,M., Laeyendecker,O., Lee,S., Gamiel,J., Wawer,M.J., Gray,R.H., Serwadda,D., Sewankambo,N.K., Shepherd,J.C., Toma,J., Huang,W. and Quinn,T.C.",2009
EU853070,A1,1997,19143562,Selection of HIV Variants with Signature Genotypic Characteristics during Heterosexual Transmission,"Sagar,M., Laeyendecker,O., Lee,S., Gamiel,J., Wawer,M.J., Gray,R.H., Serwadda,D., Sewankambo,N.K., Shepherd,J.C., Toma,J., Huang,W. and Quinn,T.C.",2009
EU853078,D,1998,19143562,Selection of HIV Variants with Signature Genotypic Characteristics during Heterosexual Transmission,"Sagar,M., Laeyendecker,O., Lee,S., Gamiel,J., Wawer,M.J., Gray,R.H., Serwadda,D., Sewankambo,N.K., Shepherd,J.C., Toma,J., Huang,W. and Quinn,T.C.",2009
EU853086,D,1998,19143562,Selection of HIV Variants with Signature Genotypic Characteristics during Heterosexual Transmission,"Sagar,M., Laeyendecker,O., Lee,S., Gamiel,J., Wawer,M.J., Gray,R.H., Serwadda,D., Sewankambo,N.K., Shepherd,J.C., Toma,J., Huang,W. and Quinn,T.C.",2009
EU853094,D,1998,19143562,Selection of HIV Variants with Signature Genotypic Characteristics during Heterosexual Transmission,"Sagar,M., Laeyendecker,O., Lee,S., Gamiel,J., Wawer,M.J., Gray,R.H., Serwadda,D., Sewankambo,N.K., Shepherd,J.C., Toma,J., Huang,W. and Quinn,T.C.",2009
EU853102,D,1998,19143562,Selection of HIV Variants with Signature Genotypic Characteristics during Heterosexual Transmission,"Sagar,M., Laeyendecker,O., Lee,S., Gamiel,J., Wawer,M.J., Gray,R.H., Serwadda,D., Sewankambo,N.K., Shepherd,J.C., Toma,J., Huang,W. and Quinn,T.C.",2009
EU853110,D,2001,19143562,Selection of HIV Variants with Signature Genotypic Characteristics during Heterosexual Transmission,"Sagar,M., Laeyendecker,O., Lee,S., Gamiel,J., Wawer,M.J., Gray,R.H., Serwadda,D., Sewankambo,N.K., Shepherd,J.C., Toma,J., Huang,W. and Quinn,T.C.",2009
EU853118,D,2001,19143562,Selection of HIV Variants with Signature Genotypic Characteristics during Heterosexual Transmission,"Sagar,M., Laeyendecker,O., Lee,S., Gamiel,J., Wawer,M.J., Gray,R.H., Serwadda,D., Sewankambo,N.K., Shepherd,J.C., Toma,J., Huang,W. and Quinn,T.C.",2009
EU853126,D,1997,19143562,Selection of HIV Variants with Signature Genotypic Characteristics during Heterosexual Transmission,"Sagar,M., Laeyendecker,O., Lee,S., Gamiel,J., Wawer,M.J., Gray,R.H., Serwadda,D., Sewankambo,N.K., Shepherd,J.C., Toma,J., Huang,W. and Quinn,T.C.",2009
EU853134,D,1997,19143562,Selection of HIV Variants with Signature Genotypic Characteristics during Heterosexual Transmission,"Sagar,M., Laeyendecker,O., Lee,S., Gamiel,J., Wawer,M.J., Gray,R.H., Serwadda,D., Sewankambo,N.K., Shepherd,J.C., Toma,J., Huang,W. and Quinn,T.C.",2009
EU861977,A6,2002,18851681,Identification of a possible ancestor of the subtype A1 HIV Type 1 variant circulating in the former Soviet Union,"Riva,C., Romano,L., Saladini,F., Lai,A., Carr,J.K., Francisci,D., Balotta,C. and Zazzi,M.",2008
EU863416,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863417,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863418,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863419,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863420,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863421,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863422,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863423,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863424,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863425,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863426,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863427,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863428,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863429,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863430,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863431,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863432,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863433,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863434,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863435,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863436,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863437,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863438,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863439,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863440,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863441,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863442,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863443,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863444,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863445,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863446,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863447,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863448,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863449,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863450,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU863451,C,2000,,Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies,"Rademeyer,C., Moore,P. and Williamson,C.",
EU884500,C,2007,19113978,Development of a panel of well-characterized human immunodeficiency virus type 1 isolates from newly diagnosed patients including acute and recent infections,"Fernandez-Garcia,A., Cuevas,M.T., Munoz-Nieto,M., Ocampo,A., Pinilla,M., Garcia,V., Serrano-Bengoechea,E., Lezaun,M.J., Delgado,E., Thomson,M., Gonzalez-Galeano,M., Contreras,G., Najera,R. and Perez-Alvarez,L.",2009
EU884501,02_AG,2006,19113978,Development of a panel of well-characterized human immunodeficiency virus type 1 isolates from newly diagnosed patients including acute and recent infections,"Fernandez-Garcia,A., Cuevas,M.T., Munoz-Nieto,M., Ocampo,A., Pinilla,M., Garcia,V., Serrano-Bengoechea,E., Lezaun,M.J., Delgado,E., Thomson,M., Gonzalez-Galeano,M., Contreras,G., Najera,R. and Perez-Alvarez,L.",2009
EU885759,G,2002,,Functional molecular clones of HIV-1 env of subtypes G and BG recombinants,"Revilla,A., Delgado,E., Vega,Y. and Thomson,M.M.",
EU885760,BG,2002,,Functional molecular clones of HIV-1 env of subtypes G and BG recombinants,"Revilla,A., Delgado,E., Vega,Y. and Thomson,M.M.",
EU885761,G,2002,,Functional molecular clones of HIV-1 env of subtypes G and BG recombinants,"Revilla,A., Delgado,E., Vega,Y. and Thomson,M.M.",
EU885762,G,2003,,Functional molecular clones of HIV-1 env of subtypes G and BG recombinants,"Revilla,A., Delgado,E., Vega,Y. and Thomson,M.M.",
EU885763,G,2005,,Functional molecular clones of HIV-1 env of subtypes G and BG recombinants,"Revilla,A., Delgado,E., Vega,Y. and Thomson,M.M.",
EU885764,G,2006,,Functional molecular clones of HIV-1 env of subtypes G and BG recombinants,"Revilla,A., Delgado,E., Vega,Y. and Thomson,M.M.",
EU885765,G,2007,,Functional molecular clones of HIV-1 env of subtypes G and BG recombinants,"Revilla,A., Delgado,E., Vega,Y. and Thomson,M.M.",
EU885766,14_BG,2007,,Functional molecular clones of HIV-1 env of subtypes G and BG recombinants,"Revilla,A., Delgado,E., Vega,Y. and Thomson,M.M.",
EU908214,C,2006,,Direct Submission,"Ringe,R., Gharu,L., Pandey,S., Satyakumar,A., Thakar,M. and Bhattacharya,J.",2008
EU908216,C,2006,,Direct Submission,"Ringe,R., Gharu,L., Pandey,S., Satyakumar,A., Thakar,M. and Bhattacharya,J.",2008
EU908218,C,2007,,Direct Submission,"Ringe,R., Gharu,L., Pandey,S., Satyakumar,A., Thakar,M. and Bhattacharya,J.",2008
EU908221,C,2007,,Direct Submission,"Ringe,R., Gharu,L., Pandey,S., Satyakumar,A., Thakar,M. and Bhattacharya,J.",2008
EU908222,C,2007,,Direct Submission,"Ringe,R., Gharu,L., Pandey,S., Satyakumar,A., Thakar,M. and Bhattacharya,J.",2008
EU908224,C,2008,,Direct Submission,"Ringe,R., Gharu,L., Pandey,S., Satyakumar,A., Thakar,M. and Bhattacharya,J.",2008
FJ147116,B,2005,18987151,Continuous viral escape and selection by autologous neutralizing antibodies in drug-naive human immunodeficiency virus controllers,"Mahalanabis,M., Jayaraman,P., Miura,T., Pereyra,F., Chester,E.M., Richardson,B., Walker,B. and Haigwood,N.L.",2009
FJ147134,B,2005,18987151,Continuous viral escape and selection by autologous neutralizing antibodies in drug-naive human immunodeficiency virus controllers,"Mahalanabis,M., Jayaraman,P., Miura,T., Pereyra,F., Chester,E.M., Richardson,B., Walker,B. and Haigwood,N.L.",2009
FJ152546,B,2006,,"Identifying the Achilles heel of HIV: Broadly neutralizing antibodies to the CD4 binding, superantigenic 421-433 epitope","Planque,S., Salas,M., Mitsuda,Y., Jena,B., Sienczyk,M., Escobar,M., Morris,M.-K., Nishiyama,Y., Kumar,A., Gao,F., Sheppard,H., Montefiori,D.C., Hanson,C.V. and Paul,S.",
FJ152547,B,2006,,"Identifying the Achilles heel of HIV: Broadly neutralizing antibodies to the CD4 binding, superantigenic 421-433 epitope","Planque,S., Salas,M., Mitsuda,Y., Jena,B., Sienczyk,M., Escobar,M., Morris,M.-K., Nishiyama,Y., Kumar,A., Gao,F., Sheppard,H., Montefiori,D.C., Hanson,C.V. and Paul,S.",
FJ152548,B,2006,,"Identifying the Achilles heel of HIV: Broadly neutralizing antibodies to the CD4 binding, superantigenic 421-433 epitope","Planque,S., Salas,M., Mitsuda,Y., Jena,B., Sienczyk,M., Escobar,M., Morris,M.-K., Nishiyama,Y., Kumar,A., Gao,F., Sheppard,H., Montefiori,D.C., Hanson,C.V. and Paul,S.",
FJ185237,01_AE,1997,19540543,Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam,"Liao,H., Tee,K.K., Hase,S., Uenishi,R., Li,X.J., Kusagawa,S., Thang,P.H., Hien,N.T., Pybus,O.G. and Takebe,Y.",2009
FJ185238,01_AE,1997,19540543,Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam,"Liao,H., Tee,K.K., Hase,S., Uenishi,R., Li,X.J., Kusagawa,S., Thang,P.H., Hien,N.T., Pybus,O.G. and Takebe,Y.",2009
FJ185239,01_AE,1997,19540543,Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam,"Liao,H., Tee,K.K., Hase,S., Uenishi,R., Li,X.J., Kusagawa,S., Thang,P.H., Hien,N.T., Pybus,O.G. and Takebe,Y.",2009
FJ185240,01_AE,1997,19540543,Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam,"Liao,H., Tee,K.K., Hase,S., Uenishi,R., Li,X.J., Kusagawa,S., Thang,P.H., Hien,N.T., Pybus,O.G. and Takebe,Y.",2009
FJ185241,01_AE,1997,19540543,Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam,"Liao,H., Tee,K.K., Hase,S., Uenishi,R., Li,X.J., Kusagawa,S., Thang,P.H., Hien,N.T., Pybus,O.G. and Takebe,Y.",2009
FJ185242,01_AE,1997,19540543,Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam,"Liao,H., Tee,K.K., Hase,S., Uenishi,R., Li,X.J., Kusagawa,S., Thang,P.H., Hien,N.T., Pybus,O.G. and Takebe,Y.",2009
FJ185243,01_AE,1997,19540543,Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam,"Liao,H., Tee,K.K., Hase,S., Uenishi,R., Li,X.J., Kusagawa,S., Thang,P.H., Hien,N.T., Pybus,O.G. and Takebe,Y.",2009
FJ185244,01_AE,1997,19540543,Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam,"Liao,H., Tee,K.K., Hase,S., Uenishi,R., Li,X.J., Kusagawa,S., Thang,P.H., Hien,N.T., Pybus,O.G. and Takebe,Y.",2009
FJ185245,01_AE,1997,19540543,Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam,"Liao,H., Tee,K.K., Hase,S., Uenishi,R., Li,X.J., Kusagawa,S., Thang,P.H., Hien,N.T., Pybus,O.G. and Takebe,Y.",2009
FJ185246,01_AE,1997,19540543,Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam,"Liao,H., Tee,K.K., Hase,S., Uenishi,R., Li,X.J., Kusagawa,S., Thang,P.H., Hien,N.T., Pybus,O.G. and Takebe,Y.",2009
FJ185247,01_AE,1997,19540543,Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam,"Liao,H., Tee,K.K., Hase,S., Uenishi,R., Li,X.J., Kusagawa,S., Thang,P.H., Hien,N.T., Pybus,O.G. and Takebe,Y.",2009
FJ185248,01_AE,1997,19540543,Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam,"Liao,H., Tee,K.K., Hase,S., Uenishi,R., Li,X.J., Kusagawa,S., Thang,P.H., Hien,N.T., Pybus,O.G. and Takebe,Y.",2009
FJ185249,01_AE,1997,19540543,Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam,"Liao,H., Tee,K.K., Hase,S., Uenishi,R., Li,X.J., Kusagawa,S., Thang,P.H., Hien,N.T., Pybus,O.G. and Takebe,Y.",2009
FJ185250,01_AE,1997,19540543,Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam,"Liao,H., Tee,K.K., Hase,S., Uenishi,R., Li,X.J., Kusagawa,S., Thang,P.H., Hien,N.T., Pybus,O.G. and Takebe,Y.",2009
FJ185251,01_AE,1997,19540543,Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam,"Liao,H., Tee,K.K., Hase,S., Uenishi,R., Li,X.J., Kusagawa,S., Thang,P.H., Hien,N.T., Pybus,O.G. and Takebe,Y.",2009
FJ185252,01_AE,1997,19540543,Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam,"Liao,H., Tee,K.K., Hase,S., Uenishi,R., Li,X.J., Kusagawa,S., Thang,P.H., Hien,N.T., Pybus,O.G. and Takebe,Y.",2009
FJ185253,01_AE,1997,19540543,Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam,"Liao,H., Tee,K.K., Hase,S., Uenishi,R., Li,X.J., Kusagawa,S., Thang,P.H., Hien,N.T., Pybus,O.G. and Takebe,Y.",2009
FJ185254,01_AE,1997,19540543,Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam,"Liao,H., Tee,K.K., Hase,S., Uenishi,R., Li,X.J., Kusagawa,S., Thang,P.H., Hien,N.T., Pybus,O.G. and Takebe,Y.",2009
FJ185255,01_AE,1997,19540543,Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam,"Liao,H., Tee,K.K., Hase,S., Uenishi,R., Li,X.J., Kusagawa,S., Thang,P.H., Hien,N.T., Pybus,O.G. and Takebe,Y.",2009
FJ185256,01_AE,1997,19540543,Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam,"Liao,H., Tee,K.K., Hase,S., Uenishi,R., Li,X.J., Kusagawa,S., Thang,P.H., Hien,N.T., Pybus,O.G. and Takebe,Y.",2009
FJ185257,01_AE,1997,19540543,Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam,"Liao,H., Tee,K.K., Hase,S., Uenishi,R., Li,X.J., Kusagawa,S., Thang,P.H., Hien,N.T., Pybus,O.G. and Takebe,Y.",2009
FJ185258,01_AE,1997,19540543,Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam,"Liao,H., Tee,K.K., Hase,S., Uenishi,R., Li,X.J., Kusagawa,S., Thang,P.H., Hien,N.T., Pybus,O.G. and Takebe,Y.",2009
FJ185259,01_AE,1997,19540543,Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam,"Liao,H., Tee,K.K., Hase,S., Uenishi,R., Li,X.J., Kusagawa,S., Thang,P.H., Hien,N.T., Pybus,O.G. and Takebe,Y.",2009
FJ185260,01_AE,1997,19540543,Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam,"Liao,H., Tee,K.K., Hase,S., Uenishi,R., Li,X.J., Kusagawa,S., Thang,P.H., Hien,N.T., Pybus,O.G. and Takebe,Y.",2009
FJ195086,B,2004,18809195,Selective regimes and evolutionary rates of HIV-1 subtype B V3 variants in the Brazilian epidemic,"Diaz,R.S., Leal,E., Sanabani,S., Sucupira,M.C., Tanuri,A., Sabino,E.C. and Janini,L.M.",2008
FJ195087,B,2003,18809195,Selective regimes and evolutionary rates of HIV-1 subtype B V3 variants in the Brazilian epidemic,"Diaz,R.S., Leal,E., Sanabani,S., Sucupira,M.C., Tanuri,A., Sabino,E.C. and Janini,L.M.",2008
FJ195088,B,2005,18809195,Selective regimes and evolutionary rates of HIV-1 subtype B V3 variants in the Brazilian epidemic,"Diaz,R.S., Leal,E., Sanabani,S., Sucupira,M.C., Tanuri,A., Sabino,E.C. and Janini,L.M.",2008
FJ195089,B,2005,18809195,Selective regimes and evolutionary rates of HIV-1 subtype B V3 variants in the Brazilian epidemic,"Diaz,R.S., Leal,E., Sanabani,S., Sucupira,M.C., Tanuri,A., Sabino,E.C. and Janini,L.M.",2008
FJ195090,B,2004,18809195,Selective regimes and evolutionary rates of HIV-1 subtype B V3 variants in the Brazilian epidemic,"Diaz,R.S., Leal,E., Sanabani,S., Sucupira,M.C., Tanuri,A., Sabino,E.C. and Janini,L.M.",2008
FJ195091,B,2005,18809195,Selective regimes and evolutionary rates of HIV-1 subtype B V3 variants in the Brazilian epidemic,"Diaz,R.S., Leal,E., Sanabani,S., Sucupira,M.C., Tanuri,A., Sabino,E.C. and Janini,L.M.",2008
FJ213780,38_BF1,2005,19327055,Identification of a new HIV Type 1 circulating recombinant form (CRF38_BF1) in Uruguay,"Ruchansky,D., Casado,C., Russi,J.C., Arbiza,J.R. and Lopez-Galindez,C.",2009
FJ213781,38_BF1,2004,19327055,Identification of a new HIV Type 1 circulating recombinant form (CRF38_BF1) in Uruguay,"Ruchansky,D., Casado,C., Russi,J.C., Arbiza,J.R. and Lopez-Galindez,C.",2009
FJ213782,38_BF1,2004,19327055,Identification of a new HIV Type 1 circulating recombinant form (CRF38_BF1) in Uruguay,"Ruchansky,D., Casado,C., Russi,J.C., Arbiza,J.R. and Lopez-Galindez,C.",2009
FJ213783,38_BF1,2003,19327055,Identification of a new HIV Type 1 circulating recombinant form (CRF38_BF1) in Uruguay,"Ruchansky,D., Casado,C., Russi,J.C., Arbiza,J.R. and Lopez-Galindez,C.",2009
FJ222409,B,1983,18815295,Evolution of CCR5 use before and during coreceptor switching,"Coetzer,M., Nedellec,R., Salkowitz,J., McLaughlin,S., Liu,Y., Heath,L., Mullins,J.I. and Mosier,D.E.",2008
FJ229800,C,2004,19025632,Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection,"Bandawe,G.P., Martin,D.P., Treurnicht,F., Mlisana,K., Karim,S.S. and Williamson,C.",2008
FJ229801,C,2006,19025632,Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection,"Bandawe,G.P., Martin,D.P., Treurnicht,F., Mlisana,K., Karim,S.S. and Williamson,C.",2008
FJ229805,C,2005,19025632,Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection,"Bandawe,G.P., Martin,D.P., Treurnicht,F., Mlisana,K., Karim,S.S. and Williamson,C.",2008
FJ229806,C,2006,19025632,Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection,"Bandawe,G.P., Martin,D.P., Treurnicht,F., Mlisana,K., Karim,S.S. and Williamson,C.",2008
FJ229810,C,2006,19025632,Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection,"Bandawe,G.P., Martin,D.P., Treurnicht,F., Mlisana,K., Karim,S.S. and Williamson,C.",2008
FJ229811,C,2006,19025632,Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection,"Bandawe,G.P., Martin,D.P., Treurnicht,F., Mlisana,K., Karim,S.S. and Williamson,C.",2008
FJ229812,C,2006,19025632,Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection,"Bandawe,G.P., Martin,D.P., Treurnicht,F., Mlisana,K., Karim,S.S. and Williamson,C.",2008
FJ229813,C,2005,19025632,Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection,"Bandawe,G.P., Martin,D.P., Treurnicht,F., Mlisana,K., Karim,S.S. and Williamson,C.",2008
FJ229814,C,2006,19025632,Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection,"Bandawe,G.P., Martin,D.P., Treurnicht,F., Mlisana,K., Karim,S.S. and Williamson,C.",2008
FJ229817,C,2006,19025632,Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection,"Bandawe,G.P., Martin,D.P., Treurnicht,F., Mlisana,K., Karim,S.S. and Williamson,C.",2008
FJ229818,C,2006,19025632,Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection,"Bandawe,G.P., Martin,D.P., Treurnicht,F., Mlisana,K., Karim,S.S. and Williamson,C.",2008
FJ229819,C,2005,19025632,Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection,"Bandawe,G.P., Martin,D.P., Treurnicht,F., Mlisana,K., Karim,S.S. and Williamson,C.",2008
FJ229821,C,2005,19025632,Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection,"Bandawe,G.P., Martin,D.P., Treurnicht,F., Mlisana,K., Karim,S.S. and Williamson,C.",2008
FJ229824,C,2005,19025632,Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection,"Bandawe,G.P., Martin,D.P., Treurnicht,F., Mlisana,K., Karim,S.S. and Williamson,C.",2008
FJ229827,C,2005,19025632,Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection,"Bandawe,G.P., Martin,D.P., Treurnicht,F., Mlisana,K., Karim,S.S. and Williamson,C.",2008
FJ229828,C,2005,19025632,Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection,"Bandawe,G.P., Martin,D.P., Treurnicht,F., Mlisana,K., Karim,S.S. and Williamson,C.",2008
FJ229829,C,2005,19025632,Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection,"Bandawe,G.P., Martin,D.P., Treurnicht,F., Mlisana,K., Karim,S.S. and Williamson,C.",2008
FJ229830,C,2006,19025632,Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection,"Bandawe,G.P., Martin,D.P., Treurnicht,F., Mlisana,K., Karim,S.S. and Williamson,C.",2008
FJ229831,C,2006,19025632,Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection,"Bandawe,G.P., Martin,D.P., Treurnicht,F., Mlisana,K., Karim,S.S. and Williamson,C.",2008
FJ229832,C,2006,19025632,Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection,"Bandawe,G.P., Martin,D.P., Treurnicht,F., Mlisana,K., Karim,S.S. and Williamson,C.",2008
FJ229833,C,2006,19025632,Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection,"Bandawe,G.P., Martin,D.P., Treurnicht,F., Mlisana,K., Karim,S.S. and Williamson,C.",2008
FJ229834,C,2006,19025632,Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection,"Bandawe,G.P., Martin,D.P., Treurnicht,F., Mlisana,K., Karim,S.S. and Williamson,C.",2008
FJ229835,C,2006,19025632,Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection,"Bandawe,G.P., Martin,D.P., Treurnicht,F., Mlisana,K., Karim,S.S. and Williamson,C.",2008
FJ229836,C,2006,19025632,Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection,"Bandawe,G.P., Martin,D.P., Treurnicht,F., Mlisana,K., Karim,S.S. and Williamson,C.",2008
FJ229837,C,2006,19025632,Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection,"Bandawe,G.P., Martin,D.P., Treurnicht,F., Mlisana,K., Karim,S.S. and Williamson,C.",2008
FJ229838,C,2006,19025632,Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection,"Bandawe,G.P., Martin,D.P., Treurnicht,F., Mlisana,K., Karim,S.S. and Williamson,C.",2008
FJ238521,0107,2007,19320602,"First detection of a novel HIV Type 1 CRF01_AE/07_BC recombinant among an epidemiologically linked cohort of IDUs in Jiangsu, China","Guo,H., Guo,D., Wei,J.F., Yang,H., Huan,X., Tsui,S.K., Yang,R. and Zhang,C.",2009
FJ240219,C,1999,,Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection,"Bandawe,G.P., Martin,D.P., Treurnicht,F., Mlisana,K., Abdool Karim,S.S. and Williamson,C.",
FJ240220,C,1999,,Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection,"Bandawe,G.P., Martin,D.P., Treurnicht,F., Mlisana,K., Abdool Karim,S.S. and Williamson,C.",
FJ358521,44_BF,2000,20618101,Identification of a new HIV type 1 BF intersubtype circulating recombinant form (CRF44_BF) in Chile,"Delgado,E., Rios,M., Fernandez,J., Perez-Alvarez,L., Najera,R. and Thomson,M.M.",2010
FJ388890,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388891,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388892,A6,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388893,A1,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388894,A1,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388895,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388896,02B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388897,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388898,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388899,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388900,A1B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388901,C,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388903,A1,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388904,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388905,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388908,DG,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388909,A1,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388910,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388911,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388912,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388913,C,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388914,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388915,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388916,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388917,04_cpx,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388918,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388919,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388921,U,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388922,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388923,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388924,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388925,A1,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388927,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388930,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388931,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388932,A1,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388933,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388934,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388935,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388936,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388937,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388938,A1,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388939,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388940,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388941,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388943,A1,2006,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388945,D,2006,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388946,A1,2006,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388947,B,2006,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388949,B,2006,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388955,B,2006,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kosrtikis,L.G.",
FJ388956,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kostrikis,L.G.",
FJ388957,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kostrikis,L.G.",
FJ388959,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kostrikis,L.G.",
FJ388960,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kostrikis,L.G.",
FJ388961,BC,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kostrikis,L.G.",
FJ388962,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kostrikis,L.G.",
FJ388963,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kostrikis,L.G.",
FJ388964,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kostrikis,L.G.",
FJ389363,G,2004,19361281,HIV type 1 group M subtype G in Cameroon: five genome sequences,"Yamaguchi,J., Ndembi,N., Ngansop,C., Mbanya,D., Kaptue,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2009
FJ389364,G,2004,19361281,HIV type 1 group M subtype G in Cameroon: five genome sequences,"Yamaguchi,J., Ndembi,N., Ngansop,C., Mbanya,D., Kaptue,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2009
FJ389365,G,2004,19361281,HIV type 1 group M subtype G in Cameroon: five genome sequences,"Yamaguchi,J., Ndembi,N., Ngansop,C., Mbanya,D., Kaptue,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2009
FJ389366,G,2004,19361281,HIV type 1 group M subtype G in Cameroon: five genome sequences,"Yamaguchi,J., Ndembi,N., Ngansop,C., Mbanya,D., Kaptue,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2009
FJ389367,G,2001,19361281,HIV type 1 group M subtype G in Cameroon: five genome sequences,"Yamaguchi,J., Ndembi,N., Ngansop,C., Mbanya,D., Kaptue,L., Gurtler,L.G., Devare,S.G. and Brennan,C.A.",2009
FJ396012,A1D,1996,18842728,Human immunodeficiency virus type 1 superinfection occurs despite relatively robust neutralizing antibody responses,"Blish,C.A., Dogan,O.C., Derby,N.R., Nguyen,M.A., Chohan,B., Richardson,B.A. and Overbaugh,J.",2008
FJ396016,A1,1998,18842728,Human immunodeficiency virus type 1 superinfection occurs despite relatively robust neutralizing antibody responses,"Blish,C.A., Dogan,O.C., Derby,N.R., Nguyen,M.A., Chohan,B., Richardson,B.A. and Overbaugh,J.",2008
FJ396022,A1C,1997,18842728,Human immunodeficiency virus type 1 superinfection occurs despite relatively robust neutralizing antibody responses,"Blish,C.A., Dogan,O.C., Derby,N.R., Nguyen,M.A., Chohan,B., Richardson,B.A. and Overbaugh,J.",2008
FJ396026,A1,1998,18842728,Human immunodeficiency virus type 1 superinfection occurs despite relatively robust neutralizing antibody responses,"Blish,C.A., Dogan,O.C., Derby,N.R., Nguyen,M.A., Chohan,B., Richardson,B.A. and Overbaugh,J.",2008
FJ396028,C,2002,18842728,Human immunodeficiency virus type 1 superinfection occurs despite relatively robust neutralizing antibody responses,"Blish,C.A., Dogan,O.C., Derby,N.R., Nguyen,M.A., Chohan,B., Richardson,B.A. and Overbaugh,J.",2008
FJ403482,B,2005,,Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection,"Kousiappa,I., Van de Vijver,D.A.M.C. and Kostrikis,L.G.",
FJ441290,01_AE,2007,19534629,"Near full-length genome characterization of an HIV-1 CRF01_AE strain in Jiangsu, China: evidence of two independent introductions from Fujian","Guo,D., Ding,N., Xu,Y., Guo,H., Wei,J.F., Wang,J.H., He,G., Yang,R. and Zhang,C.",2009
FJ443274,C,2005,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ443367,C,2005,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ443455,C,2006,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ443520,C,2007,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ443533,C,2006,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ443548,C,2007,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ443557,C,2007,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ443575,C,2007,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ443600,C,2007,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ443624,C,2007,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ443644,C,2007,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ443666,C,2007,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ443690,C,2007,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ443713,C,2007,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ443734,C,2007,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ443757,C,2006,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ443782,C,2007,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ443839,C,2007,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ443861,C,2007,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ443883,C,2007,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ443938,C,2007,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ443989,C,2007,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ444007,C,2007,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ444035,C,2007,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ444058,C,2007,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ444077,C,2007,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ444092,C,2007,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ444120,C,2007,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ444159,C,2003,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ444186,C,2003,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ444208,C,2003,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ444230,C,2003,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ444253,C,2003,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ444281,C,2003,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ444305,C,2003,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ444325,C,2003,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ444347,C,2003,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ444369,C,2004,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ444392,C,2004,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ444416,C,2004,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ444436,C,2004,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ444457,C,2004,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ444480,C,2004,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ444501,C,2004,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ444523,C,2004,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ444543,C,2005,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ444566,C,2006,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ444589,C,2005,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ444611,C,2005,19193811,Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,"Abrahams,M.R., Anderson,J.A., Giorgi,E.E., Seoighe,C., Mlisana,K., Ping,L.H., Athreya,G.S., Treurnicht,F.K., Keele,B.F., Wood,N., Salazar-Gonzalez,J.F., Bhattacharya,T., Chu,H., Hoffman,I., Galvin,S., Mapanje,C., Kazembe,P., Thebus,R., Fiscus,S., Hide,W., Cohen,M.S., Karim,S.A., Haynes,B.F., Shaw,G.M., Hahn,B.H., Korber,B.T., Swanstrom,R. and Williamson,C.",2009
FJ469705,B,,19036810,Protective HLA class I alleles that restrict acute-phase CD8+ T-cell responses are associated with viral escape mutations located in highly conserved regions of human immunodeficiency virus type 1,"Wang,Y.E., Li,B., Carlson,J.M., Streeck,H., Gladden,A.D., Goodman,R., Schneidewind,A., Power,K.A., Toth,I., Frahm,N., Alter,G., Brander,C., Carrington,M., Walker,B.D., Altfeld,M., Heckerman,D. and Allen,T.M.",2009
FJ469718,B,2005,19036810,Protective HLA class I alleles that restrict acute-phase CD8+ T-cell responses are associated with viral escape mutations located in highly conserved regions of human immunodeficiency virus type 1,"Wang,Y.E., Li,B., Carlson,J.M., Streeck,H., Gladden,A.D., Goodman,R., Schneidewind,A., Power,K.A., Toth,I., Frahm,N., Alter,G., Brander,C., Carrington,M., Walker,B.D., Altfeld,M., Heckerman,D. and Allen,T.M.",2009
FJ469721,B,2007,19036810,Protective HLA class I alleles that restrict acute-phase CD8+ T-cell responses are associated with viral escape mutations located in highly conserved regions of human immunodeficiency virus type 1,"Wang,Y.E., Li,B., Carlson,J.M., Streeck,H., Gladden,A.D., Goodman,R., Schneidewind,A., Power,K.A., Toth,I., Frahm,N., Alter,G., Brander,C., Carrington,M., Walker,B.D., Altfeld,M., Heckerman,D. and Allen,T.M.",2009
FJ469744,B,,19036810,Protective HLA class I alleles that restrict acute-phase CD8+ T-cell responses are associated with viral escape mutations located in highly conserved regions of human immunodeficiency virus type 1,"Wang,Y.E., Li,B., Carlson,J.M., Streeck,H., Gladden,A.D., Goodman,R., Schneidewind,A., Power,K.A., Toth,I., Frahm,N., Alter,G., Brander,C., Carrington,M., Walker,B.D., Altfeld,M., Heckerman,D. and Allen,T.M.",2009
FJ469752,B,,19036810,Protective HLA class I alleles that restrict acute-phase CD8+ T-cell responses are associated with viral escape mutations located in highly conserved regions of human immunodeficiency virus type 1,"Wang,Y.E., Li,B., Carlson,J.M., Streeck,H., Gladden,A.D., Goodman,R., Schneidewind,A., Power,K.A., Toth,I., Frahm,N., Alter,G., Brander,C., Carrington,M., Walker,B.D., Altfeld,M., Heckerman,D. and Allen,T.M.",2009
FJ469764,B,2003,19036810,Protective HLA class I alleles that restrict acute-phase CD8+ T-cell responses are associated with viral escape mutations located in highly conserved regions of human immunodeficiency virus type 1,"Wang,Y.E., Li,B., Carlson,J.M., Streeck,H., Gladden,A.D., Goodman,R., Schneidewind,A., Power,K.A., Toth,I., Frahm,N., Alter,G., Brander,C., Carrington,M., Walker,B.D., Altfeld,M., Heckerman,D. and Allen,T.M.",2009
FJ496072,B,2002,19487424,"Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection","Salazar-Gonzalez,J.F., Salazar,M.G., Keele,B.F., Learn,G.H., Giorgi,E.E., Li,H., Decker,J.M., Wang,S., Baalwa,J., Kraus,M.H., Parrish,N.F., Shaw,K.S., Guffey,M.B., Bar,K.J., Davis,K.L., Ochsenbauer-Jambor,C., Kappes,J.C., Saag,M.S., Cohen,M.S., Mulenga,J., Derdeyn,C.A., Allen,S., Hunter,E., Markowitz,M., Hraber,P., Perelson,A.S., Bhattacharya,T., Haynes,B.F., Korber,B.T., Hahn,B.H. and Shaw,G.M.",2009
FJ496081,B,2005,19487424,"Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection","Salazar-Gonzalez,J.F., Salazar,M.G., Keele,B.F., Learn,G.H., Giorgi,E.E., Li,H., Decker,J.M., Wang,S., Baalwa,J., Kraus,M.H., Parrish,N.F., Shaw,K.S., Guffey,M.B., Bar,K.J., Davis,K.L., Ochsenbauer-Jambor,C., Kappes,J.C., Saag,M.S., Cohen,M.S., Mulenga,J., Derdeyn,C.A., Allen,S., Hunter,E., Markowitz,M., Hraber,P., Perelson,A.S., Bhattacharya,T., Haynes,B.F., Korber,B.T., Hahn,B.H. and Shaw,G.M.",2009
FJ515874,B,2007,21916806,Characterization of Circulating HIV Type 1 env Genes in Plasma of Two Antiretroviral-Naive Slow Progressing Patients with Broad Neutralizing Antibody Response with Evidence of Recombination,"Mukhopadhyay,S., Ringe,R., Patil,A., Paranjape,R. and Bhattacharya,J.",2012
FJ623475,A1,2006,20156095,"Evaluation of HIV type 1 strains in men having sex with men and in female sex workers in Mombasa, Kenya","Tovanabutra,S., Sanders,E.J., Graham,S.M., Mwangome,M., Peshu,N., McClelland,R.S., Muhaari,A., Crossler,J., Price,M.A., Gilmour,J., Michael,N.L. and McCutchan,F.M.",2010
FJ623476,A1,2006,20156095,"Evaluation of HIV type 1 strains in men having sex with men and in female sex workers in Mombasa, Kenya","Tovanabutra,S., Sanders,E.J., Graham,S.M., Mwangome,M., Peshu,N., McClelland,R.S., Muhaari,A., Crossler,J., Price,M.A., Gilmour,J., Michael,N.L. and McCutchan,F.M.",2010
FJ623477,A1,2006,20156095,"Evaluation of HIV type 1 strains in men having sex with men and in female sex workers in Mombasa, Kenya","Tovanabutra,S., Sanders,E.J., Graham,S.M., Mwangome,M., Peshu,N., McClelland,R.S., Muhaari,A., Crossler,J., Price,M.A., Gilmour,J., Michael,N.L. and McCutchan,F.M.",2010
FJ623478,A1,2006,20156095,"Evaluation of HIV type 1 strains in men having sex with men and in female sex workers in Mombasa, Kenya","Tovanabutra,S., Sanders,E.J., Graham,S.M., Mwangome,M., Peshu,N., McClelland,R.S., Muhaari,A., Crossler,J., Price,M.A., Gilmour,J., Michael,N.L. and McCutchan,F.M.",2010
FJ623479,A1,2006,20156095,"Evaluation of HIV type 1 strains in men having sex with men and in female sex workers in Mombasa, Kenya","Tovanabutra,S., Sanders,E.J., Graham,S.M., Mwangome,M., Peshu,N., McClelland,R.S., Muhaari,A., Crossler,J., Price,M.A., Gilmour,J., Michael,N.L. and McCutchan,F.M.",2010
FJ623480,A1,2006,20156095,"Evaluation of HIV type 1 strains in men having sex with men and in female sex workers in Mombasa, Kenya","Tovanabutra,S., Sanders,E.J., Graham,S.M., Mwangome,M., Peshu,N., McClelland,R.S., Muhaari,A., Crossler,J., Price,M.A., Gilmour,J., Michael,N.L. and McCutchan,F.M.",2010
FJ623481,A1,2006,20156095,"Evaluation of HIV type 1 strains in men having sex with men and in female sex workers in Mombasa, Kenya","Tovanabutra,S., Sanders,E.J., Graham,S.M., Mwangome,M., Peshu,N., McClelland,R.S., Muhaari,A., Crossler,J., Price,M.A., Gilmour,J., Michael,N.L. and McCutchan,F.M.",2010
FJ623482,A1,2006,20156095,"Evaluation of HIV type 1 strains in men having sex with men and in female sex workers in Mombasa, Kenya","Tovanabutra,S., Sanders,E.J., Graham,S.M., Mwangome,M., Peshu,N., McClelland,R.S., Muhaari,A., Crossler,J., Price,M.A., Gilmour,J., Michael,N.L. and McCutchan,F.M.",2010
FJ623483,A1,2006,20156095,"Evaluation of HIV type 1 strains in men having sex with men and in female sex workers in Mombasa, Kenya","Tovanabutra,S., Sanders,E.J., Graham,S.M., Mwangome,M., Peshu,N., McClelland,R.S., Muhaari,A., Crossler,J., Price,M.A., Gilmour,J., Michael,N.L. and McCutchan,F.M.",2010
FJ623484,A1,2006,20156095,"Evaluation of HIV type 1 strains in men having sex with men and in female sex workers in Mombasa, Kenya","Tovanabutra,S., Sanders,E.J., Graham,S.M., Mwangome,M., Peshu,N., McClelland,R.S., Muhaari,A., Crossler,J., Price,M.A., Gilmour,J., Michael,N.L. and McCutchan,F.M.",2010
FJ623485,A1,2006,20156095,"Evaluation of HIV type 1 strains in men having sex with men and in female sex workers in Mombasa, Kenya","Tovanabutra,S., Sanders,E.J., Graham,S.M., Mwangome,M., Peshu,N., McClelland,R.S., Muhaari,A., Crossler,J., Price,M.A., Gilmour,J., Michael,N.L. and McCutchan,F.M.",2010
FJ623486,A1,2006,20156095,"Evaluation of HIV type 1 strains in men having sex with men and in female sex workers in Mombasa, Kenya","Tovanabutra,S., Sanders,E.J., Graham,S.M., Mwangome,M., Peshu,N., McClelland,R.S., Muhaari,A., Crossler,J., Price,M.A., Gilmour,J., Michael,N.L. and McCutchan,F.M.",2010
FJ623487,A1,2006,20156095,"Evaluation of HIV type 1 strains in men having sex with men and in female sex workers in Mombasa, Kenya","Tovanabutra,S., Sanders,E.J., Graham,S.M., Mwangome,M., Peshu,N., McClelland,R.S., Muhaari,A., Crossler,J., Price,M.A., Gilmour,J., Michael,N.L. and McCutchan,F.M.",2010
FJ623488,A1,2006,20156095,"Evaluation of HIV type 1 strains in men having sex with men and in female sex workers in Mombasa, Kenya","Tovanabutra,S., Sanders,E.J., Graham,S.M., Mwangome,M., Peshu,N., McClelland,R.S., Muhaari,A., Crossler,J., Price,M.A., Gilmour,J., Michael,N.L. and McCutchan,F.M.",2010
FJ623489,A1C,2006,20156095,"Evaluation of HIV type 1 strains in men having sex with men and in female sex workers in Mombasa, Kenya","Tovanabutra,S., Sanders,E.J., Graham,S.M., Mwangome,M., Peshu,N., McClelland,R.S., Muhaari,A., Crossler,J., Price,M.A., Gilmour,J., Michael,N.L. and McCutchan,F.M.",2010
FJ623490,A1D,2006,20156095,"Evaluation of HIV type 1 strains in men having sex with men and in female sex workers in Mombasa, Kenya","Tovanabutra,S., Sanders,E.J., Graham,S.M., Mwangome,M., Peshu,N., McClelland,R.S., Muhaari,A., Crossler,J., Price,M.A., Gilmour,J., Michael,N.L. and McCutchan,F.M.",2010
FJ623491,A1D,2006,20156095,"Evaluation of HIV type 1 strains in men having sex with men and in female sex workers in Mombasa, Kenya","Tovanabutra,S., Sanders,E.J., Graham,S.M., Mwangome,M., Peshu,N., McClelland,R.S., Muhaari,A., Crossler,J., Price,M.A., Gilmour,J., Michael,N.L. and McCutchan,F.M.",2010
FJ623492,A1A2D,2006,20156095,"Evaluation of HIV type 1 strains in men having sex with men and in female sex workers in Mombasa, Kenya","Tovanabutra,S., Sanders,E.J., Graham,S.M., Mwangome,M., Peshu,N., McClelland,R.S., Muhaari,A., Crossler,J., Price,M.A., Gilmour,J., Michael,N.L. and McCutchan,F.M.",2010
FJ623493,A1A2CD,2006,20156095,"Evaluation of HIV type 1 strains in men having sex with men and in female sex workers in Mombasa, Kenya","Tovanabutra,S., Sanders,E.J., Graham,S.M., Mwangome,M., Peshu,N., McClelland,R.S., Muhaari,A., Crossler,J., Price,M.A., Gilmour,J., Michael,N.L. and McCutchan,F.M.",2010
FJ623494,A1A2CD,2006,20156095,"Evaluation of HIV type 1 strains in men having sex with men and in female sex workers in Mombasa, Kenya","Tovanabutra,S., Sanders,E.J., Graham,S.M., Mwangome,M., Peshu,N., McClelland,R.S., Muhaari,A., Crossler,J., Price,M.A., Gilmour,J., Michael,N.L. and McCutchan,F.M.",2010
FJ623495,DG,2006,20156095,"Evaluation of HIV type 1 strains in men having sex with men and in female sex workers in Mombasa, Kenya","Tovanabutra,S., Sanders,E.J., Graham,S.M., Mwangome,M., Peshu,N., McClelland,R.S., Muhaari,A., Crossler,J., Price,M.A., Gilmour,J., Michael,N.L. and McCutchan,F.M.",2010
FJ647145,B,1985,,"Molecular characterization of non-subtype C and recombinant HIV-1 viruses from Cape Town, South Africa","Wilkinson,E. and Engelbrecht,S.",
FJ647147,A1C,2000,,"Molecular characterization of non-subtype C and recombinant HIV-1 viruses from Cape Town, South Africa","Wilkinson,E. and Engelbrecht,S.",
FJ647148,A1,2001,,"Molecular characterization of non-subtype C and recombinant HIV-1 viruses from Cape Town, South Africa","Wilkinson,E. and Engelbrecht,S.",
FJ653098,B,2005,19075055,"Virologic failure in first-line human immunodeficiency virus therapy with a CCR5 entry inhibitor, aplaviroc, plus a fixed-dose combination of lamivudine-zidovudine: nucleoside reverse transcriptase inhibitor resistance regardless of envelope tropism","Demarest,J.F., Amrine-Madsen,H., Irlbeck,D.M. and Kitrinos,K.M.",2009
FJ653122,B,2005,19075055,"Virologic failure in first-line human immunodeficiency virus therapy with a CCR5 entry inhibitor, aplaviroc, plus a fixed-dose combination of lamivudine-zidovudine: nucleoside reverse transcriptase inhibitor resistance regardless of envelope tropism","Demarest,J.F., Amrine-Madsen,H., Irlbeck,D.M. and Kitrinos,K.M.",2009
FJ653146,B,2005,19075055,"Virologic failure in first-line human immunodeficiency virus therapy with a CCR5 entry inhibitor, aplaviroc, plus a fixed-dose combination of lamivudine-zidovudine: nucleoside reverse transcriptase inhibitor resistance regardless of envelope tropism","Demarest,J.F., Amrine-Madsen,H., Irlbeck,D.M. and Kitrinos,K.M.",2009
FJ653194,B,2005,19075055,"Virologic failure in first-line human immunodeficiency virus therapy with a CCR5 entry inhibitor, aplaviroc, plus a fixed-dose combination of lamivudine-zidovudine: nucleoside reverse transcriptase inhibitor resistance regardless of envelope tropism","Demarest,J.F., Amrine-Madsen,H., Irlbeck,D.M. and Kitrinos,K.M.",2009
FJ653218,B,2005,19075055,"Virologic failure in first-line human immunodeficiency virus therapy with a CCR5 entry inhibitor, aplaviroc, plus a fixed-dose combination of lamivudine-zidovudine: nucleoside reverse transcriptase inhibitor resistance regardless of envelope tropism","Demarest,J.F., Amrine-Madsen,H., Irlbeck,D.M. and Kitrinos,K.M.",2009
FJ653242,B,2005,19075055,"Virologic failure in first-line human immunodeficiency virus therapy with a CCR5 entry inhibitor, aplaviroc, plus a fixed-dose combination of lamivudine-zidovudine: nucleoside reverse transcriptase inhibitor resistance regardless of envelope tropism","Demarest,J.F., Amrine-Madsen,H., Irlbeck,D.M. and Kitrinos,K.M.",2009
FJ653278,C,2005,19075055,"Virologic failure in first-line human immunodeficiency virus therapy with a CCR5 entry inhibitor, aplaviroc, plus a fixed-dose combination of lamivudine-zidovudine: nucleoside reverse transcriptase inhibitor resistance regardless of envelope tropism","Demarest,J.F., Amrine-Madsen,H., Irlbeck,D.M. and Kitrinos,K.M.",2009
FJ653332,B,2005,19075068,Virologic failure in therapy-naive subjects on aplaviroc plus lopinavir-ritonavir: detection of aplaviroc resistance requires clonal analysis of envelope,"Kitrinos,K.M., Amrine-Madsen,H., Irlbeck,D.M., Word,J.M. and Demarest,J.F.",2009
FJ653380,B,2005,19075068,Virologic failure in therapy-naive subjects on aplaviroc plus lopinavir-ritonavir: detection of aplaviroc resistance requires clonal analysis of envelope,"Kitrinos,K.M., Amrine-Madsen,H., Irlbeck,D.M., Word,J.M. and Demarest,J.F.",2009
FJ653404,B,2005,19075068,Virologic failure in therapy-naive subjects on aplaviroc plus lopinavir-ritonavir: detection of aplaviroc resistance requires clonal analysis of envelope,"Kitrinos,K.M., Amrine-Madsen,H., Irlbeck,D.M., Word,J.M. and Demarest,J.F.",2009
FJ653428,B,2005,19075068,Virologic failure in therapy-naive subjects on aplaviroc plus lopinavir-ritonavir: detection of aplaviroc resistance requires clonal analysis of envelope,"Kitrinos,K.M., Amrine-Madsen,H., Irlbeck,D.M., Word,J.M. and Demarest,J.F.",2009
FJ653452,B,2005,19075068,Virologic failure in therapy-naive subjects on aplaviroc plus lopinavir-ritonavir: detection of aplaviroc resistance requires clonal analysis of envelope,"Kitrinos,K.M., Amrine-Madsen,H., Irlbeck,D.M., Word,J.M. and Demarest,J.F.",2009
FJ653476,B,2005,19075068,Virologic failure in therapy-naive subjects on aplaviroc plus lopinavir-ritonavir: detection of aplaviroc resistance requires clonal analysis of envelope,"Kitrinos,K.M., Amrine-Madsen,H., Irlbeck,D.M., Word,J.M. and Demarest,J.F.",2009
FJ653500,B,2005,19075068,Virologic failure in therapy-naive subjects on aplaviroc plus lopinavir-ritonavir: detection of aplaviroc resistance requires clonal analysis of envelope,"Kitrinos,K.M., Amrine-Madsen,H., Irlbeck,D.M., Word,J.M. and Demarest,J.F.",2009
FJ653524,B,2005,19075068,Virologic failure in therapy-naive subjects on aplaviroc plus lopinavir-ritonavir: detection of aplaviroc resistance requires clonal analysis of envelope,"Kitrinos,K.M., Amrine-Madsen,H., Irlbeck,D.M., Word,J.M. and Demarest,J.F.",2009
FJ653548,B,2005,19075068,Virologic failure in therapy-naive subjects on aplaviroc plus lopinavir-ritonavir: detection of aplaviroc resistance requires clonal analysis of envelope,"Kitrinos,K.M., Amrine-Madsen,H., Irlbeck,D.M., Word,J.M. and Demarest,J.F.",2009
FJ653572,B,2005,19075068,Virologic failure in therapy-naive subjects on aplaviroc plus lopinavir-ritonavir: detection of aplaviroc resistance requires clonal analysis of envelope,"Kitrinos,K.M., Amrine-Madsen,H., Irlbeck,D.M., Word,J.M. and Demarest,J.F.",2009
FJ653596,B,2005,19075068,Virologic failure in therapy-naive subjects on aplaviroc plus lopinavir-ritonavir: detection of aplaviroc resistance requires clonal analysis of envelope,"Kitrinos,K.M., Amrine-Madsen,H., Irlbeck,D.M., Word,J.M. and Demarest,J.F.",2009
FJ670515,02A,2005,20707647,Short Communication: Biological and Genetic Characterization of HIV Type 1 Subtype B and Nonsubtype B Transmitted Viruses: Usefulness for Vaccine Candidate Assessment,"Cuevas,M.T., Fernandez-Garcia,A., Pinilla,M., Garcia-Alvarez,V., Thomson,M., Delgado,E., Gonzalez-Galeano,M., Miralles,C., Serrano-Bengoechea,E., Ojea de Castro,R., Lopez-Alvarez,M.J., Lezaun,M.J., Sanchez-Garcia,A.M., Sanchez-Martinez,M., Munoz-Nieto,M. and Perez-Alvarez,L.",2010
FJ670516,F1,2002,19943791,"Near full-length genome characterization of a newly identified HIV type 1 subtype F variant circulating in St. Petersburg, Russia","Fernandez-Garcia,A., Cuevas,M.T., Vinogradova,A., Rakhmanova,A., Perez-Alvarez,L., de Castro,R.O., Osmanov,S. and Thomson,M.M.",2009
FJ670517,14_BG,2004,,Biological and genetic characterization of HIV-1 subtype B and non subtype-B transmitted viruses: usefulness for vaccine candidate assessment,"Cuevas,M.T., Fernandez-Garcia,A., Pinilla,M., Garcia,V., Thomson,M.M., Delgado,E., Gonzalez-Galeano,M., Miralles,C., Serrano-Bengoechea,E., Ojea de Castro,R., Lopez-Alvarez,M.J., Lezaun,M.J., Sanchez,A.M., Sanchez-Martinez,M., Munoz-Nieto,M. and Perez-Alvarez,L.",2010
FJ670518,14_BG,2004,,Biological and genetic characterization of HIV-1 subtype B and non subtype-B transmitted viruses: usefulness for vaccine candidate assessment,"Cuevas,M.T., Fernandez-Garcia,A., Pinilla,M., Garcia,V., Thomson,M.M., Delgado,E., Gonzalez-Galeano,M., Miralles,C., Serrano-Bengoechea,E., Ojea de Castro,R., Lopez-Alvarez,M.J., Lezaun,M.J., Sanchez,A.M., Sanchez-Martinez,M., Munoz-Nieto,M. and Perez-Alvarez,L.",2010
FJ670519,A1,2005,,Biological and genetic characterization of HIV-1 subtype B and non subtype-B transmitted viruses: usefulness for vaccine candidate assessment,"Cuevas,M.T., Fernandez-Garcia,A., Pinilla,M., Garcia,V., Thomson,M.M., Delgado,E., Gonzalez-Galeano,M., Miralles,C., Serrano-Bengoechea,E., Ojea de Castro,R., Lopez-Alvarez,M.J., Lezaun,M.J., Sanchez,A.M., Sanchez-Martinez,M., Munoz-Nieto,M. and Perez-Alvarez,L.",2010
FJ670520,G,2005,,Biological and genetic characterization of HIV-1 subtype B and non subtype-B transmitted viruses: usefulness for vaccine candidate assessment,"Cuevas,M.T., Fernandez-Garcia,A., Pinilla,M., Garcia,V., Thomson,M.M., Delgado,E., Gonzalez-Galeano,M., Miralles,C., Serrano-Bengoechea,E., Ojea de Castro,R., Lopez-Alvarez,M.J., Lezaun,M.J., Sanchez,A.M., Sanchez-Martinez,M., Munoz-Nieto,M. and Perez-Alvarez,L.",2010
FJ670521,C,2005,,Biological and genetic characterization of HIV-1 subtype B and non subtype-B transmitted viruses: usefulness for vaccine candidate assessment,"Cuevas,M.T., Fernandez-Garcia,A., Pinilla,M., Garcia,V., Thomson,M.M., Delgado,E., Gonzalez-Galeano,M., Miralles,C., Serrano-Bengoechea,E., Ojea de Castro,R., Lopez-Alvarez,M.J., Lezaun,M.J., Sanchez,A.M., Sanchez-Martinez,M., Munoz-Nieto,M. and Perez-Alvarez,L.",2010
FJ670522,14_BG,2005,,Biological and genetic characterization of HIV-1 subtype B and non subtype-B transmitted viruses: usefulness for vaccine candidate assessment,"Cuevas,M.T., Fernandez-Garcia,A., Pinilla,M., Garcia,V., Thomson,M.M., Delgado,E., Gonzalez-Galeano,M., Miralles,C., Serrano-Bengoechea,E., Ojea de Castro,R., Lopez-Alvarez,M.J., Lezaun,M.J., Sanchez,A.M., Sanchez-Martinez,M., Munoz-Nieto,M. and Perez-Alvarez,L.",2010
FJ670523,A1,2006,,Biological and genetic characterization of HIV-1 subtype B and non subtype-B transmitted viruses: usefulness for vaccine candidate assessment,"Cuevas,M.T., Fernandez-Garcia,A., Pinilla,M., Garcia,V., Thomson,M.M., Delgado,E., Gonzalez-Galeano,M., Miralles,C., Serrano-Bengoechea,E., Ojea de Castro,R., Lopez-Alvarez,M.J., Lezaun,M.J., Sanchez,A.M., Sanchez-Martinez,M., Munoz-Nieto,M. and Perez-Alvarez,L.",2010
FJ670524,B,2008,,Biological and genetic characterization of HIV-1 subtype B and non subtype-B transmitted viruses: usefulness for vaccine candidate assessment,"Cuevas,M.T., Fernandez-Garcia,A., Pinilla,M., Garcia,V., Thomson,M.M., Delgado,E., Gonzalez-Galeano,M., Miralles,C., Serrano-Bengoechea,E., Ojea de Castro,R., Lopez-Alvarez,M.J., Lezaun,M.J., Sanchez,A.M., Sanchez-Martinez,M., Munoz-Nieto,M. and Perez-Alvarez,L.",2010
FJ670525,B,2008,,Biological and genetic characterization of HIV-1 subtype B and non subtype-B transmitted viruses: usefulness for vaccine candidate assessment,"Cuevas,M.T., Fernandez-Garcia,A., Pinilla,M., Garcia,V., Thomson,M.M., Delgado,E., Gonzalez-Galeano,M., Miralles,C., Serrano-Bengoechea,E., Ojea de Castro,R., Lopez-Alvarez,M.J., Lezaun,M.J., Sanchez,A.M., Sanchez-Martinez,M., Munoz-Nieto,M. and Perez-Alvarez,L.",2010
FJ670526,24_BG,2008,,Biological and genetic characterization of HIV-1 subtype B and non subtype-B transmitted viruses: usefulness for vaccine candidate assessment,"Cuevas,M.T., Fernandez-Garcia,A., Pinilla,M., Garcia,V., Thomson,M.M., Delgado,E., Gonzalez-Galeano,M., Miralles,C., Serrano-Bengoechea,E., Ojea de Castro,R., Lopez-Alvarez,M.J., Lezaun,M.J., Sanchez,A.M., Sanchez-Martinez,M., Munoz-Nieto,M. and Perez-Alvarez,L.",2010
FJ670527,DF1G,2004,,Biological and genetic characterization of HIV-1 subtype B and non subtype-B transmitted viruses: usefulness for vaccine candidate assessment,"Cuevas,M.T., Fernandez-Garcia,A., Pinilla,M., Garcia,V., Thomson,M.M., Delgado,E., Gonzalez-Galeano,M., Miralles,C., Serrano-Bengoechea,E., Ojea de Castro,R., Lopez-Alvarez,M.J., Lezaun,M.J., Sanchez,A.M., Sanchez-Martinez,M., Munoz-Nieto,M. and Perez-Alvarez,L.",2010
FJ670528,14_BG,2005,,Biological and genetic characterization of HIV-1 subtype B and non subtype-B transmitted viruses: usefulness for vaccine candidate assessment,"Cuevas,M.T., Fernandez-Garcia,A., Pinilla,M., Garcia,V., Thomson,M.M., Delgado,E., Gonzalez-Galeano,M., Miralles,C., Serrano-Bengoechea,E., Ojea de Castro,R., Lopez-Alvarez,M.J., Lezaun,M.J., Sanchez,A.M., Sanchez-Martinez,M., Munoz-Nieto,M. and Perez-Alvarez,L.",2010
FJ670529,47_BF,2008,20618102,Identification of a new HIV type 1 circulating BF intersubtype recombinant form (CRF47_BF) in Spain,"Fernandez-Garcia,A., Perez-Alvarez,L., Cuevas,M.T., Delgado,E., Munoz-Nieto,M., Cilla,G., Iribarren,J.A., Pinilla,M., Ocampo,A., Miralles,C., Perez-Castro,S., Gonzalez-Galeano,M., de Castro,R.O., Trigo,M., Garcia,V., Sanchez,A.M. and Thomson,M.M.",2010
FJ670530,G,2008,,Biological and genetic characterization of HIV-1 subtype B and non subtype-B transmitted viruses: usefulness for vaccine candidate assessment,"Cuevas,M.T., Fernandez-Garcia,A., Pinilla,M., Garcia,V., Thomson,M.M., Delgado,E., Gonzalez-Galeano,M., Miralles,C., Serrano-Bengoechea,E., Ojea de Castro,R., Lopez-Alvarez,M.J., Lezaun,M.J., Sanchez,A.M., Sanchez-Martinez,M., Munoz-Nieto,M. and Perez-Alvarez,L.",2010
FJ670531,B,2008,,Biological and genetic characterization of HIV-1 subtype B and non subtype-B transmitted viruses: usefulness for vaccine candidate assessment,"Cuevas,M.T., Fernandez-Garcia,A., Pinilla,M., Garcia,V., Thomson,M.M., Delgado,E., Gonzalez-Galeano,M., Miralles,C., Serrano-Bengoechea,E., Ojea de Castro,R., Lopez-Alvarez,M.J., Lezaun,M.J., Sanchez,A.M., Sanchez-Martinez,M., Munoz-Nieto,M. and Perez-Alvarez,L.",2010
FJ687532,B,,19321618,Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brain,"Gray,L., Roche,M., Churchill,M.J., Sterjovski,J., Ellett,A., Poumbourios,P., Sheffief,S., Wang,B., Saksena,N., Purcell,D.F., Wesselingh,S., Cunningham,A.L., Brew,B.J., Gabuzda,D. and Gorry,P.R.",2009
FJ711703,H,2000,19552591,Characterization of genetically diverse HIV type 1 from a London cohort: near full-length genomic analysis of a subtype H strain,"Holzmayer,V., Aitken,C., Skinner,C., Ryall,L., Devare,S.G. and Hackett,J. Jr.",2009
FJ798320,B,,19211740,Major coexisting human immunodeficiency virus type 1 env gene subpopulations in the peripheral blood are produced by cells with similar turnover rates and show little evidence of genetic compartmentalization,"Ince,W.L., Harrington,P.R., Schnell,G.L., Patel-Chhabra,M., Burch,C.L., Menezes,P., Price,R.W., Eron,J.J. Jr. and Swanstrom,R.I.",2009
FJ798366,B,,19211740,Major coexisting human immunodeficiency virus type 1 env gene subpopulations in the peripheral blood are produced by cells with similar turnover rates and show little evidence of genetic compartmentalization,"Ince,W.L., Harrington,P.R., Schnell,G.L., Patel-Chhabra,M., Burch,C.L., Menezes,P., Price,R.W., Eron,J.J. Jr. and Swanstrom,R.I.",2009
FJ798391,B,,19211740,Major coexisting human immunodeficiency virus type 1 env gene subpopulations in the peripheral blood are produced by cells with similar turnover rates and show little evidence of genetic compartmentalization,"Ince,W.L., Harrington,P.R., Schnell,G.L., Patel-Chhabra,M., Burch,C.L., Menezes,P., Price,R.W., Eron,J.J. Jr. and Swanstrom,R.I.",2009
FJ798405,B,,19211740,Major coexisting human immunodeficiency virus type 1 env gene subpopulations in the peripheral blood are produced by cells with similar turnover rates and show little evidence of genetic compartmentalization,"Ince,W.L., Harrington,P.R., Schnell,G.L., Patel-Chhabra,M., Burch,C.L., Menezes,P., Price,R.W., Eron,J.J. Jr. and Swanstrom,R.I.",2009
FJ798415,B,,19211740,Major coexisting human immunodeficiency virus type 1 env gene subpopulations in the peripheral blood are produced by cells with similar turnover rates and show little evidence of genetic compartmentalization,"Ince,W.L., Harrington,P.R., Schnell,G.L., Patel-Chhabra,M., Burch,C.L., Menezes,P., Price,R.W., Eron,J.J. Jr. and Swanstrom,R.I.",2009
FJ798433,B,,19211740,Major coexisting human immunodeficiency virus type 1 env gene subpopulations in the peripheral blood are produced by cells with similar turnover rates and show little evidence of genetic compartmentalization,"Ince,W.L., Harrington,P.R., Schnell,G.L., Patel-Chhabra,M., Burch,C.L., Menezes,P., Price,R.W., Eron,J.J. Jr. and Swanstrom,R.I.",2009
FJ798457,B,,19211740,Major coexisting human immunodeficiency virus type 1 env gene subpopulations in the peripheral blood are produced by cells with similar turnover rates and show little evidence of genetic compartmentalization,"Ince,W.L., Harrington,P.R., Schnell,G.L., Patel-Chhabra,M., Burch,C.L., Menezes,P., Price,R.W., Eron,J.J. Jr. and Swanstrom,R.I.",2009
FJ798474,B,,19211740,Major coexisting human immunodeficiency virus type 1 env gene subpopulations in the peripheral blood are produced by cells with similar turnover rates and show little evidence of genetic compartmentalization,"Ince,W.L., Harrington,P.R., Schnell,G.L., Patel-Chhabra,M., Burch,C.L., Menezes,P., Price,R.W., Eron,J.J. Jr. and Swanstrom,R.I.",2009
FJ798503,B,,19211740,Major coexisting human immunodeficiency virus type 1 env gene subpopulations in the peripheral blood are produced by cells with similar turnover rates and show little evidence of genetic compartmentalization,"Ince,W.L., Harrington,P.R., Schnell,G.L., Patel-Chhabra,M., Burch,C.L., Menezes,P., Price,R.W., Eron,J.J. Jr. and Swanstrom,R.I.",2009
FJ798521,B,,19211740,Major coexisting human immunodeficiency virus type 1 env gene subpopulations in the peripheral blood are produced by cells with similar turnover rates and show little evidence of genetic compartmentalization,"Ince,W.L., Harrington,P.R., Schnell,G.L., Patel-Chhabra,M., Burch,C.L., Menezes,P., Price,R.W., Eron,J.J. Jr. and Swanstrom,R.I.",2009
FJ798544,B,,19211740,Major coexisting human immunodeficiency virus type 1 env gene subpopulations in the peripheral blood are produced by cells with similar turnover rates and show little evidence of genetic compartmentalization,"Ince,W.L., Harrington,P.R., Schnell,G.L., Patel-Chhabra,M., Burch,C.L., Menezes,P., Price,R.W., Eron,J.J. Jr. and Swanstrom,R.I.",2009
FJ817365,B,2008,,"Functional molecular clones of HIV-1 env of subtypes F, B, G and BG recombinants","Revilla,A., Delgado,E., Vega,Y. and Thomson,M.",
FJ817366,B,2007,,"Functional molecular clones of HIV-1 env of subtypes F, B, G and BG recombinants","Revilla,A., Delgado,E., Vega,Y. and Thomson,M.",
FJ817368,G,2005,21226626,Construction and Phenotypic Characterization of HIV Type 1 Functional Envelope Clones of Subtypes G and F,"Revilla,A., Delgado,E., Christian,E.C., Dalrymple,J., Vega,Y., Carrera,C., Gonzalez-Galeano,M., Ocampo,A., de Castro,R.O., Lezaun,M.J., Rodriguez,R., Marino,A., Ordonez,P., Cilla,G., Cisterna,R., Santamaria,J.M., Prieto,S., Rakhmanova,A., Vinogradova,A., Rios,M., Perez-Alvarez,L., Najera,R., Montefiori,D.C., Seaman,M.S. and Thomson,M.M.",2011
FJ817370,G,2004,21226626,Construction and Phenotypic Characterization of HIV Type 1 Functional Envelope Clones of Subtypes G and F,"Revilla,A., Delgado,E., Christian,E.C., Dalrymple,J., Vega,Y., Carrera,C., Gonzalez-Galeano,M., Ocampo,A., de Castro,R.O., Lezaun,M.J., Rodriguez,R., Marino,A., Ordonez,P., Cilla,G., Cisterna,R., Santamaria,J.M., Prieto,S., Rakhmanova,A., Vinogradova,A., Rios,M., Perez-Alvarez,L., Najera,R., Montefiori,D.C., Seaman,M.S. and Thomson,M.M.",2011
FJ817371,F1,2007,21226626,Construction and Phenotypic Characterization of HIV Type 1 Functional Envelope Clones of Subtypes G and F,"Revilla,A., Delgado,E., Christian,E.C., Dalrymple,J., Vega,Y., Carrera,C., Gonzalez-Galeano,M., Ocampo,A., de Castro,R.O., Lezaun,M.J., Rodriguez,R., Marino,A., Ordonez,P., Cilla,G., Cisterna,R., Santamaria,J.M., Prieto,S., Rakhmanova,A., Vinogradova,A., Rios,M., Perez-Alvarez,L., Najera,R., Montefiori,D.C., Seaman,M.S. and Thomson,M.M.",2011
FJ817372,F1,2006,,"Functional molecular clones of HIV-1 env of subtypes F, B, G and BG recombinants","Revilla,A., Delgado,E., Vega,Y. and Thomson,M.",
FJ846628,C,2001,,Clonal Functional and Genetic Analysis of Coreceptor Usage by Dualtropic HIV-1 Subtype C Strains,"Singh,A., Page,T., Allgaier,R.L., Hiramen,K., Coovadia,H.M., Moore,P., Morris,L. and Ndungu,T.",
FJ846633,C,1996,19695656,Functional and genetic analysis of coreceptor usage by dualtropic HIV-1 subtype C isolates,"Singh,A., Page,T., Moore,P.L., Allgaier,R.L., Hiramen,K., Coovadia,H.M., Walker,B.D., Morris,L. and Ndung'u,T.",2009
FJ853620,B,2008,20707647,Short Communication: Biological and Genetic Characterization of HIV Type 1 Subtype B and Nonsubtype B Transmitted Viruses: Usefulness for Vaccine Candidate Assessment,"Cuevas,M.T., Fernandez-Garcia,A., Pinilla,M., Garcia-Alvarez,V., Thomson,M., Delgado,E., Gonzalez-Galeano,M., Miralles,C., Serrano-Bengoechea,E., Ojea de Castro,R., Lopez-Alvarez,M.J., Lezaun,M.J., Sanchez-Garcia,A.M., Sanchez-Martinez,M., Munoz-Nieto,M. and Perez-Alvarez,L.",2010
FJ853621,BF1,2008,20707647,Short Communication: Biological and Genetic Characterization of HIV Type 1 Subtype B and Nonsubtype B Transmitted Viruses: Usefulness for Vaccine Candidate Assessment,"Cuevas,M.T., Fernandez-Garcia,A., Pinilla,M., Garcia-Alvarez,V., Thomson,M., Delgado,E., Gonzalez-Galeano,M., Miralles,C., Serrano-Bengoechea,E., Ojea de Castro,R., Lopez-Alvarez,M.J., Lezaun,M.J., Sanchez-Garcia,A.M., Sanchez-Martinez,M., Munoz-Nieto,M. and Perez-Alvarez,L.",2010
FJ853622,B,2008,20707647,Short Communication: Biological and Genetic Characterization of HIV Type 1 Subtype B and Nonsubtype B Transmitted Viruses: Usefulness for Vaccine Candidate Assessment,"Cuevas,M.T., Fernandez-Garcia,A., Pinilla,M., Garcia-Alvarez,V., Thomson,M., Delgado,E., Gonzalez-Galeano,M., Miralles,C., Serrano-Bengoechea,E., Ojea de Castro,R., Lopez-Alvarez,M.J., Lezaun,M.J., Sanchez-Garcia,A.M., Sanchez-Martinez,M., Munoz-Nieto,M. and Perez-Alvarez,L.",2010
FJ864679,A6,2008,22236080,"Isolation, Characterization, and Sequence Analysis of a Novel HIV Type 1 Subtype A1 Strain from Russia","Galkin,A.N., Bychenko,A.B., Kuznecovs,G. and Filinova,E.Y.",2012
FJ866113,A1,2005,19474105,"Cross-subtype neutralization sensitivity despite monoclonal antibody resistance among early subtype A, C, and D envelope variants of human immunodeficiency virus type 1","Blish,C.A., Jalalian-Lechak,Z., Rainwater,S., Nguyen,M.A., Dogan,O.C. and Overbaugh,J.",2009
FJ866117,A1,2004,19474105,"Cross-subtype neutralization sensitivity despite monoclonal antibody resistance among early subtype A, C, and D envelope variants of human immunodeficiency virus type 1","Blish,C.A., Jalalian-Lechak,Z., Rainwater,S., Nguyen,M.A., Dogan,O.C. and Overbaugh,J.",2009
FJ866118,A1,2005,19474105,"Cross-subtype neutralization sensitivity despite monoclonal antibody resistance among early subtype A, C, and D envelope variants of human immunodeficiency virus type 1","Blish,C.A., Jalalian-Lechak,Z., Rainwater,S., Nguyen,M.A., Dogan,O.C. and Overbaugh,J.",2009
FJ866119,A1,2005,19474105,"Cross-subtype neutralization sensitivity despite monoclonal antibody resistance among early subtype A, C, and D envelope variants of human immunodeficiency virus type 1","Blish,C.A., Jalalian-Lechak,Z., Rainwater,S., Nguyen,M.A., Dogan,O.C. and Overbaugh,J.",2009
FJ866121,A1,2005,19474105,"Cross-subtype neutralization sensitivity despite monoclonal antibody resistance among early subtype A, C, and D envelope variants of human immunodeficiency virus type 1","Blish,C.A., Jalalian-Lechak,Z., Rainwater,S., Nguyen,M.A., Dogan,O.C. and Overbaugh,J.",2009
FJ866124,A1D,1996,19474105,"Cross-subtype neutralization sensitivity despite monoclonal antibody resistance among early subtype A, C, and D envelope variants of human immunodeficiency virus type 1","Blish,C.A., Jalalian-Lechak,Z., Rainwater,S., Nguyen,M.A., Dogan,O.C. and Overbaugh,J.",2009
FJ866128,A2D,2004,19474105,"Cross-subtype neutralization sensitivity despite monoclonal antibody resistance among early subtype A, C, and D envelope variants of human immunodeficiency virus type 1","Blish,C.A., Jalalian-Lechak,Z., Rainwater,S., Nguyen,M.A., Dogan,O.C. and Overbaugh,J.",2009
FJ866131,C,1995,19474105,"Cross-subtype neutralization sensitivity despite monoclonal antibody resistance among early subtype A, C, and D envelope variants of human immunodeficiency virus type 1","Blish,C.A., Jalalian-Lechak,Z., Rainwater,S., Nguyen,M.A., Dogan,O.C. and Overbaugh,J.",2009
FJ866133,C,1997,19474105,"Cross-subtype neutralization sensitivity despite monoclonal antibody resistance among early subtype A, C, and D envelope variants of human immunodeficiency virus type 1","Blish,C.A., Jalalian-Lechak,Z., Rainwater,S., Nguyen,M.A., Dogan,O.C. and Overbaugh,J.",2009
FJ866136,D,1993,19474105,"Cross-subtype neutralization sensitivity despite monoclonal antibody resistance among early subtype A, C, and D envelope variants of human immunodeficiency virus type 1","Blish,C.A., Jalalian-Lechak,Z., Rainwater,S., Nguyen,M.A., Dogan,O.C. and Overbaugh,J.",2009
FJ866138,D,1997,19474105,"Cross-subtype neutralization sensitivity despite monoclonal antibody resistance among early subtype A, C, and D envelope variants of human immunodeficiency virus type 1","Blish,C.A., Jalalian-Lechak,Z., Rainwater,S., Nguyen,M.A., Dogan,O.C. and Overbaugh,J.",2009
FJ866139,D,1999,19474105,"Cross-subtype neutralization sensitivity despite monoclonal antibody resistance among early subtype A, C, and D envelope variants of human immunodeficiency virus type 1","Blish,C.A., Jalalian-Lechak,Z., Rainwater,S., Nguyen,M.A., Dogan,O.C. and Overbaugh,J.",2009
FJ904244,BF1,2008,19751146,Use of massive parallel pyrosequencing for near full-length characterization of a unique HIV Type 1 BF recombinant associated with a fatal primary infection,"Bruselles,A., Rozera,G., Bartolini,B., Prosperi,M., Del Nonno,F., Narciso,P., Capobianchi,M.R. and Abbate,I.",2009
FJ977091,C,2001,20484560,Novel subtype C human immunodeficiency virus type 1 envelopes cloned directly from plasma: coreceptor usage and neutralization phenotypes,"Koh,W.W., Forsman,A., Hue,S., van der Velden,G.J., Yirrell,D.L., McKnight,A., Weiss,R.A. and Aasa-Chapman,M.M.",2010
FJ977092,C,2001,20484560,Novel subtype C human immunodeficiency virus type 1 envelopes cloned directly from plasma: coreceptor usage and neutralization phenotypes,"Koh,W.W., Forsman,A., Hue,S., van der Velden,G.J., Yirrell,D.L., McKnight,A., Weiss,R.A. and Aasa-Chapman,M.M.",2010
FJ977095,C,2001,20484560,Novel subtype C human immunodeficiency virus type 1 envelopes cloned directly from plasma: coreceptor usage and neutralization phenotypes,"Koh,W.W., Forsman,A., Hue,S., van der Velden,G.J., Yirrell,D.L., McKnight,A., Weiss,R.A. and Aasa-Chapman,M.M.",2010
FM165626,A1,1997,19886837,HIV type 1 subtype A envelope genetic evolution in a slow progressing individual with consistent broadly neutralizing antibodies,"Dieltjens,T., Loots,N., Vereecken,K., Grupping,K., Heyndrickx,L., Bottieau,E., Vanham,G., Davis,D. and Janssens,W.",2009
FM165645,A1,1994,19886837,HIV type 1 subtype A envelope genetic evolution in a slow progressing individual with consistent broadly neutralizing antibodies,"Dieltjens,T., Loots,N., Vereecken,K., Grupping,K., Heyndrickx,L., Bottieau,E., Vanham,G., Davis,D. and Janssens,W.",2009
FM877777,26_A5U,1997,19678767,"Genetic characterization of eight full-length HIV type 1 genomes from the Democratic Republic of Congo (DRC) reveal a new subsubtype, A5, in the A radiation that predominates in the recombinant structure of CRF26_A5U","Vidal,N., Bazepeo,S.E., Mulanga,C., Delaporte,E. and Peeters,M.",2009
FM877779,26C,2002,19678767,"Genetic characterization of eight full-length HIV type 1 genomes from the Democratic Republic of Congo (DRC) reveal a new subsubtype, A5, in the A radiation that predominates in the recombinant structure of CRF26_A5U","Vidal,N., Bazepeo,S.E., Mulanga,C., Delaporte,E. and Peeters,M.",2009
FM877780,26_A5U,2002,19678767,"Genetic characterization of eight full-length HIV type 1 genomes from the Democratic Republic of Congo (DRC) reveal a new subsubtype, A5, in the A radiation that predominates in the recombinant structure of CRF26_A5U","Vidal,N., Bazepeo,S.E., Mulanga,C., Delaporte,E. and Peeters,M.",2009
FM877781,26_A5U,2002,19678767,"Genetic characterization of eight full-length HIV type 1 genomes from the Democratic Republic of Congo (DRC) reveal a new subsubtype, A5, in the A radiation that predominates in the recombinant structure of CRF26_A5U","Vidal,N., Bazepeo,S.E., Mulanga,C., Delaporte,E. and Peeters,M.",2009
FM877782,26_A5U,2002,19678767,"Genetic characterization of eight full-length HIV type 1 genomes from the Democratic Republic of Congo (DRC) reveal a new subsubtype, A5, in the A radiation that predominates in the recombinant structure of CRF26_A5U","Vidal,N., Bazepeo,S.E., Mulanga,C., Delaporte,E. and Peeters,M.",2009
FN392869,KU,1997,,"CRF45_AKU, a new circulating recombinant form from Central Africa, is the common ancestor of HIV-1 MAL and HIV-1 NOGIL","Niama,F.R., Vidal,N., Bazepeo,S.E., Mpoudi,E., Parra,H.J., Delaporte,E. and Peeters,M.",
FN392870,U,,,"CRF45_AKU, a new circulating recombinant form from Central Africa, is the common ancestor of HIV-1 MAL and HIV-1 NOGIL","Niama,F.R., Vidal,N., Bazepeo,S.E., Mpoudi,E., Parra,H.J., Delaporte,E. and Peeters,M.",
FN392871,U,,,"CRF45_AKU, a new circulating recombinant form from Central Africa, is the common ancestor of HIV-1 MAL and HIV-1 NOGIL","Niama,F.R., Vidal,N., Bazepeo,S.E., Mpoudi,E., Parra,H.J., Delaporte,E. and Peeters,M.",
FN392873,U,2002,,"CRF45_AKU, a new circulating recombinant form from Central Africa, is the common ancestor of HIV-1 MAL and HIV-1 NOGIL","Niama,F.R., Vidal,N., Bazepeo,S.E., Mpoudi,E., Parra,H.J., Delaporte,E. and Peeters,M.",
FN392874,45_cpx,1997,20001521,"CRF45_AKU, a circulating recombinant from Central Africa, is probably the common ancestor of HIV type 1 MAL and HIV type 1 NOGIL","Niama,F.R., Vidal,N., Bazepeo,S.E., Mpoudi,E., Toure-Kane,C., Parra,H.J., Delaporte,E. and Peeters,M.",2009
FN392875,45_cpx,1997,20001521,"CRF45_AKU, a circulating recombinant from Central Africa, is probably the common ancestor of HIV type 1 MAL and HIV type 1 NOGIL","Niama,F.R., Vidal,N., Bazepeo,S.E., Mpoudi,E., Toure-Kane,C., Parra,H.J., Delaporte,E. and Peeters,M.",2009
FN392876,45_cpx,1997,20001521,"CRF45_AKU, a circulating recombinant from Central Africa, is probably the common ancestor of HIV type 1 MAL and HIV type 1 NOGIL","Niama,F.R., Vidal,N., Bazepeo,S.E., Mpoudi,E., Toure-Kane,C., Parra,H.J., Delaporte,E. and Peeters,M.",2009
FN392877,45_cpx,1997,20001521,"CRF45_AKU, a circulating recombinant from Central Africa, is probably the common ancestor of HIV type 1 MAL and HIV type 1 NOGIL","Niama,F.R., Vidal,N., Bazepeo,S.E., Mpoudi,E., Toure-Kane,C., Parra,H.J., Delaporte,E. and Peeters,M.",2009
FN432725,02_AG,2001,,Evolution of antibody landscape and viral escape in an HIV-1 CRF02_AG infected patient with 4E10-like antibodies,"Dieltjens,T., Heyndrickx,L., Vanham,G. and Janssens,W.",
FR846408,G,,,Novel multi-region hybridization assay for the identification of the most prevalent genetic forms of the human immunodeficiency virus type 1 (HIV-1) circulating in Portugal,"Freitas,F.B., Esteves,A., Piedade,J. and Parreira,R.",2012
FR846409,G,,,Novel multi-region hybridization assay for the identification of the most prevalent genetic forms of the human immunodeficiency virus type 1 (HIV-1) circulating in Portugal,"Freitas,F.B., Esteves,A., Piedade,J. and Parreira,R.",2012
FR846410,G,,,Novel multi-region hybridization assay for the identification of the most prevalent genetic forms of the human immunodeficiency virus type 1 (HIV-1) circulating in Portugal,"Freitas,F.B., Esteves,A., Piedade,J. and Parreira,R.",2012
GQ153936,B,,19474108,Novel ring structure in the gp41 trimer of human immunodeficiency virus type 1 that modulates sensitivity and resistance to broadly neutralizing antibodies,"O'Rourke,S.M., Schweighardt,B., Scott,W.G., Wrin,T., Fonseca,D.P., Sinangil,F. and Berman,P.W.",2009
GQ175881,48_01B,2007,20386110,Identification of a novel second-generation circulating recombinant form (CRF48_01B) in Malaysia: a descendant of the previously identified CRF33_01B,"Li,Y., Tee,K.K., Liao,H., Hase,S., Uenishi,R., Li,X.J., Tsuchiura,T., Yang,R., Govindasamy,S., Yong,Y.K., Tan,H.Y., Pybus,O.G., Kamarulzaman,A. and Takebe,Y.",2010
GQ175882,48_01B,2007,20386110,Identification of a novel second-generation circulating recombinant form (CRF48_01B) in Malaysia: a descendant of the previously identified CRF33_01B,"Li,Y., Tee,K.K., Liao,H., Hase,S., Uenishi,R., Li,X.J., Tsuchiura,T., Yang,R., Govindasamy,S., Yong,Y.K., Tan,H.Y., Pybus,O.G., Kamarulzaman,A. and Takebe,Y.",2010
GQ175883,48_01B,2007,20386110,Identification of a novel second-generation circulating recombinant form (CRF48_01B) in Malaysia: a descendant of the previously identified CRF33_01B,"Li,Y., Tee,K.K., Liao,H., Hase,S., Uenishi,R., Li,X.J., Tsuchiura,T., Yang,R., Govindasamy,S., Yong,Y.K., Tan,H.Y., Pybus,O.G., Kamarulzaman,A. and Takebe,Y.",2010
GQ222685,G,2008,21226626,Construction and Phenotypic Characterization of HIV Type 1 Functional Envelope Clones of Subtypes G and F,"Revilla,A., Delgado,E., Christian,E.C., Dalrymple,J., Vega,Y., Carrera,C., Gonzalez-Galeano,M., Ocampo,A., de Castro,R.O., Lezaun,M.J., Rodriguez,R., Marino,A., Ordonez,P., Cilla,G., Cisterna,R., Santamaria,J.M., Prieto,S., Rakhmanova,A., Vinogradova,A., Rios,M., Perez-Alvarez,L., Najera,R., Montefiori,D.C., Seaman,M.S. and Thomson,M.M.",2011
GQ229529,22_01A1,2002,20812894,Identification and Genetic Characterization of a Novel CRF22_01A1 Recombinant Form of HIV Type 1 in Cameroon,"Zhao,J., Tang,S., Ragupathy,V., Carr,J.K., Wolfe,N.D., Awazi,B. and Hewlett,I.",2010
GQ245681,D,1996,19553323,Virus entry via the alternative coreceptors CCR3 and FPRL1 differs by human immunodeficiency virus type 1 subtype,"Nedellec,R., Coetzer,M., Shimizu,N., Hoshino,H., Polonis,V.R., Morris,L., Martensson,U.E., Binley,J., Overbaugh,J. and Mosier,D.E.",2009
GQ256645,B,2007,,HIV-1 Evolution Following Transmission to an HLA-B*5801 Positive Subject,"Blankson,J.N., O'Connell,K.A. and Siliciano,R.F.",
GQ256646,B,2007,,HIV-1 Evolution Following Transmission to an HLA-B*5801 Positive Subject,"Blankson,J.N., O'Connell,K.A. and Siliciano,R.F.",
GQ290462,F1,2008,19943791,"Near full-length genome characterization of a newly identified HIV type 1 subtype F variant circulating in St. Petersburg, Russia","Fernandez-Garcia,A., Cuevas,M.T., Vinogradova,A., Rakhmanova,A., Perez-Alvarez,L., de Castro,R.O., Osmanov,S. and Thomson,M.M.",2009
GQ304518,B,2005,,An HIV-1 dually infected individual,"Aasa-Chapman,M.M.I. and McKnight,A.",
GQ324958,N,,20059396,Four new HIV-1 group N isolates from Cameroon: Prevalence continues to be low,"Vallari,A., Bodelle,P., Ngansop,C., Makamche,F., Ndembi,N., Mbanya,D., Kaptue,L., Gurtler,L.G., McArthur,C.P., Devare,S.G. and Brennan,C.A.",2010
GQ324962,N,,20059396,Four new HIV-1 group N isolates from Cameroon: Prevalence continues to be low,"Vallari,A., Bodelle,P., Ngansop,C., Makamche,F., Ndembi,N., Mbanya,D., Kaptue,L., Gurtler,L.G., McArthur,C.P., Devare,S.G. and Brennan,C.A.",2010
GQ328744,P,,19648927,A new human immunodeficiency virus derived from gorillas,"Plantier,J.C., Leoz,M., Dickerson,J.E., De Oliveira,F., Cordonnier,F., Lemee,V., Damond,F., Robertson,D.L. and Simon,F.",2009
GQ351296,DO,2008,20386379,First evidence of a HIV-1 M/O recombinant form circulating outside Cameroon,"Vessiere,A., Leoz,M., Brodard,V., Strady,C., Lemee,V., Depatureaux,A., Simon,F. and Plantier,J.C.",2010
GQ372986,A,2007,20707647,Short Communication: Biological and Genetic Characterization of HIV Type 1 Subtype B and Nonsubtype B Transmitted Viruses: Usefulness for Vaccine Candidate Assessment,"Cuevas,M.T., Fernandez-Garcia,A., Pinilla,M., Garcia-Alvarez,V., Thomson,M., Delgado,E., Gonzalez-Galeano,M., Miralles,C., Serrano-Bengoechea,E., Ojea de Castro,R., Lopez-Alvarez,M.J., Lezaun,M.J., Sanchez-Garcia,A.M., Sanchez-Martinez,M., Munoz-Nieto,M. and Perez-Alvarez,L.",2010
GQ372987,47_BF,2008,20618102,Identification of a new HIV type 1 circulating BF intersubtype recombinant form (CRF47_BF) in Spain,"Fernandez-Garcia,A., Perez-Alvarez,L., Cuevas,M.T., Delgado,E., Munoz-Nieto,M., Cilla,G., Iribarren,J.A., Pinilla,M., Ocampo,A., Miralles,C., Perez-Castro,S., Gonzalez-Galeano,M., de Castro,R.O., Trigo,M., Garcia,V., Sanchez,A.M. and Thomson,M.M.",2010
GQ372988,B,2008,20707647,Short Communication: Biological and Genetic Characterization of HIV Type 1 Subtype B and Nonsubtype B Transmitted Viruses: Usefulness for Vaccine Candidate Assessment,"Cuevas,M.T., Fernandez-Garcia,A., Pinilla,M., Garcia-Alvarez,V., Thomson,M., Delgado,E., Gonzalez-Galeano,M., Miralles,C., Serrano-Bengoechea,E., Ojea de Castro,R., Lopez-Alvarez,M.J., Lezaun,M.J., Sanchez-Garcia,A.M., Sanchez-Martinez,M., Munoz-Nieto,M. and Perez-Alvarez,L.",2010
GQ372989,BF1,2008,20707647,Short Communication: Biological and Genetic Characterization of HIV Type 1 Subtype B and Nonsubtype B Transmitted Viruses: Usefulness for Vaccine Candidate Assessment,"Cuevas,M.T., Fernandez-Garcia,A., Pinilla,M., Garcia-Alvarez,V., Thomson,M., Delgado,E., Gonzalez-Galeano,M., Miralles,C., Serrano-Bengoechea,E., Ojea de Castro,R., Lopez-Alvarez,M.J., Lezaun,M.J., Sanchez-Garcia,A.M., Sanchez-Martinez,M., Munoz-Nieto,M. and Perez-Alvarez,L.",2010
GQ372990,B,2008,20707647,Short Communication: Biological and Genetic Characterization of HIV Type 1 Subtype B and Nonsubtype B Transmitted Viruses: Usefulness for Vaccine Candidate Assessment,"Cuevas,M.T., Fernandez-Garcia,A., Pinilla,M., Garcia-Alvarez,V., Thomson,M., Delgado,E., Gonzalez-Galeano,M., Miralles,C., Serrano-Bengoechea,E., Ojea de Castro,R., Lopez-Alvarez,M.J., Lezaun,M.J., Sanchez-Garcia,A.M., Sanchez-Martinez,M., Munoz-Nieto,M. and Perez-Alvarez,L.",2010
GQ477441,01_AE,2007,20438383,Distinct circulating recombinant HIV-1 strains among injecting drug users and sex workers in Afghanistan,"Sanders-Buell,E., Bose,M., Nasir,A., Todd,C.S., Stanekzai,M.R., Tovanabutra,S., Scott,P.T., Strathdee,S.A., Tjaden,J., Michael,N.L. and McCutchan,F.E.",2010
GQ477442,35_AD,2006,20438383,Distinct circulating recombinant HIV-1 strains among injecting drug users and sex workers in Afghanistan,"Sanders-Buell,E., Bose,M., Nasir,A., Todd,C.S., Stanekzai,M.R., Tovanabutra,S., Scott,P.T., Strathdee,S.A., Tjaden,J., Michael,N.L. and McCutchan,F.E.",2010
GQ477443,35_AD,2006,20438383,Distinct circulating recombinant HIV-1 strains among injecting drug users and sex workers in Afghanistan,"Sanders-Buell,E., Bose,M., Nasir,A., Todd,C.S., Stanekzai,M.R., Tovanabutra,S., Scott,P.T., Strathdee,S.A., Tjaden,J., Michael,N.L. and McCutchan,F.E.",2010
GQ477444,35_AD,2006,20438383,Distinct circulating recombinant HIV-1 strains among injecting drug users and sex workers in Afghanistan,"Sanders-Buell,E., Bose,M., Nasir,A., Todd,C.S., Stanekzai,M.R., Tovanabutra,S., Scott,P.T., Strathdee,S.A., Tjaden,J., Michael,N.L. and McCutchan,F.E.",2010
GQ477445,35_AD,2006,20438383,Distinct circulating recombinant HIV-1 strains among injecting drug users and sex workers in Afghanistan,"Sanders-Buell,E., Bose,M., Nasir,A., Todd,C.S., Stanekzai,M.R., Tovanabutra,S., Scott,P.T., Strathdee,S.A., Tjaden,J., Michael,N.L. and McCutchan,F.E.",2010
GQ477446,35_AD,2007,20438383,Distinct circulating recombinant HIV-1 strains among injecting drug users and sex workers in Afghanistan,"Sanders-Buell,E., Bose,M., Nasir,A., Todd,C.S., Stanekzai,M.R., Tovanabutra,S., Scott,P.T., Strathdee,S.A., Tjaden,J., Michael,N.L. and McCutchan,F.E.",2010
GQ477447,A1D,2006,20438383,Distinct circulating recombinant HIV-1 strains among injecting drug users and sex workers in Afghanistan,"Sanders-Buell,E., Bose,M., Nasir,A., Todd,C.S., Stanekzai,M.R., Tovanabutra,S., Scott,P.T., Strathdee,S.A., Tjaden,J., Michael,N.L. and McCutchan,F.E.",2010
GQ477448,35_AD,2007,20438383,Distinct circulating recombinant HIV-1 strains among injecting drug users and sex workers in Afghanistan,"Sanders-Buell,E., Bose,M., Nasir,A., Todd,C.S., Stanekzai,M.R., Tovanabutra,S., Scott,P.T., Strathdee,S.A., Tjaden,J., Michael,N.L. and McCutchan,F.E.",2010
GQ477449,35_AD,2007,20438383,Distinct circulating recombinant HIV-1 strains among injecting drug users and sex workers in Afghanistan,"Sanders-Buell,E., Bose,M., Nasir,A., Todd,C.S., Stanekzai,M.R., Tovanabutra,S., Scott,P.T., Strathdee,S.A., Tjaden,J., Michael,N.L. and McCutchan,F.E.",2010
GQ477450,35_AD,2006,20438383,Distinct circulating recombinant HIV-1 strains among injecting drug users and sex workers in Afghanistan,"Sanders-Buell,E., Bose,M., Nasir,A., Todd,C.S., Stanekzai,M.R., Tovanabutra,S., Scott,P.T., Strathdee,S.A., Tjaden,J., Michael,N.L. and McCutchan,F.E.",2010
GQ477451,35_AD,2006,20438383,Distinct circulating recombinant HIV-1 strains among injecting drug users and sex workers in Afghanistan,"Sanders-Buell,E., Bose,M., Nasir,A., Todd,C.S., Stanekzai,M.R., Tovanabutra,S., Scott,P.T., Strathdee,S.A., Tjaden,J., Michael,N.L. and McCutchan,F.E.",2010
GQ485312,C,2002,19763269,Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways,"Rong,R., Li,B., Lynch,R.M., Haaland,R.E., Murphy,M.K., Mulenga,J., Allen,S.A., Pinter,A., Shaw,G.M., Hunter,E., Robinson,J.E., Gnanakaran,S. and Derdeyn,C.A.",2009
GQ485415,C,2003,19763269,Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways,"Rong,R., Li,B., Lynch,R.M., Haaland,R.E., Murphy,M.K., Mulenga,J., Allen,S.A., Pinter,A., Shaw,G.M., Hunter,E., Robinson,J.E., Gnanakaran,S. and Derdeyn,C.A.",2009
GQ845124,01_AE,2005,20528151,"Genetic characterization of 13 subtype CRF01_AE near full-length genomes in Guangxi, China","Li,L., Liang,S., Chen,L., Liu,W., Li,H., Liu,Y., Bao,Z., Wang,Z., Zhuang,D., Liu,S. and Li,J.",2010
GQ845125,01_AE,2005,20528151,"Genetic characterization of 13 subtype CRF01_AE near full-length genomes in Guangxi, China","Li,L., Liang,S., Chen,L., Liu,W., Li,H., Liu,Y., Bao,Z., Wang,Z., Zhuang,D., Liu,S. and Li,J.",2010
GQ845126,01_AE,2005,20528151,"Genetic characterization of 13 subtype CRF01_AE near full-length genomes in Guangxi, China","Li,L., Liang,S., Chen,L., Liu,W., Li,H., Liu,Y., Bao,Z., Wang,Z., Zhuang,D., Liu,S. and Li,J.",2010
GQ859273,B,2001,19706711,Preinfection human immunodeficiency virus (HIV)-specific cytotoxic T lymphocytes failed to prevent HIV type 1 infection from strains genetically unrelated to viruses in long-term exposed partners,"Liu,Y., Woodward,A., Zhu,H., Andrus,T., McNevin,J., Lee,J., Mullins,J.I., Corey,L., McElrath,M.J. and Zhu,T.",2009
GQ859285,B,2001,19706711,Preinfection human immunodeficiency virus (HIV)-specific cytotoxic T lymphocytes failed to prevent HIV type 1 infection from strains genetically unrelated to viruses in long-term exposed partners,"Liu,Y., Woodward,A., Zhu,H., Andrus,T., McNevin,J., Lee,J., Mullins,J.I., Corey,L., McElrath,M.J. and Zhu,T.",2009
GQ859295,B,1999,19706711,Preinfection human immunodeficiency virus (HIV)-specific cytotoxic T lymphocytes failed to prevent HIV type 1 infection from strains genetically unrelated to viruses in long-term exposed partners,"Liu,Y., Woodward,A., Zhu,H., Andrus,T., McNevin,J., Lee,J., Mullins,J.I., Corey,L., McElrath,M.J. and Zhu,T.",2009
GQ862780,G,2009,21226626,Construction and Phenotypic Characterization of HIV Type 1 Functional Envelope Clones of Subtypes G and F,"Revilla,A., Delgado,E., Christian,E.C., Dalrymple,J., Vega,Y., Carrera,C., Gonzalez-Galeano,M., Ocampo,A., de Castro,R.O., Lezaun,M.J., Rodriguez,R., Marino,A., Ordonez,P., Cilla,G., Cisterna,R., Santamaria,J.M., Prieto,S., Rakhmanova,A., Vinogradova,A., Rios,M., Perez-Alvarez,L., Najera,R., Montefiori,D.C., Seaman,M.S. and Thomson,M.M.",2011
GQ862781,G,2008,21226626,Construction and Phenotypic Characterization of HIV Type 1 Functional Envelope Clones of Subtypes G and F,"Revilla,A., Delgado,E., Christian,E.C., Dalrymple,J., Vega,Y., Carrera,C., Gonzalez-Galeano,M., Ocampo,A., de Castro,R.O., Lezaun,M.J., Rodriguez,R., Marino,A., Ordonez,P., Cilla,G., Cisterna,R., Santamaria,J.M., Prieto,S., Rakhmanova,A., Vinogradova,A., Rios,M., Perez-Alvarez,L., Najera,R., Montefiori,D.C., Seaman,M.S. and Thomson,M.M.",2011
GU074012,B,,19913863,Enhanced CD4+ cellular apoptosis by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with progressive HIV-1 infection,"Wade,J., Sterjovski,J., Gray,L., Roche,M., Chiavaroli,L., Ellett,A., Jakobsen,M.R., Cowley,D., Pereira Cda,F., Saksena,N., Wang,B., Purcell,D.F., Karlsson,I., Fenyo,E.M., Churchill,M. and Gorry,P.R.",2010
GU177863,B,1999,20697919,"Construction and characterization of a full-length infectious clone from a fast-replicating, X4-tropic HIV-1 subtype B' isolate","Wu,S.L., Yan,Y.S., Yan,P.P., Huang,H.L. and Wang,H.R.",1923
GU191348,B,2004,20373959,Characterization of emergent HIV resistance in treatment-naive subjects enrolled in a vicriviroc phase 2 trial,"McNicholas,P., Wei,Y., Whitcomb,J., Greaves,W., Black,T.A., Tremblay,C.L. and Strizki,J.M.",2010
GU191360,D,2004,20373959,Characterization of emergent HIV resistance in treatment-naive subjects enrolled in a vicriviroc phase 2 trial,"McNicholas,P., Wei,Y., Whitcomb,J., Greaves,W., Black,T.A., Tremblay,C.L. and Strizki,J.M.",2010
GU191372,B,2005,20373959,Characterization of emergent HIV resistance in treatment-naive subjects enrolled in a vicriviroc phase 2 trial,"McNicholas,P., Wei,Y., Whitcomb,J., Greaves,W., Black,T.A., Tremblay,C.L. and Strizki,J.M.",2010
GU191384,B,2005,20373959,Characterization of emergent HIV resistance in treatment-naive subjects enrolled in a vicriviroc phase 2 trial,"McNicholas,P., Wei,Y., Whitcomb,J., Greaves,W., Black,T.A., Tremblay,C.L. and Strizki,J.M.",2010
GU201611,A1C,2008,21087143,Genetic Analysis of the Near Full-Length Genome of an HIV Type 1 A1/C Unique Recombinant Form from Northern South Africa,"Iweriebor,B.C., Bessong,P.O., Mavhandu,L.G., Masebe,T.M., Nwobegahay,J., Moyo,S.R. and Mphahlele,J.M.",2011
GU204919,B,1989,20463072,HIV-2 genetic evolution in patients with advanced disease is faster than that in matched HIV-1 patients,"Skar,H., Borrego,P., Wallstrom,T.C., Mild,M., Marcelino,J.M., Barroso,H., Taveira,N., Leitner,T. and Albert,J.",2010
GU204922,B,1987,20463072,HIV-2 genetic evolution in patients with advanced disease is faster than that in matched HIV-1 patients,"Skar,H., Borrego,P., Wallstrom,T.C., Mild,M., Marcelino,J.M., Barroso,H., Taveira,N., Leitner,T. and Albert,J.",2010
GU204925,B,1995,20463072,HIV-2 genetic evolution in patients with advanced disease is faster than that in matched HIV-1 patients,"Skar,H., Borrego,P., Wallstrom,T.C., Mild,M., Marcelino,J.M., Barroso,H., Taveira,N., Leitner,T. and Albert,J.",2010
GU204929,B,1992,20463072,HIV-2 genetic evolution in patients with advanced disease is faster than that in matched HIV-1 patients,"Skar,H., Borrego,P., Wallstrom,T.C., Mild,M., Marcelino,J.M., Barroso,H., Taveira,N., Leitner,T. and Albert,J.",2010
GU204933,B,1992,20463072,HIV-2 genetic evolution in patients with advanced disease is faster than that in matched HIV-1 patients,"Skar,H., Borrego,P., Wallstrom,T.C., Mild,M., Marcelino,J.M., Barroso,H., Taveira,N., Leitner,T. and Albert,J.",2010
GU204937,D,1994,20463072,HIV-2 genetic evolution in patients with advanced disease is faster than that in matched HIV-1 patients,"Skar,H., Borrego,P., Wallstrom,T.C., Mild,M., Marcelino,J.M., Barroso,H., Taveira,N., Leitner,T. and Albert,J.",2010
GU204941,B,1992,20463072,HIV-2 genetic evolution in patients with advanced disease is faster than that in matched HIV-1 patients,"Skar,H., Borrego,P., Wallstrom,T.C., Mild,M., Marcelino,J.M., Barroso,H., Taveira,N., Leitner,T. and Albert,J.",2010
GU207884,BF1G,2005,,Direct Submission,"Tsui,S.K.W., Au,T.C.C., Wong,C.H., Fong,N.Y., Chan,P.K.S. and Lee,S.S.",2009
GU216724,C,,,Single genome sequencing reveals distinguishing envelope characteristics between non-progressors and progressors in chronic HIV-1 subtype C infection,"Archary,D., Gordon,M.L., Green,T.N., Coovadia,H., Goulder,P.J.R., Walker,B.D. and Ndung'u,T.P.",
GU216803,C,,,Single genome sequencing reveals distinguishing envelope characteristics between non-progressors and progressors in chronic HIV-1 subtype C infection,"Archary,D., Gordon,M.L., Green,T.N., Coovadia,H., Goulder,P.J.R., Walker,B.D. and Ndung'u,T.P.",
GU216838,C,,,Single genome sequencing reveals distinguishing envelope characteristics between non-progressors and progressors in chronic HIV-1 subtype C infection,"Archary,D., Gordon,M.L., Green,T.N., Coovadia,H., Goulder,P.J.R., Walker,B.D. and Ndung'u,T.P.",
GU230137,14_BG,2000,21969855,Origin and Epidemiological History of HIV-1 CRF14_BG,"Bartolo,I., Abecasis,A.B., Borrego,P., Barroso,H., McCutchan,F., Gomes,P., Camacho,R. and Taveira,N.",2011
GU230139,14_BG,1998,21969855,Origin and Epidemiological History of HIV-1 CRF14_BG,"Bartolo,I., Abecasis,A.B., Borrego,P., Barroso,H., McCutchan,F., Gomes,P., Camacho,R. and Taveira,N.",2011
GU252766,B,,20373959,Characterization of emergent HIV resistance in treatment-naive subjects enrolled in a vicriviroc phase 2 trial,"McNicholas,P., Wei,Y., Whitcomb,J., Greaves,W., Black,T.A., Tremblay,C.L. and Strizki,J.M.",2010
GU252767,B,,20373959,Characterization of emergent HIV resistance in treatment-naive subjects enrolled in a vicriviroc phase 2 trial,"McNicholas,P., Wei,Y., Whitcomb,J., Greaves,W., Black,T.A., Tremblay,C.L. and Strizki,J.M.",2010
GU252769,B,,20373959,Characterization of emergent HIV resistance in treatment-naive subjects enrolled in a vicriviroc phase 2 trial,"McNicholas,P., Wei,Y., Whitcomb,J., Greaves,W., Black,T.A., Tremblay,C.L. and Strizki,J.M.",2010
GU252771,B,,20373959,Characterization of emergent HIV resistance in treatment-naive subjects enrolled in a vicriviroc phase 2 trial,"McNicholas,P., Wei,Y., Whitcomb,J., Greaves,W., Black,T.A., Tremblay,C.L. and Strizki,J.M.",2010
GU252773,B,,20373959,Characterization of emergent HIV resistance in treatment-naive subjects enrolled in a vicriviroc phase 2 trial,"McNicholas,P., Wei,Y., Whitcomb,J., Greaves,W., Black,T.A., Tremblay,C.L. and Strizki,J.M.",2010
GU252775,F1,,20373959,Characterization of emergent HIV resistance in treatment-naive subjects enrolled in a vicriviroc phase 2 trial,"McNicholas,P., Wei,Y., Whitcomb,J., Greaves,W., Black,T.A., Tremblay,C.L. and Strizki,J.M.",2010
GU252777,B,,20373959,Characterization of emergent HIV resistance in treatment-naive subjects enrolled in a vicriviroc phase 2 trial,"McNicholas,P., Wei,Y., Whitcomb,J., Greaves,W., Black,T.A., Tremblay,C.L. and Strizki,J.M.",2010
GU252779,B,,20373959,Characterization of emergent HIV resistance in treatment-naive subjects enrolled in a vicriviroc phase 2 trial,"McNicholas,P., Wei,Y., Whitcomb,J., Greaves,W., Black,T.A., Tremblay,C.L. and Strizki,J.M.",2010
GU252788,B,,20373959,Characterization of emergent HIV resistance in treatment-naive subjects enrolled in a vicriviroc phase 2 trial,"McNicholas,P., Wei,Y., Whitcomb,J., Greaves,W., Black,T.A., Tremblay,C.L. and Strizki,J.M.",2010
GU252789,B,,20373959,Characterization of emergent HIV resistance in treatment-naive subjects enrolled in a vicriviroc phase 2 trial,"McNicholas,P., Wei,Y., Whitcomb,J., Greaves,W., Black,T.A., Tremblay,C.L. and Strizki,J.M.",2010
GU252793,B,,20373959,Characterization of emergent HIV resistance in treatment-naive subjects enrolled in a vicriviroc phase 2 trial,"McNicholas,P., Wei,Y., Whitcomb,J., Greaves,W., Black,T.A., Tremblay,C.L. and Strizki,J.M.",2010
GU252795,B,,20373959,Characterization of emergent HIV resistance in treatment-naive subjects enrolled in a vicriviroc phase 2 trial,"McNicholas,P., Wei,Y., Whitcomb,J., Greaves,W., Black,T.A., Tremblay,C.L. and Strizki,J.M.",2010
GU252799,B,,20373959,Characterization of emergent HIV resistance in treatment-naive subjects enrolled in a vicriviroc phase 2 trial,"McNicholas,P., Wei,Y., Whitcomb,J., Greaves,W., Black,T.A., Tremblay,C.L. and Strizki,J.M.",2010
GU252803,B,,20373959,Characterization of emergent HIV resistance in treatment-naive subjects enrolled in a vicriviroc phase 2 trial,"McNicholas,P., Wei,Y., Whitcomb,J., Greaves,W., Black,T.A., Tremblay,C.L. and Strizki,J.M.",2010
GU252807,D,,20373959,Characterization of emergent HIV resistance in treatment-naive subjects enrolled in a vicriviroc phase 2 trial,"McNicholas,P., Wei,Y., Whitcomb,J., Greaves,W., Black,T.A., Tremblay,C.L. and Strizki,J.M.",2010
GU252809,B,,20373959,Characterization of emergent HIV resistance in treatment-naive subjects enrolled in a vicriviroc phase 2 trial,"McNicholas,P., Wei,Y., Whitcomb,J., Greaves,W., Black,T.A., Tremblay,C.L. and Strizki,J.M.",2010
GU252811,B,,20373959,Characterization of emergent HIV resistance in treatment-naive subjects enrolled in a vicriviroc phase 2 trial,"McNicholas,P., Wei,Y., Whitcomb,J., Greaves,W., Black,T.A., Tremblay,C.L. and Strizki,J.M.",2010
GU329048,C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329053,C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329063,C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329078,C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329094,C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329107,C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329121,A1C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329131,C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329144,C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329154,C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329164,C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329175,D,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329184,C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329195,C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329205,C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329216,C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329236,C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329257,C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329271,C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329289,C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329300,C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329310,C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329321,C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329333,C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329343,GJ,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329354,C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329364,C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329375,C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329389,C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329399,C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329415,C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329437,C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329458,C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329481,C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329490,C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329500,C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU329510,C,2005,21036380,Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120,"Kirchherr,J.L., Hamilton,J., Lu,X., Gnanakaran,S., Muldoon,M., Daniels,M., Kasongo,W., Chalwe,V., Mulenga,C., Mwananyanda,L., Musonda,R.M., Yuan,X., Montefiori,D.C., Korber,B.T., Haynes,B.F. and Gao,F.",2011
GU330247,B,2002,20485520,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,"Li,H., Bar,K.J., Wang,S., Decker,J.M., Chen,Y., Sun,C., Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Morgan,C.J., Schumacher,J.E., Hraber,P., Giorgi,E.E., Bhattacharya,T., Korber,B.T., Perelson,A.S., Eron,J.J., Cohen,M.S., Hicks,C.B., Haynes,B.F., Markowitz,M., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU330333,B,2002,20485520,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,"Li,H., Bar,K.J., Wang,S., Decker,J.M., Chen,Y., Sun,C., Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Morgan,C.J., Schumacher,J.E., Hraber,P., Giorgi,E.E., Bhattacharya,T., Korber,B.T., Perelson,A.S., Eron,J.J., Cohen,M.S., Hicks,C.B., Haynes,B.F., Markowitz,M., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU330396,B,2003,20485520,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,"Li,H., Bar,K.J., Wang,S., Decker,J.M., Chen,Y., Sun,C., Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Morgan,C.J., Schumacher,J.E., Hraber,P., Giorgi,E.E., Bhattacharya,T., Korber,B.T., Perelson,A.S., Eron,J.J., Cohen,M.S., Hicks,C.B., Haynes,B.F., Markowitz,M., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU330462,B,2003,20485520,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,"Li,H., Bar,K.J., Wang,S., Decker,J.M., Chen,Y., Sun,C., Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Morgan,C.J., Schumacher,J.E., Hraber,P., Giorgi,E.E., Bhattacharya,T., Korber,B.T., Perelson,A.S., Eron,J.J., Cohen,M.S., Hicks,C.B., Haynes,B.F., Markowitz,M., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU330499,B,2003,20485520,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,"Li,H., Bar,K.J., Wang,S., Decker,J.M., Chen,Y., Sun,C., Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Morgan,C.J., Schumacher,J.E., Hraber,P., Giorgi,E.E., Bhattacharya,T., Korber,B.T., Perelson,A.S., Eron,J.J., Cohen,M.S., Hicks,C.B., Haynes,B.F., Markowitz,M., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU330524,B,2003,20485520,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,"Li,H., Bar,K.J., Wang,S., Decker,J.M., Chen,Y., Sun,C., Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Morgan,C.J., Schumacher,J.E., Hraber,P., Giorgi,E.E., Bhattacharya,T., Korber,B.T., Perelson,A.S., Eron,J.J., Cohen,M.S., Hicks,C.B., Haynes,B.F., Markowitz,M., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU330549,B,2003,20485520,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,"Li,H., Bar,K.J., Wang,S., Decker,J.M., Chen,Y., Sun,C., Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Morgan,C.J., Schumacher,J.E., Hraber,P., Giorgi,E.E., Bhattacharya,T., Korber,B.T., Perelson,A.S., Eron,J.J., Cohen,M.S., Hicks,C.B., Haynes,B.F., Markowitz,M., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU330598,B,2004,20485520,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,"Li,H., Bar,K.J., Wang,S., Decker,J.M., Chen,Y., Sun,C., Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Morgan,C.J., Schumacher,J.E., Hraber,P., Giorgi,E.E., Bhattacharya,T., Korber,B.T., Perelson,A.S., Eron,J.J., Cohen,M.S., Hicks,C.B., Haynes,B.F., Markowitz,M., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU330622,B,2005,20485520,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,"Li,H., Bar,K.J., Wang,S., Decker,J.M., Chen,Y., Sun,C., Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Morgan,C.J., Schumacher,J.E., Hraber,P., Giorgi,E.E., Bhattacharya,T., Korber,B.T., Perelson,A.S., Eron,J.J., Cohen,M.S., Hicks,C.B., Haynes,B.F., Markowitz,M., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU330692,B,2005,20485520,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,"Li,H., Bar,K.J., Wang,S., Decker,J.M., Chen,Y., Sun,C., Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Morgan,C.J., Schumacher,J.E., Hraber,P., Giorgi,E.E., Bhattacharya,T., Korber,B.T., Perelson,A.S., Eron,J.J., Cohen,M.S., Hicks,C.B., Haynes,B.F., Markowitz,M., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU330731,B,2006,20485520,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,"Li,H., Bar,K.J., Wang,S., Decker,J.M., Chen,Y., Sun,C., Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Morgan,C.J., Schumacher,J.E., Hraber,P., Giorgi,E.E., Bhattacharya,T., Korber,B.T., Perelson,A.S., Eron,J.J., Cohen,M.S., Hicks,C.B., Haynes,B.F., Markowitz,M., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU330809,B,2006,20485520,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,"Li,H., Bar,K.J., Wang,S., Decker,J.M., Chen,Y., Sun,C., Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Morgan,C.J., Schumacher,J.E., Hraber,P., Giorgi,E.E., Bhattacharya,T., Korber,B.T., Perelson,A.S., Eron,J.J., Cohen,M.S., Hicks,C.B., Haynes,B.F., Markowitz,M., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU330839,B,2006,20485520,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,"Li,H., Bar,K.J., Wang,S., Decker,J.M., Chen,Y., Sun,C., Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Morgan,C.J., Schumacher,J.E., Hraber,P., Giorgi,E.E., Bhattacharya,T., Korber,B.T., Perelson,A.S., Eron,J.J., Cohen,M.S., Hicks,C.B., Haynes,B.F., Markowitz,M., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU330862,B,2007,20485520,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,"Li,H., Bar,K.J., Wang,S., Decker,J.M., Chen,Y., Sun,C., Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Morgan,C.J., Schumacher,J.E., Hraber,P., Giorgi,E.E., Bhattacharya,T., Korber,B.T., Perelson,A.S., Eron,J.J., Cohen,M.S., Hicks,C.B., Haynes,B.F., Markowitz,M., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU330916,B,2006,20485520,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,"Li,H., Bar,K.J., Wang,S., Decker,J.M., Chen,Y., Sun,C., Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Morgan,C.J., Schumacher,J.E., Hraber,P., Giorgi,E.E., Bhattacharya,T., Korber,B.T., Perelson,A.S., Eron,J.J., Cohen,M.S., Hicks,C.B., Haynes,B.F., Markowitz,M., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU330956,B,2007,20485520,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,"Li,H., Bar,K.J., Wang,S., Decker,J.M., Chen,Y., Sun,C., Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Morgan,C.J., Schumacher,J.E., Hraber,P., Giorgi,E.E., Bhattacharya,T., Korber,B.T., Perelson,A.S., Eron,J.J., Cohen,M.S., Hicks,C.B., Haynes,B.F., Markowitz,M., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU330994,B,2007,20485520,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,"Li,H., Bar,K.J., Wang,S., Decker,J.M., Chen,Y., Sun,C., Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Morgan,C.J., Schumacher,J.E., Hraber,P., Giorgi,E.E., Bhattacharya,T., Korber,B.T., Perelson,A.S., Eron,J.J., Cohen,M.S., Hicks,C.B., Haynes,B.F., Markowitz,M., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU331039,B,2006,20485520,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,"Li,H., Bar,K.J., Wang,S., Decker,J.M., Chen,Y., Sun,C., Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Morgan,C.J., Schumacher,J.E., Hraber,P., Giorgi,E.E., Bhattacharya,T., Korber,B.T., Perelson,A.S., Eron,J.J., Cohen,M.S., Hicks,C.B., Haynes,B.F., Markowitz,M., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU331066,B,2006,20485520,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,"Li,H., Bar,K.J., Wang,S., Decker,J.M., Chen,Y., Sun,C., Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Morgan,C.J., Schumacher,J.E., Hraber,P., Giorgi,E.E., Bhattacharya,T., Korber,B.T., Perelson,A.S., Eron,J.J., Cohen,M.S., Hicks,C.B., Haynes,B.F., Markowitz,M., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU331094,B,2006,20485520,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,"Li,H., Bar,K.J., Wang,S., Decker,J.M., Chen,Y., Sun,C., Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Morgan,C.J., Schumacher,J.E., Hraber,P., Giorgi,E.E., Bhattacharya,T., Korber,B.T., Perelson,A.S., Eron,J.J., Cohen,M.S., Hicks,C.B., Haynes,B.F., Markowitz,M., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU331183,B,2007,20485520,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,"Li,H., Bar,K.J., Wang,S., Decker,J.M., Chen,Y., Sun,C., Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Morgan,C.J., Schumacher,J.E., Hraber,P., Giorgi,E.E., Bhattacharya,T., Korber,B.T., Perelson,A.S., Eron,J.J., Cohen,M.S., Hicks,C.B., Haynes,B.F., Markowitz,M., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU331218,B,1999,20485520,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,"Li,H., Bar,K.J., Wang,S., Decker,J.M., Chen,Y., Sun,C., Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Morgan,C.J., Schumacher,J.E., Hraber,P., Giorgi,E.E., Bhattacharya,T., Korber,B.T., Perelson,A.S., Eron,J.J., Cohen,M.S., Hicks,C.B., Haynes,B.F., Markowitz,M., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU331463,B,1999,20485520,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,"Li,H., Bar,K.J., Wang,S., Decker,J.M., Chen,Y., Sun,C., Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Morgan,C.J., Schumacher,J.E., Hraber,P., Giorgi,E.E., Bhattacharya,T., Korber,B.T., Perelson,A.S., Eron,J.J., Cohen,M.S., Hicks,C.B., Haynes,B.F., Markowitz,M., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU331496,B,2002,20485520,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,"Li,H., Bar,K.J., Wang,S., Decker,J.M., Chen,Y., Sun,C., Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Morgan,C.J., Schumacher,J.E., Hraber,P., Giorgi,E.E., Bhattacharya,T., Korber,B.T., Perelson,A.S., Eron,J.J., Cohen,M.S., Hicks,C.B., Haynes,B.F., Markowitz,M., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU331550,B,2002,20485520,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,"Li,H., Bar,K.J., Wang,S., Decker,J.M., Chen,Y., Sun,C., Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Morgan,C.J., Schumacher,J.E., Hraber,P., Giorgi,E.E., Bhattacharya,T., Korber,B.T., Perelson,A.S., Eron,J.J., Cohen,M.S., Hicks,C.B., Haynes,B.F., Markowitz,M., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU331590,B,2003,20485520,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,"Li,H., Bar,K.J., Wang,S., Decker,J.M., Chen,Y., Sun,C., Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Morgan,C.J., Schumacher,J.E., Hraber,P., Giorgi,E.E., Bhattacharya,T., Korber,B.T., Perelson,A.S., Eron,J.J., Cohen,M.S., Hicks,C.B., Haynes,B.F., Markowitz,M., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU331722,B,1991,20485520,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,"Li,H., Bar,K.J., Wang,S., Decker,J.M., Chen,Y., Sun,C., Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Morgan,C.J., Schumacher,J.E., Hraber,P., Giorgi,E.E., Bhattacharya,T., Korber,B.T., Perelson,A.S., Eron,J.J., Cohen,M.S., Hicks,C.B., Haynes,B.F., Markowitz,M., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU331748,B,1990,20485520,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,"Li,H., Bar,K.J., Wang,S., Decker,J.M., Chen,Y., Sun,C., Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Morgan,C.J., Schumacher,J.E., Hraber,P., Giorgi,E.E., Bhattacharya,T., Korber,B.T., Perelson,A.S., Eron,J.J., Cohen,M.S., Hicks,C.B., Haynes,B.F., Markowitz,M., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU332506,F,2004,21226626,Construction and phenotypic characterization of HIV type 1 functional envelope clones of subtypes G and F,"Revilla,A., Delgado,E., Christian,E.C., Dalrymple,J., Vega,Y., Carrera,C., Gonzalez-Galeano,M., Ocampo,A., de Castro,R.O., Lezaun,M.J., Rodriguez,R., Marino,A., Ordonez,P., Cilla,G., Cisterna,R., Santamaria,J.M., Prieto,S., Rakhmanova,A., Vinogradova,A., Rios,M., Perez-Alvarez,L., Najera,R., Montefiori,D.C., Seaman,M.S. and Thomson,M.M.",2011
GU332507,12_BF,2009,21226626,Construction and phenotypic characterization of HIV type 1 functional envelope clones of subtypes G and F,"Revilla,A., Delgado,E., Christian,E.C., Dalrymple,J., Vega,Y., Carrera,C., Gonzalez-Galeano,M., Ocampo,A., de Castro,R.O., Lezaun,M.J., Rodriguez,R., Marino,A., Ordonez,P., Cilla,G., Cisterna,R., Santamaria,J.M., Prieto,S., Rakhmanova,A., Vinogradova,A., Rios,M., Perez-Alvarez,L., Najera,R., Montefiori,D.C., Seaman,M.S. and Thomson,M.M.",2011
GU332508,F1,2009,21226626,Construction and phenotypic characterization of HIV type 1 functional envelope clones of subtypes G and F,"Revilla,A., Delgado,E., Christian,E.C., Dalrymple,J., Vega,Y., Carrera,C., Gonzalez-Galeano,M., Ocampo,A., de Castro,R.O., Lezaun,M.J., Rodriguez,R., Marino,A., Ordonez,P., Cilla,G., Cisterna,R., Santamaria,J.M., Prieto,S., Rakhmanova,A., Vinogradova,A., Rios,M., Perez-Alvarez,L., Najera,R., Montefiori,D.C., Seaman,M.S. and Thomson,M.M.",2011
GU332509,F2,2008,21226626,Construction and phenotypic characterization of HIV type 1 functional envelope clones of subtypes G and F,"Revilla,A., Delgado,E., Christian,E.C., Dalrymple,J., Vega,Y., Carrera,C., Gonzalez-Galeano,M., Ocampo,A., de Castro,R.O., Lezaun,M.J., Rodriguez,R., Marino,A., Ordonez,P., Cilla,G., Cisterna,R., Santamaria,J.M., Prieto,S., Rakhmanova,A., Vinogradova,A., Rios,M., Perez-Alvarez,L., Najera,R., Montefiori,D.C., Seaman,M.S. and Thomson,M.M.",2011
GU332511,A1G,2007,21226626,Construction and phenotypic characterization of HIV type 1 functional envelope clones of subtypes G and F,"Revilla,A., Delgado,E., Christian,E.C., Dalrymple,J., Vega,Y., Carrera,C., Gonzalez-Galeano,M., Ocampo,A., de Castro,R.O., Lezaun,M.J., Rodriguez,R., Marino,A., Ordonez,P., Cilla,G., Cisterna,R., Santamaria,J.M., Prieto,S., Rakhmanova,A., Vinogradova,A., Rios,M., Perez-Alvarez,L., Najera,R., Montefiori,D.C., Seaman,M.S. and Thomson,M.M.",2011
GU332512,C,2009,21226626,Construction and phenotypic characterization of HIV type 1 functional envelope clones of subtypes G and F,"Revilla,A., Delgado,E., Christian,E.C., Dalrymple,J., Vega,Y., Carrera,C., Gonzalez-Galeano,M., Ocampo,A., de Castro,R.O., Lezaun,M.J., Rodriguez,R., Marino,A., Ordonez,P., Cilla,G., Cisterna,R., Santamaria,J.M., Prieto,S., Rakhmanova,A., Vinogradova,A., Rios,M., Perez-Alvarez,L., Najera,R., Montefiori,D.C., Seaman,M.S. and Thomson,M.M.",2011
GU332513,G,2008,21226626,Construction and phenotypic characterization of HIV type 1 functional envelope clones of subtypes G and F,"Revilla,A., Delgado,E., Christian,E.C., Dalrymple,J., Vega,Y., Carrera,C., Gonzalez-Galeano,M., Ocampo,A., de Castro,R.O., Lezaun,M.J., Rodriguez,R., Marino,A., Ordonez,P., Cilla,G., Cisterna,R., Santamaria,J.M., Prieto,S., Rakhmanova,A., Vinogradova,A., Rios,M., Perez-Alvarez,L., Najera,R., Montefiori,D.C., Seaman,M.S. and Thomson,M.M.",2011
GU362013,BC,2008,20528150,"Near full-length genomic characterization of a novel HIV type 1 subtype B/C recombinant strain from Yunnan, China","Li,L., Chen,L., Yang,S., Liu,Y., Li,H., Bao,Z., Wang,Z., Zhuang,D., Liu,S. and Li,J.",2010
GU362881,B,2009,20707647,Short Communication: Biological and Genetic Characterization of HIV Type 1 Subtype B and Nonsubtype B Transmitted Viruses: Usefulness for Vaccine Candidate Assessment,"Cuevas,M.T., Fernandez-Garcia,A., Pinilla,M., Garcia-Alvarez,V., Thomson,M., Delgado,E., Gonzalez-Galeano,M., Miralles,C., Serrano-Bengoechea,E., Ojea de Castro,R., Lopez-Alvarez,M.J., Lezaun,M.J., Sanchez-Garcia,A.M., Sanchez-Martinez,M., Munoz-Nieto,M. and Perez-Alvarez,L.",2010
GU362882,G,2009,20707647,Short Communication: Biological and Genetic Characterization of HIV Type 1 Subtype B and Nonsubtype B Transmitted Viruses: Usefulness for Vaccine Candidate Assessment,"Cuevas,M.T., Fernandez-Garcia,A., Pinilla,M., Garcia-Alvarez,V., Thomson,M., Delgado,E., Gonzalez-Galeano,M., Miralles,C., Serrano-Bengoechea,E., Ojea de Castro,R., Lopez-Alvarez,M.J., Lezaun,M.J., Sanchez-Garcia,A.M., Sanchez-Martinez,M., Munoz-Nieto,M. and Perez-Alvarez,L.",2010
GU362883,B,2008,20707647,Short Communication: Biological and Genetic Characterization of HIV Type 1 Subtype B and Nonsubtype B Transmitted Viruses: Usefulness for Vaccine Candidate Assessment,"Cuevas,M.T., Fernandez-Garcia,A., Pinilla,M., Garcia-Alvarez,V., Thomson,M., Delgado,E., Gonzalez-Galeano,M., Miralles,C., Serrano-Bengoechea,E., Ojea de Castro,R., Lopez-Alvarez,M.J., Lezaun,M.J., Sanchez-Garcia,A.M., Sanchez-Martinez,M., Munoz-Nieto,M. and Perez-Alvarez,L.",2010
GU362884,G,2009,20707647,Short Communication: Biological and Genetic Characterization of HIV Type 1 Subtype B and Nonsubtype B Transmitted Viruses: Usefulness for Vaccine Candidate Assessment,"Cuevas,M.T., Fernandez-Garcia,A., Pinilla,M., Garcia-Alvarez,V., Thomson,M., Delgado,E., Gonzalez-Galeano,M., Miralles,C., Serrano-Bengoechea,E., Ojea de Castro,R., Lopez-Alvarez,M.J., Lezaun,M.J., Sanchez-Garcia,A.M., Sanchez-Martinez,M., Munoz-Nieto,M. and Perez-Alvarez,L.",2010
GU362885,B,2009,20707647,Short Communication: Biological and Genetic Characterization of HIV Type 1 Subtype B and Nonsubtype B Transmitted Viruses: Usefulness for Vaccine Candidate Assessment,"Cuevas,M.T., Fernandez-Garcia,A., Pinilla,M., Garcia-Alvarez,V., Thomson,M., Delgado,E., Gonzalez-Galeano,M., Miralles,C., Serrano-Bengoechea,E., Ojea de Castro,R., Lopez-Alvarez,M.J., Lezaun,M.J., Sanchez-Garcia,A.M., Sanchez-Martinez,M., Munoz-Nieto,M. and Perez-Alvarez,L.",2010
GU362886,B,2008,20707647,Short Communication: Biological and Genetic Characterization of HIV Type 1 Subtype B and Nonsubtype B Transmitted Viruses: Usefulness for Vaccine Candidate Assessment,"Cuevas,M.T., Fernandez-Garcia,A., Pinilla,M., Garcia-Alvarez,V., Thomson,M., Delgado,E., Gonzalez-Galeano,M., Miralles,C., Serrano-Bengoechea,E., Ojea de Castro,R., Lopez-Alvarez,M.J., Lezaun,M.J., Sanchez-Garcia,A.M., Sanchez-Martinez,M., Munoz-Nieto,M. and Perez-Alvarez,L.",2010
GU367395,B,,,Impaired fitness of acute/early viruses in persons who become HIV controllers,"Miura,T.",
GU367398,B,,,Impaired fitness of acute/early viruses in persons who become HIV controllers,"Miura,T.",
GU367399,B,,,Impaired fitness of acute/early viruses in persons who become HIV controllers,"Miura,T.",
GU367403,B,,,Impaired fitness of acute/early viruses in persons who become HIV controllers,"Miura,T.",
GU367404,B,,,Impaired fitness of acute/early viruses in persons who become HIV controllers,"Miura,T.",
GU367405,B,,,Impaired fitness of acute/early viruses in persons who become HIV controllers,"Miura,T.",
GU367406,B,,,Impaired fitness of acute/early viruses in persons who become HIV controllers,"Miura,T.",
GU367407,B,,,Impaired fitness of acute/early viruses in persons who become HIV controllers,"Miura,T.",
GU367408,B,,,Impaired fitness of acute/early viruses in persons who become HIV controllers,"Miura,T.",
GU367409,B,,,Impaired fitness of acute/early viruses in persons who become HIV controllers,"Miura,T.",
GU367410,B,,,Impaired fitness of acute/early viruses in persons who become HIV controllers,"Miura,T.",
GU367412,A1,,,Impaired fitness of acute/early viruses in persons who become HIV controllers,"Miura,T.",
GU455425,B,1985,20071586,Rapid escape from preserved cross-reactive neutralizing humoral immunity without loss of viral fitness in HIV-1-infected progressors and long-term nonprogressors,"van Gils,M.J., Bunnik,E.M., Burger,J.A., Jacob,Y., Schweighardt,B., Wrin,T. and Schuitemaker,H.",2010
GU455456,B,1987,20071586,Rapid escape from preserved cross-reactive neutralizing humoral immunity without loss of viral fitness in HIV-1-infected progressors and long-term nonprogressors,"van Gils,M.J., Bunnik,E.M., Burger,J.A., Jacob,Y., Schweighardt,B., Wrin,T. and Schuitemaker,H.",2010
GU455476,B,1985,20071586,Rapid escape from preserved cross-reactive neutralizing humoral immunity without loss of viral fitness in HIV-1-infected progressors and long-term nonprogressors,"van Gils,M.J., Bunnik,E.M., Burger,J.A., Jacob,Y., Schweighardt,B., Wrin,T. and Schuitemaker,H.",2010
GU455494,B,1987,20071586,Rapid escape from preserved cross-reactive neutralizing humoral immunity without loss of viral fitness in HIV-1-infected progressors and long-term nonprogressors,"van Gils,M.J., Bunnik,E.M., Burger,J.A., Jacob,Y., Schweighardt,B., Wrin,T. and Schuitemaker,H.",2010
GU455514,B,1985,20071586,Rapid escape from preserved cross-reactive neutralizing humoral immunity without loss of viral fitness in HIV-1-infected progressors and long-term nonprogressors,"van Gils,M.J., Bunnik,E.M., Burger,J.A., Jacob,Y., Schweighardt,B., Wrin,T. and Schuitemaker,H.",2010
GU481107,A6,2008,20423223,"A substantial transmission bottleneck among newly and recently HIV-1-infected injection drug users in St Petersburg, Russia","Masharsky,A.E., Dukhovlinova,E.N., Verevochkin,S.V., Toussova,O.V., Skochilov,R.V., Anderson,J.A., Hoffman,I., Cohen,M.S., Swanstrom,R. and Kozlov,A.P.",2010
GU481156,A6,2002,20423223,"A substantial transmission bottleneck among newly and recently HIV-1-infected injection drug users in St Petersburg, Russia","Masharsky,A.E., Dukhovlinova,E.N., Verevochkin,S.V., Toussova,O.V., Skochilov,R.V., Anderson,J.A., Hoffman,I., Cohen,M.S., Swanstrom,R. and Kozlov,A.P.",2010
GU481203,A6,2002,20423223,"A substantial transmission bottleneck among newly and recently HIV-1-infected injection drug users in St Petersburg, Russia","Masharsky,A.E., Dukhovlinova,E.N., Verevochkin,S.V., Toussova,O.V., Skochilov,R.V., Anderson,J.A., Hoffman,I., Cohen,M.S., Swanstrom,R. and Kozlov,A.P.",2010
GU481254,A6,2008,20423223,"A substantial transmission bottleneck among newly and recently HIV-1-infected injection drug users in St Petersburg, Russia","Masharsky,A.E., Dukhovlinova,E.N., Verevochkin,S.V., Toussova,O.V., Skochilov,R.V., Anderson,J.A., Hoffman,I., Cohen,M.S., Swanstrom,R. and Kozlov,A.P.",2010
GU481277,A6,2008,20423223,"A substantial transmission bottleneck among newly and recently HIV-1-infected injection drug users in St Petersburg, Russia","Masharsky,A.E., Dukhovlinova,E.N., Verevochkin,S.V., Toussova,O.V., Skochilov,R.V., Anderson,J.A., Hoffman,I., Cohen,M.S., Swanstrom,R. and Kozlov,A.P.",2010
GU481329,A6,2008,20423223,"A substantial transmission bottleneck among newly and recently HIV-1-infected injection drug users in St Petersburg, Russia","Masharsky,A.E., Dukhovlinova,E.N., Verevochkin,S.V., Toussova,O.V., Skochilov,R.V., Anderson,J.A., Hoffman,I., Cohen,M.S., Swanstrom,R. and Kozlov,A.P.",2010
GU481371,A6,2006,20423223,"A substantial transmission bottleneck among newly and recently HIV-1-infected injection drug users in St Petersburg, Russia","Masharsky,A.E., Dukhovlinova,E.N., Verevochkin,S.V., Toussova,O.V., Skochilov,R.V., Anderson,J.A., Hoffman,I., Cohen,M.S., Swanstrom,R. and Kozlov,A.P.",2010
GU481392,A6,2006,20423223,"A substantial transmission bottleneck among newly and recently HIV-1-infected injection drug users in St Petersburg, Russia","Masharsky,A.E., Dukhovlinova,E.N., Verevochkin,S.V., Toussova,O.V., Skochilov,R.V., Anderson,J.A., Hoffman,I., Cohen,M.S., Swanstrom,R. and Kozlov,A.P.",2010
GU481421,A6,2007,20423223,"A substantial transmission bottleneck among newly and recently HIV-1-infected injection drug users in St Petersburg, Russia","Masharsky,A.E., Dukhovlinova,E.N., Verevochkin,S.V., Toussova,O.V., Skochilov,R.V., Anderson,J.A., Hoffman,I., Cohen,M.S., Swanstrom,R. and Kozlov,A.P.",2010
GU481472,A6,2007,20423223,"A substantial transmission bottleneck among newly and recently HIV-1-infected injection drug users in St Petersburg, Russia","Masharsky,A.E., Dukhovlinova,E.N., Verevochkin,S.V., Toussova,O.V., Skochilov,R.V., Anderson,J.A., Hoffman,I., Cohen,M.S., Swanstrom,R. and Kozlov,A.P.",2010
GU481519,A6,2007,20423223,"A substantial transmission bottleneck among newly and recently HIV-1-infected injection drug users in St Petersburg, Russia","Masharsky,A.E., Dukhovlinova,E.N., Verevochkin,S.V., Toussova,O.V., Skochilov,R.V., Anderson,J.A., Hoffman,I., Cohen,M.S., Swanstrom,R. and Kozlov,A.P.",2010
GU481537,A6,2008,20423223,"A substantial transmission bottleneck among newly and recently HIV-1-infected injection drug users in St Petersburg, Russia","Masharsky,A.E., Dukhovlinova,E.N., Verevochkin,S.V., Toussova,O.V., Skochilov,R.V., Anderson,J.A., Hoffman,I., Cohen,M.S., Swanstrom,R. and Kozlov,A.P.",2010
GU481566,A6,2006,20423223,"A substantial transmission bottleneck among newly and recently HIV-1-infected injection drug users in St Petersburg, Russia","Masharsky,A.E., Dukhovlinova,E.N., Verevochkin,S.V., Toussova,O.V., Skochilov,R.V., Anderson,J.A., Hoffman,I., Cohen,M.S., Swanstrom,R. and Kozlov,A.P.",2010
GU481591,06_cpx,2006,20423223,"A substantial transmission bottleneck among newly and recently HIV-1-infected injection drug users in St Petersburg, Russia","Masharsky,A.E., Dukhovlinova,E.N., Verevochkin,S.V., Toussova,O.V., Skochilov,R.V., Anderson,J.A., Hoffman,I., Cohen,M.S., Swanstrom,R. and Kozlov,A.P.",2010
GU481615,A6,2006,20423223,"A substantial transmission bottleneck among newly and recently HIV-1-infected injection drug users in St Petersburg, Russia","Masharsky,A.E., Dukhovlinova,E.N., Verevochkin,S.V., Toussova,O.V., Skochilov,R.V., Anderson,J.A., Hoffman,I., Cohen,M.S., Swanstrom,R. and Kozlov,A.P.",2010
GU481636,A6,2007,20423223,"A substantial transmission bottleneck among newly and recently HIV-1-infected injection drug users in St Petersburg, Russia","Masharsky,A.E., Dukhovlinova,E.N., Verevochkin,S.V., Toussova,O.V., Skochilov,R.V., Anderson,J.A., Hoffman,I., Cohen,M.S., Swanstrom,R. and Kozlov,A.P.",2010
GU481661,A6,2008,20423223,"A substantial transmission bottleneck among newly and recently HIV-1-infected injection drug users in St Petersburg, Russia","Masharsky,A.E., Dukhovlinova,E.N., Verevochkin,S.V., Toussova,O.V., Skochilov,R.V., Anderson,J.A., Hoffman,I., Cohen,M.S., Swanstrom,R. and Kozlov,A.P.",2010
GU562001,B,1998,20375173,Wide variation in the multiplicity of HIV-1 infection among injection drug users,"Bar,K.J., Li,H., Chamberland,A., Tremblay,C., Routy,J.P., Grayson,T., Sun,C., Wang,S., Learn,G.H., Morgan,C.J., Schumacher,J.E., Haynes,B.F., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU562028,B,1997,20375173,Wide variation in the multiplicity of HIV-1 infection among injection drug users,"Bar,K.J., Li,H., Chamberland,A., Tremblay,C., Routy,J.P., Grayson,T., Sun,C., Wang,S., Learn,G.H., Morgan,C.J., Schumacher,J.E., Haynes,B.F., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU562058,B,1997,20375173,Wide variation in the multiplicity of HIV-1 infection among injection drug users,"Bar,K.J., Li,H., Chamberland,A., Tremblay,C., Routy,J.P., Grayson,T., Sun,C., Wang,S., Learn,G.H., Morgan,C.J., Schumacher,J.E., Haynes,B.F., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU562080,B,1998,20375173,Wide variation in the multiplicity of HIV-1 infection among injection drug users,"Bar,K.J., Li,H., Chamberland,A., Tremblay,C., Routy,J.P., Grayson,T., Sun,C., Wang,S., Learn,G.H., Morgan,C.J., Schumacher,J.E., Haynes,B.F., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU562105,B,2003,20375173,Wide variation in the multiplicity of HIV-1 infection among injection drug users,"Bar,K.J., Li,H., Chamberland,A., Tremblay,C., Routy,J.P., Grayson,T., Sun,C., Wang,S., Learn,G.H., Morgan,C.J., Schumacher,J.E., Haynes,B.F., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU562134,B,2003,20375173,Wide variation in the multiplicity of HIV-1 infection among injection drug users,"Bar,K.J., Li,H., Chamberland,A., Tremblay,C., Routy,J.P., Grayson,T., Sun,C., Wang,S., Learn,G.H., Morgan,C.J., Schumacher,J.E., Haynes,B.F., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU562153,B,2004,20375173,Wide variation in the multiplicity of HIV-1 infection among injection drug users,"Bar,K.J., Li,H., Chamberland,A., Tremblay,C., Routy,J.P., Grayson,T., Sun,C., Wang,S., Learn,G.H., Morgan,C.J., Schumacher,J.E., Haynes,B.F., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU562218,B,1997,20375173,Wide variation in the multiplicity of HIV-1 infection among injection drug users,"Bar,K.J., Li,H., Chamberland,A., Tremblay,C., Routy,J.P., Grayson,T., Sun,C., Wang,S., Learn,G.H., Morgan,C.J., Schumacher,J.E., Haynes,B.F., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU562249,B,2006,20375173,Wide variation in the multiplicity of HIV-1 infection among injection drug users,"Bar,K.J., Li,H., Chamberland,A., Tremblay,C., Routy,J.P., Grayson,T., Sun,C., Wang,S., Learn,G.H., Morgan,C.J., Schumacher,J.E., Haynes,B.F., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU562271,B,2003,20375173,Wide variation in the multiplicity of HIV-1 infection among injection drug users,"Bar,K.J., Li,H., Chamberland,A., Tremblay,C., Routy,J.P., Grayson,T., Sun,C., Wang,S., Learn,G.H., Morgan,C.J., Schumacher,J.E., Haynes,B.F., Keele,B.F., Hahn,B.H. and Shaw,G.M.",2010
GU564221,01_AE,2005,20528151,"Genetic characterization of 13 subtype CRF01_AE near full-length genomes in Guangxi, China","Li,L., Liang,S., Chen,L., Liu,W., Li,H., Liu,Y., Bao,Z., Wang,Z., Zhuang,D., Liu,S. and Li,J.",2010
GU564222,01_AE,2005,20528151,"Genetic characterization of 13 subtype CRF01_AE near full-length genomes in Guangxi, China","Li,L., Liang,S., Chen,L., Liu,W., Li,H., Liu,Y., Bao,Z., Wang,Z., Zhuang,D., Liu,S. and Li,J.",2010
GU564223,01_AE,2005,20528151,"Genetic characterization of 13 subtype CRF01_AE near full-length genomes in Guangxi, China","Li,L., Liang,S., Chen,L., Liu,W., Li,H., Liu,Y., Bao,Z., Wang,Z., Zhuang,D., Liu,S. and Li,J.",2010
GU564224,01_AE,2005,20528151,"Genetic characterization of 13 subtype CRF01_AE near full-length genomes in Guangxi, China","Li,L., Liang,S., Chen,L., Liu,W., Li,H., Liu,Y., Bao,Z., Wang,Z., Zhuang,D., Liu,S. and Li,J.",2010
GU564225,01_AE,2005,20528151,"Genetic characterization of 13 subtype CRF01_AE near full-length genomes in Guangxi, China","Li,L., Liang,S., Chen,L., Liu,W., Li,H., Liu,Y., Bao,Z., Wang,Z., Zhuang,D., Liu,S. and Li,J.",2010
GU564226,01_AE,2005,20528151,"Genetic characterization of 13 subtype CRF01_AE near full-length genomes in Guangxi, China","Li,L., Liang,S., Chen,L., Liu,W., Li,H., Liu,Y., Bao,Z., Wang,Z., Zhuang,D., Liu,S. and Li,J.",2010
GU564227,01_AE,2005,20528151,"Genetic characterization of 13 subtype CRF01_AE near full-length genomes in Guangxi, China","Li,L., Liang,S., Chen,L., Liu,W., Li,H., Liu,Y., Bao,Z., Wang,Z., Zhuang,D., Liu,S. and Li,J.",2010
GU564228,01_AE,2005,20528151,"Genetic characterization of 13 subtype CRF01_AE near full-length genomes in Guangxi, China","Li,L., Liang,S., Chen,L., Liu,W., Li,H., Liu,Y., Bao,Z., Wang,Z., Zhuang,D., Liu,S. and Li,J.",2010
GU564229,01_AE,2005,20528151,"Genetic characterization of 13 subtype CRF01_AE near full-length genomes in Guangxi, China","Li,L., Liang,S., Chen,L., Liu,W., Li,H., Liu,Y., Bao,Z., Wang,Z., Zhuang,D., Liu,S. and Li,J.",2010
GU564230,01_AE,2006,20528151,"Genetic characterization of 13 subtype CRF01_AE near full-length genomes in Guangxi, China","Li,L., Liang,S., Chen,L., Liu,W., Li,H., Liu,Y., Bao,Z., Wang,Z., Zhuang,D., Liu,S. and Li,J.",2010
GU595148,BF1,2002,21740272,Near Full-Length Sequence Analysis of HIV Type 1 BF Recombinants from Italy,"Saladini,F., Foley,B.T., Rosi,A., Vicenti,I., Nannetti,G., Meini,G., Razzolini,F. and Zazzi,M.",2012
GU595149,BF1,2001,21740272,Near Full-Length Sequence Analysis of HIV Type 1 BF Recombinants from Italy,"Saladini,F., Foley,B.T., Rosi,A., Vicenti,I., Nannetti,G., Meini,G., Razzolini,F. and Zazzi,M.",2012
GU595150,BF1,2002,21740272,Near Full-Length Sequence Analysis of HIV Type 1 BF Recombinants from Italy,"Saladini,F., Foley,B.T., Rosi,A., Vicenti,I., Nannetti,G., Meini,G., Razzolini,F. and Zazzi,M.",2012
GU595151,BF1,2002,21740272,Near Full-Length Sequence Analysis of HIV Type 1 BF Recombinants from Italy,"Saladini,F., Foley,B.T., Rosi,A., Vicenti,I., Nannetti,G., Meini,G., Razzolini,F. and Zazzi,M.",2012
GU595152,BF1,2005,21740272,Near Full-Length Sequence Analysis of HIV Type 1 BF Recombinants from Italy,"Saladini,F., Foley,B.T., Rosi,A., Vicenti,I., Nannetti,G., Meini,G., Razzolini,F. and Zazzi,M.",2012
GU595153,BF1,2006,21740272,Near Full-Length Sequence Analysis of HIV Type 1 BF Recombinants from Italy,"Saladini,F., Foley,B.T., Rosi,A., Vicenti,I., Nannetti,G., Meini,G., Razzolini,F. and Zazzi,M.",2012
GU595154,BF1,2002,21740272,Near Full-Length Sequence Analysis of HIV Type 1 BF Recombinants from Italy,"Saladini,F., Foley,B.T., Rosi,A., Vicenti,I., Nannetti,G., Meini,G., Razzolini,F. and Zazzi,M.",2012
GU595155,BF1,2005,21740272,Near Full-Length Sequence Analysis of HIV Type 1 BF Recombinants from Italy,"Saladini,F., Foley,B.T., Rosi,A., Vicenti,I., Nannetti,G., Meini,G., Razzolini,F. and Zazzi,M.",2012
GU595156,BF1,2001,21740272,Near Full-Length Sequence Analysis of HIV Type 1 BF Recombinants from Italy,"Saladini,F., Foley,B.T., Rosi,A., Vicenti,I., Nannetti,G., Meini,G., Razzolini,F. and Zazzi,M.",2012
GU595157,BF1,2002,21740272,Near Full-Length Sequence Analysis of HIV Type 1 BF Recombinants from Italy,"Saladini,F., Foley,B.T., Rosi,A., Vicenti,I., Nannetti,G., Meini,G., Razzolini,F. and Zazzi,M.",2012
GU595158,BF1,2005,21740272,Near Full-Length Sequence Analysis of HIV Type 1 BF Recombinants from Italy,"Saladini,F., Foley,B.T., Rosi,A., Vicenti,I., Nannetti,G., Meini,G., Razzolini,F. and Zazzi,M.",2012
GU595159,BF1,2007,21740272,Near Full-Length Sequence Analysis of HIV Type 1 BF Recombinants from Italy,"Saladini,F., Foley,B.T., Rosi,A., Vicenti,I., Nannetti,G., Meini,G., Razzolini,F. and Zazzi,M.",2012
GU595160,BF1,2002,21740272,Near Full-Length Sequence Analysis of HIV Type 1 BF Recombinants from Italy,"Saladini,F., Foley,B.T., Rosi,A., Vicenti,I., Nannetti,G., Meini,G., Razzolini,F. and Zazzi,M.",2012
GU724973,B,,15194768,Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages,"Peters,P.J., Bhattacharya,J., Hibbitts,S., Dittmar,M.T., Simmons,G., Bell,J., Simmonds,P. and Clapham,P.R.",2004
GU727872,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727873,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727875,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727876,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727879,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727880,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727882,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727883,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727884,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727885,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727886,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727887,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727889,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727890,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727891,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727893,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727895,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727897,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727898,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727899,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727902,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727905,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727906,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727908,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727910,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727912,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727913,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727916,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727917,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727919,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727928,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727932,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727933,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727934,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727938,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727941,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727943,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727944,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727945,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727946,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727948,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727949,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727950,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727951,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727952,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727954,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727955,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727956,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727957,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727958,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727960,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727961,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727967,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727970,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727972,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727973,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727974,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727977,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727978,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727980,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727981,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727982,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727983,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727984,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727985,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727986,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727988,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727989,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727990,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727992,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727995,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU727999,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728000,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728001,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728005,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728008,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728010,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728014,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728015,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728019,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728025,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728027,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728030,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728032,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728034,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728036,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728039,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728041,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728042,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728043,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728044,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728046,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728049,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728050,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728051,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728053,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728054,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728055,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728056,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728059,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728060,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728062,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728064,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728066,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728067,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728070,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728072,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728073,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728074,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728082,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728084,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728085,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728086,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728088,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728089,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728090,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728092,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728093,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728094,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728097,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728098,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728099,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728100,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728101,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728102,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728103,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728104,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728105,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728107,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728112,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728116,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728120,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728122,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728123,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728125,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728130,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728132,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728133,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728134,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728137,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728138,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728140,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728141,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728144,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728145,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728149,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728150,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728151,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728152,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728153,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728154,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728155,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728156,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728157,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728158,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728159,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728160,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728163,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728164,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728167,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728168,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728169,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728171,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728172,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728173,C,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728174,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728175,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728176,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728178,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728179,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728180,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728181,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728182,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728184,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728185,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728186,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728188,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728189,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728191,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728192,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728193,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728194,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728195,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728196,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728197,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728199,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728200,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728201,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728204,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728205,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728207,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728208,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728209,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728214,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728215,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728216,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728217,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728219,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728220,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728222,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728223,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728224,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728225,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728226,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728227,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728229,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728230,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728231,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728233,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728234,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728235,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728236,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728237,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728238,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728240,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728241,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728242,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728243,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728244,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728246,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728247,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728249,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728250,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728251,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728252,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728253,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728254,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728255,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728257,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728262,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728263,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728264,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728265,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728267,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728268,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728269,02_AG,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728271,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728272,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728273,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728274,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728276,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728277,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728278,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728279,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728280,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728281,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728282,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728283,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728285,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728287,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728288,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728289,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728290,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728291,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728293,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728294,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728295,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728296,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728297,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728298,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728299,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728300,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728304,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728307,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728308,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728309,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728310,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728311,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728313,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728314,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728315,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728318,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728319,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728320,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728321,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728322,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728323,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728325,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728326,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728327,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728328,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728329,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728330,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728332,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728333,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728334,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728335,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728336,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728337,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728339,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728341,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728342,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728343,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728344,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728345,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728346,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728347,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728348,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728349,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728350,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728352,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728354,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728355,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728356,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728357,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728359,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728361,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728362,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728363,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728365,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728366,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728367,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728368,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728369,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728370,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728371,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728372,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728375,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728376,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728377,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728378,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728379,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728380,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728381,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728382,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728383,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728384,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728385,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728388,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728389,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728390,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728391,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728392,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728393,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728395,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728396,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728398,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728399,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728400,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728401,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728402,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728403,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728404,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728406,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728407,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728408,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728409,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728410,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728411,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728412,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728413,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU728416,B,,20231689,Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs,"John,M., Heckerman,D., James,I., Park,L.P., Carlson,J.M., Chopra,A., Gaudieri,S., Nolan,D., Haas,D.W., Riddler,S.A., Haubrich,R. and Mallal,S.",2010
GU733713,B,2009,20519388,"Recovery of replication-competent residual HIV-1 from plasma of a patient receiving prolonged, suppressive highly active antiretroviral therapy","Sahu,G.K., Sarria,J.C. and Cloyd,M.W.",2010
GU939049,C,2001,20352106,4E10-resistant HIV-1 isolated from four subjects with rare membrane-proximal external region polymorphisms,"Nakamura,K.J., Gach,J.S., Jones,L., Semrau,K., Walter,J., Bibollet-Ruche,F., Decker,J.M., Heath,L., Decker,W.D., Sinkala,M., Kankasa,C., Thea,D., Mullins,J., Kuhn,L., Zwick,M.B. and Aldrovandi,G.M.",2010
GU939062,C,2001,20352106,4E10-resistant HIV-1 isolated from four subjects with rare membrane-proximal external region polymorphisms,"Nakamura,K.J., Gach,J.S., Jones,L., Semrau,K., Walter,J., Bibollet-Ruche,F., Decker,J.M., Heath,L., Decker,W.D., Sinkala,M., Kankasa,C., Thea,D., Mullins,J., Kuhn,L., Zwick,M.B. and Aldrovandi,G.M.",2010
GU939124,C,2004,20352106,4E10-resistant HIV-1 isolated from four subjects with rare membrane-proximal external region polymorphisms,"Nakamura,K.J., Gach,J.S., Jones,L., Semrau,K., Walter,J., Bibollet-Ruche,F., Decker,J.M., Heath,L., Decker,W.D., Sinkala,M., Kankasa,C., Thea,D., Mullins,J., Kuhn,L., Zwick,M.B. and Aldrovandi,G.M.",2010
GU939129,C,2004,20352106,4E10-resistant HIV-1 isolated from four subjects with rare membrane-proximal external region polymorphisms,"Nakamura,K.J., Gach,J.S., Jones,L., Semrau,K., Walter,J., Bibollet-Ruche,F., Decker,J.M., Heath,L., Decker,W.D., Sinkala,M., Kankasa,C., Thea,D., Mullins,J., Kuhn,L., Zwick,M.B. and Aldrovandi,G.M.",2010
GU939143,C,2002,20352106,4E10-resistant HIV-1 isolated from four subjects with rare membrane-proximal external region polymorphisms,"Nakamura,K.J., Gach,J.S., Jones,L., Semrau,K., Walter,J., Bibollet-Ruche,F., Decker,J.M., Heath,L., Decker,W.D., Sinkala,M., Kankasa,C., Thea,D., Mullins,J., Kuhn,L., Zwick,M.B. and Aldrovandi,G.M.",2010
HM014318,B,,15194768,Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages,"Peters,P.J., Bhattacharya,J., Hibbitts,S., Dittmar,M.T., Simmons,G., Bell,J., Simmonds,P. and Clapham,P.R.",2004
HM026455,BF1,2006,20398371,"Characterization and frequency of a newly identified HIV-1 BF1 intersubtype circulating recombinant form in Sao Paulo, Brazil","Sanabani,S.S., Pastena,E.R., Neto,W.K., Martinez,V.P. and Sabino,E.C.",2010
HM026456,46_BF,2007,20398371,"Characterization and frequency of a newly identified HIV-1 BF1 intersubtype circulating recombinant form in Sao Paulo, Brazil","Sanabani,S.S., Pastena,E.R., Neto,W.K., Martinez,V.P. and Sabino,E.C.",2010
HM026457,46_BF,2007,20398371,"Characterization and frequency of a newly identified HIV-1 BF1 intersubtype circulating recombinant form in Sao Paulo, Brazil","Sanabani,S.S., Pastena,E.R., Neto,W.K., Martinez,V.P. and Sabino,E.C.",2010
HM026458,46_BF,2007,20398371,"Characterization and frequency of a newly identified HIV-1 BF1 intersubtype circulating recombinant form in Sao Paulo, Brazil","Sanabani,S.S., Pastena,E.R., Neto,W.K., Martinez,V.P. and Sabino,E.C.",2010
HM026459,46_BF,2007,20398371,"Characterization and frequency of a newly identified HIV-1 BF1 intersubtype circulating recombinant form in Sao Paulo, Brazil","Sanabani,S.S., Pastena,E.R., Neto,W.K., Martinez,V.P. and Sabino,E.C.",2010
HM026460,46_BF,2007,20398371,"Characterization and frequency of a newly identified HIV-1 BF1 intersubtype circulating recombinant form in Sao Paulo, Brazil","Sanabani,S.S., Pastena,E.R., Neto,W.K., Martinez,V.P. and Sabino,E.C.",2010
HM027823,A1,2007,21239033,Multiple HIV-1 infections with evidence of recombination in heterosexual partnerships in a low risk Rural Clinical Cohort in Uganda,"Ssemwanga,D., Lyagoba,F., Ndembi,N., Mayanja,B.N., Larke,N., Wang,S., Baalwa,J., Williamson,C., Grosskurth,H. and Kaleebu,P.",2011
HM027827,A1D,2005,21239033,Multiple HIV-1 infections with evidence of recombination in heterosexual partnerships in a low risk Rural Clinical Cohort in Uganda,"Ssemwanga,D., Lyagoba,F., Ndembi,N., Mayanja,B.N., Larke,N., Wang,S., Baalwa,J., Williamson,C., Grosskurth,H. and Kaleebu,P.",2011
HM027838,A1D,2005,21239033,Multiple HIV-1 infections with evidence of recombination in heterosexual partnerships in a low risk Rural Clinical Cohort in Uganda,"Ssemwanga,D., Lyagoba,F., Ndembi,N., Mayanja,B.N., Larke,N., Wang,S., Baalwa,J., Williamson,C., Grosskurth,H. and Kaleebu,P.",2011
HM027846,A1,2000,21239033,Multiple HIV-1 infections with evidence of recombination in heterosexual partnerships in a low risk Rural Clinical Cohort in Uganda,"Ssemwanga,D., Lyagoba,F., Ndembi,N., Mayanja,B.N., Larke,N., Wang,S., Baalwa,J., Williamson,C., Grosskurth,H. and Kaleebu,P.",2011
HM027850,A1D,2000,21239033,Multiple HIV-1 infections with evidence of recombination in heterosexual partnerships in a low risk Rural Clinical Cohort in Uganda,"Ssemwanga,D., Lyagoba,F., Ndembi,N., Mayanja,B.N., Larke,N., Wang,S., Baalwa,J., Williamson,C., Grosskurth,H. and Kaleebu,P.",2011
HM027851,A1D,2000,21239033,Multiple HIV-1 infections with evidence of recombination in heterosexual partnerships in a low risk Rural Clinical Cohort in Uganda,"Ssemwanga,D., Lyagoba,F., Ndembi,N., Mayanja,B.N., Larke,N., Wang,S., Baalwa,J., Williamson,C., Grosskurth,H. and Kaleebu,P.",2011
HM027859,A1D,2000,21239033,Multiple HIV-1 infections with evidence of recombination in heterosexual partnerships in a low risk Rural Clinical Cohort in Uganda,"Ssemwanga,D., Lyagoba,F., Ndembi,N., Mayanja,B.N., Larke,N., Wang,S., Baalwa,J., Williamson,C., Grosskurth,H. and Kaleebu,P.",2011
HM027863,A1D,2000,21239033,Multiple HIV-1 infections with evidence of recombination in heterosexual partnerships in a low risk Rural Clinical Cohort in Uganda,"Ssemwanga,D., Lyagoba,F., Ndembi,N., Mayanja,B.N., Larke,N., Wang,S., Baalwa,J., Williamson,C., Grosskurth,H. and Kaleebu,P.",2011
HM027864,A1D,2003,21239033,Multiple HIV-1 infections with evidence of recombination in heterosexual partnerships in a low risk Rural Clinical Cohort in Uganda,"Ssemwanga,D., Lyagoba,F., Ndembi,N., Mayanja,B.N., Larke,N., Wang,S., Baalwa,J., Williamson,C., Grosskurth,H. and Kaleebu,P.",2011
HM027869,A1D,2003,21239033,Multiple HIV-1 infections with evidence of recombination in heterosexual partnerships in a low risk Rural Clinical Cohort in Uganda,"Ssemwanga,D., Lyagoba,F., Ndembi,N., Mayanja,B.N., Larke,N., Wang,S., Baalwa,J., Williamson,C., Grosskurth,H. and Kaleebu,P.",2011
HM030559,B,2009,20929350,Genotypic Characterization of HIV Type 1 in Jamaica,"Roye,M.E., Amarakoon,I.I., Hamilton,C.L., Eyzaguirre,L.M., Figueroa,P. and Carr,J.K.",2011
HM030560,B,2009,20929350,Genotypic Characterization of HIV Type 1 in Jamaica,"Roye,M.E., Amarakoon,I.I., Hamilton,C.L., Eyzaguirre,L.M., Figueroa,P. and Carr,J.K.",2011
HM030561,B,2009,20929350,Genotypic Characterization of HIV Type 1 in Jamaica,"Roye,M.E., Amarakoon,I.I., Hamilton,C.L., Eyzaguirre,L.M., Figueroa,P. and Carr,J.K.",2011
HM030562,B,2009,20929350,Genotypic Characterization of HIV Type 1 in Jamaica,"Roye,M.E., Amarakoon,I.I., Hamilton,C.L., Eyzaguirre,L.M., Figueroa,P. and Carr,J.K.",2011
HM030563,B,2009,20929350,Genotypic Characterization of HIV Type 1 in Jamaica,"Roye,M.E., Amarakoon,I.I., Hamilton,C.L., Eyzaguirre,L.M., Figueroa,P. and Carr,J.K.",2011
HM030564,B,2009,20929350,Genotypic Characterization of HIV Type 1 in Jamaica,"Roye,M.E., Amarakoon,I.I., Hamilton,C.L., Eyzaguirre,L.M., Figueroa,P. and Carr,J.K.",2011
HM030565,B,2009,20929350,Genotypic Characterization of HIV Type 1 in Jamaica,"Roye,M.E., Amarakoon,I.I., Hamilton,C.L., Eyzaguirre,L.M., Figueroa,P. and Carr,J.K.",2011
HM036739,C,2004,20422033,Restriction of HIV-1 genotypes in breast milk does not account for the population transmission genetic bottleneck that occurs following transmission,"Heath,L., Conway,S., Jones,L., Semrau,K., Nakamura,K., Walter,J., Decker,W.D., Hong,J., Chen,T., Heil,M., Sinkala,M., Kankasa,C., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",2010
HM036760,C,2002,20422033,Restriction of HIV-1 genotypes in breast milk does not account for the population transmission genetic bottleneck that occurs following transmission,"Heath,L., Conway,S., Jones,L., Semrau,K., Nakamura,K., Walter,J., Decker,W.D., Hong,J., Chen,T., Heil,M., Sinkala,M., Kankasa,C., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",2010
HM036792,C,2004,20422033,Restriction of HIV-1 genotypes in breast milk does not account for the population transmission genetic bottleneck that occurs following transmission,"Heath,L., Conway,S., Jones,L., Semrau,K., Nakamura,K., Walter,J., Decker,W.D., Hong,J., Chen,T., Heil,M., Sinkala,M., Kankasa,C., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",2010
HM036812,C,2002,20422033,Restriction of HIV-1 genotypes in breast milk does not account for the population transmission genetic bottleneck that occurs following transmission,"Heath,L., Conway,S., Jones,L., Semrau,K., Nakamura,K., Walter,J., Decker,W.D., Hong,J., Chen,T., Heil,M., Sinkala,M., Kankasa,C., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",2010
HM036832,C,2002,20422033,Restriction of HIV-1 genotypes in breast milk does not account for the population transmission genetic bottleneck that occurs following transmission,"Heath,L., Conway,S., Jones,L., Semrau,K., Nakamura,K., Walter,J., Decker,W.D., Hong,J., Chen,T., Heil,M., Sinkala,M., Kankasa,C., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",2010
HM036843,C,2003,20422033,Restriction of HIV-1 genotypes in breast milk does not account for the population transmission genetic bottleneck that occurs following transmission,"Heath,L., Conway,S., Jones,L., Semrau,K., Nakamura,K., Walter,J., Decker,W.D., Hong,J., Chen,T., Heil,M., Sinkala,M., Kankasa,C., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",2010
HM036864,C,2002,20422033,Restriction of HIV-1 genotypes in breast milk does not account for the population transmission genetic bottleneck that occurs following transmission,"Heath,L., Conway,S., Jones,L., Semrau,K., Nakamura,K., Walter,J., Decker,W.D., Hong,J., Chen,T., Heil,M., Sinkala,M., Kankasa,C., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",2010
HM036903,C,2003,20422033,Restriction of HIV-1 genotypes in breast milk does not account for the population transmission genetic bottleneck that occurs following transmission,"Heath,L., Conway,S., Jones,L., Semrau,K., Nakamura,K., Walter,J., Decker,W.D., Hong,J., Chen,T., Heil,M., Sinkala,M., Kankasa,C., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",2010
HM036960,CG,2002,20422033,Restriction of HIV-1 genotypes in breast milk does not account for the population transmission genetic bottleneck that occurs following transmission,"Heath,L., Conway,S., Jones,L., Semrau,K., Nakamura,K., Walter,J., Decker,W.D., Hong,J., Chen,T., Heil,M., Sinkala,M., Kankasa,C., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",2010
HM036983,C,2002,20422033,Restriction of HIV-1 genotypes in breast milk does not account for the population transmission genetic bottleneck that occurs following transmission,"Heath,L., Conway,S., Jones,L., Semrau,K., Nakamura,K., Walter,J., Decker,W.D., Hong,J., Chen,T., Heil,M., Sinkala,M., Kankasa,C., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",2010
HM037006,C,2002,20422033,Restriction of HIV-1 genotypes in breast milk does not account for the population transmission genetic bottleneck that occurs following transmission,"Heath,L., Conway,S., Jones,L., Semrau,K., Nakamura,K., Walter,J., Decker,W.D., Hong,J., Chen,T., Heil,M., Sinkala,M., Kankasa,C., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",2010
HM068551,F1,2009,21226626,Construction and Phenotypic Characterization of HIV Type 1 Functional Envelope Clones of Subtypes G and F,"Revilla,A., Delgado,E., Christian,E.C., Dalrymple,J., Vega,Y., Carrera,C., Gonzalez-Galeano,M., Ocampo,A., de Castro,R.O., Lezaun,M.J., Rodriguez,R., Marino,A., Ordonez,P., Cilla,G., Cisterna,R., Santamaria,J.M., Prieto,S., Rakhmanova,A., Vinogradova,A., Rios,M., Perez-Alvarez,L., Najera,R., Montefiori,D.C., Seaman,M.S. and Thomson,M.M.",2011
HM068552,F1,2009,,"Functional molecular clones of HIV-1 env of subtypes F, B, G and BG recombinants","Revilla,A., Delgado,E., Vega,Y. and Thomson,M.",
HM068554,F1,2009,,"Functional molecular clones of HIV-1 env of subtypes F, B, G and BG recombinants","Revilla,A., Delgado,E., Vega,Y. and Thomson,M.",
HM068555,D,2007,,"Functional molecular clones of HIV-1 env of subtypes F, B, G and BG recombinants","Revilla,A., Delgado,E., Vega,Y. and Thomson,M.",
HM068556,D,2007,,"Functional molecular clones of HIV-1 env of subtypes F, B, G and BG recombinants","Revilla,A., Delgado,E., Vega,Y. and Thomson,M.",
HM068596,C,2002,20494390,Subtype-specific conservation of isoleucine 309 in the envelope V3 domain is linked to immune evasion in subtype C HIV-1 infection,"Lynch,R.M., Rong,R., Li,B., Shen,T., Honnen,W., Mulenga,J., Allen,S., Pinter,A., Gnanakaran,S. and Derdeyn,C.A.",2010
HM068598,C,2003,20494390,Subtype-specific conservation of isoleucine 309 in the envelope V3 domain is linked to immune evasion in subtype C HIV-1 infection,"Lynch,R.M., Rong,R., Li,B., Shen,T., Honnen,W., Mulenga,J., Allen,S., Pinter,A., Gnanakaran,S. and Derdeyn,C.A.",2010
HM070449,C,2008,21191008,Origin and Evolution of HIV-1 in Breast Milk Determined by Single-Genome Amplification and Sequencing,"Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Fouda,G.G., Kang,H.H., Mahlokozera,T., Wilks,A.B., Lovingood,R.V., Stacey,A., Kalilani,L., Meshnick,S.R., Borrow,P., Montefiori,D.C., Denny,T.N., Letvin,N.L., Shaw,G.M., Hahn,B.H. and Permar,S.R.",2011
HM070491,C,2008,21191008,Origin and Evolution of HIV-1 in Breast Milk Determined by Single-Genome Amplification and Sequencing,"Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Fouda,G.G., Kang,H.H., Mahlokozera,T., Wilks,A.B., Lovingood,R.V., Stacey,A., Kalilani,L., Meshnick,S.R., Borrow,P., Montefiori,D.C., Denny,T.N., Letvin,N.L., Shaw,G.M., Hahn,B.H. and Permar,S.R.",2011
HM070529,C,2008,21191008,Origin and Evolution of HIV-1 in Breast Milk Determined by Single-Genome Amplification and Sequencing,"Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Fouda,G.G., Kang,H.H., Mahlokozera,T., Wilks,A.B., Lovingood,R.V., Stacey,A., Kalilani,L., Meshnick,S.R., Borrow,P., Montefiori,D.C., Denny,T.N., Letvin,N.L., Shaw,G.M., Hahn,B.H. and Permar,S.R.",2011
HM070571,C,2008,21191008,Origin and Evolution of HIV-1 in Breast Milk Determined by Single-Genome Amplification and Sequencing,"Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Fouda,G.G., Kang,H.H., Mahlokozera,T., Wilks,A.B., Lovingood,R.V., Stacey,A., Kalilani,L., Meshnick,S.R., Borrow,P., Montefiori,D.C., Denny,T.N., Letvin,N.L., Shaw,G.M., Hahn,B.H. and Permar,S.R.",2011
HM070630,C,2008,21191008,Origin and Evolution of HIV-1 in Breast Milk Determined by Single-Genome Amplification and Sequencing,"Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Fouda,G.G., Kang,H.H., Mahlokozera,T., Wilks,A.B., Lovingood,R.V., Stacey,A., Kalilani,L., Meshnick,S.R., Borrow,P., Montefiori,D.C., Denny,T.N., Letvin,N.L., Shaw,G.M., Hahn,B.H. and Permar,S.R.",2011
HM070674,C,2008,21191008,Origin and Evolution of HIV-1 in Breast Milk Determined by Single-Genome Amplification and Sequencing,"Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Fouda,G.G., Kang,H.H., Mahlokozera,T., Wilks,A.B., Lovingood,R.V., Stacey,A., Kalilani,L., Meshnick,S.R., Borrow,P., Montefiori,D.C., Denny,T.N., Letvin,N.L., Shaw,G.M., Hahn,B.H. and Permar,S.R.",2011
HM070791,C,2008,21191008,Origin and Evolution of HIV-1 in Breast Milk Determined by Single-Genome Amplification and Sequencing,"Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Fouda,G.G., Kang,H.H., Mahlokozera,T., Wilks,A.B., Lovingood,R.V., Stacey,A., Kalilani,L., Meshnick,S.R., Borrow,P., Montefiori,D.C., Denny,T.N., Letvin,N.L., Shaw,G.M., Hahn,B.H. and Permar,S.R.",2011
HM100716,BC,1992,20854199,Genetic analysis of a UNAIDS HIV type 1 from Brazil revealed an unexpected recombination pattern,"Chin,M.P. and Ristic,N.",2010
HM138656,01C,2008,20977354,"Near Full-Length Sequence Analysis of a Novel HIV-1 C/CRF01_AE Recombinant Variant from Yunnan, China","Li,L., Chen,L., Yang,S., Liu,Y., Li,J., Wang,Z., Yang,B., Li,H., Bao,Z., Zhuang,D., Liu,S. and Li,J.",2010
HM204583,C,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM204584,C,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM204588,C,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM204592,C,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM204593,CF1,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM204599,C,2008,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM204614,C,2008,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM204621,A1,2008,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM204622,C,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM204623,C,2008,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM204647,B,2008,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215249,U,1999,21291604,"Novel HIV-1 Recombinant Forms in Antenatal Cohort, Montreal, Quebec, Canada","Quesnel-Vallieres,M., Kouzayha,I., Tran,E., Barry,I., Lasgi,C., Merindol,N., Monteil,V., Ransy,D.G., Boucher,M., Lapointe,N. and Soudeyns,H.",2011
HM215250,U,2001,21291604,"Novel HIV-1 Recombinant Forms in Antenatal Cohort, Montreal, Quebec, Canada","Quesnel-Vallieres,M., Kouzayha,I., Tran,E., Barry,I., Lasgi,C., Merindol,N., Monteil,V., Ransy,D.G., Boucher,M., Lapointe,N. and Soudeyns,H.",2011
HM215251,U,2001,21291604,"Novel HIV-1 Recombinant Forms in Antenatal Cohort, Montreal, Quebec, Canada","Quesnel-Vallieres,M., Kouzayha,I., Tran,E., Barry,I., Lasgi,C., Merindol,N., Monteil,V., Ransy,D.G., Boucher,M., Lapointe,N. and Soudeyns,H.",2011
HM215252,U,2003,21291604,"Novel HIV-1 Recombinant Forms in Antenatal Cohort, Montreal, Quebec, Canada","Quesnel-Vallieres,M., Kouzayha,I., Tran,E., Barry,I., Lasgi,C., Merindol,N., Monteil,V., Ransy,D.G., Boucher,M., Lapointe,N. and Soudeyns,H.",2011
HM215253,C,2004,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215254,C,2003,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215255,A1,2005,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215258,A1,2005,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215259,A1C,2005,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215261,A1D,2005,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215262,C,2004,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215263,C,2004,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215264,02_AG,1999,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215266,A1,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215267,D,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215270,D,2006,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215271,A1,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215272,A1,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215273,A1D,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215274,A1D,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215275,A1,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215276,A1C,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215277,A1C,,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215279,A1C,,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215280,A1CD,2006,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215281,02_AG,2000,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215282,02A1,1999,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215283,D,2005,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215286,C,2001,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215288,A1CD,2004,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215289,C,2005,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215290,02_AG,1999,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215291,02_AG,1999,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215292,02_AG,2001,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215293,02_AG,1999,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215294,C,2003,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215296,CD,2005,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215297,CD,2004,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215298,A1,2004,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215299,A1,2003,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215300,C,2005,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215301,A1D,2003,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215302,C,2001,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215303,A1,2006,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215304,A1C,2003,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215305,C,2005,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215306,A1,2004,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215307,C,2004,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215308,C,2004,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215309,A1C,2006,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215310,CD,2004,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215311,C,2003,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215312,A1,,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215313,CD,,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215314,C,,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215315,A1C,,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215317,C,2001,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215318,C,2001,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215319,C,2006,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215320,C,2005,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215321,A1C,2004,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215322,A1C,,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215323,A1D,2003,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215324,C,2006,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215325,C,2004,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215326,C,2005,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215327,D,2004,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215328,C,2003,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215329,CD,2004,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215330,A1C,2004,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215331,A1C,2004,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215333,A1,2005,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215335,C,2004,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215336,C,2004,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215337,CD,2003,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215338,C,2005,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215339,CD,2005,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215341,C,2003,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215343,CD,2003,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215344,C,2003,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215349,CD,,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215350,A1,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215351,D,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215352,C,2005,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215354,C,2001,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215355,C,2004,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215360,C,2002,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215361,C,,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215362,C,,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215363,07_BC,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215365,B,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215367,01_AE,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215369,B,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215370,B,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215371,01_AE,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215372,01_AE,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215373,01_AE,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215375,07_BC,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215376,01_AE,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215377,01_AE,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215378,01_AE,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215379,01_AE,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215380,07_BC,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215382,B,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215383,01_AE,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215384,B,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215385,01_AE,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215386,01_AE,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215388,07_BC,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215389,01_AE,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215392,07_BC,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215393,01_AE,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215394,01_AE,2008,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215397,B,2004,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215398,B,2005,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215399,B,2004,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215400,B,2004,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215401,BC,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215402,BC,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215403,C,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215404,BC,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215405,07_BC,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215406,07_BC,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215407,07_BC,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215408,C,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215409,01_AE,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215410,01_AE,2006,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215411,C,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215412,C,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215413,B,2006,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215414,BC,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215415,01_AE,2006,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215416,08_BC,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215417,08_BC,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215418,01_AE,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215419,01_AE,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215420,B,2005,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215421,C,2006,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215422,01_AE,2006,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215423,B,2006,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215424,01_AE,2005,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215425,BC,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215427,01_AE,2006,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215428,B,2005,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM215434,A1,2007,20949103,Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies,"Gnanakaran,S., Daniels,M.G., Bhattacharya,T., Lapedes,A.S., Sethi,A., Li,M., Tang,H., Greene,K., Gao,H., Haynes,B.F., Cohen,M.S., Shaw,G.M., Seaman,M.S., Kumar,A., Gao,F., Montefiori,D.C. and Korber,B.",2010
HM234502,B,2003,21078948,In Vivo Resistance Patterns to the HIV Attachment Inhibitor BMS-488043,"Zhou,N., Nowicka-Sans,B., Zhang,S., Fan,L., Fang,J., Fang,H., Gong,Y.F., Eggers,B., Langley,D.R., Wang,T., Kadow,J., Grasela,D., Hanna,G.J., Alexander,L., Colonno,R., Krystal,M. and Lin,P.F.",2010
HM355543,B,1997,,Increased Spontaneous Shedding of Soluble gp120 by HIV in Brain from Patients with Dementia,"Mefford,M.E., Kamat,A., Kunstman,K., Wolinsky,S.M. and Gabuzda,D.",
HM368224,B,1990,,Early infant HIV-1 envelopes exhibit more rapid entry kinetics than non-transmitted maternal variants,"Kishko,M., Somasundaran,M., Brewster,F., Sullivan,J., Clapham,P. and Luzuriaga,K.",
HM368226,B,1990,,Early infant HIV-1 envelopes exhibit more rapid entry kinetics than non-transmitted maternal variants,"Kishko,M., Somasundaran,M., Brewster,F., Sullivan,J., Clapham,P. and Luzuriaga,K.",
HM368230,B,1988,,Early infant HIV-1 envelopes exhibit more rapid entry kinetics than non-transmitted maternal variants,"Kishko,M., Somasundaran,M., Brewster,F., Sullivan,J., Clapham,P. and Luzuriaga,K.",
HM368233,B,1988,,Early infant HIV-1 envelopes exhibit more rapid entry kinetics than non-transmitted maternal variants,"Kishko,M., Somasundaran,M., Brewster,F., Sullivan,J., Clapham,P. and Luzuriaga,K.",
HM368238,B,1986,,Early infant HIV-1 envelopes exhibit more rapid entry kinetics than non-transmitted maternal variants,"Kishko,M., Somasundaran,M., Brewster,F., Sullivan,J., Clapham,P. and Luzuriaga,K.",
HM368240,B,1986,,Early infant HIV-1 envelopes exhibit more rapid entry kinetics than non-transmitted maternal variants,"Kishko,M., Somasundaran,M., Brewster,F., Sullivan,J., Clapham,P. and Luzuriaga,K.",
HM368244,B,1991,,Early infant HIV-1 envelopes exhibit more rapid entry kinetics than non-transmitted maternal variants,"Kishko,M., Somasundaran,M., Brewster,F., Sullivan,J., Clapham,P. and Luzuriaga,K.",
HM368248,B,1991,,Early infant HIV-1 envelopes exhibit more rapid entry kinetics than non-transmitted maternal variants,"Kishko,M., Somasundaran,M., Brewster,F., Sullivan,J., Clapham,P. and Luzuriaga,K.",
HM368252,B,1995,,Early infant HIV-1 envelopes exhibit more rapid entry kinetics than non-transmitted maternal variants,"Kishko,M., Somasundaran,M., Brewster,F., Sullivan,J., Clapham,P. and Luzuriaga,K.",
HM368254,B,1995,,Early infant HIV-1 envelopes exhibit more rapid entry kinetics than non-transmitted maternal variants,"Kishko,M., Somasundaran,M., Brewster,F., Sullivan,J., Clapham,P. and Luzuriaga,K.",
HM573466,BC,2008,,HIV-1 recombinants among Maipur IDUs,"Chakrabarti,S. and Sarkar,R.",
HM586187,B,2003,19454710,Kinetics of expansion of epitope-specific T cell responses during primary HIV-1 infection,"Turnbull,E.L., Wong,M., Wang,S., Wei,X., Jones,N.A., Conrod,K.E., Aldam,D., Turner,J., Pellegrino,P., Keele,B.F., Williams,I., Shaw,G.M. and Borrow,P.",2009
HM586193,B,2004,19454710,Kinetics of expansion of epitope-specific T cell responses during primary HIV-1 infection,"Turnbull,E.L., Wong,M., Wang,S., Wei,X., Jones,N.A., Conrod,K.E., Aldam,D., Turner,J., Pellegrino,P., Keele,B.F., Williams,I., Shaw,G.M. and Borrow,P.",2009
HM586198,B,2004,19454710,Kinetics of expansion of epitope-specific T cell responses during primary HIV-1 infection,"Turnbull,E.L., Wong,M., Wang,S., Wei,X., Jones,N.A., Conrod,K.E., Aldam,D., Turner,J., Pellegrino,P., Keele,B.F., Williams,I., Shaw,G.M. and Borrow,P.",2009
HM586206,B,2004,19454710,Kinetics of expansion of epitope-specific T cell responses during primary HIV-1 infection,"Turnbull,E.L., Wong,M., Wang,S., Wei,X., Jones,N.A., Conrod,K.E., Aldam,D., Turner,J., Pellegrino,P., Keele,B.F., Williams,I., Shaw,G.M. and Borrow,P.",2009
HM586210,B,2005,19454710,Kinetics of expansion of epitope-specific T cell responses during primary HIV-1 infection,"Turnbull,E.L., Wong,M., Wang,S., Wei,X., Jones,N.A., Conrod,K.E., Aldam,D., Turner,J., Pellegrino,P., Keele,B.F., Williams,I., Shaw,G.M. and Borrow,P.",2009
HM598635,BC,2008,,"HIV-1 recombinants among Manipur IDUs, India","Sarkar,R. and Chakrabarti,S.",
HM638460,B,2007,20808902,HIV-1 Populations in Semen Arise through Multiple Mechanisms,"Anderson,J.A., Ping,L.H., Dibben,O., Jabara,C.B., Arney,L., Kincer,L., Tang,Y., Hobbs,M., Hoffman,I., Kazembe,P., Jones,C.D., Borrow,P., Fiscus,S., Cohen,M.S. and Swanstrom,R.",2010
HM638516,B,2008,20808902,HIV-1 Populations in Semen Arise through Multiple Mechanisms,"Anderson,J.A., Ping,L.H., Dibben,O., Jabara,C.B., Arney,L., Kincer,L., Tang,Y., Hobbs,M., Hoffman,I., Kazembe,P., Jones,C.D., Borrow,P., Fiscus,S., Cohen,M.S. and Swanstrom,R.",2010
HM638548,B,2009,20808902,HIV-1 Populations in Semen Arise through Multiple Mechanisms,"Anderson,J.A., Ping,L.H., Dibben,O., Jabara,C.B., Arney,L., Kincer,L., Tang,Y., Hobbs,M., Hoffman,I., Kazembe,P., Jones,C.D., Borrow,P., Fiscus,S., Cohen,M.S. and Swanstrom,R.",2010
HM638583,B,2008,20808902,HIV-1 Populations in Semen Arise through Multiple Mechanisms,"Anderson,J.A., Ping,L.H., Dibben,O., Jabara,C.B., Arney,L., Kincer,L., Tang,Y., Hobbs,M., Hoffman,I., Kazembe,P., Jones,C.D., Borrow,P., Fiscus,S., Cohen,M.S. and Swanstrom,R.",2010
HM638616,C,1996,20808902,HIV-1 Populations in Semen Arise through Multiple Mechanisms,"Anderson,J.A., Ping,L.H., Dibben,O., Jabara,C.B., Arney,L., Kincer,L., Tang,Y., Hobbs,M., Hoffman,I., Kazembe,P., Jones,C.D., Borrow,P., Fiscus,S., Cohen,M.S. and Swanstrom,R.",2010
HM638668,C,1996,20808902,HIV-1 Populations in Semen Arise through Multiple Mechanisms,"Anderson,J.A., Ping,L.H., Dibben,O., Jabara,C.B., Arney,L., Kincer,L., Tang,Y., Hobbs,M., Hoffman,I., Kazembe,P., Jones,C.D., Borrow,P., Fiscus,S., Cohen,M.S. and Swanstrom,R.",2010
HM638722,C,1996,20808902,HIV-1 Populations in Semen Arise through Multiple Mechanisms,"Anderson,J.A., Ping,L.H., Dibben,O., Jabara,C.B., Arney,L., Kincer,L., Tang,Y., Hobbs,M., Hoffman,I., Kazembe,P., Jones,C.D., Borrow,P., Fiscus,S., Cohen,M.S. and Swanstrom,R.",2010
HM638780,C,1996,20808902,HIV-1 Populations in Semen Arise through Multiple Mechanisms,"Anderson,J.A., Ping,L.H., Dibben,O., Jabara,C.B., Arney,L., Kincer,L., Tang,Y., Hobbs,M., Hoffman,I., Kazembe,P., Jones,C.D., Borrow,P., Fiscus,S., Cohen,M.S. and Swanstrom,R.",2010
HM638826,C,1996,20808902,HIV-1 Populations in Semen Arise through Multiple Mechanisms,"Anderson,J.A., Ping,L.H., Dibben,O., Jabara,C.B., Arney,L., Kincer,L., Tang,Y., Hobbs,M., Hoffman,I., Kazembe,P., Jones,C.D., Borrow,P., Fiscus,S., Cohen,M.S. and Swanstrom,R.",2010
HM638888,C,1996,20808902,HIV-1 Populations in Semen Arise through Multiple Mechanisms,"Anderson,J.A., Ping,L.H., Dibben,O., Jabara,C.B., Arney,L., Kincer,L., Tang,Y., Hobbs,M., Hoffman,I., Kazembe,P., Jones,C.D., Borrow,P., Fiscus,S., Cohen,M.S. and Swanstrom,R.",2010
HM638963,C,1996,20808902,HIV-1 Populations in Semen Arise through Multiple Mechanisms,"Anderson,J.A., Ping,L.H., Dibben,O., Jabara,C.B., Arney,L., Kincer,L., Tang,Y., Hobbs,M., Hoffman,I., Kazembe,P., Jones,C.D., Borrow,P., Fiscus,S., Cohen,M.S. and Swanstrom,R.",2010
HM639009,C,1996,20808902,HIV-1 Populations in Semen Arise through Multiple Mechanisms,"Anderson,J.A., Ping,L.H., Dibben,O., Jabara,C.B., Arney,L., Kincer,L., Tang,Y., Hobbs,M., Hoffman,I., Kazembe,P., Jones,C.D., Borrow,P., Fiscus,S., Cohen,M.S. and Swanstrom,R.",2010
HM639073,C,1996,20808902,HIV-1 Populations in Semen Arise through Multiple Mechanisms,"Anderson,J.A., Ping,L.H., Dibben,O., Jabara,C.B., Arney,L., Kincer,L., Tang,Y., Hobbs,M., Hoffman,I., Kazembe,P., Jones,C.D., Borrow,P., Fiscus,S., Cohen,M.S. and Swanstrom,R.",2010
HM639117,C,1996,20808902,HIV-1 Populations in Semen Arise through Multiple Mechanisms,"Anderson,J.A., Ping,L.H., Dibben,O., Jabara,C.B., Arney,L., Kincer,L., Tang,Y., Hobbs,M., Hoffman,I., Kazembe,P., Jones,C.D., Borrow,P., Fiscus,S., Cohen,M.S. and Swanstrom,R.",2010
HM639160,C,1996,20808902,HIV-1 Populations in Semen Arise through Multiple Mechanisms,"Anderson,J.A., Ping,L.H., Dibben,O., Jabara,C.B., Arney,L., Kincer,L., Tang,Y., Hobbs,M., Hoffman,I., Kazembe,P., Jones,C.D., Borrow,P., Fiscus,S., Cohen,M.S. and Swanstrom,R.",2010
HM639204,C,1996,20808902,HIV-1 Populations in Semen Arise through Multiple Mechanisms,"Anderson,J.A., Ping,L.H., Dibben,O., Jabara,C.B., Arney,L., Kincer,L., Tang,Y., Hobbs,M., Hoffman,I., Kazembe,P., Jones,C.D., Borrow,P., Fiscus,S., Cohen,M.S. and Swanstrom,R.",2010
HM769943,B,2001,20702624,Mutation at a Single Position in the V2 Domain of the HIV-1 Envelope Protein Confers Neutralization Sensitivity to a Highly Neutralization-Resistant Virus,"O'Rourke,S.M., Schweighardt,B., Phung,P., Fonseca,D.P., Terry,K., Wrin,T., Sinangil,F. and Berman,P.W.",2010
HM771412,B,1998,,Variation in HIV-1 R5 macrophage-tropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors,"Peters,P.J., Duenas-Decamp,M.J., Sullivan,W.M., Brown,R., Ankghaumbom,C., Luzuriaga,K., Robinson,J., Burton,D.R., Bell,J., Simmonds,P., Ball,J. and Clapham,P.R.",
HM771417,B,,,Variation in HIV-1 R5 macrophage-tropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors,"Peters,P.J., Duenas-Decamp,M.J., Sullivan,W.M., Brown,R., Ankghaumbom,C., Luzuriaga,K., Robinson,J., Burton,D.R., Bell,J., Simmonds,P., Ball,J. and Clapham,P.R.",
HM771420,B,,,Variation in HIV-1 R5 macrophage-tropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors,"Peters,P.J., Duenas-Decamp,M.J., Sullivan,W.M., Brown,R., Ankghaumbom,C., Luzuriaga,K., Robinson,J., Burton,D.R., Bell,J., Simmonds,P., Ball,J. and Clapham,P.R.",
HM771422,B,,,Variation in HIV-1 R5 macrophage-tropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors,"Peters,P.J., Duenas-Decamp,M.J., Sullivan,W.M., Brown,R., Ankghaumbom,C., Luzuriaga,K., Robinson,J., Burton,D.R., Bell,J., Simmonds,P., Ball,J. and Clapham,P.R.",
HM771423,B,2004,,A conserved HIV-1 R5 envelope determinant in the V1 loop modulates the V3 loop to expose or protect the CD4 binding site and alter macrophage-tropism,"Musich,T., Peters,P.J., Duenas-Decamp,M.J., Gonzalez-Perez,M.P., Zolla-Pazner,S., Ball,J., Luzuriaga,K. and Clapham,P.R.",
HM776938,BC,2007,20977352,Identification and Characterization of Two New HIV Type 1 Unique (B/C) Recombinant Forms in China,"Liu,Y., Li,L., Yang,S., Bao,Z., Li,H., Wang,Z., Zhuang,D., Liu,S., Chen,L., Fan,Y., Zhong,M., Gao,L., Wang,X. and Li,J.",2011
HM776939,57_BC,2007,20977352,Identification and Characterization of Two New HIV Type 1 Unique (B/C) Recombinant Forms in China,"Liu,Y., Li,L., Yang,S., Bao,Z., Li,H., Wang,Z., Zhuang,D., Liu,S., Chen,L., Fan,Y., Zhong,M., Gao,L., Wang,X. and Li,J.",2011
HQ110634,B,1986,,Direct Submission,"Wernly,C.H. and Quinnan,G.V. Jr.",2010
HQ122390,B,,,Increased Spontaneous Shedding of Soluble gp120 by HIV in Brain from Patients with Dementia,"Mefford,M.E., Kunstman,K., Wolinsky,S.M. and Gabuzda,D.",
HQ143536,C,2001,20921899,Extreme Genetic Divergence is Required for Coreceptor Switching in HIV-1 Subtype C,"Coetzer,M., Nedellec,R., Cilliers,T., Meyers,T., Morris,L. and Mosier,D.E.",2010
HQ162499,B,,15858036,Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B,"Frost,S.D., Liu,Y., Pond,S.L., Chappey,C., Wrin,T., Petropoulos,C.J., Little,S.J. and Richman,D.D.",2005
HQ162511,B,,15858036,Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B,"Frost,S.D., Liu,Y., Pond,S.L., Chappey,C., Wrin,T., Petropoulos,C.J., Little,S.J. and Richman,D.D.",2005
HQ162523,B,,15858036,Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B,"Frost,S.D., Liu,Y., Pond,S.L., Chappey,C., Wrin,T., Petropoulos,C.J., Little,S.J. and Richman,D.D.",2005
HQ162534,B,,15858036,Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B,"Frost,S.D., Liu,Y., Pond,S.L., Chappey,C., Wrin,T., Petropoulos,C.J., Little,S.J. and Richman,D.D.",2005
HQ162548,B,,15858036,Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B,"Frost,S.D., Liu,Y., Pond,S.L., Chappey,C., Wrin,T., Petropoulos,C.J., Little,S.J. and Richman,D.D.",2005
HQ162559,B,,15858036,Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B,"Frost,S.D., Liu,Y., Pond,S.L., Chappey,C., Wrin,T., Petropoulos,C.J., Little,S.J. and Richman,D.D.",2005
HQ162572,B,,15858036,Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B,"Frost,S.D., Liu,Y., Pond,S.L., Chappey,C., Wrin,T., Petropoulos,C.J., Little,S.J. and Richman,D.D.",2005
HQ162584,B,,15858036,Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B,"Frost,S.D., Liu,Y., Pond,S.L., Chappey,C., Wrin,T., Petropoulos,C.J., Little,S.J. and Richman,D.D.",2005
HQ162597,B,,15858036,Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B,"Frost,S.D., Liu,Y., Pond,S.L., Chappey,C., Wrin,T., Petropoulos,C.J., Little,S.J. and Richman,D.D.",2005
HQ162608,B,,15858036,Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B,"Frost,S.D., Liu,Y., Pond,S.L., Chappey,C., Wrin,T., Petropoulos,C.J., Little,S.J. and Richman,D.D.",2005
HQ162620,B,,15858036,Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B,"Frost,S.D., Liu,Y., Pond,S.L., Chappey,C., Wrin,T., Petropoulos,C.J., Little,S.J. and Richman,D.D.",2005
HQ162634,B,,15858036,Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B,"Frost,S.D., Liu,Y., Pond,S.L., Chappey,C., Wrin,T., Petropoulos,C.J., Little,S.J. and Richman,D.D.",2005
HQ179987,P,,21084486,Confirmation of Putative HIV-1 Group P in Cameroon,"Vallari,A., Holzmayer,V., Harris,B., Yamaguchi,J., Ngansop,C., Makamche,F., Mbanya,D., Kaptue,L., Ndembi,N., Gurtler,L., Devare,S. and Brennan,C.A.",2011
HQ215552,07_BC,2008,21645646,"High genetic diversity of HIV-1 was found in men who have sex with men in Shijiazhuang, China","Li,L., Lu,X., Li,H., Chen,L., Wang,Z., Liu,Y., Bao,Z., Li,T., Tian,C., Liu,H., Zhuang,D., Liu,S. and Li,J.",2011
HQ215553,01_AE,2009,21645646,"High genetic diversity of HIV-1 was found in men who have sex with men in Shijiazhuang, China","Li,L., Lu,X., Li,H., Chen,L., Wang,Z., Liu,Y., Bao,Z., Li,T., Tian,C., Liu,H., Zhuang,D., Liu,S. and Li,J.",2011
HQ215554,B,2008,21645646,"High genetic diversity of HIV-1 was found in men who have sex with men in Shijiazhuang, China","Li,L., Lu,X., Li,H., Chen,L., Wang,Z., Liu,Y., Bao,Z., Li,T., Tian,C., Liu,H., Zhuang,D., Liu,S. and Li,J.",2011
HQ215555,01_AE,2009,21645646,"High genetic diversity of HIV-1 was found in men who have sex with men in Shijiazhuang, China","Li,L., Lu,X., Li,H., Chen,L., Wang,Z., Liu,Y., Bao,Z., Li,T., Tian,C., Liu,H., Zhuang,D., Liu,S. and Li,J.",2011
HQ215556,B,2009,21645646,"High genetic diversity of HIV-1 was found in men who have sex with men in Shijiazhuang, China","Li,L., Lu,X., Li,H., Chen,L., Wang,Z., Liu,Y., Bao,Z., Li,T., Tian,C., Liu,H., Zhuang,D., Liu,S. and Li,J.",2011
HQ216367,B,2004,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ216397,B,2004,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ216471,B,2004,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ216501,B,2004,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ216557,B,2005,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ216577,B,2005,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ216601,B,2005,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ216632,B,2005,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ216675,B,2005,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ216702,B,2005,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ216730,B,2005,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ216755,B,2005,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ216785,B,2005,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ216810,B,2005,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ216841,B,2005,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ216861,B,2005,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ216893,B,2006,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ216915,B,2006,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ216949,B,2006,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ216971,B,2007,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ217019,B,2006,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ217043,B,2007,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ217079,B,2007,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ217099,B,2007,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ217115,B,2007,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ217144,B,2007,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ217167,B,2004,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ217193,B,2002,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ217256,B,2006,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ217283,B,2007,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ217315,B,2004,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ217340,B,2007,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ217368,B,2007,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ217393,B,2007,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ217418,B,2007,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ217443,B,2003,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ217474,B,2005,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ217505,B,2007,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ217541,B,2005,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ217574,B,2007,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ217651,B,2000,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ217708,B,2007,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ217733,B,2005,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ217760,B,2001,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ217784,B,2007,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ217818,B,2005,,Transmission Signature Patterns in Human Immunodeficiency Virus Type-1 B clade Envelope Proteins,"Gnanakaran,G., Keele,B.F., Li,H., Gao,F., Swanstrom,R., Cohen,M., Daniels,M., Hraber,P., Gaschen,B., Ashmal,M., Letvin,N.L., Haynes,B.F., Hahn,B.H., Shaw,G.M., Bhattacharya,T. and Korber,B.",
HQ217840,B,2005,,Transmission Signature Patterns in Human Immunodeficiency Virus Type-1 B clade Envelope Proteins,"Gnanakaran,G., Keele,B.F., Li,H., Gao,F., Swanstrom,R., Cohen,M., Daniels,M., Hraber,P., Gaschen,B., Ashmal,M., Letvin,N.L., Haynes,B.F., Hahn,B.H., Shaw,G.M., Bhattacharya,T. and Korber,B.",
HQ217860,B,2005,,Transmission Signature Patterns in Human Immunodeficiency Virus Type-1 B clade Envelope Proteins,"Gnanakaran,G., Keele,B.F., Li,H., Gao,F., Swanstrom,R., Cohen,M., Daniels,M., Hraber,P., Gaschen,B., Ashmal,M., Letvin,N.L., Haynes,B.F., Hahn,B.H., Shaw,G.M., Bhattacharya,T. and Korber,B.",
HQ217874,B,2005,,Transmission Signature Patterns in Human Immunodeficiency Virus Type-1 B clade Envelope Proteins,"Gnanakaran,G., Keele,B.F., Li,H., Gao,F., Swanstrom,R., Cohen,M., Daniels,M., Hraber,P., Gaschen,B., Ashmal,M., Letvin,N.L., Haynes,B.F., Hahn,B.H., Shaw,G.M., Bhattacharya,T. and Korber,B.",
HQ217892,B,2005,,Transmission Signature Patterns in Human Immunodeficiency Virus Type-1 B clade Envelope Proteins,"Gnanakaran,G., Keele,B.F., Li,H., Gao,F., Swanstrom,R., Cohen,M., Daniels,M., Hraber,P., Gaschen,B., Ashmal,M., Letvin,N.L., Haynes,B.F., Hahn,B.H., Shaw,G.M., Bhattacharya,T. and Korber,B.",
HQ217914,B,2005,,Transmission Signature Patterns in Human Immunodeficiency Virus Type-1 B clade Envelope Proteins,"Gnanakaran,G., Keele,B.F., Li,H., Gao,F., Swanstrom,R., Cohen,M., Daniels,M., Hraber,P., Gaschen,B., Ashmal,M., Letvin,N.L., Haynes,B.F., Hahn,B.H., Shaw,G.M., Bhattacharya,T. and Korber,B.",
HQ217930,B,2006,,Transmission Signature Patterns in Human Immunodeficiency Virus Type-1 B clade Envelope Proteins,"Gnanakaran,G., Keele,B.F., Li,H., Gao,F., Swanstrom,R., Cohen,M., Daniels,M., Hraber,P., Gaschen,B., Ashmal,M., Letvin,N.L., Haynes,B.F., Hahn,B.H., Shaw,G.M., Bhattacharya,T. and Korber,B.",
HQ217947,B,2006,,Transmission Signature Patterns in Human Immunodeficiency Virus Type-1 B clade Envelope Proteins,"Gnanakaran,G., Keele,B.F., Li,H., Gao,F., Swanstrom,R., Cohen,M., Daniels,M., Hraber,P., Gaschen,B., Ashmal,M., Letvin,N.L., Haynes,B.F., Hahn,B.H., Shaw,G.M., Bhattacharya,T. and Korber,B.",
HQ217967,B,2006,,Transmission Signature Patterns in Human Immunodeficiency Virus Type-1 B clade Envelope Proteins,"Gnanakaran,G., Keele,B.F., Li,H., Gao,F., Swanstrom,R., Cohen,M., Daniels,M., Hraber,P., Gaschen,B., Ashmal,M., Letvin,N.L., Haynes,B.F., Hahn,B.H., Shaw,G.M., Bhattacharya,T. and Korber,B.",
HQ217984,B,2006,,Transmission Signature Patterns in Human Immunodeficiency Virus Type-1 B clade Envelope Proteins,"Gnanakaran,G., Keele,B.F., Li,H., Gao,F., Swanstrom,R., Cohen,M., Daniels,M., Hraber,P., Gaschen,B., Ashmal,M., Letvin,N.L., Haynes,B.F., Hahn,B.H., Shaw,G.M., Bhattacharya,T. and Korber,B.",
HQ218001,B,2006,,Transmission Signature Patterns in Human Immunodeficiency Virus Type-1 B clade Envelope Proteins,"Gnanakaran,G., Keele,B.F., Li,H., Gao,F., Swanstrom,R., Cohen,M., Daniels,M., Hraber,P., Gaschen,B., Ashmal,M., Letvin,N.L., Haynes,B.F., Hahn,B.H., Shaw,G.M., Bhattacharya,T. and Korber,B.",
HQ218020,B,2006,,Transmission Signature Patterns in Human Immunodeficiency Virus Type-1 B clade Envelope Proteins,"Gnanakaran,G., Keele,B.F., Li,H., Gao,F., Swanstrom,R., Cohen,M., Daniels,M., Hraber,P., Gaschen,B., Ashmal,M., Letvin,N.L., Haynes,B.F., Hahn,B.H., Shaw,G.M., Bhattacharya,T. and Korber,B.",
HQ218034,B,2006,,Transmission Signature Patterns in Human Immunodeficiency Virus Type-1 B clade Envelope Proteins,"Gnanakaran,G., Keele,B.F., Li,H., Gao,F., Swanstrom,R., Cohen,M., Daniels,M., Hraber,P., Gaschen,B., Ashmal,M., Letvin,N.L., Haynes,B.F., Hahn,B.H., Shaw,G.M., Bhattacharya,T. and Korber,B.",
HQ225812,0708,2008,21083434,"Near Full-Length Genomic Characterization of a Novel HIV Type 1 CRF07_ BC/CRF08_ BC Recombinant Strain from Yunnan, China","Chen,L., Yang,S., Li,J., Li,J., Liu,Y., Wang,Z., Yang,B., Li,T., Li,H., Bao,Z., Zhuang,D., Liu,S. and Li,L.",2011
HQ236564,G,2007,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ236569,F1,2006,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ236571,B,2006,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ236575,F1,2007,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ236576,G,2007,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ236581,G,2008,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ236587,F1,2008,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ236594,C,2008,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ236606,G,,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ236607,G,,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ236608,G,2007,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ236609,B,2007,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ236610,BF1,2008,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ236611,CG,2008,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ236612,G,2008,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ236615,G,2008,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ236619,G,2006,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ238279,B,2005,21980282,Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections,"Gnanakaran,S., Bhattacharya,T., Daniels,M., Keele,B.F., Hraber,P.T., Lapedes,A.S., Shen,T., Gaschen,B., Krishnamoorthy,M., Li,H., Decker,J.M., Salazar-Gonzalez,J.F., Wang,S., Jiang,C., Gao,F., Swanstrom,R., Anderson,J.A., Ping,L.H., Cohen,M.S., Markowitz,M., Goepfert,P.A., Saag,M.S., Eron,J.J., Hicks,C.B., Blattner,W.A., Tomaras,G.D., Asmal,M., Letvin,N.L., Gilbert,P.B., Decamp,A.C., Magaret,C.A., Schief,W.R., Ban,Y.E., Zhang,M., Soderberg,K.A., Sodroski,J.G., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Korber,B.",2011
HQ336425,02A1,,,Defining new unique recombinant forms of HIV-1 from Rural Cameroon Villagers,"Lwembe,R.M., Carr,J.K., Wolfe,N.D. and Lewis,M.J.",
HQ336426,02A1,,,Defining new unique recombinant forms of HIV-1 from Rural Cameroon Villagers,"Lwembe,R.M., Carr,J.K., Wolfe,N.D. and Lewis,M.J.",
HQ336427,02F2,,,Defining new unique recombinant forms of HIV-1 from Rural Cameroon Villagers,"Lwembe,R.M., Carr,J.K., Wolfe,N.D. and Lewis,M.J.",
HQ336428,A1G,,,Defining new unique recombinant forms of HIV-1 from Rural Cameroon Villagers,"Lwembe,R.M., Carr,J.K., Wolfe,N.D. and Lewis,M.J.",
HQ336429,A1G,,,Defining new unique recombinant forms of HIV-1 from Rural Cameroon Villagers,"Lwembe,R.M., Carr,J.K., Wolfe,N.D. and Lewis,M.J.",
HQ336430,02_AG,,,Defining new unique recombinant forms of HIV-1 from Rural Cameroon Villagers,"Lwembe,R.M., Carr,J.K., Wolfe,N.D. and Lewis,M.J.",
HQ336432,02A1,,,Defining new unique recombinant forms of HIV-1 from Rural Cameroon Villagers,"Lwembe,R.M., Carr,J.K., Wolfe,N.D. and Lewis,M.J.",
HQ336433,02A1,,,Defining new unique recombinant forms of HIV-1 from Rural Cameroon Villagers,"Lwembe,R.M., Carr,J.K., Wolfe,N.D. and Lewis,M.J.",
HQ336434,02A1,,,Defining new unique recombinant forms of HIV-1 from Rural Cameroon Villagers,"Lwembe,R.M., Carr,J.K., Wolfe,N.D. and Lewis,M.J.",
HQ336435,02A1,,,Defining new unique recombinant forms of HIV-1 from Rural Cameroon Villagers,"Lwembe,R.M., Carr,J.K., Wolfe,N.D. and Lewis,M.J.",
HQ336436,02_AG,,,Defining new unique recombinant forms of HIV-1 from Rural Cameroon Villagers,"Lwembe,R.M., Carr,J.K., Wolfe,N.D. and Lewis,M.J.",
HQ338111,A6,2007,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ338112,A6,2007,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ338113,A6,2007,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ338115,A6,2006,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ338116,A6,2006,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ338117,A6,2006,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ377375,B,2006,21209592,Mapping and Characterization of Vicriviroc Resistance Mutations From Human Immunodeficiency Virus Type-1 Isolated from Treatment-Experienced Subjects Enrolled in a Phase II Study (VICTOR-E1),"McNicholas,P.M., Mann,P.A., Bsc,L.W., Phd,P.Q., Lee,E., McCarthy,M., Shen,J., Black,T.A. and Strizki,J.M.",2011
HQ377411,B,2006,21209592,Mapping and Characterization of Vicriviroc Resistance Mutations From Human Immunodeficiency Virus Type-1 Isolated from Treatment-Experienced Subjects Enrolled in a Phase II Study (VICTOR-E1),"McNicholas,P.M., Mann,P.A., Bsc,L.W., Phd,P.Q., Lee,E., McCarthy,M., Shen,J., Black,T.A. and Strizki,J.M.",2011
HQ377435,B,2006,21209592,Mapping and Characterization of Vicriviroc Resistance Mutations From Human Immunodeficiency Virus Type-1 Isolated from Treatment-Experienced Subjects Enrolled in a Phase II Study (VICTOR-E1),"McNicholas,P.M., Mann,P.A., Bsc,L.W., Phd,P.Q., Lee,E., McCarthy,M., Shen,J., Black,T.A. and Strizki,J.M.",2011
HQ377459,B,2007,21209592,Mapping and Characterization of Vicriviroc Resistance Mutations From Human Immunodeficiency Virus Type-1 Isolated from Treatment-Experienced Subjects Enrolled in a Phase II Study (VICTOR-E1),"McNicholas,P.M., Mann,P.A., Bsc,L.W., Phd,P.Q., Lee,E., McCarthy,M., Shen,J., Black,T.A. and Strizki,J.M.",2011
HQ377483,B,2006,21209592,Mapping and Characterization of Vicriviroc Resistance Mutations From Human Immunodeficiency Virus Type-1 Isolated from Treatment-Experienced Subjects Enrolled in a Phase II Study (VICTOR-E1),"McNicholas,P.M., Mann,P.A., Bsc,L.W., Phd,P.Q., Lee,E., McCarthy,M., Shen,J., Black,T.A. and Strizki,J.M.",2011
HQ385442,D,1999,20932333,"HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form","de Silva,T.I., Turner,R., Hue,S., Trikha,R., van Tienen,C., Onyango,C., Jaye,A., Foley,B., Whittle,H., Rowland-Jones,S.L. and Cotten,M.",2010
HQ385443,49_cpx,1999,20932333,"HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form","de Silva,T.I., Turner,R., Hue,S., Trikha,R., van Tienen,C., Onyango,C., Jaye,A., Foley,B., Whittle,H., Rowland-Jones,S.L. and Cotten,M.",2010
HQ385444,02A1,2000,20932333,"HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form","de Silva,T.I., Turner,R., Hue,S., Trikha,R., van Tienen,C., Onyango,C., Jaye,A., Foley,B., Whittle,H., Rowland-Jones,S.L. and Cotten,M.",2010
HQ385445,0209,2002,20932333,"HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form","de Silva,T.I., Turner,R., Hue,S., Trikha,R., van Tienen,C., Onyango,C., Jaye,A., Foley,B., Whittle,H., Rowland-Jones,S.L. and Cotten,M.",2010
HQ385446,02_AG,2005,20932333,"HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form","de Silva,T.I., Turner,R., Hue,S., Trikha,R., van Tienen,C., Onyango,C., Jaye,A., Foley,B., Whittle,H., Rowland-Jones,S.L. and Cotten,M.",2010
HQ385447,02_AG,2006,20932333,"HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form","de Silva,T.I., Turner,R., Hue,S., Trikha,R., van Tienen,C., Onyango,C., Jaye,A., Foley,B., Whittle,H., Rowland-Jones,S.L. and Cotten,M.",2010
HQ385448,D,1994,20932333,"HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form","de Silva,T.I., Turner,R., Hue,S., Trikha,R., van Tienen,C., Onyango,C., Jaye,A., Foley,B., Whittle,H., Rowland-Jones,S.L. and Cotten,M.",2010
HQ385449,02_AG,1997,20932333,"HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form","de Silva,T.I., Turner,R., Hue,S., Trikha,R., van Tienen,C., Onyango,C., Jaye,A., Foley,B., Whittle,H., Rowland-Jones,S.L. and Cotten,M.",2010
HQ385450,02_AG,2001,20932333,"HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form","de Silva,T.I., Turner,R., Hue,S., Trikha,R., van Tienen,C., Onyango,C., Jaye,A., Foley,B., Whittle,H., Rowland-Jones,S.L. and Cotten,M.",2010
HQ385451,02_AG,2002,20932333,"HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form","de Silva,T.I., Turner,R., Hue,S., Trikha,R., van Tienen,C., Onyango,C., Jaye,A., Foley,B., Whittle,H., Rowland-Jones,S.L. and Cotten,M.",2010
HQ385452,A1,2005,20932333,"HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form","de Silva,T.I., Turner,R., Hue,S., Trikha,R., van Tienen,C., Onyango,C., Jaye,A., Foley,B., Whittle,H., Rowland-Jones,S.L. and Cotten,M.",2010
HQ385453,A1,2009,20932333,"HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form","de Silva,T.I., Turner,R., Hue,S., Trikha,R., van Tienen,C., Onyango,C., Jaye,A., Foley,B., Whittle,H., Rowland-Jones,S.L. and Cotten,M.",2010
HQ385454,02_AG,1999,20932333,"HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form","de Silva,T.I., Turner,R., Hue,S., Trikha,R., van Tienen,C., Onyango,C., Jaye,A., Foley,B., Whittle,H., Rowland-Jones,S.L. and Cotten,M.",2010
HQ385455,02_AG,2009,20932333,"HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form","de Silva,T.I., Turner,R., Hue,S., Trikha,R., van Tienen,C., Onyango,C., Jaye,A., Foley,B., Whittle,H., Rowland-Jones,S.L. and Cotten,M.",2010
HQ385456,B,2009,20932333,"HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form","de Silva,T.I., Turner,R., Hue,S., Trikha,R., van Tienen,C., Onyango,C., Jaye,A., Foley,B., Whittle,H., Rowland-Jones,S.L. and Cotten,M.",2010
HQ385457,02_AG,1994,20932333,"HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form","de Silva,T.I., Turner,R., Hue,S., Trikha,R., van Tienen,C., Onyango,C., Jaye,A., Foley,B., Whittle,H., Rowland-Jones,S.L. and Cotten,M.",2010
HQ385458,C,1999,20932333,"HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form","de Silva,T.I., Turner,R., Hue,S., Trikha,R., van Tienen,C., Onyango,C., Jaye,A., Foley,B., Whittle,H., Rowland-Jones,S.L. and Cotten,M.",2010
HQ385459,A1,2000,20932333,"HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form","de Silva,T.I., Turner,R., Hue,S., Trikha,R., van Tienen,C., Onyango,C., Jaye,A., Foley,B., Whittle,H., Rowland-Jones,S.L. and Cotten,M.",2010
HQ385460,02_AG,2003,20932333,"HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form","de Silva,T.I., Turner,R., Hue,S., Trikha,R., van Tienen,C., Onyango,C., Jaye,A., Foley,B., Whittle,H., Rowland-Jones,S.L. and Cotten,M.",2010
HQ385461,49_cpx,2003,20932333,"HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form","de Silva,T.I., Turner,R., Hue,S., Trikha,R., van Tienen,C., Onyango,C., Jaye,A., Foley,B., Whittle,H., Rowland-Jones,S.L. and Cotten,M.",2010
HQ385462,02_AG,2007,20932333,"HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form","de Silva,T.I., Turner,R., Hue,S., Trikha,R., van Tienen,C., Onyango,C., Jaye,A., Foley,B., Whittle,H., Rowland-Jones,S.L. and Cotten,M.",2010
HQ385463,02_AG,2003,20932333,"HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form","de Silva,T.I., Turner,R., Hue,S., Trikha,R., van Tienen,C., Onyango,C., Jaye,A., Foley,B., Whittle,H., Rowland-Jones,S.L. and Cotten,M.",2010
HQ385464,A1,1994,20932333,"HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form","de Silva,T.I., Turner,R., Hue,S., Trikha,R., van Tienen,C., Onyango,C., Jaye,A., Foley,B., Whittle,H., Rowland-Jones,S.L. and Cotten,M.",2010
HQ385472,A1,2009,20932333,"HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form","de Silva,T.I., Turner,R., Hue,S., Trikha,R., van Tienen,C., Onyango,C., Jaye,A., Foley,B., Whittle,H., Rowland-Jones,S.L. and Cotten,M.",2010
HQ385473,A1,2009,20932333,"HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form","de Silva,T.I., Turner,R., Hue,S., Trikha,R., van Tienen,C., Onyango,C., Jaye,A., Foley,B., Whittle,H., Rowland-Jones,S.L. and Cotten,M.",2010
HQ385474,02_AG,2004,20932333,"HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form","de Silva,T.I., Turner,R., Hue,S., Trikha,R., van Tienen,C., Onyango,C., Jaye,A., Foley,B., Whittle,H., Rowland-Jones,S.L. and Cotten,M.",2010
HQ385475,02_AG,2009,20932333,"HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form","de Silva,T.I., Turner,R., Hue,S., Trikha,R., van Tienen,C., Onyango,C., Jaye,A., Foley,B., Whittle,H., Rowland-Jones,S.L. and Cotten,M.",2010
HQ385476,02_AG,2008,20932333,"HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form","de Silva,T.I., Turner,R., Hue,S., Trikha,R., van Tienen,C., Onyango,C., Jaye,A., Foley,B., Whittle,H., Rowland-Jones,S.L. and Cotten,M.",2010
HQ385477,49_cpx,2002,20932333,"HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form","de Silva,T.I., Turner,R., Hue,S., Trikha,R., van Tienen,C., Onyango,C., Jaye,A., Foley,B., Whittle,H., Rowland-Jones,S.L. and Cotten,M.",2010
HQ385478,49_cpx,1997,20932333,"HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form","de Silva,T.I., Turner,R., Hue,S., Trikha,R., van Tienen,C., Onyango,C., Jaye,A., Foley,B., Whittle,H., Rowland-Jones,S.L. and Cotten,M.",2010
HQ385479,49_cpx,2003,20932333,"HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form","de Silva,T.I., Turner,R., Hue,S., Trikha,R., van Tienen,C., Onyango,C., Jaye,A., Foley,B., Whittle,H., Rowland-Jones,S.L. and Cotten,M.",2010
HQ385811,A6,2007,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ385818,A6,2007,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ385819,A6,2007,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ385820,A6,2007,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ385821,A6,2006,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ385826,A6,2006,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ385830,A6,2006,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ385834,A6,2006,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ385835,A6,2006,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ385837,A6,2006,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ385838,A6,2006,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ385840,A6,2006,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ385841,A6,2006,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ385843,A6,2006,,Direct Submission,"Revilla,A., Delgado,E. and Thomson,M.",2010
HQ386140,B,2003,21760896,Impact of the HIV-1 env Genetic Context outside HR1-HR2 on Resistance to the Fusion Inhibitor Enfuvirtide and Viral Infectivity in Clinical Isolates,"Baatz,F., Nijhuis,M., Lemaire,M., Riedijk,M., Wensing,A.M., Servais,J.Y., van Ham,P.M., Hoepelman,A.I., Koopmans,P.P., Sprenger,H.G., Devaux,C., Schmit,J.C. and Perez Bercoff,D.",2011
HQ386159,B,2002,21760896,Impact of the HIV-1 env Genetic Context outside HR1-HR2 on Resistance to the Fusion Inhibitor Enfuvirtide and Viral Infectivity in Clinical Isolates,"Baatz,F., Nijhuis,M., Lemaire,M., Riedijk,M., Wensing,A.M., Servais,J.Y., van Ham,P.M., Hoepelman,A.I., Koopmans,P.P., Sprenger,H.G., Devaux,C., Schmit,J.C. and Perez Bercoff,D.",2011
HQ386173,B,2002,21760896,Impact of the HIV-1 env Genetic Context outside HR1-HR2 on Resistance to the Fusion Inhibitor Enfuvirtide and Viral Infectivity in Clinical Isolates,"Baatz,F., Nijhuis,M., Lemaire,M., Riedijk,M., Wensing,A.M., Servais,J.Y., van Ham,P.M., Hoepelman,A.I., Koopmans,P.P., Sprenger,H.G., Devaux,C., Schmit,J.C. and Perez Bercoff,D.",2011
HQ386192,B,2003,21760896,Impact of the HIV-1 env Genetic Context outside HR1-HR2 on Resistance to the Fusion Inhibitor Enfuvirtide and Viral Infectivity in Clinical Isolates,"Baatz,F., Nijhuis,M., Lemaire,M., Riedijk,M., Wensing,A.M., Servais,J.Y., van Ham,P.M., Hoepelman,A.I., Koopmans,P.P., Sprenger,H.G., Devaux,C., Schmit,J.C. and Perez Bercoff,D.",2011
HQ386210,B,2002,21760896,Impact of the HIV-1 env Genetic Context outside HR1-HR2 on Resistance to the Fusion Inhibitor Enfuvirtide and Viral Infectivity in Clinical Isolates,"Baatz,F., Nijhuis,M., Lemaire,M., Riedijk,M., Wensing,A.M., Servais,J.Y., van Ham,P.M., Hoepelman,A.I., Koopmans,P.P., Sprenger,H.G., Devaux,C., Schmit,J.C. and Perez Bercoff,D.",2011
HQ453404,BC,2007,22898353,Emergence of a unique recombinant form of HIV-1 from Manipur (India),"Sarkar,R., Sarkar,K., Brajachand Singh,N., Manihar Singh,Y., Mitra,D. and Chakrabarti,S.",2012
HQ540689,A1,2009,,Direct Submission,"Baalwa,J., Sanders,E., Shaw,G. and Hahn,B.",2010
HQ540690,AC,2008,,Direct Submission,"Baalwa,J., Shaw,G. and Hahn,B.",2010
HQ540691,AC,2006,,CAVD/CA-VIMC Southern Africa HIV-1 Env pseudotyped Virus Panel Project,"Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar-Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Ping,L.-H., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ595742,C,2008,22693444,Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin alpha4beta7,"Parrish,N.F., Wilen,C.B., Banks,L.B., Iyer,S.S., Pfaff,J.M., Salazar-Gonzalez,J.F., Salazar,M.G., Decker,J.M., Parrish,E.H., Berg,A., Hopper,J., Hora,B., Kumar,A., Mahlokozera,T., Yuan,S., Coleman,C., Vermeulen,M., Ding,H., Ochsenbauer,C., Tilton,J.C., Permar,S.R., Kappes,J.C., Betts,M.R., Busch,M.P., Gao,F., Montefiori,D., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Doms,R.W.",2012
HQ595743,C,2005,22693444,Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin alpha4beta7,"Parrish,N.F., Wilen,C.B., Banks,L.B., Iyer,S.S., Pfaff,J.M., Salazar-Gonzalez,J.F., Salazar,M.G., Decker,J.M., Parrish,E.H., Berg,A., Hopper,J., Hora,B., Kumar,A., Mahlokozera,T., Yuan,S., Coleman,C., Vermeulen,M., Ding,H., Ochsenbauer,C., Tilton,J.C., Permar,S.R., Kappes,J.C., Betts,M.R., Busch,M.P., Gao,F., Montefiori,D., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Doms,R.W.",2012
HQ595744,C,2006,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Ping,L.H., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ595745,C,2006,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Ping,L.H., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ595746,C,2007,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Ping,L.H., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ595747,C,2008,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Ping,L.H., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ595748,C,2008,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Ping,L.H., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ595749,C,2008,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Ping,L.H., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ595750,C,2008,22693444,Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin alpha4beta7,"Parrish,N.F., Wilen,C.B., Banks,L.B., Iyer,S.S., Pfaff,J.M., Salazar-Gonzalez,J.F., Salazar,M.G., Decker,J.M., Parrish,E.H., Berg,A., Hopper,J., Hora,B., Kumar,A., Mahlokozera,T., Yuan,S., Coleman,C., Vermeulen,M., Ding,H., Ochsenbauer,C., Tilton,J.C., Permar,S.R., Kappes,J.C., Betts,M.R., Busch,M.P., Gao,F., Montefiori,D., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Doms,R.W.",2012
HQ595751,C,2009,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Ping,L.H., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ595752,C,2009,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Ping,L.H., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ595753,C,2009,22693444,Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin alpha4beta7,"Parrish,N.F., Wilen,C.B., Banks,L.B., Iyer,S.S., Pfaff,J.M., Salazar-Gonzalez,J.F., Salazar,M.G., Decker,J.M., Parrish,E.H., Berg,A., Hopper,J., Hora,B., Kumar,A., Mahlokozera,T., Yuan,S., Coleman,C., Vermeulen,M., Ding,H., Ochsenbauer,C., Tilton,J.C., Permar,S.R., Kappes,J.C., Betts,M.R., Busch,M.P., Gao,F., Montefiori,D., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Doms,R.W.",2012
HQ595755,B,2009,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Ping,L.H., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ595756,C,2009,22693444,Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin alpha4beta7,"Parrish,N.F., Wilen,C.B., Banks,L.B., Iyer,S.S., Pfaff,J.M., Salazar-Gonzalez,J.F., Salazar,M.G., Decker,J.M., Parrish,E.H., Berg,A., Hopper,J., Hora,B., Kumar,A., Mahlokozera,T., Yuan,S., Coleman,C., Vermeulen,M., Ding,H., Ochsenbauer,C., Tilton,J.C., Permar,S.R., Kappes,J.C., Betts,M.R., Busch,M.P., Gao,F., Montefiori,D., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Doms,R.W.",2012
HQ595757,C,2006,22693444,Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin alpha4beta7,"Parrish,N.F., Wilen,C.B., Banks,L.B., Iyer,S.S., Pfaff,J.M., Salazar-Gonzalez,J.F., Salazar,M.G., Decker,J.M., Parrish,E.H., Berg,A., Hopper,J., Hora,B., Kumar,A., Mahlokozera,T., Yuan,S., Coleman,C., Vermeulen,M., Ding,H., Ochsenbauer,C., Tilton,J.C., Permar,S.R., Kappes,J.C., Betts,M.R., Busch,M.P., Gao,F., Montefiori,D., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Doms,R.W.",2012
HQ595758,C,2007,22693444,Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin alpha4beta7,"Parrish,N.F., Wilen,C.B., Banks,L.B., Iyer,S.S., Pfaff,J.M., Salazar-Gonzalez,J.F., Salazar,M.G., Decker,J.M., Parrish,E.H., Berg,A., Hopper,J., Hora,B., Kumar,A., Mahlokozera,T., Yuan,S., Coleman,C., Vermeulen,M., Ding,H., Ochsenbauer,C., Tilton,J.C., Permar,S.R., Kappes,J.C., Betts,M.R., Busch,M.P., Gao,F., Montefiori,D., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Doms,R.W.",2012
HQ595759,C,2007,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Ping,L.H., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ595760,C,2009,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Ping,L.H., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ595761,C,2007,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Ping,L.H., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ595762,C,2007,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Ping,L.H., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ595765,C,2009,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Ping,L.H., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ595766,C,2007,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Ping,L.H., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ595767,A1,2008,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595768,B,2008,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595769,B,2009,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595770,B,2009,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595771,B,2008,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595772,B,2008,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595773,AD,2009,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595774,B,2008,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595775,B,2008,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595776,B,2008,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595777,B,2009,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595778,B,2008,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595779,B,2008,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595780,B,2008,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595781,B,2008,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595782,A1,2008,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595783,B,2009,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595784,A1,2008,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595785,B,2008,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595786,B,2009,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595787,C,2008,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595788,B,2008,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595789,C,2008,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595790,B,2008,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595791,D,2008,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595792,B,2008,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595793,AD,2009,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595794,B,2008,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595795,B,2008,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595796,02_AG,2009,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595797,B,2009,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595798,B,2008,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595799,AC,2008,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595800,C,2008,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595801,B,2009,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595802,B,2009,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595803,B,2008,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595804,B,2009,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595805,B,2009,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595806,B,2009,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Salazar,M.G., Salazar Gonzalez,J.F., Ojeda,S. and Anderson,J.A.",
HQ595810,C,2009,21191008,Origin and evolution of HIV-1 in breast milk determined by single-genome amplification and sequencing,"Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Fouda,G.G., Kang,H.H., Mahlokozera,T., Wilks,A.B., Lovingood,R.V., Stacey,A., Kalilani,L., Meshnick,S.R., Borrow,P., Montefiori,D.C., Denny,T.N., Letvin,N.L., Shaw,G.M., Hahn,B.H. and Permar,S.R.",2011
HQ595978,C,2008,21191008,Origin and evolution of HIV-1 in breast milk determined by single-genome amplification and sequencing,"Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Fouda,G.G., Kang,H.H., Mahlokozera,T., Wilks,A.B., Lovingood,R.V., Stacey,A., Kalilani,L., Meshnick,S.R., Borrow,P., Montefiori,D.C., Denny,T.N., Letvin,N.L., Shaw,G.M., Hahn,B.H. and Permar,S.R.",2011
HQ596030,C,2008,21191008,Origin and evolution of HIV-1 in breast milk determined by single-genome amplification and sequencing,"Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Fouda,G.G., Kang,H.H., Mahlokozera,T., Wilks,A.B., Lovingood,R.V., Stacey,A., Kalilani,L., Meshnick,S.R., Borrow,P., Montefiori,D.C., Denny,T.N., Letvin,N.L., Shaw,G.M., Hahn,B.H. and Permar,S.R.",2011
HQ596137,C,2008,21191008,Origin and evolution of HIV-1 in breast milk determined by single-genome amplification and sequencing,"Salazar-Gonzalez,J.F., Salazar,M.G., Learn,G.H., Fouda,G.G., Kang,H.H., Mahlokozera,T., Wilks,A.B., Lovingood,R.V., Stacey,A., Kalilani,L., Meshnick,S.R., Borrow,P., Montefiori,D.C., Denny,T.N., Letvin,N.L., Shaw,G.M., Hahn,B.H. and Permar,S.R.",2011
HQ615941,C,2009,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Ping,L.-H., Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar-Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ615942,C,2007,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Ping,L.-H., Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar-Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ615943,C,2008,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Ping,L.-H., Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar-Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ615944,C,2007,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Ping,L.-H., Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar-Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ615945,C,2007,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Ping,L.-H., Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar-Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ615946,C,2008,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Ping,L.-H., Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar-Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ615947,C,2009,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Ping,L.-H., Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar-Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ615948,C,2005,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Ping,L.-H., Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar-Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ615949,C,2009,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Ping,L.-H., Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar-Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ615950,C,2007,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Ping,L.-H., Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar-Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ615951,C,2006,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Ping,L.-H., Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar-Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ615952,C,2006,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Ping,L.-H., Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar-Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ615953,C,2005,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Ping,L.-H., Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar-Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ615955,C,2007,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Ping,L.-H., Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar-Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ615956,C,2009,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Ping,L.-H., Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar-Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ615957,C,2009,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Ping,L.-H., Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar-Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ615958,C,2005,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Ping,L.-H., Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar-Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ615959,C,2006,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Ping,L.-H., Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar-Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ615960,C,2009,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Ping,L.-H., Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar-Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ615961,C,2009,,CAVD/CA-VIMC Southern Africa HIV-1 Env-pseudotyped Virus Panel Project,"Ping,L.-H., Hahn,B.H., Montefiori,D.C., Williamson,C., Swanstrom,R., Anderson,J.A., Salazar-Gonzalez,J.F., Salazar,M.G., Iyer,S.S., Learn,G.H., Decker,J.M., Kincer,L., Arney,L., Vermeulen,M. and Saville,A.",
HQ616081,A6,2008,,"Construction of a panel of functional HIV-1 envelope clones of subtype A1, Former Soviet Union Variant","Fernandez Garcia,A., Revilla,A., Delgado,E. and Thomson,M.M.",
HQ616082,A6,,,"Construction of a panel of functional HIV-1 envelope clones of subtype A1, Former Soviet Union Variant","Fernandez Garcia,A., Revilla,A., Delgado,E. and Thomson,M.M.",
HQ616083,A6,2008,,"Construction of a panel of functional HIV-1 envelope clones of subtype A1, Former Soviet Union Variant","Fernandez Garcia,A., Revilla,A., Delgado,E. and Thomson,M.M.",
HQ616085,A6,2008,,"Construction of a panel of functional HIV-1 envelope clones of subtype A1, Former Soviet Union Variant","Fernandez Garcia,A., Revilla,A., Delgado,E. and Thomson,M.M.",
HQ616086,02_AG,2008,,"Construction of a panel of functional HIV-1 envelope clones of subtype A1, Former Soviet Union Variant","Fernandez Garcia,A., Revilla,A., Delgado,E. and Thomson,M.M.",
HQ616088,A6,2008,,"Construction of a panel of functional HIV-1 envelope clones of subtype A1, Former Soviet Union Variant","Fernandez Garcia,A., Revilla,A., Delgado,E. and Thomson,M.M.",
HQ616091,A6,2008,,"Construction of a panel of functional HIV-1 envelope clones of subtype A1, Former Soviet Union Variant","Fernandez Garcia,A., Revilla,A., Delgado,E. and Thomson,M.M.",
HQ616093,A6,2008,,"Construction of a panel of functional HIV-1 envelope clones of subtype A1, Former Soviet Union Variant","Fernandez Garcia,A., Revilla,A., Delgado,E. and Thomson,M.M.",
HQ616097,02_AG,2008,,"Construction of a panel of functional HIV-1 envelope clones of subtype A1, Former Soviet Union Variant","Fernandez Garcia,A., Revilla,A., Delgado,E. and Thomson,M.M.",
HQ616100,A6,,,"Construction of a panel of functional HIV-1 envelope clones of subtype A1, Former Soviet Union Variant","Fernandez Garcia,A., Revilla,A., Delgado,E. and Thomson,M.M.",
HQ625569,C,,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Morris,L. and Thebus,R.",
HQ625577,C,,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Morris,L. and Thebus,R.",
HQ625590,C,,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Hahn,B.H., Swanstrom,R., Gao,F., Kim,J., Seaman,M.S., Williamson,C., Montefiori,D.C., Morris,L. and Thebus,R.",
HQ659584,C,2000,21531432,Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms,"Nofemela,A., Bandawe,G., Thebus,R., Marais,J., Wood,N., Hoffmann,O., Maboko,L., Hoelscher,M., Woodman,Z. and Williamson,C.",2011
HQ659593,A1,2000,21531432,Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms,"Nofemela,A., Bandawe,G., Thebus,R., Marais,J., Wood,N., Hoffmann,O., Maboko,L., Hoelscher,M., Woodman,Z. and Williamson,C.",2011
HQ659612,A1CD,2000,21531432,Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms,"Nofemela,A., Bandawe,G., Thebus,R., Marais,J., Wood,N., Hoffmann,O., Maboko,L., Hoelscher,M., Woodman,Z. and Williamson,C.",2011
HQ659623,D,2000,21531432,Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms,"Nofemela,A., Bandawe,G., Thebus,R., Marais,J., Wood,N., Hoffmann,O., Maboko,L., Hoelscher,M., Woodman,Z. and Williamson,C.",2011
HQ659632,CD,2000,21531432,Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms,"Nofemela,A., Bandawe,G., Thebus,R., Marais,J., Wood,N., Hoffmann,O., Maboko,L., Hoelscher,M., Woodman,Z. and Williamson,C.",2011
HQ690964,01_AE,2005,,CAVD CAVIMC Neutralization Serotype Discovery Project,"Sanders-Buell,E., Montefiori,D., Seaman,M., Williamson,C., Hahn,B., Gao,F., Swanstrom,R., Sutthent,R., Permpikul,P., Sullivan,A.O., Lei,E., Kim,J. and Tovanabutra,S.",
HQ690973,01_AE,2007,,CAVD CAVIMC Neutralization Serotype Discovery Project,"Sanders-Buell,E., Montefiori,D., Seaman,M., Williamson,C., Hahn,B., Gao,F., Swanstrom,R., Sutthent,R., Permpikul,P., Sullivan,A.O., Lei,E., Kim,J. and Tovanabutra,S.",
HQ691003,01_AE,2004,,CAVD CAVIMC Neutralization Serotype Discovery Project,"Sanders-Buell,E., Montefiori,D., Seaman,M., Williamson,C., Hahn,B., Gao,F., Swanstrom,R., Sutthent,R., Permpikul,P., Sullivan,A.O., Lei,E., Kim,J. and Tovanabutra,S.",
HQ691004,01_AE,2007,,CAVD CAVIMC Neutralization Serotype Discovery Project,"Sanders-Buell,E., Montefiori,D., Seaman,M., Williamson,C., Hahn,B., Gao,F., Swanstrom,R., Sutthent,R., Permpikul,P., Sullivan,A.O., Lei,E., Kim,J. and Tovanabutra,S.",
HQ691013,01_AE,2004,,CAVD CAVIMC Neutralization Serotype Discovery Project,"Sanders-Buell,E., Montefiori,D., Seaman,M., Williamson,C., Hahn,B., Gao,F., Swanstrom,R., Sutthent,R., Permpikul,P., Sullivan,A.O., Lei,E., Kim,J. and Tovanabutra,S.",
HQ691020,01_AE,2007,,CAVD CAVIMC Neutralization Serotype Discovery Project,"Sanders-Buell,E., Montefiori,D., Seaman,M., Williamson,C., Hahn,B., Gao,F., Swanstrom,R., Sutthent,R., Permpikul,P., Sullivan,A.O., Lei,E., Kim,J. and Tovanabutra,S.",
HQ691028,01_AE,2008,,CAVD CAVIMC Neutralization Serotype Discovery Project,"Sanders-Buell,E., Montefiori,D., Seaman,M., Williamson,C., Hahn,B., Gao,F., Swanstrom,R., Sutthent,R., Permpikul,P., Sullivan,A.O., Lei,E., Kim,J. and Tovanabutra,S.",
HQ691039,01_AE,2007,,CAVD CAVIMC Neutralization Serotype Discovery Project,"Sanders-Buell,E., Montefiori,D., Seaman,M., Williamson,C., Hahn,B., Gao,F., Swanstrom,R., Sutthent,R., Permpikul,P., Sullivan,A.O., Lei,E., Kim,J. and Tovanabutra,S.",
HQ691052,01_AE,2007,,CAVD CAVIMC Neutralization Serotype Discovery Project,"Sanders-Buell,E., Montefiori,D., Seaman,M., Williamson,C., Hahn,B., Gao,F., Swanstrom,R., Sutthent,R., Permpikul,P., Sullivan,A.O., Lei,E., Kim,J. and Tovanabutra,S.",
HQ691073,01_AE,2007,,CAVD CAVIMC Neutralization Serotype Discovery Project,"Sanders-Buell,E., Montefiori,D., Seaman,M., Williamson,C., Hahn,B., Gao,F., Swanstrom,R., Sutthent,R., Permpikul,P., Sullivan,A.O., Lei,E., Kim,J. and Tovanabutra,S.",
HQ691082,01_AE,2006,,CAVD CAVIMC Neutralization Serotype Discovery Project,"Sanders-Buell,E., Montefiori,D., Seaman,M., Williamson,C., Hahn,B., Gao,F., Swanstrom,R., Sutthent,R., Permpikul,P., Sullivan,A.O., Lei,E., Kim,J. and Tovanabutra,S.",
HQ697934,C,2000,21531432,Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms,"Nofemela,A., Bandawe,G., Thebus,R., Marais,J., Wood,N., Hoffmann,O., Maboko,L., Hoelscher,M., Woodman,Z. and Williamson,C.",2011
HQ697983,C,2000,21531432,Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms,"Nofemela,A., Bandawe,G., Thebus,R., Marais,J., Wood,N., Hoffmann,O., Maboko,L., Hoelscher,M., Woodman,Z. and Williamson,C.",2011
HQ698029,A1,2000,21531432,Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms,"Nofemela,A., Bandawe,G., Thebus,R., Marais,J., Wood,N., Hoffmann,O., Maboko,L., Hoelscher,M., Woodman,Z. and Williamson,C.",2011
HQ698034,A1D,2000,21531432,Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms,"Nofemela,A., Bandawe,G., Thebus,R., Marais,J., Wood,N., Hoffmann,O., Maboko,L., Hoelscher,M., Woodman,Z. and Williamson,C.",2011
HQ699949,B,2006,21325278,Genetic and Neutralization Sensitivity of Diverse HIV-1 env Clones from Chronically Infected Patients in China,"Shang,H., Han,X., Shi,X., Zuo,T., Goldin,M., Chen,D., Han,B., Sun,W., Wu,H., Wang,X. and Zhang,L.",2011
HQ699971,08_BC,2007,21325278,Genetic and Neutralization Sensitivity of Diverse HIV-1 env Clones from Chronically Infected Patients in China,"Shang,H., Han,X., Shi,X., Zuo,T., Goldin,M., Chen,D., Han,B., Sun,W., Wu,H., Wang,X. and Zhang,L.",2011
HQ699972,08_BC,2007,21325278,Genetic and Neutralization Sensitivity of Diverse HIV-1 env Clones from Chronically Infected Patients in China,"Shang,H., Han,X., Shi,X., Zuo,T., Goldin,M., Chen,D., Han,B., Sun,W., Wu,H., Wang,X. and Zhang,L.",2011
HQ699974,08_BC,2007,21325278,Genetic and Neutralization Sensitivity of Diverse HIV-1 env Clones from Chronically Infected Patients in China,"Shang,H., Han,X., Shi,X., Zuo,T., Goldin,M., Chen,D., Han,B., Sun,W., Wu,H., Wang,X. and Zhang,L.",2011
HQ699979,B,2004,21325278,Genetic and Neutralization Sensitivity of Diverse HIV-1 env Clones from Chronically Infected Patients in China,"Shang,H., Han,X., Shi,X., Zuo,T., Goldin,M., Chen,D., Han,B., Sun,W., Wu,H., Wang,X. and Zhang,L.",2011
HQ699980,C,2007,21325278,Genetic and Neutralization Sensitivity of Diverse HIV-1 env Clones from Chronically Infected Patients in China,"Shang,H., Han,X., Shi,X., Zuo,T., Goldin,M., Chen,D., Han,B., Sun,W., Wu,H., Wang,X. and Zhang,L.",2011
HQ699981,C,2007,21325278,Genetic and Neutralization Sensitivity of Diverse HIV-1 env Clones from Chronically Infected Patients in China,"Shang,H., Han,X., Shi,X., Zuo,T., Goldin,M., Chen,D., Han,B., Sun,W., Wu,H., Wang,X. and Zhang,L.",2011
HQ699982,07_BC,2007,21325278,Genetic and Neutralization Sensitivity of Diverse HIV-1 env Clones from Chronically Infected Patients in China,"Shang,H., Han,X., Shi,X., Zuo,T., Goldin,M., Chen,D., Han,B., Sun,W., Wu,H., Wang,X. and Zhang,L.",2011
HQ699986,01_AE,2007,21325278,Genetic and Neutralization Sensitivity of Diverse HIV-1 env Clones from Chronically Infected Patients in China,"Shang,H., Han,X., Shi,X., Zuo,T., Goldin,M., Chen,D., Han,B., Sun,W., Wu,H., Wang,X. and Zhang,L.",2011
HQ834965,A6,2008,,"Construction of a panel of functional HIV-1 envelope clones of subtype A1, former Soviet Union variant","Fernandez-Garcia,A., Revilla,A., Elena,D. and Thomson,M.M.",
HQ846900,B,2010,21550842,Sustained elite suppression of replication competent HIV-1 in a patient treated with rituximab based chemotherapy,"Gaillard,S., Dinoso,J.B., Marsh,J.A., Dezern,A.E., O'Connell,K.A., Spivak,A.M., Alwood,K., Durand,C.M., Ambinder,R.F. and Blankson,J.N.",2011
HQ882159,B,1999,21372727,Combined antiretroviral therapy and immune pressure lead to in vivo HIV-1 recombination with ancestral viral genomes,"Buzon,M.J., Wrin,T., Codoner,F.M., Dalmau,J., Phung,P., Bonjoch,A., Coakley,E., Clotet,B. and Martinez-Picado,J.",2011
HQ901998,B,2003,21593147,Longer V1V2 Region with Increased Number of Potential N-Linked Glycosylation Sites in the HIV-1 Envelope Glycoprotein Protects against HIV-Specific Neutralizing Antibodies,"van Gils,M.J., Bunnik,E.M., Boeser-Nunnink,B.D., Burger,J.A., Terlouw-Klein,M., Verwer,N. and Schuitemaker,H.",2011
HQ901999,B,2003,21593147,Longer V1V2 Region with Increased Number of Potential N-Linked Glycosylation Sites in the HIV-1 Envelope Glycoprotein Protects against HIV-Specific Neutralizing Antibodies,"van Gils,M.J., Bunnik,E.M., Boeser-Nunnink,B.D., Burger,J.A., Terlouw-Klein,M., Verwer,N. and Schuitemaker,H.",2011
HQ902000,B,2005,21593147,Longer V1V2 Region with Increased Number of Potential N-Linked Glycosylation Sites in the HIV-1 Envelope Glycoprotein Protects against HIV-Specific Neutralizing Antibodies,"van Gils,M.J., Bunnik,E.M., Boeser-Nunnink,B.D., Burger,J.A., Terlouw-Klein,M., Verwer,N. and Schuitemaker,H.",2011
HQ902001,B,2004,21593147,Longer V1V2 Region with Increased Number of Potential N-Linked Glycosylation Sites in the HIV-1 Envelope Glycoprotein Protects against HIV-Specific Neutralizing Antibodies,"van Gils,M.J., Bunnik,E.M., Boeser-Nunnink,B.D., Burger,J.A., Terlouw-Klein,M., Verwer,N. and Schuitemaker,H.",2011
HQ902002,B,2005,21593147,Longer V1V2 Region with Increased Number of Potential N-Linked Glycosylation Sites in the HIV-1 Envelope Glycoprotein Protects against HIV-Specific Neutralizing Antibodies,"van Gils,M.J., Bunnik,E.M., Boeser-Nunnink,B.D., Burger,J.A., Terlouw-Klein,M., Verwer,N. and Schuitemaker,H.",2011
HQ908109,B,2007,21573003,"Cross-Sectional Detection of Acute HIV Infection: Timing of Transmission, Inflammation and Antiretroviral Therapy","Gay,C., Dibben,O., Anderson,J.A., Stacey,A., Mayo,A.J., Norris,P.J., Kuruc,J.D., Salazar-Gonzalez,J.F., Li,H., Keele,B.F., Hicks,C., Margolis,D., Ferrari,G., Haynes,B., Swanstrom,R., Shaw,G.M., Hahn,B.H., Eron,J.J., Borrow,P. and Cohen,M.S.",2011
HQ908139,B,2007,21573003,"Cross-Sectional Detection of Acute HIV Infection: Timing of Transmission, Inflammation and Antiretroviral Therapy","Gay,C., Dibben,O., Anderson,J.A., Stacey,A., Mayo,A.J., Norris,P.J., Kuruc,J.D., Salazar-Gonzalez,J.F., Li,H., Keele,B.F., Hicks,C., Margolis,D., Ferrari,G., Haynes,B., Swanstrom,R., Shaw,G.M., Hahn,B.H., Eron,J.J., Borrow,P. and Cohen,M.S.",2011
HQ908150,B,2007,21573003,"Cross-Sectional Detection of Acute HIV Infection: Timing of Transmission, Inflammation and Antiretroviral Therapy","Gay,C., Dibben,O., Anderson,J.A., Stacey,A., Mayo,A.J., Norris,P.J., Kuruc,J.D., Salazar-Gonzalez,J.F., Li,H., Keele,B.F., Hicks,C., Margolis,D., Ferrari,G., Haynes,B., Swanstrom,R., Shaw,G.M., Hahn,B.H., Eron,J.J., Borrow,P. and Cohen,M.S.",2011
HQ908184,B,2007,21573003,"Cross-Sectional Detection of Acute HIV Infection: Timing of Transmission, Inflammation and Antiretroviral Therapy","Gay,C., Dibben,O., Anderson,J.A., Stacey,A., Mayo,A.J., Norris,P.J., Kuruc,J.D., Salazar-Gonzalez,J.F., Li,H., Keele,B.F., Hicks,C., Margolis,D., Ferrari,G., Haynes,B., Swanstrom,R., Shaw,G.M., Hahn,B.H., Eron,J.J., Borrow,P. and Cohen,M.S.",2011
HQ908219,B,2008,21573003,"Cross-Sectional Detection of Acute HIV Infection: Timing of Transmission, Inflammation and Antiretroviral Therapy","Gay,C., Dibben,O., Anderson,J.A., Stacey,A., Mayo,A.J., Norris,P.J., Kuruc,J.D., Salazar-Gonzalez,J.F., Li,H., Keele,B.F., Hicks,C., Margolis,D., Ferrari,G., Haynes,B., Swanstrom,R., Shaw,G.M., Hahn,B.H., Eron,J.J., Borrow,P. and Cohen,M.S.",2011
HQ908232,B,2006,21573003,"Cross-Sectional Detection of Acute HIV Infection: Timing of Transmission, Inflammation and Antiretroviral Therapy","Gay,C., Dibben,O., Anderson,J.A., Stacey,A., Mayo,A.J., Norris,P.J., Kuruc,J.D., Salazar-Gonzalez,J.F., Li,H., Keele,B.F., Hicks,C., Margolis,D., Ferrari,G., Haynes,B., Swanstrom,R., Shaw,G.M., Hahn,B.H., Eron,J.J., Borrow,P. and Cohen,M.S.",2011
HQ912706,02_AG,1993,22016769,"Characterization of Neutralizing Profiles in HIV-1 Infected Patients from whom the HJ16, HGN194 and HK20 mAbs were Obtained","Balla-Jhagjhoorsingh,S.S., Willems,B., Heyndrickx,L., Heyndrickx,L., Vereecken,K., Janssens,W., Seaman,M.S., Corti,D., Lanzavecchia,A., Davis,D. and Vanham,G.",2011
HQ912707,02_AG,1992,22016769,"Characterization of Neutralizing Profiles in HIV-1 Infected Patients from whom the HJ16, HGN194 and HK20 mAbs were Obtained","Balla-Jhagjhoorsingh,S.S., Willems,B., Heyndrickx,L., Heyndrickx,L., Vereecken,K., Janssens,W., Seaman,M.S., Corti,D., Lanzavecchia,A., Davis,D. and Vanham,G.",2011
HQ912708,C,1993,22016769,"Characterization of Neutralizing Profiles in HIV-1 Infected Patients from whom the HJ16, HGN194 and HK20 mAbs were Obtained","Balla-Jhagjhoorsingh,S.S., Willems,B., Heyndrickx,L., Heyndrickx,L., Vereecken,K., Janssens,W., Seaman,M.S., Corti,D., Lanzavecchia,A., Davis,D. and Vanham,G.",2011
HQ912709,D,1993,22016769,"Characterization of Neutralizing Profiles in HIV-1 Infected Patients from whom the HJ16, HGN194 and HK20 mAbs were Obtained","Balla-Jhagjhoorsingh,S.S., Willems,B., Heyndrickx,L., Heyndrickx,L., Vereecken,K., Janssens,W., Seaman,M.S., Corti,D., Lanzavecchia,A., Davis,D. and Vanham,G.",2011
HQ912710,02_AG,1993,22016769,"Characterization of Neutralizing Profiles in HIV-1 Infected Patients from whom the HJ16, HGN194 and HK20 mAbs were Obtained","Balla-Jhagjhoorsingh,S.S., Willems,B., Heyndrickx,L., Heyndrickx,L., Vereecken,K., Janssens,W., Seaman,M.S., Corti,D., Lanzavecchia,A., Davis,D. and Vanham,G.",2011
HQ912711,C,1994,22016769,"Characterization of Neutralizing Profiles in HIV-1 Infected Patients from whom the HJ16, HGN194 and HK20 mAbs were Obtained","Balla-Jhagjhoorsingh,S.S., Willems,B., Heyndrickx,L., Heyndrickx,L., Vereecken,K., Janssens,W., Seaman,M.S., Corti,D., Lanzavecchia,A., Davis,D. and Vanham,G.",2011
JF297221,01_AE,2004,,CAVD CAVIMC Neutralization Serotype Discovery Project,"Sanders-Buell,E., Montefiori,D., Seaman,M., Williamson,C., Hahn,B., Gao,F., Swanstrom,R., Sutthent,R., Permpikul,P., Sullivan,A.O., Lei,E., Kim,J. and Tovanabutra,S.",
JF297222,B,2005,,CAVD CAVIMC Neutralization Serotype Discovery Project,"Sanders-Buell,E., Montefiori,D., Seaman,M., Williamson,C., Hahn,B., Gao,F., Swanstrom,R., Sutthent,R., Permpikul,P., Sullivan,A.O., Lei,E., Kim,J. and Tovanabutra,S.",
JF297225,01_AE,2006,,CAVD CAVIMC Neutralization Serotype Discovery Project,"Sanders-Buell,E., Montefiori,D., Seaman,M., Williamson,C., Hahn,B., Gao,F., Swanstrom,R., Sutthent,R., Permpikul,P., Sullivan,A.O., Lei,E., Kim,J. and Tovanabutra,S.",
JF297229,B,2008,,CAVD CAVIMC Neutralization Serotype Discovery Project,"Sanders-Buell,E., Montefiori,D., Seaman,M., Williamson,C., Hahn,B., Gao,F., Swanstrom,R., Sutthent,R., Permpikul,P., Sullivan,A.O., Lei,E., Kim,J. and Tovanabutra,S.",
JF320002,B,2006,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320007,B,2006,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320008,B,2006,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320011,B,2006,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320012,B,2007,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320017,B,2007,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320018,B,2007,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320028,B,2007,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320036,B,2006,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320038,B,2006,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320043,B,2005,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320044,B,2006,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320045,B,2007,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320048,B,2006,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320054,B,2005,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320059,B,2005,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320072,B,2007,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320083,B,2006,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320099,B,2007,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320120,B,2006,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320131,B,2007,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320144,B,2006,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320145,B,2006,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320150,B,2007,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320160,B,2006,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320173,B,2007,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320178,B,2007,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320183,B,2006,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320184,B,2006,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320185,B,2005,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320186,B,2006,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320189,B,2007,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320191,B,2007,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320196,B,2006,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320197,B,2007,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320198,B,2007,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320230,B,2006,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320241,B,2006,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320259,B,2006,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320276,B,2007,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320296,02_AG,2006,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320308,B,2006,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320315,B,2007,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320329,B,2006,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320356,B,2006,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320361,B,2005,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320363,B,2006,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320375,B,2007,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320380,B,2007,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320387,B,2007,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320394,B,2007,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320411,B,2006,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320422,B,2007,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320427,B,2006,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320460,B,2007,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320482,B,2005,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320497,B,2006,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320520,B,2006,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320530,B,2007,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320539,B,2007,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320559,B,2007,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320564,B,2006,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320570,B,2007,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320592,B,2006,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320613,B,2006,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320615,B,2006,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF320630,B,2007,21358627,Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial,"Rolland,M., Tovanabutra,S., deCamp,A.C., Frahm,N., Gilbert,P.B., Sanders-Buell,E., Heath,L., Magaret,C.A., Bose,M., Bradfield,A., O'Sullivan,A., Crossler,J., Jones,T., Nau,M., Wong,K., Zhao,H., Raugi,D.N., Sorensen,S., Stoddard,J.N., Maust,B.S., Deng,W., Hural,J., Dubey,S., Michael,N.L., Shiver,J., Corey,L., Li,F., Self,S.G., Kim,J., Buchbinder,S., Casimiro,D.R., Robertson,M.N., Duerr,A., McElrath,M.J., McCutchan,F.E. and Mullins,J.I.",2011
JF327808,G,2008,,Direct Submission,"Revilla,A., Delgado,E., Fernandez,A. and Thomson,M.",2011
JF340053,01B,2008,21902589,Near Full-Length Sequence Analysis of Two New HIV Type 1 Unique (CRF01_AE/B) Recombinant Forms Among Men Who Have Sex with Men in China,"Wang,W., Meng,Z., Zhou,M., Guo,C., Zhang,F., Xu,J. and Zhang,X.",2012
JF340054,55_01B,2008,21902589,Near Full-Length Sequence Analysis of Two New HIV Type 1 Unique (CRF01_AE/B) Recombinant Forms Among Men Who Have Sex with Men in China,"Wang,W., Meng,Z., Zhou,M., Guo,C., Zhang,F., Xu,J. and Zhang,X.",2012
JF346900,07_BC,2004,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Chen,Y., Gao,F., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",
JF346901,07_BC,2004,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Chen,Y., Gao,F., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",
JF346902,07_BC,2004,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Chen,Y., Gao,F., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",
JF346903,07_BC,2004,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Chen,Y., Gao,F., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",
JF346904,07_BC,2004,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Chen,Y., Gao,F., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",
JF346905,07_BC,2004,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Chen,Y., Gao,F., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",
JF346906,07_BC,2004,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Chen,Y., Gao,F., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",
JF346907,07_BC,2009,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Chen,Y., Gao,F., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",
JF346908,07_BC,2009,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Chen,Y., Gao,F., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",
JF346909,07_BC,2009,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Chen,Y., Gao,F., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",
JF346910,07_BC,2009,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Chen,Y., Gao,F., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",
JF346911,07_BC,2009,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Chen,Y., Gao,F., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",
JF346912,07_BC,2009,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Chen,Y., Gao,F., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",
JF346913,07_BC,2009,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Chen,Y., Gao,F., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",
JF346914,07_BC,2009,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Chen,Y., Gao,F., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",
JF346915,07_BC,2006,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Chen,Y., Gao,F., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",
JF346916,B,2009,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Chen,Y., Gao,F., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",
JF346917,B,2008,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Chen,Y., Gao,F., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",
JF346918,B,2008,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Chen,Y., Gao,F., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",
JF346919,B,2008,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Chen,Y., Gao,F., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",
JF680905,U,2009,,Direct Submission,"Gao,F., Kumar,A., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",2011
JF680906,B,2009,,Direct Submission,"Gao,F., Kumar,A., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",2011
JF680907,B,2009,,Direct Submission,"Gao,F., Kumar,A., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",2011
JF680908,C,2009,,Direct Submission,"Gao,F., Kumar,A., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",2011
JF680909,B,2009,,Direct Submission,"Gao,F., Kumar,A., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",2011
JF680910,B,2009,,Direct Submission,"Gao,F., Kumar,A., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",2011
JF680911,B,2009,,Direct Submission,"Gao,F., Kumar,A., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",2011
JF680912,U,2009,,Direct Submission,"Gao,F., Kumar,A., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",2011
JF680913,B,2009,,Direct Submission,"Gao,F., Kumar,A., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",2011
JF680918,C,2009,,Direct Submission,"Gao,F., Kumar,A., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",2011
JF680919,B,2009,,Direct Submission,"Gao,F., Kumar,A., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",2011
JF680920,B,2009,,Direct Submission,"Gao,F., Kumar,A., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",2011
JF680921,A1,2009,,Direct Submission,"Gao,F., Kumar,A., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",2011
JF680922,A1C,2009,,Direct Submission,"Gao,F., Kumar,A., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",2011
JF680923,B,2009,,Direct Submission,"Gao,F., Kumar,A., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",2011
JF680924,B,2009,,Direct Submission,"Gao,F., Kumar,A., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",2011
JF680925,B,2008,,Direct Submission,"Gao,F., Kumar,A., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",2011
JF680926,D,2009,,Direct Submission,"Gao,F., Kumar,A., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",2011
JF680927,C,2009,,Direct Submission,"Gao,F., Kumar,A., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",2011
JF680928,B,2009,,Direct Submission,"Gao,F., Kumar,A., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",2011
JF680929,B,2009,,Direct Submission,"Gao,F., Kumar,A., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",2011
JF680930,B,2009,,Direct Submission,"Gao,F., Kumar,A., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",2011
JF680931,B,2009,,Direct Submission,"Gao,F., Kumar,A., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",2011
JF680932,01_AE,2009,,Direct Submission,"Gao,F., Kumar,A., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",2011
JF680933,B,2009,,Direct Submission,"Gao,F., Kumar,A., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",2011
JF680934,B,2009,,Direct Submission,"Gao,F., Kumar,A., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",2011
JF680935,C,2009,,Direct Submission,"Gao,F., Kumar,A., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",2011
JF680936,B,2009,,Direct Submission,"Gao,F., Kumar,A., Hahn,B.H., Swanstrom,R., Kim,J., Seaman,M.S., Williamson,C. and Montefiori,D.C.",2011
JF683736,B,2007,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683737,A1,2007,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683738,B,2007,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683739,A1U,2007,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683740,C,2007,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683741,B,2007,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683742,B,2007,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683743,B,2007,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683744,A1F1,2007,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683745,37_cpx,2007,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683746,B,2007,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683747,B,2007,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683748,A1,2007,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683749,B,2007,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683750,B,2007,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683751,B,2007,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683752,02BG,2007,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683753,B,2007,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683754,B,2007,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683755,C,2007,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683756,B,2007,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683757,C,2007,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683758,02_AG,2007,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683759,A1,2007,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683760,A1,2007,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683761,A1,2007,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683762,BF1,2007,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683763,A6,2007,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683764,B,2007,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683765,B,2007,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683766,02D,2008,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683767,A1,2008,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683768,C,2008,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683769,B,2008,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683770,C,2008,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683771,F1,2008,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683772,U,2008,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683773,B,2008,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683774,A1B,2008,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683775,B,2008,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683776,C,2008,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683777,C,2008,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683778,B,2008,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683779,A1,2008,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683780,A6,2008,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683781,B,2008,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683782,A1,2008,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683783,A1,2008,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683784,B,2008,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683785,B,2008,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683786,02_AG,2008,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683787,B,2009,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683788,B,2009,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683789,A1,2009,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683790,B,2009,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683791,B,2009,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683792,02_AG,2009,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683793,B,2009,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683794,B,2009,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683795,02_AG,2009,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683796,B,2009,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683797,B,2009,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683798,A6,2009,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683799,02_AG,2009,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683800,A1B,2009,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683801,B,2009,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683802,11_cpx,2009,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683803,C,2009,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683804,B,2009,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683805,B,2009,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683806,02_AG,2009,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683807,B,2009,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683808,B,2009,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF683809,B,2009,21453134,Molecular Characterization of HIV Type 1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance,"Kousiappa,I., Achilleos,C., Hezka,J., Lazarou,Y., Othonos,K., Demetriades,I. and Kostrikis,L.G.",2011
JF689852,B,2005,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689853,B,2005,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689854,B,2005,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689855,B,2005,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689856,B,2005,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689857,B,2005,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689858,B,2005,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689859,B,2005,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689860,B,2005,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689861,B,2006,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689862,B,2006,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689863,B,2006,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689864,B,2006,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689865,B,2006,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689866,B,2006,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689867,B,2006,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689868,B,2006,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689869,B,2006,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689870,B,2006,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689871,B,2006,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689872,B,2006,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689873,B,2006,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689874,B,2006,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689875,B,2006,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689876,B,2006,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689877,B,2007,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689878,B,2007,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689879,B,2007,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689880,B,2007,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689881,B,2007,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689882,B,2007,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689883,B,2007,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689884,B,2007,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689885,B,2007,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689886,B,2007,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689887,B,2007,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689888,B,2007,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689889,B,2007,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689890,B,2007,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689891,B,2007,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689892,B,2007,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689893,B,2007,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689894,B,2008,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689895,B,2008,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689896,B,2008,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF689897,B,2008,23791226,Elevated hypermutation levels in HIV-1 natural viral suppressors,"Eyzaguirre,L.M., Charurat,M., Redfield,R.R., Blattner,W.A., Carr,J.K. and Sajadi,M.M.",2013
JF706370,B,1991,21471230,Intercompartmental Recombination of HIV-1 Contributes to env Intrahost Diversity and Modulates Viral Tropism and Sensitivity to Entry Inhibitors,"Brown,R.J., Peters,P.J., Caron,C., Gonzalez-Perez,M.P., Stones,L., Ankghuambom,C., Pondei,K., McClure,C.P., Alemnji,G., Taylor,S., Sharp,P.M., Clapham,P.R. and Ball,J.K.",2011
JF706405,02_AG,2005,21471230,Intercompartmental Recombination of HIV-1 Contributes to env Intrahost Diversity and Modulates Viral Tropism and Sensitivity to Entry Inhibitors,"Brown,R.J., Peters,P.J., Caron,C., Gonzalez-Perez,M.P., Stones,L., Ankghuambom,C., Pondei,K., McClure,C.P., Alemnji,G., Taylor,S., Sharp,P.M., Clapham,P.R. and Ball,J.K.",2011
JF706428,02_AG,2005,21471230,Intercompartmental Recombination of HIV-1 Contributes to env Intrahost Diversity and Modulates Viral Tropism and Sensitivity to Entry Inhibitors,"Brown,R.J., Peters,P.J., Caron,C., Gonzalez-Perez,M.P., Stones,L., Ankghuambom,C., Pondei,K., McClure,C.P., Alemnji,G., Taylor,S., Sharp,P.M., Clapham,P.R. and Ball,J.K.",2011
JF706448,U,2006,21471230,Intercompartmental Recombination of HIV-1 Contributes to env Intrahost Diversity and Modulates Viral Tropism and Sensitivity to Entry Inhibitors,"Brown,R.J., Peters,P.J., Caron,C., Gonzalez-Perez,M.P., Stones,L., Ankghuambom,C., Pondei,K., McClure,C.P., Alemnji,G., Taylor,S., Sharp,P.M., Clapham,P.R. and Ball,J.K.",2011
JF706472,B,2007,21471230,Intercompartmental Recombination of HIV-1 Contributes to env Intrahost Diversity and Modulates Viral Tropism and Sensitivity to Entry Inhibitors,"Brown,R.J., Peters,P.J., Caron,C., Gonzalez-Perez,M.P., Stones,L., Ankghuambom,C., Pondei,K., McClure,C.P., Alemnji,G., Taylor,S., Sharp,P.M., Clapham,P.R. and Ball,J.K.",2011
JF719818,08_BC,2007,22363589,Parental LTRs Are Important in a Construct of a Stable and Efficient Replication-Competent Infectious Molecular Clone of HIV-1 CRF08_BC,"Zhang,Q., Zhang,X., Wu,H., Seto,D., Zhang,H.J., Chen,Z., Wan,C. and Zheng,B.J.",2012
JF804805,BF1,2005,22176121,"Characterization of Primary Isolates of HIV Type 1 CRF28_BF, CRF29_BF, and Unique BF Recombinants Circulating in Sao Paulo, Brazil","Melo,F.L., Jamal,L.F. and Zanotto,P.M.",2012
JF804806,29_BF,2005,22176121,"Characterization of Primary Isolates of HIV Type 1 CRF28_BF, CRF29_BF, and Unique BF Recombinants Circulating in Sao Paulo, Brazil","Melo,F.L., Jamal,L.F. and Zanotto,P.M.",2012
JF804807,29_BF,2005,22176121,"Characterization of Primary Isolates of HIV Type 1 CRF28_BF, CRF29_BF, and Unique BF Recombinants Circulating in Sao Paulo, Brazil","Melo,F.L., Jamal,L.F. and Zanotto,P.M.",2012
JF804808,BF1,2005,22176121,"Characterization of Primary Isolates of HIV Type 1 CRF28_BF, CRF29_BF, and Unique BF Recombinants Circulating in Sao Paulo, Brazil","Melo,F.L., Jamal,L.F. and Zanotto,P.M.",2012
JF804809,28_BF,2005,22176121,"Characterization of Primary Isolates of HIV Type 1 CRF28_BF, CRF29_BF, and Unique BF Recombinants Circulating in Sao Paulo, Brazil","Melo,F.L., Jamal,L.F. and Zanotto,P.M.",2012
JF804810,BF1,2005,22176121,"Characterization of Primary Isolates of HIV Type 1 CRF28_BF, CRF29_BF, and Unique BF Recombinants Circulating in Sao Paulo, Brazil","Melo,F.L., Jamal,L.F. and Zanotto,P.M.",2012
JF804811,29_BF,2005,22176121,"Characterization of Primary Isolates of HIV Type 1 CRF28_BF, CRF29_BF, and Unique BF Recombinants Circulating in Sao Paulo, Brazil","Melo,F.L., Jamal,L.F. and Zanotto,P.M.",2012
JF804812,28_BF,2005,22176121,"Characterization of Primary Isolates of HIV Type 1 CRF28_BF, CRF29_BF, and Unique BF Recombinants Circulating in Sao Paulo, Brazil","Melo,F.L., Jamal,L.F. and Zanotto,P.M.",2012
JF804813,BF1,2005,22176121,"Characterization of Primary Isolates of HIV Type 1 CRF28_BF, CRF29_BF, and Unique BF Recombinants Circulating in Sao Paulo, Brazil","Melo,F.L., Jamal,L.F. and Zanotto,P.M.",2012
JF804814,29_BF,2005,22176121,"Characterization of Primary Isolates of HIV Type 1 CRF28_BF, CRF29_BF, and Unique BF Recombinants Circulating in Sao Paulo, Brazil","Melo,F.L., Jamal,L.F. and Zanotto,P.M.",2012
JF910191,B,2003,21561918,"Activity of Broadly Neutralizing Antibodies, Including PG9, PG16, and VRC01, against Recently Transmitted Subtype B HIV-1 Variants from Early and Late in the Epidemic","Euler,Z., Bunnik,E.M., Burger,J.A., Boeser-Nunnink,B.D., Grijsen,M.L., Prins,J.M. and Schuitemaker,H.",2011
JF910199,B,2003,21561918,"Activity of Broadly Neutralizing Antibodies, Including PG9, PG16, and VRC01, against Recently Transmitted Subtype B HIV-1 Variants from Early and Late in the Epidemic","Euler,Z., Bunnik,E.M., Burger,J.A., Boeser-Nunnink,B.D., Grijsen,M.L., Prins,J.M. and Schuitemaker,H.",2011
JF910200,B,2003,21561918,"Activity of Broadly Neutralizing Antibodies, Including PG9, PG16, and VRC01, against Recently Transmitted Subtype B HIV-1 Variants from Early and Late in the Epidemic","Euler,Z., Bunnik,E.M., Burger,J.A., Boeser-Nunnink,B.D., Grijsen,M.L., Prins,J.M. and Schuitemaker,H.",2011
JF910207,B,2004,21561918,"Activity of Broadly Neutralizing Antibodies, Including PG9, PG16, and VRC01, against Recently Transmitted Subtype B HIV-1 Variants from Early and Late in the Epidemic","Euler,Z., Bunnik,E.M., Burger,J.A., Boeser-Nunnink,B.D., Grijsen,M.L., Prins,J.M. and Schuitemaker,H.",2011
JF910215,B,2005,21561918,"Activity of Broadly Neutralizing Antibodies, Including PG9, PG16, and VRC01, against Recently Transmitted Subtype B HIV-1 Variants from Early and Late in the Epidemic","Euler,Z., Bunnik,E.M., Burger,J.A., Boeser-Nunnink,B.D., Grijsen,M.L., Prins,J.M. and Schuitemaker,H.",2011
JF910219,B,2006,21561918,"Activity of Broadly Neutralizing Antibodies, Including PG9, PG16, and VRC01, against Recently Transmitted Subtype B HIV-1 Variants from Early and Late in the Epidemic","Euler,Z., Bunnik,E.M., Burger,J.A., Boeser-Nunnink,B.D., Grijsen,M.L., Prins,J.M. and Schuitemaker,H.",2011
JF910221,B,1986,21561918,"Activity of Broadly Neutralizing Antibodies, Including PG9, PG16, and VRC01, against Recently Transmitted Subtype B HIV-1 Variants from Early and Late in the Epidemic","Euler,Z., Bunnik,E.M., Burger,J.A., Boeser-Nunnink,B.D., Grijsen,M.L., Prins,J.M. and Schuitemaker,H.",2011
JF910228,B,2004,21561918,"Activity of Broadly Neutralizing Antibodies, Including PG9, PG16, and VRC01, against Recently Transmitted Subtype B HIV-1 Variants from Early and Late in the Epidemic","Euler,Z., Bunnik,E.M., Burger,J.A., Boeser-Nunnink,B.D., Grijsen,M.L., Prins,J.M. and Schuitemaker,H.",2011
JF910231,B,2004,21561918,"Activity of Broadly Neutralizing Antibodies, Including PG9, PG16, and VRC01, against Recently Transmitted Subtype B HIV-1 Variants from Early and Late in the Epidemic","Euler,Z., Bunnik,E.M., Burger,J.A., Boeser-Nunnink,B.D., Grijsen,M.L., Prins,J.M. and Schuitemaker,H.",2011
JF910234,B,2004,21561918,"Activity of Broadly Neutralizing Antibodies, Including PG9, PG16, and VRC01, against Recently Transmitted Subtype B HIV-1 Variants from Early and Late in the Epidemic","Euler,Z., Bunnik,E.M., Burger,J.A., Boeser-Nunnink,B.D., Grijsen,M.L., Prins,J.M. and Schuitemaker,H.",2011
JF910235,B,2004,21561918,"Activity of Broadly Neutralizing Antibodies, Including PG9, PG16, and VRC01, against Recently Transmitted Subtype B HIV-1 Variants from Early and Late in the Epidemic","Euler,Z., Bunnik,E.M., Burger,J.A., Boeser-Nunnink,B.D., Grijsen,M.L., Prins,J.M. and Schuitemaker,H.",2011
JF910236,B,2004,21561918,"Activity of Broadly Neutralizing Antibodies, Including PG9, PG16, and VRC01, against Recently Transmitted Subtype B HIV-1 Variants from Early and Late in the Epidemic","Euler,Z., Bunnik,E.M., Burger,J.A., Boeser-Nunnink,B.D., Grijsen,M.L., Prins,J.M. and Schuitemaker,H.",2011
JF910242,B,2004,21561918,"Activity of Broadly Neutralizing Antibodies, Including PG9, PG16, and VRC01, against Recently Transmitted Subtype B HIV-1 Variants from Early and Late in the Epidemic","Euler,Z., Bunnik,E.M., Burger,J.A., Boeser-Nunnink,B.D., Grijsen,M.L., Prins,J.M. and Schuitemaker,H.",2011
JF910254,B,2005,21561918,"Activity of Broadly Neutralizing Antibodies, Including PG9, PG16, and VRC01, against Recently Transmitted Subtype B HIV-1 Variants from Early and Late in the Epidemic","Euler,Z., Bunnik,E.M., Burger,J.A., Boeser-Nunnink,B.D., Grijsen,M.L., Prins,J.M. and Schuitemaker,H.",2011
JF910256,B,2005,21561918,"Activity of Broadly Neutralizing Antibodies, Including PG9, PG16, and VRC01, against Recently Transmitted Subtype B HIV-1 Variants from Early and Late in the Epidemic","Euler,Z., Bunnik,E.M., Burger,J.A., Boeser-Nunnink,B.D., Grijsen,M.L., Prins,J.M. and Schuitemaker,H.",2011
JF910259,B,2005,21561918,"Activity of Broadly Neutralizing Antibodies, Including PG9, PG16, and VRC01, against Recently Transmitted Subtype B HIV-1 Variants from Early and Late in the Epidemic","Euler,Z., Bunnik,E.M., Burger,J.A., Boeser-Nunnink,B.D., Grijsen,M.L., Prins,J.M. and Schuitemaker,H.",2011
JF910265,B,2006,21561918,"Activity of Broadly Neutralizing Antibodies, Including PG9, PG16, and VRC01, against Recently Transmitted Subtype B HIV-1 Variants from Early and Late in the Epidemic","Euler,Z., Bunnik,E.M., Burger,J.A., Boeser-Nunnink,B.D., Grijsen,M.L., Prins,J.M. and Schuitemaker,H.",2011
JF932473,B,2007,22269972,Tracing the origin and history of HIV-1 subtype B' epidemic by near full-length genome analyses,"Li,Z., He,X., Wang,Z., Xing,H., Li,F., Yang,Y., Wang,Q., Takebe,Y. and Shao,Y.",2012
JF932483,B,2007,22269972,Tracing the origin and history of HIV-1 subtype B' epidemic by near full-length genome analyses,"Li,Z., He,X., Wang,Z., Xing,H., Li,F., Yang,Y., Wang,Q., Takebe,Y. and Shao,Y.",2012
JF932484,B,2007,22269972,Tracing the origin and history of HIV-1 subtype B' epidemic by near full-length genome analyses,"Li,Z., He,X., Wang,Z., Xing,H., Li,F., Yang,Y., Wang,Q., Takebe,Y. and Shao,Y.",2012
JF932491,B,2007,22269972,Tracing the origin and history of HIV-1 subtype B' epidemic by near full-length genome analyses,"Li,Z., He,X., Wang,Z., Xing,H., Li,F., Yang,Y., Wang,Q., Takebe,Y. and Shao,Y.",2012
JF932492,B,2003,22269972,Tracing the origin and history of HIV-1 subtype B' epidemic by near full-length genome analyses,"Li,Z., He,X., Wang,Z., Xing,H., Li,F., Yang,Y., Wang,Q., Takebe,Y. and Shao,Y.",2012
JF932493,B,2007,22269972,Tracing the origin and history of HIV-1 subtype B' epidemic by near full-length genome analyses,"Li,Z., He,X., Wang,Z., Xing,H., Li,F., Yang,Y., Wang,Q., Takebe,Y. and Shao,Y.",2012
JF932494,B,2009,22269972,Tracing the origin and history of HIV-1 subtype B' epidemic by near full-length genome analyses,"Li,Z., He,X., Wang,Z., Xing,H., Li,F., Yang,Y., Wang,Q., Takebe,Y. and Shao,Y.",2012
JF932495,B,1998,22269972,Tracing the origin and history of HIV-1 subtype B' epidemic by near full-length genome analyses,"Li,Z., He,X., Wang,Z., Xing,H., Li,F., Yang,Y., Wang,Q., Takebe,Y. and Shao,Y.",2012
JF932496,B,1998,22269972,Tracing the origin and history of HIV-1 subtype B' epidemic by near full-length genome analyses,"Li,Z., He,X., Wang,Z., Xing,H., Li,F., Yang,Y., Wang,Q., Takebe,Y. and Shao,Y.",2012
JF952012,A6,2000,,Direct Submission,"Revilla,A., Fernandez-Garcia,A., Delgado,E. and Thomson,M.",2011
JF952013,A6,2000,,Direct Submission,"Revilla,A., Fernandez-Garcia,A., Delgado,E. and Thomson,M.",2011
JF952014,A6,1999,,Direct Submission,"Revilla,A., Fernandez-Garcia,A., Delgado,E. and Thomson,M.",2011
JF952015,A6,2000,,Direct Submission,"Revilla,A., Fernandez-Garcia,A., Delgado,E. and Thomson,M.",2011
JF952016,A6,1999,,Direct Submission,"Revilla,A., Fernandez-Garcia,A., Delgado,E. and Thomson,M.",2011
JF952017,A6,2006,,Direct Submission,"Revilla,A., Fernandez-Garcia,A., Delgado,E. and Thomson,M.",2011
JN001990,B,,21635737,Conformational alterations in the CD4 binding cavity of HIV-1 gp120 influencing gp120-CD4 interactions and fusogenicity of HIV-1 envelopes derived from brain and other tissues,"Gray,L., Sterjovski,J., Ramsland,P.A., Churchill,M.J. and Gorry,P.R.",2011
JN002008,B,,21635737,Conformational alterations in the CD4 binding cavity of HIV-1 gp120 influencing gp120-CD4 interactions and fusogenicity of HIV-1 envelopes derived from brain and other tissues,"Gray,L., Sterjovski,J., Ramsland,P.A., Churchill,M.J. and Gorry,P.R.",2011
JN024100,B,2004,21593162,Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes,"Herbeck,J.T., Rolland,M., Liu,Y., McLaughlin,S., McNevin,J., Zhao,H., Wong,K., Stoddard,J.N., Raugi,D., Sorensen,S., Genowati,I., Birditt,B., McKay,A., Diem,K., Maust,B.S., Deng,W., Collier,A.C., Stekler,J.D., McElrath,M.J. and Mullins,J.I.",2011
JN024203,B,2004,21593162,Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes,"Herbeck,J.T., Rolland,M., Liu,Y., McLaughlin,S., McNevin,J., Zhao,H., Wong,K., Stoddard,J.N., Raugi,D., Sorensen,S., Genowati,I., Birditt,B., McKay,A., Diem,K., Maust,B.S., Deng,W., Collier,A.C., Stekler,J.D., McElrath,M.J. and Mullins,J.I.",2011
JN024274,B,1995,21593162,Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes,"Herbeck,J.T., Rolland,M., Liu,Y., McLaughlin,S., McNevin,J., Zhao,H., Wong,K., Stoddard,J.N., Raugi,D., Sorensen,S., Genowati,I., Birditt,B., McKay,A., Diem,K., Maust,B.S., Deng,W., Collier,A.C., Stekler,J.D., McElrath,M.J. and Mullins,J.I.",2011
JN024339,B,2005,21593162,Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes,"Herbeck,J.T., Rolland,M., Liu,Y., McLaughlin,S., McNevin,J., Zhao,H., Wong,K., Stoddard,J.N., Raugi,D., Sorensen,S., Genowati,I., Birditt,B., McKay,A., Diem,K., Maust,B.S., Deng,W., Collier,A.C., Stekler,J.D., McElrath,M.J. and Mullins,J.I.",2011
JN024349,B,2005,21593162,Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes,"Herbeck,J.T., Rolland,M., Liu,Y., McLaughlin,S., McNevin,J., Zhao,H., Wong,K., Stoddard,J.N., Raugi,D., Sorensen,S., Genowati,I., Birditt,B., McKay,A., Diem,K., Maust,B.S., Deng,W., Collier,A.C., Stekler,J.D., McElrath,M.J. and Mullins,J.I.",2011
JN024450,B,2005,21593162,Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes,"Herbeck,J.T., Rolland,M., Liu,Y., McLaughlin,S., McNevin,J., Zhao,H., Wong,K., Stoddard,J.N., Raugi,D., Sorensen,S., Genowati,I., Birditt,B., McKay,A., Diem,K., Maust,B.S., Deng,W., Collier,A.C., Stekler,J.D., McElrath,M.J. and Mullins,J.I.",2011
JN024459,B,2005,21593162,Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes,"Herbeck,J.T., Rolland,M., Liu,Y., McLaughlin,S., McNevin,J., Zhao,H., Wong,K., Stoddard,J.N., Raugi,D., Sorensen,S., Genowati,I., Birditt,B., McKay,A., Diem,K., Maust,B.S., Deng,W., Collier,A.C., Stekler,J.D., McElrath,M.J. and Mullins,J.I.",2011
JN024469,B,2005,21593162,Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes,"Herbeck,J.T., Rolland,M., Liu,Y., McLaughlin,S., McNevin,J., Zhao,H., Wong,K., Stoddard,J.N., Raugi,D., Sorensen,S., Genowati,I., Birditt,B., McKay,A., Diem,K., Maust,B.S., Deng,W., Collier,A.C., Stekler,J.D., McElrath,M.J. and Mullins,J.I.",2011
JN029801,51_01B,2011,21902588,Identification of New CRF51_01B in Singapore Using Full Genome Analysis of Three HIV Type 1 Isolates,"Ng,O.T., Eyzaguirre,L.M., Carr,J.K., Chew,K.K., Lin,L., Chua,A., Leo,Y.S., Redd,A.D., Quinn,T.C. and Laeyendecker,O.",2012
JN029802,51_01B,2011,21902588,Identification of New CRF51_01B in Singapore Using Full Genome Analysis of Three HIV Type 1 Isolates,"Ng,O.T., Eyzaguirre,L.M., Carr,J.K., Chew,K.K., Lin,L., Chua,A., Leo,Y.S., Redd,A.D., Quinn,T.C. and Laeyendecker,O.",2012
JN029803,51_01B,2011,21902588,Identification of New CRF51_01B in Singapore Using Full Genome Analysis of Three HIV Type 1 Isolates,"Ng,O.T., Eyzaguirre,L.M., Carr,J.K., Chew,K.K., Lin,L., Chua,A., Leo,Y.S., Redd,A.D., Quinn,T.C. and Laeyendecker,O.",2012
JN034137,B,2001,21887353,In Vivo Emergence of HIV-1 Highly Sensitive to Neutralizing Antibodies,"Aasa-Chapman,M.M., Cheney,K.M., Hue,S., Forsman,A., O'Farrell,S., Pellegrino,P., Williams,I. and McKnight,A.",2011
JN034158,B,2000,21887353,In Vivo Emergence of HIV-1 Highly Sensitive to Neutralizing Antibodies,"Aasa-Chapman,M.M., Cheney,K.M., Hue,S., Forsman,A., O'Farrell,S., Pellegrino,P., Williams,I. and McKnight,A.",2011
JN054257,B,2009,,Molecular clones of HIV-1 env of different genetic forms,"Delgado,E., Revilla,A. and Thomson,M.M.",
JN054258,G,2002,,Molecular clones of HIV-1 env of different genetic forms,"Delgado,E., Revilla,A. and Thomson,M.M.",
JN054260,BG,2006,,Molecular clones of HIV-1 env of different genetic forms,"Delgado,E., Revilla,A. and Thomson,M.M.",
JN054263,A1U,2008,,Molecular clones of HIV-1 env of different genetic forms,"Delgado,E., Revilla,A. and Thomson,M.M.",
JN054265,G,2008,,Molecular clones of HIV-1 env of different genetic forms,"Delgado,E., Revilla,A. and Thomson,M.M.",
JN054269,G,2009,,Molecular clones of HIV-1 env of different genetic forms,"Delgado,E., Revilla,A. and Thomson,M.M.",
JN054273,12_BF,2009,,Molecular clones of HIV-1 env of different genetic forms,"Delgado,E., Revilla,A. and Thomson,M.M.",
JN054274,D,2009,,Molecular clones of HIV-1 env of different genetic forms,"Delgado,E., Revilla,A. and Thomson,M.M.",
JN054279,12_BF,2004,,Molecular clones of HIV-1 env of different genetic forms,"Delgado,E., Revilla,A. and Thomson,M.M.",
JN054280,12_BF,2006,,Molecular clones of HIV-1 env of different genetic forms,"Delgado,E., Revilla,A. and Thomson,M.M.",
JN054285,G,2009,,Molecular clones of HIV-1 env of different genetic forms,"Delgado,E., Revilla,A. and Thomson,M.M.",
JN054287,G,2009,,Molecular clones of HIV-1 env of different genetic forms,"Delgado,E., Revilla,A. and Thomson,M.M.",
JN054289,G,2009,,Molecular clones of HIV-1 env of different genetic forms,"Delgado,E., Revilla,A. and Thomson,M.M.",
JN054296,G,2009,,Molecular clones of HIV-1 env of different genetic forms,"Delgado,E., Revilla,A. and Thomson,M.M.",
JN054300,01_AE,2009,,Molecular clones of HIV-1 env of different genetic forms,"Delgado,E., Revilla,A. and Thomson,M.M.",
JN188292,C,1989,23170185,Construction of a High Titer Infectious HIV-1 Subtype C Proviral Clone from South Africa,"Jacobs,G.B., Bock,S., Schuch,A., Moschall,R., Schrom,E.M., Zahn,J., Reuter,C., Preiser,W., Rethwilm,A., Engelbrecht,S., Kerkau,T. and Bodem,J.",2012
JN230353,63_02A1,2010,22903393,"Genetic characterization of an isolate of HIV type 1 AG recombinant form circulating in Siberia, Russia","Baryshev,P.B., Bogachev,V.V. and Gashnikova,N.M.",2012
JN235952,BF,2000,,Molecular Epidemiology of Human Immunodeficiency Virus Infected Individuals in Uruguay,"Eyzaguirre,L.M., Vinoles,J., Serra,M., Russi,J.C., Montano,S.M., Sanchez,G. and Carr,J.K.",
JN235953,BF,2001,,Molecular Epidemiology of Human Immunodeficiency Virus Infected Individuals in Uruguay,"Eyzaguirre,L.M., Vinoles,J., Serra,M., Russi,J.C., Montano,S.M., Sanchez,G. and Carr,J.K.",
JN235954,BF,2001,,Molecular Epidemiology of Human Immunodeficiency Virus Infected Individuals in Uruguay,"Eyzaguirre,L.M., Vinoles,J., Serra,M., Russi,J.C., Montano,S.M., Sanchez,G. and Carr,J.K.",
JN235955,BF,2001,,Molecular Epidemiology of Human Immunodeficiency Virus Infected Individuals in Uruguay,"Eyzaguirre,L.M., Vinoles,J., Serra,M., Russi,J.C., Montano,S.M., Sanchez,G. and Carr,J.K.",
JN235956,BF,2001,,Molecular Epidemiology of Human Immunodeficiency Virus Infected Individuals in Uruguay,"Eyzaguirre,L.M., Vinoles,J., Serra,M., Russi,J.C., Montano,S.M., Sanchez,G. and Carr,J.K.",
JN235957,BC,2002,,Molecular Epidemiology of Human Immunodeficiency Virus Infected Individuals in Uruguay,"Eyzaguirre,L.M., Vinoles,J., Serra,M., Russi,J.C., Montano,S.M., Sanchez,G. and Carr,J.K.",
JN235958,B,2002,,Molecular Epidemiology of Human Immunodeficiency Virus Infected Individuals in Uruguay,"Eyzaguirre,L.M., Vinoles,J., Serra,M., Russi,J.C., Montano,S.M., Sanchez,G. and Carr,J.K.",
JN235959,B,1999,,Molecular Epidemiology of Human Immunodeficiency Virus Infected Individuals in Uruguay,"Eyzaguirre,L.M., Vinoles,J., Serra,M., Russi,J.C., Montano,S.M., Sanchez,G. and Carr,J.K.",
JN235960,BF,1999,,Molecular Epidemiology of Human Immunodeficiency Virus Infected Individuals in Uruguay,"Eyzaguirre,L.M., Vinoles,J., Serra,M., Russi,J.C., Montano,S.M., Sanchez,G. and Carr,J.K.",
JN235961,B,1999,,Molecular Epidemiology of Human Immunodeficiency Virus Infected Individuals in Uruguay,"Eyzaguirre,L.M., Vinoles,J., Serra,M., Russi,J.C., Montano,S.M., Sanchez,G. and Carr,J.K.",
JN235962,38_BF,1999,,Molecular Epidemiology of Human Immunodeficiency Virus Infected Individuals in Uruguay,"Eyzaguirre,L.M., Vinoles,J., Serra,M., Russi,J.C., Montano,S.M., Sanchez,G. and Carr,J.K.",
JN235963,BF,1999,,Molecular Epidemiology of Human Immunodeficiency Virus Infected Individuals in Uruguay,"Eyzaguirre,L.M., Vinoles,J., Serra,M., Russi,J.C., Montano,S.M., Sanchez,G. and Carr,J.K.",
JN235964,BF,1999,,Molecular Epidemiology of Human Immunodeficiency Virus Infected Individuals in Uruguay,"Eyzaguirre,L.M., Vinoles,J., Serra,M., Russi,J.C., Montano,S.M., Sanchez,G. and Carr,J.K.",
JN235965,B,1999,,Molecular Epidemiology of Human Immunodeficiency Virus Infected Individuals in Uruguay,"Eyzaguirre,L.M., Vinoles,J., Serra,M., Russi,J.C., Montano,S.M., Sanchez,G. and Carr,J.K.",
JN248580,02_AG,2006,22357663,Characterization of Acute HIV-1 Infection in High-Risk Nigerian Populations,"Charurat,M., Nasidi,A., Delaney,K., Saidu,A., Croxton,T., Mondal,P., Aliyu,G.G., Constantine,N., Abimiku,A., Carr,J.K., Vertefeuille,J. and Blattner,W.",2012
JN248581,02_AG,2007,22357663,Characterization of Acute HIV-1 Infection in High-Risk Nigerian Populations,"Charurat,M., Nasidi,A., Delaney,K., Saidu,A., Croxton,T., Mondal,P., Aliyu,G.G., Constantine,N., Abimiku,A., Carr,J.K., Vertefeuille,J. and Blattner,W.",2012
JN248582,G,2008,22357663,Characterization of Acute HIV-1 Infection in High-Risk Nigerian Populations,"Charurat,M., Nasidi,A., Delaney,K., Saidu,A., Croxton,T., Mondal,P., Aliyu,G.G., Constantine,N., Abimiku,A., Carr,J.K., Vertefeuille,J. and Blattner,W.",2012
JN248583,G,2009,22357663,Characterization of Acute HIV-1 Infection in High-Risk Nigerian Populations,"Charurat,M., Nasidi,A., Delaney,K., Saidu,A., Croxton,T., Mondal,P., Aliyu,G.G., Constantine,N., Abimiku,A., Carr,J.K., Vertefeuille,J. and Blattner,W.",2012
JN248584,G,2009,22357663,Characterization of Acute HIV-1 Infection in High-Risk Nigerian Populations,"Charurat,M., Nasidi,A., Delaney,K., Saidu,A., Croxton,T., Mondal,P., Aliyu,G.G., Constantine,N., Abimiku,A., Carr,J.K., Vertefeuille,J. and Blattner,W.",2012
JN248585,02_AG,2009,22357663,Characterization of Acute HIV-1 Infection in High-Risk Nigerian Populations,"Charurat,M., Nasidi,A., Delaney,K., Saidu,A., Croxton,T., Mondal,P., Aliyu,G.G., Constantine,N., Abimiku,A., Carr,J.K., Vertefeuille,J. and Blattner,W.",2012
JN248586,G,2009,22357663,Characterization of Acute HIV-1 Infection in High-Risk Nigerian Populations,"Charurat,M., Nasidi,A., Delaney,K., Saidu,A., Croxton,T., Mondal,P., Aliyu,G.G., Constantine,N., Abimiku,A., Carr,J.K., Vertefeuille,J. and Blattner,W.",2012
JN248587,02A,2009,22357663,Characterization of Acute HIV-1 Infection in High-Risk Nigerian Populations,"Charurat,M., Nasidi,A., Delaney,K., Saidu,A., Croxton,T., Mondal,P., Aliyu,G.G., Constantine,N., Abimiku,A., Carr,J.K., Vertefeuille,J. and Blattner,W.",2012
JN248588,02_AG,2009,22357663,Characterization of Acute HIV-1 Infection in High-Risk Nigerian Populations,"Charurat,M., Nasidi,A., Delaney,K., Saidu,A., Croxton,T., Mondal,P., Aliyu,G.G., Constantine,N., Abimiku,A., Carr,J.K., Vertefeuille,J. and Blattner,W.",2012
JN248589,02_AG,2009,22357663,Characterization of Acute HIV-1 Infection in High-Risk Nigerian Populations,"Charurat,M., Nasidi,A., Delaney,K., Saidu,A., Croxton,T., Mondal,P., Aliyu,G.G., Constantine,N., Abimiku,A., Carr,J.K., Vertefeuille,J. and Blattner,W.",2012
JN248590,02_AG,2009,22357663,Characterization of Acute HIV-1 Infection in High-Risk Nigerian Populations,"Charurat,M., Nasidi,A., Delaney,K., Saidu,A., Croxton,T., Mondal,P., Aliyu,G.G., Constantine,N., Abimiku,A., Carr,J.K., Vertefeuille,J. and Blattner,W.",2012
JN248591,G,2009,22357663,Characterization of Acute HIV-1 Infection in High-Risk Nigerian Populations,"Charurat,M., Nasidi,A., Delaney,K., Saidu,A., Croxton,T., Mondal,P., Aliyu,G.G., Constantine,N., Abimiku,A., Carr,J.K., Vertefeuille,J. and Blattner,W.",2012
JN248592,02_AG,2009,22357663,Characterization of Acute HIV-1 Infection in High-Risk Nigerian Populations,"Charurat,M., Nasidi,A., Delaney,K., Saidu,A., Croxton,T., Mondal,P., Aliyu,G.G., Constantine,N., Abimiku,A., Carr,J.K., Vertefeuille,J. and Blattner,W.",2012
JN248593,G,2009,22357663,Characterization of Acute HIV-1 Infection in High-Risk Nigerian Populations,"Charurat,M., Nasidi,A., Delaney,K., Saidu,A., Croxton,T., Mondal,P., Aliyu,G.G., Constantine,N., Abimiku,A., Carr,J.K., Vertefeuille,J. and Blattner,W.",2012
JN251812,B,2000,21829600,Daily Sampling of an HIV-1 Patient with Slowly Progressing Disease Displays Persistence of Multiple env Subpopulations Consistent with Neutrality,"Skar,H., Gutenkunst,R.N., Wilbe Ramsay,K., Alaeus,A., Albert,J. and Leitner,T.",2011
JN251896,B,2002,,Molecular Epidemiology of Human Immunodeficiency Virus-Infected Individuals in Paraguay,"Eyzaguirre,L.M., Avila,M., Gomez-Carrillo,M., Sanchez,G., Sanchez,J., Montano,S. and Carr,J.K.",
JN251897,BF1,2002,,Molecular Epidemiology of Human Immunodeficiency Virus-Infected Individuals in Paraguay,"Eyzaguirre,L.M., Avila,M., Gomez-Carrillo,M., Sanchez,G., Sanchez,J., Montano,S. and Carr,J.K.",
JN251898,BF1,2002,,Molecular Epidemiology of Human Immunodeficiency Virus-Infected Individuals in Paraguay,"Eyzaguirre,L.M., Avila,M., Gomez-Carrillo,M., Sanchez,G., Sanchez,J., Montano,S. and Carr,J.K.",
JN251899,BF1,2002,,Molecular Epidemiology of Human Immunodeficiency Virus-Infected Individuals in Paraguay,"Eyzaguirre,L.M., Avila,M., Gomez-Carrillo,M., Sanchez,G., Sanchez,J., Montano,S. and Carr,J.K.",
JN251900,BF1,2002,,Molecular Epidemiology of Human Immunodeficiency Virus-Infected Individuals in Paraguay,"Eyzaguirre,L.M., Avila,M., Gomez-Carrillo,M., Sanchez,G., Sanchez,J., Montano,S. and Carr,J.K.",
JN251901,B,2002,,Molecular Epidemiology of Human Immunodeficiency Virus-Infected Individuals in Paraguay,"Eyzaguirre,L.M., Avila,M., Gomez-Carrillo,M., Sanchez,G., Sanchez,J., Montano,S. and Carr,J.K.",
JN251902,BF1,2002,,Molecular Epidemiology of Human Immunodeficiency Virus-Infected Individuals in Paraguay,"Eyzaguirre,L.M., Avila,M., Gomez-Carrillo,M., Sanchez,G., Sanchez,J., Montano,S. and Carr,J.K.",
JN251903,BF1,2002,,Molecular Epidemiology of Human Immunodeficiency Virus-Infected Individuals in Paraguay,"Eyzaguirre,L.M., Avila,M., Gomez-Carrillo,M., Sanchez,G., Sanchez,J., Montano,S. and Carr,J.K.",
JN251904,BF1,2003,,Molecular Epidemiology of Human Immunodeficiency Virus-Infected Individuals in Paraguay,"Eyzaguirre,L.M., Avila,M., Gomez-Carrillo,M., Sanchez,G., Sanchez,J., Montano,S. and Carr,J.K.",
JN251905,BF1,2003,,Molecular Epidemiology of Human Immunodeficiency Virus-Infected Individuals in Paraguay,"Eyzaguirre,L.M., Avila,M., Gomez-Carrillo,M., Sanchez,G., Sanchez,J., Montano,S. and Carr,J.K.",
JN251906,B,2003,,Molecular Epidemiology of Human Immunodeficiency Virus-Infected Individuals in Paraguay,"Eyzaguirre,L.M., Avila,M., Gomez-Carrillo,M., Sanchez,G., Sanchez,J., Montano,S. and Carr,J.K.",
JN388081,01_AE,2008,22073263,Molecular Evolution of HIV-1 CRF01_AE Env in Thai Patients,"Boonchawalit,S., Jullaksorn,D., Uttiyoung,J., Yowang,A., Krathong,N., Chautrakul,S., Yamashita,A., Ikuta,K., Roobsoong,A., Kanitvittaya,S., Sawanpanyalert,P. and Kameoka,M.",2011
JN388091,01_AE,2008,22073263,Molecular Evolution of HIV-1 CRF01_AE Env in Thai Patients,"Boonchawalit,S., Jullaksorn,D., Uttiyoung,J., Yowang,A., Krathong,N., Chautrakul,S., Yamashita,A., Ikuta,K., Roobsoong,A., Kanitvittaya,S., Sawanpanyalert,P. and Kameoka,M.",2011
JN388101,01_AE,2008,22073263,Molecular Evolution of HIV-1 CRF01_AE Env in Thai Patients,"Boonchawalit,S., Jullaksorn,D., Uttiyoung,J., Yowang,A., Krathong,N., Chautrakul,S., Yamashita,A., Ikuta,K., Roobsoong,A., Kanitvittaya,S., Sawanpanyalert,P. and Kameoka,M.",2011
JN388111,01_AE,2008,22073263,Molecular Evolution of HIV-1 CRF01_AE Env in Thai Patients,"Boonchawalit,S., Jullaksorn,D., Uttiyoung,J., Yowang,A., Krathong,N., Chautrakul,S., Yamashita,A., Ikuta,K., Roobsoong,A., Kanitvittaya,S., Sawanpanyalert,P. and Kameoka,M.",2011
JN388121,01_AE,2008,22073263,Molecular Evolution of HIV-1 CRF01_AE Env in Thai Patients,"Boonchawalit,S., Jullaksorn,D., Uttiyoung,J., Yowang,A., Krathong,N., Chautrakul,S., Yamashita,A., Ikuta,K., Roobsoong,A., Kanitvittaya,S., Sawanpanyalert,P. and Kameoka,M.",2011
JN388131,01_AE,2008,22073263,Molecular Evolution of HIV-1 CRF01_AE Env in Thai Patients,"Boonchawalit,S., Jullaksorn,D., Uttiyoung,J., Yowang,A., Krathong,N., Chautrakul,S., Yamashita,A., Ikuta,K., Roobsoong,A., Kanitvittaya,S., Sawanpanyalert,P. and Kameoka,M.",2011
JN388141,01_AE,2008,22073263,Molecular Evolution of HIV-1 CRF01_AE Env in Thai Patients,"Boonchawalit,S., Jullaksorn,D., Uttiyoung,J., Yowang,A., Krathong,N., Chautrakul,S., Yamashita,A., Ikuta,K., Roobsoong,A., Kanitvittaya,S., Sawanpanyalert,P. and Kameoka,M.",2011
JN388151,01_AE,2008,22073263,Molecular Evolution of HIV-1 CRF01_AE Env in Thai Patients,"Boonchawalit,S., Jullaksorn,D., Uttiyoung,J., Yowang,A., Krathong,N., Chautrakul,S., Yamashita,A., Ikuta,K., Roobsoong,A., Kanitvittaya,S., Sawanpanyalert,P. and Kameoka,M.",2011
JN388161,01_AE,2008,22073263,Molecular Evolution of HIV-1 CRF01_AE Env in Thai Patients,"Boonchawalit,S., Jullaksorn,D., Uttiyoung,J., Yowang,A., Krathong,N., Chautrakul,S., Yamashita,A., Ikuta,K., Roobsoong,A., Kanitvittaya,S., Sawanpanyalert,P. and Kameoka,M.",2011
JN388171,01_AE,2008,22073263,Molecular Evolution of HIV-1 CRF01_AE Env in Thai Patients,"Boonchawalit,S., Jullaksorn,D., Uttiyoung,J., Yowang,A., Krathong,N., Chautrakul,S., Yamashita,A., Ikuta,K., Roobsoong,A., Kanitvittaya,S., Sawanpanyalert,P. and Kameoka,M.",2011
JN388181,01_AE,2008,22073263,Molecular Evolution of HIV-1 CRF01_AE Env in Thai Patients,"Boonchawalit,S., Jullaksorn,D., Uttiyoung,J., Yowang,A., Krathong,N., Chautrakul,S., Yamashita,A., Ikuta,K., Roobsoong,A., Kanitvittaya,S., Sawanpanyalert,P. and Kameoka,M.",2011
JN388191,01_AE,2008,22073263,Molecular Evolution of HIV-1 CRF01_AE Env in Thai Patients,"Boonchawalit,S., Jullaksorn,D., Uttiyoung,J., Yowang,A., Krathong,N., Chautrakul,S., Yamashita,A., Ikuta,K., Roobsoong,A., Kanitvittaya,S., Sawanpanyalert,P. and Kameoka,M.",2011
JN388201,01_AE,2008,22073263,Molecular Evolution of HIV-1 CRF01_AE Env in Thai Patients,"Boonchawalit,S., Jullaksorn,D., Uttiyoung,J., Yowang,A., Krathong,N., Chautrakul,S., Yamashita,A., Ikuta,K., Roobsoong,A., Kanitvittaya,S., Sawanpanyalert,P. and Kameoka,M.",2011
JN388211,01_AE,2008,22073263,Molecular Evolution of HIV-1 CRF01_AE Env in Thai Patients,"Boonchawalit,S., Jullaksorn,D., Uttiyoung,J., Yowang,A., Krathong,N., Chautrakul,S., Yamashita,A., Ikuta,K., Roobsoong,A., Kanitvittaya,S., Sawanpanyalert,P. and Kameoka,M.",2011
JN388221,01_AE,2008,22073263,Molecular Evolution of HIV-1 CRF01_AE Env in Thai Patients,"Boonchawalit,S., Jullaksorn,D., Uttiyoung,J., Yowang,A., Krathong,N., Chautrakul,S., Yamashita,A., Ikuta,K., Roobsoong,A., Kanitvittaya,S., Sawanpanyalert,P. and Kameoka,M.",2011
JN397362,B,2011,22395607,Host factors dictate control of viral replication in two HIV-1 controller/chronic progressor transmission pairs,"Buckheit,R.W. 3rd, Allen,T.G., Alme,A., Salgado,M., O'Connell,K.A., Huculak,S., Falade-Nwulia,O., Williams,T.M., Gallant,J.E., Siliciano,R.F. and Blankson,J.N.",2012
JN397363,B,2011,22395607,Host factors dictate control of viral replication in two HIV-1 controller/chronic progressor transmission pairs,"Buckheit,R.W. 3rd, Allen,T.G., Alme,A., Salgado,M., O'Connell,K.A., Huculak,S., Falade-Nwulia,O., Williams,T.M., Gallant,J.E., Siliciano,R.F. and Blankson,J.N.",2012
JN397364,B,2010,22395607,Host factors dictate control of viral replication in two HIV-1 controller/chronic progressor transmission pairs,"Buckheit,R.W. 3rd, Allen,T.G., Alme,A., Salgado,M., O'Connell,K.A., Huculak,S., Falade-Nwulia,O., Williams,T.M., Gallant,J.E., Siliciano,R.F. and Blankson,J.N.",2012
JN397365,B,2010,22395607,Host factors dictate control of viral replication in two HIV-1 controller/chronic progressor transmission pairs,"Buckheit,R.W. 3rd, Allen,T.G., Alme,A., Salgado,M., O'Connell,K.A., Huculak,S., Falade-Nwulia,O., Williams,T.M., Gallant,J.E., Siliciano,R.F. and Blankson,J.N.",2012
JN400529,C,2007,21916806,Characterization of Circulating HIV Type 1 env Genes in Plasma of Two Antiretroviral-Naive Slow Progressing Patients with Broad Neutralizing Antibody Response with Evidence of Recombination,"Mukhopadhyay,S., Ringe,R., Patil,A., Paranjape,R. and Bhattacharya,J.",2012
JN417236,50_A1D,2000,24454702,Novel HIV-1 recombinants spreading across multiple risk groups in the United Kingdom: the identification and phylogeography of Circulating Recombinant Form (CRF) 50_A1D,"Foster,G.M., Ambrose,J.C., Hue,S., Delpech,V.C., Fearnhill,E., Abecasis,A.B., Leigh Brown,A.J. and Geretti,A.M.",2014
JN417237,50_A1D,2003,24454702,Novel HIV-1 recombinants spreading across multiple risk groups in the United Kingdom: the identification and phylogeography of Circulating Recombinant Form (CRF) 50_A1D,"Foster,G.M., Ambrose,J.C., Hue,S., Delpech,V.C., Fearnhill,E., Abecasis,A.B., Leigh Brown,A.J. and Geretti,A.M.",2014
JN417238,A1BD,2003,24454702,Novel HIV-1 recombinants spreading across multiple risk groups in the United Kingdom: the identification and phylogeography of Circulating Recombinant Form (CRF) 50_A1D,"Foster,G.M., Ambrose,J.C., Hue,S., Delpech,V.C., Fearnhill,E., Abecasis,A.B., Leigh Brown,A.J. and Geretti,A.M.",2014
JN417239,50_A1D,2003,24454702,Novel HIV-1 recombinants spreading across multiple risk groups in the United Kingdom: the identification and phylogeography of Circulating Recombinant Form (CRF) 50_A1D,"Foster,G.M., Ambrose,J.C., Hue,S., Delpech,V.C., Fearnhill,E., Abecasis,A.B., Leigh Brown,A.J. and Geretti,A.M.",2014
JN417240,50_A1D,2010,24454702,Novel HIV-1 recombinants spreading across multiple risk groups in the United Kingdom: the identification and phylogeography of Circulating Recombinant Form (CRF) 50_A1D,"Foster,G.M., Ambrose,J.C., Hue,S., Delpech,V.C., Fearnhill,E., Abecasis,A.B., Leigh Brown,A.J. and Geretti,A.M.",2014
JN417241,50_A1D,2010,24454702,Novel HIV-1 recombinants spreading across multiple risk groups in the United Kingdom: the identification and phylogeography of Circulating Recombinant Form (CRF) 50_A1D,"Foster,G.M., Ambrose,J.C., Hue,S., Delpech,V.C., Fearnhill,E., Abecasis,A.B., Leigh Brown,A.J. and Geretti,A.M.",2014
JN562755,B,1997,22007152,HIV-1 Replication in the Central Nervous System Occurs in Two Distinct Cell Types,"Schnell,G., Joseph,S., Spudich,S., Price,R.W. and Swanstrom,R.",2011
JN562759,B,1999,22007152,HIV-1 Replication in the Central Nervous System Occurs in Two Distinct Cell Types,"Schnell,G., Joseph,S., Spudich,S., Price,R.W. and Swanstrom,R.",2011
JN562764,B,2000,22007152,HIV-1 Replication in the Central Nervous System Occurs in Two Distinct Cell Types,"Schnell,G., Joseph,S., Spudich,S., Price,R.W. and Swanstrom,R.",2011
JN562770,B,1997,22007152,HIV-1 replication in the central nervous system occurs in two distinct cell types,"Schnell,G., Joseph,S., Spudich,S., Price,R.W. and Swanstrom,R.",2011
JN562775,B,2004,22007152,HIV-1 replication in the central nervous system occurs in two distinct cell types,"Schnell,G., Joseph,S., Spudich,S., Price,R.W. and Swanstrom,R.",2011
JN562779,B,2006,22007152,HIV-1 replication in the central nervous system occurs in two distinct cell types,"Schnell,G., Joseph,S., Spudich,S., Price,R.W. and Swanstrom,R.",2011
JN562785,B,1997,22007152,HIV-1 replication in the central nervous system occurs in two distinct cell types,"Schnell,G., Joseph,S., Spudich,S., Price,R.W. and Swanstrom,R.",2011
JN562791,B,1997,22007152,HIV-1 replication in the central nervous system occurs in two distinct cell types,"Schnell,G., Joseph,S., Spudich,S., Price,R.W. and Swanstrom,R.",2011
JN562797,B,2004,22007152,HIV-1 replication in the central nervous system occurs in two distinct cell types,"Schnell,G., Joseph,S., Spudich,S., Price,R.W. and Swanstrom,R.",2011
JN562802,B,2002,22007152,HIV-1 replication in the central nervous system occurs in two distinct cell types,"Schnell,G., Joseph,S., Spudich,S., Price,R.W. and Swanstrom,R.",2011
JN571034,O,,24798496,"Long-Term Control of Viral Replication in a Group O, Human Immunodeficiency Virus Type 1-Infected Individual","Buckheit,R.W. III, Sexauer,S.B., Sedaghat,A.R., Wilke,C.O., Laeyendecker,O., Basseth,C.R. and Blankson,J.N.",2014
JN572926,N,,22118443,HIV-1 group N: travelling beyond Cameroon,"Delaugerre,C., De Oliveira,F., Lascoux-Combe,C., Plantier,J.C. and Simon,F.",2011
JN599164,B,2010,22141397,Prolonged control of replication-competent dual tropic human immunodeficiency virus-1 following cessation of highly active antiretroviral therapy,"Salgado,M., Rabi,S.A., O'Connell,K.A., Buckheit,R.W. III, Bailey,J.R., Chaudhry,A.A., Breaud,A.R., Marzinke,M.A., Clarke,W., Margolick,J.B., Siliciano,R.F. and Blankson,J.N.",2011
JN681219,C,2009,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
JN681220,C,2008,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
JN681221,C,2007,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
JN681222,C,2008,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
JN681232,C,2007,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
JN681233,C,2007,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
JN681234,C,2007,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
JN681235,A1,2004,,Direct Submission,"Bandawe,G.",2011
JN681236,C,2007,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
JN681237,C,2008,,Direct Submission,"Bandawe,G.",2011
JN681238,C,2008,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
JN681239,C,2008,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
JN681240,C,2008,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
JN681241,C,2008,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
JN681242,C,2008,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
JN681243,C,2008,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
JN681244,C,2008,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
JN681245,C,2008,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
JN681246,C,2007,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
JN681247,C,2008,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
JN681248,C,2008,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
JN681249,C,2008,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
JN681250,C,2007,,Direct Submission,"Bandawe,G.",2011
JN681251,A1C,2007,,Direct Submission,"Bandawe,G.",2011
JN681252,C,2007,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
JN681253,C,2008,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
JN681254,C,2008,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
JN681255,C,2008,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
JN681256,C,2008,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
JN681257,C,2009,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
JN681258,C,2009,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
JN681259,C,2009,,Direct Submission,"Bandawe,G.",2011
JN687694,C,2007,22149143,Pilot Studies for Development of an HIV Subtype Panel for Surveillance of Global Diversity,"Manak,M., Sina,S., Anekella,B., Hewlett,I., Sanders-Buell,E.E., Ragupathy,V., Kim,J.H., Vermeulen,M., Stramer,S., Sabino,E., Grabarczyk,P., Michael,N.L., Peel,S., Garrett,P.E., Tovanabutra,S., Busch,M. and Schito,M.",2012
JN687704,C,2007,22149143,Pilot Studies for Development of an HIV Subtype Panel for Surveillance of Global Diversity,"Manak,M., Sina,S., Anekella,B., Hewlett,I., Sanders-Buell,E.E., Ragupathy,V., Kim,J.H., Vermeulen,M., Stramer,S., Sabino,E., Grabarczyk,P., Michael,N.L., Peel,S., Garrett,P.E., Tovanabutra,S., Busch,M. and Schito,M.",2012
JN687706,C,2007,22149143,Pilot Studies for Development of an HIV Subtype Panel for Surveillance of Global Diversity,"Manak,M., Sina,S., Anekella,B., Hewlett,I., Sanders-Buell,E.E., Ragupathy,V., Kim,J.H., Vermeulen,M., Stramer,S., Sabino,E., Grabarczyk,P., Michael,N.L., Peel,S., Garrett,P.E., Tovanabutra,S., Busch,M. and Schito,M.",2012
JN687717,C,2007,22149143,Pilot Studies for Development of an HIV Subtype Panel for Surveillance of Global Diversity,"Manak,M., Sina,S., Anekella,B., Hewlett,I., Sanders-Buell,E.E., Ragupathy,V., Kim,J.H., Vermeulen,M., Stramer,S., Sabino,E., Grabarczyk,P., Michael,N.L., Peel,S., Garrett,P.E., Tovanabutra,S., Busch,M. and Schito,M.",2012
JN687718,C,2007,22149143,Pilot Studies for Development of an HIV Subtype Panel for Surveillance of Global Diversity,"Manak,M., Sina,S., Anekella,B., Hewlett,I., Sanders-Buell,E.E., Ragupathy,V., Kim,J.H., Vermeulen,M., Stramer,S., Sabino,E., Grabarczyk,P., Michael,N.L., Peel,S., Garrett,P.E., Tovanabutra,S., Busch,M. and Schito,M.",2012
JN687726,C,2008,22149143,Pilot Studies for Development of an HIV Subtype Panel for Surveillance of Global Diversity,"Manak,M., Sina,S., Anekella,B., Hewlett,I., Sanders-Buell,E.E., Ragupathy,V., Kim,J.H., Vermeulen,M., Stramer,S., Sabino,E., Grabarczyk,P., Michael,N.L., Peel,S., Garrett,P.E., Tovanabutra,S., Busch,M. and Schito,M.",2012
JN687728,C,2008,22149143,Pilot Studies for Development of an HIV Subtype Panel for Surveillance of Global Diversity,"Manak,M., Sina,S., Anekella,B., Hewlett,I., Sanders-Buell,E.E., Ragupathy,V., Kim,J.H., Vermeulen,M., Stramer,S., Sabino,E., Grabarczyk,P., Michael,N.L., Peel,S., Garrett,P.E., Tovanabutra,S., Busch,M. and Schito,M.",2012
JN687730,C,2008,22149143,Pilot Studies for Development of an HIV Subtype Panel for Surveillance of Global Diversity,"Manak,M., Sina,S., Anekella,B., Hewlett,I., Sanders-Buell,E.E., Ragupathy,V., Kim,J.H., Vermeulen,M., Stramer,S., Sabino,E., Grabarczyk,P., Michael,N.L., Peel,S., Garrett,P.E., Tovanabutra,S., Busch,M. and Schito,M.",2012
JN687731,C,2008,22149143,Pilot Studies for Development of an HIV Subtype Panel for Surveillance of Global Diversity,"Manak,M., Sina,S., Anekella,B., Hewlett,I., Sanders-Buell,E.E., Ragupathy,V., Kim,J.H., Vermeulen,M., Stramer,S., Sabino,E., Grabarczyk,P., Michael,N.L., Peel,S., Garrett,P.E., Tovanabutra,S., Busch,M. and Schito,M.",2012
JN687734,C,2008,22149143,Pilot Studies for Development of an HIV Subtype Panel for Surveillance of Global Diversity,"Manak,M., Sina,S., Anekella,B., Hewlett,I., Sanders-Buell,E.E., Ragupathy,V., Kim,J.H., Vermeulen,M., Stramer,S., Sabino,E., Grabarczyk,P., Michael,N.L., Peel,S., Garrett,P.E., Tovanabutra,S., Busch,M. and Schito,M.",2012
JN687735,C,2007,22149143,Pilot Studies for Development of an HIV Subtype Panel for Surveillance of Global Diversity,"Manak,M., Sina,S., Anekella,B., Hewlett,I., Sanders-Buell,E.E., Ragupathy,V., Kim,J.H., Vermeulen,M., Stramer,S., Sabino,E., Grabarczyk,P., Michael,N.L., Peel,S., Garrett,P.E., Tovanabutra,S., Busch,M. and Schito,M.",2012
JN687736,C,2007,22149143,Pilot Studies for Development of an HIV Subtype Panel for Surveillance of Global Diversity,"Manak,M., Sina,S., Anekella,B., Hewlett,I., Sanders-Buell,E.E., Ragupathy,V., Kim,J.H., Vermeulen,M., Stramer,S., Sabino,E., Grabarczyk,P., Michael,N.L., Peel,S., Garrett,P.E., Tovanabutra,S., Busch,M. and Schito,M.",2012
JN687737,C,2007,22149143,Pilot Studies for Development of an HIV Subtype Panel for Surveillance of Global Diversity,"Manak,M., Sina,S., Anekella,B., Hewlett,I., Sanders-Buell,E.E., Ragupathy,V., Kim,J.H., Vermeulen,M., Stramer,S., Sabino,E., Grabarczyk,P., Michael,N.L., Peel,S., Garrett,P.E., Tovanabutra,S., Busch,M. and Schito,M.",2012
JN687738,BF,2007,22149143,Pilot Studies for Development of an HIV Subtype Panel for Surveillance of Global Diversity,"Manak,M., Sina,S., Anekella,B., Hewlett,I., Sanders-Buell,E.E., Ragupathy,V., Kim,J.H., Vermeulen,M., Stramer,S., Sabino,E., Grabarczyk,P., Michael,N.L., Peel,S., Garrett,P.E., Tovanabutra,S., Busch,M. and Schito,M.",2012
JN687739,B,2007,22149143,Pilot Studies for Development of an HIV Subtype Panel for Surveillance of Global Diversity,"Manak,M., Sina,S., Anekella,B., Hewlett,I., Sanders-Buell,E.E., Ragupathy,V., Kim,J.H., Vermeulen,M., Stramer,S., Sabino,E., Grabarczyk,P., Michael,N.L., Peel,S., Garrett,P.E., Tovanabutra,S., Busch,M. and Schito,M.",2012
JN687742,04_cpx,2000,22149143,Pilot Studies for Development of an HIV Subtype Panel for Surveillance of Global Diversity,"Manak,M., Sina,S., Anekella,B., Hewlett,I., Sanders-Buell,E.E., Ragupathy,V., Kim,J.H., Vermeulen,M., Stramer,S., Sabino,E., Grabarczyk,P., Michael,N.L., Peel,S., Garrett,P.E., Tovanabutra,S., Busch,M. and Schito,M.",2012
JN687744,04_cpx,2000,22149143,Pilot Studies for Development of an HIV Subtype Panel for Surveillance of Global Diversity,"Manak,M., Sina,S., Anekella,B., Hewlett,I., Sanders-Buell,E.E., Ragupathy,V., Kim,J.H., Vermeulen,M., Stramer,S., Sabino,E., Grabarczyk,P., Michael,N.L., Peel,S., Garrett,P.E., Tovanabutra,S., Busch,M. and Schito,M.",2012
JN687746,04_cpx,2004,22149143,Pilot Studies for Development of an HIV Subtype Panel for Surveillance of Global Diversity,"Manak,M., Sina,S., Anekella,B., Hewlett,I., Sanders-Buell,E.E., Ragupathy,V., Kim,J.H., Vermeulen,M., Stramer,S., Sabino,E., Grabarczyk,P., Michael,N.L., Peel,S., Garrett,P.E., Tovanabutra,S., Busch,M. and Schito,M.",2012
JN687748,04_cpx,2004,22149143,Pilot Studies for Development of an HIV Subtype Panel for Surveillance of Global Diversity,"Manak,M., Sina,S., Anekella,B., Hewlett,I., Sanders-Buell,E.E., Ragupathy,V., Kim,J.H., Vermeulen,M., Stramer,S., Sabino,E., Grabarczyk,P., Michael,N.L., Peel,S., Garrett,P.E., Tovanabutra,S., Busch,M. and Schito,M.",2012
JN687749,B,2006,22149143,Pilot Studies for Development of an HIV Subtype Panel for Surveillance of Global Diversity,"Manak,M., Sina,S., Anekella,B., Hewlett,I., Sanders-Buell,E.E., Ragupathy,V., Kim,J.H., Vermeulen,M., Stramer,S., Sabino,E., Grabarczyk,P., Michael,N.L., Peel,S., Garrett,P.E., Tovanabutra,S., Busch,M. and Schito,M.",2012
JN687750,B,2006,22149143,Pilot Studies for Development of an HIV Subtype Panel for Surveillance of Global Diversity,"Manak,M., Sina,S., Anekella,B., Hewlett,I., Sanders-Buell,E.E., Ragupathy,V., Kim,J.H., Vermeulen,M., Stramer,S., Sabino,E., Grabarczyk,P., Michael,N.L., Peel,S., Garrett,P.E., Tovanabutra,S., Busch,M. and Schito,M.",2012
JN687758,B,2006,22149143,Pilot Studies for Development of an HIV Subtype Panel for Surveillance of Global Diversity,"Manak,M., Sina,S., Anekella,B., Hewlett,I., Sanders-Buell,E.E., Ragupathy,V., Kim,J.H., Vermeulen,M., Stramer,S., Sabino,E., Grabarczyk,P., Michael,N.L., Peel,S., Garrett,P.E., Tovanabutra,S., Busch,M. and Schito,M.",2012
JN687759,B,2007,22149143,Pilot Studies for Development of an HIV Subtype Panel for Surveillance of Global Diversity,"Manak,M., Sina,S., Anekella,B., Hewlett,I., Sanders-Buell,E.E., Ragupathy,V., Kim,J.H., Vermeulen,M., Stramer,S., Sabino,E., Grabarczyk,P., Michael,N.L., Peel,S., Garrett,P.E., Tovanabutra,S., Busch,M. and Schito,M.",2012
JN687760,B,2008,22149143,Pilot Studies for Development of an HIV Subtype Panel for Surveillance of Global Diversity,"Manak,M., Sina,S., Anekella,B., Hewlett,I., Sanders-Buell,E.E., Ragupathy,V., Kim,J.H., Vermeulen,M., Stramer,S., Sabino,E., Grabarczyk,P., Michael,N.L., Peel,S., Garrett,P.E., Tovanabutra,S., Busch,M. and Schito,M.",2012
JN687761,B,2007,22149143,Pilot Studies for Development of an HIV Subtype Panel for Surveillance of Global Diversity,"Manak,M., Sina,S., Anekella,B., Hewlett,I., Sanders-Buell,E.E., Ragupathy,V., Kim,J.H., Vermeulen,M., Stramer,S., Sabino,E., Grabarczyk,P., Michael,N.L., Peel,S., Garrett,P.E., Tovanabutra,S., Busch,M. and Schito,M.",2012
JN687762,B,2007,22149143,Pilot Studies for Development of an HIV Subtype Panel for Surveillance of Global Diversity,"Manak,M., Sina,S., Anekella,B., Hewlett,I., Sanders-Buell,E.E., Ragupathy,V., Kim,J.H., Vermeulen,M., Stramer,S., Sabino,E., Grabarczyk,P., Michael,N.L., Peel,S., Garrett,P.E., Tovanabutra,S., Busch,M. and Schito,M.",2012
JN687763,B,2007,22149143,Pilot Studies for Development of an HIV Subtype Panel for Surveillance of Global Diversity,"Manak,M., Sina,S., Anekella,B., Hewlett,I., Sanders-Buell,E.E., Ragupathy,V., Kim,J.H., Vermeulen,M., Stramer,S., Sabino,E., Grabarczyk,P., Michael,N.L., Peel,S., Garrett,P.E., Tovanabutra,S., Busch,M. and Schito,M.",2012
JN687773,B,2008,22149143,Pilot Studies for Development of an HIV Subtype Panel for Surveillance of Global Diversity,"Manak,M., Sina,S., Anekella,B., Hewlett,I., Sanders-Buell,E.E., Ragupathy,V., Kim,J.H., Vermeulen,M., Stramer,S., Sabino,E., Grabarczyk,P., Michael,N.L., Peel,S., Garrett,P.E., Tovanabutra,S., Busch,M. and Schito,M.",2012
JN687774,B,2008,22149143,Pilot Studies for Development of an HIV Subtype Panel for Surveillance of Global Diversity,"Manak,M., Sina,S., Anekella,B., Hewlett,I., Sanders-Buell,E.E., Ragupathy,V., Kim,J.H., Vermeulen,M., Stramer,S., Sabino,E., Grabarczyk,P., Michael,N.L., Peel,S., Garrett,P.E., Tovanabutra,S., Busch,M. and Schito,M.",2012
JN687775,02_AG,,22149143,Pilot Studies for Development of an HIV Subtype Panel for Surveillance of Global Diversity,"Manak,M., Sina,S., Anekella,B., Hewlett,I., Sanders-Buell,E.E., Ragupathy,V., Kim,J.H., Vermeulen,M., Stramer,S., Sabino,E., Grabarczyk,P., Michael,N.L., Peel,S., Garrett,P.E., Tovanabutra,S., Busch,M. and Schito,M.",2012
JN687776,02_AG,2008,22149143,Pilot Studies for Development of an HIV Subtype Panel for Surveillance of Global Diversity,"Manak,M., Sina,S., Anekella,B., Hewlett,I., Sanders-Buell,E.E., Ragupathy,V., Kim,J.H., Vermeulen,M., Stramer,S., Sabino,E., Grabarczyk,P., Michael,N.L., Peel,S., Garrett,P.E., Tovanabutra,S., Busch,M. and Schito,M.",2012
JN687821,C,2006,22149143,Pilot Studies for Development of an HIV Subtype Panel for Surveillance of Global Diversity,"Manak,M., Sina,S., Anekella,B., Hewlett,I., Sanders-Buell,E.E., Ragupathy,V., Kim,J.H., Vermeulen,M., Stramer,S., Sabino,E., Grabarczyk,P., Michael,N.L., Peel,S., Garrett,P.E., Tovanabutra,S., Busch,M. and Schito,M.",2012
JN692431,B,2002,22022460,"Characterization of Partial and Near Full-Length Genomes of HIV-1 Strains Sampled from Recently Infected Individuals in Sao Paulo, Brazil","Sanabani,S.S., Pastena,E.R., da Costa,A.C., Martinez,V.P., Kleine-Neto,W., de Oliveira,A.C., Sauer,M.M., Bassichetto,K.C., Oliveira,S.M., Tomiyama,H.T., Sabino,E.C. and Kallas,E.G.",2011
JN692445,B,2003,22022460,"Characterization of Partial and Near Full-Length Genomes of HIV-1 Strains Sampled from Recently Infected Individuals in Sao Paulo, Brazil","Sanabani,S.S., Pastena,E.R., da Costa,A.C., Martinez,V.P., Kleine-Neto,W., de Oliveira,A.C., Sauer,M.M., Bassichetto,K.C., Oliveira,S.M., Tomiyama,H.T., Sabino,E.C. and Kallas,E.G.",2011
JN692449,BF1,2003,22022460,"Characterization of Partial and Near Full-Length Genomes of HIV-1 Strains Sampled from Recently Infected Individuals in Sao Paulo, Brazil","Sanabani,S.S., Pastena,E.R., da Costa,A.C., Martinez,V.P., Kleine-Neto,W., de Oliveira,A.C., Sauer,M.M., Bassichetto,K.C., Oliveira,S.M., Tomiyama,H.T., Sabino,E.C. and Kallas,E.G.",2011
JN692456,BF1,2004,22022460,"Characterization of Partial and Near Full-Length Genomes of HIV-1 Strains Sampled from Recently Infected Individuals in Sao Paulo, Brazil","Sanabani,S.S., Pastena,E.R., da Costa,A.C., Martinez,V.P., Kleine-Neto,W., de Oliveira,A.C., Sauer,M.M., Bassichetto,K.C., Oliveira,S.M., Tomiyama,H.T., Sabino,E.C. and Kallas,E.G.",2011
JN692460,B,2005,22022460,"Characterization of Partial and Near Full-Length Genomes of HIV-1 Strains Sampled from Recently Infected Individuals in Sao Paulo, Brazil","Sanabani,S.S., Pastena,E.R., da Costa,A.C., Martinez,V.P., Kleine-Neto,W., de Oliveira,A.C., Sauer,M.M., Bassichetto,K.C., Oliveira,S.M., Tomiyama,H.T., Sabino,E.C. and Kallas,E.G.",2011
JN692475,B,2005,22022460,"Characterization of Partial and Near Full-Length Genomes of HIV-1 Strains Sampled from Recently Infected Individuals in Sao Paulo, Brazil","Sanabani,S.S., Pastena,E.R., da Costa,A.C., Martinez,V.P., Kleine-Neto,W., de Oliveira,A.C., Sauer,M.M., Bassichetto,K.C., Oliveira,S.M., Tomiyama,H.T., Sabino,E.C. and Kallas,E.G.",2011
JN786724,B,1999,22420378,Independent evolution of macrophage-tropism and increased charge between HIV-1 R5 envelopes present in brain and immune tissue,"Gonzalez-Perez,M.P., O'Connell,O.J., Lin,R., Sullivan,W.M., Bell,J., Simmonds,P. and Clapham,P.R.",2012
JN786767,B,1999,22420378,Independent evolution of macrophage-tropism and increased charge between HIV-1 R5 envelopes present in brain and immune tissue,"Gonzalez-Perez,M.P., O'Connell,O.J., Lin,R., Sullivan,W.M., Bell,J., Simmonds,P. and Clapham,P.R.",2012
JN786795,B,1999,22420378,Independent evolution of macrophage-tropism and increased charge between HIV-1 R5 envelopes present in brain and immune tissue,"Gonzalez-Perez,M.P., O'Connell,O.J., Lin,R., Sullivan,W.M., Bell,J., Simmonds,P. and Clapham,P.R.",2012
JN860761,01_AE,2007,22587412,Two Unique Recombinant Forms Identified in Incident HIV Type 1 Infections in Thai Blood Donors,"Rutvisuttinunt,W., Sirivichayakul,S., Oota,S., Assawadarachai,V., Poltavee,K., Savadsuk,H., Pattanachaiwit,S., Chaemchuen,S., Arroyo,M.A., Paris,R.M., Michael,N.L., Kim,J.H., Ruxrungtham,K., de Souza,M., Phanuphak,P. and Tovanabutra,S.",2012
JN860762,01B,2007,22587412,Two Unique Recombinant Forms Identified in Incident HIV Type 1 Infections in Thai Blood Donors,"Rutvisuttinunt,W., Sirivichayakul,S., Oota,S., Assawadarachai,V., Poltavee,K., Savadsuk,H., Pattanachaiwit,S., Chaemchuen,S., Arroyo,M.A., Paris,R.M., Michael,N.L., Kim,J.H., Ruxrungtham,K., de Souza,M., Phanuphak,P. and Tovanabutra,S.",2012
JN860763,01_AE,2007,22587412,Two Unique Recombinant Forms Identified in Incident HIV Type 1 Infections in Thai Blood Donors,"Rutvisuttinunt,W., Sirivichayakul,S., Oota,S., Assawadarachai,V., Poltavee,K., Savadsuk,H., Pattanachaiwit,S., Chaemchuen,S., Arroyo,M.A., Paris,R.M., Michael,N.L., Kim,J.H., Ruxrungtham,K., de Souza,M., Phanuphak,P. and Tovanabutra,S.",2012
JN860764,01_AE,2007,22587412,Two Unique Recombinant Forms Identified in Incident HIV Type 1 Infections in Thai Blood Donors,"Rutvisuttinunt,W., Sirivichayakul,S., Oota,S., Assawadarachai,V., Poltavee,K., Savadsuk,H., Pattanachaiwit,S., Chaemchuen,S., Arroyo,M.A., Paris,R.M., Michael,N.L., Kim,J.H., Ruxrungtham,K., de Souza,M., Phanuphak,P. and Tovanabutra,S.",2012
JN860765,01B,2007,22587412,Two Unique Recombinant Forms Identified in Incident HIV Type 1 Infections in Thai Blood Donors,"Rutvisuttinunt,W., Sirivichayakul,S., Oota,S., Assawadarachai,V., Poltavee,K., Savadsuk,H., Pattanachaiwit,S., Chaemchuen,S., Arroyo,M.A., Paris,R.M., Michael,N.L., Kim,J.H., Ruxrungtham,K., de Souza,M., Phanuphak,P. and Tovanabutra,S.",2012
JN860766,01_AE,2007,22587412,Two Unique Recombinant Forms Identified in Incident HIV Type 1 Infections in Thai Blood Donors,"Rutvisuttinunt,W., Sirivichayakul,S., Oota,S., Assawadarachai,V., Poltavee,K., Savadsuk,H., Pattanachaiwit,S., Chaemchuen,S., Arroyo,M.A., Paris,R.M., Michael,N.L., Kim,J.H., Ruxrungtham,K., de Souza,M., Phanuphak,P. and Tovanabutra,S.",2012
JN860767,01_AE,2007,22587412,Two Unique Recombinant Forms Identified in Incident HIV Type 1 Infections in Thai Blood Donors,"Rutvisuttinunt,W., Sirivichayakul,S., Oota,S., Assawadarachai,V., Poltavee,K., Savadsuk,H., Pattanachaiwit,S., Chaemchuen,S., Arroyo,M.A., Paris,R.M., Michael,N.L., Kim,J.H., Ruxrungtham,K., de Souza,M., Phanuphak,P. and Tovanabutra,S.",2012
JN860768,01_AE,2008,22587412,Two Unique Recombinant Forms Identified in Incident HIV Type 1 Infections in Thai Blood Donors,"Rutvisuttinunt,W., Sirivichayakul,S., Oota,S., Assawadarachai,V., Poltavee,K., Savadsuk,H., Pattanachaiwit,S., Chaemchuen,S., Arroyo,M.A., Paris,R.M., Michael,N.L., Kim,J.H., Ruxrungtham,K., de Souza,M., Phanuphak,P. and Tovanabutra,S.",2012
JN860769,B,2008,22587412,Two Unique Recombinant Forms Identified in Incident HIV Type 1 Infections in Thai Blood Donors,"Rutvisuttinunt,W., Sirivichayakul,S., Oota,S., Assawadarachai,V., Poltavee,K., Savadsuk,H., Pattanachaiwit,S., Chaemchuen,S., Arroyo,M.A., Paris,R.M., Michael,N.L., Kim,J.H., Ruxrungtham,K., de Souza,M., Phanuphak,P. and Tovanabutra,S.",2012
JN864047,0222,2006,22549382,CRF22_01A1 is Involved in the Emergence of New HIV-1 Recombinants in Cameroon,"Zhao,J., Tang,S., Ragupathy,V., Gaddam,D., Wang,X., Zhang,P., Nyambi,P.N. and Hewlett,I.",2012
JN864048,0222,2006,22549382,CRF22_01A1 is Involved in the Emergence of New HIV-1 Recombinants in Cameroon,"Zhao,J., Tang,S., Ragupathy,V., Gaddam,D., Wang,X., Zhang,P., Nyambi,P.N. and Hewlett,I.",2012
JN864049,22_01A1,2006,22549382,CRF22_01A1 is Involved in the Emergence of New HIV-1 Recombinants in Cameroon,"Zhao,J., Tang,S., Ragupathy,V., Gaddam,D., Wang,X., Zhang,P., Nyambi,P.N. and Hewlett,I.",2012
JN864050,22_01A1,2010,22549382,CRF22_01A1 is Involved in the Emergence of New HIV-1 Recombinants in Cameroon,"Zhao,J., Tang,S., Ragupathy,V., Gaddam,D., Wang,X., Zhang,P., Nyambi,P.N. and Hewlett,I.",2012
JN864051,22_01A1,2010,22549382,CRF22_01A1 is Involved in the Emergence of New HIV-1 Recombinants in Cameroon,"Zhao,J., Tang,S., Ragupathy,V., Gaddam,D., Wang,X., Zhang,P., Nyambi,P.N. and Hewlett,I.",2012
JN864052,0222,2008,22549382,CRF22_01A1 is Involved in the Emergence of New HIV-1 Recombinants in Cameroon,"Zhao,J., Tang,S., Ragupathy,V., Gaddam,D., Wang,X., Zhang,P., Nyambi,P.N. and Hewlett,I.",2012
JN864053,0222,2010,22549382,CRF22_01A1 is Involved in the Emergence of New HIV-1 Recombinants in Cameroon,"Zhao,J., Tang,S., Ragupathy,V., Gaddam,D., Wang,X., Zhang,P., Nyambi,P.N. and Hewlett,I.",2012
JN864054,0222,2010,22549382,CRF22_01A1 is Involved in the Emergence of New HIV-1 Recombinants in Cameroon,"Zhao,J., Tang,S., Ragupathy,V., Gaddam,D., Wang,X., Zhang,P., Nyambi,P.N. and Hewlett,I.",2012
JN864055,02B,2006,22549382,CRF22_01A1 is Involved in the Emergence of New HIV-1 Recombinants in Cameroon,"Zhao,J., Tang,S., Ragupathy,V., Gaddam,D., Wang,X., Zhang,P., Nyambi,P.N. and Hewlett,I.",2012
JN864056,01F2G,2002,22549382,CRF22_01A1 is Involved in the Emergence of New HIV-1 Recombinants in Cameroon,"Zhao,J., Tang,S., Ragupathy,V., Gaddam,D., Wang,X., Zhang,P., Nyambi,P.N. and Hewlett,I.",2012
JN864057,02F2G,2002,22549382,CRF22_01A1 is Involved in the Emergence of New HIV-1 Recombinants in Cameroon,"Zhao,J., Tang,S., Ragupathy,V., Gaddam,D., Wang,X., Zhang,P., Nyambi,P.N. and Hewlett,I.",2012
JN864058,22_01A1,2010,22549382,CRF22_01A1 is Involved in the Emergence of New HIV-1 Recombinants in Cameroon,"Zhao,J., Tang,S., Ragupathy,V., Gaddam,D., Wang,X., Zhang,P., Nyambi,P.N. and Hewlett,I.",2012
JN864059,22_01A1,2010,22549382,CRF22_01A1 is Involved in the Emergence of New HIV-1 Recombinants in Cameroon,"Zhao,J., Tang,S., Ragupathy,V., Gaddam,D., Wang,X., Zhang,P., Nyambi,P.N. and Hewlett,I.",2012
JN882651,02B,2009,21522007,Circulation of multiple patterns of unique recombinant forms B/CRF02_AG in France: precursor signs of the emergence of an upcoming CRF B/02,"Leoz,M., Chaix,M.L., Delaugerre,C., Rivoisy,C., Meyer,L., Rouzioux,C., Simon,F. and Plantier,J.C.",2011
JN882652,02B,2002,21522007,Circulation of multiple patterns of unique recombinant forms B/CRF02_AG in France: precursor signs of the emergence of an upcoming CRF B/02,"Leoz,M., Chaix,M.L., Delaugerre,C., Rivoisy,C., Meyer,L., Rouzioux,C., Simon,F. and Plantier,J.C.",2011
JN882653,02BD,2008,21522007,Circulation of multiple patterns of unique recombinant forms B/CRF02_AG in France: precursor signs of the emergence of an upcoming CRF B/02,"Leoz,M., Chaix,M.L., Delaugerre,C., Rivoisy,C., Meyer,L., Rouzioux,C., Simon,F. and Plantier,J.C.",2011
JN882654,02B,2009,21522007,Circulation of multiple patterns of unique recombinant forms B/CRF02_AG in France: precursor signs of the emergence of an upcoming CRF B/02,"Leoz,M., Chaix,M.L., Delaugerre,C., Rivoisy,C., Meyer,L., Rouzioux,C., Simon,F. and Plantier,J.C.",2011
JN882655,56_cpx,2010,21522007,Circulation of multiple patterns of unique recombinant forms B/CRF02_AG in France: precursor signs of the emergence of an upcoming CRF B/02,"Leoz,M., Chaix,M.L., Delaugerre,C., Rivoisy,C., Meyer,L., Rouzioux,C., Simon,F. and Plantier,J.C.",2011
JN944654,01_AE,2005,22634875,Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials,"Montefiori,D.C., Karnasuta,C., Huang,Y., Ahmed,H., Gilbert,P., de Souza,M.S., McLinden,R., Tovanabutra,S., Laurence-Chenine,A., Sanders-Buell,E., Moody,M.A., Bonsignori,M., Ochsenbauer,C., Kappes,J., Tang,H., Greene,K., Gao,H., Labranche,C.C., Andrews,C., Polonis,V.R., Rerks-Ngarm,S., Pitisuttithum,P., Nitayaphan,S., Kaewkungwal,J., Self,S.G., Berman,P.W., Francis,D., Sinangil,F., Lee,C., Tartaglia,J., Robb,M.L., Haynes,B.F., Michael,N.L. and Kim,J.H.",2012
JN944655,01_AE,2006,22634875,Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials,"Montefiori,D.C., Karnasuta,C., Huang,Y., Ahmed,H., Gilbert,P., de Souza,M.S., McLinden,R., Tovanabutra,S., Laurence-Chenine,A., Sanders-Buell,E., Moody,M.A., Bonsignori,M., Ochsenbauer,C., Kappes,J., Tang,H., Greene,K., Gao,H., Labranche,C.C., Andrews,C., Polonis,V.R., Rerks-Ngarm,S., Pitisuttithum,P., Nitayaphan,S., Kaewkungwal,J., Self,S.G., Berman,P.W., Francis,D., Sinangil,F., Lee,C., Tartaglia,J., Robb,M.L., Haynes,B.F., Michael,N.L. and Kim,J.H.",2012
JN944656,01_AE,2005,22634875,Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials,"Montefiori,D.C., Karnasuta,C., Huang,Y., Ahmed,H., Gilbert,P., de Souza,M.S., McLinden,R., Tovanabutra,S., Laurence-Chenine,A., Sanders-Buell,E., Moody,M.A., Bonsignori,M., Ochsenbauer,C., Kappes,J., Tang,H., Greene,K., Gao,H., Labranche,C.C., Andrews,C., Polonis,V.R., Rerks-Ngarm,S., Pitisuttithum,P., Nitayaphan,S., Kaewkungwal,J., Self,S.G., Berman,P.W., Francis,D., Sinangil,F., Lee,C., Tartaglia,J., Robb,M.L., Haynes,B.F., Michael,N.L. and Kim,J.H.",2012
JN944657,01_AE,2006,22634875,Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials,"Montefiori,D.C., Karnasuta,C., Huang,Y., Ahmed,H., Gilbert,P., de Souza,M.S., McLinden,R., Tovanabutra,S., Laurence-Chenine,A., Sanders-Buell,E., Moody,M.A., Bonsignori,M., Ochsenbauer,C., Kappes,J., Tang,H., Greene,K., Gao,H., Labranche,C.C., Andrews,C., Polonis,V.R., Rerks-Ngarm,S., Pitisuttithum,P., Nitayaphan,S., Kaewkungwal,J., Self,S.G., Berman,P.W., Francis,D., Sinangil,F., Lee,C., Tartaglia,J., Robb,M.L., Haynes,B.F., Michael,N.L. and Kim,J.H.",2012
JN944658,01_AE,2005,22634875,Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials,"Montefiori,D.C., Karnasuta,C., Huang,Y., Ahmed,H., Gilbert,P., de Souza,M.S., McLinden,R., Tovanabutra,S., Laurence-Chenine,A., Sanders-Buell,E., Moody,M.A., Bonsignori,M., Ochsenbauer,C., Kappes,J., Tang,H., Greene,K., Gao,H., Labranche,C.C., Andrews,C., Polonis,V.R., Rerks-Ngarm,S., Pitisuttithum,P., Nitayaphan,S., Kaewkungwal,J., Self,S.G., Berman,P.W., Francis,D., Sinangil,F., Lee,C., Tartaglia,J., Robb,M.L., Haynes,B.F., Michael,N.L. and Kim,J.H.",2012
JN944659,01_AE,2006,22634875,Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials,"Montefiori,D.C., Karnasuta,C., Huang,Y., Ahmed,H., Gilbert,P., de Souza,M.S., McLinden,R., Tovanabutra,S., Laurence-Chenine,A., Sanders-Buell,E., Moody,M.A., Bonsignori,M., Ochsenbauer,C., Kappes,J., Tang,H., Greene,K., Gao,H., Labranche,C.C., Andrews,C., Polonis,V.R., Rerks-Ngarm,S., Pitisuttithum,P., Nitayaphan,S., Kaewkungwal,J., Self,S.G., Berman,P.W., Francis,D., Sinangil,F., Lee,C., Tartaglia,J., Robb,M.L., Haynes,B.F., Michael,N.L. and Kim,J.H.",2012
JN944663,01_AE,1990,22634875,Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials,"Montefiori,D.C., Karnasuta,C., Huang,Y., Ahmed,H., Gilbert,P., de Souza,M.S., McLinden,R., Tovanabutra,S., Laurence-Chenine,A., Sanders-Buell,E., Moody,M.A., Bonsignori,M., Ochsenbauer,C., Kappes,J., Tang,H., Greene,K., Gao,H., Labranche,C.C., Andrews,C., Polonis,V.R., Rerks-Ngarm,S., Pitisuttithum,P., Nitayaphan,S., Kaewkungwal,J., Self,S.G., Berman,P.W., Francis,D., Sinangil,F., Lee,C., Tartaglia,J., Robb,M.L., Haynes,B.F., Michael,N.L. and Kim,J.H.",2012
JN944664,01_AE,1996,22634875,Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials,"Montefiori,D.C., Karnasuta,C., Huang,Y., Ahmed,H., Gilbert,P., de Souza,M.S., McLinden,R., Tovanabutra,S., Laurence-Chenine,A., Sanders-Buell,E., Moody,M.A., Bonsignori,M., Ochsenbauer,C., Kappes,J., Tang,H., Greene,K., Gao,H., Labranche,C.C., Andrews,C., Polonis,V.R., Rerks-Ngarm,S., Pitisuttithum,P., Nitayaphan,S., Kaewkungwal,J., Self,S.G., Berman,P.W., Francis,D., Sinangil,F., Lee,C., Tartaglia,J., Robb,M.L., Haynes,B.F., Michael,N.L. and Kim,J.H.",2012
JN977603,AC,2006,,Direct Submission,"Salazar-Gonzalez,J., Derdeyn,C., Hunter,E., Hahn,B. and Shaw,G.",2011
JN977604,C,2007,,Direct Submission,"Salazar-Gonzalez,J., Derdeyn,C., Hunter,E., Hahn,B. and Shaw,G.",2011
JN983803,C,2002,23075434,Short Communication: HIV Type 1 Subtype C Variants Transmitted Through the Bottleneck of Breastfeeding Are Sensitive to New Generation Broadly Neutralizing Antibodies Directed Against Quaternary and CD4-Binding Site Epitopes,"Russell,E.S., Ojeda,S., Fouda,G.G., Meshnick,S.R., Montefiori,D., Permar,S.R. and Swanstrom,R.",2013
JN983804,C,2002,23075434,Short Communication: HIV Type 1 Subtype C Variants Transmitted Through the Bottleneck of Breastfeeding Are Sensitive to New Generation Broadly Neutralizing Antibodies Directed Against Quaternary and CD4-Binding Site Epitopes,"Russell,E.S., Ojeda,S., Fouda,G.G., Meshnick,S.R., Montefiori,D., Permar,S.R. and Swanstrom,R.",2013
JN983805,C,2002,23075434,Short Communication: HIV Type 1 Subtype C Variants Transmitted Through the Bottleneck of Breastfeeding Are Sensitive to New Generation Broadly Neutralizing Antibodies Directed Against Quaternary and CD4-Binding Site Epitopes,"Russell,E.S., Ojeda,S., Fouda,G.G., Meshnick,S.R., Montefiori,D., Permar,S.R. and Swanstrom,R.",2013
JQ061131,C,2007,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
JQ085287,B,,22933284,"Sequences in Glycoprotein gp41, the CD4 Binding Site, and the V2 Domain Regulate Sensitivity and Resistance of HIV-1 to Broadly Neutralizing Antibodies","O'Rourke,S.M., Schweighardt,B., Phung,P., Mesa,K.A., Vollrath,A.L., Tatsuno,G.P., To,B., Sinangil,F., Limoli,K., Wrin,T. and Berman,P.W.",2012
JQ085289,B,,22933284,"Sequences in Glycoprotein gp41, the CD4 Binding Site, and the V2 Domain Regulate Sensitivity and Resistance of HIV-1 to Broadly Neutralizing Antibodies","O'Rourke,S.M., Schweighardt,B., Phung,P., Mesa,K.A., Vollrath,A.L., Tatsuno,G.P., To,B., Sinangil,F., Limoli,K., Wrin,T. and Berman,P.W.",2012
JQ085291,B,,22933284,"Sequences in Glycoprotein gp41, the CD4 Binding Site, and the V2 Domain Regulate Sensitivity and Resistance of HIV-1 to Broadly Neutralizing Antibodies","O'Rourke,S.M., Schweighardt,B., Phung,P., Mesa,K.A., Vollrath,A.L., Tatsuno,G.P., To,B., Sinangil,F., Limoli,K., Wrin,T. and Berman,P.W.",2012
JQ085293,B,,22933284,"Sequences in Glycoprotein gp41, the CD4 Binding Site, and the V2 Domain Regulate Sensitivity and Resistance of HIV-1 to Broadly Neutralizing Antibodies","O'Rourke,S.M., Schweighardt,B., Phung,P., Mesa,K.A., Vollrath,A.L., Tatsuno,G.P., To,B., Sinangil,F., Limoli,K., Wrin,T. and Berman,P.W.",2012
JQ085295,B,,22933284,"Sequences in Glycoprotein gp41, the CD4 Binding Site, and the V2 Domain Regulate Sensitivity and Resistance of HIV-1 to Broadly Neutralizing Antibodies","O'Rourke,S.M., Schweighardt,B., Phung,P., Mesa,K.A., Vollrath,A.L., Tatsuno,G.P., To,B., Sinangil,F., Limoli,K., Wrin,T. and Berman,P.W.",2012
JQ085297,B,,,"Analysis of HIV-1 Quasi-Species Demonstrates that Polymorphisms in gp41, have a Significant Role in Regulating Sensitivity and Resistance to Broadly Neutralizing Antibodies","O'Rourke,S.M., Schweighardt,B., Phung,P., Mesa,K., Vollrath,A., Sinangil,F., Limoli,K., Wrin,T. and Berman,P.W.",
JQ182774,B,2010,22090117,HIV-1 Clinical Isolates Resistant to CCR5 Antagonists Exhibit Delayed Entry Kinetics That Are Corrected in the Presence of Drug,"Putcharoen,O., Lee,S.H., Henrich,T.J., Hu,Z., Vanichanan,J., Coakley,E., Greaves,W., Gulick,R.M., Kuritzkes,D.R. and Tsibris,A.M.",2012
JQ182896,B,2010,22090117,HIV-1 Clinical Isolates Resistant to CCR5 Antagonists Exhibit Delayed Entry Kinetics That Are Corrected in the Presence of Drug,"Putcharoen,O., Lee,S.H., Henrich,T.J., Hu,Z., Vanichanan,J., Coakley,E., Greaves,W., Gulick,R.M., Kuritzkes,D.R. and Tsibris,A.M.",2012
JQ250832,B,2007,22319447,Absence of HIV-1 Evolution in the Gut-Associated Lymphoid Tissue from Patients on Combination Antiviral Therapy Initiated during Primary Infection,"Evering,T.H., Mehandru,S., Racz,P., Tenner-Racz,K., Poles,M.A., Figueroa,A., Mohri,H. and Markowitz,M.",2012
JQ250872,B,2006,22319447,Absence of HIV-1 Evolution in the Gut-Associated Lymphoid Tissue from Patients on Combination Antiviral Therapy Initiated during Primary Infection,"Evering,T.H., Mehandru,S., Racz,P., Tenner-Racz,K., Poles,M.A., Figueroa,A., Mohri,H. and Markowitz,M.",2012
JQ250925,B,2004,22319447,Absence of HIV-1 Evolution in the Gut-Associated Lymphoid Tissue from Patients on Combination Antiviral Therapy Initiated during Primary Infection,"Evering,T.H., Mehandru,S., Racz,P., Tenner-Racz,K., Poles,M.A., Figueroa,A., Mohri,H. and Markowitz,M.",2012
JQ251015,B,2004,22319447,Absence of HIV-1 Evolution in the Gut-Associated Lymphoid Tissue from Patients on Combination Antiviral Therapy Initiated during Primary Infection,"Evering,T.H., Mehandru,S., Racz,P., Tenner-Racz,K., Poles,M.A., Figueroa,A., Mohri,H. and Markowitz,M.",2012
JQ251105,B,2004,22319447,Absence of HIV-1 Evolution in the Gut-Associated Lymphoid Tissue from Patients on Combination Antiviral Therapy Initiated during Primary Infection,"Evering,T.H., Mehandru,S., Racz,P., Tenner-Racz,K., Poles,M.A., Figueroa,A., Mohri,H. and Markowitz,M.",2012
JQ292892,A6,2002,22251084,The Analysis of Near Full-Length Genome Sequences of HIV Type 1 Subtype A Viruses from Russia Supports the Monophyly of Major Intrasubtype Clusters,"Fernandez-Garcia,A., Revilla,A., Vazquez-de Parga,E., Vinogradova,A., Rakhmanova,A., Karamov,E., Carrera,C., Delgado,E., Perez-Alvarez,L., Najera,R., Osmanov,S. and Thomson,M.M.",2012
JQ292900,A6,2006,22251084,The Analysis of Near Full-Length Genome Sequences of HIV Type 1 Subtype A Viruses from Russia Supports the Monophyly of Major Intrasubtype Clusters,"Fernandez-Garcia,A., Revilla,A., Vazquez-de Parga,E., Vinogradova,A., Rakhmanova,A., Karamov,E., Carrera,C., Delgado,E., Perez-Alvarez,L., Najera,R., Osmanov,S. and Thomson,M.M.",2012
JQ316126,B,2004,23199052,Phylogenetic Analysis of Near Full-Length HIV Type 1 Genomic Sequences from 21 Korean Individuals,"Cho,Y.K., Kim,J.E. and Foley,B.T.",2013
JQ316127,B,2003,23199052,Phylogenetic Analysis of Near Full-Length HIV Type 1 Genomic Sequences from 21 Korean Individuals,"Cho,Y.K., Kim,J.E. and Foley,B.T.",2013
JQ316128,B,2003,23199052,Phylogenetic Analysis of Near Full-Length HIV Type 1 Genomic Sequences from 21 Korean Individuals,"Cho,Y.K., Kim,J.E. and Foley,B.T.",2013
JQ316129,B,1999,23199052,Phylogenetic Analysis of Near Full-Length HIV Type 1 Genomic Sequences from 21 Korean Individuals,"Cho,Y.K., Kim,J.E. and Foley,B.T.",2013
JQ316130,B,2004,23199052,Phylogenetic Analysis of Near Full-Length HIV Type 1 Genomic Sequences from 21 Korean Individuals,"Cho,Y.K., Kim,J.E. and Foley,B.T.",2013
JQ316131,B,2003,23199052,Phylogenetic Analysis of Near Full-Length HIV Type 1 Genomic Sequences from 21 Korean Individuals,"Cho,Y.K., Kim,J.E. and Foley,B.T.",2013
JQ316132,B,2003,23199052,Phylogenetic Analysis of Near Full-Length HIV Type 1 Genomic Sequences from 21 Korean Individuals,"Cho,Y.K., Kim,J.E. and Foley,B.T.",2013
JQ316134,B,2005,23199052,Phylogenetic Analysis of Near Full-Length HIV Type 1 Genomic Sequences from 21 Korean Individuals,"Cho,Y.K., Kim,J.E. and Foley,B.T.",2013
JQ316135,B,2003,23199052,Phylogenetic Analysis of Near Full-Length HIV Type 1 Genomic Sequences from 21 Korean Individuals,"Cho,Y.K., Kim,J.E. and Foley,B.T.",2013
JQ316136,02_AG,2007,23199052,Phylogenetic Analysis of Near Full-Length HIV Type 1 Genomic Sequences from 21 Korean Individuals,"Cho,Y.K., Kim,J.E. and Foley,B.T.",2013
JQ341411,B,2007,23199052,Phylogenetic Analysis of Near Full-Length HIV Type 1 Genomic Sequences from 21 Korean Individuals,"Cho,Y.K., Kim,J.E. and Foley,B.T.",2013
JQ352781,B,2007,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Sanders-Buell,E., Montefiori,D., Seaman,M., Williamson,C., Hahn,B., Gao,F., Swanstrom,R., Sutthent,R., Permpikul,P., O'Sullivan,A., Lei,E., Kim,J. and Tovanabutra,S.",
JQ361079,D,2001,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Sanders-Buell,E., Montefiori,D., Seaman,M., Williamson,C., Hahn,B., Gao,F., Swanstrom,R., Serwadda,D., Sewankambo,N., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Lutalo,T., Lane,J.R., Laeyendecker,O., Gray,R., Wawer,M., Birx,D.L., Robb,M.L., McCutchan,F.E., O'Sullivan,A., Lei,E., Kim,J. and Tovanabutra,S.",
JQ403030,B,2008,22412369,Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection,"Henn,M.R., Boutwell,C.L., Charlebois,P., Lennon,N.J., Power,K.A., Macalalad,A.R., Berlin,A.M., Malboeuf,C.M., Ryan,E.M., Gnerre,S., Zody,M.C., Erlich,R.L., Green,L.M., Berical,A., Wang,Y., Casali,M., Streeck,H., Bloom,A.K., Dudek,T., Tully,D., Newman,R., Axten,K.L., Gladden,A.D., Battis,L., Kemper,M., Zeng,Q., Shea,T.P., Gujja,S., Zedlack,C., Gasser,O., Brander,C., Hess,C., Gunthard,H.F., Brumme,Z.L., Brumme,C.J., Bazner,S., Rychert,J., Tinsley,J.P., Mayer,K.H., Rosenberg,E., Pereyra,F., Levin,J.Z., Young,S.K., Jessen,H., Altfeld,M., Birren,B.W., Walker,B.D. and Allen,T.M.",2012
JQ403035,B,2008,22412369,Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection,"Henn,M.R., Boutwell,C.L., Charlebois,P., Lennon,N.J., Power,K.A., Macalalad,A.R., Berlin,A.M., Malboeuf,C.M., Ryan,E.M., Gnerre,S., Zody,M.C., Erlich,R.L., Green,L.M., Berical,A., Wang,Y., Casali,M., Streeck,H., Bloom,A.K., Dudek,T., Tully,D., Newman,R., Axten,K.L., Gladden,A.D., Battis,L., Kemper,M., Zeng,Q., Shea,T.P., Gujja,S., Zedlack,C., Gasser,O., Brander,C., Hess,C., Gunthard,H.F., Brumme,Z.L., Brumme,C.J., Bazner,S., Rychert,J., Tinsley,J.P., Mayer,K.H., Rosenberg,E., Pereyra,F., Levin,J.Z., Young,S.K., Jessen,H., Altfeld,M., Birren,B.W., Walker,B.D. and Allen,T.M.",2012
JQ403048,B,2003,22412369,Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection,"Henn,M.R., Boutwell,C.L., Charlebois,P., Lennon,N.J., Power,K.A., Macalalad,A.R., Berlin,A.M., Malboeuf,C.M., Ryan,E.M., Gnerre,S., Zody,M.C., Erlich,R.L., Green,L.M., Berical,A., Wang,Y., Casali,M., Streeck,H., Bloom,A.K., Dudek,T., Tully,D., Newman,R., Axten,K.L., Gladden,A.D., Battis,L., Kemper,M., Zeng,Q., Shea,T.P., Gujja,S., Zedlack,C., Gasser,O., Brander,C., Hess,C., Gunthard,H.F., Brumme,Z.L., Brumme,C.J., Bazner,S., Rychert,J., Tinsley,J.P., Mayer,K.H., Rosenberg,E., Pereyra,F., Levin,J.Z., Young,S.K., Jessen,H., Altfeld,M., Birren,B.W., Walker,B.D. and Allen,T.M.",2012
JQ403050,B,2004,22412369,Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection,"Henn,M.R., Boutwell,C.L., Charlebois,P., Lennon,N.J., Power,K.A., Macalalad,A.R., Berlin,A.M., Malboeuf,C.M., Ryan,E.M., Gnerre,S., Zody,M.C., Erlich,R.L., Green,L.M., Berical,A., Wang,Y., Casali,M., Streeck,H., Bloom,A.K., Dudek,T., Tully,D., Newman,R., Axten,K.L., Gladden,A.D., Battis,L., Kemper,M., Zeng,Q., Shea,T.P., Gujja,S., Zedlack,C., Gasser,O., Brander,C., Hess,C., Gunthard,H.F., Brumme,Z.L., Brumme,C.J., Bazner,S., Rychert,J., Tinsley,J.P., Mayer,K.H., Rosenberg,E., Pereyra,F., Levin,J.Z., Young,S.K., Jessen,H., Altfeld,M., Birren,B.W., Walker,B.D. and Allen,T.M.",2012
JQ403060,B,2007,22412369,Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection,"Henn,M.R., Boutwell,C.L., Charlebois,P., Lennon,N.J., Power,K.A., Macalalad,A.R., Berlin,A.M., Malboeuf,C.M., Ryan,E.M., Gnerre,S., Zody,M.C., Erlich,R.L., Green,L.M., Berical,A., Wang,Y., Casali,M., Streeck,H., Bloom,A.K., Dudek,T., Tully,D., Newman,R., Axten,K.L., Gladden,A.D., Battis,L., Kemper,M., Zeng,Q., Shea,T.P., Gujja,S., Zedlack,C., Gasser,O., Brander,C., Hess,C., Gunthard,H.F., Brumme,Z.L., Brumme,C.J., Bazner,S., Rychert,J., Tinsley,J.P., Mayer,K.H., Rosenberg,E., Pereyra,F., Levin,J.Z., Young,S.K., Jessen,H., Altfeld,M., Birren,B.W., Walker,B.D. and Allen,T.M.",2012
JQ403062,B,2008,22412369,Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection,"Henn,M.R., Boutwell,C.L., Charlebois,P., Lennon,N.J., Power,K.A., Macalalad,A.R., Berlin,A.M., Malboeuf,C.M., Ryan,E.M., Gnerre,S., Zody,M.C., Erlich,R.L., Green,L.M., Berical,A., Wang,Y., Casali,M., Streeck,H., Bloom,A.K., Dudek,T., Tully,D., Newman,R., Axten,K.L., Gladden,A.D., Battis,L., Kemper,M., Zeng,Q., Shea,T.P., Gujja,S., Zedlack,C., Gasser,O., Brander,C., Hess,C., Gunthard,H.F., Brumme,Z.L., Brumme,C.J., Bazner,S., Rychert,J., Tinsley,J.P., Mayer,K.H., Rosenberg,E., Pereyra,F., Levin,J.Z., Young,S.K., Jessen,H., Altfeld,M., Birren,B.W., Walker,B.D. and Allen,T.M.",2012
JQ403102,B,2002,22412369,Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection,"Henn,M.R., Boutwell,C.L., Charlebois,P., Lennon,N.J., Power,K.A., Macalalad,A.R., Berlin,A.M., Malboeuf,C.M., Ryan,E.M., Gnerre,S., Zody,M.C., Erlich,R.L., Green,L.M., Berical,A., Wang,Y., Casali,M., Streeck,H., Bloom,A.K., Dudek,T., Tully,D., Newman,R., Axten,K.L., Gladden,A.D., Battis,L., Kemper,M., Zeng,Q., Shea,T.P., Gujja,S., Zedlack,C., Gasser,O., Brander,C., Hess,C., Gunthard,H.F., Brumme,Z.L., Brumme,C.J., Bazner,S., Rychert,J., Tinsley,J.P., Mayer,K.H., Rosenberg,E., Pereyra,F., Levin,J.Z., Young,S.K., Jessen,H., Altfeld,M., Birren,B.W., Walker,B.D. and Allen,T.M.",2012
JQ423923,07_BC,2007,22984494,Identification of Drug Resistant Mutations in HIV-1 CRF07_BC Variants Selected by Nevirapine In Vitro,"Wu,H., Zhang,H.J., Zhang,X.M., Xu,H.F., Wang,M., Huang,J.D. and Zheng,B.J.",2012
JQ429433,B,2002,23199052,Phylogenetic Analysis of Near Full-Length HIV Type 1 Genomic Sequences from 21 Korean Individuals,"Cho,Y.K., Kim,J.E. and Foley,B.T.",2013
JQ609684,B,2001,22419808,Selection Pressure on HIV-1 Envelope by Broadly Neutralizing Antibodies to the Conserved CD4-Binding Site,"Wu,X., Wang,C., O'Dell,S., Li,Y., Keele,B.F., Yang,Z., Imamichi,H., Doria-Rose,N., Hoxie,J.A., Connors,M., Shaw,G.M., Wyatt,R.T. and Mascola,J.R.",2012
JQ609870,B,1995,22419808,Selection Pressure on HIV-1 Envelope by Broadly Neutralizing Antibodies to the Conserved CD4-Binding Site,"Wu,X., Wang,C., O'Dell,S., Li,Y., Keele,B.F., Yang,Z., Imamichi,H., Doria-Rose,N., Hoxie,J.A., Connors,M., Shaw,G.M., Wyatt,R.T. and Mascola,J.R.",2012
JQ609961,B,1988,22419808,Selection Pressure on HIV-1 Envelope by Broadly Neutralizing Antibodies to the Conserved CD4-Binding Site,"Wu,X., Wang,C., O'Dell,S., Li,Y., Keele,B.F., Yang,Z., Imamichi,H., Doria-Rose,N., Hoxie,J.A., Connors,M., Shaw,G.M., Wyatt,R.T. and Mascola,J.R.",2012
JQ609973,B,1999,22419808,Selection Pressure on HIV-1 Envelope by Broadly Neutralizing Antibodies to the Conserved CD4-Binding Site,"Wu,X., Wang,C., O'Dell,S., Li,Y., Keele,B.F., Yang,Z., Imamichi,H., Doria-Rose,N., Hoxie,J.A., Connors,M., Shaw,G.M., Wyatt,R.T. and Mascola,J.R.",2012
JQ610053,B,2007,22419808,Selection Pressure on HIV-1 Envelope by Broadly Neutralizing Antibodies to the Conserved CD4-Binding Site,"Wu,X., Wang,C., O'Dell,S., Li,Y., Keele,B.F., Yang,Z., Imamichi,H., Doria-Rose,N., Hoxie,J.A., Connors,M., Shaw,G.M., Wyatt,R.T. and Mascola,J.R.",2012
JQ610120,B,2008,22419808,Selection Pressure on HIV-1 Envelope by Broadly Neutralizing Antibodies to the Conserved CD4-Binding Site,"Wu,X., Wang,C., O'Dell,S., Li,Y., Keele,B.F., Yang,Z., Imamichi,H., Doria-Rose,N., Hoxie,J.A., Connors,M., Shaw,G.M., Wyatt,R.T. and Mascola,J.R.",2012
JQ730708,C,,,Direct Submission,"Bandawe,G.",2012
JQ777026,C,2007,22693444,Transmitted/Founder and Chronic Subtype C HIV-1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin alpha4beta7,"Parrish,N.F., Wilen,C.B., Banks,L.B., Iyer,S.S., Pfaff,J.M., Salazar-Gonzalez,J.F., Salazar,M.G., Decker,J.M., Parrish,E.H., Berg,A., Hopper,J., Hora,B., Kumar,A., Mahlokozera,T., Yuan,S., Coleman,C., Vermeulen,M., Ding,H., Ochsenbauer,C., Tilton,J.C., Permar,S.R., Kappes,J.C., Betts,M.R., Busch,M.P., Gao,F., Montefiori,D., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Doms,R.W.",2012
JQ777061,C,2007,22693444,Transmitted/Founder and Chronic Subtype C HIV-1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin alpha4beta7,"Parrish,N.F., Wilen,C.B., Banks,L.B., Iyer,S.S., Pfaff,J.M., Salazar-Gonzalez,J.F., Salazar,M.G., Decker,J.M., Parrish,E.H., Berg,A., Hopper,J., Hora,B., Kumar,A., Mahlokozera,T., Yuan,S., Coleman,C., Vermeulen,M., Ding,H., Ochsenbauer,C., Tilton,J.C., Permar,S.R., Kappes,J.C., Betts,M.R., Busch,M.P., Gao,F., Montefiori,D., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Doms,R.W.",2012
JQ777087,C,2007,22693444,Transmitted/Founder and Chronic Subtype C HIV-1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin alpha4beta7,"Parrish,N.F., Wilen,C.B., Banks,L.B., Iyer,S.S., Pfaff,J.M., Salazar-Gonzalez,J.F., Salazar,M.G., Decker,J.M., Parrish,E.H., Berg,A., Hopper,J., Hora,B., Kumar,A., Mahlokozera,T., Yuan,S., Coleman,C., Vermeulen,M., Ding,H., Ochsenbauer,C., Tilton,J.C., Permar,S.R., Kappes,J.C., Betts,M.R., Busch,M.P., Gao,F., Montefiori,D., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Doms,R.W.",2012
JQ777111,C,2008,22693444,Transmitted/Founder and Chronic Subtype C HIV-1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin alpha4beta7,"Parrish,N.F., Wilen,C.B., Banks,L.B., Iyer,S.S., Pfaff,J.M., Salazar-Gonzalez,J.F., Salazar,M.G., Decker,J.M., Parrish,E.H., Berg,A., Hopper,J., Hora,B., Kumar,A., Mahlokozera,T., Yuan,S., Coleman,C., Vermeulen,M., Ding,H., Ochsenbauer,C., Tilton,J.C., Permar,S.R., Kappes,J.C., Betts,M.R., Busch,M.P., Gao,F., Montefiori,D., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Doms,R.W.",2012
JQ777137,C,2008,22693444,Transmitted/Founder and Chronic Subtype C HIV-1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin alpha4beta7,"Parrish,N.F., Wilen,C.B., Banks,L.B., Iyer,S.S., Pfaff,J.M., Salazar-Gonzalez,J.F., Salazar,M.G., Decker,J.M., Parrish,E.H., Berg,A., Hopper,J., Hora,B., Kumar,A., Mahlokozera,T., Yuan,S., Coleman,C., Vermeulen,M., Ding,H., Ochsenbauer,C., Tilton,J.C., Permar,S.R., Kappes,J.C., Betts,M.R., Busch,M.P., Gao,F., Montefiori,D., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Doms,R.W.",2012
JQ777144,C,2008,22693444,Transmitted/Founder and Chronic Subtype C HIV-1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin alpha4beta7,"Parrish,N.F., Wilen,C.B., Banks,L.B., Iyer,S.S., Pfaff,J.M., Salazar-Gonzalez,J.F., Salazar,M.G., Decker,J.M., Parrish,E.H., Berg,A., Hopper,J., Hora,B., Kumar,A., Mahlokozera,T., Yuan,S., Coleman,C., Vermeulen,M., Ding,H., Ochsenbauer,C., Tilton,J.C., Permar,S.R., Kappes,J.C., Betts,M.R., Busch,M.P., Gao,F., Montefiori,D., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Doms,R.W.",2012
JQ779074,C,2009,22693444,Transmitted/Founder and Chronic Subtype C HIV-1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin alpha4beta7,"Parrish,N.F., Wilen,C.B., Banks,L.B., Iyer,S.S., Pfaff,J.M., Salazar-Gonzalez,J.F., Salazar,M.G., Decker,J.M., Parrish,E.H., Berg,A., Hopper,J., Hora,B., Kumar,A., Mahlokozera,T., Yuan,S., Coleman,C., Vermeulen,M., Ding,H., Ochsenbauer,C., Tilton,J.C., Permar,S.R., Kappes,J.C., Betts,M.R., Busch,M.P., Gao,F., Montefiori,D., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Doms,R.W.",2012
JQ779170,C,2008,22693444,Transmitted/Founder and Chronic Subtype C HIV-1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin alpha4beta7,"Parrish,N.F., Wilen,C.B., Banks,L.B., Iyer,S.S., Pfaff,J.M., Salazar-Gonzalez,J.F., Salazar,M.G., Decker,J.M., Parrish,E.H., Berg,A., Hopper,J., Hora,B., Kumar,A., Mahlokozera,T., Yuan,S., Coleman,C., Vermeulen,M., Ding,H., Ochsenbauer,C., Tilton,J.C., Permar,S.R., Kappes,J.C., Betts,M.R., Busch,M.P., Gao,F., Montefiori,D., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Doms,R.W.",2012
JQ779226,C,2008,22693444,Transmitted/Founder and Chronic Subtype C HIV-1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin alpha4beta7,"Parrish,N.F., Wilen,C.B., Banks,L.B., Iyer,S.S., Pfaff,J.M., Salazar-Gonzalez,J.F., Salazar,M.G., Decker,J.M., Parrish,E.H., Berg,A., Hopper,J., Hora,B., Kumar,A., Mahlokozera,T., Yuan,S., Coleman,C., Vermeulen,M., Ding,H., Ochsenbauer,C., Tilton,J.C., Permar,S.R., Kappes,J.C., Betts,M.R., Busch,M.P., Gao,F., Montefiori,D., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Doms,R.W.",2012
JQ779286,C,2007,22693444,Transmitted/Founder and Chronic Subtype C HIV-1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin alpha4beta7,"Parrish,N.F., Wilen,C.B., Banks,L.B., Iyer,S.S., Pfaff,J.M., Salazar-Gonzalez,J.F., Salazar,M.G., Decker,J.M., Parrish,E.H., Berg,A., Hopper,J., Hora,B., Kumar,A., Mahlokozera,T., Yuan,S., Coleman,C., Vermeulen,M., Ding,H., Ochsenbauer,C., Tilton,J.C., Permar,S.R., Kappes,J.C., Betts,M.R., Busch,M.P., Gao,F., Montefiori,D., Haynes,B.F., Shaw,G.M., Hahn,B.H. and Doms,R.W.",2012
JX096639,A1,2007,23468623,Viral Escape from Neutralizing Antibodies in Early Subtype A HIV-1 Infection Drives an Increase in Autologous Neutralization Breadth,"Murphy,M.K., Yue,L., Pan,R., Boliar,S., Sethi,A., Tian,J., Pfafferot,K., Karita,E., Allen,S.A., Cormier,E., Goepfert,P.A., Borrow,P., Robinson,J.E., Gnanakaran,S., Hunter,E., Kong,X.P. and Derdeyn,C.A.",2013
JX112796,01_AE,2010,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112797,01_AE,2010,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112798,01_AE,2010,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112799,01_AE,2010,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112800,01_AE,2010,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112801,01_AE,2010,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112802,01_AE,2010,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112803,01_AE,2010,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112804,01_AE,2010,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112805,01_AE,2010,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112806,01_AE,2010,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112807,01_AE,2010,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112808,01_AE,2010,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112809,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112810,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112811,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112812,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112813,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112814,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112815,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112816,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112817,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112818,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112819,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112820,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112821,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112822,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112823,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112824,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112825,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112826,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112827,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112828,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112829,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112830,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112831,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112832,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112833,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112834,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112835,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112836,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112837,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112838,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112839,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112840,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112841,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112842,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112843,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112844,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112845,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112846,01_AE,2010,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112847,01_AE,2010,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112848,01_AE,2010,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112849,01_AE,2010,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112850,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112851,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112852,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112853,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112854,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112855,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112856,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112857,01_AE,2006,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112858,01_AE,2006,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112859,01_AE,2007,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112860,01_AE,2002,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112861,01_AE,2002,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112862,01_AE,2002,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112863,01_AE,2002,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112864,01_AE,2002,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112865,01_AE,2002,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112866,01_AE,2002,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112867,01_AE,2009,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112868,01_AE,2009,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112869,01_AE,2009,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX112870,01_AE,2009,23807275,The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s,"Feng,Y., He,X., Hsi,J.H., Li,F., Li,X., Wang,Q., Ruan,Y., Xing,H., Lam,T.T., Pybus,O.G., Takebe,Y. and Shao,Y.",2013
JX140646,02_AG,2008,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N. and Gao,F.",
JX140647,02_AG,2008,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N. and Gao,F.",
JX140652,B,2005,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N. and Gao,F.",
JX140654,B,2008,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N. and Gao,F.",
JX140656,B,2009,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N. and Gao,F.",
JX140657,B,2009,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N. and Gao,F.",
JX140658,B,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N. and Gao,F.",
JX140659,B,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N. and Gao,F.",
JX140660,BF1,2009,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N. and Gao,F.",
JX140661,BF1,2009,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N. and Gao,F.",
JX140667,C,2009,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N. and Gao,F.",
JX140668,C,2009,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N. and Gao,F.",
JX140670,D,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N. and Gao,F.",
JX140671,F1,2011,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N. and Gao,F.",
JX140672,F2,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N. and Gao,F.",
JX140673,F2,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N. and Gao,F.",
JX140676,G,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N. and Gao,F.",
JX140678,A1B,2009,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N. and Gao,F.",
JX140679,U,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N. and Gao,F.",
JX202955,D,2005,23123038,"Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones","Baalwa,J., Wang,S., Parrish,N.F., Decker,J.M., Keele,B.F., Learn,G.H., Yue,L., Ruzagira,E., Ssemwanga,D., Kamali,A., Amornkul,P.N., Price,M.A., Kappes,J.C., Karita,E., Kaleebu,P., Sanders,E., Gilmour,J., Allen,S., Hunter,E., Montefiori,D.C., Haynes,B.F., Cormier,E., Hahn,B.H. and Shaw,G.M.",2013
JX202976,D,2007,23123038,"Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones","Baalwa,J., Wang,S., Parrish,N.F., Decker,J.M., Keele,B.F., Learn,G.H., Yue,L., Ruzagira,E., Ssemwanga,D., Kamali,A., Amornkul,P.N., Price,M.A., Kappes,J.C., Karita,E., Kaleebu,P., Sanders,E., Gilmour,J., Allen,S., Hunter,E., Montefiori,D.C., Haynes,B.F., Cormier,E., Hahn,B.H. and Shaw,G.M.",2013
JX203061,D,2008,23123038,"Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones","Baalwa,J., Wang,S., Parrish,N.F., Decker,J.M., Keele,B.F., Learn,G.H., Yue,L., Ruzagira,E., Ssemwanga,D., Kamali,A., Amornkul,P.N., Price,M.A., Kappes,J.C., Karita,E., Kaleebu,P., Sanders,E., Gilmour,J., Allen,S., Hunter,E., Montefiori,D.C., Haynes,B.F., Cormier,E., Hahn,B.H. and Shaw,G.M.",2013
JX203082,D,2007,23123038,"Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones","Baalwa,J., Wang,S., Parrish,N.F., Decker,J.M., Keele,B.F., Learn,G.H., Yue,L., Ruzagira,E., Ssemwanga,D., Kamali,A., Amornkul,P.N., Price,M.A., Kappes,J.C., Karita,E., Kaleebu,P., Sanders,E., Gilmour,J., Allen,S., Hunter,E., Montefiori,D.C., Haynes,B.F., Cormier,E., Hahn,B.H. and Shaw,G.M.",2013
JX203100,A1D,2007,23123038,"Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones","Baalwa,J., Wang,S., Parrish,N.F., Decker,J.M., Keele,B.F., Learn,G.H., Yue,L., Ruzagira,E., Ssemwanga,D., Kamali,A., Amornkul,P.N., Price,M.A., Kappes,J.C., Karita,E., Kaleebu,P., Sanders,E., Gilmour,J., Allen,S., Hunter,E., Montefiori,D.C., Haynes,B.F., Cormier,E., Hahn,B.H. and Shaw,G.M.",2013
JX203116,A1D,2008,23123038,"Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones","Baalwa,J., Wang,S., Parrish,N.F., Decker,J.M., Keele,B.F., Learn,G.H., Yue,L., Ruzagira,E., Ssemwanga,D., Kamali,A., Amornkul,P.N., Price,M.A., Kappes,J.C., Karita,E., Kaleebu,P., Sanders,E., Gilmour,J., Allen,S., Hunter,E., Montefiori,D.C., Haynes,B.F., Cormier,E., Hahn,B.H. and Shaw,G.M.",2013
JX213352,C,2006,22995123,HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection,"Basu,D., Kraft,C.S., Murphy,M.K., Campbell,P.J., Yu,T., Hraber,P.T., Irene,C., Pinter,A., Chomba,E., Mulenga,J., Kilembe,W., Allen,S.A., Derdeyn,C.A. and Hunter,E.",2012
JX213359,C,2007,22995123,HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection,"Basu,D., Kraft,C.S., Murphy,M.K., Campbell,P.J., Yu,T., Hraber,P.T., Irene,C., Pinter,A., Chomba,E., Mulenga,J., Kilembe,W., Allen,S.A., Derdeyn,C.A. and Hunter,E.",2012
JX213375,C,2002,22995123,HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection,"Basu,D., Kraft,C.S., Murphy,M.K., Campbell,P.J., Yu,T., Hraber,P.T., Irene,C., Pinter,A., Chomba,E., Mulenga,J., Kilembe,W., Allen,S.A., Derdeyn,C.A. and Hunter,E.",2012
JX213387,C,2003,22995123,HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection,"Basu,D., Kraft,C.S., Murphy,M.K., Campbell,P.J., Yu,T., Hraber,P.T., Irene,C., Pinter,A., Chomba,E., Mulenga,J., Kilembe,W., Allen,S.A., Derdeyn,C.A. and Hunter,E.",2012
JX213405,C,2004,22995123,HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection,"Basu,D., Kraft,C.S., Murphy,M.K., Campbell,P.J., Yu,T., Hraber,P.T., Irene,C., Pinter,A., Chomba,E., Mulenga,J., Kilembe,W., Allen,S.A., Derdeyn,C.A. and Hunter,E.",2012
JX213416,C,2005,22995123,HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection,"Basu,D., Kraft,C.S., Murphy,M.K., Campbell,P.J., Yu,T., Hraber,P.T., Irene,C., Pinter,A., Chomba,E., Mulenga,J., Kilembe,W., Allen,S.A., Derdeyn,C.A. and Hunter,E.",2012
JX213435,C,2005,22995123,HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection,"Basu,D., Kraft,C.S., Murphy,M.K., Campbell,P.J., Yu,T., Hraber,P.T., Irene,C., Pinter,A., Chomba,E., Mulenga,J., Kilembe,W., Allen,S.A., Derdeyn,C.A. and Hunter,E.",2012
JX213443,C,2005,22995123,HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection,"Basu,D., Kraft,C.S., Murphy,M.K., Campbell,P.J., Yu,T., Hraber,P.T., Irene,C., Pinter,A., Chomba,E., Mulenga,J., Kilembe,W., Allen,S.A., Derdeyn,C.A. and Hunter,E.",2012
JX213454,C,2005,22995123,HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection,"Basu,D., Kraft,C.S., Murphy,M.K., Campbell,P.J., Yu,T., Hraber,P.T., Irene,C., Pinter,A., Chomba,E., Mulenga,J., Kilembe,W., Allen,S.A., Derdeyn,C.A. and Hunter,E.",2012
JX213464,C,2007,22995123,HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection,"Basu,D., Kraft,C.S., Murphy,M.K., Campbell,P.J., Yu,T., Hraber,P.T., Irene,C., Pinter,A., Chomba,E., Mulenga,J., Kilembe,W., Allen,S.A., Derdeyn,C.A. and Hunter,E.",2012
JX239287,C,2002,22995123,HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection,"Basu,D., Kraft,C.S., Murphy,M.K., Campbell,P.J., Yu,T., Hraber,P.T., Irene,C., Pinter,A., Chomba,E., Mulenga,J., Kilembe,W., Allen,S.A., Derdeyn,C.A. and Hunter,E.",2012
JX239327,C,2003,22995123,HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection,"Basu,D., Kraft,C.S., Murphy,M.K., Campbell,P.J., Yu,T., Hraber,P.T., Irene,C., Pinter,A., Chomba,E., Mulenga,J., Kilembe,W., Allen,S.A., Derdeyn,C.A. and Hunter,E.",2012
JX239342,C,2006,22995123,HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection,"Basu,D., Kraft,C.S., Murphy,M.K., Campbell,P.J., Yu,T., Hraber,P.T., Irene,C., Pinter,A., Chomba,E., Mulenga,J., Kilembe,W., Allen,S.A., Derdeyn,C.A. and Hunter,E.",2012
JX245014,O,,23409798,HIV Type-1 Group O Infection in Gabon: Low Prevalence Rate But Circulation of Genetically Diverse and Drug-Resistant HIV Type-1 Group O Strains,"Liegeois,F., Boue,V., Butel,C., Mouinga-Ondeme,A., Sica,J., Zamba,C., Peeters,M., Delaporte,E. and Rouet,F.",2013
JX245015,O,,23409798,HIV Type-1 Group O Infection in Gabon: Low Prevalence Rate But Circulation of Genetically Diverse and Drug-Resistant HIV Type-1 Group O Strains,"Liegeois,F., Boue,V., Butel,C., Mouinga-Ondeme,A., Sica,J., Zamba,C., Peeters,M., Delaporte,E. and Rouet,F.",2013
JX390611,53_01B,2010,22997419,Genome Sequences of a Novel HIV-1 CRF53_01B Identified in Malaysia,"Chow,W.Z., Al-Darraji,H., Lee,Y.M., Takebe,Y., Kamarulzaman,A. and Tee,K.K.",2012
JX390612,53_01B,2010,22997419,Genome Sequences of a Novel HIV-1 CRF53_01B Identified in Malaysia,"Chow,W.Z., Al-Darraji,H., Lee,Y.M., Takebe,Y., Kamarulzaman,A. and Tee,K.K.",2012
JX390977,54_01B,2008,22997423,Genome Sequence of a Novel HIV-1 Circulating Recombinant Form 54_01B from Malaysia,"Ng,K.T., Ong,L.Y., Takebe,Y., Kamarulzaman,A. and Tee,K.K.",2012
JX392378,07_BC,2006,,"Five new CRF07_BC near full-length sequences isolated from Sichuan, China","Meng,Z., Xin,R., Zhang,X. and Xu,J.",
JX392380,07_BC,2006,,"Five new CRF07_BC near full-length sequences isolated from Sichuan, China","Meng,Z., Xin,R., Zhang,X. and Xu,J.",
JX392381,07_BC,2006,,"Five new CRF07_BC near full-length sequences isolated from Sichuan, China","Meng,Z., Xin,R., Zhang,X. and Xu,J.",
JX392382,07_BC,2006,,"Five new CRF07_BC near full-length sequences isolated from Sichuan, China","Meng,Z., Xin,R., Zhang,X. and Xu,J.",
JX392383,07_BC,2006,,"Five new CRF07_BC near full-length sequences isolated from Sichuan, China","Meng,Z., Xin,R., Zhang,X. and Xu,J.",
JX392384,07_BC,2006,,"Five new CRF07_BC near full-length sequences isolated from Sichuan, China","Meng,Z., Xin,R., Zhang,X. and Xu,J.",
JX422199,B,2010,,Development of a panel of HIV-1 strains of different genetic foms,"Delgado,E., Cuevas,M.T., Fernandez Garcia,A., Pinilla,M., Sanchez,M., Marino,A., Cilla,G., Aguirrebengoa,K., Ojea,R., Castro,A., Miralles,C., Rodriguez,R., Lopez Alvarez,M.J., Portu,J.J., Thomson,M.M. and Perez Alvarez,L.",
JX422200,B,2010,,Development of a panel of HIV-1 strains of different genetic foms,"Delgado,E., Cuevas,M.T., Fernandez Garcia,A., Pinilla,M., Sanchez,M., Marino,A., Cilla,G., Aguirrebengoa,K., Ojea,R., Castro,A., Miralles,C., Rodriguez,R., Lopez Alvarez,M.J., Portu,J.J., Thomson,M.M. and Perez Alvarez,L.",
JX422206,F1,,,Development of a panel of HIV-1 strains of different genetic foms,"Delgado,E., Cuevas,M.T., Fernandez Garcia,A., Pinilla,M., Sanchez,M., Marino,A., Cilla,G., Aguirrebengoa,K., Ojea,R., Castro,A., Miralles,C., Rodriguez,R., Lopez Alvarez,M.J., Portu,J.J., Thomson,M.M. and Perez Alvarez,L.",
JX422207,F1,,,Development of a panel of HIV-1 strains of different genetic foms,"Delgado,E., Cuevas,M.T., Fernandez Garcia,A., Pinilla,M., Sanchez,M., Marino,A., Cilla,G., Aguirrebengoa,K., Ojea,R., Castro,A., Miralles,C., Rodriguez,R., Lopez Alvarez,M.J., Portu,J.J., Thomson,M.M. and Perez Alvarez,L.",
JX422210,F1,,,Development of a panel of HIV-1 strains of different genetic foms,"Delgado,E., Cuevas,M.T., Fernandez Garcia,A., Pinilla,M., Sanchez,M., Marino,A., Cilla,G., Aguirrebengoa,K., Ojea,R., Castro,A., Miralles,C., Rodriguez,R., Lopez Alvarez,M.J., Portu,J.J., Thomson,M.M. and Perez Alvarez,L.",
JX446655,01_AE,2008,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX446666,01_AE,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX446698,01_AE,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX446710,01_AE,2005,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX446728,01_AE,2007,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX446736,01_AE,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX446755,01_AE,2008,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX446775,01_AE,2007,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX446790,01_AE,2007,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX446795,B,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX446817,B,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX446837,01_AE,2007,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX446848,01_AE,2008,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX446853,01_AE,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX446873,01_AE,2007,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX446888,01_AE,2008,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX446898,01_AE,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX446910,01_AE,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX446916,01_AE,2007,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX446927,01B,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX446942,01_AE,2007,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX446960,01_AE,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX446976,01_AE,2005,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX446987,01_AE,2007,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX446997,01B,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447013,01_AE,2007,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447018,01_AE,2004,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447028,01_AE,2007,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447043,01_AE,2005,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447054,01_AE,2007,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447063,01_AE,2007,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447072,01_AE,2008,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447077,01_AE,2005,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447087,01_AE,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447102,01_AE,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447117,01_AE,2007,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447122,01_AE,2008,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447132,01_AE,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447146,02_AG,2007,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447156,B,2007,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447177,01_AE,2007,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447199,01_AE,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447220,01_AE,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447235,01_AE,2009,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447252,01_AE,2007,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447266,01_AE,2005,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447283,01_AE,2007,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447294,01_AE,2005,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447300,01_AE,2008,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447305,01_AE,2008,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447310,01_AE,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447315,01_AE,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447328,01_AE,2008,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447344,01_AE,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447349,01_AE,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447359,01_AE,2008,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447379,01_AE,2007,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447395,01_AE,2005,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447402,01_AE,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447412,01_AE,2005,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447427,01_AE,2007,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447447,01_AE,2005,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447454,01_AE,2008,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447465,01_AE,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447480,01_AE,2007,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447493,01_AE,2008,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447499,01_AE,2007,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447515,01_AE,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447529,01_AE,2004,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447535,01_AE,2004,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447550,01_AE,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447559,01_AE,2005,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447579,01_AE,2005,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447589,01_AE,2005,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447608,01_AE,2007,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447637,01_AE,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447657,01_AE,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447668,01B,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447678,01_AE,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447699,01_AE,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447709,01_AE,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447721,01_AE,2007,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447726,01_AE,2009,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447746,01_AE,2007,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447773,01_AE,2007,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447795,B,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447814,01_AE,2005,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447827,01B,2005,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447833,01B,2007,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447853,01_AE,2005,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447874,01_AE,2007,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447884,01_AE,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447902,01_AE,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447921,01_AE,2005,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447941,01_AE,2008,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447958,01_AE,2005,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX447978,01_AE,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX448001,01_AE,2007,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX448016,01B,2005,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX448019,01_AE,2005,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX448028,01_AE,2008,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX448039,01_AE,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX448051,01_AE,2008,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX448057,01_AE,2009,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX448071,01_AE,2008,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX448086,01_AE,2008,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX448101,B,2008,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX448198,01_AE,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX448217,01_AE,2005,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX448238,01_AE,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX448253,01_AE,2005,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX448270,01_AE,2005,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX448279,01_AE,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX448289,01_AE,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX448301,01_AE,2006,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX448312,01_AE,2008,22960785,Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2,"Rolland,M., Edlefsen,P.T., Larsen,B.B., Tovanabutra,S., Sanders-Buell,E., Hertz,T., deCamp,A.C., Carrico,C., Menis,S., Magaret,C.A., Ahmed,H., Juraska,M., Chen,L., Konopa,P., Nariya,S., Stoddard,J.N., Wong,K., Zhao,H., Deng,W., Maust,B.S., Bose,M., Howell,S., Bates,A., Lazzaro,M., O'Sullivan,A., Lei,E., Bradfield,A., Ibitamuno,G., Assawadarachai,V., O'Connell,R.J., deSouza,M.S., Nitayaphan,S., Rerks-Ngarm,S., Robb,M.L., McLellan,J.S., Georgiev,I., Kwong,P.D., Carlson,J.M., Michael,N.L., Schief,W.R., Gilbert,P.B., Mullins,J.I. and Kim,J.H.",2012
JX500695,A6,2010,24279614,"HIV-1 Genetic Diversity in Russia: CRF63_02A1, a New HIV Type 1 Genetic Variant Spreading in Siberia","Baryshev,P.B., Bogachev,V.V. and Gashnikova,N.M.",2014
JX500696,A6,2010,24279614,"HIV-1 Genetic Diversity in Russia: CRF63_02A1, a New HIV Type 1 Genetic Variant Spreading in Siberia","Baryshev,P.B., Bogachev,V.V. and Gashnikova,N.M.",2014
JX500699,63_02A1,2011,24279614,"HIV-1 Genetic Diversity in Russia: CRF63_02A1, a New HIV Type 1 Genetic Variant Spreading in Siberia","Baryshev,P.B., Bogachev,V.V. and Gashnikova,N.M.",2014
JX500700,63_02A1,2010,24279614,"HIV-1 Genetic Diversity in Russia: CRF63_02A1, a New HIV Type 1 Genetic Variant Spreading in Siberia","Baryshev,P.B., Bogachev,V.V. and Gashnikova,N.M.",2014
JX500701,63_02A1,2009,24279614,"HIV-1 Genetic Diversity in Russia: CRF63_02A1, a New HIV Type 1 Genetic Variant Spreading in Siberia","Baryshev,P.B., Bogachev,V.V. and Gashnikova,N.M.",2014
JX500702,63_02A1,2010,24279614,"HIV-1 Genetic Diversity in Russia: CRF63_02A1, a New HIV Type 1 Genetic Variant Spreading in Siberia","Baryshev,P.B., Bogachev,V.V. and Gashnikova,N.M.",2014
JX500703,02A1,2010,24279614,"HIV-1 Genetic Diversity in Russia: CRF63_02A1, a New HIV Type 1 Genetic Variant Spreading in Siberia","Baryshev,P.B., Bogachev,V.V. and Gashnikova,N.M.",2014
JX500704,63_02A1,2010,24279614,"HIV-1 Genetic Diversity in Russia: CRF63_02A1, a New HIV Type 1 Genetic Variant Spreading in Siberia","Baryshev,P.B., Bogachev,V.V. and Gashnikova,N.M.",2014
JX500707,B,2010,,"Genetic analysis of nearly full-length genome sequences of HIV-1, circulating in Russia","Baryshev,P.B., Gashnikova,N.M. and Bogachev,V.V.",
JX500708,B,2011,,"Genetic analysis of nearly full-length genome sequences of HIV-1, circulating in Russia","Baryshev,P.B., Gashnikova,N.M. and Bogachev,V.V.",
JX500709,B,2009,,"Genetic analysis of nearly full-length genome sequences of HIV-1, circulating in Russia","Baryshev,P.B., Gashnikova,N.M. and Bogachev,V.V.",
JX503071,B,,22962364,Complete viral RNA genome sequencing of ultra-low copy samples by sequence-independent amplification,"Malboeuf,C.M., Yang,X., Charlebois,P., Qu,J., Berlin,A.M., Casali,M., Pesko,K.N., Boutwell,C.L., DeVincenzo,J.P., Ebel,G.D., Allen,T.M., Zody,M.C., Henn,M.R. and Levin,J.Z.",2013
JX503074,B,,22962364,Complete viral RNA genome sequencing of ultra-low copy samples by sequence-independent amplification,"Malboeuf,C.M., Yang,X., Charlebois,P., Qu,J., Berlin,A.M., Casali,M., Pesko,K.N., Boutwell,C.L., DeVincenzo,J.P., Ebel,G.D., Allen,T.M., Zody,M.C., Henn,M.R. and Levin,J.Z.",2013
JX503075,B,,22962364,Complete viral RNA genome sequencing of ultra-low copy samples by sequence-independent amplification,"Malboeuf,C.M., Yang,X., Charlebois,P., Qu,J., Berlin,A.M., Casali,M., Pesko,K.N., Boutwell,C.L., DeVincenzo,J.P., Ebel,G.D., Allen,T.M., Zody,M.C., Henn,M.R. and Levin,J.Z.",2013
JX508855,A1,2001,23874931,HIV-1 Autologous Antibody Neutralization Associates with Mother to Child Transmission,"Baan,E., de Ronde,A., Stax,M., Sanders,R.W., Luchters,S., Vyankandondera,J., Lange,J.M., Pollakis,G. and Paxton,W.A.",2013
JX508857,A1,2001,23874931,HIV-1 Autologous Antibody Neutralization Associates with Mother to Child Transmission,"Baan,E., de Ronde,A., Stax,M., Sanders,R.W., Luchters,S., Vyankandondera,J., Lange,J.M., Pollakis,G. and Paxton,W.A.",2013
JX508859,A1,2001,23874931,HIV-1 Autologous Antibody Neutralization Associates with Mother to Child Transmission,"Baan,E., de Ronde,A., Stax,M., Sanders,R.W., Luchters,S., Vyankandondera,J., Lange,J.M., Pollakis,G. and Paxton,W.A.",2013
JX508862,A1,2001,23874931,HIV-1 Autologous Antibody Neutralization Associates with Mother to Child Transmission,"Baan,E., de Ronde,A., Stax,M., Sanders,R.W., Luchters,S., Vyankandondera,J., Lange,J.M., Pollakis,G. and Paxton,W.A.",2013
JX508863,C,2001,23874931,HIV-1 Autologous Antibody Neutralization Associates with Mother to Child Transmission,"Baan,E., de Ronde,A., Stax,M., Sanders,R.W., Luchters,S., Vyankandondera,J., Lange,J.M., Pollakis,G. and Paxton,W.A.",2013
JX508865,C,2001,23874931,HIV-1 Autologous Antibody Neutralization Associates with Mother to Child Transmission,"Baan,E., de Ronde,A., Stax,M., Sanders,R.W., Luchters,S., Vyankandondera,J., Lange,J.M., Pollakis,G. and Paxton,W.A.",2013
JX508866,A1,2001,23874931,HIV-1 Autologous Antibody Neutralization Associates with Mother to Child Transmission,"Baan,E., de Ronde,A., Stax,M., Sanders,R.W., Luchters,S., Vyankandondera,J., Lange,J.M., Pollakis,G. and Paxton,W.A.",2013
JX508868,A1,2001,23874931,HIV-1 Autologous Antibody Neutralization Associates with Mother to Child Transmission,"Baan,E., de Ronde,A., Stax,M., Sanders,R.W., Luchters,S., Vyankandondera,J., Lange,J.M., Pollakis,G. and Paxton,W.A.",2013
JX508873,C,2001,23874931,HIV-1 Autologous Antibody Neutralization Associates with Mother to Child Transmission,"Baan,E., de Ronde,A., Stax,M., Sanders,R.W., Luchters,S., Vyankandondera,J., Lange,J.M., Pollakis,G. and Paxton,W.A.",2013
JX508875,A1,2001,23874931,HIV-1 Autologous Antibody Neutralization Associates with Mother to Child Transmission,"Baan,E., de Ronde,A., Stax,M., Sanders,R.W., Luchters,S., Vyankandondera,J., Lange,J.M., Pollakis,G. and Paxton,W.A.",2013
JX508877,A1,2001,23874931,HIV-1 Autologous Antibody Neutralization Associates with Mother to Child Transmission,"Baan,E., de Ronde,A., Stax,M., Sanders,R.W., Luchters,S., Vyankandondera,J., Lange,J.M., Pollakis,G. and Paxton,W.A.",2013
JX508878,A1,2001,23874931,HIV-1 Autologous Antibody Neutralization Associates with Mother to Child Transmission,"Baan,E., de Ronde,A., Stax,M., Sanders,R.W., Luchters,S., Vyankandondera,J., Lange,J.M., Pollakis,G. and Paxton,W.A.",2013
JX508880,A1,2001,23874931,HIV-1 Autologous Antibody Neutralization Associates with Mother to Child Transmission,"Baan,E., de Ronde,A., Stax,M., Sanders,R.W., Luchters,S., Vyankandondera,J., Lange,J.M., Pollakis,G. and Paxton,W.A.",2013
JX508881,A1,2001,23874931,HIV-1 Autologous Antibody Neutralization Associates with Mother to Child Transmission,"Baan,E., de Ronde,A., Stax,M., Sanders,R.W., Luchters,S., Vyankandondera,J., Lange,J.M., Pollakis,G. and Paxton,W.A.",2013
JX508883,A1,2001,23874931,HIV-1 Autologous Antibody Neutralization Associates with Mother to Child Transmission,"Baan,E., de Ronde,A., Stax,M., Sanders,R.W., Luchters,S., Vyankandondera,J., Lange,J.M., Pollakis,G. and Paxton,W.A.",2013
JX508884,A1C,2001,23874931,HIV-1 Autologous Antibody Neutralization Associates with Mother to Child Transmission,"Baan,E., de Ronde,A., Stax,M., Sanders,R.W., Luchters,S., Vyankandondera,J., Lange,J.M., Pollakis,G. and Paxton,W.A.",2013
JX512892,01_AE,2009,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Sanders-Buell,E., Montefiori,D., Seaman,M., Williamson,C., Hahn,B., Gao,F., Swanstrom,R., Bradfield,A., Lei,E., Rutvisuttinunt,W., Assawadarachai,V., Heipertz,R., De Souza,M., Ananworanich,J., Kim,J. and Tovanabutra,S.",
JX512893,01_AE,2009,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Sanders-Buell,E., Montefiori,D., Seaman,M., Williamson,C., Hahn,B., Gao,F., Swanstrom,R., Bradfield,A., Lei,E., Rutvisuttinunt,W., Assawadarachai,V., Heipertz,R., De Souza,M., Ananworanich,J., Kim,J. and Tovanabutra,S.",
JX512894,01_AE,2009,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Sanders-Buell,E., Montefiori,D., Seaman,M., Williamson,C., Hahn,B., Gao,F., Swanstrom,R., Bradfield,A., Lei,E., Rutvisuttinunt,W., Assawadarachai,V., Heipertz,R., De Souza,M., Ananworanich,J., Kim,J. and Tovanabutra,S.",
JX512895,01_AE,2009,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Sanders-Buell,E., Montefiori,D., Seaman,M., Williamson,C., Hahn,B., Gao,F., Swanstrom,R., Bradfield,A., Lei,E., Rutvisuttinunt,W., Assawadarachai,V., Heipertz,R., De Souza,M., Ananworanich,J., Kim,J. and Tovanabutra,S.",
JX512896,01_AE,2009,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Sanders-Buell,E., Montefiori,D., Seaman,M., Williamson,C., Hahn,B., Gao,F., Swanstrom,R., Bradfield,A., Lei,E., Rutvisuttinunt,W., Assawadarachai,V., Heipertz,R., De Souza,M., Ananworanich,J., Kim,J. and Tovanabutra,S.",
JX512898,01_AE,2009,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Sanders-Buell,E., Montefiori,D., Seaman,M., Williamson,C., Hahn,B., Gao,F., Swanstrom,R., Bradfield,A., Lei,E., Rutvisuttinunt,W., Assawadarachai,V., Heipertz,R., De Souza,M., Ananworanich,J., Kim,J. and Tovanabutra,S.",
JX512899,D,2001,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Sanders-Buell,E., Montefiori,D., Seaman,M., Williamson,C., Hahn,B., Gao,F., Swanstrom,R., Serwadda,D., Sewankambo,N., Kigozi,G., Kiwanuka,N., Phillips,J.B., Wabwire,F., Lutalo,T., Lane,J.R., Laeyendecker,O., Gray,R., Wawer,M., Birx,D.L., Robb,M.L., McCutchan,F.E., O Sullivan,A.M., Lei,E., Kim,J. and Tovanabutra,S.",
JX512901,01_AE,2009,,CAVD/CA-VIMC Neutralization Serotype Discovery Project,"Sanders-Buell,E., Montefiori,D., Seaman,M., Williamson,C., Hahn,B., Gao,F., Swanstrom,R., Bradfield,A., Lei,E., Heipertz,R., De Souza,M., Eller,L.A., Robb,M.L., Kim,J. and Tovanabutra,S.",
JX574661,55_01B,2010,23405298,"Genome Sequences of a Novel HIV-1 Circulating Recombinant Form, CRF55_01B, Identified in China","Han,X., An,M., Zhang,W., Cai,W., Chen,X., Takebe,Y. and Shang,H.",2013
JX574662,55_01B,2011,23405298,"Genome Sequences of a Novel HIV-1 Circulating Recombinant Form, CRF55_01B, Identified in China","Han,X., An,M., Zhang,W., Cai,W., Chen,X., Takebe,Y. and Shang,H.",2013
JX574663,55_01B,2011,23405298,"Genome Sequences of a Novel HIV-1 Circulating Recombinant Form, CRF55_01B, Identified in China","Han,X., An,M., Zhang,W., Cai,W., Chen,X., Takebe,Y. and Shang,H.",2013
JX658588,D,2005,22997233,Previously transmitted HIV-1 strains are preferentially selected during subsequent sexual transmissions,"Redd,A.D., Collinson-Streng,A.N., Chatziandreou,N., Mullis,C.E., Laeyendecker,O., Martens,C., Ricklefs,S., Kiwanuka,N., Nyein,P.H., Lutalo,T., Grabowski,M.K., Kong,X., Manucci,J., Sewankambo,N., Wawer,M.J., Gray,R.H., Porcella,S.F., Fauci,A.S., Sagar,M., Serwadda,D. and Quinn,T.C.",2012
JX658600,D,2005,22997233,Previously transmitted HIV-1 strains are preferentially selected during subsequent sexual transmissions,"Redd,A.D., Collinson-Streng,A.N., Chatziandreou,N., Mullis,C.E., Laeyendecker,O., Martens,C., Ricklefs,S., Kiwanuka,N., Nyein,P.H., Lutalo,T., Grabowski,M.K., Kong,X., Manucci,J., Sewankambo,N., Wawer,M.J., Gray,R.H., Porcella,S.F., Fauci,A.S., Sagar,M., Serwadda,D. and Quinn,T.C.",2012
JX658625,A1D,2004,22997233,Previously transmitted HIV-1 strains are preferentially selected during subsequent sexual transmissions,"Redd,A.D., Collinson-Streng,A.N., Chatziandreou,N., Mullis,C.E., Laeyendecker,O., Martens,C., Ricklefs,S., Kiwanuka,N., Nyein,P.H., Lutalo,T., Grabowski,M.K., Kong,X., Manucci,J., Sewankambo,N., Wawer,M.J., Gray,R.H., Porcella,S.F., Fauci,A.S., Sagar,M., Serwadda,D. and Quinn,T.C.",2012
JX658657,A1D,2006,22997233,Previously transmitted HIV-1 strains are preferentially selected during subsequent sexual transmissions,"Redd,A.D., Collinson-Streng,A.N., Chatziandreou,N., Mullis,C.E., Laeyendecker,O., Martens,C., Ricklefs,S., Kiwanuka,N., Nyein,P.H., Lutalo,T., Grabowski,M.K., Kong,X., Manucci,J., Sewankambo,N., Wawer,M.J., Gray,R.H., Porcella,S.F., Fauci,A.S., Sagar,M., Serwadda,D. and Quinn,T.C.",2012
JX679207,57_BC,2009,23056447,"Recombination Form and Epidemiology of HIV-1 Unique Recombinant Strains Identified in Yunnan, China","Li,L., Chen,L., Yang,S., Li,T., Li,J., Liu,Y., Jia,L., Yang,B., Bao,Z., Li,H., Wang,X., Zhuang,D., Liu,S. and Li,J.",2012
JX845585,C,2000,23151449,Pilot study on the immunogenicity of paired Env immunogens from mother-to-child transmitted HIV-1 isolates,"Wang,S., Kishko,M., Wan,S., Wang,Y., Brewster,F., Gray,G.E., Violari,A., Sullivan,J.L., Somasundaran,M., Luzuriaga,K. and Lu,S.",2012
JX845589,C,2000,23151449,Pilot study on the immunogenicity of paired Env immunogens from mother-to-child transmitted HIV-1 isolates,"Wang,S., Kishko,M., Wan,S., Wang,Y., Brewster,F., Gray,G.E., Violari,A., Sullivan,J.L., Somasundaran,M., Luzuriaga,K. and Lu,S.",2012
JX845592,C,2000,23151449,Pilot study on the immunogenicity of paired Env immunogens from mother-to-child transmitted HIV-1 isolates,"Wang,S., Kishko,M., Wan,S., Wang,Y., Brewster,F., Gray,G.E., Violari,A., Sullivan,J.L., Somasundaran,M., Luzuriaga,K. and Lu,S.",2012
JX845596,C,2000,23151449,Pilot study on the immunogenicity of paired Env immunogens from mother-to-child transmitted HIV-1 isolates,"Wang,S., Kishko,M., Wan,S., Wang,Y., Brewster,F., Gray,G.E., Violari,A., Sullivan,J.L., Somasundaran,M., Luzuriaga,K. and Lu,S.",2012
JX845599,C,2000,23151449,Pilot study on the immunogenicity of paired Env immunogens from mother-to-child transmitted HIV-1 isolates,"Wang,S., Kishko,M., Wan,S., Wang,Y., Brewster,F., Gray,G.E., Violari,A., Sullivan,J.L., Somasundaran,M., Luzuriaga,K. and Lu,S.",2012
JX845602,C,2000,23151449,Pilot study on the immunogenicity of paired Env immunogens from mother-to-child transmitted HIV-1 isolates,"Wang,S., Kishko,M., Wan,S., Wang,Y., Brewster,F., Gray,G.E., Violari,A., Sullivan,J.L., Somasundaran,M., Luzuriaga,K. and Lu,S.",2012
JX845604,C,2000,23151449,Pilot study on the immunogenicity of paired Env immunogens from mother-to-child transmitted HIV-1 isolates,"Wang,S., Kishko,M., Wan,S., Wang,Y., Brewster,F., Gray,G.E., Violari,A., Sullivan,J.L., Somasundaran,M., Luzuriaga,K. and Lu,S.",2012
JX845608,C,2000,23151449,Pilot study on the immunogenicity of paired Env immunogens from mother-to-child transmitted HIV-1 isolates,"Wang,S., Kishko,M., Wan,S., Wang,Y., Brewster,F., Gray,G.E., Violari,A., Sullivan,J.L., Somasundaran,M., Luzuriaga,K. and Lu,S.",2012
JX845611,C,2000,23151449,Pilot study on the immunogenicity of paired Env immunogens from mother-to-child transmitted HIV-1 isolates,"Wang,S., Kishko,M., Wan,S., Wang,Y., Brewster,F., Gray,G.E., Violari,A., Sullivan,J.L., Somasundaran,M., Luzuriaga,K. and Lu,S.",2012
JX845612,C,2000,23151449,Pilot study on the immunogenicity of paired Env immunogens from mother-to-child transmitted HIV-1 isolates,"Wang,S., Kishko,M., Wan,S., Wang,Y., Brewster,F., Gray,G.E., Violari,A., Sullivan,J.L., Somasundaran,M., Luzuriaga,K. and Lu,S.",2012
JX848346,01_AE,,25793890,Glycans Flanking the Hypervariable Connecting Peptide between the A and B Strands of the V1/V2 Domain of HIV-1 gp120 Confer Resistance to Antibodies That Neutralize CRF01_AE Viruses,"O'Rourke,S.M., Sutthent,R., Phung,P., Mesa,K.A., Frigon,N.L., To,B., Horthongkham,N., Limoli,K., Wrin,T. and Berman,P.W.",2015
JX848348,01_AE,,25793890,Glycans Flanking the Hypervariable Connecting Peptide between the A and B Strands of the V1/V2 Domain of HIV-1 gp120 Confer Resistance to Antibodies That Neutralize CRF01_AE Viruses,"O'Rourke,S.M., Sutthent,R., Phung,P., Mesa,K.A., Frigon,N.L., To,B., Horthongkham,N., Limoli,K., Wrin,T. and Berman,P.W.",2015
JX848350,01_AE,,25793890,Glycans Flanking the Hypervariable Connecting Peptide between the A and B Strands of the V1/V2 Domain of HIV-1 gp120 Confer Resistance to Antibodies That Neutralize CRF01_AE Viruses,"O'Rourke,S.M., Sutthent,R., Phung,P., Mesa,K.A., Frigon,N.L., To,B., Horthongkham,N., Limoli,K., Wrin,T. and Berman,P.W.",2015
JX863919,B,2005,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX863920,01_AE,2005,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX863921,B,2007,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX863922,B,2007,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX863923,B,2009,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX863924,B,2009,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX863965,B,2005,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX863966,B,2005,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX863967,B,2002,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX863968,B,2004,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX863969,B,2004,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX863970,B,2004,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX863971,B,2005,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX863972,B,2005,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX863983,B,2005,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX863984,B,2005,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX863985,B,2005,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX863986,B,2005,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX863987,B,2006,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX863988,B,2006,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX863989,B,2006,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX863990,B,2006,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX863991,B,2006,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX863992,B,2006,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX863993,B,2006,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX863994,B,2007,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX863995,B,2007,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX864006,B,2007,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX864007,B,2007,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX864008,B,2007,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX864019,B,2007,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX864020,B,2007,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX864021,B,2007,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX864022,B,2007,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX864023,B,2008,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX864024,B,2008,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX864025,B,2008,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX864026,B,2008,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX864027,B,2009,23972100,"Molecular Epidemiology of Early and Acute HIV Type 1 Infections in the United States Navy and Marine Corps, 2005-2010","Heipertz,R.A. Jr., Sanders-Buell,E., Kijak,G., Howell,S., Lazzaro,M., Jagodzinski,L.L., Eggleston,J., Peel,S., Malia,J., Armstrong,A., Michael,N.L., Kim,J.H., O'Connell,R.J., Scott,P.T., Brett-Major,D.M. and Tovanabutra,S.",2013
JX877522,A1,2007,,"Molecular detection, cloning and characterization of HIV-1 subtype A, D and AD transmitted/founder infectious molecular clones","Baalwa,J., Kaleebu,P., Hahn,B.H. and Shaw,G.M.",
JX960597,B,2009,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960598,B,2009,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960599,B,2009,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960600,07_BC,2009,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960601,07_BC,2008,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960602,07_BC,2009,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960603,01_AE,2009,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960604,01_AE,2009,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960605,01_AE,2009,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960606,01_AE,2008,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960607,01_AE,2009,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960608,01_AE,2010,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960609,01_AE,2010,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960610,01_AE,2010,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960611,01_AE,2010,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960612,01_AE,2008,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960613,01_AE,2009,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960614,01_AE,2009,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960615,01_AE,2009,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960616,01_AE,2010,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960617,01_AE,2008,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960618,01_AE,2009,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960619,01_AE,2010,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960620,01_AE,2010,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960621,01_AE,2009,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960622,01_AE,2010,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960623,01_AE,2009,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960624,01_AE,2010,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960625,01_AE,2009,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960626,01_AE,2009,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960627,01_AE,2009,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960628,01_AE,2009,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960629,01_AE,2009,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960630,01_AE,2009,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960631,01_AE,2009,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960632,01_AE,2010,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960633,01_AE,2010,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960634,01_AE,2009,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960635,59_01B,2009,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960636,01_AE,2009,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960637,01_AE,2010,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960638,01_AE,2009,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX960639,01_AE,2009,22933290,"Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China","An,M., Han,X., Xu,J., Chu,Z., Jia,M., Wu,H., Lu,L., Takebe,Y. and Shang,H.",2012
JX972390,B,2008,23221345,Vertical T cell immunodominance and epitope entropy determine HIV-1 escape,"Liu,M.K., Hawkins,N., Ritchie,A.J., Ganusov,V.V., Whale,V., Brackenridge,S., Li,H., Pavlicek,J.W., Cai,F., Rose-Abrahams,M., Treurnicht,F., Hraber,P., Riou,C., Gray,C., Ferrari,G., Tanner,R., Ping,L.H., Anderson,J.A., Swanstrom,R., Cohen,M., Karim,S.S., Haynes,B., Borrow,P., Perelson,A.S., Shaw,G.M., Hahn,B.H., Williamson,C., Korber,B.T., Gao,F., Self,S., McMichael,A. and Goonetilleke,N.",2013
JX972931,C,2007,23221345,Vertical T cell immunodominance and epitope entropy determine HIV-1 escape,"Liu,M.K., Hawkins,N., Ritchie,A.J., Ganusov,V.V., Whale,V., Brackenridge,S., Li,H., Pavlicek,J.W., Cai,F., Rose-Abrahams,M., Treurnicht,F., Hraber,P., Riou,C., Gray,C., Ferrari,G., Tanner,R., Ping,L.H., Anderson,J.A., Swanstrom,R., Cohen,M., Karim,S.S., Haynes,B., Borrow,P., Perelson,A.S., Shaw,G.M., Hahn,B.H., Williamson,C., Korber,B.T., Gao,F., Self,S., McMichael,A. and Goonetilleke,N.",2013
JX972986,C,2007,23221345,Vertical T cell immunodominance and epitope entropy determine HIV-1 escape,"Liu,M.K., Hawkins,N., Ritchie,A.J., Ganusov,V.V., Whale,V., Brackenridge,S., Li,H., Pavlicek,J.W., Cai,F., Rose-Abrahams,M., Treurnicht,F., Hraber,P., Riou,C., Gray,C., Ferrari,G., Tanner,R., Ping,L.H., Anderson,J.A., Swanstrom,R., Cohen,M., Karim,S.S., Haynes,B., Borrow,P., Perelson,A.S., Shaw,G.M., Hahn,B.H., Williamson,C., Korber,B.T., Gao,F., Self,S., McMichael,A. and Goonetilleke,N.",2013
JX973075,C,2007,23221345,Vertical T cell immunodominance and epitope entropy determine HIV-1 escape,"Liu,M.K., Hawkins,N., Ritchie,A.J., Ganusov,V.V., Whale,V., Brackenridge,S., Li,H., Pavlicek,J.W., Cai,F., Rose-Abrahams,M., Treurnicht,F., Hraber,P., Riou,C., Gray,C., Ferrari,G., Tanner,R., Ping,L.H., Anderson,J.A., Swanstrom,R., Cohen,M., Karim,S.S., Haynes,B., Borrow,P., Perelson,A.S., Shaw,G.M., Hahn,B.H., Williamson,C., Korber,B.T., Gao,F., Self,S., McMichael,A. and Goonetilleke,N.",2013
JX973171,C,2007,23221345,Vertical T cell immunodominance and epitope entropy determine HIV-1 escape,"Liu,M.K., Hawkins,N., Ritchie,A.J., Ganusov,V.V., Whale,V., Brackenridge,S., Li,H., Pavlicek,J.W., Cai,F., Rose-Abrahams,M., Treurnicht,F., Hraber,P., Riou,C., Gray,C., Ferrari,G., Tanner,R., Ping,L.H., Anderson,J.A., Swanstrom,R., Cohen,M., Karim,S.S., Haynes,B., Borrow,P., Perelson,A.S., Shaw,G.M., Hahn,B.H., Williamson,C., Korber,B.T., Gao,F., Self,S., McMichael,A. and Goonetilleke,N.",2013
K02007,B,1983,2578227,Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2),"Sanchez-Pescador,R., Power,M.D., Barr,P.J., Steimer,K.S., Stempien,M.M., Brown-Shimer,S.L., Gee,W.W., Renard,A., Randolph,A., Levy,J.A., Dina,D. and Luciw,P.A.",1985
K03458,D,1985,3036660,Molecular characterization of human immunodeficiency virus from Zaire: nucleotide sequence analysis identifies conserved and variable domains in the envelope gene,"Srinivasan,A., Anand,R., York,D., Ranganathan,P., Feorino,P., Schochetman,G., Curran,J., Kalyanaraman,V.S., Luciw,P.A. and Sanchez-Pescador,R.",1987
KC112999,B,2011,,Direct Submission,"Delgado,E., Thomson,M., Fernandez-Garcia,A., Cuevas,T. and Perez-Alvarez,L.",2012
KC113001,A1DG,2009,,Direct Submission,"Delgado,E., Thomson,M., Fernandez-Garcia,A., Cuevas,T. and Perez-Alvarez,L.",2012
KC148637,C,2007,,Analysis of recombinant viral genomes in individuals infected with multiple transmitted/founder HIV-1 strains,"Song,H., Cai,F., Chen,S., Hoper,J., Jiang,C. and Gao,F.",
KC149470,C,2007,,Analysis of recombinant viral genomes in individuals infected with multiple transmitted/founder HIV-1 strains,"Song,H., Cai,F., Chen,S., Hoper,J., Jiang,C. and Gao,F.",
KC154012,C,2004,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
KC154013,C,2005,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
KC154014,C,2005,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
KC154015,C,2006,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
KC154016,C,2008,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
KC154017,C,2008,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
KC154018,C,2008,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
KC154019,C,2008,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
KC154020,C,2008,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
KC154021,C,2008,,Direct Submission,"Thebus,R., Rademeyer,C. and Williamson,C.",2012
KC154022,C,2008,,Direct Submission,"Thebus,R., Rademeyer,C. and Williamson,C.",2012
KC154023,C,2008,,Direct Submission,"Thebus,R., Rademeyer,C. and Williamson,C.",2012
KC154024,C,2008,,Direct Submission,"Thebus,R., Rademeyer,C. and Williamson,C.",2012
KC154025,C,2008,,Direct Submission,"Thebus,R., Rademeyer,C. and Williamson,C.",2012
KC154026,C,2009,,Direct Submission,"Thebus,R., Rademeyer,C. and Williamson,C.",2012
KC154027,C,2009,,Direct Submission,"Thebus,R., Rademeyer,C. and Williamson,C.",2012
KC154028,C,2010,,Direct Submission,"Thebus,R., Rademeyer,C. and Williamson,C.",2012
KC183774,01BC,2011,23372706,New Emerging Recombinant HIV-1 Strains and Close Transmission Linkage of HIV-1 Strains in the Chinese MSM Population Indicate a New Epidemic Risk,"Wu,J., Meng,Z., Xu,J., Lei,Y., Jin,L., Zhong,P., Han,R. and Su,B.",2013
KC183776,55_01B,2011,23372706,New Emerging Recombinant HIV-1 Strains and Close Transmission Linkage of HIV-1 Strains in the Chinese MSM Population Indicate a New Epidemic Risk,"Wu,J., Meng,Z., Xu,J., Lei,Y., Jin,L., Zhong,P., Han,R. and Su,B.",2013
KC183777,55_01B,2011,23372706,New Emerging Recombinant HIV-1 Strains and Close Transmission Linkage of HIV-1 Strains in the Chinese MSM Population Indicate a New Epidemic Risk,"Wu,J., Meng,Z., Xu,J., Lei,Y., Jin,L., Zhong,P., Han,R. and Su,B.",2013
KC183778,65_cpx,2011,23372706,New Emerging Recombinant HIV-1 Strains and Close Transmission Linkage of HIV-1 Strains in the Chinese MSM Population Indicate a New Epidemic Risk,"Wu,J., Meng,Z., Xu,J., Lei,Y., Jin,L., Zhong,P., Han,R. and Su,B.",2013
KC183779,67_01B,2011,23372706,New Emerging Recombinant HIV-1 Strains and Close Transmission Linkage of HIV-1 Strains in the Chinese MSM Population Indicate a New Epidemic Risk,"Wu,J., Meng,Z., Xu,J., Lei,Y., Jin,L., Zhong,P., Han,R. and Su,B.",2013
KC183780,67_01B,2011,23372706,New Emerging Recombinant HIV-1 Strains and Close Transmission Linkage of HIV-1 Strains in the Chinese MSM Population Indicate a New Epidemic Risk,"Wu,J., Meng,Z., Xu,J., Lei,Y., Jin,L., Zhong,P., Han,R. and Su,B.",2013
KC183781,01BC,2011,23372706,New Emerging Recombinant HIV-1 Strains and Close Transmission Linkage of HIV-1 Strains in the Chinese MSM Population Indicate a New Epidemic Risk,"Wu,J., Meng,Z., Xu,J., Lei,Y., Jin,L., Zhong,P., Han,R. and Su,B.",2013
KC183782,68_01B,2011,23372706,New Emerging Recombinant HIV-1 Strains and Close Transmission Linkage of HIV-1 Strains in the Chinese MSM Population Indicate a New Epidemic Risk,"Wu,J., Meng,Z., Xu,J., Lei,Y., Jin,L., Zhong,P., Han,R. and Su,B.",2013
KC183783,68_01B,2011,23372706,New Emerging Recombinant HIV-1 Strains and Close Transmission Linkage of HIV-1 Strains in the Chinese MSM Population Indicate a New Epidemic Risk,"Wu,J., Meng,Z., Xu,J., Lei,Y., Jin,L., Zhong,P., Han,R. and Su,B.",2013
KC186127,C,2009,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC186165,C,2010,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC186203,C,2010,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC186237,C,2009,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC186271,C,2009,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC186308,C,2009,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC186349,C,2009,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC186388,C,2009,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC186421,C,2010,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC186457,C,2009,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC186498,C,2010,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC186544,A1GJ,2010,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC186577,C,2010,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC186611,C,2009,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC186650,C,2009,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC186693,C,2009,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC186730,C,2009,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC186771,C,2009,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC186814,C,2009,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC186855,A1C,2009,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC186893,C,2009,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC186934,C,2009,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC186976,C,2009,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC187022,C,2009,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC187067,C,2009,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC187107,C,2009,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC187145,C,2009,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC187179,C,2009,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC187216,U,2009,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC187247,C,2010,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC187280,C,2010,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC187314,C,2009,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC187349,C,2009,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC187374,C,2009,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC187417,C,2009,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC187461,C,2009,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC187499,C,2010,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC187538,C,2009,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC187577,C,2009,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC187611,C,2009,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC187627,C,2010,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC187662,C,2009,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC187699,C,2009,23300446,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,"Sturdevant,C.B., Dow,A., Jabara,C.B., Joseph,S.B., Schnell,G., Takamune,N., Mallewa,M., Heyderman,R.S., Van Rie,A. and Swanstrom,R.",2012
KC247375,C,2009,23552890,Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus,"Liao,H.X., Lynch,R., Zhou,T., Gao,F., Alam,S.M., Boyd,S.D., Fire,A.Z., Roskin,K.M., Schramm,C.A., Zhang,Z., Zhu,J., Shapiro,L., Becker,J., Benjamin,B., Blakesley,R., Bouffard,G., Brooks,S., Coleman,H., Dekhtyar,M., Gregory,M., Guan,X., Gupta,J., Han,J., Hargrove,A., Ho,S.L., Johnson,T., Legaspi,R., Lovett,S., Maduro,Q., Masiello,C., Maskeri,B., McDowell,J., Montemayor,C., Mullikin,J., Park,M., Riebow,N., Schandler,K., Schmidt,B., Sison,C., Stantripop,M., Thomas,J., Thomas,P., Vemulapalli,M., Young,A., Mullikin,J.C., Gnanakaran,S., Hraber,P., Wiehe,K., Kelsoe,G., Yang,G., Xia,S.M., Montefiori,D.C., Parks,R., Lloyd,K.E., Scearce,R.M., Soderberg,K.A., Cohen,M., Kamanga,G., Louder,M.K., Tran,L.M., Chen,Y., Cai,F., Chen,S., Moquin,S., Du,X., Joyce,M.G., Srivatsan,S., Zhang,B., Zheng,A., Shaw,G.M., Hahn,B.H., Kepler,T.B., Korber,B.T., Kwong,P.D., Mascola,J.R. and Haynes,B.F.",2013
KC462190,59_01B,2011,23792741,Genome Sequences of a Novel HIV-1 Circulating Recombinant Form (CRF59_01B) Identified among Men Who Have Sex with Men in Northeastern China,"Han,X., An,M., Zhang,W., Zhao,B., Chu,Z., Takebe,Y. and Shang,H.",2013
KC462191,59_01B,2010,23792741,Genome Sequences of a Novel HIV-1 Circulating Recombinant Form (CRF59_01B) Identified among Men Who Have Sex with Men in Northeastern China,"Han,X., An,M., Zhang,W., Zhao,B., Chu,Z., Takebe,Y. and Shang,H.",2013
KC473824,B,2009,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Busch,M., Stramer,S. and Gao,F.",
KC473825,B,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Busch,M., Stramer,S. and Gao,F.",
KC473826,B,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Busch,M., Stramer,S. and Gao,F.",
KC473827,B,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Busch,M., Stramer,S. and Gao,F.",
KC473828,B,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Busch,M., Stramer,S. and Gao,F.",
KC473829,B,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Busch,M., Stramer,S. and Gao,F.",
KC473830,B,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Busch,M., Stramer,S. and Gao,F.",
KC473831,B,2011,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Busch,M., Stramer,S. and Gao,F.",
KC473832,B,2011,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Busch,M., Stramer,S. and Gao,F.",
KC473833,B,2011,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Busch,M., Stramer,S. and Gao,F.",
KC473834,B,2011,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Busch,M., Stramer,S. and Gao,F.",
KC473835,B,2011,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Busch,M., Stramer,S. and Gao,F.",
KC473836,A1B,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Busch,M., Stramer,S. and Gao,F.",
KC473846,B,2003,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Busch,M., Tadokoro,K. and Gao,F.",
KC492737,07_BC,2005,24324545,"Construction and Characterization of Highly Infectious Full-Length Molecular Clones of a HIV-1 CRF07_BC Isolate from Xinjiang, China","Wang,Z., Hong,K., Zhang,J., Zhang,L., Li,D., Ren,L., Liang,H. and Shao,Y.",2013
KC522031,58_01B,2009,24465513,A Newly Emerging HIV-1 Recombinant Lineage (CRF58_01B) Disseminating among People Who Inject Drugs in Malaysia,"Chow,W.Z., Takebe,Y., Syafina,N.E., Prakasa,M.S., Chan,K.G., Al-Darraji,H.A., Koh,C., Kamarulzaman,A. and Tee,K.K.",2014
KC522032,58_01B,2011,24465513,A Newly Emerging HIV-1 Recombinant Lineage (CRF58_01B) Disseminating among People Who Inject Drugs in Malaysia,"Chow,W.Z., Takebe,Y., Syafina,N.E., Prakasa,M.S., Chan,K.G., Al-Darraji,H.A., Koh,C., Kamarulzaman,A. and Tee,K.K.",2014
KC522033,58_01B,2011,24465513,A Newly Emerging HIV-1 Recombinant Lineage (CRF58_01B) Disseminating among People Who Inject Drugs in Malaysia,"Chow,W.Z., Takebe,Y., Syafina,N.E., Prakasa,M.S., Chan,K.G., Al-Darraji,H.A., Koh,C., Kamarulzaman,A. and Tee,K.K.",2014
KC522034,58_01B,2011,24465513,A Newly Emerging HIV-1 Recombinant Lineage (CRF58_01B) Disseminating among People Who Inject Drugs in Malaysia,"Chow,W.Z., Takebe,Y., Syafina,N.E., Prakasa,M.S., Chan,K.G., Al-Darraji,H.A., Koh,C., Kamarulzaman,A. and Tee,K.K.",2014
KC522035,58_01B,2010,24465513,A Newly Emerging HIV-1 Recombinant Lineage (CRF58_01B) Disseminating among People Who Inject Drugs in Malaysia,"Chow,W.Z., Takebe,Y., Syafina,N.E., Prakasa,M.S., Chan,K.G., Al-Darraji,H.A., Koh,C., Kamarulzaman,A. and Tee,K.K.",2014
KC595149,B,2005,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595150,B,2004,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595151,B,2005,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595153,B,2004,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595154,B,2004,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595155,B,2004,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595156,B,2004,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595159,B,1999,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595160,B,2004,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595161,B,2004,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595162,B,2004,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595163,B,2004,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595164,B,2004,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595166,B,2004,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595167,B,2004,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595168,B,2005,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595169,B,1989,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595170,B,1989,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595171,B,1989,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595172,B,1989,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595173,B,1989,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595174,B,1989,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595175,B,1989,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595176,B,1989,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595177,B,1989,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595178,B,1989,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595182,B,1998,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595183,B,2004,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595184,B,2007,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595185,B,2005,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595186,B,2004,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595187,B,2005,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595188,B,2007,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595189,B,2005,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595194,B,2004,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595195,B,1989,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595196,B,2007,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595197,B,2004,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595200,B,2005,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595201,B,2004,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595202,B,2004,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595203,B,2004,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595204,B,,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595206,B,,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC595208,B,,23714744,Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers,"Pernas,M., Casado,C., Sandonis,V., Arcones,C., Rodriguez,C., Ruiz-Mateos,E., Ramirez de Arellano,E., Rallon,N., Del Val,M., Grau,E., Lopez-Vazquez,M., Leal,M., Del Romero,J. and Lopez Galindez,C.",2013
KC596064,01_AE,2011,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Hora,B., Chen,Y., Denny,T.N., Cui,H., Sun,H., Geng,W., Shang,H. and Gao,F.",
KC596065,01_AE,2011,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Hora,B., Chen,Y., Denny,T.N., Cui,H., Sun,H., Geng,W., Shang,H. and Gao,F.",
KC596066,B,2009,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Hora,B., Chen,Y., Denny,T.N., Cui,H., Sun,H., Geng,W., Shang,H. and Gao,F.",
KC596067,B,,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Busch,M., Schmidt,M. and Gao,F.",
KC596068,BC,2007,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Sabino,E., Busch,M. and Gao,F.",
KC634109,C,2010,24086252,HIV-1 Transmission during Early Antiretroviral Therapy: Evaluation of Two HIV-1 Transmission Events in the HPTN 052 Prevention Study,"Ping,L.H., Jabara,C.B., Rodrigo,A.G., Hudelson,S.E., Piwowar-Manning,E., Wang,L., Eshleman,S.H., Cohen,M.S. and Swanstrom,R.",2013
KC634136,C,2010,24086252,HIV-1 Transmission during Early Antiretroviral Therapy: Evaluation of Two HIV-1 Transmission Events in the HPTN 052 Prevention Study,"Ping,L.H., Jabara,C.B., Rodrigo,A.G., Hudelson,S.E., Piwowar-Manning,E., Wang,L., Eshleman,S.H., Cohen,M.S. and Swanstrom,R.",2013
KC634164,C,2009,24086252,HIV-1 Transmission during Early Antiretroviral Therapy: Evaluation of Two HIV-1 Transmission Events in the HPTN 052 Prevention Study,"Ping,L.H., Jabara,C.B., Rodrigo,A.G., Hudelson,S.E., Piwowar-Manning,E., Wang,L., Eshleman,S.H., Cohen,M.S. and Swanstrom,R.",2013
KC634184,C,2009,24086252,HIV-1 Transmission during Early Antiretroviral Therapy: Evaluation of Two HIV-1 Transmission Events in the HPTN 052 Prevention Study,"Ping,L.H., Jabara,C.B., Rodrigo,A.G., Hudelson,S.E., Piwowar-Manning,E., Wang,L., Eshleman,S.H., Cohen,M.S. and Swanstrom,R.",2013
KC699001,B,1991,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699002,B,1988,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699003,B,1989,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699004,B,1989,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699005,B,1991,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699006,B,1988,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699007,B,1989,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699008,B,1989,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699009,B,1989,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699010,B,1989,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699011,B,1988,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699012,B,1997,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699013,B,1999,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699014,B,1997,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699015,B,1999,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699016,B,1997,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699017,B,1997,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699018,B,2000,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699019,B,1998,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699020,B,1998,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699021,B,1999,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699022,B,2000,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699023,B,1999,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699024,B,1997,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699025,B,1999,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699026,B,1998,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699027,B,2007,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699028,B,2008,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699029,B,2007,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699030,B,2007,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699031,B,2010,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699032,B,2008,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699033,BG,2009,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699034,B,2010,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699035,B,2009,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699036,B,2009,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699037,B,2009,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699038,B,2008,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699039,B,2008,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC699040,B,2007,23853594,Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic,"Bouvin-Pley,M., Morgand,M., Moreau,A., Jestin,P., Simonnet,C., Tran,L., Goujard,C., Meyer,L., Barin,F. and Braibant,M.",2013
KC748972,01_AE,2004,,Direct Submission,"Bailer,R., Bhattacharya,T., Chen,Y., DeCamp,A., Gao,F., Gao,H., Giorgi,E., Gottardo,R., Greene,K., Hahn,B., Hraber,P., Kim,J., Korber,B., Lapedes,A., Mascola,J., Montefiori,D., O'Sullivan,A., Permpikul,P., Poltavaee,K., Sanders-Buell,E., Seaman,M., Self,S., Sutthent,R., Swanstrom,R., Williamson,C. and Tovanabutra,S.",2013
KC749001,B,2005,,Direct Submission,"Bailer,R., Bhattacharya,T., Chen,Y., DeCamp,A., Gao,F., Gao,H., Giorgi,E., Gottardo,R., Greene,K., Hahn,B., Hraber,P., Kim,J., Korber,B., Lapedes,A., Mascola,J., Montefiori,D., O'Sullivan,A., Permpikul,P., Poltavaee,K., Sanders-Buell,E., Seaman,M., Self,S., Sutthent,R., Swanstrom,R., Williamson,C. and Tovanabutra,S.",2013
KC749033,B,2008,,Direct Submission,"Bailer,R., Bhattacharya,T., Chen,Y., DeCamp,A., Gao,F., Gao,H., Giorgi,E., Gottardo,R., Greene,K., Hahn,B., Hraber,P., Kim,J., Korber,B., Lapedes,A., Mascola,J., Montefiori,D., O'Sullivan,A., Permpikul,P., Poltavaee,K., Sanders-Buell,E., Seaman,M., Self,S., Sutthent,R., Swanstrom,R., Williamson,C. and Tovanabutra,S.",2013
KC797171,B,2000,,HIV-1 superinfection with a triple class drug resistant strain in a patient successfully controlled with antiretroviral treatment,"Mullins,J.I., Pantaleo,G., Bart,P.-A., Castro,E., Zhao,H. and Cavassini,M.",
KC797215,B,2008,,HIV-1 superinfection with a triple class drug resistant strain in a patient successfully controlled with antiretroviral treatment,"Mullins,J.I., Pantaleo,G., Bart,P.-A., Castro,E., Zhao,H. and Cavassini,M.",
KC807912,C,2010,,Cross-subtype neutralizing antibodies in treatment-naive HIV-1-infected individuals in China and characteristics of viral envelope derived from broad neutralizers,"Liu,S., Ren,C., Li,Y., Yu,H., Wang,J., Sun,F., Zhong,P., Zhuang,M. and Ling,H.",
KC807924,C,2010,,Cross-subtype neutralizing antibodies in treatment-naive HIV-1-infected individuals in China and characteristics of viral envelope derived from broad neutralizers,"Liu,S., Ren,C., Li,Y., Yu,H., Wang,J., Sun,F., Zhong,P., Zhuang,M. and Ling,H.",
KC807932,C,2010,,Cross-subtype neutralizing antibodies in treatment-naive HIV-1-infected individuals in China and characteristics of viral envelope derived from broad neutralizers,"Liu,S., Ren,C., Li,Y., Yu,H., Wang,J., Sun,F., Zhong,P., Zhuang,M. and Ling,H.",
KC807943,C,2010,,Cross-subtype neutralizing antibodies in treatment-naive HIV-1-infected individuals in China and characteristics of viral envelope derived from broad neutralizers,"Liu,S., Ren,C., Li,Y., Yu,H., Wang,J., Sun,F., Zhong,P., Zhuang,M. and Ling,H.",
KC807954,C,2010,,Cross-subtype neutralizing antibodies in treatment-naive HIV-1-infected individuals in China and characteristics of viral envelope derived from broad neutralizers,"Liu,S., Ren,C., Li,Y., Yu,H., Wang,J., Sun,F., Zhong,P., Zhuang,M. and Ling,H.",
KC807957,C,2010,,Cross-subtype neutralizing antibodies in treatment-naive HIV-1-infected individuals in China and characteristics of viral envelope derived from broad neutralizers,"Liu,S., Ren,C., Li,Y., Yu,H., Wang,J., Sun,F., Zhong,P., Zhuang,M. and Ling,H.",
KC807969,C,2010,,Cross-subtype neutralizing antibodies in treatment-naive HIV-1-infected individuals in China and characteristics of viral envelope derived from broad neutralizers,"Liu,S., Ren,C., Li,Y., Yu,H., Wang,J., Sun,F., Zhong,P., Zhuang,M. and Ling,H.",
KC807981,C,2010,,Cross-subtype neutralizing antibodies in treatment-naive HIV-1-infected individuals in China and characteristics of viral envelope derived from broad neutralizers,"Liu,S., Ren,C., Li,Y., Yu,H., Wang,J., Sun,F., Zhong,P., Zhuang,M. and Ling,H.",
KC833436,0107,2007,23594292,"Near Full-Length Genomic Characterization of a Novel HIV Type 1 CRF07_ BC/01_AE Recombinant in Men Who Have Sex with Men from Sichuan, China","Wei,H., Su,L., Feng,Y., He,X., His,J., Liang,S. and Shao,Y.",2013
KC852172,56_cpx,2010,24157908,"Characterization of CRF56_cpx, a new circulating B/CRF02/G recombinant form identified in MSM in France","Leoz,M., Feyertag,F., Charpentier,C., Delaugerre,C., Wirden,M., Lemee,V. and Plantier,J.C.",2013
KC852173,56_cpx,2011,24157908,"Characterization of CRF56_cpx, a new circulating B/CRF02/G recombinant form identified in MSM in France","Leoz,M., Feyertag,F., Charpentier,C., Delaugerre,C., Wirden,M., Lemee,V. and Plantier,J.C.",2013
KC852174,56_cpx,2010,24157908,"Characterization of CRF56_cpx, a new circulating B/CRF02/G recombinant form identified in MSM in France","Leoz,M., Feyertag,F., Charpentier,C., Delaugerre,C., Wirden,M., Lemee,V. and Plantier,J.C.",2013
KC862610,C,2005,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC862627,C,2005,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC862648,C,2005,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC862666,C,2005,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC862690,C,2005,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC862709,C,2005,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC862732,C,2005,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC862752,C,2005,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC862774,C,2005,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC862793,C,2005,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC862809,C,2005,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC862828,C,2005,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC862848,C,2005,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC862858,C,2005,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC862875,C,2005,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC862891,C,2005,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC862912,C,2005,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC862931,C,2005,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC862949,C,2005,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC862967,C,2005,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC862986,C,2005,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC863009,C,2005,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC863032,C,2005,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC863053,C,2007,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC863073,C,2007,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC863092,C,1996,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC863108,C,1996,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC863126,C,1996,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC863145,C,1996,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC863162,C,1996,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC863178,C,1996,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC863201,C,2001,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC863215,C,2003,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC863239,C,2003,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC863305,A1,2006,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC863324,C,2006,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC863361,C,2006,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC863362,C,2006,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC863569,C,2007,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC863583,C,2007,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC863599,C,2007,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC863613,C,2007,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC863633,C,2007,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC870027,65_cpx,2010,24279591,"Identification of a Novel HIV Type 1 Circulating Recombinant Form (CRF65_cpx) Composed of CRF01_AE and Subtypes B and C in Western Yunnan, China","Feng,Y., Wei,H., Hsi,J., Xing,H., He,X., Liao,L., Ma,Y., Ning,C., Wang,N., Takebe,Y. and Shao,Y.",2014
KC870028,65_cpx,2010,24279591,"Identification of a Novel HIV Type 1 Circulating Recombinant Form (CRF65_cpx) Composed of CRF01_AE and Subtypes B and C in Western Yunnan, China","Feng,Y., Wei,H., Hsi,J., Xing,H., He,X., Liao,L., Ma,Y., Ning,C., Wang,N., Takebe,Y. and Shao,Y.",2014
KC870029,01_AE,2010,,Direct Submission,"Wei,H.",2013
KC870030,65_cpx,2009,24279591,"Identification of a Novel HIV Type 1 Circulating Recombinant Form (CRF65_cpx) Composed of CRF01_AE and Subtypes B and C in Western Yunnan, China","Feng,Y., Wei,H., Hsi,J., Xing,H., He,X., Liao,L., Ma,Y., Ning,C., Wang,N., Takebe,Y. and Shao,Y.",2014
KC870031,64_BC,2009,,Direct Submission,"Wei,H.",2013
KC870032,64_BC,2010,24205972,"Genome Sequence of a Novel HIV-1 Circulating Recombinant Form (CRF64_BC) Identified from Yunnan, China","Hsi,J., Wei,H., Xing,H., Feng,Y., He,X., Liao,L., Jia,M., Wang,N., Ning,C. and Shao,Y.",2014
KC870034,62_BC,2010,24164474,Identification of a Novel HIV-1 Circulating Recombinant Form (CRF62_BC) in Western Yunnan of China,"Wei,H., His,J., Feng,Y., Xing,H., He,X., Liao,L., Duan,S., Ning,C., Wang,N., Takebe,Y. and Shao,Y.",2014
KC870035,62_BC,2010,24164474,Identification of a Novel HIV-1 Circulating Recombinant Form (CRF62_BC) in Western Yunnan of China,"Wei,H., His,J., Feng,Y., Xing,H., He,X., Liao,L., Duan,S., Ning,C., Wang,N., Takebe,Y. and Shao,Y.",2014
KC870036,64_BC,2010,24205972,"Genome Sequence of a Novel HIV-1 Circulating Recombinant Form (CRF64_BC) Identified from Yunnan, China","Hsi,J., Wei,H., Xing,H., Feng,Y., He,X., Liao,L., Jia,M., Wang,N., Ning,C. and Shao,Y.",2014
KC870037,62_BC,2010,24164474,Identification of a Novel HIV-1 Circulating Recombinant Form (CRF62_BC) in Western Yunnan of China,"Wei,H., His,J., Feng,Y., Xing,H., He,X., Liao,L., Duan,S., Ning,C., Wang,N., Takebe,Y. and Shao,Y.",2014
KC870038,C,2010,,Direct Submission,"Wei,H.",2013
KC870039,01_AE,2010,,Direct Submission,"Wei,H.",2013
KC870040,64_BC,2010,24205972,"Genome Sequence of a Novel HIV-1 Circulating Recombinant Form (CRF64_BC) Identified from Yunnan, China","Hsi,J., Wei,H., Xing,H., Feng,Y., He,X., Liao,L., Jia,M., Wang,N., Ning,C. and Shao,Y.",2014
KC870041,01_AE,2010,,Direct Submission,"Wei,H.",2013
KC870042,64_BC,2009,24205972,"Genome Sequence of a Novel HIV-1 Circulating Recombinant Form (CRF64_BC) Identified from Yunnan, China","Hsi,J., Wei,H., Xing,H., Feng,Y., He,X., Liao,L., Jia,M., Wang,N., Ning,C. and Shao,Y.",2014
KC870043,64_BC,2009,24205972,"Genome Sequence of a Novel HIV-1 Circulating Recombinant Form (CRF64_BC) Identified from Yunnan, China","Hsi,J., Wei,H., Xing,H., Feng,Y., He,X., Liao,L., Jia,M., Wang,N., Ning,C. and Shao,Y.",2014
KC870044,57_BC,2009,24205935,"Genome Sequence of a Novel HIV-1 Circulating Recombinant Form (CRF57_BC) Identified from Yunnan, China","Wei,H., Liu,Y., Feng,Y., Hsi,J., Xing,H., He,X., Liao,L., Yutaka,T., Li,J. and Shao,Y.",2014
KC894117,C,2007,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC894120,C,2007,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC894121,C,,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC894123,C,2007,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC894128,C,1996,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC894130,C,1996,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC894132,C,1996,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC894383,C,2005,23616655,Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design,"Ping,L.H., Joseph,S.B., Anderson,J.A., Abrahams,M.R., Salazar-Gonzalez,J.F., Kincer,L.P., Treurnicht,F.K., Arney,L., Ojeda,S., Zhang,M., Keys,J., Potter,E.L., Chu,H., Moore,P., Salazar,M.G., Iyer,S., Jabara,C., Kirchherr,J., Mapanje,C., Ngandu,N., Seoighe,C., Hoffman,I., Gao,F., Tang,Y., Labranche,C., Lee,B., Saville,A., Vermeulen,M., Fiscus,S., Morris,L., Karim,S.A., Haynes,B.F., Shaw,G.M., Korber,B.T., Hahn,B.H., Cohen,M.S., Montefiori,D., Williamson,C. and Swanstrom,R.",2013
KC898975,88_BC,2005,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC898976,BC,2005,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC898977,BC,2005,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC898978,BC,2005,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC898979,88_BC,2005,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC898980,C,2006,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC898981,BC,2006,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC898982,BC,2007,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC898983,BC,2007,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC898984,BC,2009,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC898985,BC,2009,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC898986,BC,2009,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC898987,BC,2009,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC898988,BC,2009,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC898989,BC,2009,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC898990,BC,2009,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC898991,BC,2009,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC898992,87_cpx,2009,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC898993,BC,2009,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC898994,64_BC,2009,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC898995,C,2009,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC898996,C,2009,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC899003,BC,2009,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC899004,C,2006,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC899005,C,2009,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC899006,BC,2005,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC899007,BC,2007,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC899008,57_BC,2009,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC899009,64_BC,2009,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC899010,BC,2009,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC899011,B,2009,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC899012,87_cpx,2009,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC899013,BC,2009,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC899014,BC,2009,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC899015,BC,2009,23741489,"High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China","Han,X., An,M., Zhao,B., Duan,S., Yang,S., Xu,J., Zhang,M., McGoogan,J.M., Takebe,Y. and Shang,H.",2013
KC899079,60_BC,2011,24602697,Identification of a new HIV-1 BC circulating recombinant form (CRF60_BC) in Italian young men having sex with men,"Simonetti,F.R., Lai,A., Monno,L., Binda,F., Brindicci,G., Punzi,G., Bozzi,G., Violin,M., Galli,M., Zazzi,M., Angarano,G. and Balotta,C.",2014
KC899080,60_BC,2011,24602697,Identification of a new HIV-1 BC circulating recombinant form (CRF60_BC) in Italian young men having sex with men,"Simonetti,F.R., Lai,A., Monno,L., Binda,F., Brindicci,G., Punzi,G., Bozzi,G., Violin,M., Galli,M., Zazzi,M., Angarano,G. and Balotta,C.",2014
KC899081,60_BC,2011,24602697,Identification of a new HIV-1 BC circulating recombinant form (CRF60_BC) in Italian young men having sex with men,"Simonetti,F.R., Lai,A., Monno,L., Binda,F., Brindicci,G., Punzi,G., Bozzi,G., Violin,M., Galli,M., Zazzi,M., Angarano,G. and Balotta,C.",2014
KC911635,A1C,2009,23742670,"Molecular Characterization of Unique Intersubtype HIV Type 1 A1/C Recombinant Strain Circulating in Pune, India","Pandey,S., Tripathy,S. and Paranjape,R.",2013
KC935957,B,2004,24117037,Evolution of an Attenuated HIV-1 Isolate in an Elite Suppressor,"Salgado,M., Gandhi,S., Buckheit,R.W., Berkenblit,G.V. and Blankson,J.N.",2014
KC935958,B,2009,,Infection with defective virus results in different clinical outcomes of infection in three HIV-1 infected individuals,"Buckheit,R.W. III and Blankson,J.N.",
KC935959,B,2009,,Infection with defective virus results in different clinical outcomes of infection in three HIV-1 infected individuals,"Buckheit,R.W. III and Blankson,J.N.",
KC990124,61_BC,2010,23814029,Genome Sequences of a Novel HIV-1 Circulating Recombinant Form (CRF61_BC) Identified among Heterosexuals in China,"Li,X., Ning,C., He,X., Yang,Y., Li,F., Xing,H., Hong,K., Yang,R. and Shao,Y.",2013
KC990125,61_BC,2007,23814029,Genome Sequences of a Novel HIV-1 Circulating Recombinant Form (CRF61_BC) Identified among Heterosexuals in China,"Li,X., Ning,C., He,X., Yang,Y., Li,F., Xing,H., Hong,K., Yang,R. and Shao,Y.",2013
KC990126,61_BC,2007,23814029,Genome Sequences of a Novel HIV-1 Circulating Recombinant Form (CRF61_BC) Identified among Heterosexuals in China,"Li,X., Ning,C., He,X., Yang,Y., Li,F., Xing,H., Hong,K., Yang,R. and Shao,Y.",2013
KC990127,0107,2007,23809010,"Near Full-Length Genome Sequence of a Novel HIV Type 1 Second-Generation Recombinant Form (CRF01_AE/CRF07_BC) Identified Among Men Who Have Sex with Men in Jilin, China","Li,X., Ning,C., He,X., Yang,Y., Xing,H., Hong,K., Shao,Y. and Yang,R.",2013
KF011493,BC,2010,23800314,"Near Full-Length Genome Identification of a Novel HIV Type 1 B'/C Recombinant Isolate JL100091 in Jilin, China","Ning,C., Li,X., He,X., Xing,H., Hong,K., Yang,R. and Shao,Y.",2013
KF011494,59_01B,2007,,"Near Full-length Genome Analyses of a Novel HIV-1 Circulating Recombinant Form, CRF63_01B, Identified among MSM in China","Li,X.",
KF011495,59_01B,2007,,"Near Full-length Genome Analyses of a Novel HIV-1 Circulating Recombinant Form, CRF63_01B, Identified among MSM in China","Li,X.",
KF061031,B,1994,24023951,Selected HIV-1 Env Trimeric Formulations Act as Potent Immunogens in a Rabbit Vaccination Model,"Heyndrickx,L., Stewart-Jones,G., Jansson,M., Schuitemaker,H., Bowles,E., Buonaguro,L., Grevstad,B., Vinner,L., Vereecken,K., Parker,J., Ramaswamy,M., Biswas,P., Vanham,G., Scarlatti,G. and Fomsgaard,A.",2013
KF061032,B,1992,24023951,Selected HIV-1 Env Trimeric Formulations Act as Potent Immunogens in a Rabbit Vaccination Model,"Heyndrickx,L., Stewart-Jones,G., Jansson,M., Schuitemaker,H., Bowles,E., Buonaguro,L., Grevstad,B., Vinner,L., Vereecken,K., Parker,J., Ramaswamy,M., Biswas,P., Vanham,G., Scarlatti,G. and Fomsgaard,A.",2013
KF114881,C,2006,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
KF114882,C,2007,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
KF114883,A1C,2009,,Direct Submission,"Thebus,R., Rademeyer,C., Marais,J. and Williamson,C.",2013
KF114884,C,2008,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
KF114885,C,2008,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
KF114886,C,2009,,Direct Submission,"Thebus,R., Rademeyer,C., Marais,J. and Williamson,C.",2013
KF114887,C,2009,,Direct Submission,"Thebus,R., Rademeyer,C., Marais,J. and Williamson,C.",2013
KF114888,C,2010,,Direct Submission,"Thebus,R., Rademeyer,C., Marais,J. and Williamson,C.",2013
KF114889,C,2007,,Direct Submission,"Thebus,R., Rademeyer,C., Marais,J. and Williamson,C.",2013
KF114890,C,2009,,Direct Submission,"Thebus,R., Rademeyer,C., Marais,J. and Williamson,C.",2013
KF114891,C,2007,,Direct Submission,"Thebus,R., Rademeyer,C., Marais,J. and Williamson,C.",2013
KF114892,C,2009,,Direct Submission,"Thebus,R., Rademeyer,C., Marais,J. and Williamson,C.",2013
KF114893,C,2008,,Direct Submission,"Thebus,R., Rademeyer,C., Marais,J. and Williamson,C.",2013
KF114894,C,2008,,Direct Submission,"Thebus,R., Rademeyer,C., Marais,J. and Williamson,C.",2013
KF114895,C,2008,,Direct Submission,"Thebus,R., Rademeyer,C., Marais,J. and Williamson,C.",2013
KF234628,07_BC,2013,,Slow Immunologic Progression in Injecting Drug Users Infected with Human Immunodeficiency Virus Type 1 CRF07_BC,"Chang,S.-Y. and Hung,C.-C.",
KF250366,07_BC,2007,26763952,"Geographic origin and evolutionary history of China's two predominant HIV-1 circulating recombinant forms, CRF07_BC and CRF08_BC","Feng,Y., Takebe,Y., Wei,H., He,X., Hsi,J.H., Li,Z., Xing,H., Ruan,Y., Yang,Y., Li,F., Wei,J., Li,X. and Shao,Y.",2016
KF250368,08_BC,2007,26763952,"Geographic origin and evolutionary history of China's two predominant HIV-1 circulating recombinant forms, CRF07_BC and CRF08_BC","Feng,Y., Takebe,Y., Wei,H., He,X., Hsi,J.H., Li,Z., Xing,H., Ruan,Y., Yang,Y., Li,F., Wei,J., Li,X. and Shao,Y.",2016
KF250369,08_BC,2007,26763952,"Geographic origin and evolutionary history of China's two predominant HIV-1 circulating recombinant forms, CRF07_BC and CRF08_BC","Feng,Y., Takebe,Y., Wei,H., He,X., Hsi,J.H., Li,Z., Xing,H., Ruan,Y., Yang,Y., Li,F., Wei,J., Li,X. and Shao,Y.",2016
KF250370,08_BC,2007,26763952,"Geographic origin and evolutionary history of China's two predominant HIV-1 circulating recombinant forms, CRF07_BC and CRF08_BC","Feng,Y., Takebe,Y., Wei,H., He,X., Hsi,J.H., Li,Z., Xing,H., Ruan,Y., Yang,Y., Li,F., Wei,J., Li,X. and Shao,Y.",2016
KF250371,07_BC,2007,26763952,"Geographic origin and evolutionary history of China's two predominant HIV-1 circulating recombinant forms, CRF07_BC and CRF08_BC","Feng,Y., Takebe,Y., Wei,H., He,X., Hsi,J.H., Li,Z., Xing,H., Ruan,Y., Yang,Y., Li,F., Wei,J., Li,X. and Shao,Y.",2016
KF250372,07_BC,2007,26763952,"Geographic origin and evolutionary history of China's two predominant HIV-1 circulating recombinant forms, CRF07_BC and CRF08_BC","Feng,Y., Takebe,Y., Wei,H., He,X., Hsi,J.H., Li,Z., Xing,H., Ruan,Y., Yang,Y., Li,F., Wei,J., Li,X. and Shao,Y.",2016
KF250373,07_BC,2007,26763952,"Geographic origin and evolutionary history of China's two predominant HIV-1 circulating recombinant forms, CRF07_BC and CRF08_BC","Feng,Y., Takebe,Y., Wei,H., He,X., Hsi,J.H., Li,Z., Xing,H., Ruan,Y., Yang,Y., Li,F., Wei,J., Li,X. and Shao,Y.",2016
KF250374,07_BC,2007,26763952,"Geographic origin and evolutionary history of China's two predominant HIV-1 circulating recombinant forms, CRF07_BC and CRF08_BC","Feng,Y., Takebe,Y., Wei,H., He,X., Hsi,J.H., Li,Z., Xing,H., Ruan,Y., Yang,Y., Li,F., Wei,J., Li,X. and Shao,Y.",2016
KF250375,07_BC,2007,26763952,"Geographic origin and evolutionary history of China's two predominant HIV-1 circulating recombinant forms, CRF07_BC and CRF08_BC","Feng,Y., Takebe,Y., Wei,H., He,X., Hsi,J.H., Li,Z., Xing,H., Ruan,Y., Yang,Y., Li,F., Wei,J., Li,X. and Shao,Y.",2016
KF250376,07_BC,2006,26763952,"Geographic origin and evolutionary history of China's two predominant HIV-1 circulating recombinant forms, CRF07_BC and CRF08_BC","Feng,Y., Takebe,Y., Wei,H., He,X., Hsi,J.H., Li,Z., Xing,H., Ruan,Y., Yang,Y., Li,F., Wei,J., Li,X. and Shao,Y.",2016
KF250377,07_BC,2007,26763952,"Geographic origin and evolutionary history of China's two predominant HIV-1 circulating recombinant forms, CRF07_BC and CRF08_BC","Feng,Y., Takebe,Y., Wei,H., He,X., Hsi,J.H., Li,Z., Xing,H., Ruan,Y., Yang,Y., Li,F., Wei,J., Li,X. and Shao,Y.",2016
KF250378,BC,1996,26763952,"Geographic origin and evolutionary history of China's two predominant HIV-1 circulating recombinant forms, CRF07_BC and CRF08_BC","Feng,Y., Takebe,Y., Wei,H., He,X., Hsi,J.H., Li,Z., Xing,H., Ruan,Y., Yang,Y., Li,F., Wei,J., Li,X. and Shao,Y.",2016
KF250379,BC,1996,26763952,"Geographic origin and evolutionary history of China's two predominant HIV-1 circulating recombinant forms, CRF07_BC and CRF08_BC","Feng,Y., Takebe,Y., Wei,H., He,X., Hsi,J.H., Li,Z., Xing,H., Ruan,Y., Yang,Y., Li,F., Wei,J., Li,X. and Shao,Y.",2016
KF250380,BC,1996,26763952,"Geographic origin and evolutionary history of China's two predominant HIV-1 circulating recombinant forms, CRF07_BC and CRF08_BC","Feng,Y., Takebe,Y., Wei,H., He,X., Hsi,J.H., Li,Z., Xing,H., Ruan,Y., Yang,Y., Li,F., Wei,J., Li,X. and Shao,Y.",2016
KF250381,BC,2007,26763952,"Geographic origin and evolutionary history of China's two predominant HIV-1 circulating recombinant forms, CRF07_BC and CRF08_BC","Feng,Y., Takebe,Y., Wei,H., He,X., Hsi,J.H., Li,Z., Xing,H., Ruan,Y., Yang,Y., Li,F., Wei,J., Li,X. and Shao,Y.",2016
KF250382,BC,2007,26763952,"Geographic origin and evolutionary history of China's two predominant HIV-1 circulating recombinant forms, CRF07_BC and CRF08_BC","Feng,Y., Takebe,Y., Wei,H., He,X., Hsi,J.H., Li,Z., Xing,H., Ruan,Y., Yang,Y., Li,F., Wei,J., Li,X. and Shao,Y.",2016
KF250383,BC,2007,26763952,"Geographic origin and evolutionary history of China's two predominant HIV-1 circulating recombinant forms, CRF07_BC and CRF08_BC","Feng,Y., Takebe,Y., Wei,H., He,X., Hsi,J.H., Li,Z., Xing,H., Ruan,Y., Yang,Y., Li,F., Wei,J., Li,X. and Shao,Y.",2016
KF250384,BC,2007,26763952,"Geographic origin and evolutionary history of China's two predominant HIV-1 circulating recombinant forms, CRF07_BC and CRF08_BC","Feng,Y., Takebe,Y., Wei,H., He,X., Hsi,J.H., Li,Z., Xing,H., Ruan,Y., Yang,Y., Li,F., Wei,J., Li,X. and Shao,Y.",2016
KF250385,07_BC,2007,26763952,"Geographic origin and evolutionary history of China's two predominant HIV-1 circulating recombinant forms, CRF07_BC and CRF08_BC","Feng,Y., Takebe,Y., Wei,H., He,X., Hsi,J.H., Li,Z., Xing,H., Ruan,Y., Yang,Y., Li,F., Wei,J., Li,X. and Shao,Y.",2016
KF250395,01BC,2010,,Direct Submission,"Wei,H.",2013
KF250396,01BC,2010,,Direct Submission,"Wei,H.",2013
KF250397,BC,2010,,Direct Submission,"Wei,H.",2013
KF250398,01BC,2010,,Direct Submission,"Wei,H.",2013
KF250399,BC,2010,,Direct Submission,"Wei,H.",2013
KF250400,57_BC,2010,24205935,"Genome Sequence of a Novel HIV-1 Circulating Recombinant Form (CRF57_BC) Identified from Yunnan, China","Wei,H., Liu,Y., Feng,Y., Hsi,J., Xing,H., He,X., Liao,L., Yutaka,T., Li,J. and Shao,Y.",2014
KF250401,01C,2010,,Direct Submission,"Wei,H.",2013
KF250402,88_BC,2009,,Direct Submission,"Wei,H.",2013
KF250403,C,2009,,Direct Submission,"Wei,H.",2013
KF250404,C,2009,,Direct Submission,"Wei,H.",2013
KF250405,BC,2012,,Direct Submission,"Wei,H.",2013
KF250406,BC,2012,,Direct Submission,"Wei,H.",2013
KF250407,01BC,2012,,Direct Submission,"Wei,H.",2013
KF250408,87_cpx,2012,,Direct Submission,"Wei,H.",2013
KF250409,BC,2012,,Direct Submission,"Wei,H.",2013
KF250410,BC,2012,,Direct Submission,"Wei,H.",2013
KF384798,B,2011,24390323,HLA-B*57 Elite Suppressor and Chronic Progressor HIV-1 Isolates Replicate Vigorously and Cause CD4+ T Cell Depletion in Humanized BLT Mice,"Salgado,M., Swanson,M.D., Pohlmeyer,C.W., Buckheit,R.W. III, Wu,J., Archin,N.M., Williams,T.M., Margolis,D.M., Siliciano,R.F., Garcia,J.V. and Blankson,J.N.",2014
KF384801,B,2011,24390323,HLA-B*57 Elite Suppressor and Chronic Progressor HIV-1 Isolates Replicate Vigorously and Cause CD4+ T Cell Depletion in Humanized BLT Mice,"Salgado,M., Swanson,M.D., Pohlmeyer,C.W., Buckheit,R.W. III, Wu,J., Archin,N.M., Williams,T.M., Margolis,D.M., Siliciano,R.F., Garcia,J.V. and Blankson,J.N.",2014
KF384802,B,2011,24390323,HLA-B*57 Elite Suppressor and Chronic Progressor HIV-1 Isolates Replicate Vigorously and Cause CD4+ T Cell Depletion in Humanized BLT Mice,"Salgado,M., Swanson,M.D., Pohlmeyer,C.W., Buckheit,R.W. III, Wu,J., Archin,N.M., Williams,T.M., Margolis,D.M., Siliciano,R.F., Garcia,J.V. and Blankson,J.N.",2014
KF384803,B,2011,24390323,HLA-B*57 Elite Suppressor and Chronic Progressor HIV-1 Isolates Replicate Vigorously and Cause CD4+ T Cell Depletion in Humanized BLT Mice,"Salgado,M., Swanson,M.D., Pohlmeyer,C.W., Buckheit,R.W. III, Wu,J., Archin,N.M., Williams,T.M., Margolis,D.M., Siliciano,R.F., Garcia,J.V. and Blankson,J.N.",2014
KF384804,B,2011,24390323,HLA-B*57 Elite Suppressor and Chronic Progressor HIV-1 Isolates Replicate Vigorously and Cause CD4+ T Cell Depletion in Humanized BLT Mice,"Salgado,M., Swanson,M.D., Pohlmeyer,C.W., Buckheit,R.W. III, Wu,J., Archin,N.M., Williams,T.M., Margolis,D.M., Siliciano,R.F., Garcia,J.V. and Blankson,J.N.",2014
KF384805,B,2011,24390323,HLA-B*57 Elite Suppressor and Chronic Progressor HIV-1 Isolates Replicate Vigorously and Cause CD4+ T Cell Depletion in Humanized BLT Mice,"Salgado,M., Swanson,M.D., Pohlmeyer,C.W., Buckheit,R.W. III, Wu,J., Archin,N.M., Williams,T.M., Margolis,D.M., Siliciano,R.F., Garcia,J.V. and Blankson,J.N.",2014
KF384806,B,2011,24390323,HLA-B*57 Elite Suppressor and Chronic Progressor HIV-1 Isolates Replicate Vigorously and Cause CD4+ T Cell Depletion in Humanized BLT Mice,"Salgado,M., Swanson,M.D., Pohlmeyer,C.W., Buckheit,R.W. III, Wu,J., Archin,N.M., Williams,T.M., Margolis,D.M., Siliciano,R.F., Garcia,J.V. and Blankson,J.N.",2014
KF384807,B,2011,24390323,HLA-B*57 Elite Suppressor and Chronic Progressor HIV-1 Isolates Replicate Vigorously and Cause CD4+ T Cell Depletion in Humanized BLT Mice,"Salgado,M., Swanson,M.D., Pohlmeyer,C.W., Buckheit,R.W. III, Wu,J., Archin,N.M., Williams,T.M., Margolis,D.M., Siliciano,R.F., Garcia,J.V. and Blankson,J.N.",2014
KF384808,B,2011,24390323,HLA-B*57 Elite Suppressor and Chronic Progressor HIV-1 Isolates Replicate Vigorously and Cause CD4+ T Cell Depletion in Humanized BLT Mice,"Salgado,M., Swanson,M.D., Pohlmeyer,C.W., Buckheit,R.W. III, Wu,J., Archin,N.M., Williams,T.M., Margolis,D.M., Siliciano,R.F., Garcia,J.V. and Blankson,J.N.",2014
KF384809,B,2011,24390323,HLA-B*57 Elite Suppressor and Chronic Progressor HIV-1 Isolates Replicate Vigorously and Cause CD4+ T Cell Depletion in Humanized BLT Mice,"Salgado,M., Swanson,M.D., Pohlmeyer,C.W., Buckheit,R.W. III, Wu,J., Archin,N.M., Williams,T.M., Margolis,D.M., Siliciano,R.F., Garcia,J.V. and Blankson,J.N.",2014
KF384810,B,2011,24390323,HLA-B*57 Elite Suppressor and Chronic Progressor HIV-1 Isolates Replicate Vigorously and Cause CD4+ T Cell Depletion in Humanized BLT Mice,"Salgado,M., Swanson,M.D., Pohlmeyer,C.W., Buckheit,R.W. III, Wu,J., Archin,N.M., Williams,T.M., Margolis,D.M., Siliciano,R.F., Garcia,J.V. and Blankson,J.N.",2014
KF384811,B,2011,24390323,HLA-B*57 Elite Suppressor and Chronic Progressor HIV-1 Isolates Replicate Vigorously and Cause CD4+ T Cell Depletion in Humanized BLT Mice,"Salgado,M., Swanson,M.D., Pohlmeyer,C.W., Buckheit,R.W. III, Wu,J., Archin,N.M., Williams,T.M., Margolis,D.M., Siliciano,R.F., Garcia,J.V. and Blankson,J.N.",2014
KF384812,B,2011,24390323,HLA-B*57 Elite Suppressor and Chronic Progressor HIV-1 Isolates Replicate Vigorously and Cause CD4+ T Cell Depletion in Humanized BLT Mice,"Salgado,M., Swanson,M.D., Pohlmeyer,C.W., Buckheit,R.W. III, Wu,J., Archin,N.M., Williams,T.M., Margolis,D.M., Siliciano,R.F., Garcia,J.V. and Blankson,J.N.",2014
KF384813,B,2011,24390323,HLA-B*57 Elite Suppressor and Chronic Progressor HIV-1 Isolates Replicate Vigorously and Cause CD4+ T Cell Depletion in Humanized BLT Mice,"Salgado,M., Swanson,M.D., Pohlmeyer,C.W., Buckheit,R.W. III, Wu,J., Archin,N.M., Williams,T.M., Margolis,D.M., Siliciano,R.F., Garcia,J.V. and Blankson,J.N.",2014
KF384814,B,2011,24390323,HLA-B*57 Elite Suppressor and Chronic Progressor HIV-1 Isolates Replicate Vigorously and Cause CD4+ T Cell Depletion in Humanized BLT Mice,"Salgado,M., Swanson,M.D., Pohlmeyer,C.W., Buckheit,R.W. III, Wu,J., Archin,N.M., Williams,T.M., Margolis,D.M., Siliciano,R.F., Garcia,J.V. and Blankson,J.N.",2014
KF384907,B,2011,24390323,HLA-B*57 Elite Suppressor and Chronic Progressor HIV-1 Isolates Replicate Vigorously and Cause CD4+ T Cell Depletion in Humanized BLT Mice,"Salgado,M., Swanson,M.D., Pohlmeyer,C.W., Buckheit,R.W. III, Wu,J., Archin,N.M., Williams,T.M., Margolis,D.M., Siliciano,R.F., Garcia,J.V. and Blankson,J.N.",2014
KF425293,58_01B,2010,24465513,A Newly Emerging HIV-1 Recombinant Lineage (CRF58_01B) Disseminating among People Who Inject Drugs in Malaysia,"Chow,W.Z., Takebe,Y., Syafina,N.E., Prakasa,M.S., Chan,K.G., Al-Darraji,H.A., Koh,C., Kamarulzaman,A. and Tee,K.K.",2014
KF526120,B,2010,,Replication-competent non-induced proviruses in the latent reservoir increase barrier to HIV-1 cure,"Ho,Y.-C., Shan,L., Hosmane,N.N., Wang,J., Laskey,S.B., Rosenbloom,D.I., Lai,J., Blankson,J.N. and Siliciano,R.F.",
KF526174,B,2011,,Replication-competent non-induced proviruses in the latent reservoir increase barrier to HIV-1 cure,"Ho,Y.-C., Shan,L., Hosmane,N.N., Wang,J., Laskey,S.B., Rosenbloom,D.I., Lai,J., Blankson,J.N. and Siliciano,R.F.",
KF526228,B,2011,,Replication-competent non-induced proviruses in the latent reservoir increase barrier to HIV-1 cure,"Ho,Y.-C., Shan,L., Hosmane,N.N., Wang,J., Laskey,S.B., Rosenbloom,D.I., Lai,J., Blankson,J.N. and Siliciano,R.F.",
KF526261,B,2011,,Replication-competent non-induced proviruses in the latent reservoir increase barrier to HIV-1 cure,"Ho,Y.-C., Shan,L., Hosmane,N.N., Wang,J., Laskey,S.B., Rosenbloom,D.I., Lai,J., Blankson,J.N. and Siliciano,R.F.",
KF526298,B,2011,,Replication-competent non-induced proviruses in the latent reservoir increase barrier to HIV-1 cure,"Ho,Y.-C., Shan,L., Hosmane,N.N., Wang,J., Laskey,S.B., Rosenbloom,D.I., Lai,J., Blankson,J.N. and Siliciano,R.F.",
KF526313,B,2011,,Replication-competent non-induced proviruses in the latent reservoir increase barrier to HIV-1 cure,"Ho,Y.-C., Shan,L., Hosmane,N.N., Wang,J., Laskey,S.B., Rosenbloom,D.I., Lai,J., Blankson,J.N. and Siliciano,R.F.",
KF526325,B,2010,,Replication-competent non-induced proviruses in the latent reservoir increase barrier to HIV-1 cure,"Ho,Y.-C., Shan,L., Hosmane,N.N., Wang,J., Laskey,S.B., Rosenbloom,D.I., Lai,J., Blankson,J.N. and Siliciano,R.F.",
KF527081,C,2008,23941304,Clonal amplification and maternal-infant transmission of nevirapine-resistant HIV-1 variants in breast milk following single-dose nevirapine prophylaxis,"Permar,S.R., Salazar,M.G., Gao,F., Cai,F., Learn,G.H., Kalilani,L., Hahn,B.H., Shaw,G.M. and Salazar-Gonzalez,J.F.",2013
KF541292,0108,2012,24164454,"Near Full-Length Genome Characterization of a New CRF01_AE/CRF08_BC Recombinant Transmitted Between a Heterosexual Couple in Guangxi, China","Wang,N., Wei,H., Xiong,R., Zhang,H., Hsi,J.H., Ning,C., Zhang,L., Wang,J., Feng,Y. and Shao,Y.",2014
KF561435,02_AG,2012,,Frequent genetic defects in long-term survivors for more than 26 years in the absence of antiretroviral therapy in Korea: its association with ginseng treatment,"Cho,Y.-K.",
KF561443,B,1993,,Frequent genetic defects in long-term survivors for more than 26 years in the absence of antiretroviral therapy in Korea: its association with ginseng treatment,"Cho,Y.-K.",
KF682427,B,1999,,Sequence polymorphisms in Human immunodeficiency virus type 1 envelope glycoprotein isolated from individuals homozygous for the CCR5<DELTA>32 allele are associated with significant modulation of Env-mediated fusion,"Alkhatib,G.",
KF716464,01A1G,2006,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Ragupathy,V., Hewlett,I. and Gao,F.",
KF716465,02A,2008,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Ragupathy,V., Hewlett,I. and Gao,F.",
KF716466,C,2009,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Fast,P., Amornkul,P., Price,M., Kilembe,W., Allen,S., Hunter,E. and Gao,F.",
KF716467,C,2011,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Fast,P., Amornkul,P., Price,M., Kilembe,W., Allen,S., Hunter,E. and Gao,F.",
KF716468,A1D,2009,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Fast,P., Amornkul,P., Price,M., Anzala,O., Mutua,G. and Gao,F.",
KF716469,A1C,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Fast,P., Amornkul,P., Price,M., Anzala,O., Mutua,G. and Gao,F.",
KF716470,A1CD,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Fast,P., Amornkul,P., Price,M., Anzala,O., Mutua,G. and Gao,F.",
KF716471,A1C,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Fast,P., Amornkul,P., Price,M., Anzala,O., Mutua,G. and Gao,F.",
KF716472,A1,2011,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Fast,P., Amornkul,P., Price,M., Karita,E., Allen,S., Hunter,E. and Gao,F.",
KF716473,CD,2011,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Fast,P., Amornkul,P., Price,M., Karita,E., Allen,S., Hunter,E. and Gao,F.",
KF716474,A1,2011,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Fast,P., Amornkul,P., Price,M., Sanders,E. and Gao,F.",
KF716475,A1,2011,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Fast,P., Amornkul,P., Price,M., Sanders,E. and Gao,F.",
KF716476,D,2011,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Fast,P., Amornkul,P., Price,M., Sanders,E. and Gao,F.",
KF716477,G,2009,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Fast,P., Amornkul,P., Price,M., Sanders,E. and Gao,F.",
KF716478,A1,2009,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Fast,P., Amornkul,P., Price,M., Kamali,A., Ruzagira,E. and Gao,F.",
KF716479,D,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Fast,P., Amornkul,P., Price,M., Kamali,A., Ruzagira,E. and Gao,F.",
KF716480,D,2011,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Fast,P., Amornkul,P., Price,M., Kamali,A., Ruzagira,E. and Gao,F.",
KF716481,A1D,2009,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Fast,P., Amornkul,P., Price,M., Kamali,A., Ruzagira,E. and Gao,F.",
KF716482,A1D,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Fast,P., Amornkul,P., Price,M., Kamali,A., Ruzagira,E. and Gao,F.",
KF716483,A1D,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Fast,P., Amornkul,P., Price,M., Kamali,A., Ruzagira,E. and Gao,F.",
KF716484,A1D,2011,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Fast,P., Amornkul,P., Price,M., Kamali,A., Ruzagira,E. and Gao,F.",
KF716485,A1D,2011,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Fast,P., Amornkul,P., Price,M., Kamali,A., Ruzagira,E. and Gao,F.",
KF716486,A1,2011,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Fast,P., Amornkul,P., Price,M., Kamali,A. and Gao,F.",
KF716487,A1D,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Fast,P., Amornkul,P., Price,M., Kamali,A. and Gao,F.",
KF716488,A1G,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Fast,P., Amornkul,P., Price,M., Kamali,A. and Gao,F.",
KF716489,A1CD,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Fast,P., Amornkul,P., Price,M., Kamali,A. and Gao,F.",
KF716490,A1D,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Fast,P., Amornkul,P., Price,M., Kamali,A. and Gao,F.",
KF716494,B,2009,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Busch,M., Laperche,S. and Gao,F.",
KF716495,B,2009,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Busch,M., Laperche,S. and Gao,F.",
KF716496,B,2011,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Busch,M., Laperche,S. and Gao,F.",
KF716497,B,2011,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Busch,M., Tadokoro,K. and Gao,F.",
KF716498,B,2012,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Busch,M., Tadokoro,K. and Gao,F.",
KF725883,C,2009,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725884,C,2009,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725885,C,2009,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725886,C,2009,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725887,C,2009,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725888,C,2009,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725889,C,2009,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725890,C,2009,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725891,C,2009,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725892,C,2009,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725895,C,2009,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725896,C,2009,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725897,C,2009,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725900,C,2009,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725901,C,2009,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725902,BC,2009,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725903,C,2009,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725905,C,2009,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725906,BC,2009,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725908,C,2009,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725909,C,2009,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725910,C,2009,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725911,C,2009,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725912,C,2009,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725913,A1,2009,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725914,C,2009,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725915,B,2009,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725916,C,2009,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725917,C,2009,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725918,B,2009,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725920,C,2009,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725921,C,2009,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725922,C,2009,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725924,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725926,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725927,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725928,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725929,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725930,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725931,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725933,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725934,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725935,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725936,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725937,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725938,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725939,A1,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725942,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725943,A1C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725944,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725945,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725946,B,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725947,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725948,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725949,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725950,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725952,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725953,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725954,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725955,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725956,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725957,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725958,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725959,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725960,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725961,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725962,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725963,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725964,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725966,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725967,F2,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725968,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725969,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725970,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725971,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725972,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725974,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725975,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725976,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725977,B,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725979,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725980,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725981,B,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725982,B,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725983,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725984,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725985,B,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725986,B,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725987,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725988,B,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725989,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725990,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725994,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725995,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725996,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725997,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725998,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF725999,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF726000,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF726001,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF726002,B,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF726003,B,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF726004,B,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF726007,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF726008,B,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF726009,B,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF726010,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF726011,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF726013,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF726014,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF726015,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF726016,B,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF726017,BF1,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF726018,B,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF726019,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF726020,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF726021,B,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF726022,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF726023,B,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF726025,C,2010,,"Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa","Rademeyer,C., Middelkoop,K., Brown,B., Cashmore,T.J., Marais,J., Scheibe,A., Bandawe,G., Myer,L., Williamson,C. and Bekker,L.-G.",
KF758551,68_01B,2010,24601765,"A Novel HIV-1 CRF01_AE/B Recombinant Among Men Who Have Sex with Men in Jiangsu Province, China","Guo,H., Hu,H., Zhou,Y., Yang,H., Huan,X., Qiu,T., Fu,G. and Ding,P.",2014
KF766537,C,2004,24387762,Phylogenetic Characterization of Six Full-Length HIV-1 Subtype C Molecular Clones from Three Patients: Identification of Rare Subtype C Strains Containing Two NF-kappaB Motifs in the Long Terminal Repeat,"Hanna,L.E., Neogi,U., Ranga,U., Swaminathan,S. and Prasad,V.R.",2014
KF766540,C,2005,24387762,Phylogenetic Characterization of Six Full-Length HIV-1 Subtype C Molecular Clones from Three Patients: Identification of Rare Subtype C Strains Containing Two NF-kappaB Motifs in the Long Terminal Repeat,"Hanna,L.E., Neogi,U., Ranga,U., Swaminathan,S. and Prasad,V.R.",2014
KF766541,C,2005,24387762,Phylogenetic Characterization of Six Full-Length HIV-1 Subtype C Molecular Clones from Three Patients: Identification of Rare Subtype C Strains Containing Two NF-kappaB Motifs in the Long Terminal Repeat,"Hanna,L.E., Neogi,U., Ranga,U., Swaminathan,S. and Prasad,V.R.",2014
KF773157,C,1996,24699231,The Genealogical Population Dynamics of HIV-1 in a Large Transmission Chain: Bridging within and among Host Evolutionary Rates,"Vrancken,B., Rambaut,A., Suchard,M.A., Drummond,A., Baele,G., Derdelinckx,I., Van Wijngaerden,E., Vandamme,A.M., Van Laethem,K. and Lemey,P.",2014
KF773192,C,1990,24699231,The Genealogical Population Dynamics of HIV-1 in a Large Transmission Chain: Bridging within and among Host Evolutionary Rates,"Vrancken,B., Rambaut,A., Suchard,M.A., Drummond,A., Baele,G., Derdelinckx,I., Van Wijngaerden,E., Vandamme,A.M., Van Laethem,K. and Lemey,P.",2014
KF773207,C,1994,24699231,The Genealogical Population Dynamics of HIV-1 in a Large Transmission Chain: Bridging within and among Host Evolutionary Rates,"Vrancken,B., Rambaut,A., Suchard,M.A., Drummond,A., Baele,G., Derdelinckx,I., Van Wijngaerden,E., Vandamme,A.M., Van Laethem,K. and Lemey,P.",2014
KF773246,C,1999,24699231,The Genealogical Population Dynamics of HIV-1 in a Large Transmission Chain: Bridging within and among Host Evolutionary Rates,"Vrancken,B., Rambaut,A., Suchard,M.A., Drummond,A., Baele,G., Derdelinckx,I., Van Wijngaerden,E., Vandamme,A.M., Van Laethem,K. and Lemey,P.",2014
KF773286,C,2001,24699231,The Genealogical Population Dynamics of HIV-1 in a Large Transmission Chain: Bridging within and among Host Evolutionary Rates,"Vrancken,B., Rambaut,A., Suchard,M.A., Drummond,A., Baele,G., Derdelinckx,I., Van Wijngaerden,E., Vandamme,A.M., Van Laethem,K. and Lemey,P.",2014
KF773327,C,2002,24699231,The Genealogical Population Dynamics of HIV-1 in a Large Transmission Chain: Bridging within and among Host Evolutionary Rates,"Vrancken,B., Rambaut,A., Suchard,M.A., Drummond,A., Baele,G., Derdelinckx,I., Van Wijngaerden,E., Vandamme,A.M., Van Laethem,K. and Lemey,P.",2014
KF773341,C,2002,24699231,The Genealogical Population Dynamics of HIV-1 in a Large Transmission Chain: Bridging within and among Host Evolutionary Rates,"Vrancken,B., Rambaut,A., Suchard,M.A., Drummond,A., Baele,G., Derdelinckx,I., Van Wijngaerden,E., Vandamme,A.M., Van Laethem,K. and Lemey,P.",2014
KF773351,C,1996,24699231,The Genealogical Population Dynamics of HIV-1 in a Large Transmission Chain: Bridging within and among Host Evolutionary Rates,"Vrancken,B., Rambaut,A., Suchard,M.A., Drummond,A., Baele,G., Derdelinckx,I., Van Wijngaerden,E., Vandamme,A.M., Van Laethem,K. and Lemey,P.",2014
KF773368,C,1999,24699231,The Genealogical Population Dynamics of HIV-1 in a Large Transmission Chain: Bridging within and among Host Evolutionary Rates,"Vrancken,B., Rambaut,A., Suchard,M.A., Drummond,A., Baele,G., Derdelinckx,I., Van Wijngaerden,E., Vandamme,A.M., Van Laethem,K. and Lemey,P.",2014
KF773371,C,2004,24699231,The Genealogical Population Dynamics of HIV-1 in a Large Transmission Chain: Bridging within and among Host Evolutionary Rates,"Vrancken,B., Rambaut,A., Suchard,M.A., Drummond,A., Baele,G., Derdelinckx,I., Van Wijngaerden,E., Vandamme,A.M., Van Laethem,K. and Lemey,P.",2014
KF773374,C,2006,24699231,The Genealogical Population Dynamics of HIV-1 in a Large Transmission Chain: Bridging within and among Host Evolutionary Rates,"Vrancken,B., Rambaut,A., Suchard,M.A., Drummond,A., Baele,G., Derdelinckx,I., Van Wijngaerden,E., Vandamme,A.M., Van Laethem,K. and Lemey,P.",2014
KF835493,08_BC,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835494,07_BC,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835495,08_BC,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835496,08_BC,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835497,08_BC,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835498,08_BC,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835499,01_AE,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835500,08_BC,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835501,08_BC,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835502,01_AE,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835503,01_AE,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835504,01_AE,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835505,01_AE,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835506,08_BC,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835507,08_BC,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835508,08_BC,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835509,08_BC,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835510,07_BC,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835511,07_BC,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835512,08_BC,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835513,01_AE,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835514,01_AE,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835515,C,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835516,01_AE,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835517,01BC,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835518,01_AE,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835519,01_AE,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835520,01BC,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835521,BC,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835522,C,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835523,01_AE,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835524,BC,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835525,BC,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835526,BC,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835527,01_AE,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835528,01_AE,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835529,08_BC,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835530,08_BC,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835531,08_BC,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835532,07_BC,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835533,01_AE,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835534,08_BC,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835535,08_BC,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835536,01_AE,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835537,01BC,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835538,01_AE,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835539,BC,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835540,BC,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835541,08_BC,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835542,01_AE,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835543,01_AE,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835544,BC,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835545,08_BC,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835546,01B,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF835547,08_BC,2007,,"Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms","Liu,Y.",
KF850149,01BC,2010,24446780,"Near Full-Length Genome Identification of a Novel HIV-1 Recombinant Form (CRF01_AE/B'/C) Among Heterosexuals in Jilin, China","Li,X., Ning,C., Chen,Y., Feng,Y., Wei,M., Xing,H. and Shao,Y.",2014
KF859741,01_AE,2011,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Busch,M., Tadokoro,K. and Gao,F.",
KF859742,O,,,Direct Submission,"Hora,B., Chen,Y., Denny,T. and Gao,F.",2013
KF859743,O,,,Direct Submission,"Hora,B., Chen,Y., Denny,T. and Gao,F.",2013
KF859744,O,,,Direct Submission,"Hora,B., Chen,Y., Denny,T. and Gao,F.",2013
KF859745,A1,2011,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Fast,P., Amornkul,P., Price,M., Kamali,A. and Gao,F.",
KF859746,A1D,2009,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Fast,P., Amornkul,P., Price,M., Kamali,A. and Gao,F.",
KF859747,A1D,2009,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N., Fast,P., Amornkul,P., Price,M., Kamali,A. and Gao,F.",
KF859773,01B,2010,24521207,"Near Full-Length Genome Sequence of a Novel HIV-1 Recombinant Form (CRF01_AE/B) Detected Among Men Who Have Sex with Men in Jilin Province, China","Li,X., Feng,Y., Yang,Y., Chen,Y., Guo,Q., Sun,L., Zang,X., Xing,H. and Shao,Y.",2014
KF927150,55_01B,2011,26667846,A Large-scale Survey of CRF55_01B from Men-Who-Have-Sex-with-Men in China: implying the Evolutionary History and Public Health Impact,"Han,X., Takebe,Y., Zhang,W., An,M., Zhao,B., Hu,Q., Xu,J., Wu,H., Wu,J., Lu,L., Chen,X., Liang,S., Wang,Z., Yan,H., Fu,J., Cai,W., Zhuang,M., Liao,C. and Shang,H.",2015
KF927151,55_01B,2011,26667846,A Large-scale Survey of CRF55_01B from Men-Who-Have-Sex-with-Men in China: implying the Evolutionary History and Public Health Impact,"Han,X., Takebe,Y., Zhang,W., An,M., Zhao,B., Hu,Q., Xu,J., Wu,H., Wu,J., Lu,L., Chen,X., Liang,S., Wang,Z., Yan,H., Fu,J., Cai,W., Zhuang,M., Liao,C. and Shang,H.",2015
KF985982,D,2005,24369910,HIV-1 envelope replication and alpha4beta7 utilization among newly infected subjects and their corresponding heterosexual partners,"Pena-Cruz,V., Etemad,B., Chatziandreou,N., Nyein,P.H., Stock,S., Reynolds,S.J., Laeyendecker,O., Gray,R.H., Serwadda,D., Lee,S.J., Quinn,T.C. and Sagar,M.",2013
KF985994,D,2005,24369910,HIV-1 envelope replication and alpha4beta7 utilization among newly infected subjects and their corresponding heterosexual partners,"Pena-Cruz,V., Etemad,B., Chatziandreou,N., Nyein,P.H., Stock,S., Reynolds,S.J., Laeyendecker,O., Gray,R.H., Serwadda,D., Lee,S.J., Quinn,T.C. and Sagar,M.",2013
KF986006,D,2006,24369910,HIV-1 envelope replication and alpha4beta7 utilization among newly infected subjects and their corresponding heterosexual partners,"Pena-Cruz,V., Etemad,B., Chatziandreou,N., Nyein,P.H., Stock,S., Reynolds,S.J., Laeyendecker,O., Gray,R.H., Serwadda,D., Lee,S.J., Quinn,T.C. and Sagar,M.",2013
KF986021,D,2006,24369910,HIV-1 envelope replication and alpha4beta7 utilization among newly infected subjects and their corresponding heterosexual partners,"Pena-Cruz,V., Etemad,B., Chatziandreou,N., Nyein,P.H., Stock,S., Reynolds,S.J., Laeyendecker,O., Gray,R.H., Serwadda,D., Lee,S.J., Quinn,T.C. and Sagar,M.",2013
KF986033,D,2005,24369910,HIV-1 envelope replication and alpha4beta7 utilization among newly infected subjects and their corresponding heterosexual partners,"Pena-Cruz,V., Etemad,B., Chatziandreou,N., Nyein,P.H., Stock,S., Reynolds,S.J., Laeyendecker,O., Gray,R.H., Serwadda,D., Lee,S.J., Quinn,T.C. and Sagar,M.",2013
KF986041,D,2006,24369910,HIV-1 envelope replication and alpha4beta7 utilization among newly infected subjects and their corresponding heterosexual partners,"Pena-Cruz,V., Etemad,B., Chatziandreou,N., Nyein,P.H., Stock,S., Reynolds,S.J., Laeyendecker,O., Gray,R.H., Serwadda,D., Lee,S.J., Quinn,T.C. and Sagar,M.",2013
KF986050,D,2005,24369910,HIV-1 envelope replication and alpha4beta7 utilization among newly infected subjects and their corresponding heterosexual partners,"Pena-Cruz,V., Etemad,B., Chatziandreou,N., Nyein,P.H., Stock,S., Reynolds,S.J., Laeyendecker,O., Gray,R.H., Serwadda,D., Lee,S.J., Quinn,T.C. and Sagar,M.",2013
KF986058,D,2005,24369910,HIV-1 envelope replication and alpha4beta7 utilization among newly infected subjects and their corresponding heterosexual partners,"Pena-Cruz,V., Etemad,B., Chatziandreou,N., Nyein,P.H., Stock,S., Reynolds,S.J., Laeyendecker,O., Gray,R.H., Serwadda,D., Lee,S.J., Quinn,T.C. and Sagar,M.",2013
KF986066,D,2005,24369910,HIV-1 envelope replication and alpha4beta7 utilization among newly infected subjects and their corresponding heterosexual partners,"Pena-Cruz,V., Etemad,B., Chatziandreou,N., Nyein,P.H., Stock,S., Reynolds,S.J., Laeyendecker,O., Gray,R.H., Serwadda,D., Lee,S.J., Quinn,T.C. and Sagar,M.",2013
KF986074,D,2006,24369910,HIV-1 envelope replication and alpha4beta7 utilization among newly infected subjects and their corresponding heterosexual partners,"Pena-Cruz,V., Etemad,B., Chatziandreou,N., Nyein,P.H., Stock,S., Reynolds,S.J., Laeyendecker,O., Gray,R.H., Serwadda,D., Lee,S.J., Quinn,T.C. and Sagar,M.",2013
KF986082,D,1996,24369910,HIV-1 envelope replication and alpha4beta7 utilization among newly infected subjects and their corresponding heterosexual partners,"Pena-Cruz,V., Etemad,B., Chatziandreou,N., Nyein,P.H., Stock,S., Reynolds,S.J., Laeyendecker,O., Gray,R.H., Serwadda,D., Lee,S.J., Quinn,T.C. and Sagar,M.",2013
KF986090,D,2006,24369910,HIV-1 envelope replication and alpha4beta7 utilization among newly infected subjects and their corresponding heterosexual partners,"Pena-Cruz,V., Etemad,B., Chatziandreou,N., Nyein,P.H., Stock,S., Reynolds,S.J., Laeyendecker,O., Gray,R.H., Serwadda,D., Lee,S.J., Quinn,T.C. and Sagar,M.",2013
KF986098,D,1996,24369910,HIV-1 envelope replication and alpha4beta7 utilization among newly infected subjects and their corresponding heterosexual partners,"Pena-Cruz,V., Etemad,B., Chatziandreou,N., Nyein,P.H., Stock,S., Reynolds,S.J., Laeyendecker,O., Gray,R.H., Serwadda,D., Lee,S.J., Quinn,T.C. and Sagar,M.",2013
KF986106,D,2005,24369910,HIV-1 envelope replication and alpha4beta7 utilization among newly infected subjects and their corresponding heterosexual partners,"Pena-Cruz,V., Etemad,B., Chatziandreou,N., Nyein,P.H., Stock,S., Reynolds,S.J., Laeyendecker,O., Gray,R.H., Serwadda,D., Lee,S.J., Quinn,T.C. and Sagar,M.",2013
KF986114,D,2006,24369910,HIV-1 envelope replication and alpha4beta7 utilization among newly infected subjects and their corresponding heterosexual partners,"Pena-Cruz,V., Etemad,B., Chatziandreou,N., Nyein,P.H., Stock,S., Reynolds,S.J., Laeyendecker,O., Gray,R.H., Serwadda,D., Lee,S.J., Quinn,T.C. and Sagar,M.",2013
KF986123,D,2005,24369910,HIV-1 envelope replication and alpha4beta7 utilization among newly infected subjects and their corresponding heterosexual partners,"Pena-Cruz,V., Etemad,B., Chatziandreou,N., Nyein,P.H., Stock,S., Reynolds,S.J., Laeyendecker,O., Gray,R.H., Serwadda,D., Lee,S.J., Quinn,T.C. and Sagar,M.",2013
KF986131,D,2005,24369910,HIV-1 envelope replication and alpha4beta7 utilization among newly infected subjects and their corresponding heterosexual partners,"Pena-Cruz,V., Etemad,B., Chatziandreou,N., Nyein,P.H., Stock,S., Reynolds,S.J., Laeyendecker,O., Gray,R.H., Serwadda,D., Lee,S.J., Quinn,T.C. and Sagar,M.",2013
KF986139,D,2005,24369910,HIV-1 envelope replication and alpha4beta7 utilization among newly infected subjects and their corresponding heterosexual partners,"Pena-Cruz,V., Etemad,B., Chatziandreou,N., Nyein,P.H., Stock,S., Reynolds,S.J., Laeyendecker,O., Gray,R.H., Serwadda,D., Lee,S.J., Quinn,T.C. and Sagar,M.",2013
KF990605,B,2005,25622054,Viral envelope is a major determinant of enhanced fitness of a multidrug-resistant HIV-1 variant,"Mohri,H., Prada,N. and Markowitz,M.",2015
KF990608,B,2006,25622054,Viral envelope is a major determinant of enhanced fitness of a multidrug-resistant HIV-1 variant,"Mohri,H., Prada,N. and Markowitz,M.",2015
KJ140245,B,1992,,Near full-length sequences of HIV-1 in Korean Hemophiliacs infected with Korean subclade B,"Cho,Y.-K.",
KJ140247,B,1992,,Near full-length sequences of HIV-1 in Korean Hemophiliacs infected with Korean subclade B,"Cho,Y.-K.",
KJ140248,B,1992,,Near full-length sequences of HIV-1 in Korean Hemophiliacs infected with Korean subclade B,"Cho,Y.-K.",
KJ140249,B,2002,,Near full-length sequences of HIV-1 in Korean Hemophiliacs infected with Korean subclade B,"Cho,Y.-K.",
KJ140250,B,1995,,Near full-length sequences of HIV-1 in Korean Hemophiliacs infected with Korean subclade B,"Cho,Y.-K.",
KJ140251,B,1992,,Near full-length sequences of HIV-1 in Korean Hemophiliacs infected with Korean subclade B,"Cho,Y.-K.",
KJ140252,B,1992,,Near full-length sequences of HIV-1 in Korean Hemophiliacs infected with Korean subclade B,"Cho,Y.-K.",
KJ140255,B,1992,,Near full-length sequences of HIV-1 in Korean Hemophiliacs infected with Korean subclade B,"Cho,Y.-K.",
KJ140256,B,1992,,Near full-length sequences of HIV-1 in Korean Hemophiliacs infected with Korean subclade B,"Cho,Y.-K.",
KJ140257,B,1992,,Near full-length sequences of HIV-1 in Korean Hemophiliacs infected with Korean subclade B,"Cho,Y.-K.",
KJ140259,B,1992,,Near full-length sequences of HIV-1 in Korean Hemophiliacs infected with Korean subclade B,"Cho,Y.-K.",
KJ140260,B,2003,,Near full-length sequences of HIV-1 in Korean Hemophiliacs infected with Korean subclade B,"Cho,Y.-K.",
KJ140261,B,1992,,Near full-length sequences of HIV-1 in Korean Hemophiliacs infected with Korean subclade B,"Cho,Y.-K.",
KJ140262,B,1993,,Near full-length sequences of HIV-1 in Korean Hemophiliacs infected with Korean subclade B,"Cho,Y.-K.",
KJ140264,B,2002,,Near full-length sequences of HIV-1 in Korean Hemophiliacs infected with Korean subclade B,"Cho,Y.-K.",
KJ140265,B,2002,,Near full-length sequences of HIV-1 in Korean Hemophiliacs infected with Korean subclade B,"Cho,Y.-K.",
KJ140266,B,1992,,Near full-length sequences of HIV-1 in Korean infected with Korean subclade B,"Cho,Y.-K.",
KJ140267,B,1992,,Near full-length sequences of HIV-1 in Korean infected with Korean subclade B,"Cho,Y.-K.",
KJ158421,C,2011,,Genetic Characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Athipanyasilp,N. and Kantakamalakul,W.",
KJ158422,01C,2011,,Genetic Characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Athipanyasilp,N. and Kantakamalakul,W.",
KJ158423,C,2011,,Genetic Characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Athipanyasilp,N. and Kantakamalakul,W.",
KJ158424,C,2011,,Genetic Characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Athipanyasilp,N. and Kantakamalakul,W.",
KJ158425,C,2011,,Genetic Characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Athipanyasilp,N. and Kantakamalakul,W.",
KJ158426,C,2011,,Genetic Characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Athipanyasilp,N. and Kantakamalakul,W.",
KJ158427,01C,2011,,Genetic Characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Athipanyasilp,N. and Kantakamalakul,W.",
KJ158428,C,2011,,Genetic Characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Athipanyasilp,N. and Kantakamalakul,W.",
KJ158429,CD,2011,,Genetic Characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Athipanyasilp,N. and Kantakamalakul,W.",
KJ158430,C,2011,,Genetic Characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Athipanyasilp,N. and Kantakamalakul,W.",
KJ158431,C,2011,,Genetic Characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Athipanyasilp,N. and Kantakamalakul,W.",
KJ158432,C,2011,,Genetic Characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Athipanyasilp,N. and Kantakamalakul,W.",
KJ158433,C,2011,,Genetic Characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Athipanyasilp,N. and Kantakamalakul,W.",
KJ158434,C,2011,,Genetic Characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Athipanyasilp,N. and Kantakamalakul,W.",
KJ158435,C,2011,,Genetic Characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Athipanyasilp,N. and Kantakamalakul,W.",
KJ158436,A1,2011,,Genetic Characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Athipanyasilp,N. and Kantakamalakul,W.",
KJ158437,01C,2011,,Genetic Characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Athipanyasilp,N. and Kantakamalakul,W.",
KJ158438,C,2011,,Genetic Characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Athipanyasilp,N. and Kantakamalakul,W.",
KJ158439,C,2011,,Genetic Characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Athipanyasilp,N. and Kantakamalakul,W.",
KJ158440,C,2011,,Genetic Characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Athipanyasilp,N. and Kantakamalakul,W.",
KJ184176,0107,2010,25356726,"Molecular Epidemiology of HIV-1 in Jilin Province, Northeastern China: Emergence of a New CRF07_BC Transmission Cluster and Intersubtype Recombinants","Li,X., Zang,X., Ning,C., Feng,Y., Xie,C., He,X., Takebe,Y., Sun,L., Guo,Q., Xing,H., Kalish,M.L. and Shao,Y.",2014
KJ184177,01BC,2010,25356726,"Molecular Epidemiology of HIV-1 in Jilin Province, Northeastern China: Emergence of a New CRF07_BC Transmission Cluster and Intersubtype Recombinants","Li,X., Zang,X., Ning,C., Feng,Y., Xie,C., He,X., Takebe,Y., Sun,L., Guo,Q., Xing,H., Kalish,M.L. and Shao,Y.",2014
KJ184179,0107,2011,25356726,"Molecular Epidemiology of HIV-1 in Jilin Province, Northeastern China: Emergence of a New CRF07_BC Transmission Cluster and Intersubtype Recombinants","Li,X., Zang,X., Ning,C., Feng,Y., Xie,C., He,X., Takebe,Y., Sun,L., Guo,Q., Xing,H., Kalish,M.L. and Shao,Y.",2014
KJ184180,0107,2011,24892359,"Identification of a Novel HIV-1 Second-Generation Recombinant Form (CRF01_AE/CRF07_BC) in Jilin, China","Feng,Y., Li,X., Zang,X., Guo,Q., Sun,L., He,X., Xing,H. and Shao,Y.",2014
KJ197200,63_02A1,2013,25050828,"Short Communication: Molecular Epidemiology, Phylogeny, and Phylodynamics of CRF63_02A1, a Recently Originated HIV-1 Circulating Recombinant Form Spreading in Siberia","Shcherbakova,N.S., Shalamova,L.A., Delgado,E., Fernandez-Garcia,A., Vega,Y., Karpenko,L.I., Ilyichev,A.A., Sokolov,Y.V., Shcherbakov,D.N., Perez-Alvarez,L. and Thomson,M.M.",2014
KJ197201,63_02A1,2013,25050828,"Short Communication: Molecular Epidemiology, Phylogeny, and Phylodynamics of CRF63_02A1, a Recently Originated HIV-1 Circulating Recombinant Form Spreading in Siberia","Shcherbakova,N.S., Shalamova,L.A., Delgado,E., Fernandez-Garcia,A., Vega,Y., Karpenko,L.I., Ilyichev,A.A., Sokolov,Y.V., Shcherbakov,D.N., Perez-Alvarez,L. and Thomson,M.M.",2014
KJ197202,63_02A1,2013,25050828,"Short Communication: Molecular Epidemiology, Phylogeny, and Phylodynamics of CRF63_02A1, a Recently Originated HIV-1 Circulating Recombinant Form Spreading in Siberia","Shcherbakova,N.S., Shalamova,L.A., Delgado,E., Fernandez-Garcia,A., Vega,Y., Karpenko,L.I., Ilyichev,A.A., Sokolov,Y.V., Shcherbakov,D.N., Perez-Alvarez,L. and Thomson,M.M.",2014
KJ206289,01B,2010,24675847,"Genome Sequence of a Complex HIV-1 Unique Recombinant Form Involving CRF01_AE, Subtype B, and Subtype B' Identified in Malaysia","Chow,W.Z., Nizam,S., Ong,L.Y., Ng,K.T., Chan,K.G., Takebe,Y., Koh,C., Kamarulzaman,A. and Tee,K.K.",2014
KJ484433,59_01B,2011,24978029,Identification and Characterization of a Novel HIV-1 Circulating Recombinant Form (CRF59_01B) Identified among Men-Who-Have-Sex-with-Men in China,"Zhang,W., Han,X., An,M., Zhao,B., Hu,Q., Chu,Z., Xu,J., Cai,W., Chen,X., Fu,J., Wang,Z., Wu,J., Lu,L., Zhuang,M., Wu,H., Yan,H., Liao,C., Takebe,Y. and Shang,H.",2014
KJ484434,59_01B,2011,24978029,Identification and Characterization of a Novel HIV-1 Circulating Recombinant Form (CRF59_01B) Identified among Men-Who-Have-Sex-with-Men in China,"Zhang,W., Han,X., An,M., Zhao,B., Hu,Q., Chu,Z., Xu,J., Cai,W., Chen,X., Fu,J., Wang,Z., Wu,J., Lu,L., Zhuang,M., Wu,H., Yan,H., Liao,C., Takebe,Y. and Shang,H.",2014
KJ484435,59_01B,2012,24978029,Identification and Characterization of a Novel HIV-1 Circulating Recombinant Form (CRF59_01B) Identified among Men-Who-Have-Sex-with-Men in China,"Zhang,W., Han,X., An,M., Zhao,B., Hu,Q., Chu,Z., Xu,J., Cai,W., Chen,X., Fu,J., Wang,Z., Wu,J., Lu,L., Zhuang,M., Wu,H., Yan,H., Liao,C., Takebe,Y. and Shang,H.",2014
KJ485698,51_01B,2009,25340817,Cross-Border Sexual Transmission of the Newly Emerging HIV-1 Clade CRF51_01B,"Cheong,H.T., Ng,K.T., Ong,L.Y., Chook,J.B., Chan,K.G., Takebe,Y., Kamarulzaman,A. and Tee,K.K.",2014
KJ541837,C,2011,,Genetic characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Kantakamalakul,W. and Athipanyasilp,N.",
KJ541838,A1C,2011,,Genetic characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Kantakamalakul,W. and Athipanyasilp,N.",
KJ541839,C,2011,,Genetic characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Kantakamalakul,W. and Athipanyasilp,N.",
KJ541840,C,2011,,Genetic characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Kantakamalakul,W. and Athipanyasilp,N.",
KJ541841,C,2011,,Genetic characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Kantakamalakul,W. and Athipanyasilp,N.",
KJ541842,01CD,2011,,Genetic characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Kantakamalakul,W. and Athipanyasilp,N.",
KJ541843,CD,2011,,Genetic characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Kantakamalakul,W. and Athipanyasilp,N.",
KJ541844,C,2011,,Genetic characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Kantakamalakul,W. and Athipanyasilp,N.",
KJ541845,01_AE,2011,,Genetic characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Kantakamalakul,W. and Athipanyasilp,N.",
KJ541846,C,2011,,Genetic characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Kantakamalakul,W. and Athipanyasilp,N.",
KJ541847,C,2011,,Genetic characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Kantakamalakul,W. and Athipanyasilp,N.",
KJ541848,C,2011,,Genetic characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Kantakamalakul,W. and Athipanyasilp,N.",
KJ541849,C,2011,,Genetic characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Kantakamalakul,W. and Athipanyasilp,N.",
KJ541850,01C,2011,,Genetic characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Kantakamalakul,W. and Athipanyasilp,N.",
KJ541851,A1C,2011,,Genetic characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal,"Bhusal,N., Sutthent,R., Horthongkham,N., Kantakamalakul,W. and Athipanyasilp,N.",
KJ579955,A1D,1993,24829409,Boosting of HIV-1 Neutralizing Antibody Responses by a Distally Related Retroviral Envelope Protein,"Uchtenhagen,H., Schiffner,T., Bowles,E., Heyndrickx,L., LaBranche,C., Applequist,S.E., Jansson,M., De Silva,T., Back,J.W., Achour,A., Scarlatti,G., Fomsgaard,A., Montefiori,D., Stewart-Jones,G. and Spetz,A.L.",2014
KJ669749,B,1988,24866155,Low level of HIV-1 evolution after transmission from mother to child,"Gijsbers,E.F., van Nuenen,A.C., Torrents de la Pena,A., Bowles,E.J., Stewart-Jones,G.B., Schuitemaker,H. and Kootstra,N.A.",2014
KJ669778,B,1989,24866155,Low level of HIV-1 evolution after transmission from mother to child,"Gijsbers,E.F., van Nuenen,A.C., Torrents de la Pena,A., Bowles,E.J., Stewart-Jones,G.B., Schuitemaker,H. and Kootstra,N.A.",2014
KJ669860,B,1990,24866155,Low level of HIV-1 evolution after transmission from mother to child,"Gijsbers,E.F., van Nuenen,A.C., Torrents de la Pena,A., Bowles,E.J., Stewart-Jones,G.B., Schuitemaker,H. and Kootstra,N.A.",2014
KJ669864,B,1991,24866155,Low level of HIV-1 evolution after transmission from mother to child,"Gijsbers,E.F., van Nuenen,A.C., Torrents de la Pena,A., Bowles,E.J., Stewart-Jones,G.B., Schuitemaker,H. and Kootstra,N.A.",2014
KJ669940,G,1991,24866155,Low level of HIV-1 evolution after transmission from mother to child,"Gijsbers,E.F., van Nuenen,A.C., Torrents de la Pena,A., Bowles,E.J., Stewart-Jones,G.B., Schuitemaker,H. and Kootstra,N.A.",2014
KJ669955,G,1992,24866155,Low level of HIV-1 evolution after transmission from mother to child,"Gijsbers,E.F., van Nuenen,A.C., Torrents de la Pena,A., Bowles,E.J., Stewart-Jones,G.B., Schuitemaker,H. and Kootstra,N.A.",2014
KJ669979,B,1992,24866155,Low level of HIV-1 evolution after transmission from mother to child,"Gijsbers,E.F., van Nuenen,A.C., Torrents de la Pena,A., Bowles,E.J., Stewart-Jones,G.B., Schuitemaker,H. and Kootstra,N.A.",2014
KJ669983,B,1991,24866155,Low level of HIV-1 evolution after transmission from mother to child,"Gijsbers,E.F., van Nuenen,A.C., Torrents de la Pena,A., Bowles,E.J., Stewart-Jones,G.B., Schuitemaker,H. and Kootstra,N.A.",2014
KJ670018,B,1991,24866155,Low level of HIV-1 evolution after transmission from mother to child,"Gijsbers,E.F., van Nuenen,A.C., Torrents de la Pena,A., Bowles,E.J., Stewart-Jones,G.B., Schuitemaker,H. and Kootstra,N.A.",2014
KJ670040,B,1992,24866155,Low level of HIV-1 evolution after transmission from mother to child,"Gijsbers,E.F., van Nuenen,A.C., Torrents de la Pena,A., Bowles,E.J., Stewart-Jones,G.B., Schuitemaker,H. and Kootstra,N.A.",2014
KJ671534,72_BF1,2010,24926043,Identification of a Novel HIV-1 Circulating Recombinant Form (CRF72_BF1) in Deep Sequencing Data from Blood Donors in Southeastern Brazil,"Pessoa,R., Carneiro Proietti,A.B., Busch,M.P. and Sanabani,S.S.",2014
KJ682660,B,2008,,Two Mother to Child Transmissions Within Three Generations of the Same Family,"Lewis,M., Cercillieux,A., Frohnen,P. and Bryson,Y.",
KJ682692,B,2008,,Two Mother to Child Transmissions Within Three Generations of the Same Family,"Lewis,M., Cercillieux,A., Frohnen,P. and Bryson,Y.",
KJ682706,B,2008,,Two Mother to Child Transmissions Within Three Generations of the Same Family,"Lewis,M., Cercillieux,A., Frohnen,P. and Bryson,Y.",
KJ682728,B,1991,,Two Mother to Child Transmissions Within Three Generations of the Same Family,"Lewis,M., Cercillieux,A., Frohnen,P. and Bryson,Y.",
KJ682750,B,1991,,Two Mother to Child Transmissions Within Three Generations of the Same Family,"Lewis,M., Cercillieux,A., Frohnen,P. and Bryson,Y.",
KJ682754,B,1991,,Two Mother to Child Transmissions Within Three Generations of the Same Family,"Lewis,M., Cercillieux,A., Frohnen,P. and Bryson,Y.",
KJ682764,B,1991,,Two Mother to Child Transmissions Within Three Generations of the Same Family,"Lewis,M., Cercillieux,A., Frohnen,P. and Bryson,Y.",
KJ698244,B,2003,25210191,Envelope Variants Circulating as Initial Neutralization Breadth Developed in Two HIV-Infected Subjects Stimulate Multiclade Neutralizing Antibodies in Rabbits,"Malherbe,D.C., Pissani,F., Sather,D.N., Guo,B., Pandey,S., Sutton,W.F., Stuart,A.B., Robins,H., Park,B., Krebs,S.J., Schuman,J.T., Kalams,S., Hessell,A.J. and Haigwood,N.L.",2014
KJ698295,B,2004,25210191,Envelope Variants Circulating as Initial Neutralization Breadth Developed in Two HIV-Infected Subjects Stimulate Multiclade Neutralizing Antibodies in Rabbits,"Malherbe,D.C., Pissani,F., Sather,D.N., Guo,B., Pandey,S., Sutton,W.F., Stuart,A.B., Robins,H., Park,B., Krebs,S.J., Schuman,J.T., Kalams,S., Hessell,A.J. and Haigwood,N.L.",2014
KJ700458,C,2008,27434311,Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization,"Rademeyer,C., Korber,B., Seaman,M.S., Giorgi,E.E., Thebus,R., Robles,A., Sheward,D.J., Wagh,K., Garrity,J., Carey,B.R., Gao,H., Greene,K.M., Tang,H., Bandawe,G.P., Marais,J.C., Diphoko,T.E., Hraber,P., Tumba,N., Moore,P.L., Gray,G.E., Kublin,J., McElrath,M.J., Vermeulen,M., Middelkoop,K., Bekker,L.G., Hoelscher,M., Maboko,L., Makhema,J., Robb,M.L., Abdool Karim,S., Abdool Karim,Q., Kim,J.H., Hahn,B.H., Gao,F., Swanstrom,R., Morris,L., Montefiori,D.C. and Williamson,C.",2016
KJ704787,B,1983,27783600,1970s and 'Patient 0' HIV-1 genomes illuminate early HIV/AIDS history in North America,"Worobey,M., Watts,T.D., McKay,R.A., Suchard,M.A., Granade,T., Teuwen,D.E., Koblin,B.A., Heneine,W., Lemey,P. and Jaffe,H.W.",2016
KJ704789,B,1979,27783600,1970s and 'Patient 0' HIV-1 genomes illuminate early HIV/AIDS history in North America,"Worobey,M., Watts,T.D., McKay,R.A., Suchard,M.A., Granade,T., Teuwen,D.E., Koblin,B.A., Heneine,W., Lemey,P. and Jaffe,H.W.",2016
KJ704790,B,1979,27783600,1970s and 'Patient 0' HIV-1 genomes illuminate early HIV/AIDS history in North America,"Worobey,M., Watts,T.D., McKay,R.A., Suchard,M.A., Granade,T., Teuwen,D.E., Koblin,B.A., Heneine,W., Lemey,P. and Jaffe,H.W.",2016
KJ704791,B,1979,27783600,1970s and 'Patient 0' HIV-1 genomes illuminate early HIV/AIDS history in North America,"Worobey,M., Watts,T.D., McKay,R.A., Suchard,M.A., Granade,T., Teuwen,D.E., Koblin,B.A., Heneine,W., Lemey,P. and Jaffe,H.W.",2016
KJ704792,B,1979,27783600,1970s and 'Patient 0' HIV-1 genomes illuminate early HIV/AIDS history in North America,"Worobey,M., Watts,T.D., McKay,R.A., Suchard,M.A., Granade,T., Teuwen,D.E., Koblin,B.A., Heneine,W., Lemey,P. and Jaffe,H.W.",2016
KJ704793,B,1979,27783600,1970s and 'Patient 0' HIV-1 genomes illuminate early HIV/AIDS history in North America,"Worobey,M., Watts,T.D., McKay,R.A., Suchard,M.A., Granade,T., Teuwen,D.E., Koblin,B.A., Heneine,W., Lemey,P. and Jaffe,H.W.",2016
KJ704794,B,1978,27783600,1970s and 'Patient 0' HIV-1 genomes illuminate early HIV/AIDS history in North America,"Worobey,M., Watts,T.D., McKay,R.A., Suchard,M.A., Granade,T., Teuwen,D.E., Koblin,B.A., Heneine,W., Lemey,P. and Jaffe,H.W.",2016
KJ704795,B,1978,27783600,1970s and 'Patient 0' HIV-1 genomes illuminate early HIV/AIDS history in North America,"Worobey,M., Watts,T.D., McKay,R.A., Suchard,M.A., Granade,T., Teuwen,D.E., Koblin,B.A., Heneine,W., Lemey,P. and Jaffe,H.W.",2016
KJ704796,B,1978,27783600,1970s and 'Patient 0' HIV-1 genomes illuminate early HIV/AIDS history in North America,"Worobey,M., Watts,T.D., McKay,R.A., Suchard,M.A., Granade,T., Teuwen,D.E., Koblin,B.A., Heneine,W., Lemey,P. and Jaffe,H.W.",2016
KJ778895,01C,2013,,"Near Full-Length Genomic Characterization of a Novel HIV Type 1 CRF01_ AE/07_BC Recombinant in Men Who Have Sex with Men from Shannxi, China","Ke,Z. and Yongtao,S.",
KJ778896,01C,2012,,"Near Full-Length Genomic Characterization of a Novel HIV Type 1 CRF01_ AE/07_BC Recombinant in Men Who Have Sex with Men from Shannxi, China","Ke,Z. and Yongtao,S.",
KJ778897,0107,2012,,"Near Full-Length Genomic Characterization of a Novel HIV Type 1 CRF01_ AE/07_BC Recombinant in Men Who Have Sex with Men from Shannxi, China","Ke,Z. and Yongtao,S.",
KJ787683,D,2010,24926063,Genetic Characterization of HIV-1 Subtype D Near-Full-Length Proviral Genomes by Illumina Massively Parallel Sequencing Technology,"Pessoa,R., Lopes,M.E. and Sanabani,S.S.",2014
KJ787684,D,2010,24926063,Genetic Characterization of HIV-1 Subtype D Near-Full-Length Proviral Genomes by Illumina Massively Parallel Sequencing Technology,"Pessoa,R., Lopes,M.E. and Sanabani,S.S.",2014
KJ849758,70_BF1,2010,25401747,"Deep Sequencing of HIV-1 near Full-Length Proviral Genomes Identifies High Rates of BF1 Recombinants Including Two Novel Circulating Recombinant Forms (CRF) 70_BF1 and a Disseminating 71_BF1 among Blood Donors in Pernambuco, Brazil","Pessoa,R., Watanabe,J.T., Calabria,P., Felix,A.C., Loureiro,P., Sabino,E.C., Busch,M.P. and Sanabani,S.S.",2014
KJ849759,71_BF1,2010,25401747,"Deep Sequencing of HIV-1 near Full-Length Proviral Genomes Identifies High Rates of BF1 Recombinants Including Two Novel Circulating Recombinant Forms (CRF) 70_BF1 and a Disseminating 71_BF1 among Blood Donors in Pernambuco, Brazil","Pessoa,R., Watanabe,J.T., Calabria,P., Felix,A.C., Loureiro,P., Sabino,E.C., Busch,M.P. and Sanabani,S.S.",2014
KJ849760,71_BF1,2010,25401747,"Deep Sequencing of HIV-1 near Full-Length Proviral Genomes Identifies High Rates of BF1 Recombinants Including Two Novel Circulating Recombinant Forms (CRF) 70_BF1 and a Disseminating 71_BF1 among Blood Donors in Pernambuco, Brazil","Pessoa,R., Watanabe,J.T., Calabria,P., Felix,A.C., Loureiro,P., Sabino,E.C., Busch,M.P. and Sanabani,S.S.",2014
KJ849762,70_BF1,2010,25401747,"Deep Sequencing of HIV-1 near Full-Length Proviral Genomes Identifies High Rates of BF1 Recombinants Including Two Novel Circulating Recombinant Forms (CRF) 70_BF1 and a Disseminating 71_BF1 among Blood Donors in Pernambuco, Brazil","Pessoa,R., Watanabe,J.T., Calabria,P., Felix,A.C., Loureiro,P., Sabino,E.C., Busch,M.P. and Sanabani,S.S.",2014
KJ849763,71_BF1,2010,25401747,"Deep Sequencing of HIV-1 near Full-Length Proviral Genomes Identifies High Rates of BF1 Recombinants Including Two Novel Circulating Recombinant Forms (CRF) 70_BF1 and a Disseminating 71_BF1 among Blood Donors in Pernambuco, Brazil","Pessoa,R., Watanabe,J.T., Calabria,P., Felix,A.C., Loureiro,P., Sabino,E.C., Busch,M.P. and Sanabani,S.S.",2014
KJ849766,B,2010,25401747,"Deep Sequencing of HIV-1 near Full-Length Proviral Genomes Identifies High Rates of BF1 Recombinants Including Two Novel Circulating Recombinant Forms (CRF) 70_BF1 and a Disseminating 71_BF1 among Blood Donors in Pernambuco, Brazil","Pessoa,R., Watanabe,J.T., Calabria,P., Felix,A.C., Loureiro,P., Sabino,E.C., Busch,M.P. and Sanabani,S.S.",2014
KJ849768,BF1,2010,25401747,"Deep Sequencing of HIV-1 near Full-Length Proviral Genomes Identifies High Rates of BF1 Recombinants Including Two Novel Circulating Recombinant Forms (CRF) 70_BF1 and a Disseminating 71_BF1 among Blood Donors in Pernambuco, Brazil","Pessoa,R., Watanabe,J.T., Calabria,P., Felix,A.C., Loureiro,P., Sabino,E.C., Busch,M.P. and Sanabani,S.S.",2014
KJ849769,71_BF1,2010,25401747,"Deep Sequencing of HIV-1 near Full-Length Proviral Genomes Identifies High Rates of BF1 Recombinants Including Two Novel Circulating Recombinant Forms (CRF) 70_BF1 and a Disseminating 71_BF1 among Blood Donors in Pernambuco, Brazil","Pessoa,R., Watanabe,J.T., Calabria,P., Felix,A.C., Loureiro,P., Sabino,E.C., Busch,M.P. and Sanabani,S.S.",2014
KJ849770,71_BF1,2010,25401747,"Deep Sequencing of HIV-1 near Full-Length Proviral Genomes Identifies High Rates of BF1 Recombinants Including Two Novel Circulating Recombinant Forms (CRF) 70_BF1 and a Disseminating 71_BF1 among Blood Donors in Pernambuco, Brazil","Pessoa,R., Watanabe,J.T., Calabria,P., Felix,A.C., Loureiro,P., Sabino,E.C., Busch,M.P. and Sanabani,S.S.",2014
KJ849771,71_BF1,2010,25401747,"Deep Sequencing of HIV-1 near Full-Length Proviral Genomes Identifies High Rates of BF1 Recombinants Including Two Novel Circulating Recombinant Forms (CRF) 70_BF1 and a Disseminating 71_BF1 among Blood Donors in Pernambuco, Brazil","Pessoa,R., Watanabe,J.T., Calabria,P., Felix,A.C., Loureiro,P., Sabino,E.C., Busch,M.P. and Sanabani,S.S.",2014
KJ849774,BF1,2010,25401747,"Deep Sequencing of HIV-1 near Full-Length Proviral Genomes Identifies High Rates of BF1 Recombinants Including Two Novel Circulating Recombinant Forms (CRF) 70_BF1 and a Disseminating 71_BF1 among Blood Donors in Pernambuco, Brazil","Pessoa,R., Watanabe,J.T., Calabria,P., Felix,A.C., Loureiro,P., Sabino,E.C., Busch,M.P. and Sanabani,S.S.",2014
KJ849775,71_BF1,2010,25401747,"Deep Sequencing of HIV-1 near Full-Length Proviral Genomes Identifies High Rates of BF1 Recombinants Including Two Novel Circulating Recombinant Forms (CRF) 70_BF1 and a Disseminating 71_BF1 among Blood Donors in Pernambuco, Brazil","Pessoa,R., Watanabe,J.T., Calabria,P., Felix,A.C., Loureiro,P., Sabino,E.C., Busch,M.P. and Sanabani,S.S.",2014
KJ849777,71_BF1,2010,25401747,"Deep Sequencing of HIV-1 near Full-Length Proviral Genomes Identifies High Rates of BF1 Recombinants Including Two Novel Circulating Recombinant Forms (CRF) 70_BF1 and a Disseminating 71_BF1 among Blood Donors in Pernambuco, Brazil","Pessoa,R., Watanabe,J.T., Calabria,P., Felix,A.C., Loureiro,P., Sabino,E.C., Busch,M.P. and Sanabani,S.S.",2014
KJ849778,71_BF1,2010,25401747,"Deep Sequencing of HIV-1 near Full-Length Proviral Genomes Identifies High Rates of BF1 Recombinants Including Two Novel Circulating Recombinant Forms (CRF) 70_BF1 and a Disseminating 71_BF1 among Blood Donors in Pernambuco, Brazil","Pessoa,R., Watanabe,J.T., Calabria,P., Felix,A.C., Loureiro,P., Sabino,E.C., Busch,M.P. and Sanabani,S.S.",2014
KJ849779,71_BF1,2010,25401747,"Deep Sequencing of HIV-1 near Full-Length Proviral Genomes Identifies High Rates of BF1 Recombinants Including Two Novel Circulating Recombinant Forms (CRF) 70_BF1 and a Disseminating 71_BF1 among Blood Donors in Pernambuco, Brazil","Pessoa,R., Watanabe,J.T., Calabria,P., Felix,A.C., Loureiro,P., Sabino,E.C., Busch,M.P. and Sanabani,S.S.",2014
KJ849784,B,2010,25413141,Enhanced detection of viral diversity using partial and near full-length genomes of human immunodeficiency virus Type 1 provirus deep sequencing data from recently infected donors at four blood centers in Brazil,"Pessoa,R., Watanabe,J.T., Calabria,P., Alencar,C.S., Loureiro,P., Lopes,M.E., Proetti,A.B., Felix,A.C., Sabino,E.C., Busch,M.P. and Sanabani,S.S.",2014
KJ849788,B,2010,25413141,Enhanced detection of viral diversity using partial and near full-length genomes of human immunodeficiency virus Type 1 provirus deep sequencing data from recently infected donors at four blood centers in Brazil,"Pessoa,R., Watanabe,J.T., Calabria,P., Alencar,C.S., Loureiro,P., Lopes,M.E., Proetti,A.B., Felix,A.C., Sabino,E.C., Busch,M.P. and Sanabani,S.S.",2014
KJ849793,BF1,2010,25413141,Enhanced detection of viral diversity using partial and near full-length genomes of human immunodeficiency virus Type 1 provirus deep sequencing data from recently infected donors at four blood centers in Brazil,"Pessoa,R., Watanabe,J.T., Calabria,P., Alencar,C.S., Loureiro,P., Lopes,M.E., Proetti,A.B., Felix,A.C., Sabino,E.C., Busch,M.P. and Sanabani,S.S.",2014
KJ849795,BC,2010,25413141,Enhanced detection of viral diversity using partial and near full-length genomes of human immunodeficiency virus Type 1 provirus deep sequencing data from recently infected donors at four blood centers in Brazil,"Pessoa,R., Watanabe,J.T., Calabria,P., Alencar,C.S., Loureiro,P., Lopes,M.E., Proetti,A.B., Felix,A.C., Sabino,E.C., Busch,M.P. and Sanabani,S.S.",2014
KJ849799,B,2010,25413141,Enhanced detection of viral diversity using partial and near full-length genomes of human immunodeficiency virus Type 1 provirus deep sequencing data from recently infected donors at four blood centers in Brazil,"Pessoa,R., Watanabe,J.T., Calabria,P., Alencar,C.S., Loureiro,P., Lopes,M.E., Proetti,A.B., Felix,A.C., Sabino,E.C., Busch,M.P. and Sanabani,S.S.",2014
KJ849800,BCF1,2010,25413141,Enhanced detection of viral diversity using partial and near full-length genomes of human immunodeficiency virus Type 1 provirus deep sequencing data from recently infected donors at four blood centers in Brazil,"Pessoa,R., Watanabe,J.T., Calabria,P., Alencar,C.S., Loureiro,P., Lopes,M.E., Proetti,A.B., Felix,A.C., Sabino,E.C., Busch,M.P. and Sanabani,S.S.",2014
KJ849803,B,2010,25413141,Enhanced detection of viral diversity using partial and near full-length genomes of human immunodeficiency virus Type 1 provirus deep sequencing data from recently infected donors at four blood centers in Brazil,"Pessoa,R., Watanabe,J.T., Calabria,P., Alencar,C.S., Loureiro,P., Lopes,M.E., Proetti,A.B., Felix,A.C., Sabino,E.C., Busch,M.P. and Sanabani,S.S.",2014
KJ849809,70_BF1,2010,25413141,Enhanced detection of viral diversity using partial and near full-length genomes of human immunodeficiency virus Type 1 provirus deep sequencing data from recently infected donors at four blood centers in Brazil,"Pessoa,R., Watanabe,J.T., Calabria,P., Alencar,C.S., Loureiro,P., Lopes,M.E., Proetti,A.B., Felix,A.C., Sabino,E.C., Busch,M.P. and Sanabani,S.S.",2014
KJ849817,B,2010,25413141,Enhanced detection of viral diversity using partial and near full-length genomes of human immunodeficiency virus Type 1 provirus deep sequencing data from recently infected donors at four blood centers in Brazil,"Pessoa,R., Watanabe,J.T., Calabria,P., Alencar,C.S., Loureiro,P., Lopes,M.E., Proetti,A.B., Felix,A.C., Sabino,E.C., Busch,M.P. and Sanabani,S.S.",2014
KJ849818,B,2010,25413141,Enhanced detection of viral diversity using partial and near full-length genomes of human immunodeficiency virus Type 1 provirus deep sequencing data from recently infected donors at four blood centers in Brazil,"Pessoa,R., Watanabe,J.T., Calabria,P., Alencar,C.S., Loureiro,P., Lopes,M.E., Proetti,A.B., Felix,A.C., Sabino,E.C., Busch,M.P. and Sanabani,S.S.",2014
KJ849820,B,2010,25413141,Enhanced detection of viral diversity using partial and near full-length genomes of human immunodeficiency virus Type 1 provirus deep sequencing data from recently infected donors at four blood centers in Brazil,"Pessoa,R., Watanabe,J.T., Calabria,P., Alencar,C.S., Loureiro,P., Lopes,M.E., Proetti,A.B., Felix,A.C., Sabino,E.C., Busch,M.P. and Sanabani,S.S.",2014
KJ849824,CF1,2010,25413141,Enhanced detection of viral diversity using partial and near full-length genomes of human immunodeficiency virus Type 1 provirus deep sequencing data from recently infected donors at four blood centers in Brazil,"Pessoa,R., Watanabe,J.T., Calabria,P., Alencar,C.S., Loureiro,P., Lopes,M.E., Proetti,A.B., Felix,A.C., Sabino,E.C., Busch,M.P. and Sanabani,S.S.",2014
KJ883137,F1,2010,26599410,Phylogeny and Phylogeography of a Recent HIV-1 Subtype F Outbreak among Men Who Have Sex with Men in Spain Deriving from a Cluster with a Wide Geographic Circulation in Western Europe,"Delgado,E., Cuevas,M.T., Dominguez,F., Vega,Y., Cabello,M., Fernandez-Garcia,A., Perez-Losada,M., Castro,M.A., Montero,V., Sanchez,M., Marino,A., Alvarez,H., Ordonez,P., Ocampo,A., Miralles,C., Perez-Castro,S., Lopez-Alvarez,M.J., Rodriguez,R., Trigo,M., Diz-Aren,J., Hinojosa,C., Bachiller,P., Hernaez-Crespo,S., Cisterna,R., Garduno,E., Perez-Alvarez,L. and Thomson,M.M.",2015
KJ883138,F1,2011,26599410,Phylogeny and Phylogeography of a Recent HIV-1 Subtype F Outbreak among Men Who Have Sex with Men in Spain Deriving from a Cluster with a Wide Geographic Circulation in Western Europe,"Delgado,E., Cuevas,M.T., Dominguez,F., Vega,Y., Cabello,M., Fernandez-Garcia,A., Perez-Losada,M., Castro,M.A., Montero,V., Sanchez,M., Marino,A., Alvarez,H., Ordonez,P., Ocampo,A., Miralles,C., Perez-Castro,S., Lopez-Alvarez,M.J., Rodriguez,R., Trigo,M., Diz-Aren,J., Hinojosa,C., Bachiller,P., Hernaez-Crespo,S., Cisterna,R., Garduno,E., Perez-Alvarez,L. and Thomson,M.M.",2015
KJ883142,F1,2010,26599410,Phylogeny and Phylogeography of a Recent HIV-1 Subtype F Outbreak among Men Who Have Sex with Men in Spain Deriving from a Cluster with a Wide Geographic Circulation in Western Europe,"Delgado,E., Cuevas,M.T., Dominguez,F., Vega,Y., Cabello,M., Fernandez-Garcia,A., Perez-Losada,M., Castro,M.A., Montero,V., Sanchez,M., Marino,A., Alvarez,H., Ordonez,P., Ocampo,A., Miralles,C., Perez-Castro,S., Lopez-Alvarez,M.J., Rodriguez,R., Trigo,M., Diz-Aren,J., Hinojosa,C., Bachiller,P., Hernaez-Crespo,S., Cisterna,R., Garduno,E., Perez-Alvarez,L. and Thomson,M.M.",2015
KJ883143,F1,2010,26599410,Phylogeny and Phylogeography of a Recent HIV-1 Subtype F Outbreak among Men Who Have Sex with Men in Spain Deriving from a Cluster with a Wide Geographic Circulation in Western Europe,"Delgado,E., Cuevas,M.T., Dominguez,F., Vega,Y., Cabello,M., Fernandez-Garcia,A., Perez-Losada,M., Castro,M.A., Montero,V., Sanchez,M., Marino,A., Alvarez,H., Ordonez,P., Ocampo,A., Miralles,C., Perez-Castro,S., Lopez-Alvarez,M.J., Rodriguez,R., Trigo,M., Diz-Aren,J., Hinojosa,C., Bachiller,P., Hernaez-Crespo,S., Cisterna,R., Garduno,E., Perez-Alvarez,L. and Thomson,M.M.",2015
KJ883144,F1,2010,26599410,Phylogeny and Phylogeography of a Recent HIV-1 Subtype F Outbreak among Men Who Have Sex with Men in Spain Deriving from a Cluster with a Wide Geographic Circulation in Western Europe,"Delgado,E., Cuevas,M.T., Dominguez,F., Vega,Y., Cabello,M., Fernandez-Garcia,A., Perez-Losada,M., Castro,M.A., Montero,V., Sanchez,M., Marino,A., Alvarez,H., Ordonez,P., Ocampo,A., Miralles,C., Perez-Castro,S., Lopez-Alvarez,M.J., Rodriguez,R., Trigo,M., Diz-Aren,J., Hinojosa,C., Bachiller,P., Hernaez-Crespo,S., Cisterna,R., Garduno,E., Perez-Alvarez,L. and Thomson,M.M.",2015
KJ883145,F1,2010,26599410,Phylogeny and Phylogeography of a Recent HIV-1 Subtype F Outbreak among Men Who Have Sex with Men in Spain Deriving from a Cluster with a Wide Geographic Circulation in Western Europe,"Delgado,E., Cuevas,M.T., Dominguez,F., Vega,Y., Cabello,M., Fernandez-Garcia,A., Perez-Losada,M., Castro,M.A., Montero,V., Sanchez,M., Marino,A., Alvarez,H., Ordonez,P., Ocampo,A., Miralles,C., Perez-Castro,S., Lopez-Alvarez,M.J., Rodriguez,R., Trigo,M., Diz-Aren,J., Hinojosa,C., Bachiller,P., Hernaez-Crespo,S., Cisterna,R., Garduno,E., Perez-Alvarez,L. and Thomson,M.M.",2015
KJ883146,F1,2010,26599410,Phylogeny and Phylogeography of a Recent HIV-1 Subtype F Outbreak among Men Who Have Sex with Men in Spain Deriving from a Cluster with a Wide Geographic Circulation in Western Europe,"Delgado,E., Cuevas,M.T., Dominguez,F., Vega,Y., Cabello,M., Fernandez-Garcia,A., Perez-Losada,M., Castro,M.A., Montero,V., Sanchez,M., Marino,A., Alvarez,H., Ordonez,P., Ocampo,A., Miralles,C., Perez-Castro,S., Lopez-Alvarez,M.J., Rodriguez,R., Trigo,M., Diz-Aren,J., Hinojosa,C., Bachiller,P., Hernaez-Crespo,S., Cisterna,R., Garduno,E., Perez-Alvarez,L. and Thomson,M.M.",2015
KJ883147,F1,2010,26599410,Phylogeny and Phylogeography of a Recent HIV-1 Subtype F Outbreak among Men Who Have Sex with Men in Spain Deriving from a Cluster with a Wide Geographic Circulation in Western Europe,"Delgado,E., Cuevas,M.T., Dominguez,F., Vega,Y., Cabello,M., Fernandez-Garcia,A., Perez-Losada,M., Castro,M.A., Montero,V., Sanchez,M., Marino,A., Alvarez,H., Ordonez,P., Ocampo,A., Miralles,C., Perez-Castro,S., Lopez-Alvarez,M.J., Rodriguez,R., Trigo,M., Diz-Aren,J., Hinojosa,C., Bachiller,P., Hernaez-Crespo,S., Cisterna,R., Garduno,E., Perez-Alvarez,L. and Thomson,M.M.",2015
KJ883148,F1,2011,26599410,Phylogeny and Phylogeography of a Recent HIV-1 Subtype F Outbreak among Men Who Have Sex with Men in Spain Deriving from a Cluster with a Wide Geographic Circulation in Western Europe,"Delgado,E., Cuevas,M.T., Dominguez,F., Vega,Y., Cabello,M., Fernandez-Garcia,A., Perez-Losada,M., Castro,M.A., Montero,V., Sanchez,M., Marino,A., Alvarez,H., Ordonez,P., Ocampo,A., Miralles,C., Perez-Castro,S., Lopez-Alvarez,M.J., Rodriguez,R., Trigo,M., Diz-Aren,J., Hinojosa,C., Bachiller,P., Hernaez-Crespo,S., Cisterna,R., Garduno,E., Perez-Alvarez,L. and Thomson,M.M.",2015
KJ883149,F1,2011,26599410,Phylogeny and Phylogeography of a Recent HIV-1 Subtype F Outbreak among Men Who Have Sex with Men in Spain Deriving from a Cluster with a Wide Geographic Circulation in Western Europe,"Delgado,E., Cuevas,M.T., Dominguez,F., Vega,Y., Cabello,M., Fernandez-Garcia,A., Perez-Losada,M., Castro,M.A., Montero,V., Sanchez,M., Marino,A., Alvarez,H., Ordonez,P., Ocampo,A., Miralles,C., Perez-Castro,S., Lopez-Alvarez,M.J., Rodriguez,R., Trigo,M., Diz-Aren,J., Hinojosa,C., Bachiller,P., Hernaez-Crespo,S., Cisterna,R., Garduno,E., Perez-Alvarez,L. and Thomson,M.M.",2015
KJ883150,F1,2011,26599410,Phylogeny and Phylogeography of a Recent HIV-1 Subtype F Outbreak among Men Who Have Sex with Men in Spain Deriving from a Cluster with a Wide Geographic Circulation in Western Europe,"Delgado,E., Cuevas,M.T., Dominguez,F., Vega,Y., Cabello,M., Fernandez-Garcia,A., Perez-Losada,M., Castro,M.A., Montero,V., Sanchez,M., Marino,A., Alvarez,H., Ordonez,P., Ocampo,A., Miralles,C., Perez-Castro,S., Lopez-Alvarez,M.J., Rodriguez,R., Trigo,M., Diz-Aren,J., Hinojosa,C., Bachiller,P., Hernaez-Crespo,S., Cisterna,R., Garduno,E., Perez-Alvarez,L. and Thomson,M.M.",2015
KJ883151,F1,2012,26599410,Phylogeny and Phylogeography of a Recent HIV-1 Subtype F Outbreak among Men Who Have Sex with Men in Spain Deriving from a Cluster with a Wide Geographic Circulation in Western Europe,"Delgado,E., Cuevas,M.T., Dominguez,F., Vega,Y., Cabello,M., Fernandez-Garcia,A., Perez-Losada,M., Castro,M.A., Montero,V., Sanchez,M., Marino,A., Alvarez,H., Ordonez,P., Ocampo,A., Miralles,C., Perez-Castro,S., Lopez-Alvarez,M.J., Rodriguez,R., Trigo,M., Diz-Aren,J., Hinojosa,C., Bachiller,P., Hernaez-Crespo,S., Cisterna,R., Garduno,E., Perez-Alvarez,L. and Thomson,M.M.",2015
KJ883152,F1,2012,26599410,Phylogeny and Phylogeography of a Recent HIV-1 Subtype F Outbreak among Men Who Have Sex with Men in Spain Deriving from a Cluster with a Wide Geographic Circulation in Western Europe,"Delgado,E., Cuevas,M.T., Dominguez,F., Vega,Y., Cabello,M., Fernandez-Garcia,A., Perez-Losada,M., Castro,M.A., Montero,V., Sanchez,M., Marino,A., Alvarez,H., Ordonez,P., Ocampo,A., Miralles,C., Perez-Castro,S., Lopez-Alvarez,M.J., Rodriguez,R., Trigo,M., Diz-Aren,J., Hinojosa,C., Bachiller,P., Hernaez-Crespo,S., Cisterna,R., Garduno,E., Perez-Alvarez,L. and Thomson,M.M.",2015
KJ948656,B,1998,25492033,"Sequencing and Phylogenetic Analysis of Near Full-Length HIV-1 Subtypes A, B, G and Unique Recombinant AC and AD Viral Strains Identified in South Africa","Wilkinson,E., Holzmayer,V., Jacobs,G.B., de Oliveira,T., Brennan,C.A., Hackett,J. Jr., van Rensburg,E.J. and Engelbrecht,S.",2015
KJ948657,B,2000,25492033,"Sequencing and Phylogenetic Analysis of Near Full-Length HIV-1 Subtypes A, B, G and Unique Recombinant AC and AD Viral Strains Identified in South Africa","Wilkinson,E., Holzmayer,V., Jacobs,G.B., de Oliveira,T., Brennan,C.A., Hackett,J. Jr., van Rensburg,E.J. and Engelbrecht,S.",2015
KJ948658,A1,2000,25492033,"Sequencing and Phylogenetic Analysis of Near Full-Length HIV-1 Subtypes A, B, G and Unique Recombinant AC and AD Viral Strains Identified in South Africa","Wilkinson,E., Holzmayer,V., Jacobs,G.B., de Oliveira,T., Brennan,C.A., Hackett,J. Jr., van Rensburg,E.J. and Engelbrecht,S.",2015
KJ948659,A1D,2000,25492033,"Sequencing and Phylogenetic Analysis of Near Full-Length HIV-1 Subtypes A, B, G and Unique Recombinant AC and AD Viral Strains Identified in South Africa","Wilkinson,E., Holzmayer,V., Jacobs,G.B., de Oliveira,T., Brennan,C.A., Hackett,J. Jr., van Rensburg,E.J. and Engelbrecht,S.",2015
KJ948660,B,2002,25492033,"Sequencing and Phylogenetic Analysis of Near Full-Length HIV-1 Subtypes A, B, G and Unique Recombinant AC and AD Viral Strains Identified in South Africa","Wilkinson,E., Holzmayer,V., Jacobs,G.B., de Oliveira,T., Brennan,C.A., Hackett,J. Jr., van Rensburg,E.J. and Engelbrecht,S.",2015
KJ948661,A1C,2000,25492033,"Sequencing and Phylogenetic Analysis of Near Full-Length HIV-1 Subtypes A, B, G and Unique Recombinant AC and AD Viral Strains Identified in South Africa","Wilkinson,E., Holzmayer,V., Jacobs,G.B., de Oliveira,T., Brennan,C.A., Hackett,J. Jr., van Rensburg,E.J. and Engelbrecht,S.",2015
KJ948662,G,2001,25492033,"Sequencing and Phylogenetic Analysis of Near Full-Length HIV-1 Subtypes A, B, G and Unique Recombinant AC and AD Viral Strains Identified in South Africa","Wilkinson,E., Holzmayer,V., Jacobs,G.B., de Oliveira,T., Brennan,C.A., Hackett,J. Jr., van Rensburg,E.J. and Engelbrecht,S.",2015
KJ952242,01_AE,2000,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ952283,01_AE,,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ952314,01_AE,,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ952346,01_AE,2000,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ952376,01_AE,1999,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ952432,01_AE,1999,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ952505,01_AE,2000,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ952535,B,2000,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ952562,01_AE,2000,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ952614,01_AE,1999,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ952667,01_AE,2000,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ952689,01_AE,1999,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ952712,01_AE,1999,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ952732,01_AE,1999,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ952765,01_AE,2000,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ952820,01_AE,,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ952852,01_AE,2000,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ952897,01_AE,2000,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ952917,01_AE,2000,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ952968,01_AE,2000,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ952991,01_AE,1999,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ952992,01_AE,,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ953058,01_AE,,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ953089,01_AE,2000,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ953119,01_AE,2000,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ953149,01_AE,,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ953175,B,,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ953197,15_01B,,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ953228,01_AE,1999,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ953282,01_AE,2000,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ953316,01_AE,,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ953335,01_AE,,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ953366,01_AE,1999,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ953408,01_AE,1999,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ953438,01_AE,1999,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ953459,01_AE,2000,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ953481,01_AE,2000,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ953503,01_AE,1999,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ953525,01_AE,,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ953555,01_AE,2000,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ953596,01_AE,1999,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ953611,01_AE,1999,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ953634,01_AE,2000,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ953664,01_AE,2000,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KJ953685,01_AE,,25734126,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,"Sterrett,S., Learn,G.H., Edlefsen,P.T., Haynes,B.F., Hahn,B.H., Shaw,G.M. and Bar,K.J.",2014
KM025076,B,1998,25011556,HIV latency. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection,"Wagner,T.A., McLaughlin,S., Garg,K., Cheung,C.Y., Larsen,B.B., Styrchak,S., Huang,H.C., Edlefsen,P.T., Mullins,J.I. and Frenkel,L.M.",2014
KM081846,B,2009,25713386,Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption,"Rothenberger,M.K., Keele,B.F., Wietgrefe,S.W., Fletcher,C.V., Beilman,G.J., Chipman,J.G., Khoruts,A., Estes,J.D., Anderson,J., Callisto,S.P., Schmidt,T.E., Thorkelson,A., Reilly,C., Perkey,K., Reimann,T.G., Utay,N.S., Nganou Makamdop,K., Stevenson,M., Douek,D.C., Haase,A.T. and Schacker,T.W.",2015
KM081850,B,2010,25713386,Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption,"Rothenberger,M.K., Keele,B.F., Wietgrefe,S.W., Fletcher,C.V., Beilman,G.J., Chipman,J.G., Khoruts,A., Estes,J.D., Anderson,J., Callisto,S.P., Schmidt,T.E., Thorkelson,A., Reilly,C., Perkey,K., Reimann,T.G., Utay,N.S., Nganou Makamdop,K., Stevenson,M., Douek,D.C., Haase,A.T. and Schacker,T.W.",2015
KM081860,B,2009,25713386,Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption,"Rothenberger,M.K., Keele,B.F., Wietgrefe,S.W., Fletcher,C.V., Beilman,G.J., Chipman,J.G., Khoruts,A., Estes,J.D., Anderson,J., Callisto,S.P., Schmidt,T.E., Thorkelson,A., Reilly,C., Perkey,K., Reimann,T.G., Utay,N.S., Nganou Makamdop,K., Stevenson,M., Douek,D.C., Haase,A.T. and Schacker,T.W.",2015
KM081862,B,2009,25713386,Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption,"Rothenberger,M.K., Keele,B.F., Wietgrefe,S.W., Fletcher,C.V., Beilman,G.J., Chipman,J.G., Khoruts,A., Estes,J.D., Anderson,J., Callisto,S.P., Schmidt,T.E., Thorkelson,A., Reilly,C., Perkey,K., Reimann,T.G., Utay,N.S., Nganou Makamdop,K., Stevenson,M., Douek,D.C., Haase,A.T. and Schacker,T.W.",2015
KM081898,B,2009,25713386,Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption,"Rothenberger,M.K., Keele,B.F., Wietgrefe,S.W., Fletcher,C.V., Beilman,G.J., Chipman,J.G., Khoruts,A., Estes,J.D., Anderson,J., Callisto,S.P., Schmidt,T.E., Thorkelson,A., Reilly,C., Perkey,K., Reimann,T.G., Utay,N.S., Nganou Makamdop,K., Stevenson,M., Douek,D.C., Haase,A.T. and Schacker,T.W.",2015
KM081934,B,2009,25713386,Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption,"Rothenberger,M.K., Keele,B.F., Wietgrefe,S.W., Fletcher,C.V., Beilman,G.J., Chipman,J.G., Khoruts,A., Estes,J.D., Anderson,J., Callisto,S.P., Schmidt,T.E., Thorkelson,A., Reilly,C., Perkey,K., Reimann,T.G., Utay,N.S., Nganou Makamdop,K., Stevenson,M., Douek,D.C., Haase,A.T. and Schacker,T.W.",2015
KM081999,B,2010,25713386,Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption,"Rothenberger,M.K., Keele,B.F., Wietgrefe,S.W., Fletcher,C.V., Beilman,G.J., Chipman,J.G., Khoruts,A., Estes,J.D., Anderson,J., Callisto,S.P., Schmidt,T.E., Thorkelson,A., Reilly,C., Perkey,K., Reimann,T.G., Utay,N.S., Nganou Makamdop,K., Stevenson,M., Douek,D.C., Haase,A.T. and Schacker,T.W.",2015
KM082062,B,2010,25713386,Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption,"Rothenberger,M.K., Keele,B.F., Wietgrefe,S.W., Fletcher,C.V., Beilman,G.J., Chipman,J.G., Khoruts,A., Estes,J.D., Anderson,J., Callisto,S.P., Schmidt,T.E., Thorkelson,A., Reilly,C., Perkey,K., Reimann,T.G., Utay,N.S., Nganou Makamdop,K., Stevenson,M., Douek,D.C., Haase,A.T. and Schacker,T.W.",2015
KM082076,B,2011,25713386,Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption,"Rothenberger,M.K., Keele,B.F., Wietgrefe,S.W., Fletcher,C.V., Beilman,G.J., Chipman,J.G., Khoruts,A., Estes,J.D., Anderson,J., Callisto,S.P., Schmidt,T.E., Thorkelson,A., Reilly,C., Perkey,K., Reimann,T.G., Utay,N.S., Nganou Makamdop,K., Stevenson,M., Douek,D.C., Haase,A.T. and Schacker,T.W.",2015
KM082124,B,2009,25713386,Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption,"Rothenberger,M.K., Keele,B.F., Wietgrefe,S.W., Fletcher,C.V., Beilman,G.J., Chipman,J.G., Khoruts,A., Estes,J.D., Anderson,J., Callisto,S.P., Schmidt,T.E., Thorkelson,A., Reilly,C., Perkey,K., Reimann,T.G., Utay,N.S., Nganou Makamdop,K., Stevenson,M., Douek,D.C., Haase,A.T. and Schacker,T.W.",2015
KM082156,B,2011,25713386,Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption,"Rothenberger,M.K., Keele,B.F., Wietgrefe,S.W., Fletcher,C.V., Beilman,G.J., Chipman,J.G., Khoruts,A., Estes,J.D., Anderson,J., Callisto,S.P., Schmidt,T.E., Thorkelson,A., Reilly,C., Perkey,K., Reimann,T.G., Utay,N.S., Nganou Makamdop,K., Stevenson,M., Douek,D.C., Haase,A.T. and Schacker,T.W.",2015
KM111555,01B,2011,25347352,"The identification of a novel HIV-1 CRF01_AE/B recombinant using the near full length genome in Jiangsu Province, China","Guo,H., Hu,H., Zhou,Y., Huan,X., Qiu,T., Fu,G., Lu,J. and Wang,X.",2014
KM217615,B,2007,25886933,Comprehensive Characterization of the Transmitted/founder env Genes from a Single MSM Cohort in China,"Chen,Y., Li,N., Zhang,T., Huang,X., Cai,F., Vandergrift,N., Xin,R., Meng,Z., Zhang,X., Jiang,C., Xu,X., Montefiori,D.C., Gao,F. and Wu,H.",2015
KM217780,B,2007,25886933,Comprehensive Characterization of the Transmitted/founder env Genes from a Single MSM Cohort in China,"Chen,Y., Li,N., Zhang,T., Huang,X., Cai,F., Vandergrift,N., Xin,R., Meng,Z., Zhang,X., Jiang,C., Xu,X., Montefiori,D.C., Gao,F. and Wu,H.",2015
KM217857,07_BC,2007,25886933,Comprehensive Characterization of the Transmitted/founder env Genes from a Single MSM Cohort in China,"Chen,Y., Li,N., Zhang,T., Huang,X., Cai,F., Vandergrift,N., Xin,R., Meng,Z., Zhang,X., Jiang,C., Xu,X., Montefiori,D.C., Gao,F. and Wu,H.",2015
KM218138,B,2008,25886933,Comprehensive Characterization of the Transmitted/founder env Genes from a Single MSM Cohort in China,"Chen,Y., Li,N., Zhang,T., Huang,X., Cai,F., Vandergrift,N., Xin,R., Meng,Z., Zhang,X., Jiang,C., Xu,X., Montefiori,D.C., Gao,F. and Wu,H.",2015
KM218157,07_BC,2008,25886933,Comprehensive Characterization of the Transmitted/founder env Genes from a Single MSM Cohort in China,"Chen,Y., Li,N., Zhang,T., Huang,X., Cai,F., Vandergrift,N., Xin,R., Meng,Z., Zhang,X., Jiang,C., Xu,X., Montefiori,D.C., Gao,F. and Wu,H.",2015
KM218159,B,2008,25886933,Comprehensive Characterization of the Transmitted/founder env Genes from a Single MSM Cohort in China,"Chen,Y., Li,N., Zhang,T., Huang,X., Cai,F., Vandergrift,N., Xin,R., Meng,Z., Zhang,X., Jiang,C., Xu,X., Montefiori,D.C., Gao,F. and Wu,H.",2015
KM218184,B,2008,25886933,Comprehensive Characterization of the Transmitted/founder env Genes from a Single MSM Cohort in China,"Chen,Y., Li,N., Zhang,T., Huang,X., Cai,F., Vandergrift,N., Xin,R., Meng,Z., Zhang,X., Jiang,C., Xu,X., Montefiori,D.C., Gao,F. and Wu,H.",2015
KM218210,B,2008,25886933,Comprehensive Characterization of the Transmitted/founder env Genes from a Single MSM Cohort in China,"Chen,Y., Li,N., Zhang,T., Huang,X., Cai,F., Vandergrift,N., Xin,R., Meng,Z., Zhang,X., Jiang,C., Xu,X., Montefiori,D.C., Gao,F. and Wu,H.",2015
KM218302,01_AE,2008,25886933,Comprehensive Characterization of the Transmitted/founder env Genes from a Single MSM Cohort in China,"Chen,Y., Li,N., Zhang,T., Huang,X., Cai,F., Vandergrift,N., Xin,R., Meng,Z., Zhang,X., Jiang,C., Xu,X., Montefiori,D.C., Gao,F. and Wu,H.",2015
KM248765,73_BG,2011,26900693,"Identification of an HIV-1 BG Intersubtype Recombinant Form (CRF73_BG), Partially Related to CRF14_BG, Which Is Circulating in Portugal and Spain","Fernandez-Garcia,A., Delgado,E., Cuevas,M.T., Vega,Y., Montero,V., Sanchez,M., Carrera,C., Lopez-Alvarez,M.J., Miralles,C., Perez-Castro,S., Cilla,G., Hinojosa,C., Perez-Alvarez,L. and Thomson,M.M.",2016
KM258899,B,2007,25125210,Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope,"Evering,T.H., Kamau,E., St Bernard,L., Farmer,C.B., Kong,X.P. and Markowitz,M.",2014
KM258919,B,2007,25125210,Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope,"Evering,T.H., Kamau,E., St Bernard,L., Farmer,C.B., Kong,X.P. and Markowitz,M.",2014
KM258941,B,2007,25125210,Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope,"Evering,T.H., Kamau,E., St Bernard,L., Farmer,C.B., Kong,X.P. and Markowitz,M.",2014
KM258969,B,2005,25125210,Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope,"Evering,T.H., Kamau,E., St Bernard,L., Farmer,C.B., Kong,X.P. and Markowitz,M.",2014
KM258999,B,2005,25125210,Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope,"Evering,T.H., Kamau,E., St Bernard,L., Farmer,C.B., Kong,X.P. and Markowitz,M.",2014
KM259030,B,2007,25125210,Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope,"Evering,T.H., Kamau,E., St Bernard,L., Farmer,C.B., Kong,X.P. and Markowitz,M.",2014
KM259048,B,2006,25125210,Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope,"Evering,T.H., Kamau,E., St Bernard,L., Farmer,C.B., Kong,X.P. and Markowitz,M.",2014
KM259061,B,2004,25125210,Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope,"Evering,T.H., Kamau,E., St Bernard,L., Farmer,C.B., Kong,X.P. and Markowitz,M.",2014
KM259080,B,2007,25125210,Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope,"Evering,T.H., Kamau,E., St Bernard,L., Farmer,C.B., Kong,X.P. and Markowitz,M.",2014
KM259085,B,2007,25125210,Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope,"Evering,T.H., Kamau,E., St Bernard,L., Farmer,C.B., Kong,X.P. and Markowitz,M.",2014
KM259100,B,2005,25125210,Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope,"Evering,T.H., Kamau,E., St Bernard,L., Farmer,C.B., Kong,X.P. and Markowitz,M.",2014
KM259127,B,2004,25125210,Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope,"Evering,T.H., Kamau,E., St Bernard,L., Farmer,C.B., Kong,X.P. and Markowitz,M.",2014
KM259155,B,2006,25125210,Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope,"Evering,T.H., Kamau,E., St Bernard,L., Farmer,C.B., Kong,X.P. and Markowitz,M.",2014
KM259197,B,2006,25125210,Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope,"Evering,T.H., Kamau,E., St Bernard,L., Farmer,C.B., Kong,X.P. and Markowitz,M.",2014
KM259229,B,2007,25125210,Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope,"Evering,T.H., Kamau,E., St Bernard,L., Farmer,C.B., Kong,X.P. and Markowitz,M.",2014
KM353586,B,2006,25811757,Compartmentalized Replication of R5 T Cell-Tropic HIV-1 in the Central Nervous System Early in the Course of Infection,"Sturdevant,C.B., Joseph,S.B., Schnell,G., Price,R.W., Swanstrom,R. and Spudich,S.",2015
KM353665,B,2006,25811757,Compartmentalized Replication of R5 T Cell-Tropic HIV-1 in the Central Nervous System Early in the Course of Infection,"Sturdevant,C.B., Joseph,S.B., Schnell,G., Price,R.W., Swanstrom,R. and Spudich,S.",2015
KM353701,B,2006,25811757,Compartmentalized Replication of R5 T Cell-Tropic HIV-1 in the Central Nervous System Early in the Course of Infection,"Sturdevant,C.B., Joseph,S.B., Schnell,G., Price,R.W., Swanstrom,R. and Spudich,S.",2015
KM353733,B,2007,25811757,Compartmentalized Replication of R5 T Cell-Tropic HIV-1 in the Central Nervous System Early in the Course of Infection,"Sturdevant,C.B., Joseph,S.B., Schnell,G., Price,R.W., Swanstrom,R. and Spudich,S.",2015
KM353807,B,2007,25811757,Compartmentalized Replication of R5 T Cell-Tropic HIV-1 in the Central Nervous System Early in the Course of Infection,"Sturdevant,C.B., Joseph,S.B., Schnell,G., Price,R.W., Swanstrom,R. and Spudich,S.",2015
KM353846,B,2008,25811757,Compartmentalized Replication of R5 T Cell-Tropic HIV-1 in the Central Nervous System Early in the Course of Infection,"Sturdevant,C.B., Joseph,S.B., Schnell,G., Price,R.W., Swanstrom,R. and Spudich,S.",2015
KM353922,B,2010,25811757,Compartmentalized Replication of R5 T Cell-Tropic HIV-1 in the Central Nervous System Early in the Course of Infection,"Sturdevant,C.B., Joseph,S.B., Schnell,G., Price,R.W., Swanstrom,R. and Spudich,S.",2015
KM354092,B,2007,25811757,Compartmentalized Replication of R5 T Cell-Tropic HIV-1 in the Central Nervous System Early in the Course of Infection,"Sturdevant,C.B., Joseph,S.B., Schnell,G., Price,R.W., Swanstrom,R. and Spudich,S.",2015
KM354114,B,2007,25811757,Compartmentalized Replication of R5 T Cell-Tropic HIV-1 in the Central Nervous System Early in the Course of Infection,"Sturdevant,C.B., Joseph,S.B., Schnell,G., Price,R.W., Swanstrom,R. and Spudich,S.",2015
KM354155,B,2008,25811757,Compartmentalized Replication of R5 T Cell-Tropic HIV-1 in the Central Nervous System Early in the Course of Infection,"Sturdevant,C.B., Joseph,S.B., Schnell,G., Price,R.W., Swanstrom,R. and Spudich,S.",2015
KM354232,B,2008,25811757,Compartmentalized Replication of R5 T Cell-Tropic HIV-1 in the Central Nervous System Early in the Course of Infection,"Sturdevant,C.B., Joseph,S.B., Schnell,G., Price,R.W., Swanstrom,R. and Spudich,S.",2015
KM354355,B,2008,25811757,Compartmentalized Replication of R5 T Cell-Tropic HIV-1 in the Central Nervous System Early in the Course of Infection,"Sturdevant,C.B., Joseph,S.B., Schnell,G., Price,R.W., Swanstrom,R. and Spudich,S.",2015
KM354431,B,2009,25811757,Compartmentalized Replication of R5 T Cell-Tropic HIV-1 in the Central Nervous System Early in the Course of Infection,"Sturdevant,C.B., Joseph,S.B., Schnell,G., Price,R.W., Swanstrom,R. and Spudich,S.",2015
KM354470,B,2011,25811757,Compartmentalized Replication of R5 T Cell-Tropic HIV-1 in the Central Nervous System Early in the Course of Infection,"Sturdevant,C.B., Joseph,S.B., Schnell,G., Price,R.W., Swanstrom,R. and Spudich,S.",2015
KM354585,B,2009,25811757,Compartmentalized Replication of R5 T Cell-Tropic HIV-1 in the Central Nervous System Early in the Course of Infection,"Sturdevant,C.B., Joseph,S.B., Schnell,G., Price,R.W., Swanstrom,R. and Spudich,S.",2015
KM354670,B,2009,25811757,Compartmentalized Replication of R5 T Cell-Tropic HIV-1 in the Central Nervous System Early in the Course of Infection,"Sturdevant,C.B., Joseph,S.B., Schnell,G., Price,R.W., Swanstrom,R. and Spudich,S.",2015
KM354703,B,2010,25811757,Compartmentalized Replication of R5 T Cell-Tropic HIV-1 in the Central Nervous System Early in the Course of Infection,"Sturdevant,C.B., Joseph,S.B., Schnell,G., Price,R.W., Swanstrom,R. and Spudich,S.",2015
KM354740,B,2010,25811757,Compartmentalized Replication of R5 T Cell-Tropic HIV-1 in the Central Nervous System Early in the Course of Infection,"Sturdevant,C.B., Joseph,S.B., Schnell,G., Price,R.W., Swanstrom,R. and Spudich,S.",2015
KM354781,B,2010,25811757,Compartmentalized Replication of R5 T Cell-Tropic HIV-1 in the Central Nervous System Early in the Course of Infection,"Sturdevant,C.B., Joseph,S.B., Schnell,G., Price,R.W., Swanstrom,R. and Spudich,S.",2015
KM354821,B,2010,25811757,Compartmentalized Replication of R5 T Cell-Tropic HIV-1 in the Central Nervous System Early in the Course of Infection,"Sturdevant,C.B., Joseph,S.B., Schnell,G., Price,R.W., Swanstrom,R. and Spudich,S.",2015
KM354862,B,2010,25811757,Compartmentalized Replication of R5 T Cell-Tropic HIV-1 in the Central Nervous System Early in the Course of Infection,"Sturdevant,C.B., Joseph,S.B., Schnell,G., Price,R.W., Swanstrom,R. and Spudich,S.",2015
KM354904,B,2011,25811757,Compartmentalized Replication of R5 T Cell-Tropic HIV-1 in the Central Nervous System Early in the Course of Infection,"Sturdevant,C.B., Joseph,S.B., Schnell,G., Price,R.W., Swanstrom,R. and Spudich,S.",2015
KM354962,B,2011,25811757,Compartmentalized Replication of R5 T Cell-Tropic HIV-1 in the Central Nervous System Early in the Course of Infection,"Sturdevant,C.B., Joseph,S.B., Schnell,G., Price,R.W., Swanstrom,R. and Spudich,S.",2015
KM355003,B,2011,25811757,Compartmentalized Replication of R5 T Cell-Tropic HIV-1 in the Central Nervous System Early in the Course of Infection,"Sturdevant,C.B., Joseph,S.B., Schnell,G., Price,R.W., Swanstrom,R. and Spudich,S.",2015
KM355044,B,2011,25811757,Compartmentalized Replication of R5 T Cell-Tropic HIV-1 in the Central Nervous System Early in the Course of Infection,"Sturdevant,C.B., Joseph,S.B., Schnell,G., Price,R.W., Swanstrom,R. and Spudich,S.",2015
KM355085,B,2012,25811757,Compartmentalized Replication of R5 T Cell-Tropic HIV-1 in the Central Nervous System Early in the Course of Infection,"Sturdevant,C.B., Joseph,S.B., Schnell,G., Price,R.W., Swanstrom,R. and Spudich,S.",2015
KM355159,B,2012,25811757,Compartmentalized Replication of R5 T Cell-Tropic HIV-1 in the Central Nervous System Early in the Course of Infection,"Sturdevant,C.B., Joseph,S.B., Schnell,G., Price,R.W., Swanstrom,R. and Spudich,S.",2015
KM516886,B,2011,25186731,Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface,"Huang,J., Kang,B.H., Pancera,M., Lee,J.H., Tong,T., Feng,Y., Georgiev,I.S., Chuang,G.Y., Druz,A., Doria-Rose,N.A., Laub,L., Sliepen,K., van Gils,M.J., de la Pena,A.T., Derking,R., Klasse,P.J., Migueles,S.A., Bailer,R.T., Alam,M., Pugach,P., Haynes,B.F., Wyatt,R.T., Sanders,R.W., Binley,J.M., Ward,A.B., Mascola,J.R., Kwong,P.D. and Connors,M.",2014
KM606628,32A6,2006,,Near Full-Length Genome Sequences of HIV-1 CRF06/A1 recombinat forms in Estonian Intravenous Drug Users Population,"Avi,R. and Lutsar,I.",
KM606631,32A6,2006,,Near Full-Length Genome Sequences of HIV-1 CRF06/A1 recombinat forms in Estonian Intravenous Drug Users Population,"Avi,R. and Lutsar,I.",
KM606632,32_06A6,2006,,Near Full-Length Genome Sequences of HIV-1 CRF06/A1 recombinat forms in Estonian Intravenous Drug Users Population,"Avi,R. and Lutsar,I.",
KM606633,32A6,2006,,Near Full-Length Genome Sequences of HIV-1 CRF06/A1 recombinat forms in Estonian Intravenous Drug Users Population,"Avi,R. and Lutsar,I.",
KM606635,32G,2006,,Near Full-Length Genome Sequences of HIV-1 CRF06/A1 recombinat forms in Estonian Intravenous Drug Users Population,"Avi,R. and Lutsar,I.",
KM606636,02A1,2006,,Near Full-Length Genome Sequences of HIV-1 CRF06/A1 recombinat forms in Estonian Intravenous Drug Users Population,"Avi,R. and Lutsar,I.",
KM606637,32A6,2006,,Near Full-Length Genome Sequences of HIV-1 CRF06/A1 recombinat forms in Estonian Intravenous Drug Users Population,"Avi,R. and Lutsar,I.",
KM878816,02_AG,,25366539,HIV infection en route to endogenization: two cases,"Colson,P., Ravaux,I., Tamalet,C., Glazunova,O., Baptiste,E., Chabriere,E., Wiedemann,A., Lacabaratz,C., Chefrour,M., Picard,C., Stein,A., Levy,Y. and Raoult,D.",2014
KM974719,0107,2013,25495675,"Genomic characterization of two novel HIV-1 second-generation recombinant forms among men who have sex with men in Beijing, China","Li,Z., Wei,H., Feng,Y., Li,J., Kalish,M.L., Lu,H., Yin,L., Liao,L., Qian,H.Z., Frost,S.D., Ruan,Y., Vermund,S., Shao,Y. and Xing,H.",2014
KM974720,0107,2013,25495675,"Genomic characterization of two novel HIV-1 second-generation recombinant forms among men who have sex with men in Beijing, China","Li,Z., Wei,H., Feng,Y., Li,J., Kalish,M.L., Lu,H., Yin,L., Liao,L., Qian,H.Z., Frost,S.D., Ruan,Y., Vermund,S., Shao,Y. and Xing,H.",2014
KM986883,B,2012,,Viremic Relapse Following Prolonged Antiretroviral Drug-free Remission in a Perinatally HIV-1-infected Child,"Luzuriaga,K., Gay,H., Ziemniak,C., Sanborn,K.B., Somasundaran,M., Rainwater-Lovett,K., Mellors,J., Rosenbloom,D.I.S. and Persaud,D.",
KM986886,B,2014,,Viremic Relapse Following Prolonged Antiretroviral Drug-free Remission in a Perinatally HIV-1-infected Child,"Luzuriaga,K., Gay,H., Ziemniak,C., Sanborn,K.B., Somasundaran,M., Rainwater-Lovett,K., Mellors,J., Rosenbloom,D.I.S. and Persaud,D.",
KP109490,A1,2009,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Fast,P., Amornkul,P., Price,M., Kamali,A., Denny,T.N. and Gao,F.",
KP109491,A1D,2009,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Fast,P., Amornkul,P., Price,M., Kamali,A., Denny,T.N. and Gao,F.",
KP109492,A1D,2009,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Fast,P., Amornkul,P., Price,M., Kamali,A., Denny,T.N. and Gao,F.",
KP109493,A1D,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Fast,P., Amornkul,P., Price,M., Kamali,A., Denny,T.N. and Gao,F.",
KP109494,C,2011,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Fast,P., Amornkul,P., Price,M., Kilembe,W., Allen,S., Hunter,E., Denny,T.N. and Gao,F.",
KP109495,C,2011,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Fast,P., Amornkul,P., Price,M., Kilembe,W., Allen,S., Hunter,E., Denny,T.N. and Gao,F.",
KP109496,C,2011,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Fast,P., Amornkul,P., Price,M., Kilembe,W., Allen,S., Hunter,E., Denny,T.N. and Gao,F.",
KP109497,A1D,2011,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Fast,P., Amornkul,P., Price,M., Kamali,A., Ruzagira,E., Denny,T.N. and Gao,F.",
KP109498,22_01A1,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Ragupathy,V., Hewlett,I., Denny,T.N. and Gao,F.",
KP109499,22_01A1,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Ragupathy,V., Hewlett,I., Denny,T.N. and Gao,F.",
KP109500,22_01A1,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Ragupathy,V., Hewlett,I., Denny,T.N. and Gao,F.",
KP109501,D,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Ragupathy,V., Hewlett,I., Denny,T.N. and Gao,F.",
KP109502,G,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Ragupathy,V., Hewlett,I., Denny,T.N. and Gao,F.",
KP109503,11_cpx,2011,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Ragupathy,V., Hewlett,I., Denny,T.N. and Gao,F.",
KP109504,01_AE,2009,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Cui,H., Sun,H., Geng,W., Shang,H., Denny,T.N. and Gao,F.",
KP109505,01_AE,2009,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Cui,H., Sun,H., Geng,W., Shang,H., Denny,T.N. and Gao,F.",
KP109506,01_AE,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Cui,H., Sun,H., Geng,W., Shang,H., Denny,T.N. and Gao,F.",
KP109507,01_AE,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Cui,H., Sun,H., Geng,W., Shang,H., Denny,T.N. and Gao,F.",
KP109508,01_AE,2012,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Cui,H., Sun,H., Geng,W., Shang,H., Denny,T.N. and Gao,F.",
KP109510,B,2009,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Cui,H., Sun,H., Geng,W., Shang,H., Denny,T.N. and Gao,F.",
KP109511,B,2012,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Cui,H., Sun,H., Geng,W., Shang,H., Denny,T.N. and Gao,F.",
KP109512,B,2012,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Cui,H., Sun,H., Geng,W., Shang,H., Denny,T.N. and Gao,F.",
KP109513,01_AE,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Nitayaphan,S., Robb,M., Eller,L.A., Manak,M., Polonis,V., Denny,T.N. and Gao,F.",
KP109514,B,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Nitayaphan,S., Robb,M., Eller,L.A., Manak,M., Polonis,V., Denny,T.N. and Gao,F.",
KP109515,B,2009,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Busch,M., Vermeulen,M., Denny,T.N. and Gao,F.",
KP109516,C,2012,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Busch,M., Vermeulen,M., Denny,T.N. and Gao,F.",
KP109517,C,2012,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Busch,M., Vermeulen,M., Denny,T.N. and Gao,F.",
KP109518,B,2013,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Busch,M., Sauleda,S., Denny,T.N. and Gao,F.",
KP109519,02_AG,2012,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Busch,M., Laperche,S., Denny,T.N. and Gao,F.",
KP109520,C,2007,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Kumwenda,J., Taha,T., Cohen,M., Denny,T.N. and Gao,F.",
KP109521,C,2008,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Kumwenda,J., Taha,T., Cohen,M., Denny,T.N. and Gao,F.",
KP109522,C,2008,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Kumwenda,J., Taha,T., Cohen,M., Denny,T.N. and Gao,F.",
KP109523,C,2009,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Kumwenda,J., Taha,T., Cohen,M., Denny,T.N. and Gao,F.",
KP109524,C,2009,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Kumwenda,J., Taha,T., Cohen,M., Denny,T.N. and Gao,F.",
KP109525,C,2009,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Kumwenda,J., Taha,T., Cohen,M., Denny,T.N. and Gao,F.",
KP109526,C,2009,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Kumwenda,J., Taha,T., Cohen,M., Denny,T.N. and Gao,F.",
KP109527,C,2009,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Kumwenda,J., Taha,T., Cohen,M., Denny,T.N. and Gao,F.",
KP170487,01BC,2013,25748656,"Genetic Characterization of a Unique Recombinant Originating from CRF55_01B, CRF01_AE, and CRF07_BC in Shenzhen, China","Gui,T., Zhao,J., Sun,C., Chen,L., Liu,Y., Zheng,C., Li,H., Li,T., Bao,Z., Wang,X., Li,J. and Li,L.",2015
KP171242,B,1995,25430652,Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users,"Etemad,B., Gonzalez,O.A., White,L., Laeyendecker,O., Kirk,G.D., Mehta,S. and Sagar,M.",2014
KP171254,B,1995,25430652,Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users,"Etemad,B., Gonzalez,O.A., White,L., Laeyendecker,O., Kirk,G.D., Mehta,S. and Sagar,M.",2014
KP171267,B,1996,25430652,Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users,"Etemad,B., Gonzalez,O.A., White,L., Laeyendecker,O., Kirk,G.D., Mehta,S. and Sagar,M.",2014
KP171279,B,1995,25430652,Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users,"Etemad,B., Gonzalez,O.A., White,L., Laeyendecker,O., Kirk,G.D., Mehta,S. and Sagar,M.",2014
KP171291,B,1995,25430652,Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users,"Etemad,B., Gonzalez,O.A., White,L., Laeyendecker,O., Kirk,G.D., Mehta,S. and Sagar,M.",2014
KP171303,B,1989,25430652,Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users,"Etemad,B., Gonzalez,O.A., White,L., Laeyendecker,O., Kirk,G.D., Mehta,S. and Sagar,M.",2014
KP171315,B,1992,25430652,Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users,"Etemad,B., Gonzalez,O.A., White,L., Laeyendecker,O., Kirk,G.D., Mehta,S. and Sagar,M.",2014
KP171327,B,1995,25430652,Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users,"Etemad,B., Gonzalez,O.A., White,L., Laeyendecker,O., Kirk,G.D., Mehta,S. and Sagar,M.",2014
KP171352,B,1991,25430652,Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users,"Etemad,B., Gonzalez,O.A., White,L., Laeyendecker,O., Kirk,G.D., Mehta,S. and Sagar,M.",2014
KP171376,B,1992,25430652,Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users,"Etemad,B., Gonzalez,O.A., White,L., Laeyendecker,O., Kirk,G.D., Mehta,S. and Sagar,M.",2014
KP171400,B,1995,25430652,Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users,"Etemad,B., Gonzalez,O.A., White,L., Laeyendecker,O., Kirk,G.D., Mehta,S. and Sagar,M.",2014
KP171424,B,1991,25430652,Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users,"Etemad,B., Gonzalez,O.A., White,L., Laeyendecker,O., Kirk,G.D., Mehta,S. and Sagar,M.",2014
KP171448,B,1990,25430652,Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users,"Etemad,B., Gonzalez,O.A., White,L., Laeyendecker,O., Kirk,G.D., Mehta,S. and Sagar,M.",2014
KP171472,B,1992,25430652,Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users,"Etemad,B., Gonzalez,O.A., White,L., Laeyendecker,O., Kirk,G.D., Mehta,S. and Sagar,M.",2014
KP174771,A1D,2009,21091377,Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa,"Price,M.A., Wallis,C.L., Lakhi,S., Karita,E., Kamali,A., Anzala,O., Sanders,E.J., Bekker,L.G., Twesigye,R., Hunter,E., Kaleebu,P., Kayitenkore,K., Allen,S., Ruzagira,E., Mwangome,M., Mutua,G., Amornkul,P.N., Stevens,G., Pond,S.L., Schaefer,M., Papathanasopoulos,M.A., Stevens,W. and Gilmour,J.",2011
KP178420,01_AE,2005,26018591,Development of an HIV-1 Subtype Panel in China: Isolation and Characterization of 30 HIV-1 Primary Strains Circulating in China,"Han,J., Liu,S., Guo,W., Bao,Z., Wang,X., Li,L., Liu,Y., Zhuang,D., Li,H., Jia,L., Gui,T., Sui,H., Li,T. and Li,J.",2015
KP223776,A1,2007,25569444,Transmitted Virus Fitness and Host T Cell Responses Collectively Define Divergent Infection Outcomes in Two HIV-1 Recipients,"Yue,L., Pfafferott,K.J., Baalwa,J., Conrod,K., Dong,C.C., Chui,C., Rong,R., Claiborne,D.T., Prince,J.L., Tang,J., Ribeiro,R.M., Cormier,E., Hahn,B.H., Perelson,A.S., Shaw,G.M., Karita,E., Gilmour,J., Goepfert,P., Derdeyn,C.A., Allen,S.A., Borrow,P. and Hunter,E.",2015
KP223844,A1,2007,25569444,Transmitted Virus Fitness and Host T Cell Responses Collectively Define Divergent Infection Outcomes in Two HIV-1 Recipients,"Yue,L., Pfafferott,K.J., Baalwa,J., Conrod,K., Dong,C.C., Chui,C., Rong,R., Claiborne,D.T., Prince,J.L., Tang,J., Ribeiro,R.M., Cormier,E., Hahn,B.H., Perelson,A.S., Shaw,G.M., Karita,E., Gilmour,J., Goepfert,P., Derdeyn,C.A., Allen,S.A., Borrow,P. and Hunter,E.",2015
KP411822,B,2009,26115688,Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management,"Grossmann,S., Nowak,P. and Neogi,U.",2015
KP411823,B,2010,26115688,Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management,"Grossmann,S., Nowak,P. and Neogi,U.",2015
KP411824,B,2011,26115688,Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management,"Grossmann,S., Nowak,P. and Neogi,U.",2015
KP411825,B,2011,26115688,Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management,"Grossmann,S., Nowak,P. and Neogi,U.",2015
KP411826,01B,2010,26115688,Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management,"Grossmann,S., Nowak,P. and Neogi,U.",2015
KP411827,B,2010,26115688,Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management,"Grossmann,S., Nowak,P. and Neogi,U.",2015
KP411828,B,2012,26115688,Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management,"Grossmann,S., Nowak,P. and Neogi,U.",2015
KP411829,B,2005,26115688,Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management,"Grossmann,S., Nowak,P. and Neogi,U.",2015
KP411830,C,2007,26115688,Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management,"Grossmann,S., Nowak,P. and Neogi,U.",2015
KP411831,C,2007,26115688,Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management,"Grossmann,S., Nowak,P. and Neogi,U.",2015
KP411832,C,2007,26115688,Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management,"Grossmann,S., Nowak,P. and Neogi,U.",2015
KP411833,C,2008,26115688,Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management,"Grossmann,S., Nowak,P. and Neogi,U.",2015
KP411834,C,2008,26115688,Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management,"Grossmann,S., Nowak,P. and Neogi,U.",2015
KP411835,C,2013,26115688,Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management,"Grossmann,S., Nowak,P. and Neogi,U.",2015
KP411836,C,2009,26115688,Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management,"Grossmann,S., Nowak,P. and Neogi,U.",2015
KP411837,C,2010,26115688,Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management,"Grossmann,S., Nowak,P. and Neogi,U.",2015
KP411838,C,2005,26115688,Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management,"Grossmann,S., Nowak,P. and Neogi,U.",2015
KP411839,C,2006,26115688,Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management,"Grossmann,S., Nowak,P. and Neogi,U.",2015
KP411840,01_AE,2011,26115688,Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management,"Grossmann,S., Nowak,P. and Neogi,U.",2015
KP411841,01_AE,2011,26115688,Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management,"Grossmann,S., Nowak,P. and Neogi,U.",2015
KP411842,01_AE,2011,26115688,Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management,"Grossmann,S., Nowak,P. and Neogi,U.",2015
KP411843,02_AG,2011,26115688,Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management,"Grossmann,S., Nowak,P. and Neogi,U.",2015
KP411844,02_AG,2011,26115688,Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management,"Grossmann,S., Nowak,P. and Neogi,U.",2015
KP411845,02_AG,2011,26115688,Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management,"Grossmann,S., Nowak,P. and Neogi,U.",2015
KP418805,01B,2013,26058342,"Genomic Characterization of Two Novel HIV-1 Unique (CRF01_AE/B) Recombinant Forms Among Men Who Have Sex with Men in Beijing, China","Li,Z., Li,J., Feng,Y., Kalish,M.L., Lu,H., Yin,L., Liao,L., Qian,H.Z., Frost,S.D., Ruan,Y., Vermund,S.H., Shao,Y. and Xing,H.",2015
KP418806,01B,2013,26058342,"Genomic Characterization of Two Novel HIV-1 Unique (CRF01_AE/B) Recombinant Forms Among Men Who Have Sex with Men in Beijing, China","Li,Z., Li,J., Feng,Y., Kalish,M.L., Lu,H., Yin,L., Liao,L., Qian,H.Z., Frost,S.D., Ruan,Y., Vermund,S.H., Shao,Y. and Xing,H.",2015
KP455640,01BC,2008,25970165,Near Full-Length Identification of a Novel HIV-1 CRF01_AE/B/C Recombinant in Northern Myanmar,"Zhou,Y.H., Chen,X., Liang,Y.B., Pang,W., Qin,W.H., Zhang,C. and Zheng,Y.T.",2015
KP668994,01BC,2014,25962473,"CRF01_AE/B/C, a Novel Drug-Resistant HIV-1 Recombinant in Men Who Have Sex with Men in Beijing, China","Yan,J., Xin,R., Li,Z., Feng,Y., Lu,H., Liao,L., Ruan,Y., Shao,Y. and Xing,H.",2015
KP693359,B,2000,26083631,A Conserved Glycan in the C2 Domain of HIV-1 Envelope Acts as a Molecular Switch to Control X4 Utilization by Clonal Variants with Identical V3 Loops,"Lombardi,F., Nakamura,K.J., Chen,T., Sobrera,E.R., Tobin,N.H. and Aldrovandi,G.M.",2015
KP693361,C,2006,26083631,A Conserved Glycan in the C2 Domain of HIV-1 Envelope Acts as a Molecular Switch to Control X4 Utilization by Clonal Variants with Identical V3 Loops,"Lombardi,F., Nakamura,K.J., Chen,T., Sobrera,E.R., Tobin,N.H. and Aldrovandi,G.M.",2015
KP693364,B,2004,26083631,A Conserved Glycan in the C2 Domain of HIV-1 Envelope Acts as a Molecular Switch to Control X4 Utilization by Clonal Variants with Identical V3 Loops,"Lombardi,F., Nakamura,K.J., Chen,T., Sobrera,E.R., Tobin,N.H. and Aldrovandi,G.M.",2015
KP693368,B,2003,26083631,A Conserved Glycan in the C2 Domain of HIV-1 Envelope Acts as a Molecular Switch to Control X4 Utilization by Clonal Variants with Identical V3 Loops,"Lombardi,F., Nakamura,K.J., Chen,T., Sobrera,E.R., Tobin,N.H. and Aldrovandi,G.M.",2015
KP693369,B,2001,26083631,A Conserved Glycan in the C2 Domain of HIV-1 Envelope Acts as a Molecular Switch to Control X4 Utilization by Clonal Variants with Identical V3 Loops,"Lombardi,F., Nakamura,K.J., Chen,T., Sobrera,E.R., Tobin,N.H. and Aldrovandi,G.M.",2015
KP693371,B,2006,26083631,A Conserved Glycan in the C2 Domain of HIV-1 Envelope Acts as a Molecular Switch to Control X4 Utilization by Clonal Variants with Identical V3 Loops,"Lombardi,F., Nakamura,K.J., Chen,T., Sobrera,E.R., Tobin,N.H. and Aldrovandi,G.M.",2015
KP693372,B,2002,26083631,A Conserved Glycan in the C2 Domain of HIV-1 Envelope Acts as a Molecular Switch to Control X4 Utilization by Clonal Variants with Identical V3 Loops,"Lombardi,F., Nakamura,K.J., Chen,T., Sobrera,E.R., Tobin,N.H. and Aldrovandi,G.M.",2015
KP693378,B,2002,26083631,A Conserved Glycan in the C2 Domain of HIV-1 Envelope Acts as a Molecular Switch to Control X4 Utilization by Clonal Variants with Identical V3 Loops,"Lombardi,F., Nakamura,K.J., Chen,T., Sobrera,E.R., Tobin,N.H. and Aldrovandi,G.M.",2015
KP693379,B,2003,26083631,A Conserved Glycan in the C2 Domain of HIV-1 Envelope Acts as a Molecular Switch to Control X4 Utilization by Clonal Variants with Identical V3 Loops,"Lombardi,F., Nakamura,K.J., Chen,T., Sobrera,E.R., Tobin,N.H. and Aldrovandi,G.M.",2015
KP693384,B,2001,26083631,A Conserved Glycan in the C2 Domain of HIV-1 Envelope Acts as a Molecular Switch to Control X4 Utilization by Clonal Variants with Identical V3 Loops,"Lombardi,F., Nakamura,K.J., Chen,T., Sobrera,E.R., Tobin,N.H. and Aldrovandi,G.M.",2015
KP718914,11_cpx,2006,,Utility of Unbiased Next-Generation Sequencing for HIV Surveillance,"Luk,K.-C., Berg,M.G., Naccache,S.N., Kabre,B., Federman,S., Mbanya,D., Kaptue,L., Chiu,C.Y., Brennan,C.A. and Hackett,J. Jr.",
KP718915,G,2006,,Utility of Unbiased Next-Generation Sequencing for HIV Surveillance,"Luk,K.-C., Berg,M.G., Naccache,S.N., Kabre,B., Federman,S., Mbanya,D., Kaptue,L., Chiu,C.Y., Brennan,C.A. and Hackett,J. Jr.",
KP718916,DG,2006,,Utility of Unbiased Next-Generation Sequencing for HIV Surveillance,"Luk,K.-C., Berg,M.G., Naccache,S.N., Kabre,B., Federman,S., Mbanya,D., Kaptue,L., Chiu,C.Y., Brennan,C.A. and Hackett,J. Jr.",
KP718917,37_cpx,2006,,Utility of Unbiased Next-Generation Sequencing for HIV Surveillance,"Luk,K.-C., Berg,M.G., Naccache,S.N., Kabre,B., Federman,S., Mbanya,D., Kaptue,L., Chiu,C.Y., Brennan,C.A. and Hackett,J. Jr.",
KP718918,A1,2007,,Utility of Unbiased Next-Generation Sequencing for HIV Surveillance,"Luk,K.-C., Berg,M.G., Naccache,S.N., Kabre,B., Federman,S., Mbanya,D., Kaptue,L., Chiu,C.Y., Brennan,C.A. and Hackett,J. Jr.",
KP718919,A1K,2007,,Utility of Unbiased Next-Generation Sequencing for HIV Surveillance,"Luk,K.-C., Berg,M.G., Naccache,S.N., Kabre,B., Federman,S., Mbanya,D., Kaptue,L., Chiu,C.Y., Brennan,C.A. and Hackett,J. Jr.",
KP718920,U,2007,,Utility of Unbiased Next-Generation Sequencing for HIV Surveillance,"Luk,K.-C., Berg,M.G., Naccache,S.N., Kabre,B., Federman,S., Mbanya,D., Kaptue,L., Chiu,C.Y., Brennan,C.A. and Hackett,J. Jr.",
KP718921,0102A,2007,,Utility of Unbiased Next-Generation Sequencing for HIV Surveillance,"Luk,K.-C., Berg,M.G., Naccache,S.N., Kabre,B., Federman,S., Mbanya,D., Kaptue,L., Chiu,C.Y., Brennan,C.A. and Hackett,J. Jr.",
KP718922,0102A,2007,,Utility of Unbiased Next-Generation Sequencing for HIV Surveillance,"Luk,K.-C., Berg,M.G., Naccache,S.N., Kabre,B., Federman,S., Mbanya,D., Kaptue,L., Chiu,C.Y., Brennan,C.A. and Hackett,J. Jr.",
KP718923,G,2007,,Utility of Unbiased Next-Generation Sequencing for HIV Surveillance,"Luk,K.-C., Berg,M.G., Naccache,S.N., Kabre,B., Federman,S., Mbanya,D., Kaptue,L., Chiu,C.Y., Brennan,C.A. and Hackett,J. Jr.",
KP718924,13_cpx,2008,,Utility of Unbiased Next-Generation Sequencing for HIV Surveillance,"Luk,K.-C., Berg,M.G., Naccache,S.N., Kabre,B., Federman,S., Mbanya,D., Kaptue,L., Chiu,C.Y., Brennan,C.A. and Hackett,J. Jr.",
KP718925,G,2008,,Utility of Unbiased Next-Generation Sequencing for HIV Surveillance,"Luk,K.-C., Berg,M.G., Naccache,S.N., Kabre,B., Federman,S., Mbanya,D., Kaptue,L., Chiu,C.Y., Brennan,C.A. and Hackett,J. Jr.",
KP718926,13_cpx,2008,,Utility of Unbiased Next-Generation Sequencing for HIV Surveillance,"Luk,K.-C., Berg,M.G., Naccache,S.N., Kabre,B., Federman,S., Mbanya,D., Kaptue,L., Chiu,C.Y., Brennan,C.A. and Hackett,J. Jr.",
KP718927,A1H,2008,,Utility of Unbiased Next-Generation Sequencing for HIV Surveillance,"Luk,K.-C., Berg,M.G., Naccache,S.N., Kabre,B., Federman,S., Mbanya,D., Kaptue,L., Chiu,C.Y., Brennan,C.A. and Hackett,J. Jr.",
KP718928,A1,2008,,Utility of Unbiased Next-Generation Sequencing for HIV Surveillance,"Luk,K.-C., Berg,M.G., Naccache,S.N., Kabre,B., Federman,S., Mbanya,D., Kaptue,L., Chiu,C.Y., Brennan,C.A. and Hackett,J. Jr.",
KP718929,U,2008,,Utility of Unbiased Next-Generation Sequencing for HIV Surveillance,"Luk,K.-C., Berg,M.G., Naccache,S.N., Kabre,B., Federman,S., Mbanya,D., Kaptue,L., Chiu,C.Y., Brennan,C.A. and Hackett,J. Jr.",
KP718930,01_AE,2011,,Utility of Unbiased Next-Generation Sequencing for HIV Surveillance,"Luk,K.-C., Berg,M.G., Naccache,S.N., Kabre,B., Federman,S., Mbanya,D., Kaptue,L., Chiu,C.Y., Brennan,C.A. and Hackett,J. Jr.",
KP718931,18_cpx,2011,,Utility of Unbiased Next-Generation Sequencing for HIV Surveillance,"Luk,K.-C., Berg,M.G., Naccache,S.N., Kabre,B., Federman,S., Mbanya,D., Kaptue,L., Chiu,C.Y., Brennan,C.A. and Hackett,J. Jr.",
KP718932,A1F2,2011,,Utility of Unbiased Next-Generation Sequencing for HIV Surveillance,"Luk,K.-C., Berg,M.G., Naccache,S.N., Kabre,B., Federman,S., Mbanya,D., Kaptue,L., Chiu,C.Y., Brennan,C.A. and Hackett,J. Jr.",
KP718933,A1H,2011,,Utility of Unbiased Next-Generation Sequencing for HIV Surveillance,"Luk,K.-C., Berg,M.G., Naccache,S.N., Kabre,B., Federman,S., Mbanya,D., Kaptue,L., Chiu,C.Y., Brennan,C.A. and Hackett,J. Jr.",
KP718934,11_cpx,2002,,Utility of Unbiased Next-Generation Sequencing for HIV Surveillance,"Luk,K.-C., Berg,M.G., Naccache,S.N., Kabre,B., Federman,S., Mbanya,D., Kaptue,L., Chiu,C.Y., Brennan,C.A. and Hackett,J. Jr.",
KP718935,11_cpx,2002,,Utility of Unbiased Next-Generation Sequencing for HIV Surveillance,"Luk,K.-C., Berg,M.G., Naccache,S.N., Kabre,B., Federman,S., Mbanya,D., Kaptue,L., Chiu,C.Y., Brennan,C.A. and Hackett,J. Jr.",
KP718936,11_cpx,2004,,Utility of Unbiased Next-Generation Sequencing for HIV Surveillance,"Luk,K.-C., Berg,M.G., Naccache,S.N., Kabre,B., Federman,S., Mbanya,D., Kaptue,L., Chiu,C.Y., Brennan,C.A. and Hackett,J. Jr.",
KP718937,11_cpx,2004,,Utility of Unbiased Next-Generation Sequencing for HIV Surveillance,"Luk,K.-C., Berg,M.G., Naccache,S.N., Kabre,B., Federman,S., Mbanya,D., Kaptue,L., Chiu,C.Y., Brennan,C.A. and Hackett,J. Jr.",
KP718938,11_cpx,2004,,Utility of Unbiased Next-Generation Sequencing for HIV Surveillance,"Luk,K.-C., Berg,M.G., Naccache,S.N., Kabre,B., Federman,S., Mbanya,D., Kaptue,L., Chiu,C.Y., Brennan,C.A. and Hackett,J. Jr.",
KP754463,B,,,Direct Submission,"Joshi,A., Sedano,M.J., Punke,E. and Garg,H.",2015
KP754464,B,,,Direct Submission,"Joshi,A., Sedano,M.J., Punke,E. and Garg,H.",2015
KP754465,B,,,Direct Submission,"Joshi,A., Sedano,M.J., Punke,E. and Garg,H.",2015
KP754466,B,,,Direct Submission,"Joshi,A., Sedano,M.J., Punke,E. and Garg,H.",2015
KP754467,B,,,Direct Submission,"Joshi,A., Sedano,M.J., Punke,E. and Garg,H.",2015
KP754468,B,,,Direct Submission,"Joshi,A., Sedano,M.J., Punke,E. and Garg,H.",2015
KP754469,B,,,Direct Submission,"Joshi,A., Sedano,M.J., Punke,E. and Garg,H.",2015
KP754470,B,,,Direct Submission,"Joshi,A., Sedano,M.J., Punke,E. and Garg,H.",2015
KP754471,B,,,Direct Submission,"Joshi,A., Sedano,M.J., Punke,E. and Garg,H.",2015
KP754472,B,,,Direct Submission,"Joshi,A., Sedano,M.J., Punke,E. and Garg,H.",2015
KP754473,B,,,Direct Submission,"Joshi,A., Sedano,M.J., Punke,E. and Garg,H.",2015
KP873161,01_AE,2010,26123575,Disease progression despite protective HLA expression in an HIV-infected transmission pair,"Brener,J., Gall,A., Batorsky,R., Riddell,L., Buus,S., Leitman,E., Kellam,P., Allen,T., Goulder,P. and Matthews,P.C.",2015
KP873163,01_AE,2012,26123575,Disease progression despite protective HLA expression in an HIV-infected transmission pair,"Brener,J., Gall,A., Batorsky,R., Riddell,L., Buus,S., Leitman,E., Kellam,P., Allen,T., Goulder,P. and Matthews,P.C.",2015
KR017771,02F2,2007,26354000,Near full-length HIV type 1M genomic sequences from Cameroon: evidence of early diverging under-sampled lineages in the country,"Tongo,M., Dorfman,J.R., Abrahams,M.R., Mpoudi-Ngole,E., Burgers,W.A. and Martin,D.P.",2015
KR017772,02A3,2007,26354000,Near full-length HIV type 1M genomic sequences from Cameroon: evidence of early diverging under-sampled lineages in the country,"Tongo,M., Dorfman,J.R., Abrahams,M.R., Mpoudi-Ngole,E., Burgers,W.A. and Martin,D.P.",2015
KR017773,02A1G,2007,26354000,Near full-length HIV type 1M genomic sequences from Cameroon: evidence of early diverging under-sampled lineages in the country,"Tongo,M., Dorfman,J.R., Abrahams,M.R., Mpoudi-Ngole,E., Burgers,W.A. and Martin,D.P.",2015
KR017774,36_cpx,2007,26354000,Near full-length HIV type 1M genomic sequences from Cameroon: evidence of early diverging under-sampled lineages in the country,"Tongo,M., Dorfman,J.R., Abrahams,M.R., Mpoudi-Ngole,E., Burgers,W.A. and Martin,D.P.",2015
KR017775,G,2007,26354000,Near full-length HIV type 1M genomic sequences from Cameroon: evidence of early diverging under-sampled lineages in the country,"Tongo,M., Dorfman,J.R., Abrahams,M.R., Mpoudi-Ngole,E., Burgers,W.A. and Martin,D.P.",2015
KR017776,G,2007,26354000,Near full-length HIV type 1M genomic sequences from Cameroon: evidence of early diverging under-sampled lineages in the country,"Tongo,M., Dorfman,J.R., Abrahams,M.R., Mpoudi-Ngole,E., Burgers,W.A. and Martin,D.P.",2015
KR017777,02A1F2,2007,26354000,Near full-length HIV type 1M genomic sequences from Cameroon: evidence of early diverging under-sampled lineages in the country,"Tongo,M., Dorfman,J.R., Abrahams,M.R., Mpoudi-Ngole,E., Burgers,W.A. and Martin,D.P.",2015
KR017778,11A1,2007,26354000,Near full-length HIV type 1M genomic sequences from Cameroon: evidence of early diverging under-sampled lineages in the country,"Tongo,M., Dorfman,J.R., Abrahams,M.R., Mpoudi-Ngole,E., Burgers,W.A. and Martin,D.P.",2015
KR017779,01A1F2,2007,26354000,Near full-length HIV type 1M genomic sequences from Cameroon: evidence of early diverging under-sampled lineages in the country,"Tongo,M., Dorfman,J.R., Abrahams,M.R., Mpoudi-Ngole,E., Burgers,W.A. and Martin,D.P.",2015
KR019770,74_01B,2010,26196131,Genetic Characterization of a Novel HIV-1 Circulating Recombinant Form (CRF74_01B) Identified among Intravenous Drug Users in Malaysia: Recombination History and Phylogenetic Linkage with Previously Defined Recombinant Lineages,"Cheong,H.T., Chow,W.Z., Takebe,Y., Chook,J.B., Chan,K.G., Al-Darraji,H.A., Koh,C., Kamarulzaman,A. and Tee,K.K.",2015
KR019771,74_01B,2010,26196131,Genetic Characterization of a Novel HIV-1 Circulating Recombinant Form (CRF74_01B) Identified among Intravenous Drug Users in Malaysia: Recombination History and Phylogenetic Linkage with Previously Defined Recombinant Lineages,"Cheong,H.T., Chow,W.Z., Takebe,Y., Chook,J.B., Chan,K.G., Al-Darraji,H.A., Koh,C., Kamarulzaman,A. and Tee,K.K.",2015
KR019772,74_01B,2011,26196131,Genetic Characterization of a Novel HIV-1 Circulating Recombinant Form (CRF74_01B) Identified among Intravenous Drug Users in Malaysia: Recombination History and Phylogenetic Linkage with Previously Defined Recombinant Lineages,"Cheong,H.T., Chow,W.Z., Takebe,Y., Chook,J.B., Chan,K.G., Al-Darraji,H.A., Koh,C., Kamarulzaman,A. and Tee,K.K.",2015
KR051418,G,2009,,Phylogenetics of HIV-1 subtype G env: greater complexity and older origins than previously reported,"Tongo,M., Essomba,R.G., Nindo,F., Abrahams,F., Nanfack,A.J., Fokam,J., Takou,D., Torimiro,J., Mpoudi-Ngole,E., Burgers,W., Martin,D. and Dorfman,J.R.",
KR051426,G,2009,,Phylogenetics of HIV-1 subtype G env: greater complexity and older origins than previously reported,"Tongo,M., Essomba,R.G., Nindo,F., Abrahams,F., Nanfack,A.J., Fokam,J., Takou,D., Torimiro,J., Mpoudi-Ngole,E., Burgers,W., Martin,D. and Dorfman,J.R.",
KR051432,G,2010,,Phylogenetics of HIV-1 subtype G env: greater complexity and older origins than previously reported,"Tongo,M., Essomba,R.G., Nindo,F., Abrahams,F., Nanfack,A.J., Fokam,J., Takou,D., Torimiro,J., Mpoudi-Ngole,E., Burgers,W., Martin,D. and Dorfman,J.R.",
KR051438,G,2007,,Phylogenetics of HIV-1 subtype G env: greater complexity and older origins than previously reported,"Tongo,M., Essomba,R.G., Nindo,F., Abrahams,F., Nanfack,A.J., Fokam,J., Takou,D., Torimiro,J., Mpoudi-Ngole,E., Burgers,W., Martin,D. and Dorfman,J.R.",
KR051442,G,2007,,Phylogenetics of HIV-1 subtype G env: greater complexity and older origins than previously reported,"Tongo,M., Essomba,R.G., Nindo,F., Abrahams,F., Nanfack,A.J., Fokam,J., Takou,D., Torimiro,J., Mpoudi-Ngole,E., Burgers,W., Martin,D. and Dorfman,J.R.",
KR051457,G,2007,,Phylogenetics of HIV-1 subtype G env: greater complexity and older origins than previously reported,"Tongo,M., Essomba,R.G., Nindo,F., Abrahams,F., Nanfack,A.J., Fokam,J., Takou,D., Torimiro,J., Mpoudi-Ngole,E., Burgers,W., Martin,D. and Dorfman,J.R.",
KR067667,02A,2010,26066756,Cocirculation of Several Similar But Unique HIV-1 Recombinant Forms in Guinea-Bissau Revealed by Near Full-Length Genomic Sequencing,"Palm,A.A., Esbjornsson,J., Mansson,F., Biague,A., da Silva,Z.J., Norrgren,H., Jansson,M. and Medstrand,P.",2015
KR067668,02A1,2006,26066756,Cocirculation of Several Similar But Unique HIV-1 Recombinant Forms in Guinea-Bissau Revealed by Near Full-Length Genomic Sequencing,"Palm,A.A., Esbjornsson,J., Mansson,F., Biague,A., da Silva,Z.J., Norrgren,H., Jansson,M. and Medstrand,P.",2015
KR067669,02A,2004,26066756,Cocirculation of Several Similar But Unique HIV-1 Recombinant Forms in Guinea-Bissau Revealed by Near Full-Length Genomic Sequencing,"Palm,A.A., Esbjornsson,J., Mansson,F., Biague,A., da Silva,Z.J., Norrgren,H., Jansson,M. and Medstrand,P.",2015
KR067670,02A,2008,26066756,Cocirculation of Several Similar But Unique HIV-1 Recombinant Forms in Guinea-Bissau Revealed by Near Full-Length Genomic Sequencing,"Palm,A.A., Esbjornsson,J., Mansson,F., Biague,A., da Silva,Z.J., Norrgren,H., Jansson,M. and Medstrand,P.",2015
KR067671,02A,2013,26066756,Cocirculation of Several Similar But Unique HIV-1 Recombinant Forms in Guinea-Bissau Revealed by Near Full-Length Genomic Sequencing,"Palm,A.A., Esbjornsson,J., Mansson,F., Biague,A., da Silva,Z.J., Norrgren,H., Jansson,M. and Medstrand,P.",2015
KR067672,02A,2008,26066756,Cocirculation of Several Similar But Unique HIV-1 Recombinant Forms in Guinea-Bissau Revealed by Near Full-Length Genomic Sequencing,"Palm,A.A., Esbjornsson,J., Mansson,F., Biague,A., da Silva,Z.J., Norrgren,H., Jansson,M. and Medstrand,P.",2015
KR423015,B,2006,,Direct Submission,"Swanstrom,R.",2015
KR423028,B,2006,,Direct Submission,"Swanstrom,R.",2015
KR423052,B,2006,,Direct Submission,"Swanstrom,R.",2015
KR423118,B,2007,,Direct Submission,"Swanstrom,R.",2015
KR423153,B,2007,,Direct Submission,"Swanstrom,R.",2015
KR423183,B,2007,,Direct Submission,"Swanstrom,R.",2015
KR423212,B,2008,,Direct Submission,"Swanstrom,R.",2015
KR423234,B,2008,,Direct Submission,"Swanstrom,R.",2015
KR423279,B,2008,,Direct Submission,"Swanstrom,R.",2015
KR423303,B,2008,,Direct Submission,"Swanstrom,R.",2015
KR423319,B,2008,,Direct Submission,"Swanstrom,R.",2015
KR423340,B,2008,,Direct Submission,"Swanstrom,R.",2015
KR423358,B,2008,,Direct Submission,"Swanstrom,R.",2015
KR423363,B,2008,,Direct Submission,"Swanstrom,R.",2015
KR423373,B,2008,,Direct Submission,"Swanstrom,R.",2015
KR423391,B,2008,,Direct Submission,"Swanstrom,R.",2015
KR423410,B,2008,,Direct Submission,"Swanstrom,R.",2015
KR423423,B,2009,,Direct Submission,"Swanstrom,R.",2015
KR423435,B,2009,,Direct Submission,"Swanstrom,R.",2015
KR423444,B,2009,,Direct Submission,"Swanstrom,R.",2015
KR423464,B,2009,,Direct Submission,"Swanstrom,R.",2015
KR423482,B,2009,,Direct Submission,"Swanstrom,R.",2015
KR423500,B,2007,,Direct Submission,"Swanstrom,R.",2015
KR423527,B,2007,,Direct Submission,"Swanstrom,R.",2015
KR423545,B,2008,,Direct Submission,"Swanstrom,R.",2015
KR423553,B,2008,,Direct Submission,"Swanstrom,R.",2015
KR423567,B,2008,,Direct Submission,"Swanstrom,R.",2015
KR423590,B,2008,,Direct Submission,"Swanstrom,R.",2015
KR423602,B,2008,,Direct Submission,"Swanstrom,R.",2015
KR423619,B,2009,,Direct Submission,"Swanstrom,R.",2015
KR423637,B,,,Direct Submission,"Swanstrom,R.",2015
KR423648,B,2009,,Direct Submission,"Swanstrom,R.",2015
KR423693,B,2006,,Direct Submission,"Swanstrom,R.",2015
KR423725,B,2006,,Direct Submission,"Swanstrom,R.",2015
KR423796,B,2007,,Direct Submission,"Swanstrom,R.",2015
KR425429,06A1,2007,,Direct Submission,"Swanstrom,R.",2015
KR425448,06A1,2007,,Direct Submission,"Swanstrom,R.",2015
KR820294,C,2009,26378795,Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-alpha Resistance,"Deymier,M.J., Ende,Z., Fenton-May,A.E., Dilernia,D.A., Kilembe,W., Allen,S.A., Borrow,P. and Hunter,E.",2015
KR820314,C,2009,26378795,Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-alpha Resistance,"Deymier,M.J., Ende,Z., Fenton-May,A.E., Dilernia,D.A., Kilembe,W., Allen,S.A., Borrow,P. and Hunter,E.",2015
KR820324,C,2009,26378795,Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-alpha Resistance,"Deymier,M.J., Ende,Z., Fenton-May,A.E., Dilernia,D.A., Kilembe,W., Allen,S.A., Borrow,P. and Hunter,E.",2015
KR820326,C,2009,26378795,Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-alpha Resistance,"Deymier,M.J., Ende,Z., Fenton-May,A.E., Dilernia,D.A., Kilembe,W., Allen,S.A., Borrow,P. and Hunter,E.",2015
KR820341,C,2009,26378795,Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-alpha Resistance,"Deymier,M.J., Ende,Z., Fenton-May,A.E., Dilernia,D.A., Kilembe,W., Allen,S.A., Borrow,P. and Hunter,E.",2015
KR820358,C,2009,26378795,Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-alpha Resistance,"Deymier,M.J., Ende,Z., Fenton-May,A.E., Dilernia,D.A., Kilembe,W., Allen,S.A., Borrow,P. and Hunter,E.",2015
KR820367,C,2009,26378795,Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-alpha Resistance,"Deymier,M.J., Ende,Z., Fenton-May,A.E., Dilernia,D.A., Kilembe,W., Allen,S.A., Borrow,P. and Hunter,E.",2015
KR820385,C,2009,26378795,Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-alpha Resistance,"Deymier,M.J., Ende,Z., Fenton-May,A.E., Dilernia,D.A., Kilembe,W., Allen,S.A., Borrow,P. and Hunter,E.",2015
KR820394,C,2010,26378795,Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-alpha Resistance,"Deymier,M.J., Ende,Z., Fenton-May,A.E., Dilernia,D.A., Kilembe,W., Allen,S.A., Borrow,P. and Hunter,E.",2015
KR820415,C,2010,26378795,Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-alpha Resistance,"Deymier,M.J., Ende,Z., Fenton-May,A.E., Dilernia,D.A., Kilembe,W., Allen,S.A., Borrow,P. and Hunter,E.",2015
KR820422,C,2011,26378795,Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-alpha Resistance,"Deymier,M.J., Ende,Z., Fenton-May,A.E., Dilernia,D.A., Kilembe,W., Allen,S.A., Borrow,P. and Hunter,E.",2015
KR820440,C,2011,26378795,Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-alpha Resistance,"Deymier,M.J., Ende,Z., Fenton-May,A.E., Dilernia,D.A., Kilembe,W., Allen,S.A., Borrow,P. and Hunter,E.",2015
KR822827,A1G,2006,,Utility of Unbiased Next-Generation Sequencing for Characterization of HIV Diversity,"Luk,K.-C., Berg,M.G., Naccache,S.N., Kabre,B., Federman,S., Mbanya,D., Kaptue,L., Chiu,C.Y., Brennan,C.A. and Hackett,J. Jr.",
KR822828,F2,2006,,Utility of Unbiased Next-Generation Sequencing for Characterization of HIV Diversity,"Luk,K.-C., Berg,M.G., Naccache,S.N., Kabre,B., Federman,S., Mbanya,D., Kaptue,L., Chiu,C.Y., Brennan,C.A. and Hackett,J. Jr.",
KR822829,11_cpx,2006,,Utility of Unbiased Next-Generation Sequencing for Characterization of HIV Diversity,"Luk,K.-C., Berg,M.G., Naccache,S.N., Kabre,B., Federman,S., Mbanya,D., Kaptue,L., Chiu,C.Y., Brennan,C.A. and Hackett,J. Jr.",
KR822830,11_cpx,2007,,Utility of Unbiased Next-Generation Sequencing for Characterization of HIV Diversity,"Luk,K.-C., Berg,M.G., Naccache,S.N., Kabre,B., Federman,S., Mbanya,D., Kaptue,L., Chiu,C.Y., Brennan,C.A. and Hackett,J. Jr.",
KR822831,0102A,2007,,Utility of Unbiased Next-Generation Sequencing for Characterization of HIV Diversity,"Luk,K.-C., Berg,M.G., Naccache,S.N., Kabre,B., Federman,S., Mbanya,D., Kaptue,L., Chiu,C.Y., Brennan,C.A. and Hackett,J. Jr.",
KR822832,A1G,2007,,Utility of Unbiased Next-Generation Sequencing for Characterization of HIV Diversity,"Luk,K.-C., Berg,M.G., Naccache,S.N., Kabre,B., Federman,S., Mbanya,D., Kaptue,L., Chiu,C.Y., Brennan,C.A. and Hackett,J. Jr.",
KR822833,01A1,2007,,Utility of Unbiased Next-Generation Sequencing for Characterization of HIV Diversity,"Luk,K.-C., Berg,M.G., Naccache,S.N., Kabre,B., Federman,S., Mbanya,D., Kaptue,L., Chiu,C.Y., Brennan,C.A. and Hackett,J. Jr.",
KR822834,01A1,2008,,Utility of Unbiased Next-Generation Sequencing for Characterization of HIV Diversity,"Luk,K.-C., Berg,M.G., Naccache,S.N., Kabre,B., Federman,S., Mbanya,D., Kaptue,L., Chiu,C.Y., Brennan,C.A. and Hackett,J. Jr.",
KR822835,01A1,2008,,Utility of Unbiased Next-Generation Sequencing for Characterization of HIV Diversity,"Luk,K.-C., Berg,M.G., Naccache,S.N., Kabre,B., Federman,S., Mbanya,D., Kaptue,L., Chiu,C.Y., Brennan,C.A. and Hackett,J. Jr.",
KR861256,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861257,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861258,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861259,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861260,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861261,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861262,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861263,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861264,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861265,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861266,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861267,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861268,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861269,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861270,C,2013,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861271,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861272,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861273,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861274,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861275,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861276,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861277,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861278,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861279,C,2013,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861280,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861281,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861282,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861283,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861284,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861285,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861286,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861287,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861288,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861289,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861290,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861291,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861292,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861293,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861294,C,2013,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861295,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861296,C,2013,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861297,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861298,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861299,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861300,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861301,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861302,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861303,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861304,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861305,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861306,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861307,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861308,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861309,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861310,C,2014,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861311,C,2012,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861312,C,2011,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861313,C,2010,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861314,C,2011,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861315,C,2010,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861316,C,2010,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861317,C,2010,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861318,C,,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861319,C,2012,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861320,C,2011,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861321,C,2011,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861322,C,2011,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861323,C,2011,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861324,C,2011,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861325,C,2010,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861326,C,2010,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861327,C,2012,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861328,C,2013,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861329,C,2010,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861330,C,2011,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861331,C,2010,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861332,C,2011,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861333,C,2010,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861334,C,2011,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861335,C,2011,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861336,C,2011,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861337,C,2010,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861338,C,2010,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861339,C,2011,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861340,C,2010,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861341,C,2011,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861342,C,2011,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861343,C,2011,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861344,C,2012,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR861345,C,2010,26041893,Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering,"Novitsky,V., Zahralban-Steele,M., McLane,M.F., Moyo,S., van Widenfelt,E., Gaseitsiwe,S., Makhema,J. and Essex,M.",2015
KR868834,B,2010,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KR868847,B,2003,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KR868869,B,2008,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KR868894,B,2008,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KR868913,B,2008,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT008649,A1,1995,26158467,The Broad Neutralizing Antibody Responses after HIV-1 Superinfection Are Not Dominated by Antibodies Directed to Epitopes Common in Single Infection,"Cortez,V., Wang,B., Dingens,A., Chen,M.M., Ronen,K., Georgiev,I.S., McClelland,R.S. and Overbaugh,J.",2015
KT074935,01C,2014,,"Genetic Characterization of a Unique Recombinant Form(URF) Involving HIV-1 CRF 01_AE and Subtype C from Pune, India","Karade,S., Pandey,S.S., Gianchandani,S., Kurle,S. and Gangakhedkar,R.",
KT124747,B,1998,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124748,B,2001,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124749,B,2009,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124750,B,2012,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124751,B,2008,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124752,B,2008,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124753,B,2009,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124754,B,2009,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124755,B,2008,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124756,B,2012,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124757,B,2008,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124758,B,2004,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124759,B,1999,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124760,B,2010,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124761,B,2008,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124762,B,2008,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124763,B,2010,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124764,B,2002,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124765,B,2012,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124766,B,2011,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124767,B,2013,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124768,B,2012,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124769,B,1998,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124770,B,1997,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124771,B,1998,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124772,B,2010,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124773,B,2011,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124774,B,2008,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124775,B,2011,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124776,B,1999,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124777,B,2002,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124778,B,2005,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124779,B,2010,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124782,B,2009,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124783,B,2010,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124784,B,2012,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124785,B,2012,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124786,C,2010,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124787,B,2012,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124788,B,2008,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124790,B,2012,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124791,B,2006,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124792,02_AG,2009,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124794,B,2008,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124795,B,2002,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124796,B,2013,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124797,B,2010,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124798,B,1999,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124799,B,2001,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124801,B,2007,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124802,B,2011,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124803,B,2007,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124804,B,2004,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124805,B,2009,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124806,B,2000,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124807,B,2003,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124808,B,2013,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124809,B,2011,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124810,B,2008,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124811,B,2012,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124812,B,2004,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124813,B,2003,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT124814,B,2002,27163788,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,"Tully,D.C., Ogilvie,C.B., Batorsky,R.E., Bean,D.J., Power,K.A., Ghebremichael,M., Bedard,H.E., Gladden,A.D., Seese,A.M., Amero,M.A., Lane,K., McGrath,G., Bazner,S.B., Tinsley,J., Lennon,N.J., Henn,M.R., Brumme,Z.L., Norris,P.J., Rosenberg,E.S., Mayer,K.H., Jessen,H., Kosakovsky Pond,S.L., Walker,B.D., Altfeld,M., Carlson,J.M. and Allen,T.M.",2016
KT152839,A1,2009,,Genetic characterization of six full-length HIV-1 genomes from India reveals a monophyletic lineage of Indian sub-subtype A1,"Pandey,S.S., Kulkarni,S., Thakar,M. and Paranjape,R.",
KT152840,A1,1997,,Genetic characterization of six full-length HIV-1 genomes from India reveals a monophyletic lineage of Indian sub-subtype A1,"Pandey,S.S., Kulkarni,S., Thakar,M. and Paranjape,R.",
KT152841,A1,1999,,Genetic characterization of six full-length HIV-1 genomes from India reveals a monophyletic lineage of Indian sub-subtype A1,"Pandey,S.S., Kulkarni,S., Thakar,M. and Paranjape,R.",
KT152842,A1,1999,,Genetic characterization of six full-length HIV-1 genomes from India reveals a monophyletic lineage of Indian sub-subtype A1,"Pandey,S.S., Kulkarni,S., Thakar,M. and Paranjape,R.",
KT152843,A1,1999,,Genetic characterization of six full-length HIV-1 genomes from India reveals a monophyletic lineage of Indian sub-subtype A1,"Pandey,S.S., Kulkarni,S., Thakar,M. and Paranjape,R.",
KT152846,A1,2000,,Genetic characterization of six full-length HIV-1 genomes from India reveals a monophyletic lineage of Indian sub-subtype A1,"Pandey,S.S., Kulkarni,S., Thakar,M. and Paranjape,R.",
KT175202,A1C,2006,26294622,Characterization of Novel HIV-1 Intersubtype CRF01_AE/C and A1/C Recombinants from India,"Pandey,S.S., Thakar,M. and Paranjape,R.",2015
KT175204,01C,1998,26294622,Characterization of Novel HIV-1 Intersubtype CRF01_AE/C and A1/C Recombinants from India,"Pandey,S.S., Thakar,M. and Paranjape,R.",2015
KT175205,A1C,1999,26294622,Characterization of Novel HIV-1 Intersubtype CRF01_AE/C and A1/C Recombinants from India,"Pandey,S.S., Thakar,M. and Paranjape,R.",2015
KT183056,C,2008,27756485,A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial,"Hertz,T., Logan,M.G., Rolland,M., Magaret,C.A., Rademeyer,C., Fiore-Gartland,A., Edlefsen,P.T., DeCamp,A., Ahmed,H., Ngandu,N., Larsen,B.B., Frahm,N., Marais,J., Thebus,R., Geraghty,D., Hural,J., Corey,L., Kublin,J., Gray,G., McElrath,M.J., Mullins,J.I., Gilbert,P.B. and Williamson,C.",2016
KT183068,C,2009,27756485,A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial,"Hertz,T., Logan,M.G., Rolland,M., Magaret,C.A., Rademeyer,C., Fiore-Gartland,A., Edlefsen,P.T., DeCamp,A., Ahmed,H., Ngandu,N., Larsen,B.B., Frahm,N., Marais,J., Thebus,R., Geraghty,D., Hural,J., Corey,L., Kublin,J., Gray,G., McElrath,M.J., Mullins,J.I., Gilbert,P.B. and Williamson,C.",2016
KT183073,BC,2009,27756485,A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial,"Hertz,T., Logan,M.G., Rolland,M., Magaret,C.A., Rademeyer,C., Fiore-Gartland,A., Edlefsen,P.T., DeCamp,A., Ahmed,H., Ngandu,N., Larsen,B.B., Frahm,N., Marais,J., Thebus,R., Geraghty,D., Hural,J., Corey,L., Kublin,J., Gray,G., McElrath,M.J., Mullins,J.I., Gilbert,P.B. and Williamson,C.",2016
KT183084,C,2007,27756485,A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial,"Hertz,T., Logan,M.G., Rolland,M., Magaret,C.A., Rademeyer,C., Fiore-Gartland,A., Edlefsen,P.T., DeCamp,A., Ahmed,H., Ngandu,N., Larsen,B.B., Frahm,N., Marais,J., Thebus,R., Geraghty,D., Hural,J., Corey,L., Kublin,J., Gray,G., McElrath,M.J., Mullins,J.I., Gilbert,P.B. and Williamson,C.",2016
KT183114,C,2009,27756485,A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial,"Hertz,T., Logan,M.G., Rolland,M., Magaret,C.A., Rademeyer,C., Fiore-Gartland,A., Edlefsen,P.T., DeCamp,A., Ahmed,H., Ngandu,N., Larsen,B.B., Frahm,N., Marais,J., Thebus,R., Geraghty,D., Hural,J., Corey,L., Kublin,J., Gray,G., McElrath,M.J., Mullins,J.I., Gilbert,P.B. and Williamson,C.",2016
KT183135,C,2008,27756485,A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial,"Hertz,T., Logan,M.G., Rolland,M., Magaret,C.A., Rademeyer,C., Fiore-Gartland,A., Edlefsen,P.T., DeCamp,A., Ahmed,H., Ngandu,N., Larsen,B.B., Frahm,N., Marais,J., Thebus,R., Geraghty,D., Hural,J., Corey,L., Kublin,J., Gray,G., McElrath,M.J., Mullins,J.I., Gilbert,P.B. and Williamson,C.",2016
KT183150,C,2008,27756485,A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial,"Hertz,T., Logan,M.G., Rolland,M., Magaret,C.A., Rademeyer,C., Fiore-Gartland,A., Edlefsen,P.T., DeCamp,A., Ahmed,H., Ngandu,N., Larsen,B.B., Frahm,N., Marais,J., Thebus,R., Geraghty,D., Hural,J., Corey,L., Kublin,J., Gray,G., McElrath,M.J., Mullins,J.I., Gilbert,P.B. and Williamson,C.",2016
KT183250,C,2008,27756485,A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial,"Hertz,T., Logan,M.G., Rolland,M., Magaret,C.A., Rademeyer,C., Fiore-Gartland,A., Edlefsen,P.T., DeCamp,A., Ahmed,H., Ngandu,N., Larsen,B.B., Frahm,N., Marais,J., Thebus,R., Geraghty,D., Hural,J., Corey,L., Kublin,J., Gray,G., McElrath,M.J., Mullins,J.I., Gilbert,P.B. and Williamson,C.",2016
KT183252,C,2007,27756485,A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial,"Hertz,T., Logan,M.G., Rolland,M., Magaret,C.A., Rademeyer,C., Fiore-Gartland,A., Edlefsen,P.T., DeCamp,A., Ahmed,H., Ngandu,N., Larsen,B.B., Frahm,N., Marais,J., Thebus,R., Geraghty,D., Hural,J., Corey,L., Kublin,J., Gray,G., McElrath,M.J., Mullins,J.I., Gilbert,P.B. and Williamson,C.",2016
KT183271,C,2007,27756485,A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial,"Hertz,T., Logan,M.G., Rolland,M., Magaret,C.A., Rademeyer,C., Fiore-Gartland,A., Edlefsen,P.T., DeCamp,A., Ahmed,H., Ngandu,N., Larsen,B.B., Frahm,N., Marais,J., Thebus,R., Geraghty,D., Hural,J., Corey,L., Kublin,J., Gray,G., McElrath,M.J., Mullins,J.I., Gilbert,P.B. and Williamson,C.",2016
KT183301,C,2003,27756485,A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial,"Hertz,T., Logan,M.G., Rolland,M., Magaret,C.A., Rademeyer,C., Fiore-Gartland,A., Edlefsen,P.T., DeCamp,A., Ahmed,H., Ngandu,N., Larsen,B.B., Frahm,N., Marais,J., Thebus,R., Geraghty,D., Hural,J., Corey,L., Kublin,J., Gray,G., McElrath,M.J., Mullins,J.I., Gilbert,P.B. and Williamson,C.",2016
KT185678,01_AE,2010,,HIV-1 envelope sequences from plasma and cerebrospinal fluids of CRF01_AE acutely infected individuals from Thailand,"Tovanabutra,S., Bose,M., Sanders-Buell,E., Kijak,G., Pham,P., O'Sullivan,A., Ibitamuno,G., Lazzaro,M., Ananworanich,J., Valcour,V., Spudich,S., Robb,M., Michael,N. and Kim,J.",
KT185724,01_AE,2010,,HIV-1 envelope sequences from plasma and cerebrospinal fluids of CRF01_AE acutely infected individuals from Thailand,"Tovanabutra,S., Bose,M., Sanders-Buell,E., Kijak,G., Pham,P., O'Sullivan,A., Ibitamuno,G., Lazzaro,M., Ananworanich,J., Valcour,V., Spudich,S., Robb,M., Michael,N. and Kim,J.",
KT185744,01_AE,2009,,HIV-1 envelope sequences from plasma and cerebrospinal fluids of CRF01_AE acutely infected individuals from Thailand,"Tovanabutra,S., Bose,M., Sanders-Buell,E., Kijak,G., Pham,P., O'Sullivan,A., Ibitamuno,G., Lazzaro,M., Ananworanich,J., Valcour,V., Spudich,S., Robb,M., Michael,N. and Kim,J.",
KT185793,01_AE,2010,,HIV-1 envelope sequences from plasma and cerebrospinal fluids of CRF01_AE acutely infected individuals from Thailand,"Tovanabutra,S., Bose,M., Sanders-Buell,E., Kijak,G., Pham,P., O'Sullivan,A., Ibitamuno,G., Lazzaro,M., Ananworanich,J., Valcour,V., Spudich,S., Robb,M., Michael,N. and Kim,J.",
KT185851,01_AE,2011,,HIV-1 envelope sequences from plasma and cerebrospinal fluids of CRF01_AE acutely infected individuals from Thailand,"Tovanabutra,S., Bose,M., Sanders-Buell,E., Kijak,G., Pham,P., O'Sullivan,A., Ibitamuno,G., Lazzaro,M., Ananworanich,J., Valcour,V., Spudich,S., Robb,M., Michael,N. and Kim,J.",
KT185921,01_AE,2010,,HIV-1 envelope sequences from plasma and cerebrospinal fluids of CRF01_AE acutely infected individuals from Thailand,"Tovanabutra,S., Bose,M., Sanders-Buell,E., Kijak,G., Pham,P., O'Sullivan,A., Ibitamuno,G., Lazzaro,M., Ananworanich,J., Valcour,V., Spudich,S., Robb,M., Michael,N. and Kim,J.",
KT185941,01_AE,2010,,HIV-1 envelope sequences from plasma and cerebrospinal fluids of CRF01_AE acutely infected individuals from Thailand,"Tovanabutra,S., Bose,M., Sanders-Buell,E., Kijak,G., Pham,P., O'Sullivan,A., Ibitamuno,G., Lazzaro,M., Ananworanich,J., Valcour,V., Spudich,S., Robb,M., Michael,N. and Kim,J.",
KT185962,01_AE,2010,,HIV-1 envelope sequences from plasma and cerebrospinal fluids of CRF01_AE acutely infected individuals from Thailand,"Tovanabutra,S., Bose,M., Sanders-Buell,E., Kijak,G., Pham,P., O'Sullivan,A., Ibitamuno,G., Lazzaro,M., Ananworanich,J., Valcour,V., Spudich,S., Robb,M., Michael,N. and Kim,J.",
KT185983,01_AE,2009,,HIV-1 envelope sequences from plasma and cerebrospinal fluids of CRF01_AE acutely infected individuals from Thailand,"Tovanabutra,S., Bose,M., Sanders-Buell,E., Kijak,G., Pham,P., O'Sullivan,A., Ibitamuno,G., Lazzaro,M., Ananworanich,J., Valcour,V., Spudich,S., Robb,M., Michael,N. and Kim,J.",
KT186005,01_AE,2010,,HIV-1 envelope sequences from plasma and cerebrospinal fluids of CRF01_AE acutely infected individuals from Thailand,"Tovanabutra,S., Bose,M., Sanders-Buell,E., Kijak,G., Pham,P., O'Sullivan,A., Ibitamuno,G., Lazzaro,M., Ananworanich,J., Valcour,V., Spudich,S., Robb,M., Michael,N. and Kim,J.",
KT200348,B,2013,26375597,Extremely High Mutation Rate of HIV-1 In Vivo,"Cuevas,J.M., Geller,R., Garijo,R., Lopez-Aldeguer,J. and Sanjuan,R.",2015
KT200349,B,2008,26375597,Extremely High Mutation Rate of HIV-1 In Vivo,"Cuevas,J.M., Geller,R., Garijo,R., Lopez-Aldeguer,J. and Sanjuan,R.",2015
KT200350,B,2006,26375597,Extremely High Mutation Rate of HIV-1 In Vivo,"Cuevas,J.M., Geller,R., Garijo,R., Lopez-Aldeguer,J. and Sanjuan,R.",2015
KT200351,B,2005,26375597,Extremely High Mutation Rate of HIV-1 In Vivo,"Cuevas,J.M., Geller,R., Garijo,R., Lopez-Aldeguer,J. and Sanjuan,R.",2015
KT200352,B,2010,26375597,Extremely High Mutation Rate of HIV-1 In Vivo,"Cuevas,J.M., Geller,R., Garijo,R., Lopez-Aldeguer,J. and Sanjuan,R.",2015
KT200353,B,2010,26375597,Extremely High Mutation Rate of HIV-1 In Vivo,"Cuevas,J.M., Geller,R., Garijo,R., Lopez-Aldeguer,J. and Sanjuan,R.",2015
KT200354,B,2008,26375597,Extremely High Mutation Rate of HIV-1 In Vivo,"Cuevas,J.M., Geller,R., Garijo,R., Lopez-Aldeguer,J. and Sanjuan,R.",2015
KT200355,B,2010,26375597,Extremely High Mutation Rate of HIV-1 In Vivo,"Cuevas,J.M., Geller,R., Garijo,R., Lopez-Aldeguer,J. and Sanjuan,R.",2015
KT200356,B,2010,26375597,Extremely High Mutation Rate of HIV-1 In Vivo,"Cuevas,J.M., Geller,R., Garijo,R., Lopez-Aldeguer,J. and Sanjuan,R.",2015
KT200357,B,2010,26375597,Extremely High Mutation Rate of HIV-1 In Vivo,"Cuevas,J.M., Geller,R., Garijo,R., Lopez-Aldeguer,J. and Sanjuan,R.",2015
KT200358,B,2008,26375597,Extremely High Mutation Rate of HIV-1 In Vivo,"Cuevas,J.M., Geller,R., Garijo,R., Lopez-Aldeguer,J. and Sanjuan,R.",2015
KT223503,B,2015,,Reactivation of VOA-inducible and VOA-noninducible intact HIV-1 proviruses in immune-compromised mice engrafted with human resting CD4+ T cells,"Yuan,Z., Ho,Y.-C., Kang,G., Lu,W., Siliciano,R.F. and Li,Q.",
KT252544,A1,2008,26588781,Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design,"Andrabi,R., Voss,J.E., Liang,C.H., Briney,B., McCoy,L.E., Wu,C.Y., Wong,C.H., Poignard,P. and Burton,D.R.",2015
KT252545,C,2007,26588781,Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design,"Andrabi,R., Voss,J.E., Liang,C.H., Briney,B., McCoy,L.E., Wu,C.Y., Wong,C.H., Poignard,P. and Burton,D.R.",2015
KT276254,02B,2013,,Direct Submission,"Cuevas,M.T., Delgado,E., Sanchez-Martinez,M., Thomson,M., Carrera,C., Montero,V. and Perez-Alvarez,L.",2015
KT276255,B,2014,,Direct Submission,"Cuevas,M.T., Delgado,E., Sanchez-Martinez,M., Thomson,M., Carrera,C., Montero,V. and Perez-Alvarez,L.",2015
KT276256,B,2014,,Direct Submission,"Cuevas,M.T., Delgado,E., Sanchez-Martinez,M., Thomson,M., Carrera,C., Montero,V. and Perez-Alvarez,L.",2015
KT276257,F1,2014,,Direct Submission,"Cuevas,M.T., Delgado,E., Sanchez-Martinez,M., Thomson,M., Carrera,C., Montero,V. and Perez-Alvarez,L.",2015
KT276258,C,2014,,Direct Submission,"Cuevas,M.T., Delgado,E., Sanchez-Martinez,M., Thomson,M., Carrera,C., Montero,V. and Perez-Alvarez,L.",2015
KT276259,BF1,2014,,Direct Submission,"Cuevas,M.T., Delgado,E., Sanchez-Martinez,M., Thomson,M., Carrera,C., Montero,V. and Perez-Alvarez,L.",2015
KT276260,F1,2014,,Direct Submission,"Cuevas,M.T., Delgado,E., Sanchez-Martinez,M., Thomson,M., Carrera,C., Montero,V. and Perez-Alvarez,L.",2015
KT276261,G,2014,,Direct Submission,"Cuevas,M.T., Delgado,E., Sanchez-Martinez,M., Thomson,M., Carrera,C., Montero,V. and Perez-Alvarez,L.",2015
KT276262,B,2014,,Direct Submission,"Cuevas,M.T., Delgado,E., Sanchez-Martinez,M., Thomson,M., Carrera,C., Montero,V. and Perez-Alvarez,L.",2015
KT276263,B,2014,,Direct Submission,"Cuevas,M.T., Delgado,E., Sanchez-Martinez,M., Thomson,M., Carrera,C., Montero,V. and Perez-Alvarez,L.",2015
KT276264,B,2014,,Direct Submission,"Cuevas,M.T., Delgado,E., Sanchez-Martinez,M., Thomson,M., Carrera,C., Montero,V. and Perez-Alvarez,L.",2015
KT276265,02A,2014,,Direct Submission,"Cuevas,M.T., Delgado,E., Sanchez-Martinez,M., Thomson,M., Carrera,C., Montero,V. and Perez-Alvarez,L.",2015
KT276266,B,2014,,Direct Submission,"Cuevas,M.T., Delgado,E., Sanchez-Martinez,M., Thomson,M., Carrera,C., Montero,V. and Perez-Alvarez,L.",2015
KT276267,B,2014,,Direct Submission,"Cuevas,M.T., Delgado,E., Sanchez-Martinez,M., Thomson,M., Carrera,C., Montero,V. and Perez-Alvarez,L.",2015
KT276268,B,2014,,Direct Submission,"Cuevas,M.T., Delgado,E., Sanchez-Martinez,M., Thomson,M., Carrera,C., Montero,V. and Perez-Alvarez,L.",2015
KT276269,BF1,2014,,Direct Submission,"Cuevas,M.T., Delgado,E., Sanchez-Martinez,M., Thomson,M., Carrera,C., Montero,V. and Perez-Alvarez,L.",2015
KT276270,20_BG,2014,,Direct Submission,"Cuevas,M.T., Delgado,E., Sanchez-Martinez,M., Thomson,M., Carrera,C., Montero,V. and Perez-Alvarez,L.",2015
KT276271,BF1,2014,,Direct Submission,"Cuevas,M.T., Delgado,E., Sanchez-Martinez,M., Thomson,M., Carrera,C., Montero,V. and Perez-Alvarez,L.",2015
KT284371,B,2013,,Reconstruction of Residual HIV-1 from Plasma Viral RNA of a Patient on Suppressive Antiretroviral Therapy Identifies a Novel Mutation in the Viral 5'-Major Splice Donor Motif: Implication for Residual HIV-1 Persistence in vivo,"Rassler,S., Khoury,N., Skowron,G. and Sahu,G.K.",
KT321211,01C,2014,26847649,"Identification and characterization of two human immunodeficiency virus type 1 unique recombinant forms from Yunnan, China","Li,J., Li,L., Yang,S., Li,J., Zhang,M., Yang,C., Liu,J. and Li,H.",2016
KT372798,0107,2008,26892740,Characterization of the Near Full-Length Genome of a Novel HIV-1 CRF01_AE/CRF07_BC Recombinant in an Injection Drug User from Southern Taiwan,"Lee,N.Y., Wang,J.C., Lin,Y.C., Wu,C.J., Wang,S.W., Li,C.W., Li,M.C., Tseng,F.C. and Ko,W.C.",2016
KT427677,C,2010,27031505,Ultra-Deep Sequencing of HIV-1 near Full-Length and Partial Proviral Genomes Reveals High Genetic Diversity among Brazilian Blood Donors,"Pessoa,R., Loureiro,P., Esther Lopes,M., Carneiro-Proietti,A.B., Sabino,E.C., Busch,M.P. and Sanabani,S.S.",2016
KT427752,C,2010,27031505,Ultra-Deep Sequencing of HIV-1 near Full-Length and Partial Proviral Genomes Reveals High Genetic Diversity among Brazilian Blood Donors,"Pessoa,R., Loureiro,P., Esther Lopes,M., Carneiro-Proietti,A.B., Sabino,E.C., Busch,M.P. and Sanabani,S.S.",2016
KT427814,F1,2010,27031505,Ultra-Deep Sequencing of HIV-1 near Full-Length and Partial Proviral Genomes Reveals High Genetic Diversity among Brazilian Blood Donors,"Pessoa,R., Loureiro,P., Esther Lopes,M., Carneiro-Proietti,A.B., Sabino,E.C., Busch,M.P. and Sanabani,S.S.",2016
KT427817,C,2010,27031505,Ultra-Deep Sequencing of HIV-1 near Full-Length and Partial Proviral Genomes Reveals High Genetic Diversity among Brazilian Blood Donors,"Pessoa,R., Loureiro,P., Esther Lopes,M., Carneiro-Proietti,A.B., Sabino,E.C., Busch,M.P. and Sanabani,S.S.",2016
KT438782,01B,2008,26543107,Genome Sequence of Complex HIV-1 Unique Recombinant Forms Sharing a Common Recombination Breakpoint Identified in Malaysia,"Cheong,H.T., Ng,K.T., Ong,L.Y., Takebe,Y., Chan,K.G., Koh,C., Al-Darraji,H.A., Kamarulzaman,A. and Tee,K.K.",2015
KT438783,01B,2010,26543107,Genome Sequence of Complex HIV-1 Unique Recombinant Forms Sharing a Common Recombination Breakpoint Identified in Malaysia,"Cheong,H.T., Ng,K.T., Ong,L.Y., Takebe,Y., Chan,K.G., Koh,C., Al-Darraji,H.A., Kamarulzaman,A. and Tee,K.K.",2015
KT438784,01B,2010,26543107,Genome Sequence of Complex HIV-1 Unique Recombinant Forms Sharing a Common Recombination Breakpoint Identified in Malaysia,"Cheong,H.T., Ng,K.T., Ong,L.Y., Takebe,Y., Chan,K.G., Koh,C., Al-Darraji,H.A., Kamarulzaman,A. and Tee,K.K.",2015
KT452084,B,,26339063,Characterizing the Diverse Mutational Pathways Associated with R5-Tropic Maraviroc Resistance: HIV-1 That Uses the Drug-Bound CCR5 Coreceptor,"Jiang,X., Feyertag,F., Meehan,C.J., McCormack,G.P., Travers,S.A., Craig,C., Westby,M., Lewis,M. and Robertson,D.L.",2015
KT452108,B,,26339063,Characterizing the Diverse Mutational Pathways Associated with R5-Tropic Maraviroc Resistance: HIV-1 That Uses the Drug-Bound CCR5 Coreceptor,"Jiang,X., Feyertag,F., Meehan,C.J., McCormack,G.P., Travers,S.A., Craig,C., Westby,M., Lewis,M. and Robertson,D.L.",2015
KT452143,B,,26339063,Characterizing the Diverse Mutational Pathways Associated with R5-Tropic Maraviroc Resistance: HIV-1 That Uses the Drug-Bound CCR5 Coreceptor,"Jiang,X., Feyertag,F., Meehan,C.J., McCormack,G.P., Travers,S.A., Craig,C., Westby,M., Lewis,M. and Robertson,D.L.",2015
KT452191,B,,26339063,Characterizing the Diverse Mutational Pathways Associated with R5-Tropic Maraviroc Resistance: HIV-1 That Uses the Drug-Bound CCR5 Coreceptor,"Jiang,X., Feyertag,F., Meehan,C.J., McCormack,G.P., Travers,S.A., Craig,C., Westby,M., Lewis,M. and Robertson,D.L.",2015
KT452215,B,,26339063,Characterizing the Diverse Mutational Pathways Associated with R5-Tropic Maraviroc Resistance: HIV-1 That Uses the Drug-Bound CCR5 Coreceptor,"Jiang,X., Feyertag,F., Meehan,C.J., McCormack,G.P., Travers,S.A., Craig,C., Westby,M., Lewis,M. and Robertson,D.L.",2015
KT452239,B,,26339063,Characterizing the Diverse Mutational Pathways Associated with R5-Tropic Maraviroc Resistance: HIV-1 That Uses the Drug-Bound CCR5 Coreceptor,"Jiang,X., Feyertag,F., Meehan,C.J., McCormack,G.P., Travers,S.A., Craig,C., Westby,M., Lewis,M. and Robertson,D.L.",2015
KT452263,B,,26339063,Characterizing the Diverse Mutational Pathways Associated with R5-Tropic Maraviroc Resistance: HIV-1 That Uses the Drug-Bound CCR5 Coreceptor,"Jiang,X., Feyertag,F., Meehan,C.J., McCormack,G.P., Travers,S.A., Craig,C., Westby,M., Lewis,M. and Robertson,D.L.",2015
KT452311,B,,26339063,Characterizing the Diverse Mutational Pathways Associated with R5-Tropic Maraviroc Resistance: HIV-1 That Uses the Drug-Bound CCR5 Coreceptor,"Jiang,X., Feyertag,F., Meehan,C.J., McCormack,G.P., Travers,S.A., Craig,C., Westby,M., Lewis,M. and Robertson,D.L.",2015
KT452335,B,,26339063,Characterizing the Diverse Mutational Pathways Associated with R5-Tropic Maraviroc Resistance: HIV-1 That Uses the Drug-Bound CCR5 Coreceptor,"Jiang,X., Feyertag,F., Meehan,C.J., McCormack,G.P., Travers,S.A., Craig,C., Westby,M., Lewis,M. and Robertson,D.L.",2015
KT452359,B,,26339063,Characterizing the Diverse Mutational Pathways Associated with R5-Tropic Maraviroc Resistance: HIV-1 That Uses the Drug-Bound CCR5 Coreceptor,"Jiang,X., Feyertag,F., Meehan,C.J., McCormack,G.P., Travers,S.A., Craig,C., Westby,M., Lewis,M. and Robertson,D.L.",2015
KT452383,B,,26339063,Characterizing the Diverse Mutational Pathways Associated with R5-Tropic Maraviroc Resistance: HIV-1 That Uses the Drug-Bound CCR5 Coreceptor,"Jiang,X., Feyertag,F., Meehan,C.J., McCormack,G.P., Travers,S.A., Craig,C., Westby,M., Lewis,M. and Robertson,D.L.",2015
KT452407,B,,26339063,Characterizing the Diverse Mutational Pathways Associated with R5-Tropic Maraviroc Resistance: HIV-1 That Uses the Drug-Bound CCR5 Coreceptor,"Jiang,X., Feyertag,F., Meehan,C.J., McCormack,G.P., Travers,S.A., Craig,C., Westby,M., Lewis,M. and Robertson,D.L.",2015
KT452431,B,,26339063,Characterizing the Diverse Mutational Pathways Associated with R5-Tropic Maraviroc Resistance: HIV-1 That Uses the Drug-Bound CCR5 Coreceptor,"Jiang,X., Feyertag,F., Meehan,C.J., McCormack,G.P., Travers,S.A., Craig,C., Westby,M., Lewis,M. and Robertson,D.L.",2015
KT452455,B,,26339063,Characterizing the Diverse Mutational Pathways Associated with R5-Tropic Maraviroc Resistance: HIV-1 That Uses the Drug-Bound CCR5 Coreceptor,"Jiang,X., Feyertag,F., Meehan,C.J., McCormack,G.P., Travers,S.A., Craig,C., Westby,M., Lewis,M. and Robertson,D.L.",2015
KT452479,B,,26339063,Characterizing the Diverse Mutational Pathways Associated with R5-Tropic Maraviroc Resistance: HIV-1 That Uses the Drug-Bound CCR5 Coreceptor,"Jiang,X., Feyertag,F., Meehan,C.J., McCormack,G.P., Travers,S.A., Craig,C., Westby,M., Lewis,M. and Robertson,D.L.",2015
KT452503,B,,26339063,Characterizing the Diverse Mutational Pathways Associated with R5-Tropic Maraviroc Resistance: HIV-1 That Uses the Drug-Bound CCR5 Coreceptor,"Jiang,X., Feyertag,F., Meehan,C.J., McCormack,G.P., Travers,S.A., Craig,C., Westby,M., Lewis,M. and Robertson,D.L.",2015
KT452527,B,,26339063,Characterizing the Diverse Mutational Pathways Associated with R5-Tropic Maraviroc Resistance: HIV-1 That Uses the Drug-Bound CCR5 Coreceptor,"Jiang,X., Feyertag,F., Meehan,C.J., McCormack,G.P., Travers,S.A., Craig,C., Westby,M., Lewis,M. and Robertson,D.L.",2015
KT452563,B,,26339063,Characterizing the Diverse Mutational Pathways Associated with R5-Tropic Maraviroc Resistance: HIV-1 That Uses the Drug-Bound CCR5 Coreceptor,"Jiang,X., Feyertag,F., Meehan,C.J., McCormack,G.P., Travers,S.A., Craig,C., Westby,M., Lewis,M. and Robertson,D.L.",2015
KT452599,B,,26339063,Characterizing the Diverse Mutational Pathways Associated with R5-Tropic Maraviroc Resistance: HIV-1 That Uses the Drug-Bound CCR5 Coreceptor,"Jiang,X., Feyertag,F., Meehan,C.J., McCormack,G.P., Travers,S.A., Craig,C., Westby,M., Lewis,M. and Robertson,D.L.",2015
KT592380,0107,2014,26943897,"Identification of a Novel CRF01_AE/CRF07_BC Recombinant Form in Men Who Have Sex with Men in Sichuan, China","Wang,Y., Wei,H., Xu,W., Yin,Q., Feng,Y., Liang,S., Shao,Y. and Ma,L.",2016
KT619126,0107,2014,26892263,"Near Full-Length Genomic Characterization of a Novel HIV type 1 CRF01_AE/CRF07_BC Recombinant form Transmitted between a Heterosexual Couple in Guangxi, China","Dong,Z., Shen,Z., Xiong,R., Liang,F., Liang,S., Li,J., Tan,G., Jiang,H., Yang,X., Li,F., Liao,L., Shao,Y., Feng,Y. and Zhu,Q.",2016
KT808396,B,,26842476,Development of broadly neutralizing antibodies and their mapping by monomeric gp120 in HIV-1 infected humans and SHIVSF162P3N infected macaques,"Jia,M., Lu,H., Markowitz,M., Cheng-Mayer,C. and Wu,X.",2016
KT878021,B,2009,26997611,Functional characteristics of the natural polymorphisms of HIV-1 gp41 in HIV-1 isolates from enfuvirtide-naive Korean patients,"Shin,Y., Yoon,C.H., Yang,H.J., Lim,H., Choi,B.S., Kim,S.S. and Kang,C.",2016
KT878022,B,2009,26997611,Functional characteristics of the natural polymorphisms of HIV-1 gp41 in HIV-1 isolates from enfuvirtide-naive Korean patients,"Shin,Y., Yoon,C.H., Yang,H.J., Lim,H., Choi,B.S., Kim,S.S. and Kang,C.",2016
KT878023,B,2009,26997611,Functional characteristics of the natural polymorphisms of HIV-1 gp41 in HIV-1 isolates from enfuvirtide-naive Korean patients,"Shin,Y., Yoon,C.H., Yang,H.J., Lim,H., Choi,B.S., Kim,S.S. and Kang,C.",2016
KT878024,B,2009,26997611,Functional characteristics of the natural polymorphisms of HIV-1 gp41 in HIV-1 isolates from enfuvirtide-naive Korean patients,"Shin,Y., Yoon,C.H., Yang,H.J., Lim,H., Choi,B.S., Kim,S.S. and Kang,C.",2016
KT878025,B,2009,26997611,Functional characteristics of the natural polymorphisms of HIV-1 gp41 in HIV-1 isolates from enfuvirtide-naive Korean patients,"Shin,Y., Yoon,C.H., Yang,H.J., Lim,H., Choi,B.S., Kim,S.S. and Kang,C.",2016
KT878026,B,2009,26997611,Functional characteristics of the natural polymorphisms of HIV-1 gp41 in HIV-1 isolates from enfuvirtide-naive Korean patients,"Shin,Y., Yoon,C.H., Yang,H.J., Lim,H., Choi,B.S., Kim,S.S. and Kang,C.",2016
KT878027,B,2009,26997611,Functional characteristics of the natural polymorphisms of HIV-1 gp41 in HIV-1 isolates from enfuvirtide-naive Korean patients,"Shin,Y., Yoon,C.H., Yang,H.J., Lim,H., Choi,B.S., Kim,S.S. and Kang,C.",2016
KT878028,B,2009,26997611,Functional characteristics of the natural polymorphisms of HIV-1 gp41 in HIV-1 isolates from enfuvirtide-naive Korean patients,"Shin,Y., Yoon,C.H., Yang,H.J., Lim,H., Choi,B.S., Kim,S.S. and Kang,C.",2016
KT878029,B,2009,26997611,Functional characteristics of the natural polymorphisms of HIV-1 gp41 in HIV-1 isolates from enfuvirtide-naive Korean patients,"Shin,Y., Yoon,C.H., Yang,H.J., Lim,H., Choi,B.S., Kim,S.S. and Kang,C.",2016
KT878030,B,2009,26997611,Functional characteristics of the natural polymorphisms of HIV-1 gp41 in HIV-1 isolates from enfuvirtide-naive Korean patients,"Shin,Y., Yoon,C.H., Yang,H.J., Lim,H., Choi,B.S., Kim,S.S. and Kang,C.",2016
KT878031,B,2009,26997611,Functional characteristics of the natural polymorphisms of HIV-1 gp41 in HIV-1 isolates from enfuvirtide-naive Korean patients,"Shin,Y., Yoon,C.H., Yang,H.J., Lim,H., Choi,B.S., Kim,S.S. and Kang,C.",2016
KT878032,B,2009,26997611,Functional characteristics of the natural polymorphisms of HIV-1 gp41 in HIV-1 isolates from enfuvirtide-naive Korean patients,"Shin,Y., Yoon,C.H., Yang,H.J., Lim,H., Choi,B.S., Kim,S.S. and Kang,C.",2016
KT878033,B,2009,26997611,Functional characteristics of the natural polymorphisms of HIV-1 gp41 in HIV-1 isolates from enfuvirtide-naive Korean patients,"Shin,Y., Yoon,C.H., Yang,H.J., Lim,H., Choi,B.S., Kim,S.S. and Kang,C.",2016
KT878034,B,2009,26997611,Functional characteristics of the natural polymorphisms of HIV-1 gp41 in HIV-1 isolates from enfuvirtide-naive Korean patients,"Shin,Y., Yoon,C.H., Yang,H.J., Lim,H., Choi,B.S., Kim,S.S. and Kang,C.",2016
KT878035,B,2009,26997611,Functional characteristics of the natural polymorphisms of HIV-1 gp41 in HIV-1 isolates from enfuvirtide-naive Korean patients,"Shin,Y., Yoon,C.H., Yang,H.J., Lim,H., Choi,B.S., Kim,S.S. and Kang,C.",2016
KT878036,B,2009,26997611,Functional characteristics of the natural polymorphisms of HIV-1 gp41 in HIV-1 isolates from enfuvirtide-naive Korean patients,"Shin,Y., Yoon,C.H., Yang,H.J., Lim,H., Choi,B.S., Kim,S.S. and Kang,C.",2016
KT878037,B,2009,26997611,Functional characteristics of the natural polymorphisms of HIV-1 gp41 in HIV-1 isolates from enfuvirtide-naive Korean patients,"Shin,Y., Yoon,C.H., Yang,H.J., Lim,H., Choi,B.S., Kim,S.S. and Kang,C.",2016
KT878038,B,2009,26997611,Functional characteristics of the natural polymorphisms of HIV-1 gp41 in HIV-1 isolates from enfuvirtide-naive Korean patients,"Shin,Y., Yoon,C.H., Yang,H.J., Lim,H., Choi,B.S., Kim,S.S. and Kang,C.",2016
KT878039,B,2009,26997611,Functional characteristics of the natural polymorphisms of HIV-1 gp41 in HIV-1 isolates from enfuvirtide-naive Korean patients,"Shin,Y., Yoon,C.H., Yang,H.J., Lim,H., Choi,B.S., Kim,S.S. and Kang,C.",2016
KT878040,B,2009,26997611,Functional characteristics of the natural polymorphisms of HIV-1 gp41 in HIV-1 isolates from enfuvirtide-naive Korean patients,"Shin,Y., Yoon,C.H., Yang,H.J., Lim,H., Choi,B.S., Kim,S.S. and Kang,C.",2016
KT896551,C,2011,,Treatment as Prevention: Characterization of partner infections in the HIV Prevention Trials Network 052 trial,"Eshleman,S.H., Hudelson,S.E., Redd,A.D., Swanstrom,R., Ou,S.-S., Zhang,C., Ping,L.-H., Piwowar-Manning,E., Porcella,S.F., Sievers,M., Martens,C.A., Bruno,D., Dukhovlinova,E., McCauley,M., Gamble,T., Sabin,D., Quinn,T.C., Gunde,L., Maliwichi,M., Nhando,N., Akelo,V., Moyo,S., Panchia,R., Kumarasamy,N., Chotirosniramit,N., Rocha,M.M., Grinsztejn,B., Mayer,K., Chen,Y.Q., Hughes,J.P. and Cohen,M.S.",
KT896565,C,2011,,Treatment as Prevention: Characterization of partner infections in the HIV Prevention Trials Network 052 trial,"Eshleman,S.H., Hudelson,S.E., Redd,A.D., Swanstrom,R., Ou,S.-S., Zhang,C., Ping,L.-H., Piwowar-Manning,E., Porcella,S.F., Sievers,M., Martens,C.A., Bruno,D., Dukhovlinova,E., McCauley,M., Gamble,T., Sabin,D., Quinn,T.C., Gunde,L., Maliwichi,M., Nhando,N., Akelo,V., Moyo,S., Panchia,R., Kumarasamy,N., Chotirosniramit,N., Rocha,M.M., Grinsztejn,B., Mayer,K., Chen,Y.Q., Hughes,J.P. and Cohen,M.S.",
KT960983,BC,2014,26847649,"Identification and characterization of two human immunodeficiency virus type 1 unique recombinant forms from Yunnan, China","Li,J., Li,L., Yang,S., Li,J., Zhang,M., Yang,C., Liu,J. and Li,H.",2016
KT961002,B,,26525792,Incompatible natures of HIV-1 envelope in resistance to the CCR5 antagonist cenicriviroc and neutralizing antibodies,"Kuwata,T., Enomoto,I., Baba,M. and Matsushita,S.",2015
KT982201,C,2014,28178277,"Paucity of Intact Non-Induced Provirus with Early, Long-Term Antiretroviral Therapy of Perinatal HIV Infection","Rainwater-Lovett,K., Ziemniak,C., Watson,D., Luzuriaga,K., Siberry,G., Petru,A., Chen,Y., Uprety,P., McManus,M., Ho,Y.C., Lamers,S.L. and Persaud,D.",2017
KT983615,A6,2013,,Direct Submission,"Sasinovich,S., Eremin,V., Gasich,E. and Thomson,M.",2015
KT986553,B,2014,26702094,Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection,"Lynch,R.M., Boritz,E., Coates,E.E., DeZure,A., Madden,P., Costner,P., Enama,M.E., Plummer,S., Holman,L., Hendel,C.S., Gordon,I., Casazza,J., Conan-Cibotti,M., Migueles,S.A., Tressler,R., Bailer,R.T., McDermott,A., Narpala,S., O'Dell,S., Wolf,G., Lifson,J.D., Freemire,B.A., Gorelick,R.J., Pandey,J.P., Mohan,S., Chomont,N., Fromentin,R., Chun,T.W., Fauci,A.S., Schwartz,R.M., Koup,R.A., Douek,D.C., Hu,Z., Capparelli,E., Graham,B.S., Mascola,J.R. and Ledgerwood,J.E.",2015
KT986652,B,2014,26702094,Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection,"Lynch,R.M., Boritz,E., Coates,E.E., DeZure,A., Madden,P., Costner,P., Enama,M.E., Plummer,S., Holman,L., Hendel,C.S., Gordon,I., Casazza,J., Conan-Cibotti,M., Migueles,S.A., Tressler,R., Bailer,R.T., McDermott,A., Narpala,S., O'Dell,S., Wolf,G., Lifson,J.D., Freemire,B.A., Gorelick,R.J., Pandey,J.P., Mohan,S., Chomont,N., Fromentin,R., Chun,T.W., Fauci,A.S., Schwartz,R.M., Koup,R.A., Douek,D.C., Hu,Z., Capparelli,E., Graham,B.S., Mascola,J.R. and Ledgerwood,J.E.",2015
KT986688,B,2014,26702094,Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection,"Lynch,R.M., Boritz,E., Coates,E.E., DeZure,A., Madden,P., Costner,P., Enama,M.E., Plummer,S., Holman,L., Hendel,C.S., Gordon,I., Casazza,J., Conan-Cibotti,M., Migueles,S.A., Tressler,R., Bailer,R.T., McDermott,A., Narpala,S., O'Dell,S., Wolf,G., Lifson,J.D., Freemire,B.A., Gorelick,R.J., Pandey,J.P., Mohan,S., Chomont,N., Fromentin,R., Chun,T.W., Fauci,A.S., Schwartz,R.M., Koup,R.A., Douek,D.C., Hu,Z., Capparelli,E., Graham,B.S., Mascola,J.R. and Ledgerwood,J.E.",2015
KT986762,B,2014,26702094,Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection,"Lynch,R.M., Boritz,E., Coates,E.E., DeZure,A., Madden,P., Costner,P., Enama,M.E., Plummer,S., Holman,L., Hendel,C.S., Gordon,I., Casazza,J., Conan-Cibotti,M., Migueles,S.A., Tressler,R., Bailer,R.T., McDermott,A., Narpala,S., O'Dell,S., Wolf,G., Lifson,J.D., Freemire,B.A., Gorelick,R.J., Pandey,J.P., Mohan,S., Chomont,N., Fromentin,R., Chun,T.W., Fauci,A.S., Schwartz,R.M., Koup,R.A., Douek,D.C., Hu,Z., Capparelli,E., Graham,B.S., Mascola,J.R. and Ledgerwood,J.E.",2015
KT986845,B,2015,26702094,Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection,"Lynch,R.M., Boritz,E., Coates,E.E., DeZure,A., Madden,P., Costner,P., Enama,M.E., Plummer,S., Holman,L., Hendel,C.S., Gordon,I., Casazza,J., Conan-Cibotti,M., Migueles,S.A., Tressler,R., Bailer,R.T., McDermott,A., Narpala,S., O'Dell,S., Wolf,G., Lifson,J.D., Freemire,B.A., Gorelick,R.J., Pandey,J.P., Mohan,S., Chomont,N., Fromentin,R., Chun,T.W., Fauci,A.S., Schwartz,R.M., Koup,R.A., Douek,D.C., Hu,Z., Capparelli,E., Graham,B.S., Mascola,J.R. and Ledgerwood,J.E.",2015
KT986933,B,2015,26702094,Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection,"Lynch,R.M., Boritz,E., Coates,E.E., DeZure,A., Madden,P., Costner,P., Enama,M.E., Plummer,S., Holman,L., Hendel,C.S., Gordon,I., Casazza,J., Conan-Cibotti,M., Migueles,S.A., Tressler,R., Bailer,R.T., McDermott,A., Narpala,S., O'Dell,S., Wolf,G., Lifson,J.D., Freemire,B.A., Gorelick,R.J., Pandey,J.P., Mohan,S., Chomont,N., Fromentin,R., Chun,T.W., Fauci,A.S., Schwartz,R.M., Koup,R.A., Douek,D.C., Hu,Z., Capparelli,E., Graham,B.S., Mascola,J.R. and Ledgerwood,J.E.",2015
KT987011,B,2015,26702094,Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection,"Lynch,R.M., Boritz,E., Coates,E.E., DeZure,A., Madden,P., Costner,P., Enama,M.E., Plummer,S., Holman,L., Hendel,C.S., Gordon,I., Casazza,J., Conan-Cibotti,M., Migueles,S.A., Tressler,R., Bailer,R.T., McDermott,A., Narpala,S., O'Dell,S., Wolf,G., Lifson,J.D., Freemire,B.A., Gorelick,R.J., Pandey,J.P., Mohan,S., Chomont,N., Fromentin,R., Chun,T.W., Fauci,A.S., Schwartz,R.M., Koup,R.A., Douek,D.C., Hu,Z., Capparelli,E., Graham,B.S., Mascola,J.R. and Ledgerwood,J.E.",2015
KT999999,01B,2014,,Direct Submission,"Li,J., Li,L., Li,H., Li,J. and Yang,S.",2015
KU051564,0107,2010,27018546,A Novel HIV-1 Second-Generation Recombinant Form (CRF01_AE/CRF07_BC) among heterosexuals in Nei Monggoi Autonomous Region in China,"An,M., Han,X., Zhao,B., Xu,J., Chu,Z. and Shang,H.",2016
KU161143,78_cpx,2013,26885715,"Near-full-length genome identification of a novel HIV-1 circulating recombinant form, CRF01_AE/B'/C (CRF78_cpx) in Yunnan, China","Song,Y., Feng,Y., Miao,Z., Wang,B., Yang,M., Zhang,A.M., Liu,L. and Xia,X.",2016
KU161144,78_cpx,2013,26885715,"Near-full-length genome identification of a novel HIV-1 circulating recombinant form, CRF01_AE/B'/C (CRF78_cpx) in Yunnan, China","Song,Y., Feng,Y., Miao,Z., Wang,B., Yang,M., Zhang,A.M., Liu,L. and Xia,X.",2016
KU161145,78_cpx,2013,26885715,"Near-full-length genome identification of a novel HIV-1 circulating recombinant form, CRF01_AE/B'/C (CRF78_cpx) in Yunnan, China","Song,Y., Feng,Y., Miao,Z., Wang,B., Yang,M., Zhang,A.M., Liu,L. and Xia,X.",2016
KU168256,A1,2002,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168257,B,2000,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168258,B,2002,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168259,B,2002,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168260,B,2003,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168261,B,2003,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168262,C,2003,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168263,C,2004,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168264,01_AE,2001,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168265,02_AG,2000,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168266,02_AG,2000,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168267,02_AG,2000,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168268,0206,,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168269,06_cpx,,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168270,11_cpx,2003,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168271,D,2003,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168272,D,2002,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168273,H,2004,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168274,F1,2003,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168275,F1,2003,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168276,F1,2004,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168277,G,2003,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168278,G,2003,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168279,H,2002,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168280,J,2003,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168281,O,,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168282,O,,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168283,O,,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168284,O,,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168285,O,,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168286,O,,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168288,O,,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168289,O,,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168290,O,,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168291,O,,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168292,O,,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168293,O,,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168294,O,,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168295,O,,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168296,O,,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168297,O,,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168298,O,,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168299,0206,2012,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168300,G,2008,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168301,0206,2013,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168302,G,2003,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168303,02D,2003,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168304,02A1,2003,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168305,A1,2003,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168306,A1G,2003,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU168308,C,1999,26699702,A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING,"Berg,M.G., Yamaguchi,J., Alessandri-Gradt,E., Tell,R.W., Plantier,J.C. and Brennan,C.A.",2015
KU200869,C,,27192579,Early Antibody Lineage Diversification and Independent Limb Maturation Lead to Broad HIV-1 Neutralization Targeting the Env High-Mannose Patch,"MacLeod,D.T., Choi,N.M., Briney,B., Garces,F., Ver,L.S., Landais,E., Murrell,B., Wrin,T., Kilembe,W., Liang,C.H., Ramos,A., Bian,C.B., Wickramasinghe,L., Kong,L., Eren,K., Wu,C.Y., Wong,C.H., Kosakovsky Pond,S.L., Wilson,I.A., Burton,D.R. and Poignard,P.",2016
KU230417,01_AE,2009,26849216,Production of Mucosally Transmissible SHIV Challenge Stocks from HIV-1 Circulating Recombinant Form 01_AE env Sequences,"Tartaglia,L.J., Chang,H.W., Lee,B.C., Abbink,P., Ng'ang'a,D., Boyd,M., Lavine,C.L., Lim,S.Y., Sanisetty,S., Whitney,J.B., Seaman,M.S., Rolland,M., Tovanabutra,S., Ananworanich,J., Robb,M.L., Kim,J.H., Michael,N.L. and Barouch,D.H.",2016
KU230418,01_AE,2010,26849216,Production of Mucosally Transmissible SHIV Challenge Stocks from HIV-1 Circulating Recombinant Form 01_AE env Sequences,"Tartaglia,L.J., Chang,H.W., Lee,B.C., Abbink,P., Ng'ang'a,D., Boyd,M., Lavine,C.L., Lim,S.Y., Sanisetty,S., Whitney,J.B., Seaman,M.S., Rolland,M., Tovanabutra,S., Ananworanich,J., Robb,M.L., Kim,J.H., Michael,N.L. and Barouch,D.H.",2016
KU230419,01_AE,2010,26849216,Production of Mucosally Transmissible SHIV Challenge Stocks from HIV-1 Circulating Recombinant Form 01_AE env Sequences,"Tartaglia,L.J., Chang,H.W., Lee,B.C., Abbink,P., Ng'ang'a,D., Boyd,M., Lavine,C.L., Lim,S.Y., Sanisetty,S., Whitney,J.B., Seaman,M.S., Rolland,M., Tovanabutra,S., Ananworanich,J., Robb,M.L., Kim,J.H., Michael,N.L. and Barouch,D.H.",2016
KU230420,01_AE,2010,26849216,Production of Mucosally Transmissible SHIV Challenge Stocks from HIV-1 Circulating Recombinant Form 01_AE env Sequences,"Tartaglia,L.J., Chang,H.W., Lee,B.C., Abbink,P., Ng'ang'a,D., Boyd,M., Lavine,C.L., Lim,S.Y., Sanisetty,S., Whitney,J.B., Seaman,M.S., Rolland,M., Tovanabutra,S., Ananworanich,J., Robb,M.L., Kim,J.H., Michael,N.L. and Barouch,D.H.",2016
KU230421,01_AE,2011,26849216,Production of Mucosally Transmissible SHIV Challenge Stocks from HIV-1 Circulating Recombinant Form 01_AE env Sequences,"Tartaglia,L.J., Chang,H.W., Lee,B.C., Abbink,P., Ng'ang'a,D., Boyd,M., Lavine,C.L., Lim,S.Y., Sanisetty,S., Whitney,J.B., Seaman,M.S., Rolland,M., Tovanabutra,S., Ananworanich,J., Robb,M.L., Kim,J.H., Michael,N.L. and Barouch,D.H.",2016
KU230422,01_AE,2010,26849216,Production of Mucosally Transmissible SHIV Challenge Stocks from HIV-1 Circulating Recombinant Form 01_AE env Sequences,"Tartaglia,L.J., Chang,H.W., Lee,B.C., Abbink,P., Ng'ang'a,D., Boyd,M., Lavine,C.L., Lim,S.Y., Sanisetty,S., Whitney,J.B., Seaman,M.S., Rolland,M., Tovanabutra,S., Ananworanich,J., Robb,M.L., Kim,J.H., Michael,N.L. and Barouch,D.H.",2016
KU230423,B,2010,26849216,Production of Mucosally Transmissible SHIV Challenge Stocks from HIV-1 Circulating Recombinant Form 01_AE env Sequences,"Tartaglia,L.J., Chang,H.W., Lee,B.C., Abbink,P., Ng'ang'a,D., Boyd,M., Lavine,C.L., Lim,S.Y., Sanisetty,S., Whitney,J.B., Seaman,M.S., Rolland,M., Tovanabutra,S., Ananworanich,J., Robb,M.L., Kim,J.H., Michael,N.L. and Barouch,D.H.",2016
KU230424,01_AE,2011,26849216,Production of Mucosally Transmissible SHIV Challenge Stocks from HIV-1 Circulating Recombinant Form 01_AE env Sequences,"Tartaglia,L.J., Chang,H.W., Lee,B.C., Abbink,P., Ng'ang'a,D., Boyd,M., Lavine,C.L., Lim,S.Y., Sanisetty,S., Whitney,J.B., Seaman,M.S., Rolland,M., Tovanabutra,S., Ananworanich,J., Robb,M.L., Kim,J.H., Michael,N.L. and Barouch,D.H.",2016
KU230426,01_AE,2011,26849216,Production of Mucosally Transmissible SHIV Challenge Stocks from HIV-1 Circulating Recombinant Form 01_AE env Sequences,"Tartaglia,L.J., Chang,H.W., Lee,B.C., Abbink,P., Ng'ang'a,D., Boyd,M., Lavine,C.L., Lim,S.Y., Sanisetty,S., Whitney,J.B., Seaman,M.S., Rolland,M., Tovanabutra,S., Ananworanich,J., Robb,M.L., Kim,J.H., Michael,N.L. and Barouch,D.H.",2016
KU230427,01_AE,2009,,Direct Submission,"Tovanabutra,S., Sanders-Buell,E., Bose,M., O Sullivan,A., Rolland,M., Kijak,G., Rutvisuttinunt,W., Kim,J., Michael,N., Robb,M. and Ananworanich,J.",2015
KU230428,01_AE,2009,,Direct Submission,"Tovanabutra,S., Sanders-Buell,E., Bose,M., O Sullivan,A., Rolland,M., Kijak,G., Rutvisuttinunt,W., Kim,J., Michael,N., Robb,M. and Ananworanich,J.",2015
KU230429,01_AE,2009,,Direct Submission,"Tovanabutra,S., Sanders-Buell,E., Bose,M., O Sullivan,A., Rolland,M., Kijak,G., Rutvisuttinunt,W., Kim,J., Michael,N., Robb,M. and Ananworanich,J.",2015
KU230430,01_AE,2010,,Direct Submission,"Tovanabutra,S., Sanders-Buell,E., Bose,M., O Sullivan,A., Rolland,M., Kijak,G., Rutvisuttinunt,W., Kim,J., Michael,N., Robb,M. and Ananworanich,J.",2015
KU230432,01_AE,2010,,Direct Submission,"Tovanabutra,S., Sanders-Buell,E., Bose,M., O Sullivan,A., Rolland,M., Kijak,G., Rutvisuttinunt,W., Kim,J., Michael,N., Robb,M. and Ananworanich,J.",2015
KU230433,01_AE,2010,,Direct Submission,"Tovanabutra,S., Sanders-Buell,E., Bose,M., O Sullivan,A., Rolland,M., Kijak,G., Rutvisuttinunt,W., Kim,J., Michael,N., Robb,M. and Ananworanich,J.",2015
KU230434,01_AE,2010,,Direct Submission,"Tovanabutra,S., Sanders-Buell,E., Bose,M., O Sullivan,A., Rolland,M., Kijak,G., Rutvisuttinunt,W., Kim,J., Michael,N., Robb,M. and Ananworanich,J.",2015
KU230435,01_AE,2010,,Direct Submission,"Tovanabutra,S., Sanders-Buell,E., Bose,M., O Sullivan,A., Rolland,M., Kijak,G., Rutvisuttinunt,W., Kim,J., Michael,N., Robb,M. and Ananworanich,J.",2015
KU230436,01_AE,2010,,Direct Submission,"Tovanabutra,S., Sanders-Buell,E., Bose,M., O Sullivan,A., Rolland,M., Kijak,G., Rutvisuttinunt,W., Kim,J., Michael,N., Robb,M. and Ananworanich,J.",2015
KU230437,01_AE,2010,,Direct Submission,"Tovanabutra,S., Sanders-Buell,E., Bose,M., O Sullivan,A., Rolland,M., Kijak,G., Rutvisuttinunt,W., Kim,J., Michael,N., Robb,M. and Ananworanich,J.",2015
KU310620,J,1993,,"Sequencing and phylogenetic analysis of near full-length HIV-1 subtypes H and J from Cabinda, Angola","Bartolo,I., Calado,R., Borrego,P. and Taveira,N.",
KU356857,0108,2014,,Direct Submission,"Li,J., Li,L., Li,H., Li,J. and Yang,S.",2015
KU501256,01B,2013,27080756,"Near Full-Length Genome Sequences of Two Novel HIV-1 Recombinant Forms Detected In Henan Province, China","Li,T., Sun,G., Jia,D., Sun,C., Wang,Z., Liu,S., Liu,Y., Li,H., Wang,X., Li,J. and Li,L.",2016
KU501257,01BC,2013,27080756,"Near Full-Length Genome Sequences of Two Novel HIV-1 Recombinant Forms Detected In Henan Province, China","Li,T., Sun,G., Jia,D., Sun,C., Wang,Z., Liu,S., Liu,Y., Li,H., Wang,X., Li,J. and Li,L.",2016
KU562843,01_AE,1992,,Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials,"Montefiori,D.C., Karnasuta,C., Huang,Y., Ahmed,H., Gilbert,P., de Souza,M.S., McLinden,R., Tovanabutra,S., Laurence-Chenine,A., Sanders-Buell,E., Moody,M., Bonsignori,M., Ochsenbauer,C., Kappes,J., Tang,H., Greene,K., Gao,H., LaBranche,C.C., Andrews,C., Polonis,V.R., Rerks-Ngarm,S., Pitisuttithum,P., Nitayaphan,S., Kaewkungwal,J., Self,S.G., Berman,P.W., Francis,D., Sinangil,F., Lee,C., Tartaglia,J., Robb,M.L., Haynes,B.F., Michael,N.L. and Kim,J.H.",
KU600814,B,,,"Virus, Host and Disease Factors Govern HIV-1 Broadly Neutralizing Antibody Induction","Trkola,A. and Rusert,P.",
KU600815,B,,,"Virus, Host and Disease Factors Govern HIV-1 Broadly Neutralizing Antibody Induction","Trkola,A. and Rusert,P.",
KU600816,01_AE,,,"Virus, Host and Disease Factors Govern HIV-1 Broadly Neutralizing Antibody Induction","Trkola,A. and Rusert,P.",
KU600817,01_AE,,,"Virus, Host and Disease Factors Govern HIV-1 Broadly Neutralizing Antibody Induction","Trkola,A. and Rusert,P.",
KU600818,B,,,"Virus, Host and Disease Factors Govern HIV-1 Broadly Neutralizing Antibody Induction","Trkola,A. and Rusert,P.",
KU641402,B,2011,26858442,Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo,"Simonetti,F.R., Sobolewski,M.D., Fyne,E., Shao,W., Spindler,J., Hattori,J., Anderson,E.M., Watters,S.A., Hill,S., Wu,X., Wells,D., Su,L., Luke,B.T., Halvas,E.K., Besson,G., Penrose,K.J., Yang,Z., Kwan,R.W., Van Waes,C., Uldrick,T., Citrin,D.E., Kovacs,J., Polis,M.A., Rehm,C.A., Gorelick,R., Piatak,M., Keele,B.F., Kearney,M.F., Coffin,J.M., Hughes,S.H., Mellors,J.W. and Maldarelli,F.",2016
KU677989,B,2010,27432972,Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy,"Imamichi,H., Dewar,R.L., Adelsberger,J.W., Rehm,C.A., O'Doherty,U., Paxinos,E.E., Fauci,A.S. and Lane,H.C.",2016
KU678025,B,2014,27432972,Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy,"Imamichi,H., Dewar,R.L., Adelsberger,J.W., Rehm,C.A., O'Doherty,U., Paxinos,E.E., Fauci,A.S. and Lane,H.C.",2016
KU678049,B,2014,27432972,Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy,"Imamichi,H., Dewar,R.L., Adelsberger,J.W., Rehm,C.A., O'Doherty,U., Paxinos,E.E., Fauci,A.S. and Lane,H.C.",2016
KU678069,B,2010,27432972,Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy,"Imamichi,H., Dewar,R.L., Adelsberger,J.W., Rehm,C.A., O'Doherty,U., Paxinos,E.E., Fauci,A.S. and Lane,H.C.",2016
KU678125,B,2014,27432972,Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy,"Imamichi,H., Dewar,R.L., Adelsberger,J.W., Rehm,C.A., O'Doherty,U., Paxinos,E.E., Fauci,A.S. and Lane,H.C.",2016
KU678139,BF1,2015,27432972,Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy,"Imamichi,H., Dewar,R.L., Adelsberger,J.W., Rehm,C.A., O'Doherty,U., Paxinos,E.E., Fauci,A.S. and Lane,H.C.",2016
KU678161,B,1995,27432972,Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy,"Imamichi,H., Dewar,R.L., Adelsberger,J.W., Rehm,C.A., O'Doherty,U., Paxinos,E.E., Fauci,A.S. and Lane,H.C.",2016
KU685581,19_cpx,2014,,Direct Submission,"Cuevas,T., Sanchez,M., Delgado,E., Carrera,C., Montero,V., Benito,S., Thomson,M. and Perez-Alvarez,L.",2016
KU685582,19_cpx,2014,,Direct Submission,"Cuevas,T., Sanchez,M., Delgado,E., Carrera,C., Montero,V., Benito,S., Thomson,M. and Perez-Alvarez,L.",2016
KU685583,B,2014,,Direct Submission,"Cuevas,T., Sanchez,M., Delgado,E., Carrera,C., Montero,V., Benito,S., Thomson,M. and Perez-Alvarez,L.",2016
KU685584,B,2014,,Direct Submission,"Cuevas,T., Sanchez,M., Delgado,E., Carrera,C., Montero,V., Benito,S., Thomson,M. and Perez-Alvarez,L.",2016
KU685585,B,2014,,Direct Submission,"Cuevas,T., Sanchez,M., Delgado,E., Carrera,C., Montero,V., Benito,S., Thomson,M. and Perez-Alvarez,L.",2016
KU685586,B,2014,,Direct Submission,"Cuevas,T., Sanchez,M., Delgado,E., Carrera,C., Montero,V., Benito,S., Thomson,M. and Perez-Alvarez,L.",2016
KU685587,02A,2014,,Direct Submission,"Cuevas,T., Sanchez,M., Delgado,E., Carrera,C., Montero,V., Benito,S., Thomson,M. and Perez-Alvarez,L.",2016
KU685588,B,2014,,Direct Submission,"Cuevas,T., Sanchez,M., Delgado,E., Carrera,C., Montero,V., Benito,S., Thomson,M. and Perez-Alvarez,L.",2016
KU685589,B,2014,,Direct Submission,"Cuevas,T., Sanchez,M., Delgado,E., Carrera,C., Montero,V., Benito,S., Thomson,M. and Perez-Alvarez,L.",2016
KU685590,B,2014,,Direct Submission,"Cuevas,T., Sanchez,M., Delgado,E., Carrera,C., Montero,V., Benito,S., Thomson,M. and Perez-Alvarez,L.",2016
KU685591,B,2014,,Direct Submission,"Cuevas,T., Sanchez,M., Delgado,E., Carrera,C., Montero,V., Benito,S., Thomson,M. and Perez-Alvarez,L.",2016
KU685592,G,2014,,Direct Submission,"Cuevas,T., Sanchez,M., Delgado,E., Carrera,C., Montero,V., Benito,S., Thomson,M. and Perez-Alvarez,L.",2016
KU749387,B,2013,,Characterization of near full length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Busch,M.P., Stramer,S., Denny,T.N. and Gao,F.",
KU749394,D,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Sanabani,S., Busch,M.P., Denny,T.N. and Gao,F.",
KU749396,F1,2011,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Sanabani,S., Busch,M.P., Denny,T.N. and Gao,F.",
KU749399,A6,2011,,Characterization of near full length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Busch,M.P., Denny,T.N. and Gao,F.",
KU749400,A6,2011,,Characterization of near full length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Busch,M.P., Denny,T.N. and Gao,F.",
KU749401,A6,2011,,Characterization of near full length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Busch,M.P., Denny,T.N. and Gao,F.",
KU749402,A6,2012,,Characterization of near full length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Busch,M.P., Denny,T.N. and Gao,F.",
KU749403,A6,2012,,Characterization of near full length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Busch,M.P., Denny,T.N. and Gao,F.",
KU749404,A6,2012,,Characterization of near full length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Busch,M.P., Denny,T.N. and Gao,F.",
KU749405,A6,2012,,Characterization of near full length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Busch,M.P., Denny,T.N. and Gao,F.",
KU749406,A6,2012,,Characterization of near full length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Busch,M.P., Denny,T.N. and Gao,F.",
KU749407,A6,2012,,Characterization of near full length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Busch,M.P., Denny,T.N. and Gao,F.",
KU749408,BF1,2008,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Sauleda,S., Busch,M.P., Denny,T.N. and Gao,F.",
KU749409,A1,2014,,Characterization of near full length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Shah,S.A., Busch,M.P., Denny,T.N. and Gao,F.",
KU749410,A1,2014,,Characterization of near full length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Shah,S.A., Busch,M.P., Denny,T.N. and Gao,F.",
KU749411,A1,2014,,Characterization of near full length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Shah,S.A., Busch,M.P., Denny,T.N. and Gao,F.",
KU749412,C,2014,,Characterization of near full length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Shah,S.A., Busch,M.P., Denny,T.N. and Gao,F.",
KU749413,02A1,2014,,Characterization of near full length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Shah,S.A., Busch,M.P., Denny,T.N. and Gao,F.",
KU749414,02A1,2014,,Characterization of near full length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Shah,S.A., Busch,M.P., Denny,T.N. and Gao,F.",
KU749415,C,2013,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Busch,M.P., Vermeulen,M., Denny,T.N. and Gao,F.",
KU749416,C,2013,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Busch,M.P., Vermeulen,M., Denny,T.N. and Gao,F.",
KU749417,C,2013,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Busch,M.P., Vermeulen,M., Denny,T.N. and Gao,F.",
KU749418,CD,2013,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Busch,M.P., Vermeulen,M., Denny,T.N. and Gao,F.",
KU749419,02_AG,2010,,Characterization of near full length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Ragupathy,V., Hewlett,I., Denny,T.N. and Gao,F.",
KU749420,F2,2011,,Characterization of near full length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Ragupathy,V., Hewlett,I., Denny,T.N. and Gao,F.",
KU749421,02A1F2,2010,,Characterization of near full length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Ragupathy,V., Hewlett,I., Denny,T.N. and Gao,F.",
KU749422,F2,2011,,Characterization of near full length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Ragupathy,V., Hewlett,I., Denny,T.N. and Gao,F.",
KU749423,A1,2006,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Fast,P., Amornkul,P., Price,M.A., Kamali,A., Denny,T.N. and Gao,F.",
KU749424,A1,2008,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Fast,P., Amornkul,P., Price,M.A., Kamali,A., Denny,T.N. and Gao,F.",
KU749425,C,2007,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Fast,P., Amornkul,P., Price,M.A., Kamali,A., Denny,T.N. and Gao,F.",
KU749426,C,2009,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Fast,P., Amornkul,P., Price,M.A., Kamali,A., Denny,T.N. and Gao,F.",
KU749428,A1C,2006,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Fast,P., Amornkul,P., Price,M.A., Kamali,A., Denny,T.N. and Gao,F.",
KU749429,A1A2C,2007,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Fast,P., Amornkul,P., Price,M.A., Kamali,A., Denny,T.N. and Gao,F.",
KU749430,A1CD,2008,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Fast,P., Amornkul,P., Price,M.A., Kamali,A., Denny,T.N. and Gao,F.",
KU749431,A1C,2011,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Fast,P., Amornkul,P., Price,M.A., Kamali,A., Denny,T.N. and Gao,F.",
KU749432,02A1,2008,,Characterization of near full length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Briesen,H.V., Denny,T.N. and Gao,F.",
KU820822,01C,2013,27574950,First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar,"Chen,X., Ye,M., Duo,L., Pang,W., Smith,D., Zhang,C. and Zheng,Y.T.",2016
KU820823,83_cpx,2013,27574950,First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar,"Chen,X., Ye,M., Duo,L., Pang,W., Smith,D., Zhang,C. and Zheng,Y.T.",2016
KU820824,83_cpx,2013,27574950,First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar,"Chen,X., Ye,M., Duo,L., Pang,W., Smith,D., Zhang,C. and Zheng,Y.T.",2016
KU820825,82_cpx,2013,27574950,First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar,"Chen,X., Ye,M., Duo,L., Pang,W., Smith,D., Zhang,C. and Zheng,Y.T.",2016
KU820826,83_cpx,2013,27574950,First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar,"Chen,X., Ye,M., Duo,L., Pang,W., Smith,D., Zhang,C. and Zheng,Y.T.",2016
KU820827,01BC,2013,27574950,First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar,"Chen,X., Ye,M., Duo,L., Pang,W., Smith,D., Zhang,C. and Zheng,Y.T.",2016
KU820828,83_cpx,2013,27574950,First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar,"Chen,X., Ye,M., Duo,L., Pang,W., Smith,D., Zhang,C. and Zheng,Y.T.",2016
KU820829,83_cpx,2013,27574950,First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar,"Chen,X., Ye,M., Duo,L., Pang,W., Smith,D., Zhang,C. and Zheng,Y.T.",2016
KU820830,01BC,2013,27574950,First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar,"Chen,X., Ye,M., Duo,L., Pang,W., Smith,D., Zhang,C. and Zheng,Y.T.",2016
KU820831,82_cpx,2013,27574950,First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar,"Chen,X., Ye,M., Duo,L., Pang,W., Smith,D., Zhang,C. and Zheng,Y.T.",2016
KU820832,07_BC,2013,27574950,First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar,"Chen,X., Ye,M., Duo,L., Pang,W., Smith,D., Zhang,C. and Zheng,Y.T.",2016
KU820833,83_cpx,2013,27574950,First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar,"Chen,X., Ye,M., Duo,L., Pang,W., Smith,D., Zhang,C. and Zheng,Y.T.",2016
KU820834,83_cpx,2013,27574950,First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar,"Chen,X., Ye,M., Duo,L., Pang,W., Smith,D., Zhang,C. and Zheng,Y.T.",2016
KU820835,01B,2013,27574950,First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar,"Chen,X., Ye,M., Duo,L., Pang,W., Smith,D., Zhang,C. and Zheng,Y.T.",2016
KU820836,82_cpx,2013,27574950,First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar,"Chen,X., Ye,M., Duo,L., Pang,W., Smith,D., Zhang,C. and Zheng,Y.T.",2016
KU820837,82_cpx,2013,27574950,First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar,"Chen,X., Ye,M., Duo,L., Pang,W., Smith,D., Zhang,C. and Zheng,Y.T.",2016
KU820838,01BC,2013,27574950,First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar,"Chen,X., Ye,M., Duo,L., Pang,W., Smith,D., Zhang,C. and Zheng,Y.T.",2016
KU820839,83_cpx,2013,27574950,First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar,"Chen,X., Ye,M., Duo,L., Pang,W., Smith,D., Zhang,C. and Zheng,Y.T.",2016
KU820840,08_BC,2013,27574950,First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar,"Chen,X., Ye,M., Duo,L., Pang,W., Smith,D., Zhang,C. and Zheng,Y.T.",2016
KU820841,01BC,2013,27574950,First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar,"Chen,X., Ye,M., Duo,L., Pang,W., Smith,D., Zhang,C. and Zheng,Y.T.",2016
KU820842,83_cpx,2013,27574950,First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar,"Chen,X., Ye,M., Duo,L., Pang,W., Smith,D., Zhang,C. and Zheng,Y.T.",2016
KU820843,83_cpx,2013,27574950,First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar,"Chen,X., Ye,M., Duo,L., Pang,W., Smith,D., Zhang,C. and Zheng,Y.T.",2016
KU820844,82_cpx,2013,27574950,First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar,"Chen,X., Ye,M., Duo,L., Pang,W., Smith,D., Zhang,C. and Zheng,Y.T.",2016
KU820845,82_cpx,2013,27574950,First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar,"Chen,X., Ye,M., Duo,L., Pang,W., Smith,D., Zhang,C. and Zheng,Y.T.",2016
KU820846,08_BC,2013,27574950,First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar,"Chen,X., Ye,M., Duo,L., Pang,W., Smith,D., Zhang,C. and Zheng,Y.T.",2016
KU820847,83_cpx,2013,27574950,First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar,"Chen,X., Ye,M., Duo,L., Pang,W., Smith,D., Zhang,C. and Zheng,Y.T.",2016
KU820848,01BC,2014,27574950,First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar,"Chen,X., Ye,M., Duo,L., Pang,W., Smith,D., Zhang,C. and Zheng,Y.T.",2016
KU820849,01_AE,2014,27574950,First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar,"Chen,X., Ye,M., Duo,L., Pang,W., Smith,D., Zhang,C. and Zheng,Y.T.",2016
KU820850,BC,2014,27574950,First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar,"Chen,X., Ye,M., Duo,L., Pang,W., Smith,D., Zhang,C. and Zheng,Y.T.",2016
KU820851,BC,2014,27574950,First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar,"Chen,X., Ye,M., Duo,L., Pang,W., Smith,D., Zhang,C. and Zheng,Y.T.",2016
KU820852,BC,2014,27574950,First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar,"Chen,X., Ye,M., Duo,L., Pang,W., Smith,D., Zhang,C. and Zheng,Y.T.",2016
KU865691,C,2006,,Seminal HIV compartmentalization in relation to HIV-1 transmission,"Williams,C.A., Campbell,M.S., Payant,R., Lam,A., Zhao,H., Huang,H., Wald,A., Stevens,W., Gray,G., Farquhar,C., Rees,H., Celum,C., Mullins,J.I., Lingappa,J.R. and Frenkel,L.M.",
KU865719,C,2006,,Seminal HIV compartmentalization in relation to HIV-1 transmission,"Williams,C.A., Campbell,M.S., Payant,R., Lam,A., Zhao,H., Huang,H., Wald,A., Stevens,W., Gray,G., Farquhar,C., Rees,H., Celum,C., Mullins,J.I., Lingappa,J.R. and Frenkel,L.M.",
KU865731,A1,2007,,Seminal HIV compartmentalization in relation to HIV-1 transmission,"Williams,C.A., Campbell,M.S., Payant,R., Lam,A., Zhao,H., Huang,H., Wald,A., Stevens,W., Gray,G., Farquhar,C., Rees,H., Celum,C., Mullins,J.I., Lingappa,J.R. and Frenkel,L.M.",
KU865768,A1,2008,,Seminal HIV compartmentalization in relation to HIV-1 transmission,"Williams,C.A., Campbell,M.S., Payant,R., Lam,A., Zhao,H., Huang,H., Wald,A., Stevens,W., Gray,G., Farquhar,C., Rees,H., Celum,C., Mullins,J.I., Lingappa,J.R. and Frenkel,L.M.",
KU865783,A1,2007,,Seminal HIV compartmentalization in relation to HIV-1 transmission,"Williams,C.A., Campbell,M.S., Payant,R., Lam,A., Zhao,H., Huang,H., Wald,A., Stevens,W., Gray,G., Farquhar,C., Rees,H., Celum,C., Mullins,J.I., Lingappa,J.R. and Frenkel,L.M.",
KU865820,A1,2009,,Seminal HIV compartmentalization in relation to HIV-1 transmission,"Williams,C.A., Campbell,M.S., Payant,R., Lam,A., Zhao,H., Huang,H., Wald,A., Stevens,W., Gray,G., Farquhar,C., Rees,H., Celum,C., Mullins,J.I., Lingappa,J.R. and Frenkel,L.M.",
KU865852,A1C,2007,,Seminal HIV compartmentalization in relation to HIV-1 transmission,"Williams,C.A., Campbell,M.S., Payant,R., Lam,A., Zhao,H., Huang,H., Wald,A., Stevens,W., Gray,G., Farquhar,C., Rees,H., Celum,C., Mullins,J.I., Lingappa,J.R. and Frenkel,L.M.",
KU865901,A1C,2008,,Seminal HIV compartmentalization in relation to HIV-1 transmission,"Williams,C.A., Campbell,M.S., Payant,R., Lam,A., Zhao,H., Huang,H., Wald,A., Stevens,W., Gray,G., Farquhar,C., Rees,H., Celum,C., Mullins,J.I., Lingappa,J.R. and Frenkel,L.M.",
KU865931,A1D,2006,,Seminal HIV compartmentalization in relation to HIV-1 transmission,"Williams,C.A., Campbell,M.S., Payant,R., Lam,A., Zhao,H., Huang,H., Wald,A., Stevens,W., Gray,G., Farquhar,C., Rees,H., Celum,C., Mullins,J.I., Lingappa,J.R. and Frenkel,L.M.",
KU865944,A1D,2007,,Seminal HIV compartmentalization in relation to HIV-1 transmission,"Williams,C.A., Campbell,M.S., Payant,R., Lam,A., Zhao,H., Huang,H., Wald,A., Stevens,W., Gray,G., Farquhar,C., Rees,H., Celum,C., Mullins,J.I., Lingappa,J.R. and Frenkel,L.M.",
KU865950,D,2008,,Seminal HIV compartmentalization in relation to HIV-1 transmission,"Williams,C.A., Campbell,M.S., Payant,R., Lam,A., Zhao,H., Huang,H., Wald,A., Stevens,W., Gray,G., Farquhar,C., Rees,H., Celum,C., Mullins,J.I., Lingappa,J.R. and Frenkel,L.M.",
KU865979,D,2008,,Seminal HIV compartmentalization in relation to HIV-1 transmission,"Williams,C.A., Campbell,M.S., Payant,R., Lam,A., Zhao,H., Huang,H., Wald,A., Stevens,W., Gray,G., Farquhar,C., Rees,H., Celum,C., Mullins,J.I., Lingappa,J.R. and Frenkel,L.M.",
KU865994,A1D,2008,,Seminal HIV compartmentalization in relation to HIV-1 transmission,"Williams,C.A., Campbell,M.S., Payant,R., Lam,A., Zhao,H., Huang,H., Wald,A., Stevens,W., Gray,G., Farquhar,C., Rees,H., Celum,C., Mullins,J.I., Lingappa,J.R. and Frenkel,L.M.",
KU866010,A1D,2008,,Seminal HIV compartmentalization in relation to HIV-1 transmission,"Williams,C.A., Campbell,M.S., Payant,R., Lam,A., Zhao,H., Huang,H., Wald,A., Stevens,W., Gray,G., Farquhar,C., Rees,H., Celum,C., Mullins,J.I., Lingappa,J.R. and Frenkel,L.M.",
KU866035,A1D,2008,,Seminal HIV compartmentalization in relation to HIV-1 transmission,"Williams,C.A., Campbell,M.S., Payant,R., Lam,A., Zhao,H., Huang,H., Wald,A., Stevens,W., Gray,G., Farquhar,C., Rees,H., Celum,C., Mullins,J.I., Lingappa,J.R. and Frenkel,L.M.",
KU866070,A1D,2008,,Seminal HIV compartmentalization in relation to HIV-1 transmission,"Williams,C.A., Campbell,M.S., Payant,R., Lam,A., Zhao,H., Huang,H., Wald,A., Stevens,W., Gray,G., Farquhar,C., Rees,H., Celum,C., Mullins,J.I., Lingappa,J.R. and Frenkel,L.M.",
KU869532,B,1993,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1,"Cho,Y.-K.",
KU869580,B,1992,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1,"Cho,Y.-K.",
KU869582,B,1993,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1,"Cho,Y.-K.",
KU869583,B,1993,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1,"Cho,Y.-K.",
KU869584,B,1992,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1,"Cho,Y.-K.",
KU869585,B,1993,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1,"Cho,Y.-K.",
KU869586,B,1993,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1,"Cho,Y.-K.",
KU869589,B,1992,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1,"Cho,Y.-K.",
KU869594,B,,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1,"Cho,Y.-K.",
KU869597,B,1993,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1,"Cho,Y.-K.",
KU869602,B,2000,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1,"Cho,Y.-K.",
KU869604,B,1992,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1,"Cho,Y.-K.",
KU869607,B,1992,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1,"Cho,Y.-K.",
KU886698,BC,2014,,Identification of a novel HIV-1 unique (B/C) recombinant isolate in Sichuan of China,"Wang,Y.",
KU896101,B,1993,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1,"Cho,Y.K.",
KU896108,B,1993,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1,"Cho,Y.K.",
KU896115,B,1992,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1,"Cho,Y.K.",
KU896116,B,1992,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1,"Cho,Y.K.",
KU896118,B,1992,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1,"Cho,Y.K.",
KU896119,B,1992,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1,"Cho,Y.K.",
KU896123,B,1993,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1,"Cho,Y.K.",
KU896124,B,1993,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1,"Cho,Y.K.",
KU896125,B,1992,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1,"Cho,Y.K.",
KU901727,B,2011,27819061,Use of Dried Blood Spots to Elucidate Full-Length Transmitted/Founder HIV-1 Genomes,"Salazar-Gonzalez,J.F., Salazar,M.G., Tully,D.C., Ogilvie,C.B., Learn,G.H., Allen,T.M., Heath,S.L., Goepfert,P. and Bar,K.J.",2016
KU901757,B,2011,27819061,Use of Dried Blood Spots to Elucidate Full-Length Transmitted/Founder HIV-1 Genomes,"Salazar-Gonzalez,J.F., Salazar,M.G., Tully,D.C., Ogilvie,C.B., Learn,G.H., Allen,T.M., Heath,S.L., Goepfert,P. and Bar,K.J.",2016
KU901773,B,2012,27819061,Use of Dried Blood Spots to Elucidate Full-Length Transmitted/Founder HIV-1 Genomes,"Salazar-Gonzalez,J.F., Salazar,M.G., Tully,D.C., Ogilvie,C.B., Learn,G.H., Allen,T.M., Heath,S.L., Goepfert,P. and Bar,K.J.",2016
KU901788,B,2012,27819061,Use of Dried Blood Spots to Elucidate Full-Length Transmitted/Founder HIV-1 Genomes,"Salazar-Gonzalez,J.F., Salazar,M.G., Tully,D.C., Ogilvie,C.B., Learn,G.H., Allen,T.M., Heath,S.L., Goepfert,P. and Bar,K.J.",2016
KU901807,B,2012,27819061,Use of Dried Blood Spots to Elucidate Full-Length Transmitted/Founder HIV-1 Genomes,"Salazar-Gonzalez,J.F., Salazar,M.G., Tully,D.C., Ogilvie,C.B., Learn,G.H., Allen,T.M., Heath,S.L., Goepfert,P. and Bar,K.J.",2016
KU901831,B,2011,27819061,Use of Dried Blood Spots to Elucidate Full-Length Transmitted/Founder HIV-1 Genomes,"Salazar-Gonzalez,J.F., Salazar,M.G., Tully,D.C., Ogilvie,C.B., Learn,G.H., Allen,T.M., Heath,S.L., Goepfert,P. and Bar,K.J.",2016
KU901856,B,2012,27819061,Use of Dried Blood Spots to Elucidate Full-Length Transmitted/Founder HIV-1 Genomes,"Salazar-Gonzalez,J.F., Salazar,M.G., Tully,D.C., Ogilvie,C.B., Learn,G.H., Allen,T.M., Heath,S.L., Goepfert,P. and Bar,K.J.",2016
KU901875,B,2012,27819061,Use of Dried Blood Spots to Elucidate Full-Length Transmitted/Founder HIV-1 Genomes,"Salazar-Gonzalez,J.F., Salazar,M.G., Tully,D.C., Ogilvie,C.B., Learn,G.H., Allen,T.M., Heath,S.L., Goepfert,P. and Bar,K.J.",2016
KU901898,B,2012,27819061,Use of Dried Blood Spots to Elucidate Full-Length Transmitted/Founder HIV-1 Genomes,"Salazar-Gonzalez,J.F., Salazar,M.G., Tully,D.C., Ogilvie,C.B., Learn,G.H., Allen,T.M., Heath,S.L., Goepfert,P. and Bar,K.J.",2016
KU921705,A1D,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921708,A1,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921712,A1,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921715,A1CD,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921719,A1D,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921722,C,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921726,A1,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921730,A1CD,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921732,A1,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921734,A1,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921738,A1,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921740,CD,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921743,C,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921745,A1,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921748,A1D,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921749,A1D,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921752,A1,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921755,A1,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921759,A1,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921765,A1CD,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921767,D,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921768,A1A2,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921772,A1,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921776,A1,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921779,A1,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921781,A1,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921785,A1,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921788,A1,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921789,C,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921793,A1C,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921796,A1C,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921798,A1D,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921799,A1D,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921802,A1C,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921804,A1,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921805,A1D,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921807,C,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921810,D,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921814,D,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921817,C,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921823,A1D,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921827,C,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921831,A1,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921835,A1,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921838,A1C,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921841,A1,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU921852,A1,2011,,Complex phylogeny of HIV-1 among drug users in Kenya,"Gounder,K., Ongeri,M., Padayachi,N., Zulu,T.M., de Oliveira,T., Wylie,J. and Ndung'u,T.",
KU992928,85_BC,2014,27169981,"Identification of a Novel HIV-1 Circulating Recombinant Form (CRF85_BC) in Sichuan, China","Su,L., Wei,D., Yang,H., Zeng,Y., Hu,Y., Yuan,D., Feng,L., Ruan,Y., Qin,G. and Liang,S.",2016
KU992929,85_BC,2014,27169981,"Identification of a Novel HIV-1 Circulating Recombinant Form (CRF85_BC) in Sichuan, China","Su,L., Wei,D., Yang,H., Zeng,Y., Hu,Y., Yuan,D., Feng,L., Ruan,Y., Qin,G. and Liang,S.",2016
KU992930,85_BC,2014,27169981,"Identification of a Novel HIV-1 Circulating Recombinant Form (CRF85_BC) in Sichuan, China","Su,L., Wei,D., Yang,H., Zeng,Y., Hu,Y., Yuan,D., Feng,L., Ruan,Y., Qin,G. and Liang,S.",2016
KU992931,85_BC,2014,27169981,"Identification of a Novel HIV-1 Circulating Recombinant Form (CRF85_BC) in Sichuan, China","Su,L., Wei,D., Yang,H., Zeng,Y., Hu,Y., Yuan,D., Feng,L., Ruan,Y., Qin,G. and Liang,S.",2016
KU992932,85_BC,2014,27169981,"Identification of a Novel HIV-1 Circulating Recombinant Form (CRF85_BC) in Sichuan, China","Su,L., Wei,D., Yang,H., Zeng,Y., Hu,Y., Yuan,D., Feng,L., Ruan,Y., Qin,G. and Liang,S.",2016
KU992933,85_BC,2014,27169981,"Identification of a Novel HIV-1 Circulating Recombinant Form (CRF85_BC) in Sichuan, China","Su,L., Wei,D., Yang,H., Zeng,Y., Hu,Y., Yuan,D., Feng,L., Ruan,Y., Qin,G. and Liang,S.",2016
KU992934,85_BC,2014,27169981,"Identification of a Novel HIV-1 Circulating Recombinant Form (CRF85_BC) in Sichuan, China","Su,L., Wei,D., Yang,H., Zeng,Y., Hu,Y., Yuan,D., Feng,L., Ruan,Y., Qin,G. and Liang,S.",2016
KU992935,85_BC,2014,27169981,"Identification of a Novel HIV-1 Circulating Recombinant Form (CRF85_BC) in Sichuan, China","Su,L., Wei,D., Yang,H., Zeng,Y., Hu,Y., Yuan,D., Feng,L., Ruan,Y., Qin,G. and Liang,S.",2016
KU992936,85_BC,2014,27169981,"Identification of a Novel HIV-1 Circulating Recombinant Form (CRF85_BC) in Sichuan, China","Su,L., Wei,D., Yang,H., Zeng,Y., Hu,Y., Yuan,D., Feng,L., Ruan,Y., Qin,G. and Liang,S.",2016
KU992937,85_BC,2014,27169981,"Identification of a Novel HIV-1 Circulating Recombinant Form (CRF85_BC) in Sichuan, China","Su,L., Wei,D., Yang,H., Zeng,Y., Hu,Y., Yuan,D., Feng,L., Ruan,Y., Qin,G. and Liang,S.",2016
KX010453,01BC,2015,,Direct Submission,"Wang,H., Luo,P. and Zhu,H.",2016
KX027737,B,2014,27199429,HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1,"Schoofs,T., Klein,F., Braunschweig,M., Kreider,E.F., Feldmann,A., Nogueira,L., Oliveira,T., Lorenzi,J.C., Parrish,E.H., Learn,G.H., West,A.P. Jr., Bjorkman,P.J., Schlesinger,S.J., Seaman,M.S., Czartoski,J., McElrath,M.J., Pfeifer,N., Hahn,B.H., Caskey,M. and Nussenzweig,M.C.",2016
KX027965,B,2014,27199429,HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1,"Schoofs,T., Klein,F., Braunschweig,M., Kreider,E.F., Feldmann,A., Nogueira,L., Oliveira,T., Lorenzi,J.C., Parrish,E.H., Learn,G.H., West,A.P. Jr., Bjorkman,P.J., Schlesinger,S.J., Seaman,M.S., Czartoski,J., McElrath,M.J., Pfeifer,N., Hahn,B.H., Caskey,M. and Nussenzweig,M.C.",2016
KX028066,B,2014,27199429,HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1,"Schoofs,T., Klein,F., Braunschweig,M., Kreider,E.F., Feldmann,A., Nogueira,L., Oliveira,T., Lorenzi,J.C., Parrish,E.H., Learn,G.H., West,A.P. Jr., Bjorkman,P.J., Schlesinger,S.J., Seaman,M.S., Czartoski,J., McElrath,M.J., Pfeifer,N., Hahn,B.H., Caskey,M. and Nussenzweig,M.C.",2016
KX028188,B,2014,27199429,HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1,"Schoofs,T., Klein,F., Braunschweig,M., Kreider,E.F., Feldmann,A., Nogueira,L., Oliveira,T., Lorenzi,J.C., Parrish,E.H., Learn,G.H., West,A.P. Jr., Bjorkman,P.J., Schlesinger,S.J., Seaman,M.S., Czartoski,J., McElrath,M.J., Pfeifer,N., Hahn,B.H., Caskey,M. and Nussenzweig,M.C.",2016
KX028313,B,2014,27199429,HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1,"Schoofs,T., Klein,F., Braunschweig,M., Kreider,E.F., Feldmann,A., Nogueira,L., Oliveira,T., Lorenzi,J.C., Parrish,E.H., Learn,G.H., West,A.P. Jr., Bjorkman,P.J., Schlesinger,S.J., Seaman,M.S., Czartoski,J., McElrath,M.J., Pfeifer,N., Hahn,B.H., Caskey,M. and Nussenzweig,M.C.",2016
KX028499,B,2014,27199429,HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1,"Schoofs,T., Klein,F., Braunschweig,M., Kreider,E.F., Feldmann,A., Nogueira,L., Oliveira,T., Lorenzi,J.C., Parrish,E.H., Learn,G.H., West,A.P. Jr., Bjorkman,P.J., Schlesinger,S.J., Seaman,M.S., Czartoski,J., McElrath,M.J., Pfeifer,N., Hahn,B.H., Caskey,M. and Nussenzweig,M.C.",2016
KX028620,B,2014,27199429,HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1,"Schoofs,T., Klein,F., Braunschweig,M., Kreider,E.F., Feldmann,A., Nogueira,L., Oliveira,T., Lorenzi,J.C., Parrish,E.H., Learn,G.H., West,A.P. Jr., Bjorkman,P.J., Schlesinger,S.J., Seaman,M.S., Czartoski,J., McElrath,M.J., Pfeifer,N., Hahn,B.H., Caskey,M. and Nussenzweig,M.C.",2016
KX060565,C,,,Humoral immune pressure selects for HIV-1 CXCR4-using variants,"Lin,N., Gonzalez,O., Becerril,C., Etemad,B. and Sagar,M.",
KX129172,B,1985,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129174,B,1989,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129176,B,2006,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129177,B,1985,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129180,B,1989,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129182,B,1985,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129185,B,1985,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129189,B,1985,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129192,B,2002,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129196,B,1987,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129198,B,1985,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129199,B,1987,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129202,B,1987,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129206,B,2005,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129207,B,1987,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129208,B,2006,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129213,B,2006,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129217,B,2005,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129225,B,1989,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129226,B,1989,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129227,B,2006,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129230,B,2006,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129232,B,2007,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129236,B,2007,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129240,B,2007,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129241,B,2007,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129244,B,2007,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129246,B,1991,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129249,B,1991,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129252,B,1991,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129255,B,1987,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129256,B,1986,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129259,B,2000,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129261,B,1991,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129262,B,1991,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129264,B,1991,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129267,B,1991,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129269,B,1991,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129272,B,1991,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129275,B,2004,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129278,B,1991,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129280,B,1992,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129282,B,1998,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129283,B,1997,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129288,B,1998,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129290,B,1985,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129294,B,1987,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129297,B,1993,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129300,B,1997,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129301,B,1988,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129303,B,1993,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129306,B,1993,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129308,B,1993,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129311,B,1993,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129313,B,2005,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129314,B,2003,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129321,B,1994,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129324,B,1994,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129327,B,1994,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129329,B,1994,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129331,B,1994,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129332,B,1994,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129334,B,2007,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129336,B,1994,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129350,B,2000,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129369,B,1994,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129372,B,2003,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129374,B,2006,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129375,B,2000,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129386,B,2007,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129390,B,1997,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129392,B,1992,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129393,B,2003,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129397,B,1998,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129399,B,1991,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129400,B,2006,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129402,B,1988,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129403,B,1997,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129406,B,1997,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129409,B,2004,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129414,B,1999,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129425,B,2002,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129428,B,2005,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129440,B,2000,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129444,B,2002,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129456,B,2001,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129460,B,1997,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129464,B,1999,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129469,B,2001,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129471,B,1997,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129474,B,1997,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129477,B,1998,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129482,B,1998,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129483,B,1998,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129486,B,2001,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129488,B,1999,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129493,B,2001,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129497,A1,2004,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129498,B,1999,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129501,B,2005,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129504,B,2006,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129505,B,2001,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129509,B,2001,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129510,B,2003,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129511,B,2001,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129513,D,2002,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129517,B,2011,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129519,B,2011,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129521,B,2011,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129524,B,2012,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129529,B,2011,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129533,B,2009,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129540,B,2004,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129556,B,2004,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129580,B,2004,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129587,B,2004,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129592,B,2004,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129611,B,2004,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129628,B,2004,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129636,B,2004,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129655,B,2004,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129674,B,2007,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129678,B,2006,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129682,B,2010,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX129687,B,2006,,"Accurate Predictions of Changes in Structural Features of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J. and Haim,H.",
KX159285,0107,2015,27353182,"Near Full-Length Genome Identification of a Novel HIV-1 Recombinant Form (CRF01_AE/CRF07_BC) in Zhejiang, China","Peng,X., Li-Jun,X., Xie,T., Liu,F. and Wu,N.",2016
KX168070,A1,1994,,HIV-1 neutralizing antibodies with limited hypermutation from an infant,"Simonich,C.A., Williams,K.L., Verkerke,H.P., Williams,J.A., Nduati,R., Lee,K.K. and Overbaugh,J.",
KX168085,A1,1995,,HIV-1 neutralizing antibodies with limited hypermutation from an infant,"Simonich,C.A., Williams,K.L., Verkerke,H.P., Williams,J.A., Nduati,R., Lee,K.K. and Overbaugh,J.",
KX216883,C,2008,,Staged Induction of HIV-1 Glycan-Dependent Broadly Neutralizing Antibodies,"Bonsignori,M., Kreider,E.F., Fera,D., Meyerhoff,R.R., Bradley,T., Wiehe,K., Alam,S.M., Hwang,K.-K., Saunders,K.O., Xia,S.-M., Zhang,R., Gladden,M., Monroe,A., Pier,B.W., Jette,C.A., Kelsoe,G., Louder,M.K., Morris,L., Kappes,J., Wagh,K., Kamanga,G., Cohen,M.S., Hraber,P.T., Montefiori,D.C., Trama,A., Liao,H.-X., Kepler,T.B., Moody,M.A., Gao,F., Mascola,J.R., Shaw,G.M., Hahn,B.H., Harrison,S.C., Korber,B. and Haynes,B.F.",
KX232596,02A1,2014,27973597,Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan,"Chen,Y., Hora,B., DeMarco,T., Shah,S.A., Ahmed,M., Sanchez,A.M., Su,C., Carter,M., Stone,M., Hasan,R., Hasan,Z., Busch,M.P., Denny,T.N. and Gao,F.",2016
KX232597,A1,2014,27973597,Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan,"Chen,Y., Hora,B., DeMarco,T., Shah,S.A., Ahmed,M., Sanchez,A.M., Su,C., Carter,M., Stone,M., Hasan,R., Hasan,Z., Busch,M.P., Denny,T.N. and Gao,F.",2016
KX232598,02_AG,2014,27973597,Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan,"Chen,Y., Hora,B., DeMarco,T., Shah,S.A., Ahmed,M., Sanchez,A.M., Su,C., Carter,M., Stone,M., Hasan,R., Hasan,Z., Busch,M.P., Denny,T.N. and Gao,F.",2016
KX232600,A1,2014,27973597,Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan,"Chen,Y., Hora,B., DeMarco,T., Shah,S.A., Ahmed,M., Sanchez,A.M., Su,C., Carter,M., Stone,M., Hasan,R., Hasan,Z., Busch,M.P., Denny,T.N. and Gao,F.",2016
KX232601,02A1,2014,27973597,Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan,"Chen,Y., Hora,B., DeMarco,T., Shah,S.A., Ahmed,M., Sanchez,A.M., Su,C., Carter,M., Stone,M., Hasan,R., Hasan,Z., Busch,M.P., Denny,T.N. and Gao,F.",2016
KX232603,C,2014,27973597,Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan,"Chen,Y., Hora,B., DeMarco,T., Shah,S.A., Ahmed,M., Sanchez,A.M., Su,C., Carter,M., Stone,M., Hasan,R., Hasan,Z., Busch,M.P., Denny,T.N. and Gao,F.",2016
KX232604,02A1,2014,27973597,Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan,"Chen,Y., Hora,B., DeMarco,T., Shah,S.A., Ahmed,M., Sanchez,A.M., Su,C., Carter,M., Stone,M., Hasan,R., Hasan,Z., Busch,M.P., Denny,T.N. and Gao,F.",2016
KX232605,02A1,2014,27973597,Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan,"Chen,Y., Hora,B., DeMarco,T., Shah,S.A., Ahmed,M., Sanchez,A.M., Su,C., Carter,M., Stone,M., Hasan,R., Hasan,Z., Busch,M.P., Denny,T.N. and Gao,F.",2016
KX232607,A1,2014,27973597,Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan,"Chen,Y., Hora,B., DeMarco,T., Shah,S.A., Ahmed,M., Sanchez,A.M., Su,C., Carter,M., Stone,M., Hasan,R., Hasan,Z., Busch,M.P., Denny,T.N. and Gao,F.",2016
KX232609,A1,2014,27973597,Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan,"Chen,Y., Hora,B., DeMarco,T., Shah,S.A., Ahmed,M., Sanchez,A.M., Su,C., Carter,M., Stone,M., Hasan,R., Hasan,Z., Busch,M.P., Denny,T.N. and Gao,F.",2016
KX232610,A1,2014,27973597,Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan,"Chen,Y., Hora,B., DeMarco,T., Shah,S.A., Ahmed,M., Sanchez,A.M., Su,C., Carter,M., Stone,M., Hasan,R., Hasan,Z., Busch,M.P., Denny,T.N. and Gao,F.",2016
KX232611,A1,2014,27973597,Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan,"Chen,Y., Hora,B., DeMarco,T., Shah,S.A., Ahmed,M., Sanchez,A.M., Su,C., Carter,M., Stone,M., Hasan,R., Hasan,Z., Busch,M.P., Denny,T.N. and Gao,F.",2016
KX232612,02A1,2014,27973597,Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan,"Chen,Y., Hora,B., DeMarco,T., Shah,S.A., Ahmed,M., Sanchez,A.M., Su,C., Carter,M., Stone,M., Hasan,R., Hasan,Z., Busch,M.P., Denny,T.N. and Gao,F.",2016
KX232613,A1,2014,27973597,Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan,"Chen,Y., Hora,B., DeMarco,T., Shah,S.A., Ahmed,M., Sanchez,A.M., Su,C., Carter,M., Stone,M., Hasan,R., Hasan,Z., Busch,M.P., Denny,T.N. and Gao,F.",2016
KX232614,A1,2015,27973597,Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan,"Chen,Y., Hora,B., DeMarco,T., Shah,S.A., Ahmed,M., Sanchez,A.M., Su,C., Carter,M., Stone,M., Hasan,R., Hasan,Z., Busch,M.P., Denny,T.N. and Gao,F.",2016
KX232615,02A1,2015,27973597,Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan,"Chen,Y., Hora,B., DeMarco,T., Shah,S.A., Ahmed,M., Sanchez,A.M., Su,C., Carter,M., Stone,M., Hasan,R., Hasan,Z., Busch,M.P., Denny,T.N. and Gao,F.",2016
KX232616,02_AG,2015,27973597,Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan,"Chen,Y., Hora,B., DeMarco,T., Shah,S.A., Ahmed,M., Sanchez,A.M., Su,C., Carter,M., Stone,M., Hasan,R., Hasan,Z., Busch,M.P., Denny,T.N. and Gao,F.",2016
KX232617,02A1,2015,27973597,Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan,"Chen,Y., Hora,B., DeMarco,T., Shah,S.A., Ahmed,M., Sanchez,A.M., Su,C., Carter,M., Stone,M., Hasan,R., Hasan,Z., Busch,M.P., Denny,T.N. and Gao,F.",2016
KX232618,A1,2015,27973597,Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan,"Chen,Y., Hora,B., DeMarco,T., Shah,S.A., Ahmed,M., Sanchez,A.M., Su,C., Carter,M., Stone,M., Hasan,R., Hasan,Z., Busch,M.P., Denny,T.N. and Gao,F.",2016
KX232619,A1,2014,27973597,Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan,"Chen,Y., Hora,B., DeMarco,T., Shah,S.A., Ahmed,M., Sanchez,A.M., Su,C., Carter,M., Stone,M., Hasan,R., Hasan,Z., Busch,M.P., Denny,T.N. and Gao,F.",2016
KX232620,A1,2015,27973597,Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan,"Chen,Y., Hora,B., DeMarco,T., Shah,S.A., Ahmed,M., Sanchez,A.M., Su,C., Carter,M., Stone,M., Hasan,R., Hasan,Z., Busch,M.P., Denny,T.N. and Gao,F.",2016
KX232621,A1,2015,27973597,Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan,"Chen,Y., Hora,B., DeMarco,T., Shah,S.A., Ahmed,M., Sanchez,A.M., Su,C., Carter,M., Stone,M., Hasan,R., Hasan,Z., Busch,M.P., Denny,T.N. and Gao,F.",2016
KX232622,02_AG,2015,27973597,Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan,"Chen,Y., Hora,B., DeMarco,T., Shah,S.A., Ahmed,M., Sanchez,A.M., Su,C., Carter,M., Stone,M., Hasan,R., Hasan,Z., Busch,M.P., Denny,T.N. and Gao,F.",2016
KX232623,02A1,2015,27973597,Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan,"Chen,Y., Hora,B., DeMarco,T., Shah,S.A., Ahmed,M., Sanchez,A.M., Su,C., Carter,M., Stone,M., Hasan,R., Hasan,Z., Busch,M.P., Denny,T.N. and Gao,F.",2016
KX232624,A1,2015,27973597,Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan,"Chen,Y., Hora,B., DeMarco,T., Shah,S.A., Ahmed,M., Sanchez,A.M., Su,C., Carter,M., Stone,M., Hasan,R., Hasan,Z., Busch,M.P., Denny,T.N. and Gao,F.",2016
KX232625,02_AG,2015,27973597,Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan,"Chen,Y., Hora,B., DeMarco,T., Shah,S.A., Ahmed,M., Sanchez,A.M., Su,C., Carter,M., Stone,M., Hasan,R., Hasan,Z., Busch,M.P., Denny,T.N. and Gao,F.",2016
KX232626,A1,2015,27973597,Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan,"Chen,Y., Hora,B., DeMarco,T., Shah,S.A., Ahmed,M., Sanchez,A.M., Su,C., Carter,M., Stone,M., Hasan,R., Hasan,Z., Busch,M.P., Denny,T.N. and Gao,F.",2016
KX232627,02A1,2015,27973597,Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan,"Chen,Y., Hora,B., DeMarco,T., Shah,S.A., Ahmed,M., Sanchez,A.M., Su,C., Carter,M., Stone,M., Hasan,R., Hasan,Z., Busch,M.P., Denny,T.N. and Gao,F.",2016
KX232628,02A1,2015,27973597,Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan,"Chen,Y., Hora,B., DeMarco,T., Shah,S.A., Ahmed,M., Sanchez,A.M., Su,C., Carter,M., Stone,M., Hasan,R., Hasan,Z., Busch,M.P., Denny,T.N. and Gao,F.",2016
KX232629,02A1,2015,27973597,Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan,"Chen,Y., Hora,B., DeMarco,T., Shah,S.A., Ahmed,M., Sanchez,A.M., Su,C., Carter,M., Stone,M., Hasan,R., Hasan,Z., Busch,M.P., Denny,T.N. and Gao,F.",2016
KX255824,B,1993,,"Accurate Predictions of the Evolving Structural Properties of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J.T. and Haim,H.",
KX255825,B,1993,,"Accurate Predictions of the Evolving Structural Properties of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J.T. and Haim,H.",
KX255826,B,1997,,"Accurate Predictions of the Evolving Structural Properties of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J.T. and Haim,H.",
KX255827,B,1998,,"Accurate Predictions of the Evolving Structural Properties of HIV-1 Env in Patients and Population Using a Volatility-controlled, Restrained Diffusion Model","DeLeon,O., Hodis,H., O'Malley,Y., Johnson,J., Salimi,H., Zhai,Y., Winter,E., Remec,C., Eichelberger,N., Van Cleave,B., Puliadi,R., Harrington,R., Stapleton,J.T. and Haim,H.",
KX353919,01BC,2014,,"Near Full-Length Genome Identification of a Novel HIV type 1 CRF01_AE/B /C Recombinant Isolate in Sichuan, China","Wang,Y.",
KX364401,A1D,,16378985,Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant,"Wu,X., Parast,A.B., Richardson,B.A., Nduati,R., John-Stewart,G., Mbori-Ngacha,D., Rainwater,S.M. and Overbaugh,J.",2006
KX378999,01BC,2013,27460636,"Near Full-Length Genomic Sequences of Two Novel HIV-1 Recombinant Forms identified in Shenzhen, China","Jia,D., Zhao,J., Li,T., Sun,C., Li,H., Zheng,C., Chen,L., Liu,Y., Liu,S., Zhuang,D., Wang,X., Bao,Z., Li,J. and Li,L.",2016
KX379000,01BC,2013,27460636,"Near Full-Length Genomic Sequences of Two Novel HIV-1 Recombinant Forms identified in Shenzhen, China","Jia,D., Zhao,J., Li,T., Sun,C., Li,H., Zheng,C., Chen,L., Liu,Y., Liu,S., Zhuang,D., Wang,X., Bao,Z., Li,J. and Li,L.",2016
KX389608,A1U,2010,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389609,06_cpx,2010,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389610,02_AG,2010,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389611,02U,2010,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389612,C,2010,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389613,02G,2010,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389614,02_AG,2010,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389615,G,2010,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389616,02A1,2010,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389617,02_AG,2010,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389618,G,2010,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389619,G,2010,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389620,G,2010,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389621,02_AG,2010,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389622,A,2009,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389623,02G,2009,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389624,02_AG,2009,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389625,G,2009,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389626,G,2009,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389627,02G,2009,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389628,G,2009,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389629,02_AG,2009,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389630,02_AG,2009,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389631,G,2009,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389632,02G,2009,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389633,11_cpx,2009,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389634,02G,2009,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389635,G,2009,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389636,G,2009,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389637,02G,2009,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389638,06G,2009,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389639,02_AG,2009,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389640,02_AG,2011,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389641,G,2011,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389642,G,2011,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389643,02_AG,2011,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389644,02_AG,2011,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389645,G,2011,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389646,G,2012,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389647,02_AG,2012,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389648,G,2012,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX389649,02_AG,2012,27512845,Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG,"Heipertz,R.A. Jr., Ayemoba,O., Sanders-Buell,E., Poltavee,K., Pham,P., Kijak,G.H., Lei,E., Bose,M., Howell,S., O'Sullivan,A.M., Bates,A., Cervenka,T., Kuroiwa,J., Akintunde,A., Ibezim,O., Alabi,A., Okoye,O., Manak,M., Malia,J., Peel,S., Maisaka,M., Singer,D., O'Connell,R.J., Robb,M.L., Kim,J.H., Michael,N.L., Njoku,O. and Tovanabutra,S.",2016
KX398187,02O,2007,,Multiple HIV-1/m + HIV-1/o dual infections and new HIV-1/mo inter-group recombinant forms detected in Cameroon,"De Oliveira,F., Mourez,T. and Vessiere,A.",
KX505395,B,2014,27500724,Defective proviruses rapidly accumulate during acute HIV-1 infection,"Bruner,K.M., Murray,A.J., Pollack,R.A., Soliman,M.G., Laskey,S.B., Capoferri,A.A., Lai,J., Strain,M.C., Lada,S.M., Hoh,R., Ho,Y.C., Richman,D.D., Deeks,S.G., Siliciano,J.D. and Siliciano,R.F.",2016
KX505412,B,2014,27500724,Defective proviruses rapidly accumulate during acute HIV-1 infection,"Bruner,K.M., Murray,A.J., Pollack,R.A., Soliman,M.G., Laskey,S.B., Capoferri,A.A., Lai,J., Strain,M.C., Lada,S.M., Hoh,R., Ho,Y.C., Richman,D.D., Deeks,S.G., Siliciano,J.D. and Siliciano,R.F.",2016
KX505425,B,2014,27500724,Defective proviruses rapidly accumulate during acute HIV-1 infection,"Bruner,K.M., Murray,A.J., Pollack,R.A., Soliman,M.G., Laskey,S.B., Capoferri,A.A., Lai,J., Strain,M.C., Lada,S.M., Hoh,R., Ho,Y.C., Richman,D.D., Deeks,S.G., Siliciano,J.D. and Siliciano,R.F.",2016
KX505435,B,2014,27500724,Defective proviruses rapidly accumulate during acute HIV-1 infection,"Bruner,K.M., Murray,A.J., Pollack,R.A., Soliman,M.G., Laskey,S.B., Capoferri,A.A., Lai,J., Strain,M.C., Lada,S.M., Hoh,R., Ho,Y.C., Richman,D.D., Deeks,S.G., Siliciano,J.D. and Siliciano,R.F.",2016
KX505441,B,2015,27500724,Defective proviruses rapidly accumulate during acute HIV-1 infection,"Bruner,K.M., Murray,A.J., Pollack,R.A., Soliman,M.G., Laskey,S.B., Capoferri,A.A., Lai,J., Strain,M.C., Lada,S.M., Hoh,R., Ho,Y.C., Richman,D.D., Deeks,S.G., Siliciano,J.D. and Siliciano,R.F.",2016
KX505460,B,2014,27500724,Defective proviruses rapidly accumulate during acute HIV-1 infection,"Bruner,K.M., Murray,A.J., Pollack,R.A., Soliman,M.G., Laskey,S.B., Capoferri,A.A., Lai,J., Strain,M.C., Lada,S.M., Hoh,R., Ho,Y.C., Richman,D.D., Deeks,S.G., Siliciano,J.D. and Siliciano,R.F.",2016
KX505496,B,2014,27500724,Defective proviruses rapidly accumulate during acute HIV-1 infection,"Bruner,K.M., Murray,A.J., Pollack,R.A., Soliman,M.G., Laskey,S.B., Capoferri,A.A., Lai,J., Strain,M.C., Lada,S.M., Hoh,R., Ho,Y.C., Richman,D.D., Deeks,S.G., Siliciano,J.D. and Siliciano,R.F.",2016
KX505521,B,2016,27500724,Defective proviruses rapidly accumulate during acute HIV-1 infection,"Bruner,K.M., Murray,A.J., Pollack,R.A., Soliman,M.G., Laskey,S.B., Capoferri,A.A., Lai,J., Strain,M.C., Lada,S.M., Hoh,R., Ho,Y.C., Richman,D.D., Deeks,S.G., Siliciano,J.D. and Siliciano,R.F.",2016
KX505549,B,2015,27500724,Defective proviruses rapidly accumulate during acute HIV-1 infection,"Bruner,K.M., Murray,A.J., Pollack,R.A., Soliman,M.G., Laskey,S.B., Capoferri,A.A., Lai,J., Strain,M.C., Lada,S.M., Hoh,R., Ho,Y.C., Richman,D.D., Deeks,S.G., Siliciano,J.D. and Siliciano,R.F.",2016
KX505583,B,2013,27500724,Defective proviruses rapidly accumulate during acute HIV-1 infection,"Bruner,K.M., Murray,A.J., Pollack,R.A., Soliman,M.G., Laskey,S.B., Capoferri,A.A., Lai,J., Strain,M.C., Lada,S.M., Hoh,R., Ho,Y.C., Richman,D.D., Deeks,S.G., Siliciano,J.D. and Siliciano,R.F.",2016
KX505602,B,2013,27500724,Defective proviruses rapidly accumulate during acute HIV-1 infection,"Bruner,K.M., Murray,A.J., Pollack,R.A., Soliman,M.G., Laskey,S.B., Capoferri,A.A., Lai,J., Strain,M.C., Lada,S.M., Hoh,R., Ho,Y.C., Richman,D.D., Deeks,S.G., Siliciano,J.D. and Siliciano,R.F.",2016
KX505626,B,2013,27500724,Defective proviruses rapidly accumulate during acute HIV-1 infection,"Bruner,K.M., Murray,A.J., Pollack,R.A., Soliman,M.G., Laskey,S.B., Capoferri,A.A., Lai,J., Strain,M.C., Lada,S.M., Hoh,R., Ho,Y.C., Richman,D.D., Deeks,S.G., Siliciano,J.D. and Siliciano,R.F.",2016
KX505643,B,2013,27500724,Defective proviruses rapidly accumulate during acute HIV-1 infection,"Bruner,K.M., Murray,A.J., Pollack,R.A., Soliman,M.G., Laskey,S.B., Capoferri,A.A., Lai,J., Strain,M.C., Lada,S.M., Hoh,R., Ho,Y.C., Richman,D.D., Deeks,S.G., Siliciano,J.D. and Siliciano,R.F.",2016
KX505649,B,2013,27500724,Defective proviruses rapidly accumulate during acute HIV-1 infection,"Bruner,K.M., Murray,A.J., Pollack,R.A., Soliman,M.G., Laskey,S.B., Capoferri,A.A., Lai,J., Strain,M.C., Lada,S.M., Hoh,R., Ho,Y.C., Richman,D.D., Deeks,S.G., Siliciano,J.D. and Siliciano,R.F.",2016
KX505663,B,2013,27500724,Defective proviruses rapidly accumulate during acute HIV-1 infection,"Bruner,K.M., Murray,A.J., Pollack,R.A., Soliman,M.G., Laskey,S.B., Capoferri,A.A., Lai,J., Strain,M.C., Lada,S.M., Hoh,R., Ho,Y.C., Richman,D.D., Deeks,S.G., Siliciano,J.D. and Siliciano,R.F.",2016
KX505695,B,2013,27500724,Defective proviruses rapidly accumulate during acute HIV-1 infection,"Bruner,K.M., Murray,A.J., Pollack,R.A., Soliman,M.G., Laskey,S.B., Capoferri,A.A., Lai,J., Strain,M.C., Lada,S.M., Hoh,R., Ho,Y.C., Richman,D.D., Deeks,S.G., Siliciano,J.D. and Siliciano,R.F.",2016
KX505707,B,2013,27500724,Defective proviruses rapidly accumulate during acute HIV-1 infection,"Bruner,K.M., Murray,A.J., Pollack,R.A., Soliman,M.G., Laskey,S.B., Capoferri,A.A., Lai,J., Strain,M.C., Lada,S.M., Hoh,R., Ho,Y.C., Richman,D.D., Deeks,S.G., Siliciano,J.D. and Siliciano,R.F.",2016
KX505729,B,2014,27500724,Defective proviruses rapidly accumulate during acute HIV-1 infection,"Bruner,K.M., Murray,A.J., Pollack,R.A., Soliman,M.G., Laskey,S.B., Capoferri,A.A., Lai,J., Strain,M.C., Lada,S.M., Hoh,R., Ho,Y.C., Richman,D.D., Deeks,S.G., Siliciano,J.D. and Siliciano,R.F.",2016
KX517915,B,2015,27959728,Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption,"Bar,K.J., Sneller,M.C., Harrison,L.J., Justement,J.S., Overton,E.T., Petrone,M.E., Salantes,D.B., Seamon,C.A., Scheinfeld,B., Kwan,R.W., Learn,G.H., Proschan,M.A., Kreider,E.F., Blazkova,J., Bardsley,M., Refsland,E.W., Messer,M., Clarridge,K.E., Tustin,N.B., Madden,P.J., Oden,K., O'Dell,S.J., Jarocki,B., Shiakolas,A.R., Tressler,R.L., Doria-Rose,N.A., Bailer,R.T., Ledgerwood,J.E., Capparelli,E.V., Lynch,R.M., Graham,B.S., Moir,S., Koup,R.A., Mascola,J.R., Hoxie,J.A., Fauci,A.S., Tebas,P. and Chun,T.W.",2037
KX517966,B,2015,27959728,Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption,"Bar,K.J., Sneller,M.C., Harrison,L.J., Justement,J.S., Overton,E.T., Petrone,M.E., Salantes,D.B., Seamon,C.A., Scheinfeld,B., Kwan,R.W., Learn,G.H., Proschan,M.A., Kreider,E.F., Blazkova,J., Bardsley,M., Refsland,E.W., Messer,M., Clarridge,K.E., Tustin,N.B., Madden,P.J., Oden,K., O'Dell,S.J., Jarocki,B., Shiakolas,A.R., Tressler,R.L., Doria-Rose,N.A., Bailer,R.T., Ledgerwood,J.E., Capparelli,E.V., Lynch,R.M., Graham,B.S., Moir,S., Koup,R.A., Mascola,J.R., Hoxie,J.A., Fauci,A.S., Tebas,P. and Chun,T.W.",2037
KX518115,B,2015,27959728,Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption,"Bar,K.J., Sneller,M.C., Harrison,L.J., Justement,J.S., Overton,E.T., Petrone,M.E., Salantes,D.B., Seamon,C.A., Scheinfeld,B., Kwan,R.W., Learn,G.H., Proschan,M.A., Kreider,E.F., Blazkova,J., Bardsley,M., Refsland,E.W., Messer,M., Clarridge,K.E., Tustin,N.B., Madden,P.J., Oden,K., O'Dell,S.J., Jarocki,B., Shiakolas,A.R., Tressler,R.L., Doria-Rose,N.A., Bailer,R.T., Ledgerwood,J.E., Capparelli,E.V., Lynch,R.M., Graham,B.S., Moir,S., Koup,R.A., Mascola,J.R., Hoxie,J.A., Fauci,A.S., Tebas,P. and Chun,T.W.",2037
KX518154,B,2008,27959728,Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption,"Bar,K.J., Sneller,M.C., Harrison,L.J., Justement,J.S., Overton,E.T., Petrone,M.E., Salantes,D.B., Seamon,C.A., Scheinfeld,B., Kwan,R.W., Learn,G.H., Proschan,M.A., Kreider,E.F., Blazkova,J., Bardsley,M., Refsland,E.W., Messer,M., Clarridge,K.E., Tustin,N.B., Madden,P.J., Oden,K., O'Dell,S.J., Jarocki,B., Shiakolas,A.R., Tressler,R.L., Doria-Rose,N.A., Bailer,R.T., Ledgerwood,J.E., Capparelli,E.V., Lynch,R.M., Graham,B.S., Moir,S., Koup,R.A., Mascola,J.R., Hoxie,J.A., Fauci,A.S., Tebas,P. and Chun,T.W.",2037
KX518215,B,2015,27959728,Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption,"Bar,K.J., Sneller,M.C., Harrison,L.J., Justement,J.S., Overton,E.T., Petrone,M.E., Salantes,D.B., Seamon,C.A., Scheinfeld,B., Kwan,R.W., Learn,G.H., Proschan,M.A., Kreider,E.F., Blazkova,J., Bardsley,M., Refsland,E.W., Messer,M., Clarridge,K.E., Tustin,N.B., Madden,P.J., Oden,K., O'Dell,S.J., Jarocki,B., Shiakolas,A.R., Tressler,R.L., Doria-Rose,N.A., Bailer,R.T., Ledgerwood,J.E., Capparelli,E.V., Lynch,R.M., Graham,B.S., Moir,S., Koup,R.A., Mascola,J.R., Hoxie,J.A., Fauci,A.S., Tebas,P. and Chun,T.W.",2037
KX579838,DO,2008,,Multiple HIV-1/m + HIV-1/o dual infections and new HIV-1/mo inter-group recombinant forms detected in Cameroon,"De Oliveira,F., Mourez,T. and Vessiere,A.",
KX582249,86_BC,2013,,"Genomic Characterization of a Novel Circulating Recombinant Form (CRF86_BC) identified from Yunnan, China","Feng,Y., Xia,X., Li,Y., Miao,J., Miao,Z., Song,Y., Wen,M., Zhang,Y., Guo,S. and Zhao,Y.",
KX582250,86_BC,2013,,"Genomic Characterization of a Novel Circulating Recombinant Form (CRF86_BC) identified from Yunnan, China","Feng,Y., Xia,X., Li,Y., Miao,J., Miao,Z., Song,Y., Wen,M., Zhang,Y., Guo,S. and Zhao,Y.",
KX582251,86_BC,2013,,"Genomic Characterization of a Novel Circulating Recombinant Form (CRF86_BC) identified from Yunnan, China","Feng,Y., Xia,X., Li,Y., Miao,J., Miao,Z., Song,Y., Wen,M., Zhang,Y., Guo,S. and Zhao,Y.",
KX587007,B,2015,27959728,Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption,"Bar,K.J., Sneller,M.C., Harrison,L.J., Justement,J.S., Overton,E.T., Petrone,M.E., Salantes,D.B., Seamon,C.A., Scheinfeld,B., Kwan,R.W., Learn,G.H., Proschan,M.A., Kreider,E.F., Blazkova,J., Bardsley,M., Refsland,E.W., Messer,M., Clarridge,K.E., Tustin,N.B., Madden,P.J., Oden,K., O'Dell,S.J., Jarocki,B., Shiakolas,A.R., Tressler,R.L., Doria-Rose,N.A., Bailer,R.T., Ledgerwood,J.E., Capparelli,E.V., Lynch,R.M., Graham,B.S., Moir,S., Koup,R.A., Mascola,J.R., Hoxie,J.A., Fauci,A.S., Tebas,P. and Chun,T.W.",2037
KX587035,B,2010,27959728,Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption,"Bar,K.J., Sneller,M.C., Harrison,L.J., Justement,J.S., Overton,E.T., Petrone,M.E., Salantes,D.B., Seamon,C.A., Scheinfeld,B., Kwan,R.W., Learn,G.H., Proschan,M.A., Kreider,E.F., Blazkova,J., Bardsley,M., Refsland,E.W., Messer,M., Clarridge,K.E., Tustin,N.B., Madden,P.J., Oden,K., O'Dell,S.J., Jarocki,B., Shiakolas,A.R., Tressler,R.L., Doria-Rose,N.A., Bailer,R.T., Ledgerwood,J.E., Capparelli,E.V., Lynch,R.M., Graham,B.S., Moir,S., Koup,R.A., Mascola,J.R., Hoxie,J.A., Fauci,A.S., Tebas,P. and Chun,T.W.",2037
KX587074,B,2012,27959728,Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption,"Bar,K.J., Sneller,M.C., Harrison,L.J., Justement,J.S., Overton,E.T., Petrone,M.E., Salantes,D.B., Seamon,C.A., Scheinfeld,B., Kwan,R.W., Learn,G.H., Proschan,M.A., Kreider,E.F., Blazkova,J., Bardsley,M., Refsland,E.W., Messer,M., Clarridge,K.E., Tustin,N.B., Madden,P.J., Oden,K., O'Dell,S.J., Jarocki,B., Shiakolas,A.R., Tressler,R.L., Doria-Rose,N.A., Bailer,R.T., Ledgerwood,J.E., Capparelli,E.V., Lynch,R.M., Graham,B.S., Moir,S., Koup,R.A., Mascola,J.R., Hoxie,J.A., Fauci,A.S., Tebas,P. and Chun,T.W.",2037
KX587114,B,2010,27959728,Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption,"Bar,K.J., Sneller,M.C., Harrison,L.J., Justement,J.S., Overton,E.T., Petrone,M.E., Salantes,D.B., Seamon,C.A., Scheinfeld,B., Kwan,R.W., Learn,G.H., Proschan,M.A., Kreider,E.F., Blazkova,J., Bardsley,M., Refsland,E.W., Messer,M., Clarridge,K.E., Tustin,N.B., Madden,P.J., Oden,K., O'Dell,S.J., Jarocki,B., Shiakolas,A.R., Tressler,R.L., Doria-Rose,N.A., Bailer,R.T., Ledgerwood,J.E., Capparelli,E.V., Lynch,R.M., Graham,B.S., Moir,S., Koup,R.A., Mascola,J.R., Hoxie,J.A., Fauci,A.S., Tebas,P. and Chun,T.W.",2037
KX587162,B,2006,27959728,Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption,"Bar,K.J., Sneller,M.C., Harrison,L.J., Justement,J.S., Overton,E.T., Petrone,M.E., Salantes,D.B., Seamon,C.A., Scheinfeld,B., Kwan,R.W., Learn,G.H., Proschan,M.A., Kreider,E.F., Blazkova,J., Bardsley,M., Refsland,E.W., Messer,M., Clarridge,K.E., Tustin,N.B., Madden,P.J., Oden,K., O'Dell,S.J., Jarocki,B., Shiakolas,A.R., Tressler,R.L., Doria-Rose,N.A., Bailer,R.T., Ledgerwood,J.E., Capparelli,E.V., Lynch,R.M., Graham,B.S., Moir,S., Koup,R.A., Mascola,J.R., Hoxie,J.A., Fauci,A.S., Tebas,P. and Chun,T.W.",2037
KX587201,B,2009,27959728,Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption,"Bar,K.J., Sneller,M.C., Harrison,L.J., Justement,J.S., Overton,E.T., Petrone,M.E., Salantes,D.B., Seamon,C.A., Scheinfeld,B., Kwan,R.W., Learn,G.H., Proschan,M.A., Kreider,E.F., Blazkova,J., Bardsley,M., Refsland,E.W., Messer,M., Clarridge,K.E., Tustin,N.B., Madden,P.J., Oden,K., O'Dell,S.J., Jarocki,B., Shiakolas,A.R., Tressler,R.L., Doria-Rose,N.A., Bailer,R.T., Ledgerwood,J.E., Capparelli,E.V., Lynch,R.M., Graham,B.S., Moir,S., Koup,R.A., Mascola,J.R., Hoxie,J.A., Fauci,A.S., Tebas,P. and Chun,T.W.",2037
KX587239,B,2010,27959728,Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption,"Bar,K.J., Sneller,M.C., Harrison,L.J., Justement,J.S., Overton,E.T., Petrone,M.E., Salantes,D.B., Seamon,C.A., Scheinfeld,B., Kwan,R.W., Learn,G.H., Proschan,M.A., Kreider,E.F., Blazkova,J., Bardsley,M., Refsland,E.W., Messer,M., Clarridge,K.E., Tustin,N.B., Madden,P.J., Oden,K., O'Dell,S.J., Jarocki,B., Shiakolas,A.R., Tressler,R.L., Doria-Rose,N.A., Bailer,R.T., Ledgerwood,J.E., Capparelli,E.V., Lynch,R.M., Graham,B.S., Moir,S., Koup,R.A., Mascola,J.R., Hoxie,J.A., Fauci,A.S., Tebas,P. and Chun,T.W.",2037
KX587277,B,2015,27959728,Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption,"Bar,K.J., Sneller,M.C., Harrison,L.J., Justement,J.S., Overton,E.T., Petrone,M.E., Salantes,D.B., Seamon,C.A., Scheinfeld,B., Kwan,R.W., Learn,G.H., Proschan,M.A., Kreider,E.F., Blazkova,J., Bardsley,M., Refsland,E.W., Messer,M., Clarridge,K.E., Tustin,N.B., Madden,P.J., Oden,K., O'Dell,S.J., Jarocki,B., Shiakolas,A.R., Tressler,R.L., Doria-Rose,N.A., Bailer,R.T., Ledgerwood,J.E., Capparelli,E.V., Lynch,R.M., Graham,B.S., Moir,S., Koup,R.A., Mascola,J.R., Hoxie,J.A., Fauci,A.S., Tebas,P. and Chun,T.W.",2037
KX587296,B,2010,27959728,Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption,"Bar,K.J., Sneller,M.C., Harrison,L.J., Justement,J.S., Overton,E.T., Petrone,M.E., Salantes,D.B., Seamon,C.A., Scheinfeld,B., Kwan,R.W., Learn,G.H., Proschan,M.A., Kreider,E.F., Blazkova,J., Bardsley,M., Refsland,E.W., Messer,M., Clarridge,K.E., Tustin,N.B., Madden,P.J., Oden,K., O'Dell,S.J., Jarocki,B., Shiakolas,A.R., Tressler,R.L., Doria-Rose,N.A., Bailer,R.T., Ledgerwood,J.E., Capparelli,E.V., Lynch,R.M., Graham,B.S., Moir,S., Koup,R.A., Mascola,J.R., Hoxie,J.A., Fauci,A.S., Tebas,P. and Chun,T.W.",2037
KX587339,B,2015,27959728,Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption,"Bar,K.J., Sneller,M.C., Harrison,L.J., Justement,J.S., Overton,E.T., Petrone,M.E., Salantes,D.B., Seamon,C.A., Scheinfeld,B., Kwan,R.W., Learn,G.H., Proschan,M.A., Kreider,E.F., Blazkova,J., Bardsley,M., Refsland,E.W., Messer,M., Clarridge,K.E., Tustin,N.B., Madden,P.J., Oden,K., O'Dell,S.J., Jarocki,B., Shiakolas,A.R., Tressler,R.L., Doria-Rose,N.A., Bailer,R.T., Ledgerwood,J.E., Capparelli,E.V., Lynch,R.M., Graham,B.S., Moir,S., Koup,R.A., Mascola,J.R., Hoxie,J.A., Fauci,A.S., Tebas,P. and Chun,T.W.",2037
KX587376,B,2009,27959728,Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption,"Bar,K.J., Sneller,M.C., Harrison,L.J., Justement,J.S., Overton,E.T., Petrone,M.E., Salantes,D.B., Seamon,C.A., Scheinfeld,B., Kwan,R.W., Learn,G.H., Proschan,M.A., Kreider,E.F., Blazkova,J., Bardsley,M., Refsland,E.W., Messer,M., Clarridge,K.E., Tustin,N.B., Madden,P.J., Oden,K., O'Dell,S.J., Jarocki,B., Shiakolas,A.R., Tressler,R.L., Doria-Rose,N.A., Bailer,R.T., Ledgerwood,J.E., Capparelli,E.V., Lynch,R.M., Graham,B.S., Moir,S., Koup,R.A., Mascola,J.R., Hoxie,J.A., Fauci,A.S., Tebas,P. and Chun,T.W.",2037
KX587433,B,2016,27959728,Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption,"Bar,K.J., Sneller,M.C., Harrison,L.J., Justement,J.S., Overton,E.T., Petrone,M.E., Salantes,D.B., Seamon,C.A., Scheinfeld,B., Kwan,R.W., Learn,G.H., Proschan,M.A., Kreider,E.F., Blazkova,J., Bardsley,M., Refsland,E.W., Messer,M., Clarridge,K.E., Tustin,N.B., Madden,P.J., Oden,K., O'Dell,S.J., Jarocki,B., Shiakolas,A.R., Tressler,R.L., Doria-Rose,N.A., Bailer,R.T., Ledgerwood,J.E., Capparelli,E.V., Lynch,R.M., Graham,B.S., Moir,S., Koup,R.A., Mascola,J.R., Hoxie,J.A., Fauci,A.S., Tebas,P. and Chun,T.W.",2037
KX587448,B,2016,27959728,Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption,"Bar,K.J., Sneller,M.C., Harrison,L.J., Justement,J.S., Overton,E.T., Petrone,M.E., Salantes,D.B., Seamon,C.A., Scheinfeld,B., Kwan,R.W., Learn,G.H., Proschan,M.A., Kreider,E.F., Blazkova,J., Bardsley,M., Refsland,E.W., Messer,M., Clarridge,K.E., Tustin,N.B., Madden,P.J., Oden,K., O'Dell,S.J., Jarocki,B., Shiakolas,A.R., Tressler,R.L., Doria-Rose,N.A., Bailer,R.T., Ledgerwood,J.E., Capparelli,E.V., Lynch,R.M., Graham,B.S., Moir,S., Koup,R.A., Mascola,J.R., Hoxie,J.A., Fauci,A.S., Tebas,P. and Chun,T.W.",2037
KX595119,B,2012,27851912,Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth,"Huang,J., Kang,B.H., Ishida,E., Zhou,T., Griesman,T., Sheng,Z., Wu,F., Doria-Rose,N.A., Zhang,B., McKee,K., O'Dell,S., Chuang,G.Y., Druz,A., Georgiev,I.S., Schramm,C.A., Zheng,A., Joyce,M.G., Asokan,M., Ransier,A., Darko,S., Migueles,S.A., Bailer,R.T., Louder,M.K., Alam,S.M., Parks,R., Kelsoe,G., Von Holle,T., Haynes,B.F., Douek,D.C., Hirsch,V., Seaman,M.S., Shapiro,L., Mascola,J.R., Kwong,P.D. and Connors,M.",2016
KX692903,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX692925,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX692941,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX692948,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX692969,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX692980,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX692997,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693025,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693036,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693054,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693065,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693075,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693092,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693099,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693100,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693113,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693131,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693150,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693166,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693171,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693190,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693215,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693238,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693247,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693265,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693281,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693301,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693308,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693314,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693322,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693338,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693357,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693366,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693387,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693393,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693415,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693430,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693454,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693468,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693475,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693489,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693491,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693496,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693515,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX693533,B,2012,,Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy: implication for predicting treatment outcome and designing individual therapeutic regimen,"Ouyang,Y., Yin,Q., Li,Z. and Ma,L.",
KX702368,B,1992,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type I,"Cho,Y.-K.",
KX756600,C,2014,28401776,Molecular characteristics of the envelope of vertically transmitted HIV-1 strains from infants with HIV infection,"Ashokkumar,M., Nesakumar,M., Narayanaiah,C., Kk,V.V., Hemalatha,B., Tripathy,S.P. and Hanna,L.E.",2017
KX756601,C,2014,28401776,Molecular characteristics of the envelope of vertically transmitted HIV-1 strains from infants with HIV infection,"Ashokkumar,M., Nesakumar,M., Narayanaiah,C., Kk,V.V., Hemalatha,B., Tripathy,S.P. and Hanna,L.E.",2017
KX756602,C,2013,28401776,Molecular characteristics of the envelope of vertically transmitted HIV-1 strains from infants with HIV infection,"Ashokkumar,M., Nesakumar,M., Narayanaiah,C., Kk,V.V., Hemalatha,B., Tripathy,S.P. and Hanna,L.E.",2017
KX756603,C,2014,28401776,Molecular characteristics of the envelope of vertically transmitted HIV-1 strains from infants with HIV infection,"Ashokkumar,M., Nesakumar,M., Narayanaiah,C., Kk,V.V., Hemalatha,B., Tripathy,S.P. and Hanna,L.E.",2017
KX756604,C,2014,28401776,Molecular characteristics of the envelope of vertically transmitted HIV-1 strains from infants with HIV infection,"Ashokkumar,M., Nesakumar,M., Narayanaiah,C., Kk,V.V., Hemalatha,B., Tripathy,S.P. and Hanna,L.E.",2017
KX756605,C,2014,28401776,Molecular characteristics of the envelope of vertically transmitted HIV-1 strains from infants with HIV infection,"Ashokkumar,M., Nesakumar,M., Narayanaiah,C., Kk,V.V., Hemalatha,B., Tripathy,S.P. and Hanna,L.E.",2017
KX756606,C,2014,28401776,Molecular characteristics of the envelope of vertically transmitted HIV-1 strains from infants with HIV infection,"Ashokkumar,M., Nesakumar,M., Narayanaiah,C., Kk,V.V., Hemalatha,B., Tripathy,S.P. and Hanna,L.E.",2017
KX756607,C,2014,28401776,Molecular characteristics of the envelope of vertically transmitted HIV-1 strains from infants with HIV infection,"Ashokkumar,M., Nesakumar,M., Narayanaiah,C., Kk,V.V., Hemalatha,B., Tripathy,S.P. and Hanna,L.E.",2017
KX756608,C,2014,28401776,Molecular characteristics of the envelope of vertically transmitted HIV-1 strains from infants with HIV infection,"Ashokkumar,M., Nesakumar,M., Narayanaiah,C., Kk,V.V., Hemalatha,B., Tripathy,S.P. and Hanna,L.E.",2017
KX756609,C,2014,28401776,Molecular characteristics of the envelope of vertically transmitted HIV-1 strains from infants with HIV infection,"Ashokkumar,M., Nesakumar,M., Narayanaiah,C., Kk,V.V., Hemalatha,B., Tripathy,S.P. and Hanna,L.E.",2017
KX756610,C,2013,28401776,Molecular characteristics of the envelope of vertically transmitted HIV-1 strains from infants with HIV infection,"Ashokkumar,M., Nesakumar,M., Narayanaiah,C., Kk,V.V., Hemalatha,B., Tripathy,S.P. and Hanna,L.E.",2017
KX756611,C,2013,28401776,Molecular characteristics of the envelope of vertically transmitted HIV-1 strains from infants with HIV infection,"Ashokkumar,M., Nesakumar,M., Narayanaiah,C., Kk,V.V., Hemalatha,B., Tripathy,S.P. and Hanna,L.E.",2017
KX756612,C,2013,28401776,Molecular characteristics of the envelope of vertically transmitted HIV-1 strains from infants with HIV infection,"Ashokkumar,M., Nesakumar,M., Narayanaiah,C., Kk,V.V., Hemalatha,B., Tripathy,S.P. and Hanna,L.E.",2017
KX756613,C,2013,28401776,Molecular characteristics of the envelope of vertically transmitted HIV-1 strains from infants with HIV infection,"Ashokkumar,M., Nesakumar,M., Narayanaiah,C., Kk,V.V., Hemalatha,B., Tripathy,S.P. and Hanna,L.E.",2017
KX756614,C,2013,28401776,Molecular characteristics of the envelope of vertically transmitted HIV-1 strains from infants with HIV infection,"Ashokkumar,M., Nesakumar,M., Narayanaiah,C., Kk,V.V., Hemalatha,B., Tripathy,S.P. and Hanna,L.E.",2017
KX756615,C,2013,28401776,Molecular characteristics of the envelope of vertically transmitted HIV-1 strains from infants with HIV infection,"Ashokkumar,M., Nesakumar,M., Narayanaiah,C., Kk,V.V., Hemalatha,B., Tripathy,S.P. and Hanna,L.E.",2017
KX792557,B,2003,27595568,Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs,"Oberle,C.S., Joos,B., Rusert,P., Campbell,N.K., Beauparlant,D., Kuster,H., Weber,J., Schenkel,C.D., Scherrer,A.U., Magnus,C., Kouyos,R., Rieder,P., Niederost,B., Braun,D.L., Pavlovic,J., Boni,J., Yerly,S., Klimkait,T., Aubert,V., Trkola,A., Metzner,K.J. and Gunthard,H.F.",2016
KX792565,B,2003,27595568,Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs,"Oberle,C.S., Joos,B., Rusert,P., Campbell,N.K., Beauparlant,D., Kuster,H., Weber,J., Schenkel,C.D., Scherrer,A.U., Magnus,C., Kouyos,R., Rieder,P., Niederost,B., Braun,D.L., Pavlovic,J., Boni,J., Yerly,S., Klimkait,T., Aubert,V., Trkola,A., Metzner,K.J. and Gunthard,H.F.",2016
KX792587,B,2004,27595568,Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs,"Oberle,C.S., Joos,B., Rusert,P., Campbell,N.K., Beauparlant,D., Kuster,H., Weber,J., Schenkel,C.D., Scherrer,A.U., Magnus,C., Kouyos,R., Rieder,P., Niederost,B., Braun,D.L., Pavlovic,J., Boni,J., Yerly,S., Klimkait,T., Aubert,V., Trkola,A., Metzner,K.J. and Gunthard,H.F.",2016
KX792606,B,2002,27595568,Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs,"Oberle,C.S., Joos,B., Rusert,P., Campbell,N.K., Beauparlant,D., Kuster,H., Weber,J., Schenkel,C.D., Scherrer,A.U., Magnus,C., Kouyos,R., Rieder,P., Niederost,B., Braun,D.L., Pavlovic,J., Boni,J., Yerly,S., Klimkait,T., Aubert,V., Trkola,A., Metzner,K.J. and Gunthard,H.F.",2016
KX792634,B,2002,27595568,Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs,"Oberle,C.S., Joos,B., Rusert,P., Campbell,N.K., Beauparlant,D., Kuster,H., Weber,J., Schenkel,C.D., Scherrer,A.U., Magnus,C., Kouyos,R., Rieder,P., Niederost,B., Braun,D.L., Pavlovic,J., Boni,J., Yerly,S., Klimkait,T., Aubert,V., Trkola,A., Metzner,K.J. and Gunthard,H.F.",2016
KX792657,B,2006,27595568,Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs,"Oberle,C.S., Joos,B., Rusert,P., Campbell,N.K., Beauparlant,D., Kuster,H., Weber,J., Schenkel,C.D., Scherrer,A.U., Magnus,C., Kouyos,R., Rieder,P., Niederost,B., Braun,D.L., Pavlovic,J., Boni,J., Yerly,S., Klimkait,T., Aubert,V., Trkola,A., Metzner,K.J. and Gunthard,H.F.",2016
KX792677,B,2005,27595568,Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs,"Oberle,C.S., Joos,B., Rusert,P., Campbell,N.K., Beauparlant,D., Kuster,H., Weber,J., Schenkel,C.D., Scherrer,A.U., Magnus,C., Kouyos,R., Rieder,P., Niederost,B., Braun,D.L., Pavlovic,J., Boni,J., Yerly,S., Klimkait,T., Aubert,V., Trkola,A., Metzner,K.J. and Gunthard,H.F.",2016
KX792688,B,2006,27595568,Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs,"Oberle,C.S., Joos,B., Rusert,P., Campbell,N.K., Beauparlant,D., Kuster,H., Weber,J., Schenkel,C.D., Scherrer,A.U., Magnus,C., Kouyos,R., Rieder,P., Niederost,B., Braun,D.L., Pavlovic,J., Boni,J., Yerly,S., Klimkait,T., Aubert,V., Trkola,A., Metzner,K.J. and Gunthard,H.F.",2016
KX792706,B,2007,27595568,Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs,"Oberle,C.S., Joos,B., Rusert,P., Campbell,N.K., Beauparlant,D., Kuster,H., Weber,J., Schenkel,C.D., Scherrer,A.U., Magnus,C., Kouyos,R., Rieder,P., Niederost,B., Braun,D.L., Pavlovic,J., Boni,J., Yerly,S., Klimkait,T., Aubert,V., Trkola,A., Metzner,K.J. and Gunthard,H.F.",2016
KX792725,B,2007,27595568,Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs,"Oberle,C.S., Joos,B., Rusert,P., Campbell,N.K., Beauparlant,D., Kuster,H., Weber,J., Schenkel,C.D., Scherrer,A.U., Magnus,C., Kouyos,R., Rieder,P., Niederost,B., Braun,D.L., Pavlovic,J., Boni,J., Yerly,S., Klimkait,T., Aubert,V., Trkola,A., Metzner,K.J. and Gunthard,H.F.",2016
KX792750,B,2007,27595568,Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs,"Oberle,C.S., Joos,B., Rusert,P., Campbell,N.K., Beauparlant,D., Kuster,H., Weber,J., Schenkel,C.D., Scherrer,A.U., Magnus,C., Kouyos,R., Rieder,P., Niederost,B., Braun,D.L., Pavlovic,J., Boni,J., Yerly,S., Klimkait,T., Aubert,V., Trkola,A., Metzner,K.J. and Gunthard,H.F.",2016
KX792768,B,2007,27595568,Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs,"Oberle,C.S., Joos,B., Rusert,P., Campbell,N.K., Beauparlant,D., Kuster,H., Weber,J., Schenkel,C.D., Scherrer,A.U., Magnus,C., Kouyos,R., Rieder,P., Niederost,B., Braun,D.L., Pavlovic,J., Boni,J., Yerly,S., Klimkait,T., Aubert,V., Trkola,A., Metzner,K.J. and Gunthard,H.F.",2016
KX792798,B,2007,27595568,Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs,"Oberle,C.S., Joos,B., Rusert,P., Campbell,N.K., Beauparlant,D., Kuster,H., Weber,J., Schenkel,C.D., Scherrer,A.U., Magnus,C., Kouyos,R., Rieder,P., Niederost,B., Braun,D.L., Pavlovic,J., Boni,J., Yerly,S., Klimkait,T., Aubert,V., Trkola,A., Metzner,K.J. and Gunthard,H.F.",2016
KX792808,B,2008,27595568,Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs,"Oberle,C.S., Joos,B., Rusert,P., Campbell,N.K., Beauparlant,D., Kuster,H., Weber,J., Schenkel,C.D., Scherrer,A.U., Magnus,C., Kouyos,R., Rieder,P., Niederost,B., Braun,D.L., Pavlovic,J., Boni,J., Yerly,S., Klimkait,T., Aubert,V., Trkola,A., Metzner,K.J. and Gunthard,H.F.",2016
KX792813,B,2008,27595568,Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs,"Oberle,C.S., Joos,B., Rusert,P., Campbell,N.K., Beauparlant,D., Kuster,H., Weber,J., Schenkel,C.D., Scherrer,A.U., Magnus,C., Kouyos,R., Rieder,P., Niederost,B., Braun,D.L., Pavlovic,J., Boni,J., Yerly,S., Klimkait,T., Aubert,V., Trkola,A., Metzner,K.J. and Gunthard,H.F.",2016
KX792831,B,2003,27595568,Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs,"Oberle,C.S., Joos,B., Rusert,P., Campbell,N.K., Beauparlant,D., Kuster,H., Weber,J., Schenkel,C.D., Scherrer,A.U., Magnus,C., Kouyos,R., Rieder,P., Niederost,B., Braun,D.L., Pavlovic,J., Boni,J., Yerly,S., Klimkait,T., Aubert,V., Trkola,A., Metzner,K.J. and Gunthard,H.F.",2016
KX792852,B,2003,27595568,Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs,"Oberle,C.S., Joos,B., Rusert,P., Campbell,N.K., Beauparlant,D., Kuster,H., Weber,J., Schenkel,C.D., Scherrer,A.U., Magnus,C., Kouyos,R., Rieder,P., Niederost,B., Braun,D.L., Pavlovic,J., Boni,J., Yerly,S., Klimkait,T., Aubert,V., Trkola,A., Metzner,K.J. and Gunthard,H.F.",2016
KX907336,A1,2004,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907337,C,2004,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907338,C,2005,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907339,C,2003,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907340,A1C,2004,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907341,A1,2005,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907342,A1C,2003,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907343,A1,2004,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907344,A1CD,2003,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907345,C,2004,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907346,A1,2006,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907347,A1,2005,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907348,A1,2003,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907349,C,2006,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907350,A1CD,2004,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907351,A1CD,2004,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907353,A1CD,2004,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907354,A1C,2003,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907355,A1D,2004,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907356,C,2003,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907357,C,2005,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907358,C,2003,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907359,CD,2006,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907360,A1C,2006,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907361,A1D,2004,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907362,A1C,2006,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907363,C,2005,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907364,A1,2005,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907365,A1CD,2004,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907366,C,2005,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907367,A1C,2004,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907368,C,2006,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907369,A1C,2003,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907370,A1CD,2005,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907371,CD,2004,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907372,A1,2004,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907373,A1C,2003,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907374,C,2005,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907375,C,2006,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907376,A1D,2003,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907377,A1C,2003,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907378,A1,2006,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907379,A1C,2003,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907380,C,2005,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907381,A1C,2006,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907382,C,2005,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907383,A1,2004,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907384,C,2004,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907385,C,2005,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907386,A1C,2006,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907387,A1CD,2004,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907388,C,2003,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907389,A1,2004,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907390,C,2006,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907391,C,2006,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907392,C,2004,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907393,C,2006,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907394,C,2004,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907395,C,2004,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907396,A1CD,2004,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907397,A1CD,2003,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907398,C,2005,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907399,C,2006,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907400,C,2006,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907401,A1,2005,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907402,A1CD,2005,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907403,A1C,2004,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907405,C,2004,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907406,D,2004,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907407,C,2003,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907408,CD,2004,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907409,A1C,2004,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907410,A1C,2004,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907411,41_CD,2005,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907412,A1,2005,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907413,C,2004,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907414,A1,2006,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907415,C,2004,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907416,C,2005,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907417,41_CD,2003,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907418,A1C,2005,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907419,A1CD,2004,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907420,C,2005,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907421,CD,2005,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907422,C,2004,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907423,A1,2006,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907424,C,2003,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907425,C,2006,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907426,C,2003,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907427,A1C,2004,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907428,C,2006,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907429,A1C,2006,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907430,41_CD,2003,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907431,A1,2006,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907432,CD,2004,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX907433,C,2003,27841669,"HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania","Billings,E., Sanders-Buell,E., Bose,M., Kijak,G.H., Bradfield,A., Crossler,J., Arroyo,M.A., Maboko,L., Hoffmann,O., Geis,S., Birx,D.L., Kim,J.H., Michael,N.L., Robb,M.L., Hoelscher,M. and Tovanabutra,S.",2016
KX960962,B,1994,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1,"Cho,Y.K.",
KX960963,B,1992,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1,"Cho,Y.K.",
KX960964,B,1992,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1,"Cho,Y.K.",
KX960965,B,1991,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1,"Cho,Y.K.",
KX960966,B,1991,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1,"Cho,Y.K.",
KX960967,B,1991,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1,"Cho,Y.K.",
KX960968,B,1992,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1,"Cho,Y.K.",
KX960969,B,1992,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1,"Cho,Y.K.",
KX960970,B,1992,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1,"Cho,Y.K.",
KX960972,B,1993,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1,"Cho,Y.K.",
KX960973,B,1991,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1,"Cho,Y.K.",
KX960974,B,1995,,Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1,"Cho,Y.K.",
KX983542,A1,2007,27851829,"Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth","Smith,S.A., Burton,S.L., Kilembe,W., Lakhi,S., Karita,E., Price,M., Allen,S., Hunter,E. and Derdeyn,C.A.",2016
KX983566,A1,2007,27851829,"Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth","Smith,S.A., Burton,S.L., Kilembe,W., Lakhi,S., Karita,E., Price,M., Allen,S., Hunter,E. and Derdeyn,C.A.",2016
KX983624,A1,2008,27851829,"Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth","Smith,S.A., Burton,S.L., Kilembe,W., Lakhi,S., Karita,E., Price,M., Allen,S., Hunter,E. and Derdeyn,C.A.",2016
KX983643,A1,2006,27851829,"Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth","Smith,S.A., Burton,S.L., Kilembe,W., Lakhi,S., Karita,E., Price,M., Allen,S., Hunter,E. and Derdeyn,C.A.",2016
KX983685,A1C,2007,27851829,"Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth","Smith,S.A., Burton,S.L., Kilembe,W., Lakhi,S., Karita,E., Price,M., Allen,S., Hunter,E. and Derdeyn,C.A.",2016
KX983732,C,2007,27851829,"Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth","Smith,S.A., Burton,S.L., Kilembe,W., Lakhi,S., Karita,E., Price,M., Allen,S., Hunter,E. and Derdeyn,C.A.",2016
KX983765,C,2007,27851829,"Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth","Smith,S.A., Burton,S.L., Kilembe,W., Lakhi,S., Karita,E., Price,M., Allen,S., Hunter,E. and Derdeyn,C.A.",2016
KX983797,C,2006,27851829,"Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth","Smith,S.A., Burton,S.L., Kilembe,W., Lakhi,S., Karita,E., Price,M., Allen,S., Hunter,E. and Derdeyn,C.A.",2016
KX983831,C,2007,27851829,"Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth","Smith,S.A., Burton,S.L., Kilembe,W., Lakhi,S., Karita,E., Price,M., Allen,S., Hunter,E. and Derdeyn,C.A.",2016
KX983851,C,2008,27851829,"Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth","Smith,S.A., Burton,S.L., Kilembe,W., Lakhi,S., Karita,E., Price,M., Allen,S., Hunter,E. and Derdeyn,C.A.",2016
KX983891,C,2007,27851829,"Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth","Smith,S.A., Burton,S.L., Kilembe,W., Lakhi,S., Karita,E., Price,M., Allen,S., Hunter,E. and Derdeyn,C.A.",2016
KX984367,B,,27338952,HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption,"Scheid,J.F., Horwitz,J.A., Bar-On,Y., Kreider,E.F., Lu,C.L., Lorenzi,J.C., Feldmann,A., Braunschweig,M., Nogueira,L., Oliveira,T., Shimeliovich,I., Patel,R., Burke,L., Cohen,Y.Z., Hadrigan,S., Settler,A., Witmer-Pack,M., West,A.P. Jr., Juelg,B., Keler,T., Hawthorne,T., Zingman,B., Gulick,R.M., Pfeifer,N., Learn,G.H., Seaman,M.S., Bjorkman,P.J., Klein,F., Schlesinger,S.J., Walker,B.D., Hahn,B.H. and Nussenzweig,M.C.",2016
KX984437,B,,27338952,HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption,"Scheid,J.F., Horwitz,J.A., Bar-On,Y., Kreider,E.F., Lu,C.L., Lorenzi,J.C., Feldmann,A., Braunschweig,M., Nogueira,L., Oliveira,T., Shimeliovich,I., Patel,R., Burke,L., Cohen,Y.Z., Hadrigan,S., Settler,A., Witmer-Pack,M., West,A.P. Jr., Juelg,B., Keler,T., Hawthorne,T., Zingman,B., Gulick,R.M., Pfeifer,N., Learn,G.H., Seaman,M.S., Bjorkman,P.J., Klein,F., Schlesinger,S.J., Walker,B.D., Hahn,B.H. and Nussenzweig,M.C.",2016
KX984523,B,,27338952,HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption,"Scheid,J.F., Horwitz,J.A., Bar-On,Y., Kreider,E.F., Lu,C.L., Lorenzi,J.C., Feldmann,A., Braunschweig,M., Nogueira,L., Oliveira,T., Shimeliovich,I., Patel,R., Burke,L., Cohen,Y.Z., Hadrigan,S., Settler,A., Witmer-Pack,M., West,A.P. Jr., Juelg,B., Keler,T., Hawthorne,T., Zingman,B., Gulick,R.M., Pfeifer,N., Learn,G.H., Seaman,M.S., Bjorkman,P.J., Klein,F., Schlesinger,S.J., Walker,B.D., Hahn,B.H. and Nussenzweig,M.C.",2016
KX984588,B,,27338952,HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption,"Scheid,J.F., Horwitz,J.A., Bar-On,Y., Kreider,E.F., Lu,C.L., Lorenzi,J.C., Feldmann,A., Braunschweig,M., Nogueira,L., Oliveira,T., Shimeliovich,I., Patel,R., Burke,L., Cohen,Y.Z., Hadrigan,S., Settler,A., Witmer-Pack,M., West,A.P. Jr., Juelg,B., Keler,T., Hawthorne,T., Zingman,B., Gulick,R.M., Pfeifer,N., Learn,G.H., Seaman,M.S., Bjorkman,P.J., Klein,F., Schlesinger,S.J., Walker,B.D., Hahn,B.H. and Nussenzweig,M.C.",2016
KX984665,B,,27338952,HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption,"Scheid,J.F., Horwitz,J.A., Bar-On,Y., Kreider,E.F., Lu,C.L., Lorenzi,J.C., Feldmann,A., Braunschweig,M., Nogueira,L., Oliveira,T., Shimeliovich,I., Patel,R., Burke,L., Cohen,Y.Z., Hadrigan,S., Settler,A., Witmer-Pack,M., West,A.P. Jr., Juelg,B., Keler,T., Hawthorne,T., Zingman,B., Gulick,R.M., Pfeifer,N., Learn,G.H., Seaman,M.S., Bjorkman,P.J., Klein,F., Schlesinger,S.J., Walker,B.D., Hahn,B.H. and Nussenzweig,M.C.",2016
KX984753,B,,27338952,HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption,"Scheid,J.F., Horwitz,J.A., Bar-On,Y., Kreider,E.F., Lu,C.L., Lorenzi,J.C., Feldmann,A., Braunschweig,M., Nogueira,L., Oliveira,T., Shimeliovich,I., Patel,R., Burke,L., Cohen,Y.Z., Hadrigan,S., Settler,A., Witmer-Pack,M., West,A.P. Jr., Juelg,B., Keler,T., Hawthorne,T., Zingman,B., Gulick,R.M., Pfeifer,N., Learn,G.H., Seaman,M.S., Bjorkman,P.J., Klein,F., Schlesinger,S.J., Walker,B.D., Hahn,B.H. and Nussenzweig,M.C.",2016
KX984836,B,,27338952,HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption,"Scheid,J.F., Horwitz,J.A., Bar-On,Y., Kreider,E.F., Lu,C.L., Lorenzi,J.C., Feldmann,A., Braunschweig,M., Nogueira,L., Oliveira,T., Shimeliovich,I., Patel,R., Burke,L., Cohen,Y.Z., Hadrigan,S., Settler,A., Witmer-Pack,M., West,A.P. Jr., Juelg,B., Keler,T., Hawthorne,T., Zingman,B., Gulick,R.M., Pfeifer,N., Learn,G.H., Seaman,M.S., Bjorkman,P.J., Klein,F., Schlesinger,S.J., Walker,B.D., Hahn,B.H. and Nussenzweig,M.C.",2016
KX984877,B,,27338952,HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption,"Scheid,J.F., Horwitz,J.A., Bar-On,Y., Kreider,E.F., Lu,C.L., Lorenzi,J.C., Feldmann,A., Braunschweig,M., Nogueira,L., Oliveira,T., Shimeliovich,I., Patel,R., Burke,L., Cohen,Y.Z., Hadrigan,S., Settler,A., Witmer-Pack,M., West,A.P. Jr., Juelg,B., Keler,T., Hawthorne,T., Zingman,B., Gulick,R.M., Pfeifer,N., Learn,G.H., Seaman,M.S., Bjorkman,P.J., Klein,F., Schlesinger,S.J., Walker,B.D., Hahn,B.H. and Nussenzweig,M.C.",2016
KX984902,B,,27338952,HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption,"Scheid,J.F., Horwitz,J.A., Bar-On,Y., Kreider,E.F., Lu,C.L., Lorenzi,J.C., Feldmann,A., Braunschweig,M., Nogueira,L., Oliveira,T., Shimeliovich,I., Patel,R., Burke,L., Cohen,Y.Z., Hadrigan,S., Settler,A., Witmer-Pack,M., West,A.P. Jr., Juelg,B., Keler,T., Hawthorne,T., Zingman,B., Gulick,R.M., Pfeifer,N., Learn,G.H., Seaman,M.S., Bjorkman,P.J., Klein,F., Schlesinger,S.J., Walker,B.D., Hahn,B.H. and Nussenzweig,M.C.",2016
KY057382,B,2015,,Proviruses with Identical Sequences Comprise a Large Fraction of the Replication-Competent HIV Reservoir,"Bui,J.K., Sobolewski,M.D., Keele,B.F., Spindler,J., Musick,A., Wiegand,A., Luke,B.T., Shao,W., Hughes,S.H., Coffin,J.M., Kearney,M.F. and Mellors,J.W.",
KY057496,B,2015,,Proviruses with Identical Sequences Comprise a Large Fraction of the Replication-Competent HIV Reservoir,"Bui,J.K., Sobolewski,M.D., Keele,B.F., Spindler,J., Musick,A., Wiegand,A., Luke,B.T., Shao,W., Hughes,S.H., Coffin,J.M., Kearney,M.F. and Mellors,J.W.",
KY057570,B,2015,,Proviruses with Identical Sequences Comprise a Large Fraction of the Replication-Competent HIV Reservoir,"Bui,J.K., Sobolewski,M.D., Keele,B.F., Spindler,J., Musick,A., Wiegand,A., Luke,B.T., Shao,W., Hughes,S.H., Coffin,J.M., Kearney,M.F. and Mellors,J.W.",
KY057587,B,2013,,Proviruses with Identical Sequences Comprise a Large Fraction of the Replication-Competent HIV Reservoir,"Bui,J.K., Sobolewski,M.D., Keele,B.F., Spindler,J., Musick,A., Wiegand,A., Luke,B.T., Shao,W., Hughes,S.H., Coffin,J.M., Kearney,M.F. and Mellors,J.W.",
KY111965,C,2008,28069935,Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness,"Iyer,S.S., Bibollet-Ruche,F., Sherrill-Mix,S., Learn,G.H., Plenderleith,L., Smith,A.G., Barbian,H.J., Russell,R.M., Gondim,M.V., Bahari,C.Y., Shaw,C.M., Li,Y., Decker,T., Haynes,B.F., Shaw,G.M., Sharp,P.M., Borrow,P. and Hahn,B.H.",2017
KY111987,C,2009,28069935,Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness,"Iyer,S.S., Bibollet-Ruche,F., Sherrill-Mix,S., Learn,G.H., Plenderleith,L., Smith,A.G., Barbian,H.J., Russell,R.M., Gondim,M.V., Bahari,C.Y., Shaw,C.M., Li,Y., Decker,T., Haynes,B.F., Shaw,G.M., Sharp,P.M., Borrow,P. and Hahn,B.H.",2017
KY112197,C,2008,28069935,Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness,"Iyer,S.S., Bibollet-Ruche,F., Sherrill-Mix,S., Learn,G.H., Plenderleith,L., Smith,A.G., Barbian,H.J., Russell,R.M., Gondim,M.V., Bahari,C.Y., Shaw,C.M., Li,Y., Decker,T., Haynes,B.F., Shaw,G.M., Sharp,P.M., Borrow,P. and Hahn,B.H.",2017
KY112259,CD,2008,28069935,Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness,"Iyer,S.S., Bibollet-Ruche,F., Sherrill-Mix,S., Learn,G.H., Plenderleith,L., Smith,A.G., Barbian,H.J., Russell,R.M., Gondim,M.V., Bahari,C.Y., Shaw,C.M., Li,Y., Decker,T., Haynes,B.F., Shaw,G.M., Sharp,P.M., Borrow,P. and Hahn,B.H.",2017
KY112360,C,2008,28069935,Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness,"Iyer,S.S., Bibollet-Ruche,F., Sherrill-Mix,S., Learn,G.H., Plenderleith,L., Smith,A.G., Barbian,H.J., Russell,R.M., Gondim,M.V., Bahari,C.Y., Shaw,C.M., Li,Y., Decker,T., Haynes,B.F., Shaw,G.M., Sharp,P.M., Borrow,P. and Hahn,B.H.",2017
KY112522,B,2008,28069935,Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness,"Iyer,S.S., Bibollet-Ruche,F., Sherrill-Mix,S., Learn,G.H., Plenderleith,L., Smith,A.G., Barbian,H.J., Russell,R.M., Gondim,M.V., Bahari,C.Y., Shaw,C.M., Li,Y., Decker,T., Haynes,B.F., Shaw,G.M., Sharp,P.M., Borrow,P. and Hahn,B.H.",2017
KY113379,B,2015,27872306,Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA,"Lorenzi,J.C., Cohen,Y.Z., Cohn,L.B., Kreider,E.F., Barton,J.P., Learn,G.H., Oliveira,T., Lavine,C.L., Horwitz,J.A., Settler,A., Jankovic,M., Seaman,M.S., Chakraborty,A.K., Hahn,B.H., Caskey,M. and Nussenzweig,M.C.",2016
KY113566,B,2015,27872306,Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA,"Lorenzi,J.C., Cohen,Y.Z., Cohn,L.B., Kreider,E.F., Barton,J.P., Learn,G.H., Oliveira,T., Lavine,C.L., Horwitz,J.A., Settler,A., Jankovic,M., Seaman,M.S., Chakraborty,A.K., Hahn,B.H., Caskey,M. and Nussenzweig,M.C.",2016
KY113735,B,2015,27872306,Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA,"Lorenzi,J.C., Cohen,Y.Z., Cohn,L.B., Kreider,E.F., Barton,J.P., Learn,G.H., Oliveira,T., Lavine,C.L., Horwitz,J.A., Settler,A., Jankovic,M., Seaman,M.S., Chakraborty,A.K., Hahn,B.H., Caskey,M. and Nussenzweig,M.C.",2016
KY113882,B,2015,27872306,Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA,"Lorenzi,J.C., Cohen,Y.Z., Cohn,L.B., Kreider,E.F., Barton,J.P., Learn,G.H., Oliveira,T., Lavine,C.L., Horwitz,J.A., Settler,A., Jankovic,M., Seaman,M.S., Chakraborty,A.K., Hahn,B.H., Caskey,M. and Nussenzweig,M.C.",2016
KY213715,01_AE,2009,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213716,01_AE,2008,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213717,01_AE,2008,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213718,01_AE,2009,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213719,01_AE,2008,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213720,01_AE,2008,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213721,01_AE,2009,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213722,01_AE,2008,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213723,01_AE,2008,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213724,01_AE,2008,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213725,01_AE,2008,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213726,01_AE,2008,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213727,01_AE,2008,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213728,01_AE,2008,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213729,01_AE,2009,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213730,01_AE,2008,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213731,01_AE,2008,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213732,01_AE,2008,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213733,01_AE,2008,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213734,01_AE,2009,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213735,01_AE,2008,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213736,01_AE,2008,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213737,01_AE,2008,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213738,01_AE,2008,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213739,01_AE,2008,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213740,B,2008,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213741,B,2008,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213742,B,2008,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213743,B,2008,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213744,B,2009,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213745,B,2009,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213746,B,2008,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213747,B,2008,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213748,B,2009,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213749,01_AE,2009,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY213751,B,2008,26764036,HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients,"Joshi,A., Sedano,M., Beauchamp,B., Punke,E.B., Mulla,Z.D., Meza,A., Alozie,O.K., Mukherjee,D. and Garg,H.",2016
KY216146,79_0107,2015,28557610,"Genome Sequence of a Novel HIV-1 Circulating Recombinant Form (CRF79_0107) Identified from Shanxi, China","Li,Y., Feng,Y., Li,F., Xue,Z., Hu,J., Xing,H., Ruan,Y. and Shao,Y.",2017
KY216147,79_0107,2015,28557610,"Genome Sequence of a Novel HIV-1 Circulating Recombinant Form (CRF79_0107) Identified from Shanxi, China","Li,Y., Feng,Y., Li,F., Xue,Z., Hu,J., Xing,H., Ruan,Y. and Shao,Y.",2017
KY216148,79_0107,2015,28557610,"Genome Sequence of a Novel HIV-1 Circulating Recombinant Form (CRF79_0107) Identified from Shanxi, China","Li,Y., Feng,Y., Li,F., Xue,Z., Hu,J., Xing,H., Ruan,Y. and Shao,Y.",2017
KY229251,C,2002,,Breast Milk and in utero Transmission of HIV-1 Selelct for Envelope Variants with Unique Molecular Signatures,"Nakamura,K.J., Heath,L., Sobrera,E.R., Wilkinson,T.A., Semrau,K., Kankasa,C., Tobin,N.H., Webb,N.E., Lee,B., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",
KY229257,C,2001,,Breast Milk and in utero Transmission of HIV-1 Selelct for Envelope Variants with Unique Molecular Signatures,"Nakamura,K.J., Heath,L., Sobrera,E.R., Wilkinson,T.A., Semrau,K., Kankasa,C., Tobin,N.H., Webb,N.E., Lee,B., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",
KY229265,C,2002,,Breast Milk and in utero Transmission of HIV-1 Selelct for Envelope Variants with Unique Molecular Signatures,"Nakamura,K.J., Heath,L., Sobrera,E.R., Wilkinson,T.A., Semrau,K., Kankasa,C., Tobin,N.H., Webb,N.E., Lee,B., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",
KY229291,C,2002,,Breast Milk and in utero Transmission of HIV-1 Selelct for Envelope Variants with Unique Molecular Signatures,"Nakamura,K.J., Heath,L., Sobrera,E.R., Wilkinson,T.A., Semrau,K., Kankasa,C., Tobin,N.H., Webb,N.E., Lee,B., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",
KY229314,C,2002,,Breast Milk and in utero Transmission of HIV-1 Selelct for Envelope Variants with Unique Molecular Signatures,"Nakamura,K.J., Heath,L., Sobrera,E.R., Wilkinson,T.A., Semrau,K., Kankasa,C., Tobin,N.H., Webb,N.E., Lee,B., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",
KY229316,C,2002,,Breast Milk and in utero Transmission of HIV-1 Selelct for Envelope Variants with Unique Molecular Signatures,"Nakamura,K.J., Heath,L., Sobrera,E.R., Wilkinson,T.A., Semrau,K., Kankasa,C., Tobin,N.H., Webb,N.E., Lee,B., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",
KY229337,C,2002,,Breast Milk and in utero Transmission of HIV-1 Selelct for Envelope Variants with Unique Molecular Signatures,"Nakamura,K.J., Heath,L., Sobrera,E.R., Wilkinson,T.A., Semrau,K., Kankasa,C., Tobin,N.H., Webb,N.E., Lee,B., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",
KY229347,C,2002,,Breast Milk and in utero Transmission of HIV-1 Selelct for Envelope Variants with Unique Molecular Signatures,"Nakamura,K.J., Heath,L., Sobrera,E.R., Wilkinson,T.A., Semrau,K., Kankasa,C., Tobin,N.H., Webb,N.E., Lee,B., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",
KY229356,C,2002,,Breast Milk and in utero Transmission of HIV-1 Selelct for Envelope Variants with Unique Molecular Signatures,"Nakamura,K.J., Heath,L., Sobrera,E.R., Wilkinson,T.A., Semrau,K., Kankasa,C., Tobin,N.H., Webb,N.E., Lee,B., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",
KY229379,C,2004,,Breast Milk and in utero Transmission of HIV-1 Selelct for Envelope Variants with Unique Molecular Signatures,"Nakamura,K.J., Heath,L., Sobrera,E.R., Wilkinson,T.A., Semrau,K., Kankasa,C., Tobin,N.H., Webb,N.E., Lee,B., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",
KY229391,C,2001,,Breast Milk and in utero Transmission of HIV-1 Selelct for Envelope Variants with Unique Molecular Signatures,"Nakamura,K.J., Heath,L., Sobrera,E.R., Wilkinson,T.A., Semrau,K., Kankasa,C., Tobin,N.H., Webb,N.E., Lee,B., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",
KY229397,C,2001,,Breast Milk and in utero Transmission of HIV-1 Selelct for Envelope Variants with Unique Molecular Signatures,"Nakamura,K.J., Heath,L., Sobrera,E.R., Wilkinson,T.A., Semrau,K., Kankasa,C., Tobin,N.H., Webb,N.E., Lee,B., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",
KY229414,C,2002,,Breast Milk and in utero Transmission of HIV-1 Selelct for Envelope Variants with Unique Molecular Signatures,"Nakamura,K.J., Heath,L., Sobrera,E.R., Wilkinson,T.A., Semrau,K., Kankasa,C., Tobin,N.H., Webb,N.E., Lee,B., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",
KY229423,C,2001,,Breast Milk and in utero Transmission of HIV-1 Selelct for Envelope Variants with Unique Molecular Signatures,"Nakamura,K.J., Heath,L., Sobrera,E.R., Wilkinson,T.A., Semrau,K., Kankasa,C., Tobin,N.H., Webb,N.E., Lee,B., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",
KY229434,C,2002,,Breast Milk and in utero Transmission of HIV-1 Selelct for Envelope Variants with Unique Molecular Signatures,"Nakamura,K.J., Heath,L., Sobrera,E.R., Wilkinson,T.A., Semrau,K., Kankasa,C., Tobin,N.H., Webb,N.E., Lee,B., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",
KY229450,C,2002,,Breast Milk and in utero Transmission of HIV-1 Selelct for Envelope Variants with Unique Molecular Signatures,"Nakamura,K.J., Heath,L., Sobrera,E.R., Wilkinson,T.A., Semrau,K., Kankasa,C., Tobin,N.H., Webb,N.E., Lee,B., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",
KY229460,C,2002,,Breast Milk and in utero Transmission of HIV-1 Selelct for Envelope Variants with Unique Molecular Signatures,"Nakamura,K.J., Heath,L., Sobrera,E.R., Wilkinson,T.A., Semrau,K., Kankasa,C., Tobin,N.H., Webb,N.E., Lee,B., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",
KY229472,C,2002,,Breast Milk and in utero Transmission of HIV-1 Selelct for Envelope Variants with Unique Molecular Signatures,"Nakamura,K.J., Heath,L., Sobrera,E.R., Wilkinson,T.A., Semrau,K., Kankasa,C., Tobin,N.H., Webb,N.E., Lee,B., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",
KY229484,C,2002,,Breast Milk and in utero Transmission of HIV-1 Selelct for Envelope Variants with Unique Molecular Signatures,"Nakamura,K.J., Heath,L., Sobrera,E.R., Wilkinson,T.A., Semrau,K., Kankasa,C., Tobin,N.H., Webb,N.E., Lee,B., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",
KY229510,C,2002,,Breast Milk and in utero Transmission of HIV-1 Selelct for Envelope Variants with Unique Molecular Signatures,"Nakamura,K.J., Heath,L., Sobrera,E.R., Wilkinson,T.A., Semrau,K., Kankasa,C., Tobin,N.H., Webb,N.E., Lee,B., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",
KY229518,C,2002,,Breast Milk and in utero Transmission of HIV-1 Selelct for Envelope Variants with Unique Molecular Signatures,"Nakamura,K.J., Heath,L., Sobrera,E.R., Wilkinson,T.A., Semrau,K., Kankasa,C., Tobin,N.H., Webb,N.E., Lee,B., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",
KY229519,G,2003,,Breast Milk and in utero Transmission of HIV-1 Selelct for Envelope Variants with Unique Molecular Signatures,"Nakamura,K.J., Heath,L., Sobrera,E.R., Wilkinson,T.A., Semrau,K., Kankasa,C., Tobin,N.H., Webb,N.E., Lee,B., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",
KY229533,G,2003,,Breast Milk and in utero Transmission of HIV-1 Selelct for Envelope Variants with Unique Molecular Signatures,"Nakamura,K.J., Heath,L., Sobrera,E.R., Wilkinson,T.A., Semrau,K., Kankasa,C., Tobin,N.H., Webb,N.E., Lee,B., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",
KY229542,C,2003,,Breast Milk and in utero Transmission of HIV-1 Selelct for Envelope Variants with Unique Molecular Signatures,"Nakamura,K.J., Heath,L., Sobrera,E.R., Wilkinson,T.A., Semrau,K., Kankasa,C., Tobin,N.H., Webb,N.E., Lee,B., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",
KY229554,C,2003,,Breast Milk and in utero Transmission of HIV-1 Selelct for Envelope Variants with Unique Molecular Signatures,"Nakamura,K.J., Heath,L., Sobrera,E.R., Wilkinson,T.A., Semrau,K., Kankasa,C., Tobin,N.H., Webb,N.E., Lee,B., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",
KY229565,C,2003,,Breast Milk and in utero Transmission of HIV-1 Selelct for Envelope Variants with Unique Molecular Signatures,"Nakamura,K.J., Heath,L., Sobrera,E.R., Wilkinson,T.A., Semrau,K., Kankasa,C., Tobin,N.H., Webb,N.E., Lee,B., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",
KY229617,C,2004,,Breast Milk and in utero Transmission of HIV-1 Selelct for Envelope Variants with Unique Molecular Signatures,"Nakamura,K.J., Heath,L., Sobrera,E.R., Wilkinson,T.A., Semrau,K., Kankasa,C., Tobin,N.H., Webb,N.E., Lee,B., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",
KY229633,C,2004,,Breast Milk and in utero Transmission of HIV-1 Selelct for Envelope Variants with Unique Molecular Signatures,"Nakamura,K.J., Heath,L., Sobrera,E.R., Wilkinson,T.A., Semrau,K., Kankasa,C., Tobin,N.H., Webb,N.E., Lee,B., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",
KY229639,C,2004,,Breast Milk and in utero Transmission of HIV-1 Selelct for Envelope Variants with Unique Molecular Signatures,"Nakamura,K.J., Heath,L., Sobrera,E.R., Wilkinson,T.A., Semrau,K., Kankasa,C., Tobin,N.H., Webb,N.E., Lee,B., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",
KY229650,C,2004,,Breast Milk and in utero Transmission of HIV-1 Selelct for Envelope Variants with Unique Molecular Signatures,"Nakamura,K.J., Heath,L., Sobrera,E.R., Wilkinson,T.A., Semrau,K., Kankasa,C., Tobin,N.H., Webb,N.E., Lee,B., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",
KY229661,C,2004,,Breast Milk and in utero Transmission of HIV-1 Selelct for Envelope Variants with Unique Molecular Signatures,"Nakamura,K.J., Heath,L., Sobrera,E.R., Wilkinson,T.A., Semrau,K., Kankasa,C., Tobin,N.H., Webb,N.E., Lee,B., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",
KY229671,C,2001,,Breast Milk and in utero Transmission of HIV-1 Selelct for Envelope Variants with Unique Molecular Signatures,"Nakamura,K.J., Heath,L., Sobrera,E.R., Wilkinson,T.A., Semrau,K., Kankasa,C., Tobin,N.H., Webb,N.E., Lee,B., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",
KY229675,C,2002,,Breast Milk and in utero Transmission of HIV-1 Selelct for Envelope Variants with Unique Molecular Signatures,"Nakamura,K.J., Heath,L., Sobrera,E.R., Wilkinson,T.A., Semrau,K., Kankasa,C., Tobin,N.H., Webb,N.E., Lee,B., Thea,D.M., Kuhn,L., Mullins,J.I. and Aldrovandi,G.M.",
KY323724,B,2015,28092665,Antibody 10-1074 suppresses viremia in HIV-1-infected individuals,"Caskey,M., Schoofs,T., Gruell,H., Settler,A., Karagounis,T., Kreider,E.F., Murrell,B., Pfeifer,N., Nogueira,L., Oliveira,T.Y., Learn,G.H., Cohen,Y.Z., Lehmann,C., Gillor,D., Shimeliovich,I., Unson-O'Brien,C., Weiland,D., Robles,A., Kummerle,T., Wyen,C., Levin,R., Witmer-Pack,M., Eren,K., Ignacio,C., Kiss,S., West,A.P. Jr., Mouquet,H., Zingman,B.S., Gulick,R.M., Keler,T., Bjorkman,P.J., Seaman,M.S., Hahn,B.H., Fatkenheuer,G., Schlesinger,S.J., Nussenzweig,M.C. and Klein,F.",2017
KY323813,B,2015,28092665,Antibody 10-1074 suppresses viremia in HIV-1-infected individuals,"Caskey,M., Schoofs,T., Gruell,H., Settler,A., Karagounis,T., Kreider,E.F., Murrell,B., Pfeifer,N., Nogueira,L., Oliveira,T.Y., Learn,G.H., Cohen,Y.Z., Lehmann,C., Gillor,D., Shimeliovich,I., Unson-O'Brien,C., Weiland,D., Robles,A., Kummerle,T., Wyen,C., Levin,R., Witmer-Pack,M., Eren,K., Ignacio,C., Kiss,S., West,A.P. Jr., Mouquet,H., Zingman,B.S., Gulick,R.M., Keler,T., Bjorkman,P.J., Seaman,M.S., Hahn,B.H., Fatkenheuer,G., Schlesinger,S.J., Nussenzweig,M.C. and Klein,F.",2017
KY323883,B,2015,28092665,Antibody 10-1074 suppresses viremia in HIV-1-infected individuals,"Caskey,M., Schoofs,T., Gruell,H., Settler,A., Karagounis,T., Kreider,E.F., Murrell,B., Pfeifer,N., Nogueira,L., Oliveira,T.Y., Learn,G.H., Cohen,Y.Z., Lehmann,C., Gillor,D., Shimeliovich,I., Unson-O'Brien,C., Weiland,D., Robles,A., Kummerle,T., Wyen,C., Levin,R., Witmer-Pack,M., Eren,K., Ignacio,C., Kiss,S., West,A.P. Jr., Mouquet,H., Zingman,B.S., Gulick,R.M., Keler,T., Bjorkman,P.J., Seaman,M.S., Hahn,B.H., Fatkenheuer,G., Schlesinger,S.J., Nussenzweig,M.C. and Klein,F.",2017
KY323997,B,2015,28092665,Antibody 10-1074 suppresses viremia in HIV-1-infected individuals,"Caskey,M., Schoofs,T., Gruell,H., Settler,A., Karagounis,T., Kreider,E.F., Murrell,B., Pfeifer,N., Nogueira,L., Oliveira,T.Y., Learn,G.H., Cohen,Y.Z., Lehmann,C., Gillor,D., Shimeliovich,I., Unson-O'Brien,C., Weiland,D., Robles,A., Kummerle,T., Wyen,C., Levin,R., Witmer-Pack,M., Eren,K., Ignacio,C., Kiss,S., West,A.P. Jr., Mouquet,H., Zingman,B.S., Gulick,R.M., Keler,T., Bjorkman,P.J., Seaman,M.S., Hahn,B.H., Fatkenheuer,G., Schlesinger,S.J., Nussenzweig,M.C. and Klein,F.",2017
KY324081,B,2015,28092665,Antibody 10-1074 suppresses viremia in HIV-1-infected individuals,"Caskey,M., Schoofs,T., Gruell,H., Settler,A., Karagounis,T., Kreider,E.F., Murrell,B., Pfeifer,N., Nogueira,L., Oliveira,T.Y., Learn,G.H., Cohen,Y.Z., Lehmann,C., Gillor,D., Shimeliovich,I., Unson-O'Brien,C., Weiland,D., Robles,A., Kummerle,T., Wyen,C., Levin,R., Witmer-Pack,M., Eren,K., Ignacio,C., Kiss,S., West,A.P. Jr., Mouquet,H., Zingman,B.S., Gulick,R.M., Keler,T., Bjorkman,P.J., Seaman,M.S., Hahn,B.H., Fatkenheuer,G., Schlesinger,S.J., Nussenzweig,M.C. and Klein,F.",2017
KY324166,B,2015,28092665,Antibody 10-1074 suppresses viremia in HIV-1-infected individuals,"Caskey,M., Schoofs,T., Gruell,H., Settler,A., Karagounis,T., Kreider,E.F., Murrell,B., Pfeifer,N., Nogueira,L., Oliveira,T.Y., Learn,G.H., Cohen,Y.Z., Lehmann,C., Gillor,D., Shimeliovich,I., Unson-O'Brien,C., Weiland,D., Robles,A., Kummerle,T., Wyen,C., Levin,R., Witmer-Pack,M., Eren,K., Ignacio,C., Kiss,S., West,A.P. Jr., Mouquet,H., Zingman,B.S., Gulick,R.M., Keler,T., Bjorkman,P.J., Seaman,M.S., Hahn,B.H., Fatkenheuer,G., Schlesinger,S.J., Nussenzweig,M.C. and Klein,F.",2017
KY324257,B,2016,28092665,Antibody 10-1074 suppresses viremia in HIV-1-infected individuals,"Caskey,M., Schoofs,T., Gruell,H., Settler,A., Karagounis,T., Kreider,E.F., Murrell,B., Pfeifer,N., Nogueira,L., Oliveira,T.Y., Learn,G.H., Cohen,Y.Z., Lehmann,C., Gillor,D., Shimeliovich,I., Unson-O'Brien,C., Weiland,D., Robles,A., Kummerle,T., Wyen,C., Levin,R., Witmer-Pack,M., Eren,K., Ignacio,C., Kiss,S., West,A.P. Jr., Mouquet,H., Zingman,B.S., Gulick,R.M., Keler,T., Bjorkman,P.J., Seaman,M.S., Hahn,B.H., Fatkenheuer,G., Schlesinger,S.J., Nussenzweig,M.C. and Klein,F.",2017
KY324331,B,2016,28092665,Antibody 10-1074 suppresses viremia in HIV-1-infected individuals,"Caskey,M., Schoofs,T., Gruell,H., Settler,A., Karagounis,T., Kreider,E.F., Murrell,B., Pfeifer,N., Nogueira,L., Oliveira,T.Y., Learn,G.H., Cohen,Y.Z., Lehmann,C., Gillor,D., Shimeliovich,I., Unson-O'Brien,C., Weiland,D., Robles,A., Kummerle,T., Wyen,C., Levin,R., Witmer-Pack,M., Eren,K., Ignacio,C., Kiss,S., West,A.P. Jr., Mouquet,H., Zingman,B.S., Gulick,R.M., Keler,T., Bjorkman,P.J., Seaman,M.S., Hahn,B.H., Fatkenheuer,G., Schlesinger,S.J., Nussenzweig,M.C. and Klein,F.",2017
KY324398,B,2015,28092665,Antibody 10-1074 suppresses viremia in HIV-1-infected individuals,"Caskey,M., Schoofs,T., Gruell,H., Settler,A., Karagounis,T., Kreider,E.F., Murrell,B., Pfeifer,N., Nogueira,L., Oliveira,T.Y., Learn,G.H., Cohen,Y.Z., Lehmann,C., Gillor,D., Shimeliovich,I., Unson-O'Brien,C., Weiland,D., Robles,A., Kummerle,T., Wyen,C., Levin,R., Witmer-Pack,M., Eren,K., Ignacio,C., Kiss,S., West,A.P. Jr., Mouquet,H., Zingman,B.S., Gulick,R.M., Keler,T., Bjorkman,P.J., Seaman,M.S., Hahn,B.H., Fatkenheuer,G., Schlesinger,S.J., Nussenzweig,M.C. and Klein,F.",2017
KY324503,B,2015,28092665,Antibody 10-1074 suppresses viremia in HIV-1-infected individuals,"Caskey,M., Schoofs,T., Gruell,H., Settler,A., Karagounis,T., Kreider,E.F., Murrell,B., Pfeifer,N., Nogueira,L., Oliveira,T.Y., Learn,G.H., Cohen,Y.Z., Lehmann,C., Gillor,D., Shimeliovich,I., Unson-O'Brien,C., Weiland,D., Robles,A., Kummerle,T., Wyen,C., Levin,R., Witmer-Pack,M., Eren,K., Ignacio,C., Kiss,S., West,A.P. Jr., Mouquet,H., Zingman,B.S., Gulick,R.M., Keler,T., Bjorkman,P.J., Seaman,M.S., Hahn,B.H., Fatkenheuer,G., Schlesinger,S.J., Nussenzweig,M.C. and Klein,F.",2017
KY324517,B,2016,28092665,Antibody 10-1074 suppresses viremia in HIV-1-infected individuals,"Caskey,M., Schoofs,T., Gruell,H., Settler,A., Karagounis,T., Kreider,E.F., Murrell,B., Pfeifer,N., Nogueira,L., Oliveira,T.Y., Learn,G.H., Cohen,Y.Z., Lehmann,C., Gillor,D., Shimeliovich,I., Unson-O'Brien,C., Weiland,D., Robles,A., Kummerle,T., Wyen,C., Levin,R., Witmer-Pack,M., Eren,K., Ignacio,C., Kiss,S., West,A.P. Jr., Mouquet,H., Zingman,B.S., Gulick,R.M., Keler,T., Bjorkman,P.J., Seaman,M.S., Hahn,B.H., Fatkenheuer,G., Schlesinger,S.J., Nussenzweig,M.C. and Klein,F.",2017
KY324593,B,2016,28092665,Antibody 10-1074 suppresses viremia in HIV-1-infected individuals,"Caskey,M., Schoofs,T., Gruell,H., Settler,A., Karagounis,T., Kreider,E.F., Murrell,B., Pfeifer,N., Nogueira,L., Oliveira,T.Y., Learn,G.H., Cohen,Y.Z., Lehmann,C., Gillor,D., Shimeliovich,I., Unson-O'Brien,C., Weiland,D., Robles,A., Kummerle,T., Wyen,C., Levin,R., Witmer-Pack,M., Eren,K., Ignacio,C., Kiss,S., West,A.P. Jr., Mouquet,H., Zingman,B.S., Gulick,R.M., Keler,T., Bjorkman,P.J., Seaman,M.S., Hahn,B.H., Fatkenheuer,G., Schlesinger,S.J., Nussenzweig,M.C. and Klein,F.",2017
KY324640,B,2016,28092665,Antibody 10-1074 suppresses viremia in HIV-1-infected individuals,"Caskey,M., Schoofs,T., Gruell,H., Settler,A., Karagounis,T., Kreider,E.F., Murrell,B., Pfeifer,N., Nogueira,L., Oliveira,T.Y., Learn,G.H., Cohen,Y.Z., Lehmann,C., Gillor,D., Shimeliovich,I., Unson-O'Brien,C., Weiland,D., Robles,A., Kummerle,T., Wyen,C., Levin,R., Witmer-Pack,M., Eren,K., Ignacio,C., Kiss,S., West,A.P. Jr., Mouquet,H., Zingman,B.S., Gulick,R.M., Keler,T., Bjorkman,P.J., Seaman,M.S., Hahn,B.H., Fatkenheuer,G., Schlesinger,S.J., Nussenzweig,M.C. and Klein,F.",2017
KY324735,B,2016,28092665,Antibody 10-1074 suppresses viremia in HIV-1-infected individuals,"Caskey,M., Schoofs,T., Gruell,H., Settler,A., Karagounis,T., Kreider,E.F., Murrell,B., Pfeifer,N., Nogueira,L., Oliveira,T.Y., Learn,G.H., Cohen,Y.Z., Lehmann,C., Gillor,D., Shimeliovich,I., Unson-O'Brien,C., Weiland,D., Robles,A., Kummerle,T., Wyen,C., Levin,R., Witmer-Pack,M., Eren,K., Ignacio,C., Kiss,S., West,A.P. Jr., Mouquet,H., Zingman,B.S., Gulick,R.M., Keler,T., Bjorkman,P.J., Seaman,M.S., Hahn,B.H., Fatkenheuer,G., Schlesinger,S.J., Nussenzweig,M.C. and Klein,F.",2017
KY324805,B,2016,28092665,Antibody 10-1074 suppresses viremia in HIV-1-infected individuals,"Caskey,M., Schoofs,T., Gruell,H., Settler,A., Karagounis,T., Kreider,E.F., Murrell,B., Pfeifer,N., Nogueira,L., Oliveira,T.Y., Learn,G.H., Cohen,Y.Z., Lehmann,C., Gillor,D., Shimeliovich,I., Unson-O'Brien,C., Weiland,D., Robles,A., Kummerle,T., Wyen,C., Levin,R., Witmer-Pack,M., Eren,K., Ignacio,C., Kiss,S., West,A.P. Jr., Mouquet,H., Zingman,B.S., Gulick,R.M., Keler,T., Bjorkman,P.J., Seaman,M.S., Hahn,B.H., Fatkenheuer,G., Schlesinger,S.J., Nussenzweig,M.C. and Klein,F.",2017
KY359380,A1O,2006,,HIV-1/MO recombinants detection in France: impact on diagnosis and therapeutic management,"De Oliveira,F., Cappy,P. and Lemee,V.",
KY359383,A1O,2005,,HIV-1/MO recombinants detection in France: impact on diagnosis and therapeutic management,"De Oliveira,F., Cappy,P. and Lemee,V.",
KY392767,CU,2002,28077647,Sensitive next generation sequencing method reveals deep genetic diversity of HIV-1 in the Democratic Republic of the Congo,"Rodgers,M.A., Wilkinson,E., Vallari,A., McArthur,C., Sthreshley,L., Brennan,C.A., Cloherty,G. and de Oliveira,T.",2017
KY392768,CU,2002,28077647,Sensitive next generation sequencing method reveals deep genetic diversity of HIV-1 in the Democratic Republic of the Congo,"Rodgers,M.A., Wilkinson,E., Vallari,A., McArthur,C., Sthreshley,L., Brennan,C.A., Cloherty,G. and de Oliveira,T.",2017
KY392769,D,2002,28077647,Sensitive next generation sequencing method reveals deep genetic diversity of HIV-1 in the Democratic Republic of the Congo,"Rodgers,M.A., Wilkinson,E., Vallari,A., McArthur,C., Sthreshley,L., Brennan,C.A., Cloherty,G. and de Oliveira,T.",2017
KY392770,F1F2,2002,28077647,Sensitive next generation sequencing method reveals deep genetic diversity of HIV-1 in the Democratic Republic of the Congo,"Rodgers,M.A., Wilkinson,E., Vallari,A., McArthur,C., Sthreshley,L., Brennan,C.A., Cloherty,G. and de Oliveira,T.",2017
KY392771,A1GH,2002,28077647,Sensitive next generation sequencing method reveals deep genetic diversity of HIV-1 in the Democratic Republic of the Congo,"Rodgers,M.A., Wilkinson,E., Vallari,A., McArthur,C., Sthreshley,L., Brennan,C.A., Cloherty,G. and de Oliveira,T.",2017
KY392772,A1G,2002,28077647,Sensitive next generation sequencing method reveals deep genetic diversity of HIV-1 in the Democratic Republic of the Congo,"Rodgers,M.A., Wilkinson,E., Vallari,A., McArthur,C., Sthreshley,L., Brennan,C.A., Cloherty,G. and de Oliveira,T.",2017
KY392773,U,2002,28077647,Sensitive next generation sequencing method reveals deep genetic diversity of HIV-1 in the Democratic Republic of the Congo,"Rodgers,M.A., Wilkinson,E., Vallari,A., McArthur,C., Sthreshley,L., Brennan,C.A., Cloherty,G. and de Oliveira,T.",2017
KY392774,U,2002,28077647,Sensitive next generation sequencing method reveals deep genetic diversity of HIV-1 in the Democratic Republic of the Congo,"Rodgers,M.A., Wilkinson,E., Vallari,A., McArthur,C., Sthreshley,L., Brennan,C.A., Cloherty,G. and de Oliveira,T.",2017
KY392775,U,2002,28077647,Sensitive next generation sequencing method reveals deep genetic diversity of HIV-1 in the Democratic Republic of the Congo,"Rodgers,M.A., Wilkinson,E., Vallari,A., McArthur,C., Sthreshley,L., Brennan,C.A., Cloherty,G. and de Oliveira,T.",2017
KY392776,J,2002,28077647,Sensitive next generation sequencing method reveals deep genetic diversity of HIV-1 in the Democratic Republic of the Congo,"Rodgers,M.A., Wilkinson,E., Vallari,A., McArthur,C., Sthreshley,L., Brennan,C.A., Cloherty,G. and de Oliveira,T.",2017
KY392777,H,2001,28077647,Sensitive next generation sequencing method reveals deep genetic diversity of HIV-1 in the Democratic Republic of the Congo,"Rodgers,M.A., Wilkinson,E., Vallari,A., McArthur,C., Sthreshley,L., Brennan,C.A., Cloherty,G. and de Oliveira,T.",2017
KY392778,H,2001,28077647,Sensitive next generation sequencing method reveals deep genetic diversity of HIV-1 in the Democratic Republic of the Congo,"Rodgers,M.A., Wilkinson,E., Vallari,A., McArthur,C., Sthreshley,L., Brennan,C.A., Cloherty,G. and de Oliveira,T.",2017
KY392779,H,2001,28077647,Sensitive next generation sequencing method reveals deep genetic diversity of HIV-1 in the Democratic Republic of the Congo,"Rodgers,M.A., Wilkinson,E., Vallari,A., McArthur,C., Sthreshley,L., Brennan,C.A., Cloherty,G. and de Oliveira,T.",2017
KY392780,U,2001,28077647,Sensitive next generation sequencing method reveals deep genetic diversity of HIV-1 in the Democratic Republic of the Congo,"Rodgers,M.A., Wilkinson,E., Vallari,A., McArthur,C., Sthreshley,L., Brennan,C.A., Cloherty,G. and de Oliveira,T.",2017
KY406739,BC,2014,28398773,Genetic Characterization of a Unique Recombinant strain identified in Yunnan with genome comprised of B and C,"Wang,X., Zhang,M., Li,J., Li,T., Sun,C., Li,H., Liu,Y., Liu,S., Zhuang,D., Bao,Z., Han,J., Li,J. and Li,L.",2017
KY465967,B,2014,,Direct Submission,"Cuevas,M.T., Sanchez,M., Carrera,C., Delgado,E., Thomson,M. and Perez-Alvarez,L.",2017
KY465968,B,2014,,Direct Submission,"Cuevas,M.T., Sanchez,M., Carrera,C., Delgado,E., Thomson,M. and Perez-Alvarez,L.",2017
KY465969,B,2015,,Direct Submission,"Cuevas,M.T., Sanchez,M., Carrera,C., Delgado,E., Thomson,M. and Perez-Alvarez,L.",2017
KY496622,A1,2015,,Direct Submission,"Cuevas,M.T., Sanchez,M., Carrera,C., Delgado,E., Thomson,M. and Perez Alvarez,L.",2017
KY496623,BCG,2015,,Direct Submission,"Cuevas,M.T., Sanchez,M., Carrera,C., Delgado,E., Thomson,M. and Perez Alvarez,L.",2017
KY496624,C,2015,,Direct Submission,"Cuevas,M.T., Sanchez,M., Carrera,C., Delgado,E., Thomson,M. and Perez Alvarez,L.",2017
KY498771,N,,28193549,"Identification of rare HIV-1 Group N, HBV AE, and HTLV-3 strains in rural South Cameroon","Rodgers,M.A., Vallari,A.S., Harris,B., Yamaguchi,J., Holzmayer,V., Forberg,K., Berg,M.G., Kenmenge,J., Ngansop,C., Awazi,B., Mbanya,D., Kaptue,L., Brennan,C., Cloherty,G. and Ndembi,N.",2017
KY514084,F1,2014,,Direct Submission,"Cuevas,M.T., Sanchez,M., Carrera,C., Delgado,E., Thomson,M. and Perez Alvarez,L.",2017
KY514085,F1,2014,,Direct Submission,"Cuevas,M.T., Sanchez,M., Carrera,C., Delgado,E., Thomson,M. and Perez Alvarez,L.",2017
KY557336,14F1,2015,,Direct Submission,"Cuevas,M.T., Sanchez,M., Carrera,C., Delgado,E., Thomson,M. and Perez Alvarez,L.",2017
KY580473,A1D,2011,28759651,Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection,"Kijak,G.H., Sanders-Buell,E., Chenine,A.L., Eller,M.A., Goonetilleke,N., Thomas,R., Leviyang,S., Harbolick,E.A., Bose,M., Pham,P., Oropeza,C., Poltavee,K., O'Sullivan,A.M., Billings,E., Merbah,M., Costanzo,M.C., Warren,J.A., Slike,B., Li,H., Peachman,K.K., Fischer,W., Gao,F., Cicala,C., Arthos,J., Eller,L.A., O'Connell,R.J., Sinei,S., Maganga,L., Kibuuka,H., Nitayaphan,S., Rao,M., Marovich,M.A., Krebs,S.J., Rolland,M., Korber,B.T., Shaw,G.M., Michael,N.L., Robb,M.L., Tovanabutra,S. and Kim,J.H.",2017
KY580512,A1C,2010,28759651,Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection,"Kijak,G.H., Sanders-Buell,E., Chenine,A.L., Eller,M.A., Goonetilleke,N., Thomas,R., Leviyang,S., Harbolick,E.A., Bose,M., Pham,P., Oropeza,C., Poltavee,K., O'Sullivan,A.M., Billings,E., Merbah,M., Costanzo,M.C., Warren,J.A., Slike,B., Li,H., Peachman,K.K., Fischer,W., Gao,F., Cicala,C., Arthos,J., Eller,L.A., O'Connell,R.J., Sinei,S., Maganga,L., Kibuuka,H., Nitayaphan,S., Rao,M., Marovich,M.A., Krebs,S.J., Rolland,M., Korber,B.T., Shaw,G.M., Michael,N.L., Robb,M.L., Tovanabutra,S. and Kim,J.H.",2017
KY580643,01_AE,2010,28759651,Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection,"Kijak,G.H., Sanders-Buell,E., Chenine,A.L., Eller,M.A., Goonetilleke,N., Thomas,R., Leviyang,S., Harbolick,E.A., Bose,M., Pham,P., Oropeza,C., Poltavee,K., O'Sullivan,A.M., Billings,E., Merbah,M., Costanzo,M.C., Warren,J.A., Slike,B., Li,H., Peachman,K.K., Fischer,W., Gao,F., Cicala,C., Arthos,J., Eller,L.A., O'Connell,R.J., Sinei,S., Maganga,L., Kibuuka,H., Nitayaphan,S., Rao,M., Marovich,M.A., Krebs,S.J., Rolland,M., Korber,B.T., Shaw,G.M., Michael,N.L., Robb,M.L., Tovanabutra,S. and Kim,J.H.",2017
KY612718,B,2015,,Proviruses with Identical Sequences Comprise a Large Fraction of the Replication-Competent HIV Reservoir,"Bui,J.K., Sobolewski,M.D., Keele,B.F., Spindler,J., Musick,A., Wiegand,A., Luke,B.T., Shao,W., Hughes,S.H., Coffin,J.M., Kearney,M.F. and Mellors,J.W.",
KY628216,90_BF1,2007,28628667,"Characterization of HIV-1 CRF90_BF1 and putative novel CRFs_BF1 in Central West, North and Northeast Brazilian regions","Reis,M.N.D.G., Bello,G., Guimaraes,M.L. and Stefani,M.M.A.",2017
KY628218,90_BF1,2007,28628667,"Characterization of HIV-1 CRF90_BF1 and putative novel CRFs_BF1 in Central West, North and Northeast Brazilian regions","Reis,M.N.D.G., Bello,G., Guimaraes,M.L. and Stefani,M.M.A.",2017
KY628219,90_BF1,2010,28628667,"Characterization of HIV-1 CRF90_BF1 and putative novel CRFs_BF1 in Central West, North and Northeast Brazilian regions","Reis,M.N.D.G., Bello,G., Guimaraes,M.L. and Stefani,M.M.A.",2017
KY628221,90_BF1,2011,28628667,"Characterization of HIV-1 CRF90_BF1 and putative novel CRFs_BF1 in Central West, North and Northeast Brazilian regions","Reis,M.N.D.G., Bello,G., Guimaraes,M.L. and Stefani,M.M.A.",2017
KY628223,90_BF1,2010,28628667,"Characterization of HIV-1 CRF90_BF1 and putative novel CRFs_BF1 in Central West, North and Northeast Brazilian regions","Reis,M.N.D.G., Bello,G., Guimaraes,M.L. and Stefani,M.M.A.",2017
KY628225,90_BF1,2009,28628667,"Characterization of HIV-1 CRF90_BF1 and putative novel CRFs_BF1 in Central West, North and Northeast Brazilian regions","Reis,M.N.D.G., Bello,G., Guimaraes,M.L. and Stefani,M.M.A.",2017
KY658681,A6,2012,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Singh,H., Fulidou,V., Denny,T.N. and Gao,F.",
KY658682,A6,2012,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Singh,H., Fulidou,V., Denny,T.N. and Gao,F.",
KY658683,B,2008,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Salomon,H., Busch,M.P., Denny,T.N. and Gao,F.",
KY658684,B,2010,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Salomon,H., Busch,M.P., Denny,T.N. and Gao,F.",
KY658685,B,2014,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Salomon,H., Busch,M.P., Denny,T.N. and Gao,F.",
KY658686,B,2007,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Salomon,H., Busch,M.P., Denny,T.N. and Gao,F.",
KY658687,BF1,2012,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Salomon,H., Busch,M.P., Denny,T.N. and Gao,F.",
KY658688,01_AE,2015,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Berba,R., Busch,M.P., Denny,T.N. and Gao,F.",
KY658689,B,2015,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Berba,R., Busch,M.P., Denny,T.N. and Gao,F.",
KY658690,B,2015,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Berba,R., Busch,M.P., Denny,T.N. and Gao,F.",
KY658691,01B,2015,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Berba,R., Busch,M.P., Denny,T.N. and Gao,F.",
KY658692,01B,2015,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Berba,R., Busch,M.P., Denny,T.N. and Gao,F.",
KY658693,B,2014,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Stramer,S., Busch,M.P., Denny,T.N. and Gao,F.",
KY658694,A1,2008,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Haynes,B.F., Denny,T.N. and Gao,F.",
KY658695,A1,2008,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Haynes,B.F., Denny,T.N. and Gao,F.",
KY658696,A1,2008,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Haynes,B.F., Denny,T.N. and Gao,F.",
KY658698,A1D,2008,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Haynes,B.F., Denny,T.N. and Gao,F.",
KY658699,A1C,2008,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Haynes,B.F., Denny,T.N. and Gao,F.",
KY658700,11_cpx,2011,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Ndembi,N.N., Busch,M.P., Denny,T.N. and Gao,F.",
KY658701,G,2011,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Ndembi,N.N., Busch,M.P., Denny,T.N. and Gao,F.",
KY658702,B,2011,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Denny,T.N. and Gao,F.",
KY658705,C,2000,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Novitsky,V., McLane,M.F., Essex,M., Denny,T.N. and Gao,F.",
KY658706,C,2000,,Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL),"Hora,B., Chen,Y., Novitsky,V., McLane,M.F., Essex,M., Denny,T.N. and Gao,F.",
KY748419,B,2013,,Clonal Proviruses Comprise a Large Fraction of the Replication-Competent HIV Reservoir,"Bui,J.K., Sobolewski,M.D., Keele,B.F., Spindler,J., Musick,A., Wiegand,A., Luke,B.T., Shao,W., Hughes,S.H., Coffin,J.M., Kearney,M.F. and Mellors,J.W.",
KY748513,B,2013,,Clonal Proviruses Comprise a Large Fraction of the Replication-Competent HIV Reservoir,"Bui,J.K., Sobolewski,M.D., Keele,B.F., Spindler,J., Musick,A., Wiegand,A., Luke,B.T., Shao,W., Hughes,S.H., Coffin,J.M., Kearney,M.F. and Mellors,J.W.",
KY989949,B,2015,,Direct Submission,"Cuevas,M.T., Sanchez,M., Delgado,E., Carrera,C., Thomson,M. and PerezAlvarez,L.",2017
KY989950,02_AG,2014,,Direct Submission,"Cuevas,M.T., Sanchez,M., Delgado,E., Carrera,C., Thomson,M. and PerezAlvarez,L.",2017
KY989951,B,2015,,Direct Submission,"Cuevas,M.T., Sanchez,M., Delgado,E., Carrera,C., Thomson,M. and PerezAlvarez,L.",2017
KY989952,C,2015,,Direct Submission,"Cuevas,M.T., Sanchez,M., Delgado,E., Carrera,C., Thomson,M. and PerezAlvarez,L.",2017
KY989953,B,2015,,Direct Submission,"Cuevas,M.T., Sanchez,M., Delgado,E., Carrera,C., Thomson,M. and PerezAlvarez,L.",2017
KY989954,B,2015,,Direct Submission,"Cuevas,M.T., Sanchez,M., Delgado,E., Carrera,C., Thomson,M. and PerezAlvarez,L.",2017
KY989955,F1,2015,,Direct Submission,"Cuevas,M.T., Sanchez,M., Delgado,E., Carrera,C., Thomson,M. and PerezAlvarez,L.",2017
KY989956,B,2015,,Direct Submission,"Cuevas,M.T., Sanchez,M., Delgado,E., Carrera,C., Thomson,M. and PerezAlvarez,L.",2017
KY989957,F1,2015,,Direct Submission,"Cuevas,M.T., Sanchez,M., Delgado,E., Carrera,C., Thomson,M. and PerezAlvarez,L.",2017
L02317,B,1987,8503191,A molecular clone of HIV-1 tropic and cytopathic for human and chimpanzee lymphocytes,"Ghosh,S.K., Fultz,P.N., Keddie,E., Saag,M.S., Sharp,P.M., Hahn,B.H. and Shaw,G.M.",1993
L07082,A1,,,(no title given),"Bex,F., Vanhulle,C., Van de Perre,P. and Burny,A.",
L07421,B,1991,,,"Bex,F., Vanhulle,C., Sprecher,S., Geissendorfer,M., Rubsamen-Waigmann,H. and Burny,A.",
L08655,B,,1457193,Genetic and functional analysis of a set of HIV-1 envelope genes obtained from biological clones with varying syncytium-inducing capacities,"Andeweg,A.C., Groenink,M., Leeflang,P., de Goede,R.E., Osterhaus,A.D., Tersmette,M. and Bosch,M.L.",1992
L20571,O,,8107219,A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon,"Gurtler,L.G., Hauser,P.H., Eberle,J., von Brunn,A., Knapp,S., Zekeng,L., Tsague,J.M. and Kaptue,L.",1994
L20587,O,,8107220,Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate,"Vanden Haesevelde,M., Decourt,J.L., De Leys,R.J., Vanderborght,B., van der Groen,G., van Heuverswijn,H. and Saman,E.",1994
L22939,02_AG,1991,7983718,Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin,"Louwagie,J., Janssens,W., Mascola,J., Heyndrickx,L., Hegerich,P., van der Groen,G., McCutchan,F.E. and Burke,D.S.",1995
L22942,AD,1990,7983718,Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin,"Louwagie,J., Janssens,W., Mascola,J., Heyndrickx,L., Hegerich,P., van der Groen,G., McCutchan,F.E. and Burke,D.S.",1995
L22943,A1,1990,7983718,Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin,"Louwagie,J., Janssens,W., Mascola,J., Heyndrickx,L., Hegerich,P., van der Groen,G., McCutchan,F.E. and Burke,D.S.",1995
L22948,C,1990,7983718,Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin,"Louwagie,J., Janssens,W., Mascola,J., Heyndrickx,L., Hegerich,P., van der Groen,G., McCutchan,F.E. and Burke,D.S.",1995
L22949,D,1990,7983718,Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin,"Louwagie,J., Janssens,W., Mascola,J., Heyndrickx,L., Hegerich,P., van der Groen,G., McCutchan,F.E. and Burke,D.S.",1995
L22950,D,1990,7983718,Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin,"Louwagie,J., Janssens,W., Mascola,J., Heyndrickx,L., Hegerich,P., van der Groen,G., McCutchan,F.E. and Burke,D.S.",1995
L22955,A2C,1990,7983718,Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin,"Louwagie,J., Janssens,W., Mascola,J., Heyndrickx,L., Hegerich,P., van der Groen,G., McCutchan,F.E. and Burke,D.S.",1995
L22957,A1,1990,7983718,Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin,"Louwagie,J., Janssens,W., Mascola,J., Heyndrickx,L., Hegerich,P., van der Groen,G., McCutchan,F.E. and Burke,D.S.",1995
L23065,C,1991,7983718,Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin,"Louwagie,J., Janssens,W., Mascola,J., Heyndrickx,L., Hegerich,P., van der Groen,G., McCutchan,F.E. and Burke,D.S.",1995
LC027100,69_01B,2005,26021911,"Novel HIV-1 Recombinant Identified in a Foreign Heterosexual Resident in Japan: Relatedness to Recently Reported CRF69_01B, Detected Primarily among Japanese Men Who Have Sex with Men","Kusagawa,S., Yokota,Y., Negishi,M., Kondo,M., Matano,T., Kato,S. and Takebe,Y.",2015
M12507,B,1985,2423250,"Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS","Starcich,B.R., Hahn,B.H., Shaw,G.M., McNeely,P.D., Modrow,S., Wolf,H., Parks,E.S., Parks,W.P., Josephs,S.F., Gallo,R.C. and Wong-Staal,F.",1986
M13137,B,1984,3490666,Molecular cloning and primary nucleotide sequence analysis of a distinct human immunodeficiency virus isolate reveal significant divergence in its genomic sequences,"Desai,S.M., Kalyanaraman,V.S., Casey,J.M., Srinivasan,A., Andersen,P.R. and Devare,S.G.",1986
M15896,01A1G,1976,2713163,Molecular characterization of HIV-1 isolated from a serum collected in 1976: nucleotide sequence comparison to recent isolates and generation of hybrid HIV,"Srinivasan,A., York,D., Butler,D. Jr., Jannoun-Nasr,R., Getchell,J., McCormick,J., Ou,C.Y., Myers,G., Smith,T., Chen,E., Flaggs,G., Berman,P., Schochetman,G. and Kalyanaraman,S.",1989
M17450,B,1984,3369091,Envelope sequences of two new United States HIV-1 isolates,"Gurgo,C., Guo,H.G., Franchini,G., Aldovini,A., Collalti,E., Farrell,K., Wong-Staal,F., Gallo,R.C. and Reitz,M.S. Jr.",1988
M21098,B,,2789516,Biological and molecular characterization of human immunodeficiency virus (HIV-1BR) from the brain of a patient with progressive dementia,"Anand,R., Thayer,R., Srinivasan,A., Nayyar,S., Gardner,M., Luciw,P. and Dandekar,S.",1989
M21138,B,1986,2669897,Nucleotide sequences of gag and env genes of a Japanese isolate of HIV-1 and their expression in bacteria,"Komiyama,N., Hattori,N., Inoue,J., Sakuma,S., Kurimura,T. and Yoshida,M.",1989
M26727,B,1988,2559749,A highly defective HIV-1 strain isolated from a healthy Gabonese individual presenting an atypical western blot,"Huet,T., Dazza,M.C., Brun-Vezinet,F., Roelants,G.E. and Wain-Hobson,S.",1989
M31451,B,1986,2308953,Limited sequence heterogeneity among biologically distinct human immunodeficiency virus type 1 isolates from individuals involved in a clustered infectious outbreak,"McNearney,T., Westervelt,P., Thielan,B.J., Trowbridge,D.B., Garcia,J., Whittier,R. and Ratner,L.",1917
M33943,B,,1695254,Cloning and characterization of human immunodeficiency virus type 1 variants diminished in the ability to induce syncytium-independent cytolysis,"Stevenson,M., Haggerty,S., Lamonica,C., Mann,A.M., Meier,C. and Wasiak,A.",1990
M38430,B,1985,,,"Buckler-White,A. and Theodore,T.",
M38431,B,1984,3014529,Identification of conserved and divergent domains within the envelope gene of the acquired immunodeficiency syndrome retrovirus,"Willey,R.L., Rutledge,R.A., Dias,S., Folks,T., Theodore,T., Buckler,C.E. and Martin,M.A.",1986
M62320,A1,1985,2265025,Nucleotide sequence of a Ugandan HIV-1 provirus reveals genetic diversity from other HIV-1 isolates,"Oram,J.D., Downing,R.G., Roff,M., Clegg,J.C., Serwadda,D. and Carswell,J.W.",1990
M66533,A1,,3357892,Identification of human immunodeficiency virus subtypes with distinct patterns of sensitivity to serum neutralization,"Cheng-Mayer,C., Homsy,J., Evans,L.A. and Levy,J.A.",1988
M93258,B,1986,1830110,Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes,"Li,Y., Kappes,J.C., Conway,J.A., Price,R.W., Shaw,G.M. and Hahn,B.H.",1991
M95292,B,,2243391,The viral envelope gene is involved in macrophage tropism of a human immunodeficiency virus type 1 strain isolated from brain tissue,"Liu,Z.Q., Wood,C., Levy,J.A. and Cheng-Mayer,C.",1990
MF073269,0107,2016,28586246,"Characterization of a New HIV-1 CRF01_AE/CRF07_BC Recombinant virus in Guangxi, China","Kong,D., Wang,Y., Wang,C., Liang,S., Feng,Y., Ruan,Y., Shao,Y. and Ma,L.",2017
MF084205,0107,2015,,"A unique second-generation recombinant form of HIV-1 was identified among MSM, in Beijing, China","Li,X.",
MF381270,CF1,2015,,Direct Submission,"Cuevas,M.T., Sanchez,M., Mielu,L.M., Delgado,E. and Thomson,M.M.",2017
MF381271,F1,2014,,Direct Submission,"Cuevas,M.T., Sanchez,M., Mielu,L.M., Delgado,E. and Thomson,M.M.",2017
MF381272,F1,2011,,Direct Submission,"Cuevas,M.T., Sanchez,M., Mielu,L.M., Delgado,E. and Thomson,M.M.",2017
MF381273,F1,2011,,Direct Submission,"Cuevas,M.T., Sanchez,M., Mielu,L.M., Delgado,E. and Thomson,M.M.",2017
MF381274,F1,2012,,Direct Submission,"Cuevas,M.T., Sanchez,M., Mielu,L.M., Delgado,E. and Thomson,M.M.",2017
MF381275,F1,2012,,Direct Submission,"Cuevas,M.T., Sanchez,M., Mielu,L.M., Delgado,E. and Thomson,M.M.",2017
MF381276,F1,2012,,Direct Submission,"Cuevas,M.T., Sanchez,M., Mielu,L.M., Delgado,E. and Thomson,M.M.",2017
MF381277,F1,2012,,Direct Submission,"Cuevas,M.T., Sanchez,M., Mielu,L.M., Delgado,E. and Thomson,M.M.",2017
MF381278,F1,2013,,Direct Submission,"Cuevas,M.T., Sanchez,M., Mielu,L.M., Delgado,E. and Thomson,M.M.",2017
MF381279,F1,2013,,Direct Submission,"Cuevas,M.T., Sanchez,M., Mielu,L.M., Delgado,E. and Thomson,M.M.",2017
MF381280,F1,2013,,Direct Submission,"Cuevas,M.T., Sanchez,M., Mielu,L.M., Delgado,E. and Thomson,M.M.",2017
MF381281,F1,2014,,Direct Submission,"Cuevas,M.T., Sanchez,M., Mielu,L.M., Delgado,E. and Thomson,M.M.",2017
MF381282,F1,2014,,Direct Submission,"Cuevas,M.T., Sanchez,M., Mielu,L.M., Delgado,E. and Thomson,M.M.",2017
MF381283,B,2014,,Direct Submission,"Cuevas,M.T., Lopez Herranz,M., Le Duff,Y., Carrera,C., Delgado,E. and Thomson,M.",2017
MF381284,F1,2016,,Direct Submission,"Cuevas,M.T., Carrera,C., Sanchez,M., Delgado,E. and Thomson,M.",2017
MF381285,F1,2016,,Direct Submission,"Cuevas,M.T., Carrera,C., Sanchez,M., Delgado,E. and Thomson,M.",2017
MF381286,F1,2015,,Direct Submission,"Cuevas,M.T., Carrera,C., Sanchez,M., Delgado,E. and Thomson,M.",2017
U04908,B,1992,8627686,Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization,"Gao,F., Morrison,S.G., Robertson,D.L., Thornton,C.L., Craig,S., Karlsson,G., Sodroski,J., Morgado,M., Galvao-Castro,B., von Briesen,H., Beddows,S., Weber,J., Sharp,P.M., Shaw,G.M. and Hahn,B.H.",1996
U08441,B,1991,8627686,Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization,"Gao,F., Morrison,S.G., Robertson,D.L., Thornton,C.L., Craig,S., Karlsson,G., Sodroski,J., Morgado,M., Galvao-Castro,B., von Briesen,H., Beddows,S., Weber,J., Sharp,P.M., Shaw,G.M. and Hahn,B.H.",1996
U08443,B,1991,8627686,Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization,"Gao,F., Morrison,S.G., Robertson,D.L., Thornton,C.L., Craig,S., Karlsson,G., Sodroski,J., Morgado,M., Galvao-Castro,B., von Briesen,H., Beddows,S., Weber,J., Sharp,P.M., Shaw,G.M. and Hahn,B.H.",1996
U08446,B,1992,8627686,Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization,"Gao,F., Morrison,S.G., Robertson,D.L., Thornton,C.L., Craig,S., Karlsson,G., Sodroski,J., Morgado,M., Galvao-Castro,B., von Briesen,H., Beddows,S., Weber,J., Sharp,P.M., Shaw,G.M. and Hahn,B.H.",1996
U08447,B,1992,8627686,Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization,"Gao,F., Morrison,S.G., Robertson,D.L., Thornton,C.L., Craig,S., Karlsson,G., Sodroski,J., Morgado,M., Galvao-Castro,B., von Briesen,H., Beddows,S., Weber,J., Sharp,P.M., Shaw,G.M. and Hahn,B.H.",1996
U08448,B,1992,8627686,Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization,"Gao,F., Morrison,S.G., Robertson,D.L., Thornton,C.L., Craig,S., Karlsson,G., Sodroski,J., Morgado,M., Galvao-Castro,B., von Briesen,H., Beddows,S., Weber,J., Sharp,P.M., Shaw,G.M. and Hahn,B.H.",1996
U08450,B,1992,8627686,Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization,"Gao,F., Morrison,S.G., Robertson,D.L., Thornton,C.L., Craig,S., Karlsson,G., Sodroski,J., Morgado,M., Galvao-Castro,B., von Briesen,H., Beddows,S., Weber,J., Sharp,P.M., Shaw,G.M. and Hahn,B.H.",1996
U08451,B,1992,8627686,Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization,"Gao,F., Morrison,S.G., Robertson,D.L., Thornton,C.L., Craig,S., Karlsson,G., Sodroski,J., Morgado,M., Galvao-Castro,B., von Briesen,H., Beddows,S., Weber,J., Sharp,P.M., Shaw,G.M. and Hahn,B.H.",1996
U08452,B,1992,8627686,Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization,"Gao,F., Morrison,S.G., Robertson,D.L., Thornton,C.L., Craig,S., Karlsson,G., Sodroski,J., Morgado,M., Galvao-Castro,B., von Briesen,H., Beddows,S., Weber,J., Sharp,P.M., Shaw,G.M. and Hahn,B.H.",1996
U08456,01_AE,1993,8627686,Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization,"Gao,F., Morrison,S.G., Robertson,D.L., Thornton,C.L., Craig,S., Karlsson,G., Sodroski,J., Morgado,M., Galvao-Castro,B., von Briesen,H., Beddows,S., Weber,J., Sharp,P.M., Shaw,G.M. and Hahn,B.H.",1996
U08457,01_AE,1993,8627686,Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization,"Gao,F., Morrison,S.G., Robertson,D.L., Thornton,C.L., Craig,S., Karlsson,G., Sodroski,J., Morgado,M., Galvao-Castro,B., von Briesen,H., Beddows,S., Weber,J., Sharp,P.M., Shaw,G.M. and Hahn,B.H.",1996
U08458,01_AE,1993,8627686,Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization,"Gao,F., Morrison,S.G., Robertson,D.L., Thornton,C.L., Craig,S., Karlsson,G., Sodroski,J., Morgado,M., Galvao-Castro,B., von Briesen,H., Beddows,S., Weber,J., Sharp,P.M., Shaw,G.M. and Hahn,B.H.",1996
U08801,B,1992,7888189,"Genetic variation of HIV type 1 in four World Health Organization-sponsored vaccine evaluation sites: generation of functional envelope (glycoprotein 160) clones representative of sequence subtypes A, B, C, and E. WHO Network for HIV Isolation and Characterization","Gao,F., Yue,L., Craig,S., Thornton,C.L., Robertson,D.L., McCutchan,F.E., Bradac,J.A., Sharp,P.M. and Hahn,B.H.",1994
U09126,C,1992,7888189,"Genetic variation of HIV type 1 in four World Health Organization-sponsored vaccine evaluation sites: generation of functional envelope (glycoprotein 160) clones representative of sequence subtypes A, B, C, and E. WHO Network for HIV Isolation and Characterization","Gao,F., Yue,L., Craig,S., Thornton,C.L., Robertson,D.L., McCutchan,F.E., Bradac,J.A., Sharp,P.M. and Hahn,B.H.",1994
U23487,B,,7700375,Was HIV present in 1959?,"Zhu,T. and Ho,D.D.",1995
U27419,D,1993,8627686,Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization,"Gao,F., Morrison,S.G., Robertson,D.L., Thornton,C.L., Craig,S., Karlsson,G., Sodroski,J., Morgado,M., Galvao-Castro,B., von Briesen,H., Beddows,S., Weber,J., Sharp,P.M., Shaw,G.M. and Hahn,B.H.",1996
U27426,G,1992,7576924,Identification of HIV-1 subtype G from Uganda,"Kaleebu,P., Bobkov,A., Cheingsong-Popov,R., Bieniasz,P., Garaev,M. and Weber,J.",1995
U27434,B,1991,8627686,Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization,"Gao,F., Morrison,S.G., Robertson,D.L., Thornton,C.L., Craig,S., Karlsson,G., Sodroski,J., Morgado,M., Galvao-Castro,B., von Briesen,H., Beddows,S., Weber,J., Sharp,P.M., Shaw,G.M. and Hahn,B.H.",1996
U27445,G,1992,8627686,Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization,"Gao,F., Morrison,S.G., Robertson,D.L., Thornton,C.L., Craig,S., Karlsson,G., Sodroski,J., Morgado,M., Galvao-Castro,B., von Briesen,H., Beddows,S., Weber,J., Sharp,P.M., Shaw,G.M. and Hahn,B.H.",1996
U36859,B,,8924250,An efficient method for the rescue and analysis of functional HIV-1 env genes: evidence for recombination in the vicinity of the tat/rev splice site,"Douglas,N.W., Knight,A.I., Hayhurst,A., Barrett,W.Y., Kevany,M.J. and Daniels,R.S.",1996
U36867,D,,8924250,An efficient method for the rescue and analysis of functional HIV-1 env genes: evidence for recombination in the vicinity of the tat/rev splice site,"Douglas,N.W., Knight,A.I., Hayhurst,A., Barrett,W.Y., Kevany,M.J. and Daniels,R.S.",1996
U36869,B,,8924250,An efficient method for the rescue and analysis of functional HIV-1 env genes: evidence for recombination in the vicinity of the tat/rev splice site,"Douglas,N.W., Knight,A.I., Hayhurst,A., Barrett,W.Y., Kevany,M.J. and Daniels,R.S.",1996
U36870,B,,8924250,An efficient method for the rescue and analysis of functional HIV-1 env genes: evidence for recombination in the vicinity of the tat/rev splice site,"Douglas,N.W., Knight,A.I., Hayhurst,A., Barrett,W.Y., Kevany,M.J. and Daniels,R.S.",1996
U36875,B,,8924250,An efficient method for the rescue and analysis of functional HIV-1 env genes: evidence for recombination in the vicinity of the tat/rev splice site,"Douglas,N.W., Knight,A.I., Hayhurst,A., Barrett,W.Y., Kevany,M.J. and Daniels,R.S.",1996
U36877,B,,8924250,An efficient method for the rescue and analysis of functional HIV-1 env genes: evidence for recombination in the vicinity of the tat/rev splice site,"Douglas,N.W., Knight,A.I., Hayhurst,A., Barrett,W.Y., Kevany,M.J. and Daniels,R.S.",1996
U36879,B,,8924250,An efficient method for the rescue and analysis of functional HIV-1 env genes: evidence for recombination in the vicinity of the tat/rev splice site,"Douglas,N.W., Knight,A.I., Hayhurst,A., Barrett,W.Y., Kevany,M.J. and Daniels,R.S.",1996
U36880,B,,8924250,An efficient method for the rescue and analysis of functional HIV-1 env genes: evidence for recombination in the vicinity of the tat/rev splice site,"Douglas,N.W., Knight,A.I., Hayhurst,A., Barrett,W.Y., Kevany,M.J. and Daniels,R.S.",1996
U36882,B,,8924250,An efficient method for the rescue and analysis of functional HIV-1 env genes: evidence for recombination in the vicinity of the tat/rev splice site,"Douglas,N.W., Knight,A.I., Hayhurst,A., Barrett,W.Y., Kevany,M.J. and Daniels,R.S.",1996
U39233,C,1991,8744585,"env gene sequences of primary HIV type 1 isolates of subtypes B, C, D, E, and F obtained from the World Health Organization Network for HIV Isolation and Characterization","Penny,M.A., Thomas,S.J., Douglas,N.W., Ranjbar,S., Holmes,H. and Daniels,R.S.",1996
U39234,C,1991,8744585,"env gene sequences of primary HIV type 1 isolates of subtypes B, C, D, E, and F obtained from the World Health Organization Network for HIV Isolation and Characterization","Penny,M.A., Thomas,S.J., Douglas,N.W., Ranjbar,S., Holmes,H. and Daniels,R.S.",1996
U39237,C,1991,8744585,"env gene sequences of primary HIV type 1 isolates of subtypes B, C, D, E, and F obtained from the World Health Organization Network for HIV Isolation and Characterization","Penny,M.A., Thomas,S.J., Douglas,N.W., Ranjbar,S., Holmes,H. and Daniels,R.S.",1996
U39239,C,1991,8744585,"env gene sequences of primary HIV type 1 isolates of subtypes B, C, D, E, and F obtained from the World Health Organization Network for HIV Isolation and Characterization","Penny,M.A., Thomas,S.J., Douglas,N.W., Ranjbar,S., Holmes,H. and Daniels,R.S.",1996
U39240,C,1991,8744585,"env gene sequences of primary HIV type 1 isolates of subtypes B, C, D, E, and F obtained from the World Health Organization Network for HIV Isolation and Characterization","Penny,M.A., Thomas,S.J., Douglas,N.W., Ranjbar,S., Holmes,H. and Daniels,R.S.",1996
U39241,C,1991,8744585,"env gene sequences of primary HIV type 1 isolates of subtypes B, C, D, E, and F obtained from the World Health Organization Network for HIV Isolation and Characterization","Penny,M.A., Thomas,S.J., Douglas,N.W., Ranjbar,S., Holmes,H. and Daniels,R.S.",1996
U39244,C,1991,8744585,"env gene sequences of primary HIV type 1 isolates of subtypes B, C, D, E, and F obtained from the World Health Organization Network for HIV Isolation and Characterization","Penny,M.A., Thomas,S.J., Douglas,N.W., Ranjbar,S., Holmes,H. and Daniels,R.S.",1996
U39245,C,1991,8744585,"env gene sequences of primary HIV type 1 isolates of subtypes B, C, D, E, and F obtained from the World Health Organization Network for HIV Isolation and Characterization","Penny,M.A., Thomas,S.J., Douglas,N.W., Ranjbar,S., Holmes,H. and Daniels,R.S.",1996
U39250,C,1991,8744585,"env gene sequences of primary HIV type 1 isolates of subtypes B, C, D, E, and F obtained from the World Health Organization Network for HIV Isolation and Characterization","Penny,M.A., Thomas,S.J., Douglas,N.W., Ranjbar,S., Holmes,H. and Daniels,R.S.",1996
U39253,CD,1991,8744585,"env gene sequences of primary HIV type 1 isolates of subtypes B, C, D, E, and F obtained from the World Health Organization Network for HIV Isolation and Characterization","Penny,M.A., Thomas,S.J., Douglas,N.W., Ranjbar,S., Holmes,H. and Daniels,R.S.",1996
U39255,01_AE,1992,8744585,"env gene sequences of primary HIV type 1 isolates of subtypes B, C, D, E, and F obtained from the World Health Organization Network for HIV Isolation and Characterization","Penny,M.A., Thomas,S.J., Douglas,N.W., Ranjbar,S., Holmes,H. and Daniels,R.S.",1996
U39258,B,1993,8744585,"env gene sequences of primary HIV type 1 isolates of subtypes B, C, D, E, and F obtained from the World Health Organization Network for HIV Isolation and Characterization","Penny,M.A., Thomas,S.J., Douglas,N.W., Ranjbar,S., Holmes,H. and Daniels,R.S.",1996
U39362,B,1989,7853514,V3-independent determinants of macrophage tropism in a primary human immunodeficiency virus type 1 isolate,"Kim,F.M., Kolson,D.L., Balliet,J.W., Srinivasan,A. and Collman,R.G.",1995
U43096,B,1986,1457208,Analysis of the envelope region of the highly divergent HIV-2ALT isolate extends the known range of variability within the primate immunodeficiency viruses,"Kreutz,R., Dietrich,U., Kuhnel,H., Nieselt-Struwe,K., Eigen,M. and Rubsamen-Waigmann,H.",1992
U43141,B,1986,2364020,Molecular cloning and characterization of a German HIV-1 isolate,"Sauermann,U., Schneider,J., Mous,J., Brunckhorst,U., Schedel,I., Jentsch,K.D. and Hunsmann,G.",1990
U46016,C,1986,8891112,Full-length sequence of an ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C,"Salminen,M.O., Johansson,B., Sonnerborg,A., Ayehunie,S., Gotte,D., Leinikki,P., Burke,D.S. and McCutchan,F.E.",1996
U51188,01_AE,1990,8794346,The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin,"Gao,F., Robertson,D.L., Morrison,S.G., Hui,H., Craig,S., Decker,J., Fultz,P.N., Girard,M., Shaw,G.M., Hahn,B.H. and Sharp,P.M.",1996
U51189,01_AE,1993,8794346,The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin,"Gao,F., Robertson,D.L., Morrison,S.G., Hui,H., Craig,S., Decker,J., Fultz,P.N., Girard,M., Shaw,G.M., Hahn,B.H. and Sharp,P.M.",1996
U65075,D,1987,,Genetic variability of human immunodeficiency virus type 1 in rural Northwest Tanzania,"Robbins,K.E., Bandea,C.I., Levin,A., Goedert,J.J., Blattner,W.A., Brubaker,G., Brown,T.M., Schochetman,G., Kalish,M.L., Shao,J. and O'Brien,T.R.",1996
U69584,B,1985,11679152,Analysis of transition from long-term nonprogressive to progressive infection identifies sequences that may attenuate HIV type 1,"Fang,G., Burger,H., Chappey,C., Rowland-Jones,S., Visosky,A., Chen,C.H., Moran,T., Townsend,L., Murray,M. and Weiser,B.",2001
U71182,B,,9491920,Cloning and characterization of a virtually full-length HIV type 1 genome from a subtype B'-Thai strain representing the most prevalent B-clade isolate in China,"Graf,M., Shao,Y., Zhao,Q., Seidl,T., Kostler,J., Wolf,H. and Wagner,R.",1998
U79720,B,1992,7474069,Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG,"Trkola,A., Pomales,A.B., Yuan,H., Korber,B., Maddon,P.J., Allaway,G.P., Katinger,H., Barbas,C.F. III, Burton,D.R., Ho,D.D. and  et al.",1995
U79722,B,,7884929,Sequence diversity of V1 and V2 domains of gp120 from human immunodeficiency virus type 1: lack of correlation with viral phenotype,"Wang,N., Zhu,T. and Ho,D.D.",1995
U82990,O,,9264286,Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea,"Hunt,J.C., Golden,A.M., Lund,J.K., Gurtler,L.G., Zekeng,L., Obiang,J., Kaptue,L., Hampl,H., Vallari,A. and Devare,S.G.",1997
U82991,O,,9264286,Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea,"Hunt,J.C., Golden,A.M., Lund,J.K., Gurtler,L.G., Zekeng,L., Obiang,J., Kaptue,L., Hampl,H., Vallari,A. and Devare,S.G.",1997
U82992,O,,9264286,Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea,"Hunt,J.C., Golden,A.M., Lund,J.K., Gurtler,L.G., Zekeng,L., Obiang,J., Kaptue,L., Hampl,H., Vallari,A. and Devare,S.G.",1997
U82993,O,,9264286,Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea,"Hunt,J.C., Golden,A.M., Lund,J.K., Gurtler,L.G., Zekeng,L., Obiang,J., Kaptue,L., Hampl,H., Vallari,A. and Devare,S.G.",1997
U84794,B,1994,9445059,Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines,"Connor,R.I., Korber,B.T.M., Graham,B.S., Hahn,B.H., Ho,D.D., Walker,B.D., Neumann,A.U., Vermund,S.H., Mestecky,J., Jackson,S., Fenamore,E., Cao,Y., Gao,F., Kalams,S., Kunstman,K.J., McDonald,D., McWilliams,N., Trkola,A., Moore,J.P. and Wolinsky,S.M.",1998
U84795,B,1994,9445059,Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines,"Connor,R.I., Korber,B.T.M., Graham,B.S., Hahn,B.H., Ho,D.D., Walker,B.D., Neumann,A.U., Vermund,S.H., Mestecky,J., Jackson,S., Fenamore,E., Cao,Y., Gao,F., Kalams,S., Kunstman,K.J., McDonald,D., McWilliams,N., Trkola,A., Moore,J.P. and Wolinsky,S.M.",1998
U84799,B,1994,9445059,Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines,"Connor,R.I., Korber,B.T.M., Graham,B.S., Hahn,B.H., Ho,D.D., Walker,B.D., Neumann,A.U., Vermund,S.H., Mestecky,J., Jackson,S., Fenamore,E., Cao,Y., Gao,F., Kalams,S., Kunstman,K.J., McDonald,D., McWilliams,N., Trkola,A., Moore,J.P. and Wolinsky,S.M.",1998
U84800,B,1995,9445059,Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines,"Connor,R.I., Korber,B.T.M., Graham,B.S., Hahn,B.H., Ho,D.D., Walker,B.D., Neumann,A.U., Vermund,S.H., Mestecky,J., Jackson,S., Fenamore,E., Cao,Y., Gao,F., Kalams,S., Kunstman,K.J., McDonald,D., McWilliams,N., Trkola,A., Moore,J.P. and Wolinsky,S.M.",1998
U84806,B,1995,9445059,Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines,"Connor,R.I., Korber,B.T.M., Graham,B.S., Hahn,B.H., Ho,D.D., Walker,B.D., Neumann,A.U., Vermund,S.H., Mestecky,J., Jackson,S., Fenamore,E., Cao,Y., Gao,F., Kalams,S., Kunstman,K.J., McDonald,D., McWilliams,N., Trkola,A., Moore,J.P. and Wolinsky,S.M.",1998
U84811,B,1994,9445059,Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines,"Connor,R.I., Korber,B.T.M., Graham,B.S., Hahn,B.H., Ho,D.D., Walker,B.D., Neumann,A.U., Vermund,S.H., Mestecky,J., Jackson,S., Fenamore,E., Cao,Y., Gao,F., Kalams,S., Kunstman,K.J., McDonald,D., McWilliams,N., Trkola,A., Moore,J.P. and Wolinsky,S.M.",1998
U84814,B,1995,9445059,Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines,"Connor,R.I., Korber,B.T.M., Graham,B.S., Hahn,B.H., Ho,D.D., Walker,B.D., Neumann,A.U., Vermund,S.H., Mestecky,J., Jackson,S., Fenamore,E., Cao,Y., Gao,F., Kalams,S., Kunstman,K.J., McDonald,D., McWilliams,N., Trkola,A., Moore,J.P. and Wolinsky,S.M.",1998
U84817,B,1996,9445059,Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines,"Connor,R.I., Korber,B.T.M., Graham,B.S., Hahn,B.H., Ho,D.D., Walker,B.D., Neumann,A.U., Vermund,S.H., Mestecky,J., Jackson,S., Fenamore,E., Cao,Y., Gao,F., Kalams,S., Kunstman,K.J., McDonald,D., McWilliams,N., Trkola,A., Moore,J.P. and Wolinsky,S.M.",1998
U84819,B,1996,9445059,Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines,"Connor,R.I., Korber,B.T.M., Graham,B.S., Hahn,B.H., Ho,D.D., Walker,B.D., Neumann,A.U., Vermund,S.H., Mestecky,J., Jackson,S., Fenamore,E., Cao,Y., Gao,F., Kalams,S., Kunstman,K.J., McDonald,D., McWilliams,N., Trkola,A., Moore,J.P. and Wolinsky,S.M.",1998
U84821,B,1995,9445059,Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines,"Connor,R.I., Korber,B.T.M., Graham,B.S., Hahn,B.H., Ho,D.D., Walker,B.D., Neumann,A.U., Vermund,S.H., Mestecky,J., Jackson,S., Fenamore,E., Cao,Y., Gao,F., Kalams,S., Kunstman,K.J., McDonald,D., McWilliams,N., Trkola,A., Moore,J.P. and Wolinsky,S.M.",1998
U84823,B,1994,9445059,Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines,"Connor,R.I., Korber,B.T.M., Graham,B.S., Hahn,B.H., Ho,D.D., Walker,B.D., Neumann,A.U., Vermund,S.H., Mestecky,J., Jackson,S., Fenamore,E., Cao,Y., Gao,F., Kalams,S., Kunstman,K.J., McDonald,D., McWilliams,N., Trkola,A., Moore,J.P. and Wolinsky,S.M.",1998
U84827,B,1994,9445059,Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines,"Connor,R.I., Korber,B.T.M., Graham,B.S., Hahn,B.H., Ho,D.D., Walker,B.D., Neumann,A.U., Vermund,S.H., Mestecky,J., Jackson,S., Fenamore,E., Cao,Y., Gao,F., Kalams,S., Kunstman,K.J., McDonald,D., McWilliams,N., Trkola,A., Moore,J.P. and Wolinsky,S.M.",1998
U84831,B,1994,9445059,Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines,"Connor,R.I., Korber,B.T.M., Graham,B.S., Hahn,B.H., Ho,D.D., Walker,B.D., Neumann,A.U., Vermund,S.H., Mestecky,J., Jackson,S., Fenamore,E., Cao,Y., Gao,F., Kalams,S., Kunstman,K.J., McDonald,D., McWilliams,N., Trkola,A., Moore,J.P. and Wolinsky,S.M.",1998
U84833,B,1994,9445059,Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines,"Connor,R.I., Korber,B.T.M., Graham,B.S., Hahn,B.H., Ho,D.D., Walker,B.D., Neumann,A.U., Vermund,S.H., Mestecky,J., Jackson,S., Fenamore,E., Cao,Y., Gao,F., Kalams,S., Kunstman,K.J., McDonald,D., McWilliams,N., Trkola,A., Moore,J.P. and Wolinsky,S.M.",1998
U84840,B,1995,9445059,Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines,"Connor,R.I., Korber,B.T.M., Graham,B.S., Hahn,B.H., Ho,D.D., Walker,B.D., Neumann,A.U., Vermund,S.H., Mestecky,J., Jackson,S., Fenamore,E., Cao,Y., Gao,F., Kalams,S., Kunstman,K.J., McDonald,D., McWilliams,N., Trkola,A., Moore,J.P. and Wolinsky,S.M.",1998
U84841,B,1995,9445059,Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines,"Connor,R.I., Korber,B.T.M., Graham,B.S., Hahn,B.H., Ho,D.D., Walker,B.D., Neumann,A.U., Vermund,S.H., Mestecky,J., Jackson,S., Fenamore,E., Cao,Y., Gao,F., Kalams,S., Kunstman,K.J., McDonald,D., McWilliams,N., Trkola,A., Moore,J.P. and Wolinsky,S.M.",1998
U84848,B,1996,9445059,Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines,"Connor,R.I., Korber,B.T.M., Graham,B.S., Hahn,B.H., Ho,D.D., Walker,B.D., Neumann,A.U., Vermund,S.H., Mestecky,J., Jackson,S., Fenamore,E., Cao,Y., Gao,F., Kalams,S., Kunstman,K.J., McDonald,D., McWilliams,N., Trkola,A., Moore,J.P. and Wolinsky,S.M.",1998
U84850,B,1997,9445059,Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines,"Connor,R.I., Korber,B.T.M., Graham,B.S., Hahn,B.H., Ho,D.D., Walker,B.D., Neumann,A.U., Vermund,S.H., Mestecky,J., Jackson,S., Fenamore,E., Cao,Y., Gao,F., Kalams,S., Kunstman,K.J., McDonald,D., McWilliams,N., Trkola,A., Moore,J.P. and Wolinsky,S.M.",1998
U84854,B,1997,9445059,Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines,"Connor,R.I., Korber,B.T.M., Graham,B.S., Hahn,B.H., Ho,D.D., Walker,B.D., Neumann,A.U., Vermund,S.H., Mestecky,J., Jackson,S., Fenamore,E., Cao,Y., Gao,F., Kalams,S., Kunstman,K.J., McDonald,D., McWilliams,N., Trkola,A., Moore,J.P. and Wolinsky,S.M.",1998
U84857,B,1997,9445059,Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines,"Connor,R.I., Korber,B.T.M., Graham,B.S., Hahn,B.H., Ho,D.D., Walker,B.D., Neumann,A.U., Vermund,S.H., Mestecky,J., Jackson,S., Fenamore,E., Cao,Y., Gao,F., Kalams,S., Kunstman,K.J., McDonald,D., McWilliams,N., Trkola,A., Moore,J.P. and Wolinsky,S.M.",1998
U84884,B,1995,9445059,Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines,"Connor,R.I., Korber,B.T.M., Graham,B.S., Hahn,B.H., Ho,D.D., Walker,B.D., Neumann,A.U., Vermund,S.H., Mestecky,J., Jackson,S., Fenamore,E., Cao,Y., Gao,F., Kalams,S., Kunstman,K.J., McDonald,D., McWilliams,N., Trkola,A., Moore,J.P. and Wolinsky,S.M.",1998
U84886,B,1996,9445059,Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines,"Connor,R.I., Korber,B.T.M., Graham,B.S., Hahn,B.H., Ho,D.D., Walker,B.D., Neumann,A.U., Vermund,S.H., Mestecky,J., Jackson,S., Fenamore,E., Cao,Y., Gao,F., Kalams,S., Kunstman,K.J., McDonald,D., McWilliams,N., Trkola,A., Moore,J.P. and Wolinsky,S.M.",1998
U85912,AF,1995,9557756,Molecular evidence for nosocomial transmission of human immunodeficiency virus from a surgeon to one of his patients,"Blanchard,A., Ferris,S., Chamaret,S., Guetard,D. and Montagnier,L.",1998
U85918,AF,1996,9557756,Molecular evidence for nosocomial transmission of human immunodeficiency virus from a surgeon to one of his patients,"Blanchard,A., Ferris,S., Chamaret,S., Guetard,D. and Montagnier,L.",1998
U86778,A2C,1989,9060617,Evolution and probable transmission of intersubtype recombinant human immunodeficiency virus type 1 in a Zambian couple,"Salminen,M.O., Carr,J.K., Robertson,D.L., Hegerich,P., Gotte,D., Koch,C., Sanders-Buell,E., Gao,F., Sharp,P.M., Hahn,B.H., Burke,D.S. and McCutchan,F.E.",1997
U88822,D,1984,9621027,A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1,"Gao,F., Robertson,D.L., Carruthers,C.D., Morrison,S.G., Jian,B., Chen,Y., Barre-Sinoussi,F., Girard,M., Srinivasan,A., Abimiku,A.G., Shaw,G.M., Sharp,P.M. and Hahn,B.H.",1998
U88825,AG,1992,9621027,A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1,"Gao,F., Robertson,D.L., Carruthers,C.D., Morrison,S.G., Jian,B., Chen,Y., Barre-Sinoussi,F., Girard,M., Srinivasan,A., Abimiku,A.G., Shaw,G.M., Sharp,P.M. and Hahn,B.H.",1998
U88826,G,1992,9621027,A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1,"Gao,F., Robertson,D.L., Carruthers,C.D., Morrison,S.G., Jian,B., Chen,Y., Barre-Sinoussi,F., Girard,M., Srinivasan,A., Abimiku,A.G., Shaw,G.M., Sharp,P.M. and Hahn,B.H.",1998
U90932,B,1984,,hypermutated Proviral sequences of the Human Immunodeficiency Virus Type 1 (HIV-1) Arising in vivo Show Evidence of Subsequent Replication and Recombination,"McCutchan,F.E., Sanders-Buell,E. and Sheppard,H.W.",
X61351,B,,1736940,Distinct populations of human immunodeficiency virus type 1 in blood and cerebrospinal fluid,"Steuler,H., Storch-Hagenlocher,B. and Wildemann,B.",1992
X61353,B,,1736940,Distinct populations of human immunodeficiency virus type 1 in blood and cerebrospinal fluid,"Steuler,H., Storch-Hagenlocher,B. and Wildemann,B.",1992
X61355,B,,1736940,Distinct populations of human immunodeficiency virus type 1 in blood and cerebrospinal fluid,"Steuler,H., Storch-Hagenlocher,B. and Wildemann,B.",1992
X61357,B,,1736940,Distinct populations of human immunodeficiency virus type 1 in blood and cerebrospinal fluid,"Steuler,H., Storch-Hagenlocher,B. and Wildemann,B.",1992
X61359,B,,1736940,Distinct populations of human immunodeficiency virus type 1 in blood and cerebrospinal fluid,"Steuler,H., Storch-Hagenlocher,B. and Wildemann,B.",1992
X96522,O,,10207543,Interpatient genetic variability of HIV-1 group O,"Janssens,W., Heyndrickx,L., Van der Auwera,G., Nkengasong,J., Beirnaert,E., Vereecken,K., Coppens,S., Willems,B., Fransen,K., Peeters,M., Ndumbe,P., Delaporte,E. and van der Groen,G.",1999
X96526,O,,8828748,"Epidemiological and molecular characteristics of HIV infection in Gabon, 1986-1994","Delaporte,E., Janssens,W., Peeters,M., Buve,A., Dibanga,G., Perret,J.L., Ditsambou,V., Mba,J.R., Courbot,M.C., Georges,A., Bourgeois,A., Samb,B., Henzel,D., Heyndrickx,L., Fransen,K., van der Groen,G. and Larouze,B.",1996
Y13717,A1,,9367752,HIV/SIV glycoproteins: structure-function relationships,"Douglas,N.W., Munro,G.H. and Daniels,R.S.",1997
Y13718,A1,,9367752,HIV/SIV glycoproteins: structure-function relationships,"Douglas,N.W., Munro,G.H. and Daniels,R.S.",1997
Y13719,B,,9367752,HIV/SIV glycoproteins: structure-function relationships,"Douglas,N.W., Munro,G.H. and Daniels,R.S.",1997
